{
  "category": "Anatomic Pathology",
  "subject": {
    "name": "General Topics",
    "url": "https://app.pathprimer.com/curriculum/39cf9e61-2591-4407-a612-8f18b8abe473",
    "lessons": {
      "Cell Adaptation, Injury, and Death": {
        "name": "Cell Adaptation, Injury, and Death",
        "url": "https://app.pathprimer.com/lesson/63ed988e-12c5-487a-8a64-944068749545",
        "topics": {
          "Hypertrophic Cardiomyopathy": {
            "name": "Hypertrophic Cardiomyopathy",
            "url": "https://app.pathprimer.com/document/8344e36b-f5d4-4264-b431-81b29c6fc0e6/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Autosomal dominant mutations in genes encoding protein components of sarcomere and its constituent myofibrillar proteins"
                  },
                  {
                    "text": "70% have mutations in 2 genes, β-myosin heavy chain (MYH7) and myosin binding protein C (MYBPC3)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "~ 0.2% (i.e., 1:500) in general population"
                  },
                  {
                    "text": "Palpitations, exertional dyspnea, atrial fibrillation, and sudden cardiac death"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Hypertrophy of left ventricle, asymmetrical or symmetrical"
                  },
                  {
                    "text": "Classical: Asymmetrical septal hypertrophy (septum: Free wall thickness ratio > 1.3)"
                  },
                  {
                    "text": "Systolic anterior motion of mitral valve and subaortic endocardial fibrosis"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Diffuse myocyte hypertrophy"
                  },
                  {
                    "text": "Myocyte disarray and myocytes with bizarre, disorganized myofibrillary architecture"
                  },
                  {
                    "text": "Bizarre myocyte nuclei with nuclear enlargement, pleomorphism, and hyperchromatism"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Physiologic athlete's heart"
                  },
                  {
                    "text": "Hypertensive heart disease"
                  },
                  {
                    "text": "Storage disease"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Hypertrophic cardiomyopathy (HCM)"
                  },
                  {
                    "text": "Hypertrophic obstructive cardiomyopathy (HOCM)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Asymmetric (septal) hypertrophy, hypertrophic (muscular) subaortic stenosis, obstructive cardiomyopathy"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Common inherited cardiovascular disease characterized by left &/or right ventricular hypertrophy, usually asymmetric, involving the interventricular septum, causing impaired ventricle relaxation"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Genetics": [
                  {
                    "text": "Autosomal dominant mutations in genes encoding protein components of the sarcomere and its constituent myofibrillar proteins"
                  },
                  {
                    "text": "70% have mutations in either β-myosin heavy chain (MYH7) or myosin binding protein C (MYBPC3)"
                  },
                  {
                    "text": "Troponin T (TNNT2) and several other genes each account for ≤ 5% of cases"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "~ 0.2% (1:500) in general population"
                  }
                ],
                "Age": [
                  {
                    "text": "Can present at any age (including coincidentally at autopsy in elderly)"
                  }
                ],
                "Gender": [
                  {
                    "text": "Is either under recognized or clinical diagnosis delayed, more frequently in women"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Is either under recognized or clinical diagnosis delayed, more frequently in African Americans"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Syncopal attacks, palpitations, exertional dyspnea, chest pain, atrial fibrillation, sudden cardiac death"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Endovascular alcohol septal ablation"
                  },
                  {
                    "text": "Implantable cardiac defibrillator (ICD)"
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Surgical septal myectomy"
                  }
                ],
                "Drugs": [
                  {
                    "text": "β-blocker, angiotensin-converting enzyme inhibitors, angiotensin receptor blocker"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Most patients of HCM are asymptomatic"
                  },
                  {
                    "text": "Mortality rates have ranged from < 1% to 3-6%"
                  },
                  {
                    "text": "1st manifestation may be sudden cardiac death due to ventricular fibrillationYounger patients, particularly children, have a much higher mortality rate",
                    "sub_points": [
                      "Younger patients, particularly children, have a much higher mortality rate"
                    ]
                  }
                ]
              },
              "Image Findings": {
                "EKG": [
                  {
                    "text": "Ventricular hypertrophy, ventricular tachycardia"
                  }
                ],
                "Echocardiography": [
                  {
                    "text": "Assess morphology of left ventricular hypertrophy, diastolic dysfunction"
                  },
                  {
                    "text": "Dynamic left ventricular outflow obstruction (systolic anterior motion [SAM] of anterior mitral leaflet)"
                  }
                ],
                "Stress Test": [
                  {
                    "text": "Assessment of functional capacity and response to therapy"
                  }
                ],
                "Cardiac Magnetic Resonance": [
                  {
                    "text": "Magnitude of hypertrophy and anatomy of mitral valve"
                  },
                  {
                    "text": "Ruling out sarcoidosis, amyloidosis, etc."
                  }
                ],
                "Coronary Arteriography": [
                  {
                    "text": "Rule out concomitant coronary artery disease"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Hypertrophy of left ventricleClassical: Asymmetrical septal hypertrophy (septum: Free wall thickness ratio > 1.3)Thickening of basal anterior septumSymmetrical hypertrophic form accounts for 42%Dilated or burned-out phase accounting for 10% of casesRare variants: Midventricular, apical patterns",
                    "sub_points": [
                      "Classical: Asymmetrical septal hypertrophy (septum: Free wall thickness ratio > 1.3)",
                      "Thickening of basal anterior septum",
                      "Symmetrical hypertrophic form accounts for 42%",
                      "Dilated or burned-out phase accounting for 10% of cases",
                      "Rare variants: Midventricular, apical patterns"
                    ]
                  },
                  {
                    "text": "Subaortic endocardial fibrosis (\"mitral contact lesion\")"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Myocyte hypertrophy, size > 40 μm (normal: 15 μm)"
                  },
                  {
                    "text": "Myocyte disarray (> 20% of myocardium in ≥ 2 tissue blocks)"
                  },
                  {
                    "text": "Myocytes with bizarre disorganized myofibrillary architecture"
                  },
                  {
                    "text": "Bizarre myocyte nuclei, nuclear enlargement, pleomorphism, and hyperchromatism"
                  },
                  {
                    "text": "Interstitial and replacement fibrosis"
                  },
                  {
                    "text": "Intramural coronary arteries show medial hypertrophy and luminal narrowing"
                  }
                ]
              },
              "Ancillary Tests": {
                "Molecular Genetics": [
                  {
                    "text": "DNA sequencing for identification of mutations"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Physiologic Athlete's Heart": [
                  {
                    "text": "Mild symmetric left ventricular hypertrophy"
                  },
                  {
                    "text": "Absence of familial distribution"
                  },
                  {
                    "text": "Absence of myocyte disarray"
                  }
                ],
                "Hypertensive Heart Disease": [
                  {
                    "text": "Characteristically older age group"
                  },
                  {
                    "text": "Do not have familial distribution"
                  },
                  {
                    "text": "Absence of  myocyte disarray"
                  }
                ],
                "Fabry Disease": [
                  {
                    "text": "Deficiency of lysosomal α-galactosidase AHistologically, involved cells are vacuolated with cardiac myocytes having a lace-like appearanceDeposits stain positive with toluidine blue, PAS, or Sudan black B and are birefringentUltrastructurally, presence of numerous intralysosomal deposits of concentric lamellar bodies",
                    "sub_points": [
                      "Histologically, involved cells are vacuolated with cardiac myocytes having a lace-like appearance",
                      "Deposits stain positive with toluidine blue, PAS, or Sudan black B and are birefringent",
                      "Ultrastructurally, presence of numerous intralysosomal deposits of concentric lamellar bodies"
                    ]
                  }
                ],
                "Pompe Disease": [
                  {
                    "text": "Deficiency of lysosomal acid α-1,4-glucosidaseHistologically, vacuolization of myocytes with storage of structurally normal glycogenUltrastructurally, increased glycogen both free in cytoplasm membrane bound lysosomes",
                    "sub_points": [
                      "Histologically, vacuolization of myocytes with storage of structurally normal glycogen",
                      "Ultrastructurally, increased glycogen both free in cytoplasm membrane bound lysosomes"
                    ]
                  }
                ],
                "LAMP2; Danon Disease": [
                  {
                    "text": "X-linked lysosomal-associated membrane proteinMild interstitial fibrosis and vacuolated cardiac myocytes containing glycogenUltrastructural examination reveals free and membrane-bound lysosomal glycogen",
                    "sub_points": [
                      "Mild interstitial fibrosis and vacuolated cardiac myocytes containing glycogen",
                      "Ultrastructural examination reveals free and membrane-bound lysosomal glycogen"
                    ]
                  }
                ],
                "Sigmoid Septal Curvature": [
                  {
                    "text": "Prominent subaortic bulge due to \"S\" curvature of septum in elderly"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hypertrophy of Pancreatic Islets": {
            "name": "Hypertrophy of Pancreatic Islets",
            "url": "https://app.pathprimer.com/document/884cbcc7-f798-488f-a709-92a73d6664a6/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Increase in size (hypertrophy) and number (hyperplasia) of pancreatic islets"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Infant of diabetic mother is by far the most common cause"
                  },
                  {
                    "text": "Severe unremitting hypoglycemia in infants"
                  },
                  {
                    "text": "Beckwith-Wiedemann syndrome"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Islet hypertrophy in infants > 2 months of age is defined as > 10% of islets being > 200 μm in diameter"
                  },
                  {
                    "text": "Eosinophilic insulitis is pathognomonic for infants of diabetic mothers"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Normal pancreas"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "NesidioblastosisNot a true synonym but widely used that way",
                    "sub_points": [
                      "Not a true synonym but widely used that way"
                    ]
                  },
                  {
                    "text": "Hyperinsulinemic hypoglycemiaClinical presentation associated with pancreatic islet hypertrophy",
                    "sub_points": [
                      "Clinical presentation associated with pancreatic islet hypertrophy"
                    ]
                  }
                ],
                "Definitions": [
                  {
                    "text": "Increase in size (hypertrophy) and number (hyperplasia) of pancreatic islets"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Associated Conditions": [
                  {
                    "text": "Infant of diabetic mother (IDM)By far most common causeCan be seen in maternal prediabetes (insulin resistance)Glucose crosses placenta while insulin does notFetal hyperglycemia results in increased β cells within islets",
                    "sub_points": [
                      "By far most common cause",
                      "Can be seen in maternal prediabetes (insulin resistance)",
                      "Glucose crosses placenta while insulin does notFetal hyperglycemia results in increased β cells within islets",
                      "Fetal hyperglycemia results in increased β cells within islets"
                    ]
                  },
                  {
                    "text": "NesidioblastosisSevere unremitting hypoglycemia in infants",
                    "sub_points": [
                      "Severe unremitting hypoglycemia in infants"
                    ]
                  },
                  {
                    "text": "Beckwith-Wiedemann syndrome"
                  },
                  {
                    "text": "Erythroblastosis fetalis"
                  },
                  {
                    "text": "Zellweger syndrome"
                  },
                  {
                    "text": "Donohue syndrome"
                  },
                  {
                    "text": "Tyrosinemia"
                  },
                  {
                    "text": "Cyanotic congenital heart disease"
                  },
                  {
                    "text": "Total parenteral nutrition"
                  },
                  {
                    "text": "Multiple endocrine neoplasia, type 1"
                  },
                  {
                    "text": "Type 2 diabetes mellitus"
                  }
                ]
              },
              "Clinical Issues": {
                "Presentation": [
                  {
                    "text": "Hyperinsulinemic hypoglycemiaOther signs/symptoms may point to specific etiology",
                    "sub_points": [
                      "Other signs/symptoms may point to specific etiology"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Medical support of hypoglycemiaIn IDMs, hypoglycemia can last up to a week after delivery",
                    "sub_points": [
                      "In IDMs, hypoglycemia can last up to a week after delivery"
                    ]
                  },
                  {
                    "text": "Subtotal or total pancreatectomy in rare cases"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on cause"
                  }
                ]
              },
              "Image Findings": {
                "General Features": [
                  {
                    "text": "Used only to assess other organs and make specific diagnosis"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Generally, normal gross appearance"
                  },
                  {
                    "text": "In Beckwith-Wiedemann, pancreas may be large"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Increase in size (hypertrophy) and number (hyperplasia) of islets"
                  },
                  {
                    "text": "Islet hypertrophy in infants > 2 months of age is defined as > 10% of islets being > 200 μm in diameter"
                  },
                  {
                    "text": "IDMIslets are mostly β cellsMost noticeable after 34 weeks gestation &/or in large-for-gestation fetuses/infantsIslets can reach up to 500 μm in diameterCan have nuclear enlargement and pleomorphismEosinophilic insulitis is pathognomonic for IDMTriad of increased size and number of islets, islets surrounded by fibrosis, and eosinophilic infiltrate",
                    "sub_points": [
                      "Islets are mostly β cells",
                      "Most noticeable after 34 weeks gestation &/or in large-for-gestation fetuses/infants",
                      "Islets can reach up to 500 μm in diameter",
                      "Can have nuclear enlargement and pleomorphism",
                      "Eosinophilic insulitis is pathognomonic for IDMTriad of increased size and number of islets, islets surrounded by fibrosis, and eosinophilic infiltrate",
                      "Triad of increased size and number of islets, islets surrounded by fibrosis, and eosinophilic infiltrate"
                    ]
                  },
                  {
                    "text": "NesidioblastosisHypertrophic isletsAtypical β cells with nuclear enlargement and pleomorphismDuctoinsular complexesIslets have irregular contours (not round or well circumscribed)",
                    "sub_points": [
                      "Hypertrophic islets",
                      "Atypical β cells with nuclear enlargement and pleomorphism",
                      "Ductoinsular complexes",
                      "Islets have irregular contours (not round or well circumscribed)"
                    ]
                  },
                  {
                    "text": "Beckwith-WiedemannExaggerated nesidioblastosis",
                    "sub_points": [
                      "Exaggerated nesidioblastosis"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Normal Pancreas": [
                  {
                    "text": "Islets in fetal and neonatal pancreas are more prominent than in later life"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Focal Nodular Hyperplasia": {
            "name": "Focal Nodular Hyperplasia",
            "url": "https://app.pathprimer.com/document/5a76f666-39b0-4069-a95c-5de0e291689e/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign tumor-like lesion of liver caused by hyperplastic response to localized vascular abnormality"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Mostly incidental finding on imaging studies, most common in women"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Unencapsulated, well-circumscribed lesion with bulging cut surfaceNoncirrhotic background liver",
                    "sub_points": [
                      "Noncirrhotic background liver"
                    ]
                  },
                  {
                    "text": "Central stellate scar with radiating septa"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Localized nodular parenchyma with fibrous septa and stellate central scarSepta contain thick-walled vessels and mononuclear inflammatory infiltrate",
                    "sub_points": [
                      "Septa contain thick-walled vessels and mononuclear inflammatory infiltrate"
                    ]
                  },
                  {
                    "text": "Ductular reaction at junction between septa and parenchyma"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Glutamine synthetase: Characteristic map-like pattern, with sparing of areas around scar and fibrous septa"
                  },
                  {
                    "text": "SAA is typically negative; focal staining in few case"
                  },
                  {
                    "text": "CRP staining typically restricted to periseptal areas"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Hepatocellular adenoma"
                  },
                  {
                    "text": "Cirrhosis"
                  },
                  {
                    "text": "Hepatocellular carcinoma"
                  },
                  {
                    "text": "Nodular regenerative hyperplasia"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Focal nodular hyperplasia (FNH)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Focal cirrhosis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Benign tumor-like lesion of liver caused by hyperplastic response to localized vascular abnormality"
                  },
                  {
                    "text": "Most lesions formerly labeled as telangiectatic FNH are thought to be inflammatory hepatocellular adenomas"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Localized Abnormal Blood Flow": [
                  {
                    "text": "Exact mechanism unclear"
                  },
                  {
                    "text": "Hepatocytes polyclonal, unlike hepatocytic adenomas"
                  },
                  {
                    "text": "Steroids are not thought to play role"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Mostly incidental finding on imaging studies"
                  },
                  {
                    "text": "More common in women"
                  },
                  {
                    "text": "Normal liver biochemical tests"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Reserved for large and symptomatic lesions"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Benign lesion"
                  },
                  {
                    "text": "Rupture and bleeding in rare cases"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Brightly, homogeneously enhancing mass in arterial phase CT or MR with delayed enhancement of central scar"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Unencapsulated, well-circumscribed lesionApproximately 20% are multiple",
                    "sub_points": [
                      "Approximately 20% are multiple"
                    ]
                  },
                  {
                    "text": "Firm to rubbery cut surface that bulges from surface of liver"
                  },
                  {
                    "text": "Central stellate scar with radiating septa"
                  },
                  {
                    "text": "Noncirrhotic background liver"
                  }
                ],
                "Size": [
                  {
                    "text": "Most < 5 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Hyperplastic hepatocytes arranged into plates 2 cells thickSubdivided into nodules by fibrous septaIntact reticulin framework",
                    "sub_points": [
                      "Subdivided into nodules by fibrous septa",
                      "Intact reticulin framework"
                    ]
                  },
                  {
                    "text": "Classic triadFibrous septa, usually with large central stellate scarScar contains numerous thick-walled arteriesArteries often show eccentric thickeningDuctular reaction (not true ducts) at junction between septa and parenchymaMononuclear inflammatory infiltrate in fibrous septa",
                    "sub_points": [
                      "Fibrous septa, usually with large central stellate scarScar contains numerous thick-walled arteriesArteries often show eccentric thickening",
                      "Scar contains numerous thick-walled arteries",
                      "Arteries often show eccentric thickening",
                      "Ductular reaction (not true ducts) at junction between septa and parenchyma",
                      "Mononuclear inflammatory infiltrate in fibrous septa"
                    ]
                  },
                  {
                    "text": "Focal sinusoidal dilatation may be present"
                  },
                  {
                    "text": "Periseptal hepatocytes may show positive copper staining due to cholestasis"
                  },
                  {
                    "text": "Reticulin architecture is intact, but widened plates and focal loss can be seen at the periphery"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Bland hepatocytes"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Glutamine synthetase (GS): Characteristic map-like pattern, with sparing of areas around the scar and fibrous septa"
                  },
                  {
                    "text": "CK7: Highlights ductular reaction, typically negative in lesional hepatocytes"
                  },
                  {
                    "text": "CD34: Patchy sinusoidal staining, can be variably diffuse"
                  },
                  {
                    "text": "Serum amyloid A (SAA): Typically negative, focally positive in few cases"
                  },
                  {
                    "text": "C-reactive protein: Negative or staining restricted to periseptal areas"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Inflammatory Hepatocellular Adenoma": [
                  {
                    "text": "Histologic features overlap with FNH"
                  },
                  {
                    "text": "Naked unpaired arteries in parenchyma, sinusoidal dilatation, and lesional steatosis more common in adenoma"
                  },
                  {
                    "text": "Ductular reaction, fibrous septa, and thick-walled arteries are more common in FNH"
                  },
                  {
                    "text": "Diffuse immunoreactivity for serum amyloid A (SAA) and C-reactive protein (CRP) in most cases"
                  },
                  {
                    "text": "Map-like GS staining not seen"
                  }
                ],
                "Cirrhosis": [
                  {
                    "text": "Diffuse liver involvement by nodules surrounded by fibrous septa"
                  },
                  {
                    "text": "Ductular reaction and inflammation may be present in fibrous septa"
                  },
                  {
                    "text": "Bile ducts present except in ductopenic chronic biliary disease"
                  },
                  {
                    "text": "Lack of thick-walled arteries"
                  },
                  {
                    "text": "Often underlying liver disease"
                  }
                ],
                "Hepatocellular Carcinoma": [
                  {
                    "text": "Architectural changes like thick cell plates and frequent pseudoacinar structures"
                  },
                  {
                    "text": "Cytologic atypia variable but often present"
                  },
                  {
                    "text": "Ductular reaction not present in tumor"
                  },
                  {
                    "text": "Loss of reticulin network"
                  },
                  {
                    "text": "Positive staining for glypican-3, heat shock protein 70 (HSP70) &/or diffuse glutamine synthetase can be helpful"
                  }
                ],
                "Nodular Regenerative Hyperplasia": [
                  {
                    "text": "Nodularity is typically diffuse"
                  },
                  {
                    "text": "By definition, fibrous septa are not present"
                  }
                ],
                "FNH-Like Lesion": [
                  {
                    "text": "Histologic features indistinguishable from FNH"
                  },
                  {
                    "text": "Associated with other disease processesVascular abnormalities like cavernous hemangioma and Osler-Weber-Rendu disease (hereditary hemorrhagic telangiectasia)Adjacent to other tumors, primary or metastaticOccurrence in cirrhotic liver",
                    "sub_points": [
                      "Vascular abnormalities like cavernous hemangioma and Osler-Weber-Rendu disease (hereditary hemorrhagic telangiectasia)",
                      "Adjacent to other tumors, primary or metastatic",
                      "Occurrence in cirrhotic liver"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Nodular liver parenchyma with fibrous septa containing thick-walled arteries at periphery, bile ductular reaction, and mixed mononuclear inflammation"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Reactive Follicular Hyperplasia": {
            "name": "Reactive Follicular Hyperplasia",
            "url": "https://app.pathprimer.com/document/30e5dcad-3817-46dc-9b4a-77c4b0193d01/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign, reversible process characterized by hyperplastic follicles with secondary germinal centers"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Enlarged lymph nodes, localized or widespread"
                  },
                  {
                    "text": "± systemic symptoms: Fever, fatigue, weight loss"
                  },
                  {
                    "text": "Age and duration are important clues for etiology"
                  },
                  {
                    "text": "Lymph node size, location, and consistency can suggest likely etiologic agent"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Numerous enlarged follicles, varying in size and shape, with occasional coalescence of follicles"
                  },
                  {
                    "text": "Reactive follicles have central germinal centers and peripheral, sharply demarcated mantle zones"
                  },
                  {
                    "text": "Germinal centers include predominantly centrocytes and centroblasts, few T lymphocytes and scattered histiocytes"
                  },
                  {
                    "text": "Germinal centers: Usually organized into dark and light zones (a.k.a. polarization)"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Germinal center and mantle zone B cells express polytypic Igs and pan-B markers"
                  },
                  {
                    "text": "Germinal center centrocytes and centroblasts are CD10(+), Bcl-6(+), and Bcl-2(-)"
                  },
                  {
                    "text": "PolyclonalIGHgene rearrangements"
                  },
                  {
                    "text": "No evidence of t(14;18)(q32;q21) orIGH-BCL2fusion sequences"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Follicular lymphoma"
                  },
                  {
                    "text": "Atypical follicular hyperplasia"
                  },
                  {
                    "text": "Progressive transformation of germinal centers"
                  },
                  {
                    "text": "Nodular lymphocyte predominant Hodgkin lymphoma"
                  },
                  {
                    "text": "Lymphocyte-rich classic Hodgkin lymphoma, nodular variant"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Reactive follicular hyperplasia (RFH)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Follicular hyperplasia"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Benign, reversible process characterized by hyperplastic lymphoid folliclesPredominance of hyperplastic follicles with prominent germinal centers (so-called secondary follicles)Hyperplastic follicles may be part of mixed reactive pattern",
                    "sub_points": [
                      "Predominance of hyperplastic follicles with prominent germinal centers (so-called secondary follicles)Hyperplastic follicles may be part of mixed reactive pattern",
                      "Hyperplastic follicles may be part of mixed reactive pattern"
                    ]
                  },
                  {
                    "text": "Characteristic of humoral immune reaction involving stimulation and proliferation of B cells"
                  },
                  {
                    "text": "Usually involves lymph nodes but can affect extranodal sites"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Variety of drugs, chemicals, and environmental pollutants can cause RFH"
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "Most common cause of RFH is bacterial infectionViruses such as HIV and EBV are also causes",
                    "sub_points": [
                      "Viruses such as HIV and EBV are also causes"
                    ]
                  }
                ],
                "Others": [
                  {
                    "text": "Autoimmune diseases"
                  },
                  {
                    "text": "In many cases, etiology of RFH cannot be identified"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Patients typically present with enlarged lymph nodes, either localized or generalizedSystemic symptoms, such as fever, fatigue, and weight loss may be presentLaboratory abnormalities may be detectedLeukocytosis, neutrophilia, or lymphocytosis suggest infection",
                    "sub_points": [
                      "Systemic symptoms, such as fever, fatigue, and weight loss may be present",
                      "Laboratory abnormalities may be detectedLeukocytosis, neutrophilia, or lymphocytosis suggest infection",
                      "Leukocytosis, neutrophilia, or lymphocytosis suggest infection"
                    ]
                  },
                  {
                    "text": "Lymph node size is importantSmall, shotty lymph nodes in asymptomatic patients are, as a rule, clinically irrelevantIn general, lymph nodes ≥ 1 cm in diameter are abnormalFor epitrochlear, significant size is > 0.5 cm and for inguinal is > 1.5 cm",
                    "sub_points": [
                      "Small, shotty lymph nodes in asymptomatic patients are, as a rule, clinically irrelevant",
                      "In general, lymph nodes ≥ 1 cm in diameter are abnormalFor epitrochlear, significant size is > 0.5 cm and for inguinal is > 1.5 cm",
                      "For epitrochlear, significant size is > 0.5 cm and for inguinal is > 1.5 cm"
                    ]
                  },
                  {
                    "text": "Painful lymph nodes are more often related to inflammation or hemorrhage"
                  },
                  {
                    "text": "Lymphadenopathy for > 1 month may be of clinical significance"
                  },
                  {
                    "text": "Location can suggest the underlying diseaseCervical: Infectious mononucleosisPosterior cervical: ToxoplasmosisParotid, submaxillary, epitrochlear: HIV infectionCervical and axillary: Cat-scratch diseaseInguinal: Sexually transmitted diseasesSupraclavicular: Malignancy, particularly in older patients",
                    "sub_points": [
                      "Cervical: Infectious mononucleosis",
                      "Posterior cervical: Toxoplasmosis",
                      "Parotid, submaxillary, epitrochlear: HIV infection",
                      "Cervical and axillary: Cat-scratch disease",
                      "Inguinal: Sexually transmitted diseases",
                      "Supraclavicular: Malignancy, particularly in older patients"
                    ]
                  },
                  {
                    "text": "ConsistencySoft: InflammatoryFluctuant: Suppurative infection (often bacterial or fungal)Matted: Tuberculosis, lymphogranuloma venereum, cancerFirm to hard: Malignancy, including lymphoma or metastatic carcinoma",
                    "sub_points": [
                      "Soft: Inflammatory",
                      "Fluctuant: Suppurative infection (often bacterial or fungal)",
                      "Matted: Tuberculosis, lymphogranuloma venereum, cancer",
                      "Firm to hard: Malignancy, including lymphoma or metastatic carcinoma"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Localized lymph node enlargement in absence of other symptoms requires follow-upPersistent lymphadenopathy > 3 or 4 weeks, requires additional investigation",
                    "sub_points": [
                      "Persistent lymphadenopathy > 3 or 4 weeks, requires additional investigation"
                    ]
                  },
                  {
                    "text": "Generalized lymphadenopathy usually requires investigation for etiology"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Benign, reversible process with no impact on patient survival"
                  },
                  {
                    "text": "Can be associated with other diseases such as autoimmune disease or malignancy"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Numerous enlarged follicles, varying in size and shape, with occasional coalescenceIn lymph nodes, reactive follicles usually prominent in cortex, with lesser involvement of medullaIn spleen, reactive follicles are located in white pulp",
                    "sub_points": [
                      "In lymph nodes, reactive follicles usually prominent in cortex, with lesser involvement of medulla",
                      "In spleen, reactive follicles are located in white pulp"
                    ]
                  },
                  {
                    "text": "Reactive follicles have central germinal centers and peripheral, sharply demarcated mantle zones"
                  },
                  {
                    "text": "Germinal centers cell compositionB lineage: Predominance of centrocytes and centroblastsImmunoblasts and plasma cells less commonT lymphocytes: Predominantly follicular T-helper cellsHistiocytes and follicular dendritic cells (FDC)",
                    "sub_points": [
                      "B lineage: Predominance of centrocytes and centroblastsImmunoblasts and plasma cells less common",
                      "Immunoblasts and plasma cells less common",
                      "T lymphocytes: Predominantly follicular T-helper cells",
                      "Histiocytes and follicular dendritic cells (FDC)"
                    ]
                  },
                  {
                    "text": "Centroblasts3-4x size of small lymphocytes; 1-3 peripheral nucleoliLarge vesicular nuclei, frequent mitoses, and rim of cytoplasm",
                    "sub_points": [
                      "3-4x size of small lymphocytes; 1-3 peripheral nucleoli",
                      "Large vesicular nuclei, frequent mitoses, and rim of cytoplasm"
                    ]
                  },
                  {
                    "text": "CentrocytesSmall- to intermediate-sized cells with cleaved, hyperchromatic nuclei, with small or absent nucleolusRare mitoses, and scant cytoplasm",
                    "sub_points": [
                      "Small- to intermediate-sized cells with cleaved, hyperchromatic nuclei, with small or absent nucleolus",
                      "Rare mitoses, and scant cytoplasm"
                    ]
                  },
                  {
                    "text": "T lymphocytesSmall, round, hyperchromatic lymphocytesUsually smaller and more uniform than small centrocytesCan be highlighted with CD3 immunohistochemistryT helper cells (Tfh) are CD4(+), CD10(+)Tfh cells also Bcl-6(+), CXCL13(+), PD1/CD279(+)T cytotoxic subset are CD8 (+)",
                    "sub_points": [
                      "Small, round, hyperchromatic lymphocytes",
                      "Usually smaller and more uniform than small centrocytes",
                      "Can be highlighted with CD3 immunohistochemistryT helper cells (Tfh) are CD4(+), CD10(+)Tfh cells also Bcl-6(+), CXCL13(+), PD1/CD279(+)T cytotoxic subset are CD8 (+)",
                      "T helper cells (Tfh) are CD4(+), CD10(+)Tfh cells also Bcl-6(+), CXCL13(+), PD1/CD279(+)",
                      "Tfh cells also Bcl-6(+), CXCL13(+), PD1/CD279(+)",
                      "T cytotoxic subset are CD8 (+)"
                    ]
                  },
                  {
                    "text": "Follicular dendritic cellsFew (~ 1%) have 2 square-shaped adjacent nucleiVesicular chromatin; may display small nucleolusHave long cytoplasmic processes that can be highlighted by CD21, CD23, or CD35 immunohistochemistry",
                    "sub_points": [
                      "Few (~ 1%) have 2 square-shaped adjacent nucleiVesicular chromatin; may display small nucleolus",
                      "Vesicular chromatin; may display small nucleolus",
                      "Have long cytoplasmic processes that can be highlighted by CD21, CD23, or CD35 immunohistochemistry"
                    ]
                  },
                  {
                    "text": "HistiocytesDisplay oval or twisted vesicular nuclei; faint or pink cytoplasmSubset has abundant pale cytoplasm with karyorrhectic nucleiSo-called tingible-body macrophages and impart a starry-sky pattern when prominentHistiocytes are highlighted with CD68 or CD163",
                    "sub_points": [
                      "Display oval or twisted vesicular nuclei; faint or pink cytoplasm",
                      "Subset has abundant pale cytoplasm with karyorrhectic nucleiSo-called tingible-body macrophages and impart a starry-sky pattern when prominent",
                      "So-called tingible-body macrophages and impart a starry-sky pattern when prominent",
                      "Histiocytes are highlighted with CD68 or CD163"
                    ]
                  },
                  {
                    "text": "Germinal centers: Usually organized into dark and light zones (a.k.a. polarization)Dark zone contains many centroblasts and mitotic figuresLymphocyte proliferation and somatic hypermutation ofIGHgene occur in dark zoneLight zone contains predominantly centrocytes and follicular dendritic cellsCentrocytes represent later stage of maturationInteract with T cells and FDCs",
                    "sub_points": [
                      "Dark zone contains many centroblasts and mitotic figures",
                      "Lymphocyte proliferation and somatic hypermutation ofIGHgene occur in dark zone",
                      "Light zone contains predominantly centrocytes and follicular dendritic cells",
                      "Centrocytes represent later stage of maturation",
                      "Interact with T cells and FDCs"
                    ]
                  },
                  {
                    "text": "Mantle zones: Composed of concentric layers of small naive (not antigen-exposed) B lymphocytes"
                  },
                  {
                    "text": "In some cases, microorganisms can be detectedCommon histochemical stains to detect microorganismsAcid-fast stain, periodic acid-Schiff, Gomori methenamine silver, Gram, and Warthin-StarryImmunohistochemical reagents can also be helpful according to suspected organisms",
                    "sub_points": [
                      "Common histochemical stains to detect microorganismsAcid-fast stain, periodic acid-Schiff, Gomori methenamine silver, Gram, and Warthin-Starry",
                      "Acid-fast stain, periodic acid-Schiff, Gomori methenamine silver, Gram, and Warthin-Starry",
                      "Immunohistochemical reagents can also be helpful according to suspected organisms"
                    ]
                  }
                ],
                "Predominant Pattern/Injury Type": [
                  {
                    "text": "Lymphoid, follicular"
                  }
                ],
                "Predominant Cell/Compartment Type": [
                  {
                    "text": "Lymphadenopathy"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Germinal center and mantle zone B cells express pan-B-cell antigens and polytypic immunoglobulins"
                  },
                  {
                    "text": "Centrocytes and centroblasts are CD10(+), Bcl-6(+), and Bcl-2(-)"
                  }
                ],
                "Flow Cytometry": [
                  {
                    "text": "Polytypic B cells; CD10(+), CD23(+/-), T-cell antigens (-)"
                  }
                ],
                "PCR": [
                  {
                    "text": "No monoclonal immunoglobulin heavy chain gene rearrangement by PCR"
                  },
                  {
                    "text": "No evidence of t(14;18)(q32;q21) orIGH-BCL2fusion sequences"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Rare cases of florid hyperplasia with numeric or structural abnormalities need to be better defined"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Follicular Lymphoma": [
                  {
                    "text": "Lymph node typically replaced by numerous folliclesMinimal variation of size and shapes, commonly closely packed (\"back to back\")",
                    "sub_points": [
                      "Minimal variation of size and shapes, commonly closely packed (\"back to back\")"
                    ]
                  },
                  {
                    "text": "Relatively monomorphous population of germinal center cells"
                  },
                  {
                    "text": "Neoplastic follicles often lack mantle zones"
                  },
                  {
                    "text": "Few or no tingible-body macrophages"
                  },
                  {
                    "text": "Few mitoses and low proliferation rate (Ki-67) as opposed to RFH"
                  },
                  {
                    "text": "Neoplastic follicles commonly invade lymph node capsule or extend into perinodal tissues"
                  },
                  {
                    "text": "Immunophenotyping is very helpfulFollicular lymphoma (FL) cells usually express monotypic surface Ig and Bcl-2Some cases of FL lack surface Ig; this is aberrant and supports lymphomaDiagnosis more challenging with pediatric follicular lymphoma since Bcl-2(-)",
                    "sub_points": [
                      "Follicular lymphoma (FL) cells usually express monotypic surface Ig and Bcl-2",
                      "Some cases of FL lack surface Ig; this is aberrant and supports lymphoma",
                      "Diagnosis more challenging with pediatric follicular lymphoma since Bcl-2(-)"
                    ]
                  },
                  {
                    "text": "Molecular or cytogenetic studies are also helpful for FL diagnosisMost cases of FL carry monoclonalIGHgene rearrangementst(14;18)(q32;q21) orIGH-BCL2fusion sequences present in 80-90% of FL",
                    "sub_points": [
                      "Most cases of FL carry monoclonalIGHgene rearrangements",
                      "t(14;18)(q32;q21) orIGH-BCL2fusion sequences present in 80-90% of FL"
                    ]
                  }
                ],
                "Atypical Follicular Hyperplasia": [
                  {
                    "text": "Term used for follicular lesions having some histologic features suggestive of FL"
                  },
                  {
                    "text": "Diagnosis is now uncommon with advent of immunophenotypic and molecular methodsProblem often attributable to lack of fresh tissue for ancillary studies",
                    "sub_points": [
                      "Problem often attributable to lack of fresh tissue for ancillary studies"
                    ]
                  },
                  {
                    "text": "Patients require further testing and close clinical follow-up"
                  }
                ],
                "Progressive Transformation of Germinal Centers": [
                  {
                    "text": "Typically associated with RFH"
                  },
                  {
                    "text": "Nodules with diameters that are 3-4x larger than reactive follicles"
                  },
                  {
                    "text": "Most lymphocytes in nodules are small, round to oval, and hyperchromatic"
                  },
                  {
                    "text": "Remnant centrocytes and centroblasts may be foundReactive centrocytes & centroblasts are Bcl-6(+)/Bcl-2(-)Small round lymphocytes are Bcl-6(-)/Bcl-2(+)",
                    "sub_points": [
                      "Reactive centrocytes & centroblasts are Bcl-6(+)/Bcl-2(-)",
                      "Small round lymphocytes are Bcl-6(-)/Bcl-2(+)"
                    ]
                  }
                ],
                "Nodular Lymphocyte Predominant Hodgkin Lymphoma": [
                  {
                    "text": "Nodules are typically much larger than reactive folliclesPredominance of small lymphocytes, which are mostly reactive B cellsScattered large lymphocyte predominant (LP) cellsLP cells are CD20(+), CD45(+), Bcl-2(-)",
                    "sub_points": [
                      "Predominance of small lymphocytes, which are mostly reactive B cells",
                      "Scattered large lymphocyte predominant (LP) cellsLP cells are CD20(+), CD45(+), Bcl-2(-)",
                      "LP cells are CD20(+), CD45(+), Bcl-2(-)"
                    ]
                  },
                  {
                    "text": "CD57(+) T cells are increased in nodules; T cells can form rosettes around LP cells"
                  }
                ],
                "Lymphocyte-Rich Classic Hodgkin Lymphoma": [
                  {
                    "text": "Nodular variant can closely resemble nodular LP Hodgkin lymphoma"
                  },
                  {
                    "text": "Hodgkin cells found in expanded mantle zones or interfollicular regions"
                  },
                  {
                    "text": "Neoplastic cells are CD15(+), CD30(+), CD20(-/+), pax-5(+), and CD45(-)"
                  },
                  {
                    "text": "Small reactive germinal centers can often be observed within neoplastic nodules"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Pituitary Hyperplasia": {
            "name": "Pituitary Hyperplasia",
            "url": "https://app.pathprimer.com/document/69c725fd-76c2-428d-8629-9cc4849a0ccd/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Nonneoplastic increase in adenohypophysial cell number"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Most commonProlactin cell hyperplasia in pregnancy",
                    "sub_points": [
                      "Prolactin cell hyperplasia in pregnancy"
                    ]
                  },
                  {
                    "text": "Physiologic response to end-organ failure"
                  },
                  {
                    "text": "Pathologic hyperplasia associated with ectopic excess of releasing hormones"
                  },
                  {
                    "text": "Syndromic"
                  },
                  {
                    "text": "Idiopathic"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "TreatmentCorrect underlying endocrinologic cause",
                    "sub_points": [
                      "Correct underlying endocrinologic cause"
                    ]
                  }
                ],
                "Imaging": [
                  {
                    "text": "Symmetric pituitary enlargement"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Diffuse hyperplasiaIncrease in pituitary cellsNever truly monomorphic histology",
                    "sub_points": [
                      "Increase in pituitary cells",
                      "Never truly monomorphic histology"
                    ]
                  },
                  {
                    "text": "Nodular hyperplasiaIndistinct demarcationLacks compressive effects",
                    "sub_points": [
                      "Indistinct demarcation",
                      "Lacks compressive effects"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "ReticulinHighlights acinar expansion",
                    "sub_points": [
                      "Highlights acinar expansion"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Normal adenohypophysisReticulin stains highlight normal-sized acini",
                    "sub_points": [
                      "Reticulin stains highlight normal-sized acini"
                    ]
                  },
                  {
                    "text": "Pituitary adenomaUsually larger mass, histologicallyGreater disruption of reticulin network",
                    "sub_points": [
                      "Usually larger mass, histologicallyGreater disruption of reticulin network",
                      "Greater disruption of reticulin network"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Nonneoplastic increase in adenohypophysial cell number"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Pathobiology": [
                  {
                    "text": "Physiologic response to end-organ failureProlactin (PRL) cell hyperplasia during pregnancy, lactation, or estrogen treatmentACTH cell hyperplasia due to hypocortisolism in Addison diseaseTSH cell hyperplasia with longstanding primary hypothyroidismGonadotroph hyperplasia in primary hypogonadism due to Klinefelter or Turner syndrome",
                    "sub_points": [
                      "Prolactin (PRL) cell hyperplasia during pregnancy, lactation, or estrogen treatment",
                      "ACTH cell hyperplasia due to hypocortisolism in Addison disease",
                      "TSH cell hyperplasia with longstanding primary hypothyroidism",
                      "Gonadotroph hyperplasia in primary hypogonadism due to Klinefelter or Turner syndrome"
                    ]
                  },
                  {
                    "text": "Pathologic hyperplasia associated with ectopic excess of releasing hormonesGrowth hormone (GH) cell hyperplasiaDue to increased GH-releasing hormone secreted by pancreatic islet cell tumor, pheochromocytoma, bronchial and thymic carcinoid tumorACTH cell hyperplasiaSecondary to corticotropin-releasing hormone secretion from hypothalamic hamartoma or neuroendocrine tumors",
                    "sub_points": [
                      "Growth hormone (GH) cell hyperplasiaDue to increased GH-releasing hormone secreted by pancreatic islet cell tumor, pheochromocytoma, bronchial and thymic carcinoid tumor",
                      "Due to increased GH-releasing hormone secreted by pancreatic islet cell tumor, pheochromocytoma, bronchial and thymic carcinoid tumor",
                      "ACTH cell hyperplasiaSecondary to corticotropin-releasing hormone secretion from hypothalamic hamartoma or neuroendocrine tumors",
                      "Secondary to corticotropin-releasing hormone secretion from hypothalamic hamartoma or neuroendocrine tumors"
                    ]
                  },
                  {
                    "text": "Syndromic: Mammosomatotroph hyperplasia in McCune-Albright syndrome, Carney complex"
                  },
                  {
                    "text": "Idiopathic"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare, except for PRL cell hyperplasia in pregnancy"
                  },
                  {
                    "text": "Most medically curable, no surgical specimen expected"
                  }
                ],
                "Age": [
                  {
                    "text": "Generally young adults"
                  }
                ],
                "Sex": [
                  {
                    "text": "PRL cell hyperplasia of pregnancy in women"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Hormone-related hyperplasiaGH cell: Gigantism or acromegalyPRL cell: HyperprolactinemiaACTH cell: Cushing diseaseTSH cell: HyperprolactinemiaIn hypothyroidism, associated with PRL cell hyperplasiaLH-FSH: Result of early-onset hypogonadism; may cause pituitary enlargement",
                    "sub_points": [
                      "GH cell: Gigantism or acromegaly",
                      "PRL cell: Hyperprolactinemia",
                      "ACTH cell: Cushing disease",
                      "TSH cell: HyperprolactinemiaIn hypothyroidism, associated with PRL cell hyperplasia",
                      "In hypothyroidism, associated with PRL cell hyperplasia",
                      "LH-FSH: Result of early-onset hypogonadism; may cause pituitary enlargement"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Correct underlying endocrinologic cause"
                  },
                  {
                    "text": "Surgical approachesGH, ACTH hyperplasia: Resect hypothalamic-releasing hormone-producing tumors",
                    "sub_points": [
                      "GH, ACTH hyperplasia: Resect hypothalamic-releasing hormone-producing tumors"
                    ]
                  },
                  {
                    "text": "Adjuvant therapyTSH hyperplasia: Medical treatment of hypothyroidism",
                    "sub_points": [
                      "TSH hyperplasia: Medical treatment of hypothyroidism"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent with medical treatment"
                  },
                  {
                    "text": "Rare association with adenoma formation"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "No sellar destruction"
                  }
                ],
                "Size": [
                  {
                    "text": "Symmetric 2-3x pituitary enlargement on CT/MR"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Nodular or diffuseNodularity result of acinar expansionRelative cellular monomorphism in affected aciniNoncompressive; indistinct demarcationDifficult to diagnose in fragmented specimensDiffuseNumerical increase in pituitary cells without alteration in architecture",
                    "sub_points": [
                      "Nodularity result of acinar expansionRelative cellular monomorphism in affected aciniNoncompressive; indistinct demarcationDifficult to diagnose in fragmented specimens",
                      "Relative cellular monomorphism in affected acini",
                      "Noncompressive; indistinct demarcation",
                      "Difficult to diagnose in fragmented specimens",
                      "DiffuseNumerical increase in pituitary cells without alteration in architecture",
                      "Numerical increase in pituitary cells without alteration in architecture"
                    ]
                  },
                  {
                    "text": "Mitoses rare"
                  },
                  {
                    "text": "Cytological compositionGH cell hyperplasia: Chromophobic to eosinophilic polygonal cellsPRL cell hyperplasia: Chromophobic with occasional microcalcificationsACTH cell hyperplasia: Amphophilic with very large vacuole (lysosome); variable surrounding Crooke cell changeTSH cell hyperplasia: Chromophobic, often elongated cells with multiple large PAS+ lysosomesLH-FSH hyperplasia: Hypervacuolization (castration cells)",
                    "sub_points": [
                      "GH cell hyperplasia: Chromophobic to eosinophilic polygonal cells",
                      "PRL cell hyperplasia: Chromophobic with occasional microcalcifications",
                      "ACTH cell hyperplasia: Amphophilic with very large vacuole (lysosome); variable surrounding Crooke cell change",
                      "TSH cell hyperplasia: Chromophobic, often elongated cells with multiple large PAS+ lysosomes",
                      "LH-FSH hyperplasia: Hypervacuolization (castration cells)"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Reticulin: Highlights acinar expansion; PAS: Stains lysosomes in TSH hyperplasia"
                  },
                  {
                    "text": "PAS: Stains lysosomes in TSH hyperplasia"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Cytoplasmic reactivity for respective hormones"
                  },
                  {
                    "text": "Ki-67 labeling index low level but increased over nearly immunonegative normal gland"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "No application in routine diagnosis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Normal Adenohypophysis": [
                  {
                    "text": "Heterogeneous cell populations of normal acini; reticulin stains highlight normal acini"
                  },
                  {
                    "text": "ACTH cells that are aggregated in normal way in lateral wings of anterior pituitary or as normal basophil invasion may mimic hyperplasia"
                  }
                ],
                "Pituitary Adenoma": [
                  {
                    "text": "Larger, compresses adjacent normal acini, greater disruption of reticulin network"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Parathyroid Hyperplasia": {
            "name": "Parathyroid Hyperplasia",
            "url": "https://app.pathprimer.com/document/b33fa60b-e214-489b-be60-c0a49be7519a/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Nonneoplastic increase in parenchymal cell mass of multiple parathyroid glands in absence of known clinical stimulus for increased secretion of parathyroid hormone (PTH)"
                  },
                  {
                    "text": "Parathyroid hyperplasia includesChief cell hyperplasiaWater-clear cell hyperplasia",
                    "sub_points": [
                      "Chief cell hyperplasia",
                      "Water-clear cell hyperplasia"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Sporadic cases represent 80% of patients with primary chief cell hyperplasia"
                  },
                  {
                    "text": "~ 20% of patients with primary chief cell hyperplasia have multiple endocrine neoplasia (MEN)Association most frequent in MEN type 1 (Wermer syndrome)90% have parathyroid hyperplasiaParathyroid proliferative disease seen in 30-40% of patients with MEN 2A (Sipple syndrome)",
                    "sub_points": [
                      "Association most frequent in MEN type 1 (Wermer syndrome)90% have parathyroid hyperplasia",
                      "90% have parathyroid hyperplasia",
                      "Parathyroid proliferative disease seen in 30-40% of patients with MEN 2A (Sipple syndrome)"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Chief cell hyperplasia is most common type of hyperplasia causing hyperparathyroidism (HPT)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Increase in parenchymal cell mass (diffuse or nodular)﻿"
                  },
                  {
                    "text": "Primary chief cell hyperplasiaComposed of polyhedral cells with round, centrally located nuclei, coarse chromatin, and eosinophilic to amphophilic to clear cytoplasmOncocytic cells may be presentCharacterized by striking eosinophilic granular cytoplasmStromal fat cells absent or markedly decreased in most areasMitotic figures may be seenUsually < 1 per 10 HPF",
                    "sub_points": [
                      "Composed of polyhedral cells with round, centrally located nuclei, coarse chromatin, and eosinophilic to amphophilic to clear cytoplasm",
                      "Oncocytic cells may be presentCharacterized by striking eosinophilic granular cytoplasm",
                      "Characterized by striking eosinophilic granular cytoplasm",
                      "Stromal fat cells absent or markedly decreased in most areas",
                      "Mitotic figures may be seenUsually < 1 per 10 HPF",
                      "Usually < 1 per 10 HPF"
                    ]
                  },
                  {
                    "text": "Water-clear cell hyperplasiaComposed of cells with clear cytoplasm",
                    "sub_points": [
                      "Composed of cells with clear cytoplasm"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Wasserhelle cell hyperplasia (for water-clear cell hyperplasia)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Nonneoplastic increase in parenchymal cell mass of multiple parathyroid glands in absence of known clinical stimulus for increased secretion of parathyroid hormone (PTH)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Idiopathic": [
                  {
                    "text": "Sporadic cases represent 80% of patients with primary chief cell hyperplasia"
                  }
                ],
                "Familial": [
                  {
                    "text": "20% have familial diseaseUsually associated with one of multiple endocrine neoplasia (MEN) syndromesMay occur in familial parathyroid hyperplasia without other endocrine abnormalities",
                    "sub_points": [
                      "Usually associated with one of multiple endocrine neoplasia (MEN) syndromes",
                      "May occur in familial parathyroid hyperplasia without other endocrine abnormalities"
                    ]
                  },
                  {
                    "text": "~ 20% of patients with primary chief cell hyperplasia have MENAssociation most frequent in MEN type 1 (Wermer syndrome)Autosomal dominant transmission with variable penetrance90% have parathyroid hyperplasiaLess often associated with parathyroid neoplasms (adenoma and carcinoma)Pancreatic or duodenal endocrine tumors (gastrinoma, insulinoma, glucagonoma)Gastrointestinal endocrine cell hyperplasia or neoplasia (functioning and nonfunctioning)Anterior pituitary adenoma (functioning and nonfunctioning)Some patients also develop pulmonary and thymic neuroendocrine neoplasms, adrenal cortical neoplasms, and thyroid follicular neoplasmsMEN1gene localized on chromosome 11q13Parathyroid proliferative disease (PPD) seen in 30-40% of patients with MEN 2A (Sipple syndrome) but rare in MEN 2BMEN type 2A (Sipple syndrome) characterized by development of bilateral C-cell hyperplasia, medullary thyroid carcinoma, pheochromocytoma, and parathyroid hyperplasia",
                    "sub_points": [
                      "Association most frequent in MEN type 1 (Wermer syndrome)Autosomal dominant transmission with variable penetrance90% have parathyroid hyperplasiaLess often associated with parathyroid neoplasms (adenoma and carcinoma)Pancreatic or duodenal endocrine tumors (gastrinoma, insulinoma, glucagonoma)Gastrointestinal endocrine cell hyperplasia or neoplasia (functioning and nonfunctioning)Anterior pituitary adenoma (functioning and nonfunctioning)Some patients also develop pulmonary and thymic neuroendocrine neoplasms, adrenal cortical neoplasms, and thyroid follicular neoplasmsMEN1gene localized on chromosome 11q13",
                      "Autosomal dominant transmission with variable penetrance",
                      "90% have parathyroid hyperplasia",
                      "Less often associated with parathyroid neoplasms (adenoma and carcinoma)",
                      "Pancreatic or duodenal endocrine tumors (gastrinoma, insulinoma, glucagonoma)",
                      "Gastrointestinal endocrine cell hyperplasia or neoplasia (functioning and nonfunctioning)",
                      "Anterior pituitary adenoma (functioning and nonfunctioning)",
                      "Some patients also develop pulmonary and thymic neuroendocrine neoplasms, adrenal cortical neoplasms, and thyroid follicular neoplasms",
                      "MEN1gene localized on chromosome 11q13",
                      "Parathyroid proliferative disease (PPD) seen in 30-40% of patients with MEN 2A (Sipple syndrome) but rare in MEN 2BMEN type 2A (Sipple syndrome) characterized by development of bilateral C-cell hyperplasia, medullary thyroid carcinoma, pheochromocytoma, and parathyroid hyperplasia",
                      "MEN type 2A (Sipple syndrome) characterized by development of bilateral C-cell hyperplasia, medullary thyroid carcinoma, pheochromocytoma, and parathyroid hyperplasia"
                    ]
                  }
                ],
                "Hyperparathyroidism (HPT)": [
                  {
                    "text": "Represents state of elevated serum PTH as a result of excessive secretion"
                  },
                  {
                    "text": "Divided into primary, secondary, and tertiary"
                  },
                  {
                    "text": "Primary HPTInappropriately increased PTH secretion due to intrinsic abnormality of parathyroid gland(s)Occurs in absence of known stimulus for PTH secretionCauses elevation of serum calcium (hypercalcemia) with decreased serum phosphate (hypophosphatemia)",
                    "sub_points": [
                      "Inappropriately increased PTH secretion due to intrinsic abnormality of parathyroid gland(s)Occurs in absence of known stimulus for PTH secretionCauses elevation of serum calcium (hypercalcemia) with decreased serum phosphate (hypophosphatemia)",
                      "Occurs in absence of known stimulus for PTH secretion",
                      "Causes elevation of serum calcium (hypercalcemia) with decreased serum phosphate (hypophosphatemia)"
                    ]
                  },
                  {
                    "text": "Secondary HPT: Increase in parathyroid parenchymal cell mass of multiple glands in response to known clinical stimulus for increased secretion of PTHUsually characterized by hypocalcemia and hyperphosphatemiaCauses includeChronic renal failure (most common)Dietary vitamin D deficiency or abnormalities of vitamin D metabolismMalabsorptionPseudohypoparathyroidismSymptoms primarily related to PTH-mediated bone resorption, which results inOsteomalacia and osteitis fibrosa cystica",
                    "sub_points": [
                      "Usually characterized by hypocalcemia and hyperphosphatemia",
                      "Causes includeChronic renal failure (most common)Dietary vitamin D deficiency or abnormalities of vitamin D metabolismMalabsorptionPseudohypoparathyroidism",
                      "Chronic renal failure (most common)",
                      "Dietary vitamin D deficiency or abnormalities of vitamin D metabolism",
                      "Malabsorption",
                      "Pseudohypoparathyroidism",
                      "Symptoms primarily related to PTH-mediated bone resorption, which results inOsteomalacia and osteitis fibrosa cystica",
                      "Osteomalacia and osteitis fibrosa cystica"
                    ]
                  },
                  {
                    "text": "Tertiary HPT: Absolute increase in parathyroid parenchymal cell mass associated with autonomous hyperfunctionResults in hypercalcemia in patients with known secondary HPT following implementation of dialysis or renal transplantationHypercalcemia usually develops several years after diagnosis of renal diseaseHypercalcemia due to tertiary HPT represents serious threat to renal grafts and requires prompt surgical therapyLaboratory findings similar to those of primary HPTUsually characterized by hypocalcemia and hyperphosphatemiaCauses of autonomous hyperfunction of parathyroids in patients with treated renal failure are unknownElevation of set point for serum calcium postulatedWould result in stimulation of parathyroid tissue in spite of normal serum calcium levelsEvidence that sheer mass of parathyroid tissue in patients with tertiary HPT may cause autonomous functionRemoval of bulk of hyperplastic tissue results in readily suppressible remnant",
                    "sub_points": [
                      "Results in hypercalcemia in patients with known secondary HPT following implementation of dialysis or renal transplantationHypercalcemia usually develops several years after diagnosis of renal diseaseHypercalcemia due to tertiary HPT represents serious threat to renal grafts and requires prompt surgical therapy",
                      "Hypercalcemia usually develops several years after diagnosis of renal disease",
                      "Hypercalcemia due to tertiary HPT represents serious threat to renal grafts and requires prompt surgical therapy",
                      "Laboratory findings similar to those of primary HPTUsually characterized by hypocalcemia and hyperphosphatemia",
                      "Usually characterized by hypocalcemia and hyperphosphatemia",
                      "Causes of autonomous hyperfunction of parathyroids in patients with treated renal failure are unknownElevation of set point for serum calcium postulatedWould result in stimulation of parathyroid tissue in spite of normal serum calcium levels",
                      "Elevation of set point for serum calcium postulated",
                      "Would result in stimulation of parathyroid tissue in spite of normal serum calcium levels",
                      "Evidence that sheer mass of parathyroid tissue in patients with tertiary HPT may cause autonomous function",
                      "Removal of bulk of hyperplastic tissue results in readily suppressible remnant"
                    ]
                  },
                  {
                    "text": "Parathyroid proliferative disease (PPD)Parathyroid gland histopathologic lesions causing HPT collectively referred to as PPDPPD classification includesParathyroid adenoma causes ~ 85% of HPT casesParathyroid hyperplasia causes ~ 13-15% of HPT casesParathyroid carcinoma causes ~ 1-2% of HPT cases",
                    "sub_points": [
                      "Parathyroid gland histopathologic lesions causing HPT collectively referred to as PPD",
                      "PPD classification includesParathyroid adenoma causes ~ 85% of HPT casesParathyroid hyperplasia causes ~ 13-15% of HPT casesParathyroid carcinoma causes ~ 1-2% of HPT cases",
                      "Parathyroid adenoma causes ~ 85% of HPT cases",
                      "Parathyroid hyperplasia causes ~ 13-15% of HPT cases",
                      "Parathyroid carcinoma causes ~ 1-2% of HPT cases"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Current reported annual incidence of HPT 0.04 per 1,000 persons"
                  }
                ],
                "Age": [
                  {
                    "text": "May occur over wide range (2nd-9th decades); mean: 6th decadeIncidence increases with age",
                    "sub_points": [
                      "Incidence increases with age"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "Female > male (3:1)"
                  }
                ],
                "Site": [
                  {
                    "text": "No specific localization"
                  }
                ],
                "Presentation": [
                  {
                    "text": "HPT secondary to parathyroid hyperplasia may be caused byChief cell hyperplasiaWater-clear cell hyperplasia",
                    "sub_points": [
                      "Chief cell hyperplasia",
                      "Water-clear cell hyperplasia"
                    ]
                  },
                  {
                    "text": "Chief cell hyperplasiaMost common type of hyperplasia causing HPTSymptoms related to level and duration of serum calcium elevationPatients commonly asymptomatic or present with vague complaintse.g., lethargy, weakness, polyuria, polydipsia, arthralgia, constipation, depressionNonspecific presentation encountered more often in past 2 decades due toRoutine biochemical testing resulting overall in increased prevalence in clinically silent casesSigns and symptoms of severe classical primary HPT are uncommon compared to incidence 2-3 decades agoSevere bone disease, once common complication, now rareBone manifestations more commonly seen may includeDiffuse osteopenia ± compression fracturesArticular chondrocalcinosis and other joint disorders (e.g., pseudogout, true gout)Renal manifestations also uncommon, may includeNephrolithiasis: Recurrent and severe; stones composed of calcium phosphateNephrocalcinosis: Presence of bilateral, extensive mineralization in renal pyramids and medullary regions",
                    "sub_points": [
                      "Most common type of hyperplasia causing HPT",
                      "Symptoms related to level and duration of serum calcium elevation",
                      "Patients commonly asymptomatic or present with vague complaintse.g., lethargy, weakness, polyuria, polydipsia, arthralgia, constipation, depression",
                      "e.g., lethargy, weakness, polyuria, polydipsia, arthralgia, constipation, depression",
                      "Nonspecific presentation encountered more often in past 2 decades due toRoutine biochemical testing resulting overall in increased prevalence in clinically silent cases",
                      "Routine biochemical testing resulting overall in increased prevalence in clinically silent cases",
                      "Signs and symptoms of severe classical primary HPT are uncommon compared to incidence 2-3 decades agoSevere bone disease, once common complication, now rare",
                      "Severe bone disease, once common complication, now rare",
                      "Bone manifestations more commonly seen may includeDiffuse osteopenia ± compression fracturesArticular chondrocalcinosis and other joint disorders (e.g., pseudogout, true gout)",
                      "Diffuse osteopenia ± compression fractures",
                      "Articular chondrocalcinosis and other joint disorders (e.g., pseudogout, true gout)",
                      "Renal manifestations also uncommon, may includeNephrolithiasis: Recurrent and severe; stones composed of calcium phosphateNephrocalcinosis: Presence of bilateral, extensive mineralization in renal pyramids and medullary regions",
                      "Nephrolithiasis: Recurrent and severe; stones composed of calcium phosphate",
                      "Nephrocalcinosis: Presence of bilateral, extensive mineralization in renal pyramids and medullary regions"
                    ]
                  },
                  {
                    "text": "Water-clear cell hyperplasiaRare cause of HPTWater-clear cell hyperplasia may represent advanced form of chief cell hyperplasiaNephrolithiasis occurs in 90% of patients (vs. 53% in chief cell hyperplasia patients)Overall incidence of bone disease similar to that of chief cell hyperplasiaOccasional presentation with osteitis fibrosa generalisataNo documented association with MEN or other familial syndromes",
                    "sub_points": [
                      "Rare cause of HPTWater-clear cell hyperplasia may represent advanced form of chief cell hyperplasia",
                      "Water-clear cell hyperplasia may represent advanced form of chief cell hyperplasia",
                      "Nephrolithiasis occurs in 90% of patients (vs. 53% in chief cell hyperplasia patients)",
                      "Overall incidence of bone disease similar to that of chief cell hyperplasiaOccasional presentation with osteitis fibrosa generalisata",
                      "Occasional presentation with osteitis fibrosa generalisata",
                      "No documented association with MEN or other familial syndromes"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated serum calciumMost accurately reflected by serum ionized calcium value",
                    "sub_points": [
                      "Most accurately reflected by serum ionized calcium value"
                    ]
                  },
                  {
                    "text": "Elevated serum PTH levelsNormal serum intact PTH levels 210-310 pg/mLElevations vary depending on type of assay",
                    "sub_points": [
                      "Normal serum intact PTH levels 210-310 pg/mL",
                      "Elevations vary depending on type of assay"
                    ]
                  },
                  {
                    "text": "Decrease in serum inorganic phosphorusResults from increased urinary loss of phosphates induced by action of PTH at renal tubular levelReflected by decreased tubular reabsorption of phosphate or by increased renal phosphate clearanceCorresponding increase in urinary cyclic AMP usually accompanies PTH-induced alterations in urinary phosphate metabolism",
                    "sub_points": [
                      "Results from increased urinary loss of phosphates induced by action of PTH at renal tubular level",
                      "Reflected by decreased tubular reabsorption of phosphate or by increased renal phosphate clearance",
                      "Corresponding increase in urinary cyclic AMP usually accompanies PTH-induced alterations in urinary phosphate metabolism"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Most widely accepted therapy is subtotal parathyroidectomy with complete removal of 3 glands, leaving remnant of 4th"
                  },
                  {
                    "text": "Total parathyroidectomy with autotransplantation of remnants of parathyroid tissue in forearm also common surgical therapyAutotransplantation of parathyroid tissue into forearm musculature following total parathyroidectomy may be associated withGraft failure and hypoparathyroidismRecurrent HPT due to hyperplasia of transplanted remnant of parathyroid",
                    "sub_points": [
                      "Autotransplantation of parathyroid tissue into forearm musculature following total parathyroidectomy may be associated withGraft failure and hypoparathyroidismRecurrent HPT due to hyperplasia of transplanted remnant of parathyroid",
                      "Graft failure and hypoparathyroidism",
                      "Recurrent HPT due to hyperplasia of transplanted remnant of parathyroid"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Recurrence rate of HPT following subtotal parathyroidectomy is ~ 16%Recurrences may not be evident for several yearsRecurrences may be due to inadequate neck exploration, which may result from diagnosis of adenoma in cases of asymmetrical hyperplasia",
                    "sub_points": [
                      "Recurrences may not be evident for several years",
                      "Recurrences may be due to inadequate neck exploration, which may result from diagnosis of adenoma in cases of asymmetrical hyperplasia"
                    ]
                  },
                  {
                    "text": "Less frequent causes of recurrence includeFailure to recognize supernumerary or ectopic glandsParathyromatosisSurgical implantation of hyperplastic tissue in soft tissue of neck",
                    "sub_points": [
                      "Failure to recognize supernumerary or ectopic glands",
                      "Parathyromatosis",
                      "Surgical implantation of hyperplastic tissue in soft tissue of neck"
                    ]
                  },
                  {
                    "text": "Recurrence of HPT common problem in patients with chronic renal failureStimulus for hypersecretion of PTH frequently not correctable",
                    "sub_points": [
                      "Stimulus for hypersecretion of PTH frequently not correctable"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Imaging procedures less effective in localizing glands in hyperplasia as compared to adenomas or carcinomas"
                  },
                  {
                    "text": "Tc-99m sestamibi effective in localizing up to 60% of hyperplastic glandsWidely utilized in recurrent HPT after parathyroid resection",
                    "sub_points": [
                      "Widely utilized in recurrent HPT after parathyroid resection"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Distinction between hyperplastic and adenomatous glands generally not made by gross examGlands with minimal enlargement may be indistinguishable from normal glands",
                    "sub_points": [
                      "Glands with minimal enlargement may be indistinguishable from normal glands"
                    ]
                  },
                  {
                    "text": "All 4 glands may be enlarged butNot uncommon for hyperplasia to be asymmetrical with enlargement of only 1, 2, or 3 glands1 gland may be enlarged, suggesting adenomaEmphasizes need to biopsy grossly \"normal\" glands to facilitate discrimination between hyperplasia and adenoma",
                    "sub_points": [
                      "Not uncommon for hyperplasia to be asymmetrical with enlargement of only 1, 2, or 3 glands",
                      "1 gland may be enlarged, suggesting adenoma",
                      "Emphasizes need to biopsy grossly \"normal\" glands to facilitate discrimination between hyperplasia and adenoma"
                    ]
                  },
                  {
                    "text": "Diffuse or nodular enlargement"
                  },
                  {
                    "text": "Soft, tan-brown"
                  },
                  {
                    "text": "Cystic change may be present but is not common"
                  }
                ],
                "Size": [
                  {
                    "text": "Total gland weight in primary chief cell hyperplasia variable< 1 g in ~ 50%1-5 g in ~ 30%5-10 g in ~ 20%",
                    "sub_points": [
                      "< 1 g in ~ 50%",
                      "1-5 g in ~ 30%",
                      "5-10 g in ~ 20%"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Primary Chief Cell Hyperplasia": [
                  {
                    "text": "Increase in parenchymal cell massPredominantly composed of chief cellsPolyhedral cellsRound, centrally located nuclei with coarse chromatin and well-defined nuclear membraneCytoplasm is eosinophilic to amphophilic to clear and vacuolatedOncocytic cells may be presentCharacterized by striking eosinophilic granular cytoplasmNuclei larger than those in chief cells",
                    "sub_points": [
                      "Predominantly composed of chief cellsPolyhedral cellsRound, centrally located nuclei with coarse chromatin and well-defined nuclear membraneCytoplasm is eosinophilic to amphophilic to clear and vacuolated",
                      "Polyhedral cells",
                      "Round, centrally located nuclei with coarse chromatin and well-defined nuclear membrane",
                      "Cytoplasm is eosinophilic to amphophilic to clear and vacuolated",
                      "Oncocytic cells may be presentCharacterized by striking eosinophilic granular cytoplasmNuclei larger than those in chief cells",
                      "Characterized by striking eosinophilic granular cytoplasm",
                      "Nuclei larger than those in chief cells"
                    ]
                  },
                  {
                    "text": "May be diffuse or nodularArranged in solid sheets, cords, acinar-like or follicular structures, or commonly mixed patterns identifiedVariable nodularity; nodules may be small (micronodular), solitary or multiple",
                    "sub_points": [
                      "Arranged in solid sheets, cords, acinar-like or follicular structures, or commonly mixed patterns identified",
                      "Variable nodularity; nodules may be small (micronodular), solitary or multiple"
                    ]
                  },
                  {
                    "text": "Mitotic figures may be seenUsually < 1 per 10 HPFMay be increased mitotic rates of 1-5 per HPFAtypical mitoses not present",
                    "sub_points": [
                      "Usually < 1 per 10 HPF",
                      "May be increased mitotic rates of 1-5 per HPF",
                      "Atypical mitoses not present"
                    ]
                  },
                  {
                    "text": "Stromal fat cells absent or markedly decreased in most areasAreas with residual fat may simulate appearance of normal glandWhen identified adjacent to large nodules devoid of fat, may suggest diagnosis of adenoma",
                    "sub_points": [
                      "Areas with residual fat may simulate appearance of normal glandWhen identified adjacent to large nodules devoid of fat, may suggest diagnosis of adenoma",
                      "When identified adjacent to large nodules devoid of fat, may suggest diagnosis of adenoma"
                    ]
                  },
                  {
                    "text": "Lipohyperplasia: Term used in cases of hyperplastic glands with abundant fatPresence of fat in this setting makes diagnosis of hyperplasia challengingBiopsies may contain only fat or predominantly fat with limited parenchymal cellsClinical setting and enlargement of multiple glands is of importance in diagnosis of lipohyperplasia",
                    "sub_points": [
                      "Presence of fat in this setting makes diagnosis of hyperplasia challenging",
                      "Biopsies may contain only fat or predominantly fat with limited parenchymal cells",
                      "Clinical setting and enlargement of multiple glands is of importance in diagnosis of lipohyperplasia"
                    ]
                  }
                ],
                "Water-Clear Cell Hyperplasia": [
                  {
                    "text": "Composed of cells with clear cytoplasm"
                  },
                  {
                    "text": "May contain multiple cytoplasmic vacuoles"
                  }
                ],
                "Parathyromatosis": [
                  {
                    "text": "Nests of hyperplastic parathyroid tissue in soft tissue of neck or mediastinum in primary chief cell hyperplasia"
                  },
                  {
                    "text": "Probably results from stimulation of embryonic rests of parathyroid cells in primary HPT"
                  },
                  {
                    "text": "Should not be mistaken for invasionLack of fibroblastic reaction or infiltrative contourAbsence of intravascular locationLack of histologic features of carcinoma",
                    "sub_points": [
                      "Lack of fibroblastic reaction or infiltrative contour",
                      "Absence of intravascular location",
                      "Lack of histologic features of carcinoma"
                    ]
                  },
                  {
                    "text": "May be cause of recurrent HPT after apparently complete resection of grossly evident hyperplastic glands"
                  }
                ],
                "Secondary Hyperparathyroidism": [
                  {
                    "text": "Proliferation includes chief cells, oxyphilic cells, and transitional cells"
                  },
                  {
                    "text": "Increased parenchymal cell mass varies depending on duration of diseaseParenchymal cells may grow in sheets, cords, or acinar structuresNodular aggregates of chief cells or oxyphilic cells common in very enlarged glandsOncocytic cells more common component than in primary chief cell hyperplasia",
                    "sub_points": [
                      "Parenchymal cells may grow in sheets, cords, or acinar structures",
                      "Nodular aggregates of chief cells or oxyphilic cells common in very enlarged glands",
                      "Oncocytic cells more common component than in primary chief cell hyperplasia"
                    ]
                  },
                  {
                    "text": "Presence of residual stromal fat cells varies depending on duration of diseaseIn advanced disease, fat cells are absent",
                    "sub_points": [
                      "In advanced disease, fat cells are absent"
                    ]
                  },
                  {
                    "text": "Areas of fibrosis, cystic change, and calcification may be present"
                  }
                ],
                "Tertiary Hyperparathyroidism": [
                  {
                    "text": "95% of patients have hyperplasiaChief cells predominate in hyperplasiaOncocytic cells may be seen in either diffuse or nodular hyperplasiaRarely, areas with water-clear cells may be presentAreas of hemorrhage, fibrosis, and calcification commonMitotic figures, nuclear pleomorphism uncommonStromal fat cells are sparse but more often present in areas between nodulesDistribution may suggest diagnosis of adenoma; however, multinodularity more consistent with hyperplasia",
                    "sub_points": [
                      "Chief cells predominate in hyperplasia",
                      "Oncocytic cells may be seen in either diffuse or nodular hyperplasia",
                      "Rarely, areas with water-clear cells may be present",
                      "Areas of hemorrhage, fibrosis, and calcification common",
                      "Mitotic figures, nuclear pleomorphism uncommon",
                      "Stromal fat cells are sparse but more often present in areas between nodules",
                      "Distribution may suggest diagnosis of adenoma; however, multinodularity more consistent with hyperplasia"
                    ]
                  },
                  {
                    "text": "Only 5% found to have adenomas"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Smears indistinguishable from adenoma"
                  }
                ],
                "Histochemistry": [
                  {
                    "text": "Periodic acid-SchiffSmall follicular structures may contain PAS(+) materialResembles colloidThyroglobulin negative",
                    "sub_points": [
                      "Small follicular structures may contain PAS(+) materialResembles colloidThyroglobulin negative",
                      "Resembles colloid",
                      "Thyroglobulin negative"
                    ]
                  },
                  {
                    "text": "Fat stains (oil red O, Sudan black)Hyperplastic cellsUsually contain less intracytoplasmic fat than normal or atrophic parathyroid tissueMay contain abundant intracytoplasmic fatIntracytoplasmic fat may be more abundant in chief cells between hyperplastic nodules while usually absent in cells within nodules",
                    "sub_points": [
                      "Hyperplastic cellsUsually contain less intracytoplasmic fat than normal or atrophic parathyroid tissueMay contain abundant intracytoplasmic fatIntracytoplasmic fat may be more abundant in chief cells between hyperplastic nodules while usually absent in cells within nodules",
                      "Usually contain less intracytoplasmic fat than normal or atrophic parathyroid tissue",
                      "May contain abundant intracytoplasmic fat",
                      "Intracytoplasmic fat may be more abundant in chief cells between hyperplastic nodules while usually absent in cells within nodules"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Chief cellsPositivePTH, parafibromin, cytokeratins, chromograninStaining for PTH and chromogranin is less intense as compared to normal (nonhyperplastic) chief cellsNegative: thyroglobulin and TTF-1Ki-67 (MIB-1) proliferative index is low",
                    "sub_points": [
                      "PositivePTH, parafibromin, cytokeratins, chromograninStaining for PTH and chromogranin is less intense as compared to normal (nonhyperplastic) chief cellsNegative: thyroglobulin and TTF-1Ki-67 (MIB-1) proliferative index is low",
                      "PTH, parafibromin, cytokeratins, chromograninStaining for PTH and chromogranin is less intense as compared to normal (nonhyperplastic) chief cells",
                      "Staining for PTH and chromogranin is less intense as compared to normal (nonhyperplastic) chief cells",
                      "Negative: thyroglobulin and TTF-1",
                      "Ki-67 (MIB-1) proliferative index is low"
                    ]
                  },
                  {
                    "text": "Clear cellsPositive: PTH, parafibromin (nuclear), cytokeratins, chromograninStaining for PTH and chromogranin less intense as compared to normal (nonhyperplastic) chief cellsCalcitonin staining may focally be presentCyclin-D1 expression present in majority of cases (~ 61%)Ki-67 (MIB-1) proliferative index is low",
                    "sub_points": [
                      "Positive: PTH, parafibromin (nuclear), cytokeratins, chromograninStaining for PTH and chromogranin less intense as compared to normal (nonhyperplastic) chief cells",
                      "Staining for PTH and chromogranin less intense as compared to normal (nonhyperplastic) chief cells",
                      "Calcitonin staining may focally be present",
                      "Cyclin-D1 expression present in majority of cases (~ 61%)",
                      "Ki-67 (MIB-1) proliferative index is low"
                    ]
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Chief cellsCharacteristic secretory granulesAbundant mitochondria, endoplasmic reticulum, large Golgi areas",
                    "sub_points": [
                      "Characteristic secretory granules",
                      "Abundant mitochondria, endoplasmic reticulum, large Golgi areas"
                    ]
                  },
                  {
                    "text": "Clear cellsContain numerous membrane-bound vacuoles, many appear emptySome contain intracytoplasmic electron-dense material similar to typical secretory granules seen in chief cells",
                    "sub_points": [
                      "Contain numerous membrane-bound vacuoles, many appear empty",
                      "Some contain intracytoplasmic electron-dense material similar to typical secretory granules seen in chief cells"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Parathyroid Adenoma": [
                  {
                    "text": "Almost always solitary"
                  },
                  {
                    "text": "Encapsulated to circumscribed"
                  },
                  {
                    "text": "Absence of stromal fat"
                  },
                  {
                    "text": "Remnant of normal or atrophic gland may be identifiedIncludes stromal fat",
                    "sub_points": [
                      "Includes stromal fat"
                    ]
                  }
                ],
                "Parathyroid Carcinoma": [
                  {
                    "text": "Associated with higher levels of serum calcium and PTH"
                  },
                  {
                    "text": "Single enlarged glandOften adherent to surrounding anatomic structures",
                    "sub_points": [
                      "Often adherent to surrounding anatomic structures"
                    ]
                  },
                  {
                    "text": "Invasion present in ~ 2/3 of cases, may includeAngioinvasionNeurotropismInvasion into adjacent tissues (e.g., thyroid)",
                    "sub_points": [
                      "Angioinvasion",
                      "Neurotropism",
                      "Invasion into adjacent tissues (e.g., thyroid)"
                    ]
                  },
                  {
                    "text": "May metastasize"
                  }
                ],
                "Thyroid Follicular Neoplasm": [
                  {
                    "text": "Thyroglobulin and TTF-1 (+)"
                  },
                  {
                    "text": "PTH immunostaining (-)"
                  }
                ],
                "Metastatic Renal Cell Carcinoma": [
                  {
                    "text": "May metastasize to cervical lymph nodes"
                  },
                  {
                    "text": "May share features with water-clear cell hyperplasia"
                  },
                  {
                    "text": "Immunoreactive for CD10, renal cell carcinoma antigen, carbonic anhydrase IX (CAIX), pax-8"
                  },
                  {
                    "text": "Immunostaining for PTH is negative"
                  }
                ],
                "Lithium Therapy": [
                  {
                    "text": "Associated with form of HPT similar to primary HPTHypercalcemia, elevated serum parathormone levels",
                    "sub_points": [
                      "Hypercalcemia, elevated serum parathormone levels"
                    ]
                  },
                  {
                    "text": "Both chief cell hyperplasia and adenomas described in these patients"
                  },
                  {
                    "text": "HPT resolves after discontinuing lithium therapy"
                  },
                  {
                    "text": "Patients requiring lithium may be treated successfully with subtotal parathyroidectomy"
                  }
                ],
                "Humoral Hypercalcemia of Malignancy": [
                  {
                    "text": "Important clinical differential diagnostic consideration in patients suspected of primary HPT"
                  },
                  {
                    "text": "Independent of extent of metastatic disease involving bone"
                  },
                  {
                    "text": "Characterized by hypercalcemia, hypophosphatemia, elevated urinary cyclic AMP levels"
                  },
                  {
                    "text": "Unlike HPTSerum parathormone and 1,25-dihydroxyvitamin D suppressed",
                    "sub_points": [
                      "Serum parathormone and 1,25-dihydroxyvitamin D suppressed"
                    ]
                  },
                  {
                    "text": "Mechanism for hypercalcemia appears to be increased bone resorptionDue to humoral factor known as PTH-related protein",
                    "sub_points": [
                      "Due to humoral factor known as PTH-related protein"
                    ]
                  },
                  {
                    "text": "This form of hypercalcemia most frequent in patients with squamous cell carcinomaLung, upper aerodigestive tract, female genital tractRenal cell carcinomaUrothelial (transitional) cell carcinoma",
                    "sub_points": [
                      "Lung, upper aerodigestive tract, female genital tract",
                      "Renal cell carcinoma",
                      "Urothelial (transitional) cell carcinoma"
                    ]
                  },
                  {
                    "text": "2nd mechanism of hypercalcemia associated with malignancy related directly to osteolytic effect of bone metastasesThis form of hypercalcemia more common in patients with breast carcinoma and hematologic malignanciesPatients have suppressed levels of parathormone butUrinary cyclic AMP not elevatedPTH-related protein not implicated",
                    "sub_points": [
                      "This form of hypercalcemia more common in patients with breast carcinoma and hematologic malignancies",
                      "Patients have suppressed levels of parathormone butUrinary cyclic AMP not elevatedPTH-related protein not implicated",
                      "Urinary cyclic AMP not elevated",
                      "PTH-related protein not implicated"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Prostate Hyperplasia": {
            "name": "Prostate Hyperplasia",
            "url": "https://app.pathprimer.com/document/54213885-c010-4f7f-bf1c-32443474f4f2/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Nodular prostate enlargement due to cellular proliferation of prostatic glands and stroma associated with lower urinary tract symptoms (LUTS)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "A leading cause of morbidity in elderly men"
                  },
                  {
                    "text": "Seen in 50% of men in their 50s, up to 80-90% of men in their 70s and 80s"
                  },
                  {
                    "text": "Most common noncancerous cause of serum PSA elevation"
                  },
                  {
                    "text": "Medical therapy is most frequently used approach"
                  },
                  {
                    "text": "Surgery is more effective in terms of controlling LUTS"
                  },
                  {
                    "text": "Without associated LUTS, features of glandular and stromal proliferation in needle biopsies shouldnotbe labeled as benign prostatic hyperplasia (BPH)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Hallmark of BPH is nodular prostatic enlargement"
                  },
                  {
                    "text": "Hyperplastic nodules are mainly centered on proximal prostatic urethra involving transition zone and submucosal compartment"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Epithelial predominant hyperplasia shows nodules composed of tightly clustered expanded ductal acinar elements"
                  },
                  {
                    "text": "Stromal predominant hyperplasia composed of bland spindle cells with little cytoplasm and plump nuclei seen surrounding small blood vessels"
                  },
                  {
                    "text": "Morphologic variants: Small glandular, cribriform, basal cell, leiomyomatous nodule, and phyllodes-type hyperplasia"
                  },
                  {
                    "text": "Differential diagnosis for epithelial hyperplasia: Pseudohyperplastic variant of acinar carcinoma, atypical adenomatous hyperplasia"
                  },
                  {
                    "text": "Differential diagnosis for stromal hyperplasia: Specialized stromal tumors of prostate, smooth muscle tumors, solitary fibrous tumors"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Benign prostatic hyperplasia (BPH)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Benign prostatic hypertrophy"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Nodular prostate enlargement due to cellular proliferation of prostatic glands and stroma associated with lower urinary tract symptoms (LUTS)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Origin": [
                  {
                    "text": "Prostatic glandular hyperplasiaAcinar cells and basal cells",
                    "sub_points": [
                      "Acinar cells and basal cells"
                    ]
                  },
                  {
                    "text": "Prostatic stromal hyperplasiaUndifferentiated mesenchyme, fibroblasts, and smooth muscle cells",
                    "sub_points": [
                      "Undifferentiated mesenchyme, fibroblasts, and smooth muscle cells"
                    ]
                  }
                ],
                "Etiology": [
                  {
                    "text": "Pathophysiology remains poorly understood"
                  },
                  {
                    "text": "Hormonal alteration plays central roleCellular accumulation of testosterone, particularly active metabolite dihydrotestosterone (DHT)Castrated patients with BPH experience significant decrease in prostate size",
                    "sub_points": [
                      "Cellular accumulation of testosterone, particularly active metabolite dihydrotestosterone (DHT)",
                      "Castrated patients with BPH experience significant decrease in prostate size"
                    ]
                  },
                  {
                    "text": "Known risk factors include aging and family history"
                  },
                  {
                    "text": "No association with tobacco use, weight, sexual libido, diabetes mellitus, hypertension, or cirrhosis"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "A leading cause of morbidity in elderly men"
                  },
                  {
                    "text": "Increasing incidence with age, particularly in men > 50 years of ageSeen in 50% of men in their 50s and up to 80-90% of men in their 70s and 80sIn contrast, seen in only 8% of men in their 40s and rarely in younger men",
                    "sub_points": [
                      "Seen in 50% of men in their 50s and up to 80-90% of men in their 70s and 80sIn contrast, seen in only 8% of men in their 40s and rarely in younger men",
                      "In contrast, seen in only 8% of men in their 40s and rarely in younger men"
                    ]
                  }
                ],
                "Site": [
                  {
                    "text": "Mainly in tissues surrounding proximal prostatic urethraTransition zone, submucosal compartment, specialized mesenchyme of preprostatic sphinctera.k.a. estrogen-sensitive zone",
                    "sub_points": [
                      "Transition zone, submucosal compartment, specialized mesenchyme of preprostatic sphincter",
                      "a.k.a. estrogen-sensitive zone"
                    ]
                  },
                  {
                    "text": "Peripheral zone uncommonly involved, reported in 2-15% of prostatectomies"
                  }
                ],
                "Presentation": [
                  {
                    "text": "LUTSObstructive symptoms, such as hesitancy, straining, weak flow, prolonged voiding, retention, and overflow incontinenceIrritative symptoms, such as frequency, urgency, nocturia, painful urination, and dribbling",
                    "sub_points": [
                      "Obstructive symptoms, such as hesitancy, straining, weak flow, prolonged voiding, retention, and overflow incontinence",
                      "Irritative symptoms, such as frequency, urgency, nocturia, painful urination, and dribbling"
                    ]
                  },
                  {
                    "text": "Digital rectal palpation of enlarged, nodular, often symmetric and rubbery prostate"
                  },
                  {
                    "text": "No correlation between histology and symptomsOnly 50% with histologic disease have clinical prostatic enlargement; 50% of these have symptomsWithout associated LUTS, features of glandular and stromal proliferation in needle biopsies should ﻿not be labeled as BPH",
                    "sub_points": [
                      "Only 50% with histologic disease have clinical prostatic enlargement; 50% of these have symptoms",
                      "Without associated LUTS, features of glandular and stromal proliferation in needle biopsies should ﻿not be labeled as BPH"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Most common noncancerous cause of serum PSA elevation"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Medical therapy is most frequently used approachα-adrenergic blockers or 5-α-reductase inhibitors25-30% patients do not respond",
                    "sub_points": [
                      "α-adrenergic blockers or 5-α-reductase inhibitors",
                      "25-30% patients do not respond"
                    ]
                  },
                  {
                    "text": "Surgery is more effective in terms of controlling LUTSTransurethral resection of prostate (TURP) is standard surgical procedureOpen (simple) prostatectomy for very bulky prostate",
                    "sub_points": [
                      "Transurethral resection of prostate (TURP) is standard surgical procedure",
                      "Open (simple) prostatectomy for very bulky prostate"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Benign course"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "CT, US, and MR can visualize BPH"
                  },
                  {
                    "text": "Evidence of urinary retention, dilated bladder, hydroureter, or hydronephrosis in advanced cases"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Nodular prostatic enlargement is hallmark of BPH"
                  },
                  {
                    "text": "Hyperplastic nodules identifiable in prostatic chips or more readily in prostatectomy specimensVary from millimeters to large bulging masses; sometimes prostate can be massively enlargedTypically firm and white-tan but can be spongy due to cystically dilated glands",
                    "sub_points": [
                      "Vary from millimeters to large bulging masses; sometimes prostate can be massively enlarged",
                      "Typically firm and white-tan but can be spongy due to cystically dilated glands"
                    ]
                  },
                  {
                    "text": "Hyperplastic nodules are mainly centered on proximal prostatic urethra involving submucosal compartment and transition zone"
                  },
                  {
                    "text": "Hyperplastic transition zone compresses peripheral zone, which can be markedly attenuated or atrophic"
                  },
                  {
                    "text": "Uncommon peripheral zone hyperplasia more often presents as solitary hyperplastic nodule"
                  }
                ],
                "Sections to Be Submitted": [
                  {
                    "text": "TURP specimenFor ≤ 12 g, submit entirely (usually 6-8 cassettes)For > 12 g, submit initial 12 g plus 1 cassette for every additional 5 g",
                    "sub_points": [
                      "For ≤ 12 g, submit entirely (usually 6-8 cassettes)",
                      "For > 12 g, submit initial 12 g plus 1 cassette for every additional 5 g"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Epithelial predominant hyperplasiaProliferative nodules composed of tightly clustered expanded ductal acinar elementsGlands are medium to large or sometimes cystically enlargedEnlarged glands usually show architectural complexity and papillary infoldingsDistinct acinar and basal cell layers presentAcinar cells are usually columnar or cuboidal to flat when cysticCytoplasm is abundant and paleNuclei are regular with open chromatin",
                    "sub_points": [
                      "Proliferative nodules composed of tightly clustered expanded ductal acinar elements",
                      "Glands are medium to large or sometimes cystically enlarged",
                      "Enlarged glands usually show architectural complexity and papillary infoldings",
                      "Distinct acinar and basal cell layers present",
                      "Acinar cells are usually columnar or cuboidal to flat when cystic",
                      "Cytoplasm is abundant and pale",
                      "Nuclei are regular with open chromatin"
                    ]
                  },
                  {
                    "text": "Stromal predominant hyperplasiaEarly stromal nodule seen around urethral submucosal connective tissueBland spindle cells with little cytoplasm and plump nuclei containing open chromatinContains abundant small capillaries and spindle cells typically condensed around these vesselsOccasionally can be very cellular with dense collagen around small capillariesIncreasing smooth muscle component with increasing nodule size",
                    "sub_points": [
                      "Early stromal nodule seen around urethral submucosal connective tissue",
                      "Bland spindle cells with little cytoplasm and plump nuclei containing open chromatin",
                      "Contains abundant small capillaries and spindle cells typically condensed around these vessels",
                      "Occasionally can be very cellular with dense collagen around small capillaries",
                      "Increasing smooth muscle component with increasing nodule size"
                    ]
                  },
                  {
                    "text": "Mixed epithelial and stromal hyperplasiaBoth glandular and stromal proliferations substantially present",
                    "sub_points": [
                      "Both glandular and stromal proliferations substantially present"
                    ]
                  },
                  {
                    "text": "Special morphologic variantsCan be seen within overall spectrum of BPH",
                    "sub_points": [
                      "Can be seen within overall spectrum of BPH"
                    ]
                  },
                  {
                    "text": "Small glandular hyperplasiaComposed of proliferation of relatively small glands in fibromuscular stromaAcinar cells are more cuboidal, and basal cells are more prominent than in usual hyperplasia",
                    "sub_points": [
                      "Composed of proliferation of relatively small glands in fibromuscular stroma",
                      "Acinar cells are more cuboidal, and basal cells are more prominent than in usual hyperplasia"
                    ]
                  },
                  {
                    "text": "Cribriform hyperplasiaUnique form of nodular hyperplasia wherein glandular component is composed of medium to large glands with cribriform architectureMay have clear cytoplasm (clear cell cribriform hyperplasia)",
                    "sub_points": [
                      "Unique form of nodular hyperplasia wherein glandular component is composed of medium to large glands with cribriform architecture",
                      "May have clear cytoplasm (clear cell cribriform hyperplasia)"
                    ]
                  },
                  {
                    "text": "Basal cell hyperplasiaUsually seen, but not exclusively, in cases of BPHCan also be seen associated with glandular atrophy, typically involving peripheral zone, in setting of androgen ablation therapyProliferation can be incomplete (preserving acinar cells) or complete (imparting solid nests)May have cribriform architecture (adenoid cystic-like hyperplasia)May undergo squamous metaplasiaMay show nuclear atypia (atypical basal cell hyperplasia)Basal cell markers [p63 or HMCK(34βE12)] helpful in diagnosis of challenging cases",
                    "sub_points": [
                      "Usually seen, but not exclusively, in cases of BPH",
                      "Can also be seen associated with glandular atrophy, typically involving peripheral zone, in setting of androgen ablation therapy",
                      "Proliferation can be incomplete (preserving acinar cells) or complete (imparting solid nests)",
                      "May have cribriform architecture (adenoid cystic-like hyperplasia)",
                      "May undergo squamous metaplasia",
                      "May show nuclear atypia (atypical basal cell hyperplasia)",
                      "Basal cell markers [p63 or HMCK(34βE12)] helpful in diagnosis of challenging cases"
                    ]
                  },
                  {
                    "text": "Leiomyomatous noduleStromal predominant hyperplasia with prominent smooth muscle componentUnlike leiomyoma, usually small (< 1 cm), blends into surrounding stroma, contains fibroblastic component, and is sometimes multinodular",
                    "sub_points": [
                      "Stromal predominant hyperplasia with prominent smooth muscle component",
                      "Unlike leiomyoma, usually small (< 1 cm), blends into surrounding stroma, contains fibroblastic component, and is sometimes multinodular"
                    ]
                  },
                  {
                    "text": "Fibroadenoma-like hyperplasiaGlandular and stromal proliferations are architecturally arranged to mimic fibroadenoma of breast",
                    "sub_points": [
                      "Glandular and stromal proliferations are architecturally arranged to mimic fibroadenoma of breast"
                    ]
                  },
                  {
                    "text": "Phyllodes-type hyperplasiaStromal predominant proliferation with cleft-like spaces and intramural stromal projections covered peripherally by glandular epitheliumIn contrast to phyllodes-like tumor of prostate, is focal, lacks significant atypia, and seen in background of BPH",
                    "sub_points": [
                      "Stromal predominant proliferation with cleft-like spaces and intramural stromal projections covered peripherally by glandular epithelium",
                      "In contrast to phyllodes-like tumor of prostate, is focal, lacks significant atypia, and seen in background of BPH"
                    ]
                  }
                ],
                "Predominant Pattern/Injury Type": [
                  {
                    "text": "Hyperplasia"
                  }
                ],
                "Predominant Cell/Compartment Type": [
                  {
                    "text": "Epithelial, glandular"
                  },
                  {
                    "text": "Mesenchymal, spindle"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Reactivity similar to normal benign glands"
                  },
                  {
                    "text": "Not routinely needed for diagnosis"
                  },
                  {
                    "text": "Acinar cellsPositive for PSA and PAPUnderexpresses AMACR but may be weakly positiveNegative for p63 or HMCK(34βE12)",
                    "sub_points": [
                      "Positive for PSA and PAP",
                      "Underexpresses AMACR but may be weakly positive",
                      "Negative for p63 or HMCK(34βE12)"
                    ]
                  },
                  {
                    "text": "Basal cellsNegative for PSA, PAP, or AMACRPositive for p63 or HMCK(34βE12)",
                    "sub_points": [
                      "Negative for PSA, PAP, or AMACR",
                      "Positive for p63 or HMCK(34βE12)"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pseudohyperplastic Variant of Acinar Adenocarcinoma": [
                  {
                    "text": "Large, dilated glands ± papillary fronds"
                  },
                  {
                    "text": "Single cells with basally aligned nuclei and prominent nucleoli"
                  },
                  {
                    "text": "Lumina often contain amorphous eosinophilic secretions and variable crystalloids"
                  },
                  {
                    "text": "Often associated with conventional adenocarcinoma at periphery"
                  }
                ],
                "Atypical Adenomatous Hyperplasia": [
                  {
                    "text": "Differential diagnosis for small glandular hyperplasia in limited sample, such as needle biopsy"
                  },
                  {
                    "text": "No associated stromal proliferation"
                  },
                  {
                    "text": "Less uniform glands with presence of parent duct"
                  }
                ],
                "Specialized Stromal Tumors of Prostate": [
                  {
                    "text": "Stromal tumors of uncertain malignant potentialDiagnosis may be made when sampling is limitedHypercellular stroma that often shows degenerate-type nuclear atypiaMay be admixed with benign glands, with myxoid change, or with phyllodes-type patternLacks typical intermixed small blood vessels; may lack multinodularity of BPH",
                    "sub_points": [
                      "Diagnosis may be made when sampling is limited",
                      "Hypercellular stroma that often shows degenerate-type nuclear atypia",
                      "May be admixed with benign glands, with myxoid change, or with phyllodes-type pattern",
                      "Lacks typical intermixed small blood vessels; may lack multinodularity of BPH"
                    ]
                  },
                  {
                    "text": "Stromal sarcomaShows greater degree of cellularity, significant atypia, increased mitosis, and presence of necrosis",
                    "sub_points": [
                      "Shows greater degree of cellularity, significant atypia, increased mitosis, and presence of necrosis"
                    ]
                  }
                ],
                "Smooth Muscle Tumors": [
                  {
                    "text": "Differential diagnosis for hyperplastic leiomyomatous nodule"
                  },
                  {
                    "text": "Leiomyoma is more cellular, lacks stromal vessels, and occurs without background BPH"
                  },
                  {
                    "text": "Leiomyosarcoma contains significant cytologic atypia that is often high grade with increased mitotic activity and shows coagulative necrosis"
                  }
                ],
                "Solitary Fibrous Tumor of Prostate": [
                  {
                    "text": "Uniform bland spindle cells with haphazard patternless pattern, dense ropey collagen, more variable cellularity, and staghorn vessels"
                  },
                  {
                    "text": "Borderline and malignant cases with increasing cellularity, mitotic activity, presence of necrosis, and infiltrative growth"
                  },
                  {
                    "text": "Positive for CD34, Bcl-2, and CD99"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Diagnosis of BPH is made when histologic glandular and stromal proliferation is associated with prostatic nodular enlargement accompanied by LUTS"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Atrophy and Its Variants": {
            "name": "Atrophy and Its Variants",
            "url": "https://app.pathprimer.com/document/0d6ff0fd-ed1c-4e51-afd9-7fb300fafaf0/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Cellular shrinkage with loss of cytoplasmic volume of prostatic ductal acinar unit and surrounding stroma"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Frequency increases with age; more common after 6th decade of life"
                  },
                  {
                    "text": "Remarkable in routine practice as morphologic mimicker of adenocarcinoma in prostate biopsy"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Most commonly involves peripheral zone"
                  },
                  {
                    "text": "All patterns of atrophy are characterized by acinar cells with scant cytoplasm producing higher nuclear:cytoplasmic ratio"
                  },
                  {
                    "text": "Glands contain crowded and hyperchromatic nuclei, imparting more basophilic appearance"
                  },
                  {
                    "text": "Atrophy may be diffuse or widespread; linked to aging, androgen deprivation, and radiotherapy"
                  },
                  {
                    "text": "Main morphologic types of focal atrophy include simple atrophy (SA), SA with cyst formation, postatrophic hyperplasia (PAH), and partial atrophy (PA)"
                  },
                  {
                    "text": "SA consists of atrophic acini that are spaced relatively similarly to normal glands"
                  },
                  {
                    "text": "SA with cyst formation shows cystic dilatation of atrophic acini"
                  },
                  {
                    "text": "PAH consists of proliferative atrophic acini arranged in lobules, often surrounding central larger dilated duct"
                  },
                  {
                    "text": "Unlike other forms of atrophy, PA contains relatively modest amount of pale or clear cytoplasm and has less crowded nuclei"
                  },
                  {
                    "text": "Most are positive for basal cell markers; PA and PAH may have patchy or absent staining"
                  },
                  {
                    "text": "Main differential diagnosis is prostate adenocarcinoma with atrophic features"
                  },
                  {
                    "text": "PA is common reason for consultations of atypical glands concerning for cancer in biopsies"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Cellular shrinkage with loss of cytoplasmic volume of prostatic ductal acinar unit and surrounding stroma"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Causes": [
                  {
                    "text": "Diffuse atrophy linked to aging, androgen deprivation, and radiotherapy"
                  },
                  {
                    "text": "Secondary compression by benign prostate hyperplasia (BPH) nodule, e.g., peripheral zone atrophy in BPH of transition zone"
                  },
                  {
                    "text": "End result of severe chronic inflammation (postinflammatory atrophy)"
                  },
                  {
                    "text": "Chronic local ischemia has also been suggested"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Very common; seen in 85% of prostates in autopsies of men > 40 years of age"
                  },
                  {
                    "text": "Frequency increases with age; more common after 6th decade of life"
                  }
                ],
                "Site": [
                  {
                    "text": "Commonly involves peripheral zone and, less frequently, central and transition zones"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic; incidental histologic finding"
                  },
                  {
                    "text": "Remarkable in routine practice as morphologic mimicker of adenocarcinoma in prostate biopsy"
                  }
                ],
                "Treatment": [
                  {
                    "text": "None"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Benign course"
                  },
                  {
                    "text": "Possible but very weak current evidence for atrophy as neoplastic precursor, suggested in postinflammatory atrophy with high proliferation index (proliferative inflammatory atrophy)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Characterized by acinar cells with scant cytoplasm imparting higher nuclear:cytoplasmic ratio"
                  },
                  {
                    "text": "Maintains overall lobular configuration with angular or slit-like glands, occasionally with parent duct"
                  },
                  {
                    "text": "Glands contain crowded and hyperchromatic nuclei, imparting more basophilic appearance"
                  },
                  {
                    "text": "Since secretory cells have minimal to no cytoplasm, they resemble basal cells and impart single-cell type appearance"
                  },
                  {
                    "text": "Glands may very rarely contain intraluminal mucin and crystalloids"
                  },
                  {
                    "text": "Surrounding stroma with variable amount of fibrosis"
                  },
                  {
                    "text": "Chronic inflammation may be seen in association with atrophic acini"
                  }
                ],
                "Predominant Pattern/Injury Type": [
                  {
                    "text": "Atrophy"
                  }
                ],
                "Predominant Cell/Compartment Type": [
                  {
                    "text": "Epithelial, glandular"
                  }
                ],
                "Diffuse Atrophy": [
                  {
                    "text": "Widespread, shows uniform involvement of all glands"
                  },
                  {
                    "text": "Basal cells are relatively prominent"
                  }
                ],
                "Focal Atrophy": [
                  {
                    "text": "Localized or patchy atrophy of glands"
                  }
                ],
                "Morphologic Types of Focal Atrophy": [
                  {
                    "text": "Proposed by Working Group Classification of Focal Atrophy of the Prostate in 2006 as simple atrophy (SA), SA with cyst formation, postatrophic hyperplasia (PAH), and partial atrophy (PA)Interobserver reproducibility is less than optimal; no clinical significance of subtyping atrophy at this time",
                    "sub_points": [
                      "Interobserver reproducibility is less than optimal; no clinical significance of subtyping atrophy at this time"
                    ]
                  },
                  {
                    "text": "Admixture of these patterns is commonly seen"
                  },
                  {
                    "text": "Simple atrophy (SA)Atrophic acini are spaced relatively similarly to normal glandsGlands are about normal in caliber but may be larger and are often irregular in shape",
                    "sub_points": [
                      "Atrophic acini are spaced relatively similarly to normal glands",
                      "Glands are about normal in caliber but may be larger and are often irregular in shape"
                    ]
                  },
                  {
                    "text": "SA with cyst formationSA associated with cystic dilatation of atrophic aciniDilated glands closely apposed with little amount of intervening stroma and show rounded configuration",
                    "sub_points": [
                      "SA associated with cystic dilatation of atrophic acini",
                      "Dilated glands closely apposed with little amount of intervening stroma and show rounded configuration"
                    ]
                  },
                  {
                    "text": "Postatrophic hyperplasia (PAH)Atrophic acini arranged in lobules often surrounding central larger dilated ductAcini can be oval, slit-like, or stellate-shapedNuclei typically bland but occasionally may be enlarged with distinct nucleoliAdmixed with variable amount of hyperplastic acini containing clear or pale cytoplasm",
                    "sub_points": [
                      "Atrophic acini arranged in lobules often surrounding central larger dilated duct",
                      "Acini can be oval, slit-like, or stellate-shaped",
                      "Nuclei typically bland but occasionally may be enlarged with distinct nucleoli",
                      "Admixed with variable amount of hyperplastic acini containing clear or pale cytoplasm"
                    ]
                  },
                  {
                    "text": "Partial atrophy (PA)Most common reason for consultations of atypical glands concerning for cancer in biopsiesHas relatively modest amount of pale to clear cytoplasm and less crowded nucleiAcini are small- to medium-sized and round or undulating in contourNucleoli are occasionally moderately enlarged",
                    "sub_points": [
                      "Most common reason for consultations of atypical glands concerning for cancer in biopsies",
                      "Has relatively modest amount of pale to clear cytoplasm and less crowded nuclei",
                      "Acini are small- to medium-sized and round or undulating in contour",
                      "Nucleoli are occasionally moderately enlarged"
                    ]
                  },
                  {
                    "text": "Sclerotic atrophyAtrophy containing dense fibrotic stromaAtrophic glands are more angulated or irregular",
                    "sub_points": [
                      "Atrophy containing dense fibrotic stroma",
                      "Atrophic glands are more angulated or irregular"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Positive for basal cell markers [p63 or HMWK (34βE12)]Rare glands within PAH focus may be completely negative (23%)PA shows patchy staining in 73-87% and has completely absent staining in 6%",
                    "sub_points": [
                      "Rare glands within PAH focus may be completely negative (23%)",
                      "PA shows patchy staining in 73-87% and has completely absent staining in 6%"
                    ]
                  },
                  {
                    "text": "Underexpresses or negative for AMACR10% of PA shows stronger staining than benign glands24% of PA shows combination of AMACR positivity and basal cell marker negativity",
                    "sub_points": [
                      "10% of PA shows stronger staining than benign glands",
                      "24% of PA shows combination of AMACR positivity and basal cell marker negativity"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Acinar Adenocarcinoma": [
                  {
                    "text": "Malignant acini are relatively smaller, more rigid, or less irregular in contour"
                  },
                  {
                    "text": "Shows nucleomegaly and presence of prominent &/or multiple nucleoli; most helpful particularly if appreciated in several cells"
                  },
                  {
                    "text": "Glands may contain blue mucin and crystalloids"
                  },
                  {
                    "text": "Completely negative for basal cell markers and strong circumferential staining with AMACR"
                  }
                ],
                "Prostate Adenocarcinoma With Atrophic Features": [
                  {
                    "text": "Carcinoma that is architecturally similar in appearance to atrophic benign glands"
                  },
                  {
                    "text": "Retains cytologic and other features of adenocarcinoma and is occasionally admixed with more typical carcinoma histology"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Prostate: Benign Glandular and Stromal Histology": {
            "name": "Prostate: Benign Glandular and Stromal Histology",
            "url": "https://app.pathprimer.com/document/eb6626f4-dc6a-472a-8e1d-c9a28074a386/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "PROSTATE": {
                "Macroscopic Anatomy": [
                  {
                    "text": "Prostate glandLocated inferior to urinary bladder, superior to pelvic floor, and anterior to rectum",
                    "sub_points": [
                      "Located inferior to urinary bladder, superior to pelvic floor, and anterior to rectum"
                    ]
                  },
                  {
                    "text": "Seminal vesiclesPaired glandular structures located in superior/posterior region of prostateExtend superiorly along posterior aspect of bladder",
                    "sub_points": [
                      "Paired glandular structures located in superior/posterior region of prostate",
                      "Extend superiorly along posterior aspect of bladder"
                    ]
                  },
                  {
                    "text": "Cowper (bulbourethral) glandsPaired glandular structures located just distal to prostate gland in periurethral region",
                    "sub_points": [
                      "Paired glandular structures located just distal to prostate gland in periurethral region"
                    ]
                  }
                ],
                "Microscopic Anatomy": [
                  {
                    "text": "Prostate glands are composed of 2 cell layersSecretory cellsLuminal-facing cells with clear to eosinophilic, sometimes vacuolated, cytoplasmIHC: PSA(+), PSAP(+), p63(-), high molecular weight (HMW) cytokeratin (-)Basal cellsLocated adjacent to underlying stromaHigh nuclear:cytoplasmic ratios and small nucleoliIHC: p63(+), HMW cytokeratin (+), PSA(-), PSAP(-)",
                    "sub_points": [
                      "Secretory cellsLuminal-facing cells with clear to eosinophilic, sometimes vacuolated, cytoplasmIHC: PSA(+), PSAP(+), p63(-), high molecular weight (HMW) cytokeratin (-)",
                      "Luminal-facing cells with clear to eosinophilic, sometimes vacuolated, cytoplasm",
                      "IHC: PSA(+), PSAP(+), p63(-), high molecular weight (HMW) cytokeratin (-)",
                      "Basal cellsLocated adjacent to underlying stromaHigh nuclear:cytoplasmic ratios and small nucleoliIHC: p63(+), HMW cytokeratin (+), PSA(-), PSAP(-)",
                      "Located adjacent to underlying stroma",
                      "High nuclear:cytoplasmic ratios and small nucleoli",
                      "IHC: p63(+), HMW cytokeratin (+), PSA(-), PSAP(-)"
                    ]
                  },
                  {
                    "text": "Prostatic stromaNormal stroma has fibromuscular appearanceCytologically bland spindled cells with varying collagenous to myxoid stroma and associated small blood vessels in transition zone with hyperplasiaHistologic appearance depends on presence or absence of hyperplasia",
                    "sub_points": [
                      "Normal stroma has fibromuscular appearance",
                      "Cytologically bland spindled cells with varying collagenous to myxoid stroma and associated small blood vessels in transition zone with hyperplasia",
                      "Histologic appearance depends on presence or absence of hyperplasia"
                    ]
                  },
                  {
                    "text": "Periurethral tissueComplex glandular tissue with admixture of prostatic secretory epithelium and urothelium",
                    "sub_points": [
                      "Complex glandular tissue with admixture of prostatic secretory epithelium and urothelium"
                    ]
                  },
                  {
                    "text": "Seminal vesicle and ejaculatory ductBoth feature scattered pleomorphic nuclei and intracytoplasmic lipochrome pigmentSeminal vesicle is surrounded by dense smooth muscle; ejaculatory duct is surrounded by loose collagenous stromaIHC: pax-8(+)",
                    "sub_points": [
                      "Both feature scattered pleomorphic nuclei and intracytoplasmic lipochrome pigment",
                      "Seminal vesicle is surrounded by dense smooth muscle; ejaculatory duct is surrounded by loose collagenous stroma",
                      "IHC: pax-8(+)"
                    ]
                  }
                ]
              },
              "CONSIDERATIONS AND VARIATIONS": {
                "Age-Related Variations": [
                  {
                    "text": "Benign prostatic hyperplasia and glandular atrophy are more common with increasing age"
                  }
                ],
                "Hyperplasia": [
                  {
                    "text": "Benign prostatic glandular and stromal hyperplasia in periurethral transition zoneStromal hyperplasia with cellular nodules of benign spindled cellsLobular glandular hyperplasia with increased gland density",
                    "sub_points": [
                      "Stromal hyperplasia with cellular nodules of benign spindled cells",
                      "Lobular glandular hyperplasia with increased gland density"
                    ]
                  },
                  {
                    "text": "Basal cell hyperplasiaCellular aggregates of basophilic cells at periphery of prostate glandsBasal cells may entirely fill glandsFairly common in transition zone",
                    "sub_points": [
                      "Cellular aggregates of basophilic cells at periphery of prostate glands",
                      "Basal cells may entirely fill glands",
                      "Fairly common in transition zone"
                    ]
                  },
                  {
                    "text": "Clear cell cribriform hyperplasia"
                  }
                ],
                "Metaplasia": [
                  {
                    "text": "Transitional (urothelial)Extension of urothelium into prostatic glands, typically of transition zoneStratified epithelium with longitudinal nuclear grooves",
                    "sub_points": [
                      "Extension of urothelium into prostatic glands, typically of transition zone",
                      "Stratified epithelium with longitudinal nuclear grooves"
                    ]
                  },
                  {
                    "text": "Mucinous metaplasiaRare cells with intracytoplasmic mucin may be present",
                    "sub_points": [
                      "Rare cells with intracytoplasmic mucin may be present"
                    ]
                  }
                ],
                "Pitfalls and Artifacts": [
                  {
                    "text": "Normal variations in prostate may mimic malignancyGlandular atrophyIncludes simple, cystic, partial, and sclerotic typesAdenosis, sclerosing adenosisInflammatory changesMesonephric remnantsNephrogenic adenomaClear cell cribriform hyperplasia",
                    "sub_points": [
                      "Glandular atrophyIncludes simple, cystic, partial, and sclerotic types",
                      "Includes simple, cystic, partial, and sclerotic types",
                      "Adenosis, sclerosing adenosis",
                      "Inflammatory changes",
                      "Mesonephric remnants",
                      "Nephrogenic adenoma",
                      "Clear cell cribriform hyperplasia"
                    ]
                  },
                  {
                    "text": "Radiation atypia in benign glandsGlands with scattered pleomorphic cellsAtrophic eosinophilic cytoplasm",
                    "sub_points": [
                      "Glands with scattered pleomorphic cells",
                      "Atrophic eosinophilic cytoplasm"
                    ]
                  },
                  {
                    "text": "Benign lesions typically show at least focally retained basal cell layer"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Spinal Muscular Atrophy": {
            "name": "Spinal Muscular Atrophy",
            "url": "https://app.pathprimer.com/document/0b7b9b2a-f1e8-4e4a-8afe-6be0d92198f1/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Spinal muscular atrophy (SMA) types I-IV, including infantile SMA type I, or Werdnig-Hoffmann disease"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Most often a deletion or truncation ofSMN1gene at chromosome 5q 11.2-13.3"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "2nd most common lethal, autosomal recessive disease in Caucasians after cystic fibrosis"
                  },
                  {
                    "text": "Tongue fasciculations are seen in all types of SMA"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "SMA type I: Classic pattern of variable atrophy of types I and II fibers and clusters of enlarged type I fibers"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Spinal muscular atrophy (SMA)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Wide range of mostly autosomal recessive neuromuscular disorders due to degeneration of spinal anterior horn motor neuronsLeads to symmetrical muscle weakness and atrophy",
                    "sub_points": [
                      "Leads to symmetrical muscle weakness and atrophy"
                    ]
                  },
                  {
                    "text": "4 types describedSMA type ISevere infantile acute SMA, or Werdnig-Hoffmann diseaseSMA type IIInfantile chronic SMASMA type IIIJuvenile SMA, or Wohlfart-Kugelberg-Welander diseaseSMA type IVAdult-onset SMA",
                    "sub_points": [
                      "SMA type ISevere infantile acute SMA, or Werdnig-Hoffmann disease",
                      "Severe infantile acute SMA, or Werdnig-Hoffmann disease",
                      "SMA type IIInfantile chronic SMA",
                      "Infantile chronic SMA",
                      "SMA type IIIJuvenile SMA, or Wohlfart-Kugelberg-Welander disease",
                      "Juvenile SMA, or Wohlfart-Kugelberg-Welander disease",
                      "SMA type IVAdult-onset SMA",
                      "Adult-onset SMA"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Deletion or Truncation ofSMN1": [
                  {
                    "text": "At chromosome 5q 11.2-13.3 leads to enhanced neuronal death in anterior horns of spinal cord"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "2nd most common lethal, autosomal recessive disease in Caucasians after cystic fibrosis"
                  },
                  {
                    "text": "5-7 per 100,000 live births in United States"
                  },
                  {
                    "text": "Carrier rate: 1 in 80"
                  }
                ],
                "Gender": [
                  {
                    "text": "M:F ratio is 1:1, favoring males as age of disease onset increases"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Proximal weakness"
                  },
                  {
                    "text": "Diaphragm, cardiac, and smooth muscles spared"
                  },
                  {
                    "text": "Tongue fasciculations due to degeneration of the hypoglossal nucleus are seen in all types of SMA, but rarely in SMA type III"
                  },
                  {
                    "text": "SMA type IOnset: Birth to age 6 monthsFloppy infant, never able to roll over or sit",
                    "sub_points": [
                      "Onset: Birth to age 6 months",
                      "Floppy infant, never able to roll over or sit"
                    ]
                  },
                  {
                    "text": "SMA type IIOnset: 6-12 monthsMuscular weakness greater in legs; never ambulate",
                    "sub_points": [
                      "Onset: 6-12 months",
                      "Muscular weakness greater in legs; never ambulate"
                    ]
                  },
                  {
                    "text": "SMA type IIIOnset: 2-15 yearsDifficulty climbing stairs, standing up from floor/seated position",
                    "sub_points": [
                      "Onset: 2-15 years",
                      "Difficulty climbing stairs, standing up from floor/seated position"
                    ]
                  },
                  {
                    "text": "SMA type IVOnset: Young/middle adulthood",
                    "sub_points": [
                      "Onset: Young/middle adulthood"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "SMA type IRespiratory failure with pneumonia is most frequent cause of death, usually before age of 2 years",
                    "sub_points": [
                      "Respiratory failure with pneumonia is most frequent cause of death, usually before age of 2 years"
                    ]
                  },
                  {
                    "text": "SMA type IIMost patients live into adulthood barring respiratory complications",
                    "sub_points": [
                      "Most patients live into adulthood barring respiratory complications"
                    ]
                  },
                  {
                    "text": "SMA types III and IVLife expectancy is normal or near normal",
                    "sub_points": [
                      "Life expectancy is normal or near normal"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "SMA types I and IISMA type IEarly: May only be subtle variation in fiber sizesMore advanced cases display characteristic appearance with variable rounding of atrophic types I and II fibers and clusters of markedly enlarged type I fibersSMA type IIShows similar findings with grouped atrophy and type 1 fiber predominanceSMA types III and IVShows variable denervation atrophy and fiber type grouping",
                    "sub_points": [
                      "SMA type IEarly: May only be subtle variation in fiber sizesMore advanced cases display characteristic appearance with variable rounding of atrophic types I and II fibers and clusters of markedly enlarged type I fibers",
                      "Early: May only be subtle variation in fiber sizes",
                      "More advanced cases display characteristic appearance with variable rounding of atrophic types I and II fibers and clusters of markedly enlarged type I fibers",
                      "SMA type IIShows similar findings with grouped atrophy and type 1 fiber predominance",
                      "Shows similar findings with grouped atrophy and type 1 fiber predominance",
                      "SMA types III and IVShows variable denervation atrophy and fiber type grouping",
                      "Shows variable denervation atrophy and fiber type grouping"
                    ]
                  },
                  {
                    "text": "Autopsy spinal cord examinationShows loss of spinal anterior horn motor neurons and atrophy of anterior roots and degeneration of motor neurons in cranial nerve nuclei V to XII in severe SMA",
                    "sub_points": [
                      "Shows loss of spinal anterior horn motor neurons and atrophy of anterior roots and degeneration of motor neurons in cranial nerve nuclei V to XII in severe SMA"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Genetic Testing": [
                  {
                    "text": "Most cases of SMA type I are diagnosed by genetic testing of hypotonic infants"
                  },
                  {
                    "text": "95% of SMA patients have a homozygous deletion ofSMN1exon 7"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Diseases Causing Degeneration of Anterior Horn Motor Neurons": [
                  {
                    "text": "Autosomal recessive distal spinal muscular atrophy 1 (DSMA1)a.k.a. SMA with respiratory distress (SMARD1), chromosome 11q13",
                    "sub_points": [
                      "a.k.a. SMA with respiratory distress (SMARD1), chromosome 11q13"
                    ]
                  },
                  {
                    "text": "SCO2 deficiency with cytochrome oxidase negative myofibers"
                  },
                  {
                    "text": "Pontocerebellar hypoplasia with infantile SMA"
                  },
                  {
                    "text": "SMA type I with congenital bone fractures"
                  },
                  {
                    "text": "Neuronal storage diseases affecting spinal anterior horn motor neurons"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Neurogenic atrophy with small rounded fibers with marked hypertrophy of type I fibers in absence of myopathic changes should suggest SMA type I"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Atrophy": {
            "name": "Atrophy",
            "url": "https://app.pathprimer.com/document/74413ac7-da53-4dc6-9f37-9931788b7787/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Spectrum of squamous epithelial changes related to decreased estrogen"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Usually asymptomatic"
                  },
                  {
                    "text": "May have prior abnormal Papanicolaou smearMost commonly ASCUS",
                    "sub_points": [
                      "Most commonly ASCUS"
                    ]
                  },
                  {
                    "text": "Typically postmenopausal women"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Variable appearance depending on degree of maturation"
                  },
                  {
                    "text": "Generally uniform nuclear size and spacing"
                  },
                  {
                    "text": "No mitotic activity"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Low MIB1 index"
                  },
                  {
                    "text": "p16 negative"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Postmenopausal squamous atypia (variant)"
                  },
                  {
                    "text": "Transitional cell metaplasia (variant)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Spectrum of squamous epithelial changes related to decreased estrogen"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Alteration of Normal Hormonal Milieu": [
                  {
                    "text": "Low estrogen levelsFollowing menopause (most common)Post partumOral contraceptive pills with low estrogen contentStatus post bilateral salpingo-oophorectomyTurner syndrome",
                    "sub_points": [
                      "Following menopause (most common)",
                      "Post partum",
                      "Oral contraceptive pills with low estrogen content",
                      "Status post bilateral salpingo-oophorectomy",
                      "Turner syndrome"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Typically postmenopausal women"
                  }
                ],
                "Site": [
                  {
                    "text": "Cervix and vagina most common"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Usually asymptomatic"
                  },
                  {
                    "text": "Bleeding, less commonThin epithelium does not adequately protect underlying stroma and vasculature",
                    "sub_points": [
                      "Thin epithelium does not adequately protect underlying stroma and vasculature"
                    ]
                  },
                  {
                    "text": "Prior abnormal Papanicolaou smearMost commonly ASCUS",
                    "sub_points": [
                      "Most commonly ASCUS"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Topical daily estrogen"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Spectrum of maturation disturbances (partial to complete atrophy)Range of epithelial thicknessVariable amounts of cytoplasmLittle to no intracytoplasmic glycogen",
                    "sub_points": [
                      "Range of epithelial thickness",
                      "Variable amounts of cytoplasm",
                      "Little to no intracytoplasmic glycogen"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Variable appearance depending on degree of maturationElongated (\"streaming\"), sometimes grooved nuclei (\"transitional\")Uniform cytoplasmic halos with peripheral cytoplasmic perinuclear condensation and occasional binucleation (\"pseudokoilocytosis\"); nuclei often central within haloHyperchromatic, small nuclei with increased nuclear to cytoplasmic ratio but uniform chromatin",
                    "sub_points": [
                      "Elongated (\"streaming\"), sometimes grooved nuclei (\"transitional\")",
                      "Uniform cytoplasmic halos with peripheral cytoplasmic perinuclear condensation and occasional binucleation (\"pseudokoilocytosis\"); nuclei often central within halo",
                      "Hyperchromatic, small nuclei with increased nuclear to cytoplasmic ratio but uniform chromatin"
                    ]
                  },
                  {
                    "text": "Generally uniform nuclear size and spacingOccasionally, enlarged superficial nuclei (\"postmenopausal squamous atypia\")",
                    "sub_points": [
                      "Occasionally, enlarged superficial nuclei (\"postmenopausal squamous atypia\")"
                    ]
                  },
                  {
                    "text": "Polarity at base usually maintained"
                  },
                  {
                    "text": "No mitotic activity"
                  }
                ]
              },
              "Ancillary Tests": {
                "Cytology": [
                  {
                    "text": "Increased number of basal and parabasal cells"
                  },
                  {
                    "text": "High nuclear to cytoplasmic ratio"
                  },
                  {
                    "text": "Uniform chromatin"
                  },
                  {
                    "text": "Regular, evenly spaced nuclei, often with grooves"
                  },
                  {
                    "text": "\"Blue blobs\" representing rounded, amorphous masses (bare nuclei or condensed mucus)"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Low MIB1 proliferation indexFocal basal staining only",
                    "sub_points": [
                      "Focal basal staining only"
                    ]
                  },
                  {
                    "text": "p16 and ProEx C negative"
                  }
                ]
              },
              "Differential Diagnosis": {
                "High-Grade Squamous Intraepithelial Lesion (vs. Complete Atrophy)": [
                  {
                    "text": "Loss of epithelial polarity"
                  },
                  {
                    "text": "Greater degree of nuclear variability"
                  },
                  {
                    "text": "Common mitotic activity"
                  },
                  {
                    "text": "Diffuse positivity for p16 (nuclear and cytoplasmic)"
                  },
                  {
                    "text": "Elevated MIB1 proliferation indexPositivity throughout full-thickness epithelium",
                    "sub_points": [
                      "Positivity throughout full-thickness epithelium"
                    ]
                  }
                ],
                "Low-Grade Squamous Intraepithelial Lesion (vs. Partial Atrophy)": [
                  {
                    "text": "Greater variability of nuclear size and chromasia in upper epithelial layers"
                  },
                  {
                    "text": "Variability in halo size and appearanceNuclei often irregularly placed within haloPeripheral cytoplasmic condensation and accentuation of cell borders",
                    "sub_points": [
                      "Nuclei often irregularly placed within halo",
                      "Peripheral cytoplasmic condensation and accentuation of cell borders"
                    ]
                  },
                  {
                    "text": "Atypical parakeratosis"
                  },
                  {
                    "text": "MIB1 positivity in upper epithelial layers"
                  },
                  {
                    "text": "Variable p16 positivity"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Postmenopausal age"
                  },
                  {
                    "text": "Not related to HPV"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Cytologic and histologic features of atrophy typically disappear following treatment with topical estrogen"
                  },
                  {
                    "text": "Atrophic changes should always be considered prior to making diagnosis of a squamous intraepithelial lesion in a postmenopausal patient"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Endometrial Metaplasias": {
            "name": "Endometrial Metaplasias",
            "url": "https://app.pathprimer.com/document/e978bb94-d513-4a79-bc68-8c980142b2c9/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Clinical Issues": [
                  {
                    "text": "Generally menopausal and postmenopausal"
                  },
                  {
                    "text": "Asymptomatic, vaginal discharge/bleeding"
                  },
                  {
                    "text": "Generally excellent if metaplasia not associated with complex architecture; if complex glandular architecture, higher risk of associated carcinoma"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Variable architectural complexity ranging from single layer to papillary tufts to complex microglandular, cribriform growth"
                  },
                  {
                    "text": "Types (which often coexist): Squamous, mucinous, papillary syncytial, tubal (ciliated), eosinophilic, hobnailSquamous: Reparative, morular, ichthyosisMucinous: Endocervical or less commonly intestinal typeTubal metaplasia: Recapitulates fallopian tubeEosinophilic metaplasia: Eosinophilic to granular cytoplasm without ciliaHobnail: Single cells with eosinophilic to vacuolated cytoplasm forming apical bleb",
                    "sub_points": [
                      "Squamous: Reparative, morular, ichthyosis",
                      "Mucinous: Endocervical or less commonly intestinal type",
                      "Tubal metaplasia: Recapitulates fallopian tube",
                      "Eosinophilic metaplasia: Eosinophilic to granular cytoplasm without cilia",
                      "Hobnail: Single cells with eosinophilic to vacuolated cytoplasm forming apical bleb"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Squamous metaplasia: Atypical polypoid adenomyoma, squamous cell carcinoma"
                  },
                  {
                    "text": "Mucinous metaplasia: Endocervical microglandular hyperplasia, mucinous endocervical adenocarcinoma"
                  },
                  {
                    "text": "Tubal (ciliated) metaplasia: Serous carcinoma, cervical adenocarcinoma in situ"
                  },
                  {
                    "text": "Hobnail metaplasia: Serous carcinoma, clear cell carcinoma, Arias-Stella change"
                  }
                ]
              },
              "Terminology": {
                "Definitions": [
                  {
                    "text": "Transformation of conventional endometrioid epithelium by other types of müllerian-type epithelium"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Excess Estrogen Exposure": [
                  {
                    "text": "Anovulation"
                  },
                  {
                    "text": "Hormone replacement therapy"
                  },
                  {
                    "text": "Polycystic ovarian syndrome"
                  }
                ],
                "Chemical/Physical Irritation": [
                  {
                    "text": "Intrauterine device"
                  },
                  {
                    "text": "Curettage or hysteroscopic resection"
                  },
                  {
                    "text": "Chronic endometritis"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Generally menopausal and postmenopausal"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic"
                  },
                  {
                    "text": "Vaginal discharge or bleedingBony spicules in discharge (if osseus metaplasia)",
                    "sub_points": [
                      "Bony spicules in discharge (if osseus metaplasia)"
                    ]
                  },
                  {
                    "text": "Pain rarely"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Repeat sampling/curettageIf prior biopsy with atypical featuresIf osseous fragments",
                    "sub_points": [
                      "If prior biopsy with atypical features",
                      "If osseous fragments"
                    ]
                  },
                  {
                    "text": "Close follow-up in metaplasias associated with higher risk of carcinoma"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Generally excellent if metaplasia not associated with complex architectureIsolated morular squamous metaplasia associated with 5% risk of adenocarcinomaIchthyosis uteri (mature squamous metaplasia) rarely associated with squamous carcinoma",
                    "sub_points": [
                      "Isolated morular squamous metaplasia associated with 5% risk of adenocarcinoma",
                      "Ichthyosis uteri (mature squamous metaplasia) rarely associated with squamous carcinoma"
                    ]
                  },
                  {
                    "text": "If complex glandular architecture, higher risk of associated carcinomaComplex mucinous metaplasias associated with > 60% risk of adenocarcinomaMorular squamous metaplasia associated with 20% risk of adenocarcinoma",
                    "sub_points": [
                      "Complex mucinous metaplasias associated with > 60% risk of adenocarcinoma",
                      "Morular squamous metaplasia associated with 20% risk of adenocarcinoma"
                    ]
                  }
                ]
              },
              "Image Findings": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Thickened endometrial stripe, if ichthyosis uteri"
                  },
                  {
                    "text": "Osseus fragments may appear hyperechoic"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Typically not grossly seen"
                  },
                  {
                    "text": "IchthyosisGray/white nodules/plaques with keratin debris",
                    "sub_points": [
                      "Gray/white nodules/plaques with keratin debris"
                    ]
                  },
                  {
                    "text": "Osseus metaplasiaGray/white hard fragments &/or bony spiculesOften disc shaped",
                    "sub_points": [
                      "Gray/white hard fragments &/or bony spicules",
                      "Often disc shaped"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Metaplasias often coexist (squamous, mucinous, tubal, papillary syncytial, eosinophilic, hobnail, others)"
                  },
                  {
                    "text": "Variable architectural complexity ranging from single cell layer to papillary tufts to complex microglandular, cribriform growth (mucinous and tubal most commonly)Complex growth often signifies neoplasia",
                    "sub_points": [
                      "Complex growth often signifies neoplasia"
                    ]
                  },
                  {
                    "text": "Squamous metaplasiaReparativeSmall, scattered foci of mature squamous epithelium with variable glycogenization replacing normal surface endometriumOften associated with chronic endometritisMorularBalls of relatively immature squamous epithelium ± central necrosisAt most mild cytologic atypiaLacks mitotic activityIchthyosisMature squamous epithelium extensively replacing endometrial surface/glandsMature squamous-lined, cyst-like spaces within myometrium (replacement of adenomyosis)",
                    "sub_points": [
                      "ReparativeSmall, scattered foci of mature squamous epithelium with variable glycogenization replacing normal surface endometriumOften associated with chronic endometritis",
                      "Small, scattered foci of mature squamous epithelium with variable glycogenization replacing normal surface endometrium",
                      "Often associated with chronic endometritis",
                      "MorularBalls of relatively immature squamous epithelium ± central necrosisAt most mild cytologic atypiaLacks mitotic activity",
                      "Balls of relatively immature squamous epithelium ± central necrosis",
                      "At most mild cytologic atypia",
                      "Lacks mitotic activity",
                      "IchthyosisMature squamous epithelium extensively replacing endometrial surface/glandsMature squamous-lined, cyst-like spaces within myometrium (replacement of adenomyosis)",
                      "Mature squamous epithelium extensively replacing endometrial surface/glands",
                      "Mature squamous-lined, cyst-like spaces within myometrium (replacement of adenomyosis)"
                    ]
                  },
                  {
                    "text": "Mucinous metaplasiaColumnar cells with apical mucin and basally oriented nuclei resembling endocervical epitheliumIntestinal differentiation (goblet, Paneth cells) rareCytologic atypia uncommon even with complex growth",
                    "sub_points": [
                      "Columnar cells with apical mucin and basally oriented nuclei resembling endocervical epithelium",
                      "Intestinal differentiation (goblet, Paneth cells) rare",
                      "Cytologic atypia uncommon even with complex growth"
                    ]
                  },
                  {
                    "text": "Papillary syncytial metaplasiaEndometrial surface (typically) and superficial glands (less often) involvedSyncytial-like, disorganized aggregates of squamoid-appearing cells with eosinophilic cytoplasm and indistinct cell borders forming pseudopapillaeDegenerative-type nuclear changes with pyknotic nuclei &/or smudgy chromatin commonMay show occasional mitosesOften associated with stromal breakdown related to abnormal cycles",
                    "sub_points": [
                      "Endometrial surface (typically) and superficial glands (less often) involved",
                      "Syncytial-like, disorganized aggregates of squamoid-appearing cells with eosinophilic cytoplasm and indistinct cell borders forming pseudopapillae",
                      "Degenerative-type nuclear changes with pyknotic nuclei &/or smudgy chromatin common",
                      "May show occasional mitoses",
                      "Often associated with stromal breakdown related to abnormal cycles"
                    ]
                  },
                  {
                    "text": "Tubal (ciliated) metaplasiaOften coexists with eosinophilic metaplasiaColumnar cells with bland, round vesicular nuclei, clear or eosinophilic cytoplasm, terminal bar, and luminal ciliaMay show mild cytologic atypia",
                    "sub_points": [
                      "Often coexists with eosinophilic metaplasia",
                      "Columnar cells with bland, round vesicular nuclei, clear or eosinophilic cytoplasm, terminal bar, and luminal cilia",
                      "May show mild cytologic atypia"
                    ]
                  },
                  {
                    "text": "Eosinophilic (oxyphilic, oncocytic) metaplasiaColumnar cells with abundant eosinophilic to granular cytoplasm lacking ciliaDue to abundant mitochondria (if oncocytic)No nuclear pleomorphism and infrequent mitoses",
                    "sub_points": [
                      "Columnar cells with abundant eosinophilic to granular cytoplasm lacking ciliaDue to abundant mitochondria (if oncocytic)",
                      "Due to abundant mitochondria (if oncocytic)",
                      "No nuclear pleomorphism and infrequent mitoses"
                    ]
                  },
                  {
                    "text": "Hobnail metaplasiaCommonly associated with infarcted polyps or surface reparative changeSingle cells with moderate eosinophilic to vacuolated cytoplasmApical bleb imparting a \"racquet\" or \"teardrop\" shapeAt most, mild nuclear pleomorphismInfrequent mitoses",
                    "sub_points": [
                      "Commonly associated with infarcted polyps or surface reparative change",
                      "Single cells with moderate eosinophilic to vacuolated cytoplasmApical bleb imparting a \"racquet\" or \"teardrop\" shape",
                      "Apical bleb imparting a \"racquet\" or \"teardrop\" shape",
                      "At most, mild nuclear pleomorphism",
                      "Infrequent mitoses"
                    ]
                  },
                  {
                    "text": "Other less common metaplasiasPapillary proliferations (Lehman and Hart)True papillae with variable degree of branching often localized to endometrial surface, but may be intraglandularOften seen within endometrial polypsAssociated mucinous, eosinophilic, squamous, &/or hobnail metaplasia commonBland, single to multilayered epitheliumAt most, mild cytologic atypiaOnly occasional mitotic figuresArias-Stella changePseudopapillary or tufted appearance of preexisting endometrial glandsCells with abundant, clear to pale eosinophilic cytoplasm that may be hobnailingVariable nuclear size and shape, many with degenerative appearance (smudged nuclei) with absent mitosesAdjacent decidualized stroma, if pregnantSecretory: Sub- or supranuclear vacuoles as seen in secretory phase endometriumClear cell: Columnar cells with abundant clear cytoplasm and apically oriented nucleiEndometrial stromalOsseous: Woven (mature) boneSmooth muscle: Small nodules composed of short fascicles",
                    "sub_points": [
                      "Papillary proliferations (Lehman and Hart)True papillae with variable degree of branching often localized to endometrial surface, but may be intraglandularOften seen within endometrial polypsAssociated mucinous, eosinophilic, squamous, &/or hobnail metaplasia commonBland, single to multilayered epitheliumAt most, mild cytologic atypiaOnly occasional mitotic figures",
                      "True papillae with variable degree of branching often localized to endometrial surface, but may be intraglandular",
                      "Often seen within endometrial polyps",
                      "Associated mucinous, eosinophilic, squamous, &/or hobnail metaplasia common",
                      "Bland, single to multilayered epithelium",
                      "At most, mild cytologic atypia",
                      "Only occasional mitotic figures",
                      "Arias-Stella changePseudopapillary or tufted appearance of preexisting endometrial glandsCells with abundant, clear to pale eosinophilic cytoplasm that may be hobnailingVariable nuclear size and shape, many with degenerative appearance (smudged nuclei) with absent mitosesAdjacent decidualized stroma, if pregnant",
                      "Pseudopapillary or tufted appearance of preexisting endometrial glands",
                      "Cells with abundant, clear to pale eosinophilic cytoplasm that may be hobnailing",
                      "Variable nuclear size and shape, many with degenerative appearance (smudged nuclei) with absent mitoses",
                      "Adjacent decidualized stroma, if pregnant",
                      "Secretory: Sub- or supranuclear vacuoles as seen in secretory phase endometrium",
                      "Clear cell: Columnar cells with abundant clear cytoplasm and apically oriented nuclei",
                      "Endometrial stromalOsseous: Woven (mature) boneSmooth muscle: Small nodules composed of short fascicles",
                      "Osseous: Woven (mature) bone",
                      "Smooth muscle: Small nodules composed of short fascicles"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "Tubal (ciliated) metaplasiaLow Ki-67 index, p16 patchy (+), p53 wild type",
                    "sub_points": [
                      "Low Ki-67 index, p16 patchy (+), p53 wild type"
                    ]
                  },
                  {
                    "text": "Papillary syncytial metaplasiaGenerally ER(+), p16 diffuse (+), p53 wild type",
                    "sub_points": [
                      "Generally ER(+), p16 diffuse (+), p53 wild type"
                    ]
                  },
                  {
                    "text": "Intestinal metaplasiaCK20(+), CDX-2(+), p16(-)",
                    "sub_points": [
                      "CK20(+), CDX-2(+), p16(-)"
                    ]
                  },
                  {
                    "text": "Arias-StellaKi-67 index low, p53(-)",
                    "sub_points": [
                      "Ki-67 index low, p53(-)"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Squamous Metaplasia": [
                  {
                    "text": "Atypical polypoid adenomyomaSessile, generally broad-based polypProminent fibromyomatous stroma",
                    "sub_points": [
                      "Sessile, generally broad-based polyp",
                      "Prominent fibromyomatous stroma"
                    ]
                  },
                  {
                    "text": "Squamous cell carcinomaMalignant cytologic features",
                    "sub_points": [
                      "Malignant cytologic features"
                    ]
                  }
                ],
                "Mucinous Metaplasia": [
                  {
                    "text": "Endocervical microglandular hyperplasiaSub- and supranuclear vacuolesReserve cell proliferation",
                    "sub_points": [
                      "Sub- and supranuclear vacuoles",
                      "Reserve cell proliferation"
                    ]
                  },
                  {
                    "text": "Mucinous endocervical adenocarcinomaCEA(+), p16(+) vimentin (-)",
                    "sub_points": [
                      "CEA(+), p16(+) vimentin (-)"
                    ]
                  }
                ],
                "Tubal (Ciliated) Metaplasia": [
                  {
                    "text": "Serous carcinomaOften broad-based papillae with higher order branching or solid growth with necrosisMarked nuclear and cytologic atypia with numerous, often bizarre mitosesp53(+), p16(+), ER(-), Ki-67 index usually high",
                    "sub_points": [
                      "Often broad-based papillae with higher order branching or solid growth with necrosis",
                      "Marked nuclear and cytologic atypia with numerous, often bizarre mitoses",
                      "p53(+), p16(+), ER(-), Ki-67 index usually high"
                    ]
                  },
                  {
                    "text": "Cervical adenocarcinoma in situNuclear hyperchromasia, apical mitoses, and apoptosis",
                    "sub_points": [
                      "Nuclear hyperchromasia, apical mitoses, and apoptosis"
                    ]
                  }
                ],
                "Hobnail Metaplasia": [
                  {
                    "text": "Serous carcinomaMarked nuclear atypia with frequent mitosesKi-67 index high, p53(+)",
                    "sub_points": [
                      "Marked nuclear atypia with frequent mitoses",
                      "Ki-67 index high, p53(+)"
                    ]
                  },
                  {
                    "text": "Clear cell carcinomaAdmixture of typical histologic patternsLarge, markedly atypical cells",
                    "sub_points": [
                      "Admixture of typical histologic patterns",
                      "Large, markedly atypical cells"
                    ]
                  },
                  {
                    "text": "Arias-Stella changeAdjacent decidualized stroma",
                    "sub_points": [
                      "Adjacent decidualized stroma"
                    ]
                  }
                ],
                "Papillary Proliferations (Lehman and Hart)": [
                  {
                    "text": "Endometrial adenocarcinomaTypically complex cribriform growthMore prominent nuclear atypia",
                    "sub_points": [
                      "Typically complex cribriform growth",
                      "More prominent nuclear atypia"
                    ]
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "If associated with complex glandular architecture that is not diagnostic of precancer, patients should undergo repeat sampling to exclude a coexistent neoplasia"
                  },
                  {
                    "text": "Although still within spectrum of wild-type p53 staining, papillary syncytial metaplasia typically shows greater percentage of positive cells than other types of metaplasia"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Fallopian Tube Metaplasia": {
            "name": "Fallopian Tube Metaplasia",
            "url": "https://app.pathprimer.com/document/81d9e804-17b9-421a-93b8-e8068d938103/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Clinical Issues": [
                  {
                    "text": "Involves tubal epithelium or serosal surface"
                  },
                  {
                    "text": "Presentation generally asymptomatic"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Transitional: Nuclear grooves, no mitoses"
                  },
                  {
                    "text": "Mucinous: Often pyloric phenotype"
                  },
                  {
                    "text": "Squamous: Stratified epithelium with maturation"
                  },
                  {
                    "text": "Endometrioid: Pseudostratified nuclei with no atypiaMay show sub- or supranuclear vacuoles (secretory change)",
                    "sub_points": [
                      "May show sub- or supranuclear vacuoles (secretory change)"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "p53 negative"
                  },
                  {
                    "text": "Ki-67 proliferation index low"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Salpingitis"
                  },
                  {
                    "text": "Endometriosis"
                  }
                ]
              },
              "Terminology": {
                "Definitions": [
                  {
                    "text": "Altered differentiation of tubal epithelium"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Reactive/Reparative": [
                  {
                    "text": "Often seen associated with adhesions, endometriosis, and chronic inflammation"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Variable"
                  }
                ],
                "Site": [
                  {
                    "text": "Fallopian tubal epithelium or serosal surface"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic or symptoms due to associated disease"
                  },
                  {
                    "text": "Mucinous metaplasia associated withPeutz-Jeghers syndromeMucinous tumors of ovary or cervixMucinous tumors of gastrointestinal tract, most commonly appendixOther types of concurrent metaplasia in fallopian tube",
                    "sub_points": [
                      "Peutz-Jeghers syndrome",
                      "Mucinous tumors of ovary or cervix",
                      "Mucinous tumors of gastrointestinal tract, most commonly appendix",
                      "Other types of concurrent metaplasia in fallopian tube"
                    ]
                  },
                  {
                    "text": "Extensive squamous metaplasia associated with peritoneal dialysis"
                  }
                ],
                "Treatment": [
                  {
                    "text": "None"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Transitional metaplasiaWhite to yellow small nodules, plaques, or cysts on serosal surface or in fimbrial mucosa (if Walthard rests)",
                    "sub_points": [
                      "White to yellow small nodules, plaques, or cysts on serosal surface or in fimbrial mucosa (if Walthard rests)"
                    ]
                  },
                  {
                    "text": "Mucinous metaplasiaAbundant mucinous luminal contents may be noted",
                    "sub_points": [
                      "Abundant mucinous luminal contents may be noted"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Transitional metaplasiaMultilayered epithelium with simple architectureSmall solid nests (typically Walthard rests)Small cysts lined with variably attenuated epithelium with inspissated eosinophilic secretions (typically Walthard rests)Sharply demarcated epithelial thickening (mucosal or serosal)Rarely may show complex architecture",
                    "sub_points": [
                      "Multilayered epithelium with simple architectureSmall solid nests (typically Walthard rests)Small cysts lined with variably attenuated epithelium with inspissated eosinophilic secretions (typically Walthard rests)Sharply demarcated epithelial thickening (mucosal or serosal)",
                      "Small solid nests (typically Walthard rests)",
                      "Small cysts lined with variably attenuated epithelium with inspissated eosinophilic secretions (typically Walthard rests)",
                      "Sharply demarcated epithelial thickening (mucosal or serosal)",
                      "Rarely may show complex architecture"
                    ]
                  },
                  {
                    "text": "Mucinous metaplasia1 cell layer of mucinous epithelium; occasional glands within tubal stroma",
                    "sub_points": [
                      "1 cell layer of mucinous epithelium; occasional glands within tubal stroma"
                    ]
                  },
                  {
                    "text": "Squamous metaplasiaStratified epithelium showing maturation",
                    "sub_points": [
                      "Stratified epithelium showing maturation"
                    ]
                  },
                  {
                    "text": "Endometrioid metaplasiaPredominately simple columnar epithelium",
                    "sub_points": [
                      "Predominately simple columnar epithelium"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Transitional metaplasiaBenign-appearing cells with abundant cytoplasm, fine chromatin, inconspicuous nucleoliNuclear grooves",
                    "sub_points": [
                      "Benign-appearing cells with abundant cytoplasm, fine chromatin, inconspicuous nucleoli",
                      "Nuclear grooves"
                    ]
                  },
                  {
                    "text": "Mucinous metaplasiaBasally oriented nuclei and abundant apical mucin (often with pyloric phenotype)",
                    "sub_points": [
                      "Basally oriented nuclei and abundant apical mucin (often with pyloric phenotype)"
                    ]
                  },
                  {
                    "text": "Squamous metaplasiaCells with abundant eosinophilic cytoplasm, but without keratinization",
                    "sub_points": [
                      "Cells with abundant eosinophilic cytoplasm, but without keratinization"
                    ]
                  },
                  {
                    "text": "Endometrioid metaplasiaVariably pseudostratified hyperchromatic nuclei with nuclear overlap but no atypiaSecretory variant: Sub- or supranuclear vacuoles",
                    "sub_points": [
                      "Variably pseudostratified hyperchromatic nuclei with nuclear overlap but no atypia",
                      "Secretory variant: Sub- or supranuclear vacuoles"
                    ]
                  },
                  {
                    "text": "Eosinophilic metaplasiaProminent pink granular cytoplasm with round nuclei and nucleoli",
                    "sub_points": [
                      "Prominent pink granular cytoplasm with round nuclei and nucleoli"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "MUC1 and MUC6 positive, if pyloric-type mucinous metaplasia"
                  },
                  {
                    "text": "p63 positive, if transitional and squamous metaplasia"
                  },
                  {
                    "text": "Ki-67 proliferation index low"
                  },
                  {
                    "text": "p53 negative"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Salpingitis": [
                  {
                    "text": "History of pelvic inflammatory disease"
                  },
                  {
                    "text": "Peritubal adhesions"
                  },
                  {
                    "text": "Dense acute and chronic inflammation"
                  },
                  {
                    "text": "Fusion of plicae, if chronic"
                  }
                ],
                "Endometriosis": [
                  {
                    "text": "Endometrial-type stroma"
                  },
                  {
                    "text": "Associated with hemorrhage and hemosiderin-laden macrophages"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Microscopic appearances of some metaplasias may overlap with neoplastic precursors but showNo significant cytologic atypia or mitotic activityp53 wild type",
                    "sub_points": [
                      "No significant cytologic atypia or mitotic activity",
                      "p53 wild type"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Immature Squamous Metaplasia, Cervix": {
            "name": "Immature Squamous Metaplasia, Cervix",
            "url": "https://app.pathprimer.com/document/c982fdf2-a1b6-48db-8f50-2aaf635f2114/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Clinical Issues": [
                  {
                    "text": "Incidental finding in women of reproductive age"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Overlying endocervical cells on surface"
                  },
                  {
                    "text": "Increased but uniform nuclear density"
                  },
                  {
                    "text": "Distinct cell borders; apparent spinous processes"
                  },
                  {
                    "text": "Minimal cytologic atypia with uniform nuclear size and shape, fine chromatin, and discernible nucleoli"
                  },
                  {
                    "text": "Variable mitotic rate without atypical forms"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "p63 positive"
                  },
                  {
                    "text": "p16 usually negative, occasionally focally positive"
                  },
                  {
                    "text": "MIB1 confined to basal/parabasal layers"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Squamous intraepithelial lesion in metaplasia"
                  },
                  {
                    "text": "High-grade squamous intraepithelial lesion"
                  }
                ]
              },
              "Terminology": {
                "Definitions": [
                  {
                    "text": "Nonneoplastic proliferation of immature squamous cells"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Reactive Physiologic Process": [
                  {
                    "text": "Results from chronic irritation of columnar endocervical epithelium that is exposed to acidic vaginal environmentIncreasing estrogen around puberty contributes to cervical ectropion, exposing endocervical epithelium",
                    "sub_points": [
                      "Increasing estrogen around puberty contributes to cervical ectropion, exposing endocervical epithelium"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Common"
                  }
                ],
                "Age": [
                  {
                    "text": "Reproductive"
                  }
                ],
                "Site": [
                  {
                    "text": "At or near squamocolumnar transformation zone"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Incidental finding"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Progresses to mature squamous metaplasia that is indistinguishable from ectocervical epithelium but has preserved scalloped contour of preexisting endocervical glands"
                  }
                ],
                "Treatment": [
                  {
                    "text": "None"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  }
                ]
              },
              "Macroscopic Features": {
                "On Colposcopic Examination": [
                  {
                    "text": "At or near squamocolumnar transformation zone"
                  },
                  {
                    "text": "Often sharply demarcated"
                  },
                  {
                    "text": "May have blue-white appearance with acetic acid application"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Lobular or nested arrangement of immature squamous cells"
                  },
                  {
                    "text": "Increased but uniform nuclear density"
                  },
                  {
                    "text": "Preservation of cytoplasmic maturation at surface"
                  },
                  {
                    "text": "Evenly spaced nuclei with minimal crowding"
                  },
                  {
                    "text": "Distinct cell borders often with apparent spinous processes"
                  },
                  {
                    "text": "Mucin droplets or endocervical cells on surface"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Minimal cytologic atypia with uniform nuclear size and shape"
                  },
                  {
                    "text": "Fine chromatin and discernible nucleoli"
                  },
                  {
                    "text": "Variable mitotic rate, but not atypical mitotic forms"
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "p63 diffusely positive"
                  },
                  {
                    "text": "p16 usually negative but may be focally positive"
                  },
                  {
                    "text": "Ki-67 confined to basal/parabasal layer(s)"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Squamous Intraepithelial Lesion in Setting of Metaplasia": [
                  {
                    "text": "HPV-related changes that may be subtle"
                  },
                  {
                    "text": "Diffuse p16 positivity"
                  },
                  {
                    "text": "Best considered low-grade squamous intraepithelial lesion, or squamous intraepithelial lesion, difficult to grade (CIN I-II)"
                  }
                ],
                "High-Grade Squamous Intraepithelial Lesion": [
                  {
                    "text": "Higher nuclear density often with nuclear overlapping and hyperchromasia"
                  },
                  {
                    "text": "Variation in nuclear size with irregular nuclear contours and high N:C ratio"
                  },
                  {
                    "text": "Mitoses at all levels of epithelium, including atypical forms"
                  },
                  {
                    "text": "Apoptosis and dyskeratotic cells may be seen"
                  },
                  {
                    "text": "p16 diffusely positive"
                  },
                  {
                    "text": "Ki-67 full-thickness positivity"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Suspect a squamous intraepithelial lesion if atypical mitotic figures, high-nuclear density in upper epithelial layers, or nuclear atypia at epithelial surfaces are present"
                  },
                  {
                    "text": "Squamous intraepithelial lesions in setting of metaplasia may be difficult to grade"
                  },
                  {
                    "text": "\"Atypical immature metaplasia\" denotes squamous intraepithelial lesions involving metaplasia"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Transitional Cell Metaplasia": {
            "name": "Transitional Cell Metaplasia",
            "url": "https://app.pathprimer.com/document/878cebff-d544-40be-9ec0-14598ed73d1c/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Clinical Issues": [
                  {
                    "text": "Most commonly postmenopausal women"
                  },
                  {
                    "text": "Cervix; uncommonly vagina, vulva"
                  },
                  {
                    "text": "Can present as abnormal Papanicolaou smear"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Epithelium > 10 cell layers thick"
                  },
                  {
                    "text": "Elongated (\"streaming\") nuclei with characteristic longitudinal nuclear grooves (\"coffee bean\")"
                  },
                  {
                    "text": "Uniform nuclear size, nuclear spacing, and chromatin"
                  },
                  {
                    "text": "Mitoses rare"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "p16 and HPV negative"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "High-grade squamous intraepithelial lesion (HSIL/CIN III)"
                  },
                  {
                    "text": "Low-grade squamous intraepithelial lesion (LSIL/CIN I) in metaplasia"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Transitional cell metaplasia (TCM)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Postmenopausal squamous atypia"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Squamous epithelium that cytologically and histologically resembles urothelium, considered to be within spectrum of atrophic changes"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Uncommon"
                  }
                ],
                "Age": [
                  {
                    "text": "Most commonly postmenopausal women"
                  }
                ],
                "Site": [
                  {
                    "text": "Cervix"
                  },
                  {
                    "text": "Uncommonly, vagina and vulva"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Usually asymptomatic"
                  },
                  {
                    "text": "Incidental finding"
                  },
                  {
                    "text": "Prior abnormal Papanicolaou smearMost commonly: Atypical squamous cells, cannot rule out a high-grade lesion (ASC-H)",
                    "sub_points": [
                      "Most commonly: Atypical squamous cells, cannot rule out a high-grade lesion (ASC-H)"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Generally no therapy as there is no increased risk of squamous dysplasia or carcinoma"
                  },
                  {
                    "text": "If symptomatic, topical estrogen"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Resembles hyperplastic urothelium"
                  },
                  {
                    "text": "Epithelium > 10 cell layers thick"
                  },
                  {
                    "text": "Disordered or streaming appearance"
                  },
                  {
                    "text": "Lack of \"picket-fence\" vertical orientation of basal layer"
                  },
                  {
                    "text": "Superficial cells may resemble umbrella cells"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Elongated (\"streaming\") nuclei"
                  },
                  {
                    "text": "Characteristic longitudinal nuclear grooves (\"coffee bean\")"
                  },
                  {
                    "text": "Uniform nuclear size, nuclear spacing, and chromatin"
                  },
                  {
                    "text": "Rare mitoses"
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "p63 positive"
                  },
                  {
                    "text": "Focal CK13, CK17, CK18 positivity"
                  },
                  {
                    "text": "p16 and CK20 negative"
                  },
                  {
                    "text": "May stain for calcitonin or serotonin"
                  }
                ],
                "PCR": [
                  {
                    "text": "HPV negative"
                  }
                ]
              },
              "Differential Diagnosis": {
                "High-Grade Squamous Intraepithelial Lesion (HSIL/CIN III)": [
                  {
                    "text": "Lacks nuclear grooves"
                  },
                  {
                    "text": "Hyperchromatic nuclei with coarse chromatin"
                  },
                  {
                    "text": "Frequent mitoses"
                  },
                  {
                    "text": "p16 strongly and diffusely positive"
                  }
                ],
                "Low-Grade Squamous Intraepithelial Lesion (LSIL/CIN I) in Metaplasia": [
                  {
                    "text": "Greater variability in nuclear size"
                  },
                  {
                    "text": "Less uniform chromatin distribution"
                  },
                  {
                    "text": "Subtle koilocytotic changes"
                  }
                ],
                "Reactive Squamous Metaplastic Epithelium": [
                  {
                    "text": "Preservation of normal cellular orientation"
                  },
                  {
                    "text": "Lacks nuclear grooves"
                  },
                  {
                    "text": "Usually more abundant, polygonal cytoplasm"
                  },
                  {
                    "text": "Mitoses may be frequent"
                  }
                ],
                "Atrophy": [
                  {
                    "text": "Attenuated squamous epithelium"
                  },
                  {
                    "text": "Small nuclear halos with centrally located nuclei"
                  },
                  {
                    "text": "Lacks nuclear grooves"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [],
                "Age distribution": [
                  {
                    "text": "Postmenopausal"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "In postmenopausal women, consider transitional cell metaplasia before diagnosing HSIL or ASC-H on Papanicolaou smear"
                  },
                  {
                    "text": "Disordered streaming architecture, fine chromatin pattern, and longitudinal nuclear grooves help distinguish from squamous dysplasia"
                  },
                  {
                    "text": "Rare or absent mitotic activity in transitional cell metaplasia separates it from squamous dysplasia"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Barrett Esophagus": {
            "name": "Barrett Esophagus",
            "url": "https://app.pathprimer.com/document/9a583ccf-f18b-4a28-a076-63d3bf8056a7/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Columnar-lined esophagus"
                  },
                  {
                    "text": "Change of esophageal mucosaAny lengthVisibility at endoscopyContains intestinal metaplasia on biopsy (USA definition)",
                    "sub_points": [
                      "Any length",
                      "Visibility at endoscopy",
                      "Contains intestinal metaplasia on biopsy (USA definition)"
                    ]
                  },
                  {
                    "text": "In Japan, United Kingdom\"Barrett esophagus\" is often used for any columnar mucosa found in tubular esophagus",
                    "sub_points": [
                      "\"Barrett esophagus\" is often used for any columnar mucosa found in tubular esophagus"
                    ]
                  },
                  {
                    "text": "In USA and most other placesTerm restricted to intestinal metaplasia and requires endoscopic correlation",
                    "sub_points": [
                      "Term restricted to intestinal metaplasia and requires endoscopic correlation"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Gastroesophageal reflux disease"
                  },
                  {
                    "text": "Male gender; > 50 years"
                  },
                  {
                    "text": "Obesity"
                  },
                  {
                    "text": "White race"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "10-20% of persons with longstanding gastroesophageal reflux"
                  },
                  {
                    "text": "Overall incidence unknown in USA, but prevalence of 1.6% in general Swedish population"
                  },
                  {
                    "text": "Presents as \"heartburn\""
                  },
                  {
                    "text": "Strong male predominance"
                  },
                  {
                    "text": "Estimated annual risk of adenocarcinoma (pooled data) in patients with Barrett esophagus: 0.5-1%However, 2011 Danish study reports closer to 0.1%",
                    "sub_points": [
                      "However, 2011 Danish study reports closer to 0.1%"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Columnar metaplasia with goblet cells involving esophagusGoblet cells not required in United Kingdom and Japan",
                    "sub_points": [
                      "Goblet cells not required in United Kingdom and Japan"
                    ]
                  },
                  {
                    "text": "All reports must designate dysplasia category"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Barrett esophagus (BE)"
                  },
                  {
                    "text": "Barrett oesophagus (BO) (British spelling)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Columnar-lined esophagus"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Change of esophageal mucosaAny lengthVisible at endoscopyContains intestinal metaplasia on biopsy",
                    "sub_points": [
                      "Any length",
                      "Visible at endoscopy",
                      "Contains intestinal metaplasia on biopsy"
                    ]
                  },
                  {
                    "text": "Japan, United Kingdom: \"Barrett esophagus\" is often used for any columnar mucosa found in tubular esophagus"
                  },
                  {
                    "text": "In USA and most other places: Term restricted to intestinal metaplasia and requires endoscopic correlation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Risk Factors": [
                  {
                    "text": "Gastroesophageal reflux diseaseHiatal hernia\"Heartburn\" symptoms",
                    "sub_points": [
                      "Hiatal hernia",
                      "\"Heartburn\" symptoms"
                    ]
                  },
                  {
                    "text": "Male gender"
                  },
                  {
                    "text": "Obesity"
                  },
                  {
                    "text": "White race"
                  },
                  {
                    "text": "Smoking"
                  },
                  {
                    "text": "Alcohol use"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "10-20% of persons with longstanding gastroesophageal reflux"
                  },
                  {
                    "text": "Overall incidence unknown in USA, but prevalence of 1.6% in general Swedish population"
                  }
                ],
                "Age": [
                  {
                    "text": "Typically in 5th decade"
                  }
                ],
                "Sex": [
                  {
                    "text": "Strong male predominance"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Whites most common"
                  },
                  {
                    "text": "Rare in African Americans"
                  },
                  {
                    "text": "Rare in Southeast AsiansNo word for \"heartburn\" exists in a host of Asian languages",
                    "sub_points": [
                      "No word for \"heartburn\" exists in a host of Asian languages"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "CoughSome patients present with cough from reflux",
                    "sub_points": [
                      "Some patients present with cough from reflux"
                    ]
                  },
                  {
                    "text": "\"Heartburn\""
                  },
                  {
                    "text": "Some patients are asymptomatic"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Fundoplication is option to treat reflux; may not be good idea if patient already has Barrett mucosa"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Anti-reflux medications such as proton-pump inhibitors are mainstay of treatment, although antacids and H2 blockers can also be used"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Key issue: BE is precursor to esophageal adenocarcinomaEstimated annual risk of adenocarcinoma (pooled data) in patients with BE: 0.5-1%However, 2011 Danish study reports closer to 0.1%",
                    "sub_points": [
                      "Estimated annual risk of adenocarcinoma (pooled data) in patients with BE: 0.5-1%However, 2011 Danish study reports closer to 0.1%",
                      "However, 2011 Danish study reports closer to 0.1%"
                    ]
                  },
                  {
                    "text": "Most patients have BE that does not progress to cancer"
                  },
                  {
                    "text": "Generally of little significance other than as cancer risk factor"
                  }
                ]
              },
              "MACROSCOPIC": {
                "Velvety Mucosa at Endoscopy": [
                  {
                    "text": "Salmon-colored \"tongues\" above gastroesophageal junctionLong segment > 3 cmShort segment < 3 cmUltrashort segment < 1 cm",
                    "sub_points": [
                      "Long segment > 3 cm",
                      "Short segment < 3 cm",
                      "Ultrashort segment < 1 cm"
                    ]
                  },
                  {
                    "text": "Biopsy specimens required for diagnosis"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Columnar metaplasia with goblet cells involving esophagus (goblet cells not required in United Kingdom and Japan)Debate surrounds risk of cardiac-type mucosa to progress to carcinomaBiopsies specimens should be from tubular esophagus",
                    "sub_points": [
                      "Debate surrounds risk of cardiac-type mucosa to progress to carcinoma",
                      "Biopsies specimens should be from tubular esophagus"
                    ]
                  }
                ],
                "PAS-Alcian Blue Staining": [
                  {
                    "text": "Usually shows incomplete intestinal metaplasiaGoblet cells (blue) interspersed between cells with apical neutral mucin droplet (pink) like those in gastric mucosa",
                    "sub_points": [
                      "Goblet cells (blue) interspersed between cells with apical neutral mucin droplet (pink) like those in gastric mucosa"
                    ]
                  }
                ],
                "Nondysplastic Barrett Esophagus": [
                  {
                    "text": "Shows surface maturation"
                  }
                ],
                "Multilayered Epithelium": [
                  {
                    "text": "Morphologic and ultrastructural features of both squamous and columnar epitheliaPossible precursor to BE",
                    "sub_points": [
                      "Possible precursor to BE"
                    ]
                  },
                  {
                    "text": "Cytokeratin expression profile similar to that of columnar epithelium in BECK13 and CK19 in basal \"squamoid\" cellsCK7, CK8/18, CK19, and CK20 in superficial \"columnar\" cells",
                    "sub_points": [
                      "CK13 and CK19 in basal \"squamoid\" cells",
                      "CK7, CK8/18, CK19, and CK20 in superficial \"columnar\" cells"
                    ]
                  },
                  {
                    "text": "High capacity for cellular proliferationKi-67(+) predominantly in basal cells in about 90% of cases; similar to columnar epithelium in BE",
                    "sub_points": [
                      "Ki-67(+) predominantly in basal cells in about 90% of cases; similar to columnar epithelium in BE"
                    ]
                  },
                  {
                    "text": "Differentiation similar to columnar epithelium in BETGF-α(+), EGFR(+), pS2(+), and villin (+) in 100%, 100%, 93%, and 66% of cases, respectively",
                    "sub_points": [
                      "TGF-α(+), EGFR(+), pS2(+), and villin (+) in 100%, 100%, 93%, and 66% of cases, respectively"
                    ]
                  },
                  {
                    "text": "Mucin production similar to columnar epithelium in BENeutral mucin, sialomucin, and sulfomucin in 88%, 100%, and 71% of cases, respectively",
                    "sub_points": [
                      "Neutral mucin, sialomucin, and sulfomucin in 88%, 100%, and 71% of cases, respectively"
                    ]
                  },
                  {
                    "text": "All reports must designate dysplasia categoryNegativeLow gradeHigh grade",
                    "sub_points": [
                      "Negative",
                      "Low grade",
                      "High grade"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Intestinal Metaplasia of Gastric Cardia": [
                  {
                    "text": "May be impossible to distinguishClue: Cardiac intestinal metaplasia often of complete typeShows absorptive (PAS[-]) rather than neutral mucin-producing cells between goblet cellsPaneth cellsMore likely to be associated withHelicobacter pyloriMore likely to have focal oxyntic cells (parietal cells)Must be correlated with endoscopic impression regarding site from which sample was obtained",
                    "sub_points": [
                      "Clue: Cardiac intestinal metaplasia often of complete typeShows absorptive (PAS[-]) rather than neutral mucin-producing cells between goblet cellsPaneth cells",
                      "Shows absorptive (PAS[-]) rather than neutral mucin-producing cells between goblet cells",
                      "Paneth cells",
                      "More likely to be associated withHelicobacter pylori",
                      "More likely to have focal oxyntic cells (parietal cells)",
                      "Must be correlated with endoscopic impression regarding site from which sample was obtained"
                    ]
                  }
                ],
                "Esophageal Submucosal Glands": [
                  {
                    "text": "Stain strongly with Alcian blue"
                  },
                  {
                    "text": "Lack goblet cell morphology"
                  },
                  {
                    "text": "Found in submucosa; usually absent on mucosal biopsies"
                  }
                ],
                "Gastric Foveolar Cells With Alcianophilia": [
                  {
                    "text": "Lack goblet cell morphology despite blue tint on Alcian blue stain"
                  },
                  {
                    "text": "Sometimes termed \"tall blue columnars\""
                  }
                ],
                "\"Carryover\" of Small Intestinal Tissue": [
                  {
                    "text": "Looks like small intestinePaneth cells numerousVilliBrush border",
                    "sub_points": [
                      "Paneth cells numerous",
                      "Villi",
                      "Brush border"
                    ]
                  },
                  {
                    "text": "In patients undergoing several upper GI tract biopsiesIncomplete rinsing of biopsy forceps between biopsy sites",
                    "sub_points": [
                      "Incomplete rinsing of biopsy forceps between biopsy sites"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Always correlate with biopsy site and endoscopic impression"
                  },
                  {
                    "text": "If endoscopist is uncertain about presence of \"tongues,\" pathologist is uncertain about presence of Barrett mucosaHowever, identifying esophageal submucosal glands, ducts, or multilayered mucosa might suggest that biopsy specimen is from tubular esophagus",
                    "sub_points": [
                      "However, identifying esophageal submucosal glands, ducts, or multilayered mucosa might suggest that biopsy specimen is from tubular esophagus"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Acute Myocardial Infarction": {
            "name": "Acute Myocardial Infarction",
            "url": "https://app.pathprimer.com/document/547bc38f-819b-4b72-8b14-b5e3cd23753d/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Irreversible myocardial damage caused by prolonged ischemia, resulting from sustained imbalance of perfusion, supply, and demand"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Complications: AcuteRupture of myocardium (tamponade, acquired ventricular septal defect, ruptured papillary muscle)",
                    "sub_points": [
                      "Rupture of myocardium (tamponade, acquired ventricular septal defect, ruptured papillary muscle)"
                    ]
                  },
                  {
                    "text": "Complications: Long termIschemic dilated cardiomyopathyVentricular true aneurysms (often with mural thrombus)",
                    "sub_points": [
                      "Ischemic dilated cardiomyopathy",
                      "Ventricular true aneurysms (often with mural thrombus)"
                    ]
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "12-24 hours: No changes or subtle mottling"
                  },
                  {
                    "text": "7-10 days: Grossly softened and depressed with more prominent hyperemic edges"
                  },
                  {
                    "text": "3-8 weeks: Grayish-white scar begins to form at edges and progresses to center"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "1-3 days: Coagulative necrosis with loss of nuclei, contraction bands, and heavy neutrophilic infiltration"
                  },
                  {
                    "text": "3-7 days: Myocyte loss, karyorrhexis of neutrophils (\"nuclear dust\"), early phagocytosis by macrophages at infarct border"
                  },
                  {
                    "text": "10-14 days: Well-established granulation tissue with new blood vessels and fibroblast infiltration"
                  },
                  {
                    "text": "2-8 weeks: Increased collagen deposition with decreased cellularity"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Myocardial ischemia, heart attack, acute coronary syndrome"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Myocardial infarction can be defined as irreversible myocardial muscle damage caused by prolonged ischemia, resulting from sustained imbalance of perfusion, supply, and demand"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Coronary Artery Atherosclerosis Risk Factors": [
                  {
                    "text": "Smoking"
                  },
                  {
                    "text": "Hypertension"
                  },
                  {
                    "text": "Elevated low-density lipoprotein cholesterol"
                  },
                  {
                    "text": "Diabetes"
                  },
                  {
                    "text": "Increasing age"
                  }
                ],
                "Nonatherosclerotic Coronary Disease": [
                  {
                    "text": "Coronary artery vasculitis"
                  },
                  {
                    "text": "Coronary artery amyloidosis"
                  },
                  {
                    "text": "Coronary artery dissection"
                  },
                  {
                    "text": "Coronary artery spasm"
                  },
                  {
                    "text": "Coronary artery embolus (such as from endocarditis)"
                  }
                ],
                "Other Causes of Mismatched Perfusion and Myocardial Demand": [
                  {
                    "text": "Left ventricular hypertrophy (cardiomyopathy, hypertensive heart disease)"
                  },
                  {
                    "text": "Congenital heart disease"
                  },
                  {
                    "text": "Cardiac arrest (from nonischemic causes)Metabolic, neurogenic, arrhythmia",
                    "sub_points": [
                      "Metabolic, neurogenic, arrhythmia"
                    ]
                  },
                  {
                    "text": "Impaired oxygen delivery (respiratory failure, severe anemia)"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Annual incidence of new myocardial infarction in USA has been estimated at 610,000 cases"
                  },
                  {
                    "text": "Recurrent myocardial infarction accounts for 325,000 additional episodes"
                  }
                ],
                "Age": [
                  {
                    "text": "Average: 64.5 years for men and 70.3 years for women"
                  }
                ],
                "Gender": [
                  {
                    "text": "M > F"
                  },
                  {
                    "text": "Women thought to be \"protected\" from coronary atherosclerosis in their reproductive years"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Prevalence is highest in developed nations, presumably due to comparatively high-calorie diet, more sedentary lifestyle, and longer life expectancy"
                  },
                  {
                    "text": "Significant variation in incidence across developed nations, with rates (per 100,000) such as30 in Japan39.8 in France65.2 in Italy94.9 in Canada106.5 in United States216 in Slovakia",
                    "sub_points": [
                      "30 in Japan",
                      "39.8 in France",
                      "65.2 in Italy",
                      "94.9 in Canada",
                      "106.5 in United States",
                      "216 in Slovakia"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Cardiac arrest without recognized antecedent symptoms"
                  }
                ],
                "Typical symptoms": [
                  {
                    "text": "Chest pain (angina) on exertion or rest"
                  },
                  {
                    "text": "Mandibular, upper arm, or epigastric discomfort; usually lasts > 20 minutes"
                  },
                  {
                    "text": "Associated nausea, diaphoresis, syncope"
                  }
                ],
                "No symptoms": [
                  {
                    "text": "In elderly, women, diabetic, postoperative, and critically ill"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Coronary artery bypass grafting"
                  },
                  {
                    "text": "Percutaneous coronary intervention (PCI)Usually reserved for acute ST elevation myocardial infarction (salvageable myocardium)Balloon angioplasty with coronary artery stenting",
                    "sub_points": [
                      "Usually reserved for acute ST elevation myocardial infarction (salvageable myocardium)",
                      "Balloon angioplasty with coronary artery stenting"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "Sublingual nitroglycerin"
                  },
                  {
                    "text": "Antiplatelet therapy (aspirin, clopidogrel)"
                  },
                  {
                    "text": "Morphine for pain relief"
                  },
                  {
                    "text": "Thrombolytic agents (effective only in 1st hours after acute coronary thrombosis)1st generation: Streptokinase, urokinase, acetylated plasminogen streptokinase activator complex (APSAC)2nd generation: t-PA, tenecteplase",
                    "sub_points": [
                      "1st generation: Streptokinase, urokinase, acetylated plasminogen streptokinase activator complex (APSAC)",
                      "2nd generation: t-PA, tenecteplase"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Median 30-day mortality: 16.6%"
                  },
                  {
                    "text": "Median 30-day readmission: 19.9%"
                  },
                  {
                    "text": "ComplicationsAcuteCardiogenic shockRupture of myocardium (tamponade, acquired ventricular septal defect, ruptured papillary muscle)Ventricular pseudoaneurysm (contained rupture)Pericarditis (Dressler syndrome)ArrhythmiasSudden deathLonger termCongestive heart failureIschemic dilated cardiomyopathyVentricular true aneurysms (often with mural thrombus)Mitral regurgitation (scar retraction of papillary muscle)Recurrent ventricular arrhythmias",
                    "sub_points": [
                      "AcuteCardiogenic shockRupture of myocardium (tamponade, acquired ventricular septal defect, ruptured papillary muscle)Ventricular pseudoaneurysm (contained rupture)Pericarditis (Dressler syndrome)ArrhythmiasSudden death",
                      "Cardiogenic shock",
                      "Rupture of myocardium (tamponade, acquired ventricular septal defect, ruptured papillary muscle)",
                      "Ventricular pseudoaneurysm (contained rupture)",
                      "Pericarditis (Dressler syndrome)",
                      "Arrhythmias",
                      "Sudden death",
                      "Longer termCongestive heart failureIschemic dilated cardiomyopathyVentricular true aneurysms (often with mural thrombus)Mitral regurgitation (scar retraction of papillary muscle)Recurrent ventricular arrhythmias",
                      "Congestive heart failure",
                      "Ischemic dilated cardiomyopathy",
                      "Ventricular true aneurysms (often with mural thrombus)",
                      "Mitral regurgitation (scar retraction of papillary muscle)",
                      "Recurrent ventricular arrhythmias"
                    ]
                  },
                  {
                    "text": "Risk of 2nd myocardial infarction"
                  }
                ]
              },
              "Image Findings": {
                "MR Findings": [
                  {
                    "text": "Accurate assessment of myocardial function and motion and perfusion (with contrast)"
                  }
                ],
                "Echocardiography": [
                  {
                    "text": "Assesses myocardial thickness and motion"
                  },
                  {
                    "text": "Assesses myocardial perfusion and microvascular obstruction (coronary flow reserve)"
                  }
                ],
                "Radionucleotide Imaging": [
                  {
                    "text": "Commonly used to assess perfusion and viability"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "In initial few minutes to hours (up to 8-12 hours), there is no grossly apparent abnormality"
                  },
                  {
                    "text": "Thereafter12-24 hours: No change or subtle mottling and regional stiffness1-3 days: Mottling with yellow-tan center3-7 days: Yellow-tan center with hyperemic edges7-10 days: Grossly softened and depressed with more prominent hyperemic edges10-14 days: Edges become more gray in color3-8 weeks: Grayish-white scar begins to form at edges and progresses to center8-12 weeks: Grayish-white scar with early remodeling (wall thinning and chamber dilatation)",
                    "sub_points": [
                      "12-24 hours: No change or subtle mottling and regional stiffness",
                      "1-3 days: Mottling with yellow-tan center",
                      "3-7 days: Yellow-tan center with hyperemic edges",
                      "7-10 days: Grossly softened and depressed with more prominent hyperemic edges",
                      "10-14 days: Edges become more gray in color",
                      "3-8 weeks: Grayish-white scar begins to form at edges and progresses to center",
                      "8-12 weeks: Grayish-white scar with early remodeling (wall thinning and chamber dilatation)"
                    ]
                  }
                ],
                "Hemorrhagic Infarct": [
                  {
                    "text": "After revascularization (durable or failed), restoration of blood flow to damaged tissue may result in hemorrhagic infarctionDark red-brown in color due to hemorrhage into ischemic tissues",
                    "sub_points": [
                      "Dark red-brown in color due to hemorrhage into ischemic tissues"
                    ]
                  }
                ],
                "Vital Staining of Fresh Heart Tissue (Autopsy)": [
                  {
                    "text": "Triphenyltetrazolium chloride (TTC) or nitro blue tetrazolium (NBT) dye testRedox indicator catalyzed by dehydrogenase enzymes in viable myocardium (but not infarcted myocardium)TTC will stain viable myocardium brick red (infarcted myocardium will remain unchanged)NBT will stain viable myocardium dark blue-purple (infarcted myocardium will remain unchanged)",
                    "sub_points": [
                      "Redox indicator catalyzed by dehydrogenase enzymes in viable myocardium (but not infarcted myocardium)",
                      "TTC will stain viable myocardium brick red (infarcted myocardium will remain unchanged)",
                      "NBT will stain viable myocardium dark blue-purple (infarcted myocardium will remain unchanged)"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "After 4 hours (variable), myocytes may appear wavy and elongated, interstitial edema"
                  },
                  {
                    "text": "Within 24 hours, interstitial edema, focal hemorrhage, myocyte contraction bands, and infiltration of neutrophils (margination)Staining for C4d may be positive in acutely ischemic myocytes due to complement activation",
                    "sub_points": [
                      "Staining for C4d may be positive in acutely ischemic myocytes due to complement activation"
                    ]
                  },
                  {
                    "text": "1-3 days: Coagulative necrosis with loss of nuclei, contraction bands, and heavy neutrophilic infiltration"
                  },
                  {
                    "text": "3-7 days: Myocyte loss, karyorrhexis of neutrophils (\"nuclear dust\"), early phagocytosis by macrophages at infarct border"
                  },
                  {
                    "text": "7-10 days: Well-developed phagocytosis with distended macrophages, granulation tissue at infarct border"
                  },
                  {
                    "text": "10-14 days: Well-established granulation tissue with new blood vessels and fibroblast infiltration"
                  },
                  {
                    "text": "2-8 weeks: Increased collagen deposition with decreased cellularity"
                  },
                  {
                    "text": "> 2 months: Dense collagenous scar"
                  },
                  {
                    "text": "Caveat: This sequence of changes assumes no revascularization (no reversal of ischemia)Spontaneous or interventional reperfusion must be taken into account",
                    "sub_points": [
                      "Spontaneous or interventional reperfusion must be taken into account"
                    ]
                  },
                  {
                    "text": "Reperfusion injury (after revascularization)Prominent coagulative necrosisMarked erythrocyte extravasation/hemorrhageSmall vessels may show small thrombi or atheroemboli",
                    "sub_points": [
                      "Prominent coagulative necrosis",
                      "Marked erythrocyte extravasation/hemorrhage",
                      "Small vessels may show small thrombi or atheroemboli"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "C4d, C9: Positive staining in necrotic myocardium"
                  },
                  {
                    "text": "cTnT: Negative staining in necrotic myocardium"
                  }
                ],
                "Electron Microscopy": [],
                "Transmission": [
                  {
                    "text": "Sarcolemmal disruption"
                  },
                  {
                    "text": "Mitochondrial swelling, mitochondrial amorphous densities"
                  },
                  {
                    "text": "Relaxation of myofibrils"
                  },
                  {
                    "text": "Glycogen loss"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Chest Pain": [
                  {
                    "text": "Clinically, can be due toAcute aortic dissectionPericarditisGastrointestinal disorders (reflux, cholecystitis, gastritis)PneumoniaPulmonary embolismPneumothorax",
                    "sub_points": [
                      "Acute aortic dissection",
                      "Pericarditis",
                      "Gastrointestinal disorders (reflux, cholecystitis, gastritis)",
                      "Pneumonia",
                      "Pulmonary embolism",
                      "Pneumothorax"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Infarct (Solid Organ: Spleen)": {
            "name": "Infarct (Solid Organ: Spleen)",
            "url": "https://app.pathprimer.com/document/318debc7-ee7d-4d11-8081-49bfe1a6015f/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Ischemic insult to splenic parenchyma secondary to vascular occlusion or disruption"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Splenic infarction represents presentation, natural history, or complication of some underlying disease processArterial thromboembolism or traumaSplenic red pulp occlusionHypercoagulable states",
                    "sub_points": [
                      "Arterial thromboembolism or trauma",
                      "Splenic red pulp occlusion",
                      "Hypercoagulable states"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Symptoms depend on size of infarct"
                  },
                  {
                    "text": "Left-sided upper abdominal pain, which may radiate to left shoulder tip"
                  },
                  {
                    "text": "Splenic rupture may occur in large lesions and present as acute abdomen"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Typically wedge-shaped"
                  },
                  {
                    "text": "Becomes better demarcated over time"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Temporal progression of coagulative necrosis leading to repair and eventual fibrosis"
                  },
                  {
                    "text": "May see hemosiderin, serositis, organizing thrombi"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Evaluation of underlying pathologic conditionThromboembolism, sickle cell disease, myeloproliferative neoplasms, vasculitis, sepsis",
                    "sub_points": [
                      "Thromboembolism, sickle cell disease, myeloproliferative neoplasms, vasculitis, sepsis"
                    ]
                  },
                  {
                    "text": "Exclusion of lesions that may mimic infarctionNecrotizing granulomas, metastatic malignancy",
                    "sub_points": [
                      "Necrotizing granulomas, metastatic malignancy"
                    ]
                  }
                ]
              },
              "Terminology": {
                "Definitions": [
                  {
                    "text": "Ischemic insult to splenic parenchyma secondary to vascular occlusion or disruptionCessation of blood supply results from wide variety of underlying pathologic conditionsCoagulative necrosis and eventual fibrosis develop in region of affected circulation",
                    "sub_points": [
                      "Cessation of blood supply results from wide variety of underlying pathologic conditions",
                      "Coagulative necrosis and eventual fibrosis develop in region of affected circulation"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Etiology": [
                  {
                    "text": "Splenic infarction represents presentation, natural history, or complication of some underlying disease process"
                  },
                  {
                    "text": "Investigation to determine underlying etiology &/or pathologic conditions that mimic infarction should be evaluated"
                  },
                  {
                    "text": "Arterial occlusion due to thromboembolismSterile (bland) emboliSystemic emboli including thrombi from left-sided heart chambers or atherosclerotic plaques from proximal aortaComplications of cardiac catheterizationParadoxical emboli originating from venous circulation; require septal heart defect (rare)Septic emboliInfective endocarditis (cardiac valve emboli)Infarcted areas may become secondarily infected and abscess during episodes of septicemia",
                    "sub_points": [
                      "Sterile (bland) emboliSystemic emboli including thrombi from left-sided heart chambers or atherosclerotic plaques from proximal aortaComplications of cardiac catheterizationParadoxical emboli originating from venous circulation; require septal heart defect (rare)",
                      "Systemic emboli including thrombi from left-sided heart chambers or atherosclerotic plaques from proximal aorta",
                      "Complications of cardiac catheterization",
                      "Paradoxical emboli originating from venous circulation; require septal heart defect (rare)",
                      "Septic emboliInfective endocarditis (cardiac valve emboli)Infarcted areas may become secondarily infected and abscess during episodes of septicemia",
                      "Infective endocarditis (cardiac valve emboli)",
                      "Infarcted areas may become secondarily infected and abscess during episodes of septicemia"
                    ]
                  },
                  {
                    "text": "Disruption of blood supplyTraumaWandering spleen with torsion of splenic vesselsAneurysm of splenic artery or celiac axisVasculitisInflammation and necrosis of vascular wall with superimposed thrombusExample diseases: Systemic lupus erythematosus, granulomatosis with polyangiitis (Wegener granulomatosis), polyarteritis nodosa",
                    "sub_points": [
                      "Trauma",
                      "Wandering spleen with torsion of splenic vessels",
                      "Aneurysm of splenic artery or celiac axis",
                      "VasculitisInflammation and necrosis of vascular wall with superimposed thrombusExample diseases: Systemic lupus erythematosus, granulomatosis with polyangiitis (Wegener granulomatosis), polyarteritis nodosa",
                      "Inflammation and necrosis of vascular wall with superimposed thrombus",
                      "Example diseases: Systemic lupus erythematosus, granulomatosis with polyangiitis (Wegener granulomatosis), polyarteritis nodosa"
                    ]
                  },
                  {
                    "text": "Splenic red pulp occlusionSickle cell anemia due to sludging and sequestration of deformed red blood cellsMyeloproliferative neoplasms due to extensive extramedullary hematopoiesisLongstanding congestion (e.g., cirrhosis, congestive heart failure)",
                    "sub_points": [
                      "Sickle cell anemia due to sludging and sequestration of deformed red blood cells",
                      "Myeloproliferative neoplasms due to extensive extramedullary hematopoiesis",
                      "Longstanding congestion (e.g., cirrhosis, congestive heart failure)"
                    ]
                  },
                  {
                    "text": "Hypercoagulable statesHereditary thrombophilias (protein C deficiency, factor V Leiden mutation)Acquired thrombotic disorders (antiphospholipid syndrome, heparin-induced thrombocytopenia, paroxysmal nocturnal hemoglobinuria, disseminated intravascular coagulation)",
                    "sub_points": [
                      "Hereditary thrombophilias (protein C deficiency, factor V Leiden mutation)",
                      "Acquired thrombotic disorders (antiphospholipid syndrome, heparin-induced thrombocytopenia, paroxysmal nocturnal hemoglobinuria, disseminated intravascular coagulation)"
                    ]
                  }
                ],
                "Pathogenesis": [
                  {
                    "text": "End-arterial blood supplyInfarcts typically well demarcated and nonhemorrhagic (e.g., white or anemic infarcts)Ischemic injury from arterial occlusion follows segmental anatomySplenic parenchyma arranged in segments during embryologic developmentInternal vasculature organized according to these embryologic segmentsTissue density, and possibly compartmentalization, prevents significant hemorrhage from adjacent intact parenchyma into damaged area",
                    "sub_points": [
                      "Infarcts typically well demarcated and nonhemorrhagic (e.g., white or anemic infarcts)",
                      "Ischemic injury from arterial occlusion follows segmental anatomySplenic parenchyma arranged in segments during embryologic developmentInternal vasculature organized according to these embryologic segments",
                      "Splenic parenchyma arranged in segments during embryologic development",
                      "Internal vasculature organized according to these embryologic segments",
                      "Tissue density, and possibly compartmentalization, prevents significant hemorrhage from adjacent intact parenchyma into damaged area"
                    ]
                  },
                  {
                    "text": "Ischemic coagulative necrosisNecrosis, inflammation, and repair sequence parallel responses in other organsNecrotic tissue elicits influx of neutrophilsMacrophages increase to remove necrotic tissueFibroblasts proliferate and produce collagen to form scar tissueDuration of healing process may be longer for larger lesions",
                    "sub_points": [
                      "Necrosis, inflammation, and repair sequence parallel responses in other organsNecrotic tissue elicits influx of neutrophilsMacrophages increase to remove necrotic tissueFibroblasts proliferate and produce collagen to form scar tissueDuration of healing process may be longer for larger lesions",
                      "Necrotic tissue elicits influx of neutrophils",
                      "Macrophages increase to remove necrotic tissue",
                      "Fibroblasts proliferate and produce collagen to form scar tissue",
                      "Duration of healing process may be longer for larger lesions"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Presentation": [
                  {
                    "text": "Symptoms depend on size of infarct"
                  },
                  {
                    "text": "Small infarcts are often clinically silent"
                  },
                  {
                    "text": "Large infarcts present with left-sided upper abdominal pain"
                  },
                  {
                    "text": "If diaphragmatic peritoneum becomes inflamed, pain may radiate to left shoulder tip or cause pleuritic chest pain"
                  },
                  {
                    "text": "Infarcts due to embolic etiologies are commonly associated with fever"
                  },
                  {
                    "text": "Leukocytosis and elevated lactate dehydrogenase levels are common"
                  },
                  {
                    "text": "Splenic rupture may occur in large lesions and present as acute abdomen"
                  }
                ]
              },
              "Image Findings": {
                "Ultrasonographic Findings": [
                  {
                    "text": "May aid in differentiating acute event (hypoechoic) from remote infarction (hyperechoic)"
                  },
                  {
                    "text": "Visualization of infarct evolution to abscess"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "Well-defined lesions that are better visualized with delayed contrast-enhanced images"
                  },
                  {
                    "text": "Capsular rim sign may be present due to capsular blood supply at edge of lesion"
                  },
                  {
                    "text": "High-signal intensity on T1-weighted images if hematoma develops"
                  },
                  {
                    "text": "Hypointense signal on T1- and T2-weighted images in old healed infarcts"
                  },
                  {
                    "text": "Mesenteric vasculature may also be evaluated"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Well-defined area of decreased attenuation within splenic parenchyma without contrast enhancement"
                  }
                ],
                "Visceral Angiography": [
                  {
                    "text": "Useful when splenic arterial aneurysm or other vascular etiology/anomaly is suspected"
                  }
                ]
              },
              "Macroscopic Features": {
                "Size and Weight": [
                  {
                    "text": "Variable based on size of infarct and underlying etiology"
                  },
                  {
                    "text": "Small infarcts may not affect overall organ weight or size"
                  },
                  {
                    "text": "Massive infarcts result in extensive scarring, decreased size, and functional hyposplenism (e.g., sickle cell disease)"
                  },
                  {
                    "text": "Multifocal infarction as a result of certain disease states may present as splenomegaly due to underlying disease (e.g., myeloproliferative neoplasms, chronic congestion)"
                  }
                ],
                "Infarct Morphology": [
                  {
                    "text": "Typically wedge-shaped with occluded artery at infarct apex and capsule forming the base"
                  },
                  {
                    "text": "Volume of infarct increases in size according to vascular distribution"
                  },
                  {
                    "text": "Infarct extends toward periphery, often involving capsule"
                  },
                  {
                    "text": "Capsule overlying infarct may develop fibrinous or purulent exudate"
                  },
                  {
                    "text": "Depending on etiology, infarcted area may be solitary or multiple, or may involve entire spleen"
                  },
                  {
                    "text": "Although uncommon, parenchymal disruption in extensive lesions may be great enough to result in rupture"
                  }
                ],
                "Temporal Evolution of Infarct": [
                  {
                    "text": "Gross appearance of infarct depends on length of time between ischemic event and splenectomy"
                  },
                  {
                    "text": "Days 1-3 post infarctionInfarct is initially pale compared to surrounding parenchymaLesional boundaries gradually become more distinct",
                    "sub_points": [
                      "Infarct is initially pale compared to surrounding parenchyma",
                      "Lesional boundaries gradually become more distinct"
                    ]
                  },
                  {
                    "text": "Days 3-7 post infarctionAffected tissue appears tan and soft as necrosis and inflammatory reaction ensueHyperemic rim is visible after several days as congestion and small amount of hemorrhage occur at viable/nonviable tissue interfaceHeight of necroinflammatory process may correlate with clinical presentation of splenic rupture",
                    "sub_points": [
                      "Affected tissue appears tan and soft as necrosis and inflammatory reaction ensue",
                      "Hyperemic rim is visible after several days as congestion and small amount of hemorrhage occur at viable/nonviable tissue interface",
                      "Height of necroinflammatory process may correlate with clinical presentation of splenic rupture"
                    ]
                  },
                  {
                    "text": "Days 7 and beyond post infarctionMargins become better defined as lesion maturesInfarct turns pale yellow and firm as fibroblasts replace necrotic tissue to form scar",
                    "sub_points": [
                      "Margins become better defined as lesion matures",
                      "Infarct turns pale yellow and firm as fibroblasts replace necrotic tissue to form scar"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "General featuresInfarcted area becomes well delineated from surrounding viable parenchyma as lesion agesIn larger infarcts, organizing thrombi may be identified in splenic artery or its branchesWhen involved, capsule becomes inflamed with neutrophils, and surface may contain fibrinopurulent exudate (e.g., serositis)",
                    "sub_points": [
                      "Infarcted area becomes well delineated from surrounding viable parenchyma as lesion ages",
                      "In larger infarcts, organizing thrombi may be identified in splenic artery or its branches",
                      "When involved, capsule becomes inflamed with neutrophils, and surface may contain fibrinopurulent exudate (e.g., serositis)"
                    ]
                  },
                  {
                    "text": "Days 1-3 post infarctionParenchymal architecture is disrupted with some extravasation of red blood cellsLoss of cellular detail with debris scattered throughout area of infarctAbundant acute inflammatory cellsIn septic lesions, clusters of bacteria may be present, and abscess may develop",
                    "sub_points": [
                      "Parenchymal architecture is disrupted with some extravasation of red blood cells",
                      "Loss of cellular detail with debris scattered throughout area of infarct",
                      "Abundant acute inflammatory cells",
                      "In septic lesions, clusters of bacteria may be present, and abscess may develop"
                    ]
                  },
                  {
                    "text": "Days 3-7 post infarctionNumerous macrophages containing lipid material, red blood cells, and cellular debrisVariable amounts of hemosiderin depositionHematoidin crystalline material may be presentEdge of lesion may show narrow band of hemorrhage corresponding grossly to hyperemic rim",
                    "sub_points": [
                      "Numerous macrophages containing lipid material, red blood cells, and cellular debris",
                      "Variable amounts of hemosiderin depositionHematoidin crystalline material may be present",
                      "Hematoidin crystalline material may be present",
                      "Edge of lesion may show narrow band of hemorrhage corresponding grossly to hyperemic rim"
                    ]
                  },
                  {
                    "text": "Days 7 and beyond post infarctionReparative response begins at edge of infarct with progressive in-growth toward center of lesionEdge of lesion may initially show granulation tissueLoose proliferation of fibroblasts, which increases in density over timeCollagen deposition follows and may eventually show hyalinizationGamna-Gandy bodies (fibrotic foci with iron, calcium, and other deposits) are occasionally seen in association with areas of infarction",
                    "sub_points": [
                      "Reparative response begins at edge of infarct with progressive in-growth toward center of lesion",
                      "Edge of lesion may initially show granulation tissue",
                      "Loose proliferation of fibroblasts, which increases in density over time",
                      "Collagen deposition follows and may eventually show hyalinization",
                      "Gamna-Gandy bodies (fibrotic foci with iron, calcium, and other deposits) are occasionally seen in association with areas of infarction"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Histochemistry": [
                  {
                    "text": "Useful in differentiating infectious necrotizing granulomas from infarctZiehl-Neelsen, Kinyoun, &/or Fite stains to evaluate for acid-fast bacteriaPAS-fungal &/or Grocott-Gomori methenamine silver (GMS) to evaluate for fungi",
                    "sub_points": [
                      "Ziehl-Neelsen, Kinyoun, &/or Fite stains to evaluate for acid-fast bacteria",
                      "PAS-fungal &/or Grocott-Gomori methenamine silver (GMS) to evaluate for fungi"
                    ]
                  }
                ],
                "Useful in evaluating features of infarct": [
                  {
                    "text": "PAS to assess architectural disruption in cases of recent infarct"
                  },
                  {
                    "text": "Elastin to evaluate for vascular intimal destruction in vasculitis"
                  },
                  {
                    "text": "Tissue Gram stain to evaluate bacteria in septic process"
                  },
                  {
                    "text": "Prussian blue iron stain to highlight hemosiderin in infarcted area and Gamna-Gandy bodies"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "May aid in identifying underlying disease state"
                  },
                  {
                    "text": "Myeloproliferative neoplasms and extramedullary hematopoiesisMyeloperoxidase (MPO) to highlight granulocytic precursorsCD71 or glycophorin A to identify erythroid islandsCD61 or factor VIII to highlight megakaryocytes",
                    "sub_points": [
                      "Myeloperoxidase (MPO) to highlight granulocytic precursors",
                      "CD71 or glycophorin A to identify erythroid islands",
                      "CD61 or factor VIII to highlight megakaryocytes"
                    ]
                  },
                  {
                    "text": "Lymphoproliferative disordersCD20 to evaluate for B-cell lymphomaCD3 to evaluate for T-cell lymphoma",
                    "sub_points": [
                      "CD20 to evaluate for B-cell lymphoma",
                      "CD3 to evaluate for T-cell lymphoma"
                    ]
                  },
                  {
                    "text": "Metastatic carcinomaPan cytokeratinCK7 and CK20 differential staining to begin evaluation if tumor is of unknown origin",
                    "sub_points": [
                      "Pan cytokeratin",
                      "CK7 and CK20 differential staining to begin evaluation if tumor is of unknown origin"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Etiologic Differential Considerations": [
                  {
                    "text": "Thromboembolic diseaseNo specific differentiating pathologic featuresLarger arteries may contain organizing thrombiPossible history of atherosclerotic cardiovascular disease, trauma, wandering spleen, or hypercoagulable conditionsMay bring attention to previously unrecognized underlying disease",
                    "sub_points": [
                      "No specific differentiating pathologic features",
                      "Larger arteries may contain organizing thrombi",
                      "Possible history of atherosclerotic cardiovascular disease, trauma, wandering spleen, or hypercoagulable conditions",
                      "May bring attention to previously unrecognized underlying disease"
                    ]
                  },
                  {
                    "text": "Sickle cell diseaseAccumulation of sickled erythrocytes in sinusoids and splenic cordsProgressive atrophy due to parenchymal scarringClinical history of sickling hemoglobinopathy (hemoglobin SS, SS/β-thalassemia, etc.)",
                    "sub_points": [
                      "Accumulation of sickled erythrocytes in sinusoids and splenic cords",
                      "Progressive atrophy due to parenchymal scarring",
                      "Clinical history of sickling hemoglobinopathy (hemoglobin SS, SS/β-thalassemia, etc.)"
                    ]
                  },
                  {
                    "text": "Myeloproliferative neoplasmsSplenomegaly may be massiveExtramedullary hematopoiesis is present around trabeculae and blood vessels or at red-white pulp interfaceExtensive cases may show extramedullary hematopoiesis throughout entire red pulp with clusters of megakaryocytesInfarction typically multifocal",
                    "sub_points": [
                      "Splenomegaly may be massive",
                      "Extramedullary hematopoiesis is present around trabeculae and blood vessels or at red-white pulp interface",
                      "Extensive cases may show extramedullary hematopoiesis throughout entire red pulp with clusters of megakaryocytes",
                      "Infarction typically multifocal"
                    ]
                  },
                  {
                    "text": "VasculitisFibrinoid necrosis with transmural inflammation ± leukocytoclasisThrombotic occlusion of small arteries/arteriolesMicroscopic aneurysm formationFragmentation of elastic lamina in larger blood vesselsNumerous small infarcts",
                    "sub_points": [
                      "Fibrinoid necrosis with transmural inflammation ± leukocytoclasis",
                      "Thrombotic occlusion of small arteries/arterioles",
                      "Microscopic aneurysm formation",
                      "Fragmentation of elastic lamina in larger blood vessels",
                      "Numerous small infarcts"
                    ]
                  },
                  {
                    "text": "InfectionMultifocal areas of necrosis ± abscess formationMay see bacteria within necrosisHistory of infective endocarditis with septic emboliHistory of septicemia (no distinguishing features for different organisms)History of fulminant malaria (may see fibrinoid necrosis of white pulp)",
                    "sub_points": [
                      "Multifocal areas of necrosis ± abscess formation",
                      "May see bacteria within necrosis",
                      "History of infective endocarditis with septic emboli",
                      "History of septicemia (no distinguishing features for different organisms)",
                      "History of fulminant malaria (may see fibrinoid necrosis of white pulp)"
                    ]
                  }
                ],
                "Disorders That May Mimic Infarction": [
                  {
                    "text": "NecrotizinggranulomasHistiocytes rimming area of caseation resemble fibroblasts at edge of infarctTypically numerous and lack wedge-shaped configuration of infarctPossible history of immunodeficiency &/or systemic illnessSpecial stains are required to evaluate for infectious organisms",
                    "sub_points": [
                      "Histiocytes rimming area of caseation resemble fibroblasts at edge of infarct",
                      "Typically numerous and lack wedge-shaped configuration of infarct",
                      "Possible history of immunodeficiency &/or systemic illness",
                      "Special stains are required to evaluate for infectious organisms"
                    ]
                  },
                  {
                    "text": "Metastatic malignancyMetastatic carcinoma may be associated with extensive tumor necrosisLarge lesions may cavitate and form abscessesHigh-grade lymphomas may outgrow blood supply, leaving only sheets of ghost cellsTumor may additionally infarct adjacent splenic parenchyma, increasing size of lesionExtensive sampling may be necessary to detect residual viable tumorImmunohistochemical stains may be useful, especially those that are relatively durable in setting of necrosis (e.g., cytokeratins, CD20)",
                    "sub_points": [
                      "Metastatic carcinoma may be associated with extensive tumor necrosis",
                      "Large lesions may cavitate and form abscesses",
                      "High-grade lymphomas may outgrow blood supply, leaving only sheets of ghost cells",
                      "Tumor may additionally infarct adjacent splenic parenchyma, increasing size of lesion",
                      "Extensive sampling may be necessary to detect residual viable tumor",
                      "Immunohistochemical stains may be useful, especially those that are relatively durable in setting of necrosis (e.g., cytokeratins, CD20)"
                    ]
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Splenic infarction indicates underlying pathology that requires investigationThromboembolic disease (e.g., atherosclerotic cardiovascular disease, infective endocarditis)Vascular torsion, trauma, or aneurysmSystemic vasculitis (e.g., systemic lupus, polyarteritis nodosa)Red pulp occlusive disorders (e.g., sickle cell anemia, myeloproliferative neoplasms)Hereditary thrombophilia and acquired hypercoagulable states",
                    "sub_points": [
                      "Thromboembolic disease (e.g., atherosclerotic cardiovascular disease, infective endocarditis)",
                      "Vascular torsion, trauma, or aneurysm",
                      "Systemic vasculitis (e.g., systemic lupus, polyarteritis nodosa)",
                      "Red pulp occlusive disorders (e.g., sickle cell anemia, myeloproliferative neoplasms)",
                      "Hereditary thrombophilia and acquired hypercoagulable states"
                    ]
                  },
                  {
                    "text": "Clinical presentation depends on size of infarctSmall infarcts may be incidentally discovered in splenectomy specimens performed for other reasonsLarge infarcts may present with abdominal pain radiating to left shoulder or even acute abdomen due to splenic rupture",
                    "sub_points": [
                      "Small infarcts may be incidentally discovered in splenectomy specimens performed for other reasons",
                      "Large infarcts may present with abdominal pain radiating to left shoulder or even acute abdomen due to splenic rupture"
                    ]
                  },
                  {
                    "text": "Imaging studies are useful in diagnosis and characterization of splenic infarctMR with contrast provides best visualization and may assist in lesion datingImaging may also aid in determining underlying etiology of infarct",
                    "sub_points": [
                      "MR with contrast provides best visualization and may assist in lesion dating",
                      "Imaging may also aid in determining underlying etiology of infarct"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Sharply demarcated, wedge-shaped area corresponding to vascular distribution"
                  },
                  {
                    "text": "Macroscopic and microscopic features of infarct follow temporal sequence of coagulative necrosis and tissue repairInfarct is initially pale with corresponding tissue necrosis and neutrophilic infiltration (1-3 days post infarction)Lesion softens and develops hyperemic rim as tissue necrosis continues and macrophage activity peaks (3-7 days post infarction)Infarct becomes well defined and progressively firm as fibroblasts repair area of necrosis and scar develops (≥ 7 days post infarction)",
                    "sub_points": [
                      "Infarct is initially pale with corresponding tissue necrosis and neutrophilic infiltration (1-3 days post infarction)",
                      "Lesion softens and develops hyperemic rim as tissue necrosis continues and macrophage activity peaks (3-7 days post infarction)",
                      "Infarct becomes well defined and progressively firm as fibroblasts repair area of necrosis and scar develops (≥ 7 days post infarction)"
                    ]
                  },
                  {
                    "text": "Pathologic evaluation should focus on determining underlying etiology of infarctCommon etiologies: Thromboembolic disease, infective endocarditis, trauma, myeloproliferative neoplasms, sickle cell diseaseUncommon considerations: Torsion, splenic arterial aneurysm, systemic vasculitis, hereditary thrombophilias, malaria",
                    "sub_points": [
                      "Common etiologies: Thromboembolic disease, infective endocarditis, trauma, myeloproliferative neoplasms, sickle cell disease",
                      "Uncommon considerations: Torsion, splenic arterial aneurysm, systemic vasculitis, hereditary thrombophilias, malaria"
                    ]
                  },
                  {
                    "text": "Differential diagnosis includes lesions that may mimic infarction"
                  },
                  {
                    "text": "Sufficient sampling and use of ancillary studies may be necessary to identify etiology in large extensively necrotic lesionsCaseating granulomasMetastatic carcinoma",
                    "sub_points": [
                      "Caseating granulomas",
                      "Metastatic carcinoma"
                    ]
                  },
                  {
                    "text": "Thorough evaluation of infarct may bring attention to previously unrecognized underlying disease"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Infarct (Cerebral Ischemic Infarction)": {
            "name": "Infarct (Cerebral Ischemic Infarction)",
            "url": "https://app.pathprimer.com/document/9ce88b4d-2a39-49e4-8d75-8c65df4e6cc5/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Uncommon as surgical specimenUnusual featuresYoung age, absence of sudden onset of symptoms, atypical vascular distributionWhen acute, can simulate tumor, especially in posterior fossaMore frequent hematologic causes than in older patients",
                    "sub_points": [
                      "Unusual featuresYoung age, absence of sudden onset of symptoms, atypical vascular distribution",
                      "Young age, absence of sudden onset of symptoms, atypical vascular distribution",
                      "When acute, can simulate tumor, especially in posterior fossa",
                      "More frequent hematologic causes than in older patients"
                    ]
                  }
                ],
                "Imaging": [
                  {
                    "text": "Diffusion-weighted imagingHyperacute, within 6 hoursHyperintense (bright) in contrast to dark signal with most malignant gliomas and metastases",
                    "sub_points": [
                      "Hyperacute, within 6 hours",
                      "Hyperintense (bright) in contrast to dark signal with most malignant gliomas and metastases"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "No definite gross changes until 6-8 hours"
                  },
                  {
                    "text": "Cracking of gray from white matter due to advanced tissue necrosis, 3-4 days"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Acute (12-24 hours)\"Red-dead,\" acutely ischemic neurons",
                    "sub_points": [
                      "\"Red-dead,\" acutely ischemic neurons"
                    ]
                  },
                  {
                    "text": "SubacuteProgressive influx of microglia and macrophages",
                    "sub_points": [
                      "Progressive influx of microglia and macrophages"
                    ]
                  },
                  {
                    "text": "Chronic (weeks to months)Progressive removal of necrotic debris by macrophages, cavitation",
                    "sub_points": [
                      "Progressive removal of necrotic debris by macrophages, cavitation"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Contracted \"red-dead\" neurons may be inconspicuous"
                  },
                  {
                    "text": "Hypertrophic and hyperplastic vascular cells often clue to nature of lesion but also can simulate vascular changes in malignant glioma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Cerebrovascular accident (CVA)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Loss of blood supply, and hence oxygen and nutrients, to a given area of brain due to blood vessel occlusion, resulting in tissue necrosis"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Nonmodifiable Risk Factors": [
                  {
                    "text": "Increasing age, male > female"
                  },
                  {
                    "text": "Race (lower risk for white North Americans/Europeans), family history"
                  }
                ],
                "Treatable Risk Factors": [
                  {
                    "text": "Hypertension (most important risk)"
                  },
                  {
                    "text": "Lipid disorders (high total cholesterol, low-density lipoprotein [LDL])"
                  },
                  {
                    "text": "Smoking, diabetes mellitus, obesity (relatively small risk after correction of other problems)"
                  },
                  {
                    "text": "Alcoholism (low intake decreases risk, high intake increases risk)"
                  },
                  {
                    "text": "Stimulant use/abuse"
                  }
                ],
                "Common Proximate Causes": [
                  {
                    "text": "Atherosclerosis with thrombosis"
                  },
                  {
                    "text": "Embolic occlusionSource of embolism often heart or atherosclerotic carotid arteriesCardiac disease: Atrial fibrillation, valvular defects, patent foramen ovale, atrial septal defect",
                    "sub_points": [
                      "Source of embolism often heart or atherosclerotic carotid arteries",
                      "Cardiac disease: Atrial fibrillation, valvular defects, patent foramen ovale, atrial septal defect"
                    ]
                  },
                  {
                    "text": "Hypoperfusion (profound systemic hypotension, shock)May combine with regional atherosclerosis to produce lesion in single vessel distribution",
                    "sub_points": [
                      "May combine with regional atherosclerosis to produce lesion in single vessel distribution"
                    ]
                  }
                ],
                "Uncommon Proximate Causes": [
                  {
                    "text": "Fibromuscular dysplasiaWomen in 30s and 40s; associated with arterial dissection, aneurysms",
                    "sub_points": [
                      "Women in 30s and 40s; associated with arterial dissection, aneurysms"
                    ]
                  },
                  {
                    "text": "Moyamoya diseaseFocal occlusion of middle cerebral artery, nonatherosclerotic, usually in children or women in 30s and 40s",
                    "sub_points": [
                      "Focal occlusion of middle cerebral artery, nonatherosclerotic, usually in children or women in 30s and 40s"
                    ]
                  },
                  {
                    "text": "Spontaneous arterial dissection (traumatic or nontraumatic)"
                  },
                  {
                    "text": "Hematological disorders (more associated with venous infarction than arterial)Protein C, protein S, factor V, Leiden, prothrombin gene, antithrombin (formerly antithrombin III) geneSickle cell anemia, coagulopathies associated with malignanciesOral contraceptivesPostpartum (usually venous infarction, day 3-5)Antiphospholipid syndrome",
                    "sub_points": [
                      "Protein C, protein S, factor V, Leiden, prothrombin gene, antithrombin (formerly antithrombin III) gene",
                      "Sickle cell anemia, coagulopathies associated with malignancies",
                      "Oral contraceptives",
                      "Postpartum (usually venous infarction, day 3-5)",
                      "Antiphospholipid syndrome"
                    ]
                  },
                  {
                    "text": "Migraine (vasospasm, increased platelet aggregation)"
                  },
                  {
                    "text": "Vasospasm after subarachnoid hemorrhage"
                  }
                ],
                "Rare Causes": [
                  {
                    "text": "Intravascular lymphoma"
                  },
                  {
                    "text": "Angioimmunoproliferative lesion (lymphomatoid granulomatosis)"
                  },
                  {
                    "text": "Emboli from atrial myxoma"
                  },
                  {
                    "text": "Primary CNS angiitis"
                  },
                  {
                    "text": "Radiation vasculopathy"
                  }
                ],
                "Infectious Causes": [
                  {
                    "text": "Septic emboli, infected cardiac valve"
                  },
                  {
                    "text": "Vasoinvasive fungi,Aspergillus,Rhizopus(mucormycosis)"
                  },
                  {
                    "text": "Meningovascular syphilis (usually smaller vessel infarcts)"
                  }
                ],
                "Infarct as Surgical Specimen": [
                  {
                    "text": "Uncommon"
                  },
                  {
                    "text": "Unusual features: Young patient age, absence of sudden onset of symptoms, atypical vascular distribution"
                  },
                  {
                    "text": "When acute, can simulate tumor, especially in posterior fossa"
                  },
                  {
                    "text": "More frequent hematologic causes than in older patients"
                  },
                  {
                    "text": "Exclude primary CNS angiitis"
                  },
                  {
                    "text": "Subacute superficial infarct in epilepsy patients after grid placement"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare between ages 45-55 years; more common in elderly"
                  },
                  {
                    "text": "~ 800,000 cases per year in USA"
                  },
                  {
                    "text": "Major cause of adult disability in USA"
                  },
                  {
                    "text": "3rd leading cause of mortality"
                  },
                  {
                    "text": "Increasing incidence in developing world"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Sudden onset of neurological deficitLarge vessel infarct in middle cerebral artery may cause hemiparesis, hemisensory loss, homonymous hemianopsia contralateral to vessel occlusionSmall vessel infarct (e.g., lacunar infarction) yields more isolated motor or sensory deficit",
                    "sub_points": [
                      "Large vessel infarct in middle cerebral artery may cause hemiparesis, hemisensory loss, homonymous hemianopsia contralateral to vessel occlusion",
                      "Small vessel infarct (e.g., lacunar infarction) yields more isolated motor or sensory deficit"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "1st few hours: Recombinant tissue plasminogen activator (TPA)"
                  },
                  {
                    "text": "Risk reduction: Aspirin, antiplatelet drugs, anticoagulants"
                  },
                  {
                    "text": "Endarterectomy for high-grade (70-90%) carotid stenosis"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Tissue damage irreversible"
                  },
                  {
                    "text": "Outcome/residual neurological deficits dependent on size and location of lesion"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Diffusion-weighted imagingHyperacute, within 6 hoursHyperintense (bright) with diffusion weighted imaging, in contrast to dark signal with most malignant gliomas and metastases",
                    "sub_points": [
                      "Hyperacute, within 6 hours",
                      "Hyperintense (bright) with diffusion weighted imaging, in contrast to dark signal with most malignant gliomas and metastases"
                    ]
                  },
                  {
                    "text": "Mild to moderate FLAIR hyperintensity, especially gray matter, acute"
                  },
                  {
                    "text": "Wedge shape in cortical infarcts, after 1-2 days"
                  },
                  {
                    "text": "Enhancement, cortical gyriform, develops within 1 week, persists as long as infarction undergoing resolution"
                  },
                  {
                    "text": "Cystic, chronic state"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Unremarkable in 1st few hours after stroke unless hemorrhagic"
                  },
                  {
                    "text": "Hypodense beginning at 24 hours"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Acute1st feature: Blurring of gray-white matter junction, congested vessels, tissue softening, 1-2 daysCracking of gray from white matter due to advanced tissue necrosis, 3-4 daysProgressive softening and cavitation during subacute resolving stageBland ischemic infarct: Little or no blood or blood pigmentsHemorrhagic, often embolic or venous: Blood or blood pigments, especially in gray matterNo definite gross changes until 6-8 hours",
                    "sub_points": [
                      "1st feature: Blurring of gray-white matter junction, congested vessels, tissue softening, 1-2 days",
                      "Cracking of gray from white matter due to advanced tissue necrosis, 3-4 days",
                      "Progressive softening and cavitation during subacute resolving stage",
                      "Bland ischemic infarct: Little or no blood or blood pigments",
                      "Hemorrhagic, often embolic or venous: Blood or blood pigments, especially in gray matter",
                      "No definite gross changes until 6-8 hours"
                    ]
                  },
                  {
                    "text": "RemoteCavity with variable degree of collapseIn territory of supply of occluded vessel",
                    "sub_points": [
                      "Cavity with variable degree of collapse",
                      "In territory of supply of occluded vessel"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Acute, 8-12 hoursNeurons histologically normal",
                    "sub_points": [
                      "Neurons histologically normal"
                    ]
                  },
                  {
                    "text": "Acute, 12-24 hours\"Red-dead,\" acutely ischemic neuronsShrunken, sometimes extremely soHypereosinophilic cytoplasmKaryolysisBackground vacuolization of neuropilOccluded vessel, some cases",
                    "sub_points": [
                      "\"Red-dead,\" acutely ischemic neuronsShrunken, sometimes extremely soHypereosinophilic cytoplasmKaryolysis",
                      "Shrunken, sometimes extremely so",
                      "Hypereosinophilic cytoplasm",
                      "Karyolysis",
                      "Background vacuolization of neuropil",
                      "Occluded vessel, some cases"
                    ]
                  },
                  {
                    "text": "SubacuteProgressive influx of microglia and macrophagesVessels usually sparedUnlike diffuse coagulation necrosis in malignant gliomaHypertrophy and hyperplasia of capillary vascular cellsScattered mitosesPlump reactive astrocytes at perimeter",
                    "sub_points": [
                      "Progressive influx of microglia and macrophages",
                      "Vessels usually sparedUnlike diffuse coagulation necrosis in malignant glioma",
                      "Unlike diffuse coagulation necrosis in malignant glioma",
                      "Hypertrophy and hyperplasia of capillary vascular cellsScattered mitoses",
                      "Scattered mitoses",
                      "Plump reactive astrocytes at perimeter"
                    ]
                  },
                  {
                    "text": "Chronic: Weeks to months, progressive removal of necrotic debris by macrophages, cavitation, strands of residual glial tissue, and traversing blood vessels"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Macrophages"
                  },
                  {
                    "text": "Ischemic, \"red-dead\" neurons"
                  },
                  {
                    "text": "Abnormal capillaries"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Malignant Glioma": [
                  {
                    "text": "Neoplastic cellsVery focal, some in extensively necrotic glioblastomasDeeper sections and immunohistochemistry may be necessary for detection",
                    "sub_points": [
                      "Very focal, some in extensively necrotic glioblastomas",
                      "Deeper sections and immunohistochemistry may be necessary for detection"
                    ]
                  },
                  {
                    "text": "Overt vascular proliferation, glomeruloid and true endothelial"
                  }
                ],
                "Demyelinating Disease": [
                  {
                    "text": "Restricted largely to white matter"
                  },
                  {
                    "text": "Often at angles of lateral ventricles"
                  },
                  {
                    "text": "Preserved axons (demyelination)"
                  },
                  {
                    "text": "No ischemic \"red-dead\" neurons"
                  },
                  {
                    "text": "Better preservation of axons"
                  }
                ],
                "Herpes Simplex Encephalitis": [
                  {
                    "text": "Inferofrontal-temporal, often bilateral"
                  },
                  {
                    "text": "Intranuclear inclusions"
                  },
                  {
                    "text": "Immunohistochemistry for HSV(+)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Contracted \"red-dead\" neurons may be inconspicuous"
                  },
                  {
                    "text": "Hypertrophic and hyperplastic vascular cells often a clue to nature of lesion but can also simulate vascular changes in malignant glioma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Inflammatory and Granulomatous Conditions": {
            "name": "Inflammatory and Granulomatous Conditions",
            "url": "https://app.pathprimer.com/document/57e12ca2-078a-459a-8449-747f9363cb8e/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Terminology": {
                "Definitions": [
                  {
                    "text": "Lesions of breast characterized by acute, chronic, or granulomatous inflammation"
                  }
                ],
                "Conditions": [
                  {
                    "text": "Acute mastitis/breast abscess, subareolar abscess, duct ectasia, lymphocytic mastitis, granulomatous mastitis"
                  }
                ]
              },
              "Acute Mastitis": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Usually occurs in lactating women due to abrasion or crack in nipple resulting from nursingLeads to entry of bacteria followed by acute inflammation and eventually abscess formationNonlactational causes of acute mastitis are rare and often associated with smokingCommon organisms that cause acute mastitis:Staphylococcus aureus,Staphylococcus epidermidis,anaerobicStreptococcus,Bacteroides",
                    "sub_points": [
                      "Leads to entry of bacteria followed by acute inflammation and eventually abscess formation",
                      "Nonlactational causes of acute mastitis are rare and often associated with smoking",
                      "Common organisms that cause acute mastitis:Staphylococcus aureus,Staphylococcus epidermidis,anaerobicStreptococcus,Bacteroides"
                    ]
                  }
                ],
                "Clinical Presentation": [
                  {
                    "text": "Breast swelling, redness, and warmth with feverLymphadenopathy may also be present",
                    "sub_points": [
                      "Lymphadenopathy may also be present"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Managed medically or with incision and drainage"
                  }
                ],
                "Cytopathology": [
                  {
                    "text": "Aspirate of breast abscesses can be thick yellowish green and purulent"
                  },
                  {
                    "text": "In acute phase, marked acute inflammation ± necrotic cellular debris in background"
                  },
                  {
                    "text": "In chronic phase, granulation tissue, and histiocytic and chronic inflammatory infiltration including multinucleated foreign body giant cells can be present"
                  },
                  {
                    "text": "Few clusters and single ductal and mesenchymal cells ± reactive atypia with enlarged and prominent nucleus and mitotic figures"
                  }
                ]
              },
              "Subareolar Abscess": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Squamous metaplasia of lactiferous ducts leads to keratin pluggingEventually results in duct rupture with extrusion of keratin and intense inflammatory reaction to keratinTobacco use can result in vitamin A deficiency and abnormal squamous metaplasia that can lead to subareolar abscess",
                    "sub_points": [
                      "Eventually results in duct rupture with extrusion of keratin and intense inflammatory reaction to keratin",
                      "Tobacco use can result in vitamin A deficiency and abnormal squamous metaplasia that can lead to subareolar abscess"
                    ]
                  }
                ],
                "Clinical Presentation": [
                  {
                    "text": "Painful erythematous subareolar massIn late stages, fistulous tracks can open at edge of areola",
                    "sub_points": [
                      "In late stages, fistulous tracks can open at edge of areola"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Can recur with incision and drainage; surgical removal of keratin-producing epithelium may be necessary"
                  }
                ],
                "Cytopathology": [
                  {
                    "text": "Thick yellow aspirate"
                  },
                  {
                    "text": "Marked acute inflammation associated with many squamous cells, including anucleated squames or nucleated squamous cells"
                  },
                  {
                    "text": "Multinucleated giant cells with engulfed keratinous material and squames in cytoplasm are characteristic"
                  },
                  {
                    "text": "Granulation tissue, chronic inflammation, epithelioid, and foamy histiocytes can be present in longstanding lesions"
                  },
                  {
                    "text": "Reactive changes in few clusters of ductal and squamous cells with enlarged nucleus and prominent nucleolus can mimic malignant cells"
                  }
                ]
              },
              "Duct Ectasia": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Age-related weakness of walls of large ducts, resulting in ectasia of ductsDucts are filled with \"cheesy\" secretory materialDucts can rupture, resulting in intense inflammatory reaction to extravasated lipids",
                    "sub_points": [
                      "Ducts are filled with \"cheesy\" secretory material",
                      "Ducts can rupture, resulting in intense inflammatory reaction to extravasated lipids"
                    ]
                  }
                ],
                "Clinical Presentation": [
                  {
                    "text": "Palpable, ill-defined subareolar mass that may be attached to skin and nipple; thick nipple dischargeUsually not associated with pain or redness",
                    "sub_points": [
                      "Usually not associated with pain or redness"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "No treatment is necessary if carcinoma is excluded"
                  }
                ],
                "Cytopathology": [
                  {
                    "text": "Thick, \"cheesy\" material showing amorphous granular debris, often with cholesterol clefts and calcifications"
                  },
                  {
                    "text": "Few clusters of ductal epithelial cells ± reactive changes associated with lymphocytes, plasma cells, lipofuscin-containing histiocytes referred to as ochrocytes, and multinucleated giant cells"
                  }
                ]
              },
              "Lymphocytic Mastitis": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Can be sporadic or associated with autoimmune diseases, such as type 1 diabetes mellitus, Hashimoto thyroiditis, rheumatoid arthritis"
                  }
                ],
                "Clinical Presentation": [
                  {
                    "text": "Can present as a mass"
                  }
                ],
                "Cytopathology": [
                  {
                    "text": "Few clusters of benign ductal epithelial cells associated with many lymphocytes"
                  }
                ]
              },
              "Granulomatous Mastitis": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Granulomatous inflammationBacterial infection with organisms such asTuberculosis, cat scratch disease,Actinomyces,Brucella melitensisFungal infection with organisms such asAspergillus,Histoplasma,Coccidioides,and BlastomycesParasitic infestation with organisms such asEchinococcus granulosus,Tenia solium,Wuchereria bancrofti,Dirofilaria,Trichinella spiralis,LeishmaniaSarcoidosis can rarely affect breast as 1st or only site of involvementForeign bodies: Sutures, silicone (silicone injections or leakage from silicone breast implants), polyacrylamide gelIdiopathic granulomatous mastitis occurs only in parous womenAssociation with childbirth suggests cell-mediated response to antigen within lobules arising during or after pregnancy",
                    "sub_points": [
                      "Bacterial infection with organisms such asTuberculosis, cat scratch disease,Actinomyces,Brucella melitensis",
                      "Fungal infection with organisms such asAspergillus,Histoplasma,Coccidioides,and Blastomyces",
                      "Parasitic infestation with organisms such asEchinococcus granulosus,Tenia solium,Wuchereria bancrofti,Dirofilaria,Trichinella spiralis,Leishmania",
                      "Sarcoidosis can rarely affect breast as 1st or only site of involvement",
                      "Foreign bodies: Sutures, silicone (silicone injections or leakage from silicone breast implants), polyacrylamide gel",
                      "Idiopathic granulomatous mastitis occurs only in parous womenAssociation with childbirth suggests cell-mediated response to antigen within lobules arising during or after pregnancy",
                      "Association with childbirth suggests cell-mediated response to antigen within lobules arising during or after pregnancy"
                    ]
                  }
                ],
                "Clinical Presentation": [
                  {
                    "text": "Can present as a mass; may or may not be tenderIn late stages, sinus tracts can form, which can open into skin",
                    "sub_points": [
                      "In late stages, sinus tracts can form, which can open into skin"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Treatment of pertinent infection"
                  },
                  {
                    "text": "Idiopathic granulomatous mastitis: Excisional biopsy is curative; if inflammation persists, corticosteroids may be used"
                  }
                ],
                "Cytopathology": [
                  {
                    "text": "Granulomas composed of epithelioid histiocytes and multinucleated giant cells ± central necrosis or microabscesses"
                  },
                  {
                    "text": "Silicone mastitis: Silicone may be dissolved in preparations leaving empty spacesIf not dissolved, appears as homogeneous, faintly yellow or blue, retractile nonbirefringent material in smearsAbundant histiocytes with vacuoles, multinucleated giant cells often with asteroid bodies may be seen",
                    "sub_points": [
                      "If not dissolved, appears as homogeneous, faintly yellow or blue, retractile nonbirefringent material in smears",
                      "Abundant histiocytes with vacuoles, multinucleated giant cells often with asteroid bodies may be seen"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Carcinoma": [
                  {
                    "text": "Clinical presentation of subareolar mass in subareolar abscess or duct ectasia can mimic malignant lesion"
                  },
                  {
                    "text": "Abundant clusters and single atypical cells in carcinoma unlike few clusters of ductal cells ± reactive atypia; highly atypical cells are sparse in inflammatory lesions"
                  },
                  {
                    "text": "Breast cancers are generally not associated with marked acute inflammation"
                  }
                ],
                "Lymphoma": [
                  {
                    "text": "Entities such as duct ectasia or lymphocytic mastitis are generally associated with mild to moderate infiltration of small lymphocytes, including histiocytes and plasma cells, unlike lymphoma which shows abundant lymphoid cells proven to be clonal"
                  }
                ],
                "Inflammatory Breast Carcinoma": [
                  {
                    "text": "Obstruction of dermal lymphatics by tumor cells causes erythema and edema of breast, which can mimic acute mastitis/breast abscess"
                  },
                  {
                    "text": "Usually not noted in lactational period, unlike acute mastitis or breast abscess; tissue biopsy and skin punch biopsy may be needed for distinction"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Introduction to Thrombotic Microangiopathies": {
            "name": "Introduction to Thrombotic Microangiopathies",
            "url": "https://app.pathprimer.com/document/c39a8a25-6eeb-49fa-82d7-e2e0fb8a74f0/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Thrombotic microangiopathy (TMA)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "TMA is characterized by microvascular endothelial injury and thrombosis"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Hemolytic Uremic Syndrome (HUS)": [
                  {
                    "text": "Predominantly due to endothelial injury and activation with secondary prothrombotic state"
                  },
                  {
                    "text": "Typical HUSShiga-like and Shiga toxins produced by enteric pathogensMay be genetic susceptibility in minority of cases",
                    "sub_points": [
                      "Shiga-like and Shiga toxins produced by enteric pathogens",
                      "May be genetic susceptibility in minority of cases"
                    ]
                  },
                  {
                    "text": "Atypical HUS (and other related TMA)Multifactorial",
                    "sub_points": [
                      "Multifactorial"
                    ]
                  }
                ],
                "Thrombotic Thrombocytopenic Purpura (TTP)": [
                  {
                    "text": "Predominantly due to increased thrombosis and secondary endothelial injury"
                  },
                  {
                    "text": "Deficiency of ADAMTS13 (A DisintegrinAndMetallopeptidase withThromboSpondin type 1 motif, member13)ADAMTS13 (zinc metalloproteinase) synthesized predominantly in liverRequired for cleavage of vWF multimersvWF is glycoprotein synthesized by endothelial cells and megakaryocytesAfter secretion, vWF normally proteolyzed to smaller units by ADAMTS13In absence of ADAMTS13, large vWF multimers promote platelet aggregation in microvesselsGenetic deficiency of ADAMTS13 (Upshaw-Schulman syndrome)Rare autosomal recessive inheritance results in ADAMTS13 levels < 5% of normal levelsHomozygous or compound heterozygous mutations ofADAMTS13allele cause clinical diseaseHeterozygous mutations result in ADAMTS13 levels approximately 1/2 of normal and lack clinical diseaseAutoantibodies against ADAMTS13IgG or IgM antibodies act as inhibitors against ADAMTS13Seen in approximately 30-80% of acquired idiopathic TTPAutoimmunity triggered by environmental or endogenous factors (infections, cytokines, drugs) in susceptible host",
                    "sub_points": [
                      "ADAMTS13 (zinc metalloproteinase) synthesized predominantly in liverRequired for cleavage of vWF multimersvWF is glycoprotein synthesized by endothelial cells and megakaryocytesAfter secretion, vWF normally proteolyzed to smaller units by ADAMTS13In absence of ADAMTS13, large vWF multimers promote platelet aggregation in microvessels",
                      "Required for cleavage of vWF multimersvWF is glycoprotein synthesized by endothelial cells and megakaryocytesAfter secretion, vWF normally proteolyzed to smaller units by ADAMTS13In absence of ADAMTS13, large vWF multimers promote platelet aggregation in microvessels",
                      "vWF is glycoprotein synthesized by endothelial cells and megakaryocytes",
                      "After secretion, vWF normally proteolyzed to smaller units by ADAMTS13",
                      "In absence of ADAMTS13, large vWF multimers promote platelet aggregation in microvessels",
                      "Genetic deficiency of ADAMTS13 (Upshaw-Schulman syndrome)Rare autosomal recessive inheritance results in ADAMTS13 levels < 5% of normal levelsHomozygous or compound heterozygous mutations ofADAMTS13allele cause clinical diseaseHeterozygous mutations result in ADAMTS13 levels approximately 1/2 of normal and lack clinical disease",
                      "Rare autosomal recessive inheritance results in ADAMTS13 levels < 5% of normal levels",
                      "Homozygous or compound heterozygous mutations ofADAMTS13allele cause clinical disease",
                      "Heterozygous mutations result in ADAMTS13 levels approximately 1/2 of normal and lack clinical disease",
                      "Autoantibodies against ADAMTS13IgG or IgM antibodies act as inhibitors against ADAMTS13Seen in approximately 30-80% of acquired idiopathic TTPAutoimmunity triggered by environmental or endogenous factors (infections, cytokines, drugs) in susceptible host",
                      "IgG or IgM antibodies act as inhibitors against ADAMTS13",
                      "Seen in approximately 30-80% of acquired idiopathic TTP",
                      "Autoimmunity triggered by environmental or endogenous factors (infections, cytokines, drugs) in susceptible host"
                    ]
                  }
                ]
              },
              "CLINICAL IMPLICATIONS": {
                "Clinical Presentation": [
                  {
                    "text": "Varies in HUS and TTP and also based on etiologyShiga toxin-associated HUS typically affects children < 5 years of agePatients withDGKE,CFH,THBDmutations and Cobalamin C disease present during infancyPatients with anti-factor H antibodies present 9-13 years of ageHereditary TTP typically presents in childrenEnvironmental triggers may precipitate disease in adultsAcquired ADAMTS13 deficiency-mediated TTP occurs in adults (18-50 years)More often in African Americans and females",
                    "sub_points": [
                      "Shiga toxin-associated HUS typically affects children < 5 years of age",
                      "Patients withDGKE,CFH,THBDmutations and Cobalamin C disease present during infancy",
                      "Patients with anti-factor H antibodies present 9-13 years of age",
                      "Hereditary TTP typically presents in childrenEnvironmental triggers may precipitate disease in adults",
                      "Environmental triggers may precipitate disease in adults",
                      "Acquired ADAMTS13 deficiency-mediated TTP occurs in adults (18-50 years)More often in African Americans and females",
                      "More often in African Americans and females"
                    ]
                  },
                  {
                    "text": "Atypical HUS etiologically different from TTP but has significant clinical overlapHence, clinical syndrome often referred as atypical HUS/TTP",
                    "sub_points": [
                      "Hence, clinical syndrome often referred as atypical HUS/TTP"
                    ]
                  }
                ],
                "Acute Presentation": [
                  {
                    "text": "Typical HUSWatery diarrhea followed by bloody diarrheaFeverRenal insufficiencyAcute renal failure more common in adultsHypertensionOther systemic manifestations less common",
                    "sub_points": [
                      "Watery diarrhea followed by bloody diarrhea",
                      "Fever",
                      "Renal insufficiency",
                      "Acute renal failure more common in adults",
                      "Hypertension",
                      "Other systemic manifestations less common"
                    ]
                  },
                  {
                    "text": "Subset of atypical HUSCatastrophic antiphospholipid antibody syndrome and scleroderma renal crisisAbrupt onset of symptomsNo prodrome of diarrhea",
                    "sub_points": [
                      "Catastrophic antiphospholipid antibody syndrome and scleroderma renal crisisAbrupt onset of symptomsNo prodrome of diarrhea",
                      "Abrupt onset of symptoms",
                      "No prodrome of diarrhea"
                    ]
                  }
                ],
                "Chronic/Insidious Presentation": [
                  {
                    "text": "TTP and subset of atypical HUSFeverHypertensionMild proteinuriaMicroscopic hematuriaChronic renal insufficiencyNeurological symptoms predominate in TTPRecurrences and relapses may occur with TTP",
                    "sub_points": [
                      "Fever",
                      "Hypertension",
                      "Mild proteinuria",
                      "Microscopic hematuria",
                      "Chronic renal insufficiency",
                      "Neurological symptoms predominate in TTP",
                      "Recurrences and relapses may occur with TTP"
                    ]
                  }
                ]
              },
              "Laboratory Investigations": {
                "Microangiopathic Hemolytic Anemia": [
                  {
                    "text": "Blood flow through injured or narrowed blood vessels causes erythrocyte fragmentation and platelet consumptionAnemiaThrombocytopeniaSchistocytes on peripheral smearElevated serum lactate dehydrogenaseReduced haptoglobin levelsNegative Coombs testNormal prothrombin and partial thromboplastin time",
                    "sub_points": [
                      "Anemia",
                      "Thrombocytopenia",
                      "Schistocytes on peripheral smear",
                      "Elevated serum lactate dehydrogenase",
                      "Reduced haptoglobin levels",
                      "Negative Coombs test",
                      "Normal prothrombin and partial thromboplastin time"
                    ]
                  },
                  {
                    "text": "Leukocytosis, especially in typical HUS"
                  }
                ],
                "Determination of Etiology": [
                  {
                    "text": "Stool cultures to confirm enteric bacterial infection"
                  },
                  {
                    "text": "Antiphospholipid antibodies"
                  },
                  {
                    "text": "Serum complement C3, C4 levels"
                  },
                  {
                    "text": "ANA, anti-dsDNA for systemic lupus erythematosus (SLE)"
                  },
                  {
                    "text": "ADAMTS13 autoantibodies"
                  },
                  {
                    "text": "Anti-topoisomerase 1 and anti-RNA polymerase (I & III) antibodiesIf systemic sclerosis suspected",
                    "sub_points": [
                      "If systemic sclerosis suspected"
                    ]
                  },
                  {
                    "text": "Plasma levels of complement factors H and I recommended in all aHUS cases, as are MCP levels on mononuclear cells, and screening for anti-CFH antibodies"
                  },
                  {
                    "text": "Genetic testing for specific gene mutations and deletionsADAMTS13,CFH(including recombination withCFHRgene),CFI,MCP (CD46), Thrombomodulin,CFB,C3,DGKE, deletion ofCFHR1andCFHR3genes",
                    "sub_points": [
                      "ADAMTS13,CFH(including recombination withCFHRgene),CFI,MCP (CD46), Thrombomodulin,CFB,C3,DGKE, deletion ofCFHR1andCFHR3genes"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Enlarged kidneys in acute phase"
                  },
                  {
                    "text": "Petechial hemorrhages usually seen on external surface"
                  },
                  {
                    "text": "Patchy cortical necrosis can occur"
                  },
                  {
                    "text": "In chronic phase, small kidneys with granular cortical surface"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Acute TMA": [
                  {
                    "text": "GlomeruliBloodless appearanceApparent thickening of capillary wall due to subendothelial expansionMesangiolysisEndothelial swellingThrombi, hilum or glomerular capillariesNuclear debris present but no significant inflammationSome initial data suggested HUS thrombi are fibrin rich, and TTP thrombi are platelet richNot reliable feature and not possible to differentiate histologicallyFibrinoid necrosis may be presentRare crescents seen in occasional casesFragmented RBCs entrapped in thrombi, subendothelium, and mesangiumIn presence of arteriolar changes, downstream glomeruli demonstrate ischemic collapse of capillary tuftsSegmental sclerosis with collapsing features may be observed",
                    "sub_points": [
                      "Bloodless appearance",
                      "Apparent thickening of capillary wall due to subendothelial expansion",
                      "Mesangiolysis",
                      "Endothelial swelling",
                      "Thrombi, hilum or glomerular capillariesNuclear debris present but no significant inflammationSome initial data suggested HUS thrombi are fibrin rich, and TTP thrombi are platelet richNot reliable feature and not possible to differentiate histologicallyFibrinoid necrosis may be present",
                      "Nuclear debris present but no significant inflammation",
                      "Some initial data suggested HUS thrombi are fibrin rich, and TTP thrombi are platelet richNot reliable feature and not possible to differentiate histologically",
                      "Not reliable feature and not possible to differentiate histologically",
                      "Fibrinoid necrosis may be present",
                      "Rare crescents seen in occasional cases",
                      "Fragmented RBCs entrapped in thrombi, subendothelium, and mesangium",
                      "In presence of arteriolar changes, downstream glomeruli demonstrate ischemic collapse of capillary tuftsSegmental sclerosis with collapsing features may be observed",
                      "Segmental sclerosis with collapsing features may be observed"
                    ]
                  },
                  {
                    "text": "TubulointerstitiumAcute tubular injury characterized by simplified epithelium, nuclear reactive atypiaInterstitial edemaCortical necrosis in severe cases",
                    "sub_points": [
                      "Acute tubular injury characterized by simplified epithelium, nuclear reactive atypia",
                      "Interstitial edema",
                      "Cortical necrosis in severe cases"
                    ]
                  },
                  {
                    "text": "Blood vesselsArterioles near vascular pole affected frequentlyEndothelial swelling and luminal occlusionIntimal mucoid edema with entrapped schistocytesThrombiFibrinoid necrosis may be present without evidence of inflammatory infiltrateInterlobular and arcuate arteries show similar changes",
                    "sub_points": [
                      "Arterioles near vascular pole affected frequentlyEndothelial swelling and luminal occlusionIntimal mucoid edema with entrapped schistocytesThrombiFibrinoid necrosis may be present without evidence of inflammatory infiltrate",
                      "Endothelial swelling and luminal occlusion",
                      "Intimal mucoid edema with entrapped schistocytes",
                      "ThrombiFibrinoid necrosis may be present without evidence of inflammatory infiltrate",
                      "Fibrinoid necrosis may be present without evidence of inflammatory infiltrate",
                      "Interlobular and arcuate arteries show similar changes"
                    ]
                  }
                ],
                "Chronic TMA": [
                  {
                    "text": "Changes may be seen within days of acute onset of TMA"
                  },
                  {
                    "text": "GlomeruliGBM duplication and double contoursDue to endothelial cell injuryMesangial expansion with features of mesangiolysisVariable focal segmental and global glomerulosclerosis",
                    "sub_points": [
                      "GBM duplication and double contoursDue to endothelial cell injury",
                      "Due to endothelial cell injury",
                      "Mesangial expansion with features of mesangiolysis",
                      "Variable focal segmental and global glomerulosclerosis"
                    ]
                  },
                  {
                    "text": "TubulointerstitiumTubular atrophy and interstitial fibrosis",
                    "sub_points": [
                      "Tubular atrophy and interstitial fibrosis"
                    ]
                  },
                  {
                    "text": "Arterioles and small arteriesIntimal fibrosis with narrowed luminaConcentric lamination of intimal fibrosis causes \"onion skin\" appearanceRecanalized thrombi may be identified",
                    "sub_points": [
                      "Intimal fibrosis with narrowed lumina",
                      "Concentric lamination of intimal fibrosis causes \"onion skin\" appearance",
                      "Recanalized thrombi may be identified"
                    ]
                  }
                ],
                "Immunofluorescence Microscopy": [
                  {
                    "text": "Thrombi in glomeruli and blood vessels stain for fibrinogen"
                  },
                  {
                    "text": "Nonspecific entrapment of C3 and IgM in glomeruli"
                  },
                  {
                    "text": "No immune complexes unless associated with connective tissue disorder like SLE"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Acute TMAEndothelial swelling and loss of fenestrationsExpansion of subendothelial space by electron-lucent materialEntrapped schistocytes and fibrin tactoids in subendotheliumMesangial matrix also lucent (mesangiolysis)Podocyte foot process effacement commonThrombi show mixture of platelets, fibrin, and erythrocytesMyocyte degeneration may be seen in affected arterioles",
                    "sub_points": [
                      "Endothelial swelling and loss of fenestrations",
                      "Expansion of subendothelial space by electron-lucent materialEntrapped schistocytes and fibrin tactoids in subendothelium",
                      "Entrapped schistocytes and fibrin tactoids in subendothelium",
                      "Mesangial matrix also lucent (mesangiolysis)",
                      "Podocyte foot process effacement common",
                      "Thrombi show mixture of platelets, fibrin, and erythrocytes",
                      "Myocyte degeneration may be seen in affected arterioles"
                    ]
                  },
                  {
                    "text": "Chronic TMAIncreased matrix in mesangium and subendotheliumDepolymerized fibrin may be identifiedDuplication of glomerular basement membranesMesangial cell interpositionPodocyte foot processes often effaced",
                    "sub_points": [
                      "Increased matrix in mesangium and subendothelium",
                      "Depolymerized fibrin may be identified",
                      "Duplication of glomerular basement membranes",
                      "Mesangial cell interposition",
                      "Podocyte foot processes often effaced"
                    ]
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathological Features": [
                  {
                    "text": "Isolated involvement of glomeruli associated with better prognosis than when arterioles also affected"
                  },
                  {
                    "text": "Cortical necrosis is poor prognostic factor"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Etiology cannot be distinguished based on biopsy findings"
                  },
                  {
                    "text": "Anemia, thrombocytopenia, and schistocytes may be absent in mild disease"
                  },
                  {
                    "text": "Latency period between exposure to radiation and TMA can be very long"
                  },
                  {
                    "text": "Biopsy with TMA due to malignant hypertension often shows hypertensive arteriopathy"
                  },
                  {
                    "text": "Significant thrombosis in absence of TMA or arterial remodeling should raise suspicion for antiphospholipid antibody syndrome"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Fat Necrosis": {
            "name": "Fat Necrosis",
            "url": "https://app.pathprimer.com/document/bc2168af-bd94-4978-bf73-422a88e3d939/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Common benign inflammatory reaction secondary to injury of breast adipose tissueWide spectrum of clinical and radiologic appearancesMay be confused with carcinoma, both clinically and radiologically",
                    "sub_points": [
                      "Wide spectrum of clinical and radiologic appearances",
                      "May be confused with carcinoma, both clinically and radiologically"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "May be due to trauma, surgical procedures, pressure necrosis, radiation, or other rare causes"
                  }
                ],
                "Image Findings": [
                  {
                    "text": "Reflect histological evolution of inflammatory processCommon findings are dystrophic calcifications and radiolucent oil cystsOil cysts may be associated with continuous eggshell calcificationIrregular mass may be present",
                    "sub_points": [
                      "Common findings are dystrophic calcifications and radiolucent oil cysts",
                      "Oil cysts may be associated with continuous eggshell calcification",
                      "Irregular mass may be present"
                    ]
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Early changes: Hemorrhage in fat with indurationFollowed by cystic degeneration with oily fluid secondary to necrotic fatCalcifications frequently develop in cyst wall",
                    "sub_points": [
                      "Followed by cystic degeneration with oily fluid secondary to necrotic fat",
                      "Calcifications frequently develop in cyst wall"
                    ]
                  },
                  {
                    "text": "Later changes: Hemosiderin deposition, varying degrees of fibrosis and calcification"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Granular cell tumor"
                  },
                  {
                    "text": "Other inflammatory lesions"
                  },
                  {
                    "text": "Lupus mastitis"
                  },
                  {
                    "text": "Erdheim-Chester disease"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Fat necrosis (FN)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Common benign inflammatory reaction that is secondary to injury of breast connective tissue and adipose tissue"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Causes of Fat Necrosis": [
                  {
                    "text": "TraumaBlunt trauma to breastSeat belt injury after motor vehicle crashesProduces different radiologic patterns of injury in driver and passenger",
                    "sub_points": [
                      "Blunt trauma to breast",
                      "Seat belt injury after motor vehicle crashesProduces different radiologic patterns of injury in driver and passenger",
                      "Produces different radiologic patterns of injury in driver and passenger"
                    ]
                  },
                  {
                    "text": "Pressure necrosisCan occur in lower portion of pendulous breasts",
                    "sub_points": [
                      "Can occur in lower portion of pendulous breasts"
                    ]
                  },
                  {
                    "text": "Radiation therapyPost-radiation vascular damage (endarteritis obliterans) with subsequent ischemia",
                    "sub_points": [
                      "Post-radiation vascular damage (endarteritis obliterans) with subsequent ischemia"
                    ]
                  },
                  {
                    "text": "SurgeryCyst aspirationCore needle biopsiesExcisionsReduction mammoplastyImplantsAutologous fat injection",
                    "sub_points": [
                      "Cyst aspiration",
                      "Core needle biopsies",
                      "Excisions",
                      "Reduction mammoplasty",
                      "Implants",
                      "Autologous fat injection"
                    ]
                  },
                  {
                    "text": "Other rare causesPolyarteritis nodosa, Weber-Christian disease, granulomatous angiopanniculitisHeparin-induced thrombocytopenia (single case report)",
                    "sub_points": [
                      "Polyarteritis nodosa, Weber-Christian disease, granulomatous angiopanniculitis",
                      "Heparin-induced thrombocytopenia (single case report)"
                    ]
                  },
                  {
                    "text": "In about 50% of patients, cause is unknown"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Estimated to be 0.6% of breast excisions"
                  }
                ],
                "Age": [
                  {
                    "text": "Broad range: 37-68 years (mean: ~ 50 years)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Symptomatic FN typically presents as palpable massMay enlarge, remain unchanged, regress, or resolveFN is typically detected in periareolar area and is often superficial in locationThese sites are most vulnerable to traumaCan be associated with skin changesBruising and tenderness (due to original trauma)Skin tethering or dimpling, nipple retraction (due to fibrosis associated with healing)",
                    "sub_points": [
                      "May enlarge, remain unchanged, regress, or resolve",
                      "FN is typically detected in periareolar area and is often superficial in locationThese sites are most vulnerable to trauma",
                      "These sites are most vulnerable to trauma",
                      "Can be associated with skin changesBruising and tenderness (due to original trauma)Skin tethering or dimpling, nipple retraction (due to fibrosis associated with healing)",
                      "Bruising and tenderness (due to original trauma)",
                      "Skin tethering or dimpling, nipple retraction (due to fibrosis associated with healing)"
                    ]
                  },
                  {
                    "text": "May be detected on mammographic screeningForms multiple types of lesionsLipid cysts, coarse calcifications, focal asymmetries, microcalcifications, or irregular massesMany cases can be identified by radiographic appearanceBiopsy is required for cases with unusual imaging features",
                    "sub_points": [
                      "Forms multiple types of lesionsLipid cysts, coarse calcifications, focal asymmetries, microcalcifications, or irregular masses",
                      "Lipid cysts, coarse calcifications, focal asymmetries, microcalcifications, or irregular masses",
                      "Many cases can be identified by radiographic appearanceBiopsy is required for cases with unusual imaging features",
                      "Biopsy is required for cases with unusual imaging features"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Benign inflammatory process that should regress or resolve over time"
                  }
                ],
                "Management": [
                  {
                    "text": "FN must be distinguished from carcinomaPhysical examination and imaging findings can be similar",
                    "sub_points": [
                      "Physical examination and imaging findings can be similar"
                    ]
                  },
                  {
                    "text": "Even with clear history of previous trauma, possibility of malignancy should not be overlookedPatient's attention may be drawn to a palpable mass by an episode of trauma",
                    "sub_points": [
                      "Patient's attention may be drawn to a palpable mass by an episode of trauma"
                    ]
                  },
                  {
                    "text": "Patients who have undergone breast-conserving surgery for breast cancer may develop FNFN related to treatment must be distinguished from cancer recurrence",
                    "sub_points": [
                      "FN related to treatment must be distinguished from cancer recurrence"
                    ]
                  },
                  {
                    "text": "Management may include short-term follow-up with imaging and physical examination in selected casesIn specific cases with worrisome clinical/radiographic features, biopsy is required to confirm diagnosis",
                    "sub_points": [
                      "In specific cases with worrisome clinical/radiographic features, biopsy is required to confirm diagnosis"
                    ]
                  }
                ]
              },
              "Image Findings": {
                "General Features": [],
                "Location": [
                  {
                    "text": "In lesions precipitated by trauma, mass typically occurs at site of injury"
                  },
                  {
                    "text": "In patients with no history of trauma, lesion is most often seen in upper outer quadrant of breast"
                  }
                ],
                "Morphology": [
                  {
                    "text": "Imaging features of FN reflect  histological evolution of inflammatory process"
                  }
                ],
                "Mammographic Findings": [
                  {
                    "text": "Variable"
                  },
                  {
                    "text": "Attributable to degree of fibrosis and types of calcifications changing as lesion developsEarly discrete round or oval radiolucent oil cyst with thin capsuleOil cysts may be associated with uniform continuous eggshell calcificationProgressive thickening and deformity of skin and subcutaneous tissueFormation of ill-defined irregular massDevelopment of multiple clustered pleomorphic microcalcifications, possibly suspicious for malignancy",
                    "sub_points": [
                      "Early discrete round or oval radiolucent oil cyst with thin capsuleOil cysts may be associated with uniform continuous eggshell calcification",
                      "Oil cysts may be associated with uniform continuous eggshell calcification",
                      "Progressive thickening and deformity of skin and subcutaneous tissue",
                      "Formation of ill-defined irregular mass",
                      "Development of multiple clustered pleomorphic microcalcifications, possibly suspicious for malignancy"
                    ]
                  },
                  {
                    "text": "Most common mammographic findings are dystrophic calcifications, followed by radiolucent oil cysts"
                  }
                ],
                "Ultrasonographic Findings": [
                  {
                    "text": "Appearance ranges from solid nodules with posterior shadowing to complex intracystic massesCystic lesions may appear complex with mural nodules or with internal echogenic bandsOil cysts typically show posterior acoustic shadowing, corresponding to round radiolucent lesion with curvilinear wall calcification on mammographyFat-fluid level that shifts in orientation with changes in patient position is considered diagnostic of oil cystsPresence of oil cyst within a spiculated mass is reassuring for diagnosis of fat necrosisSolid masses have well-circumscribed or ill-defined marginsOften associated with distortion of surrounding breast parenchyma",
                    "sub_points": [
                      "Cystic lesions may appear complex with mural nodules or with internal echogenic bandsOil cysts typically show posterior acoustic shadowing, corresponding to round radiolucent lesion with curvilinear wall calcification on mammographyFat-fluid level that shifts in orientation with changes in patient position is considered diagnostic of oil cystsPresence of oil cyst within a spiculated mass is reassuring for diagnosis of fat necrosis",
                      "Oil cysts typically show posterior acoustic shadowing, corresponding to round radiolucent lesion with curvilinear wall calcification on mammography",
                      "Fat-fluid level that shifts in orientation with changes in patient position is considered diagnostic of oil cysts",
                      "Presence of oil cyst within a spiculated mass is reassuring for diagnosis of fat necrosis",
                      "Solid masses have well-circumscribed or ill-defined marginsOften associated with distortion of surrounding breast parenchyma",
                      "Often associated with distortion of surrounding breast parenchyma"
                    ]
                  }
                ],
                "MR Findings": [
                  {
                    "text": "FN produces wide spectrum of findings on MRFibrosis may be seen as architectural distortion with or without irregular marginsFibrosis may appear as high, intermediate, or low signal on T1-weighted MRNecrotic fat usually shows low signal intensity on T1-weighted MRMay be due to hemorrhagic and inflammatory infiltrate",
                    "sub_points": [
                      "Fibrosis may be seen as architectural distortion with or without irregular marginsFibrosis may appear as high, intermediate, or low signal on T1-weighted MR",
                      "Fibrosis may appear as high, intermediate, or low signal on T1-weighted MR",
                      "Necrotic fat usually shows low signal intensity on T1-weighted MRMay be due to hemorrhagic and inflammatory infiltrate",
                      "May be due to hemorrhagic and inflammatory infiltrate"
                    ]
                  },
                  {
                    "text": "FN can enhance after injection of contrast materialAmount of enhancement depends on intensity of inflammatory processEnhancement can be focal or diffuse, homogeneous or heterogeneousEnhancement patterns may vary from slow gradual enhancement to rapid enhancementMost avid enhancement usually occurs in early phase after initial injuryAs inflammatory changes resolve, degree of enhancement may decrease",
                    "sub_points": [
                      "Amount of enhancement depends on intensity of inflammatory processEnhancement can be focal or diffuse, homogeneous or heterogeneousEnhancement patterns may vary from slow gradual enhancement to rapid enhancementMost avid enhancement usually occurs in early phase after initial injuryAs inflammatory changes resolve, degree of enhancement may decrease",
                      "Enhancement can be focal or diffuse, homogeneous or heterogeneous",
                      "Enhancement patterns may vary from slow gradual enhancement to rapid enhancement",
                      "Most avid enhancement usually occurs in early phase after initial injury",
                      "As inflammatory changes resolve, degree of enhancement may decrease"
                    ]
                  },
                  {
                    "text": "FN may mimic malignancy on MR on basis of morphology or contrast kinetics"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "FN forms a demarcated mass lesion with distinct yellow-gray and focally reddish colorOften retracts surrounding parenchymaCystic degeneration may occur, resulting in a cavity that contains oily fluid secondary to necrotic fat",
                    "sub_points": [
                      "Often retracts surrounding parenchyma",
                      "Cystic degeneration may occur, resulting in a cavity that contains oily fluid secondary to necrotic fat"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Varies over time from initial injury to reaction to damaged tissue and, ultimately, to resolutionEarly-stage lesionsEarly changes include hemorrhage in fat, resulting in induration and firmness on gross pathologyOver several weeks, affected area becomes demarcated, forming distinct yellow-gray and focally reddish massCystic degeneration may result in a cavity that contains oily fluid secondary to necrotic fatCalcifications frequently develop in cyst wallsIntermediate-stage lesionsInfiltration of histiocytes, lymphocytes, plasma cells, and multinucleated giant cellsFoamy cytoplasm of histocytes and giant cells is due to phagocytosis of necrotic adipose cellsLate-stage lesionsLater changes are characterized by hemosiderin deposition and the development of varying degrees of fibrosisReactive inflammatory components gradually replaced by fibrosis lead to scar formationLoculated degenerated fat may persist for months or years in a cyst surrounded by fibrosisIn some cases, fibrosis and calcifications are only sequelae of fat necrosisReparative fibrotic process may replace areas of necrotic fat, resulting in a suspicious irregular mass",
                    "sub_points": [
                      "Early-stage lesionsEarly changes include hemorrhage in fat, resulting in induration and firmness on gross pathologyOver several weeks, affected area becomes demarcated, forming distinct yellow-gray and focally reddish massCystic degeneration may result in a cavity that contains oily fluid secondary to necrotic fatCalcifications frequently develop in cyst walls",
                      "Early changes include hemorrhage in fat, resulting in induration and firmness on gross pathology",
                      "Over several weeks, affected area becomes demarcated, forming distinct yellow-gray and focally reddish mass",
                      "Cystic degeneration may result in a cavity that contains oily fluid secondary to necrotic fat",
                      "Calcifications frequently develop in cyst walls",
                      "Intermediate-stage lesionsInfiltration of histiocytes, lymphocytes, plasma cells, and multinucleated giant cellsFoamy cytoplasm of histocytes and giant cells is due to phagocytosis of necrotic adipose cells",
                      "Infiltration of histiocytes, lymphocytes, plasma cells, and multinucleated giant cells",
                      "Foamy cytoplasm of histocytes and giant cells is due to phagocytosis of necrotic adipose cells",
                      "Late-stage lesionsLater changes are characterized by hemosiderin deposition and the development of varying degrees of fibrosisReactive inflammatory components gradually replaced by fibrosis lead to scar formationLoculated degenerated fat may persist for months or years in a cyst surrounded by fibrosisIn some cases, fibrosis and calcifications are only sequelae of fat necrosisReparative fibrotic process may replace areas of necrotic fat, resulting in a suspicious irregular mass",
                      "Later changes are characterized by hemosiderin deposition and the development of varying degrees of fibrosis",
                      "Reactive inflammatory components gradually replaced by fibrosis lead to scar formation",
                      "Loculated degenerated fat may persist for months or years in a cyst surrounded by fibrosis",
                      "In some cases, fibrosis and calcifications are only sequelae of fat necrosis",
                      "Reparative fibrotic process may replace areas of necrotic fat, resulting in a suspicious irregular mass"
                    ]
                  },
                  {
                    "text": "Histiocytes adjacent to ruptured cysts are termed \"ochrocytes\" when they contain brown pigmentLikely due to oxidized secretory lipids",
                    "sub_points": [
                      "Likely due to oxidized secretory lipids"
                    ]
                  },
                  {
                    "text": "Varied appearances of FN on imaging studies is due to various amounts of histiocytic infiltration, hemorrhage, fibrosis, and calcification"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "FN is characterized by a polymorphous inflammatory infiltrate in response to tissue injuryLesion is characterized by admixed histiocytes, giant cells, lymphocytes, and fibroblastsCellular composition of infiltrate will vary with age of lesionCytologic atypia should not be present",
                    "sub_points": [
                      "Lesion is characterized by admixed histiocytes, giant cells, lymphocytes, and fibroblastsCellular composition of infiltrate will vary with age of lesionCytologic atypia should not be present",
                      "Cellular composition of infiltrate will vary with age of lesion",
                      "Cytologic atypia should not be present"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Granular Cell Tumor": [
                  {
                    "text": "Lipid-laden histocytes in FN and cells of a granular cell tumor can be similar in appearanceHistiocytes should be strongly positive for CD68 and may be positive for S100Granular cells are strongly S100 positive and may be CD68 positive",
                    "sub_points": [
                      "Histiocytes should be strongly positive for CD68 and may be positive for S100",
                      "Granular cells are strongly S100 positive and may be CD68 positive"
                    ]
                  },
                  {
                    "text": "Granular cell tumor lacks other inflammatory cells and fat involvement characteristic of FN"
                  }
                ],
                "Other Inflammatory Lesions": [
                  {
                    "text": "FN is a frequent component of other inflammatory lesionsAbscess, ruptured cysts, surgical procedures, needle tracksEtiology is usually clinically apparent",
                    "sub_points": [
                      "Abscess, ruptured cysts, surgical procedures, needle tracksEtiology is usually clinically apparent",
                      "Etiology is usually clinically apparent"
                    ]
                  },
                  {
                    "text": "Correlation with clinical, imaging, and culture studies may be needed for diagnosis"
                  }
                ],
                "Lupus Mastitis": [
                  {
                    "text": "Rare manifestation of lupusCan be presenting finding",
                    "sub_points": [
                      "Can be presenting finding"
                    ]
                  },
                  {
                    "text": "Average patient age: 40 years (range: 18-70 years)"
                  },
                  {
                    "text": "Single or multiple palpable massesSubcutaneous or deep",
                    "sub_points": [
                      "Subcutaneous or deep"
                    ]
                  },
                  {
                    "text": "Lymphocytic lobular panniculitis presentLymphocytic infiltration can be nodular or diffuse, periductal or perilobularGerminal centers may be presentMixed B- and T-cell populationMay include plasma cells",
                    "sub_points": [
                      "Lymphocytic infiltration can be nodular or diffuse, periductal or perilobular",
                      "Germinal centers may be present",
                      "Mixed B- and T-cell population",
                      "May include plasma cells"
                    ]
                  },
                  {
                    "text": "Hyaline fat necrosis also present"
                  },
                  {
                    "text": "Lymphocytic vasculitis common"
                  }
                ],
                "Erdheim-Chester Disease": [
                  {
                    "text": "Very rare non-Langerhans cell histiocytosis (\"polyostotic sclerosing histiocytosis\")  that may involve breast"
                  },
                  {
                    "text": "Characterized by infiltration of histiocytesHistiocytes are CD68 positive and negative for CD1a and S100Touton-type giant cells may be present",
                    "sub_points": [
                      "Histiocytes are CD68 positive and negative for CD1a and S100",
                      "Touton-type giant cells may be present"
                    ]
                  },
                  {
                    "text": "Mild lymphocytic infiltrate is present"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Acute Tubular Necrosis": {
            "name": "Acute Tubular Necrosis",
            "url": "https://app.pathprimer.com/document/4a967d28-4346-493f-9f05-b544393ed594/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Renal ischemia/reduced renal perfusion (90%)"
                  },
                  {
                    "text": "Nephrotoxins (10%)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Deterioration of glomerular filtration rate occurs over hours to days"
                  },
                  {
                    "text": "Urinary microscopy reveals muddy brown casts and sloughed epithelium"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Kidneys are enlarged with increased weight"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Necrosis of epithelium with bare basement membranes"
                  },
                  {
                    "text": "Most tubular cells have sublethal injury"
                  },
                  {
                    "text": "Casts of necrotic cells and debris + lipofuscin pigment"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Causes of ATNIschemiaDrugsEndogenous or exogenous toxins",
                    "sub_points": [
                      "Ischemia",
                      "Drugs",
                      "Endogenous or exogenous toxins"
                    ]
                  },
                  {
                    "text": "Mimics of ATNAcute interstitial nephritis, autolysis",
                    "sub_points": [
                      "Acute interstitial nephritis, autolysis"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Most epithelial cells have loss of apical cytoplasm, reduced  brush border on PAS stain, and open lumina"
                  },
                  {
                    "text": "Interstitial edema may be prominent, but inflammatory infiltrates are sparse"
                  },
                  {
                    "text": "Phases of ATN: Initiation, maintenance, and repair"
                  },
                  {
                    "text": "Ischemia shows little or no overt necrosis in contrast to toxins"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Acute tubular necrosis (ATN)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Acute tubular injury"
                  },
                  {
                    "text": "Acute tubular damage"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Acute renal failure caused by acute tubular epithelial injury, due to either ischemia or toxins"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Etiology": [
                  {
                    "text": "Renal ischemia due to reduced renal perfusion (~ 90%)HypovolemiaBlood loss (trauma, surgery, ante- and postpartum hemorrhage)External fluid loss (e.g., burns, sweat, diarrhea)3rd space fluid loss (e.g., hypoalbuminemia, bowel obstruction, pancreatitis)Decreased perfusion pressureSystemic: Cardiac failure, cardiac tamponade, myocardial infarction, arrhythmiaLocal: Severe renal artery stenosis, malignant hypertensionReduced effective intravascular volumeSepsis, hepatorenal syndrome, anaphylaxis, vasodilator drugs",
                    "sub_points": [
                      "HypovolemiaBlood loss (trauma, surgery, ante- and postpartum hemorrhage)External fluid loss (e.g., burns, sweat, diarrhea)3rd space fluid loss (e.g., hypoalbuminemia, bowel obstruction, pancreatitis)",
                      "Blood loss (trauma, surgery, ante- and postpartum hemorrhage)",
                      "External fluid loss (e.g., burns, sweat, diarrhea)",
                      "3rd space fluid loss (e.g., hypoalbuminemia, bowel obstruction, pancreatitis)",
                      "Decreased perfusion pressureSystemic: Cardiac failure, cardiac tamponade, myocardial infarction, arrhythmiaLocal: Severe renal artery stenosis, malignant hypertension",
                      "Systemic: Cardiac failure, cardiac tamponade, myocardial infarction, arrhythmia",
                      "Local: Severe renal artery stenosis, malignant hypertension",
                      "Reduced effective intravascular volumeSepsis, hepatorenal syndrome, anaphylaxis, vasodilator drugs",
                      "Sepsis, hepatorenal syndrome, anaphylaxis, vasodilator drugs"
                    ]
                  },
                  {
                    "text": "Nephrotoxins (~ 10%)DrugsAntibiotics (e.g., aminoglycosides, vancomycin, amphotericin)Chemotherapeutic agents (e.g., cisplatin, ifosfamide, cytarabine)Nonsteroidal anti-inflammatory agents (NSAIDs)Calcineurin inhibitors (cyclosporine, tacrolimus)Inhibitors of mTOR (rapamycin, sirolimus)Angiotensin-converting enzyme (ACE) inhibitorsAnesthetics (halothane)Radiologic contrast agentsOrganic solventsEthylene glycol, carbon tetrachlorideHeavy metalsMercury, lead, bismuth, uranium, platinumEndogenous substancesHemoglobin (hemolysis, transfusion reactions)Myoglobin (crush injury, statin drugs)Monoclonal immunoglobulin light chains (free or as crystals or casts in myeloma)Intratubular crystals (calcium oxalate, urates)Bile casts (hepatorenal syndrome)",
                    "sub_points": [
                      "DrugsAntibiotics (e.g., aminoglycosides, vancomycin, amphotericin)Chemotherapeutic agents (e.g., cisplatin, ifosfamide, cytarabine)Nonsteroidal anti-inflammatory agents (NSAIDs)Calcineurin inhibitors (cyclosporine, tacrolimus)Inhibitors of mTOR (rapamycin, sirolimus)Angiotensin-converting enzyme (ACE) inhibitorsAnesthetics (halothane)Radiologic contrast agents",
                      "Antibiotics (e.g., aminoglycosides, vancomycin, amphotericin)",
                      "Chemotherapeutic agents (e.g., cisplatin, ifosfamide, cytarabine)",
                      "Nonsteroidal anti-inflammatory agents (NSAIDs)",
                      "Calcineurin inhibitors (cyclosporine, tacrolimus)",
                      "Inhibitors of mTOR (rapamycin, sirolimus)",
                      "Angiotensin-converting enzyme (ACE) inhibitors",
                      "Anesthetics (halothane)",
                      "Radiologic contrast agents",
                      "Organic solventsEthylene glycol, carbon tetrachloride",
                      "Ethylene glycol, carbon tetrachloride",
                      "Heavy metalsMercury, lead, bismuth, uranium, platinum",
                      "Mercury, lead, bismuth, uranium, platinum",
                      "Endogenous substancesHemoglobin (hemolysis, transfusion reactions)Myoglobin (crush injury, statin drugs)Monoclonal immunoglobulin light chains (free or as crystals or casts in myeloma)Intratubular crystals (calcium oxalate, urates)Bile casts (hepatorenal syndrome)",
                      "Hemoglobin (hemolysis, transfusion reactions)",
                      "Myoglobin (crush injury, statin drugs)",
                      "Monoclonal immunoglobulin light chains (free or as crystals or casts in myeloma)",
                      "Intratubular crystals (calcium oxalate, urates)",
                      "Bile casts (hepatorenal syndrome)"
                    ]
                  }
                ],
                "Pathogenesis": [
                  {
                    "text": "Ischemic or toxic insult to tubular epithelium"
                  },
                  {
                    "text": "Tubular injury and dysfunctionAltered epithelial transport results in reduction of resorption of NaClIncreased delivery of NaCl to macula densa in distal tubule activates tubuloglomerular feedback, thereby reducing glomerular filtration rate (GFR)Loss of tubular epithelial adhesion allows leak of glomerular filtrate into interstitium, reducing effective GFRExfoliated epithelium, increased tubular sodium, and Tamm-Horsfall protein combine to form luminal casts that obstruct flow",
                    "sub_points": [
                      "Altered epithelial transport results in reduction of resorption of NaCl",
                      "Increased delivery of NaCl to macula densa in distal tubule activates tubuloglomerular feedback, thereby reducing glomerular filtration rate (GFR)",
                      "Loss of tubular epithelial adhesion allows leak of glomerular filtrate into interstitium, reducing effective GFR",
                      "Exfoliated epithelium, increased tubular sodium, and Tamm-Horsfall protein combine to form luminal casts that obstruct flow"
                    ]
                  },
                  {
                    "text": "Hemodynamic changesAfferent arteriolar vasoconstriction reduces glomerular hydrostatic pressureMesangial contraction in tubuloglomerular feedback reduces effective surface area for filtrationEndothelial activation increases adhesion molecule expression and procoagulant activity",
                    "sub_points": [
                      "Afferent arteriolar vasoconstriction reduces glomerular hydrostatic pressure",
                      "Mesangial contraction in tubuloglomerular feedback reduces effective surface area for filtration",
                      "Endothelial activation increases adhesion molecule expression and procoagulant activity"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "Recent studies suggest that the incidence of acute kidney injury in hospitalized children is increasing"
                  }
                ],
                "Presentation": [
                  {
                    "text": "HypotensionNormotensive patients with prior hypertension, chronic kidney disease, or advanced age may have reduced renal perfusion that is clinically subtle",
                    "sub_points": [
                      "Normotensive patients with prior hypertension, chronic kidney disease, or advanced age may have reduced renal perfusion that is clinically subtle"
                    ]
                  },
                  {
                    "text": "Exposure to toxin may be identified in clinical examination"
                  },
                  {
                    "text": "Urinary microscopy reveals muddy brown casts and sloughed epithelial cells"
                  },
                  {
                    "text": "PhasesOliguric: Days to weeks; low GFR and urine output < 400 mL/dEarly diuretic: Days to weeks; low GFR and increased urinary outputLate diuretic: Weeks; normalization of GFR and increased urinary output",
                    "sub_points": [
                      "Oliguric: Days to weeks; low GFR and urine output < 400 mL/d",
                      "Early diuretic: Days to weeks; low GFR and increased urinary output",
                      "Late diuretic: Weeks; normalization of GFR and increased urinary output"
                    ]
                  }
                ],
                "Acute renal failure": [
                  {
                    "text": "Deterioration of GFR, measured by elevation of serum creatinine or blood urea nitrogen, occurs over hours to days"
                  }
                ],
                "Oliguria": [
                  {
                    "text": "Nonoliguric ATN uncommonAssociated with drug toxicity, especially aminoglycosides and contrast nephropathy",
                    "sub_points": [
                      "Associated with drug toxicity, especially aminoglycosides and contrast nephropathy"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "IschemiaRestoration of intravascular volume with intravenous fluidsVasodilators may increase renal perfusion but have no effect on recovery of function",
                    "sub_points": [
                      "Restoration of intravascular volume with intravenous fluids",
                      "Vasodilators may increase renal perfusion but have no effect on recovery of function"
                    ]
                  },
                  {
                    "text": "ToxinCessation of exposureRemoval of toxin (dialysis, chelation)",
                    "sub_points": [
                      "Cessation of exposure",
                      "Removal of toxin (dialysis, chelation)"
                    ]
                  },
                  {
                    "text": "Restoration of electrolyte balance and pHHyperkalemia treated using insulin/glucose to increase cellular uptake, sodium polystyrene sulfonate for potassium bindingSevere, persistent ATN refractory to medical therapy requires dialysis",
                    "sub_points": [
                      "Hyperkalemia treated using insulin/glucose to increase cellular uptake, sodium polystyrene sulfonate for potassium binding",
                      "Severe, persistent ATN refractory to medical therapy requires dialysis"
                    ]
                  },
                  {
                    "text": "ComplicationsInfectionSource of infection: Indwelling vascular or urinary catheters, respiratory tract, urinary tractMost frequent cause of death is sepsis (30-70%)CardiovascularCongestive heart failure, pulmonary edema, hypertension (25%), cardiac arrhythmia (10-30%)GastrointestinalHemorrhage (10-30%)NeurologicEncephalopathy, seizures",
                    "sub_points": [
                      "InfectionSource of infection: Indwelling vascular or urinary catheters, respiratory tract, urinary tractMost frequent cause of death is sepsis (30-70%)",
                      "Source of infection: Indwelling vascular or urinary catheters, respiratory tract, urinary tract",
                      "Most frequent cause of death is sepsis (30-70%)",
                      "CardiovascularCongestive heart failure, pulmonary edema, hypertension (25%), cardiac arrhythmia (10-30%)",
                      "Congestive heart failure, pulmonary edema, hypertension (25%), cardiac arrhythmia (10-30%)",
                      "GastrointestinalHemorrhage (10-30%)",
                      "Hemorrhage (10-30%)",
                      "NeurologicEncephalopathy, seizures",
                      "Encephalopathy, seizures"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "5-16% of patients with ischemic ATN have irreversible renal failure"
                  },
                  {
                    "text": "Mortality is ~ 50% and as high as 79% in critically ill patients with ATN requiring dialysis"
                  },
                  {
                    "text": "Even mild sustained increase of serum creatinine is associated with increased mortality in hospitalized patients"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Kidneys are enlarged with increased weight up to ~ 130% of normal"
                  },
                  {
                    "text": "Cut surface reveals bulging pale cortex with red medulla"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Tubular epithelial injury prominent in early phaseNecrosis or apoptosis of individual cellsLoss of nucleiDenudation of tubular epithelial cellsPatchy distribution of changes with variable thickness of tubular epitheliumCell loss most prominent in distal nephron (distal:proximal ~ 4:1)Distal tubular casts of necrotic cells and cell debris, often with lipofuscin pigment",
                    "sub_points": [
                      "Necrosis or apoptosis of individual cells",
                      "Loss of nuclei",
                      "Denudation of tubular epithelial cells",
                      "Patchy distribution of changes with variable thickness of tubular epithelium",
                      "Cell loss most prominent in distal nephron (distal:proximal ~ 4:1)",
                      "Distal tubular casts of necrotic cells and cell debris, often with lipofuscin pigment"
                    ]
                  },
                  {
                    "text": "Vast majority of tubular cells have nonnecrotizing sublethal injury in ischemic injuryAttenuation with reduced apical cytoplasmReduced or absent brush borders on PAS (= simplification)Open tubular lumen",
                    "sub_points": [
                      "Attenuation with reduced apical cytoplasm",
                      "Reduced or absent brush borders on PAS (= simplification)",
                      "Open tubular lumen"
                    ]
                  },
                  {
                    "text": "Cell necrosis common in toxic injuryMost prominent in proximal tubule",
                    "sub_points": [
                      "Most prominent in proximal tubule"
                    ]
                  },
                  {
                    "text": "Regeneration prominent in later phasesIncreased cytoplasmic basophiliaTubular epithelial mitosesCrowding of proximal epithelial nuclei",
                    "sub_points": [
                      "Increased cytoplasmic basophilia",
                      "Tubular epithelial mitoses",
                      "Crowding of proximal epithelial nuclei"
                    ]
                  },
                  {
                    "text": "Dystrophic calcium phosphate or apatite may be evidentOxalate crystals common but usually sparse",
                    "sub_points": [
                      "Oxalate crystals common but usually sparse"
                    ]
                  },
                  {
                    "text": "Interstitial edema commonSparse mononuclear infiltrates; most marked at vasa recta",
                    "sub_points": [
                      "Sparse mononuclear infiltrates; most marked at vasa recta"
                    ]
                  },
                  {
                    "text": "Glomeruli generally unremarkableFibrin thrombi occur in sepsisParietal epithelium transformed from squamous to cuboidal cell type, called tubularization of Bowman capsule",
                    "sub_points": [
                      "Fibrin thrombi occur in sepsis",
                      "Parietal epithelium transformed from squamous to cuboidal cell type, called tubularization of Bowman capsule"
                    ]
                  },
                  {
                    "text": "Arteries and arterioles generally unremarkable"
                  },
                  {
                    "text": "Vasa recta may have luminal leukocytesExtramedullary hematopoiesis may occur",
                    "sub_points": [
                      "Extramedullary hematopoiesis may occur"
                    ]
                  },
                  {
                    "text": "Tubulocapillary anastomosis may form due to ruptured tubulesMay have red cell casts",
                    "sub_points": [
                      "May have red cell casts"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Causes of ATN": [
                  {
                    "text": "IschemiaTubular injury without necrosis",
                    "sub_points": [
                      "Tubular injury without necrosis"
                    ]
                  },
                  {
                    "text": "Myoglobinuria/rhabdomyolysisEosinophilic globular luminal casts that stain for myoglobin by immunohistochemistry",
                    "sub_points": [
                      "Eosinophilic globular luminal casts that stain for myoglobin by immunohistochemistry"
                    ]
                  },
                  {
                    "text": "Lead and bismuth toxicityTubular nuclear eosinophilic inclusions",
                    "sub_points": [
                      "Tubular nuclear eosinophilic inclusions"
                    ]
                  },
                  {
                    "text": "Antiviral agents (e.g., tenofovir, adefovir)Tubular nucleomegaly with pleomorphismMitochondrial enlargement and loss of cristae on electron microscopy",
                    "sub_points": [
                      "Tubular nucleomegaly with pleomorphism",
                      "Mitochondrial enlargement and loss of cristae on electron microscopy"
                    ]
                  },
                  {
                    "text": "Cisplatin and other DNA synthesis inhibitorsTubular nucleomegaly with pleomorphism",
                    "sub_points": [
                      "Tubular nucleomegaly with pleomorphism"
                    ]
                  },
                  {
                    "text": "Calcineurin inhibitor toxicityIsometric vacuolization of tubular epithelium",
                    "sub_points": [
                      "Isometric vacuolization of tubular epithelium"
                    ]
                  },
                  {
                    "text": "Ethylene glycol toxicityOxalate crystals",
                    "sub_points": [
                      "Oxalate crystals"
                    ]
                  },
                  {
                    "text": "Radiocontrast agentsIsometric vacuolization of tubular epithelium",
                    "sub_points": [
                      "Isometric vacuolization of tubular epithelium"
                    ]
                  },
                  {
                    "text": "SulfonamidesDrug crystals in tubules",
                    "sub_points": [
                      "Drug crystals in tubules"
                    ]
                  },
                  {
                    "text": "Acyclovir, indinavirDrug crystals in tubules",
                    "sub_points": [
                      "Drug crystals in tubules"
                    ]
                  }
                ],
                "Mimics of ATN": [
                  {
                    "text": "Acute interstitial nephritisInterstitial inflammation and tubulitis more prominent",
                    "sub_points": [
                      "Interstitial inflammation and tubulitis more prominent"
                    ]
                  },
                  {
                    "text": "AutolysisKidney weight not increasedLoss of cell-to-cell and cell-to-tubular basement membrane adhesionNo pigment castsNo thinned cytoplasmNo mitoses",
                    "sub_points": [
                      "Kidney weight not increased",
                      "Loss of cell-to-cell and cell-to-tubular basement membrane adhesion",
                      "No pigment casts",
                      "No thinned cytoplasm",
                      "No mitoses"
                    ]
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Phases of ATNInitiation (hours to days)Cellular injury, loss of polarity and adhesion, exfoliation and obstructionMaintenance (days to weeks)Dedifferentiation, migration, proliferation, microvascular injury (inflammation, coagulopathy)Repair (weeks to months)Differentiation, restoration of polarity",
                    "sub_points": [
                      "Initiation (hours to days)Cellular injury, loss of polarity and adhesion, exfoliation and obstruction",
                      "Cellular injury, loss of polarity and adhesion, exfoliation and obstruction",
                      "Maintenance (days to weeks)Dedifferentiation, migration, proliferation, microvascular injury (inflammation, coagulopathy)",
                      "Dedifferentiation, migration, proliferation, microvascular injury (inflammation, coagulopathy)",
                      "Repair (weeks to months)Differentiation, restoration of polarity",
                      "Differentiation, restoration of polarity"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Necrotic or apoptotic epithelial cells are fewUsually seen in casts and associated with bare segments of basement membrane",
                    "sub_points": [
                      "Usually seen in casts and associated with bare segments of basement membrane"
                    ]
                  },
                  {
                    "text": "Vast majority of epithelial cells have sublethal injury with loss of apical cytoplasm, loss of brush border on PAS stain, and dilated tubules"
                  },
                  {
                    "text": "Interstitial edema may be prominent, but inflammatory cell infiltrates are sparse"
                  },
                  {
                    "text": "Hematopoietic precursors are aggregated in vasa recta"
                  },
                  {
                    "text": "Ischemia has little or no overt necrosis vs. toxins"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Ischemia (Liver: Centrilobular Necrosis)": {
            "name": "Ischemia (Liver: Centrilobular Necrosis)",
            "url": "https://app.pathprimer.com/document/5e8658b0-afac-4b01-ade1-4b602557a123/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Ischemic hepatitis, hepatic infarction, and shock liver"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Cardiac failure"
                  },
                  {
                    "text": "Circulatory shock due to sepsis, hypovolemia, severe trauma, burns, and other causes"
                  },
                  {
                    "text": "Vascular thromboses due to stasis, endothelial injury, and hypercoagulable state"
                  },
                  {
                    "text": "In transplant patients, anastomotic complications"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Often asymptomatic"
                  },
                  {
                    "text": "Characterized by rapid and extreme rise in serum aminotransferases"
                  },
                  {
                    "text": "Patients may develop acute liver failure"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Sharply demarcated zones of coagulative hepatocyte necrosis"
                  },
                  {
                    "text": "Minimal inflammation"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Ischemic hepatitis"
                  },
                  {
                    "text": "Shock liver"
                  },
                  {
                    "text": "Hypoxic hepatitis"
                  },
                  {
                    "text": "Hepatic infarction"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Liver injury due to reduced blood flow"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Systemic Hypotension &/or Hypoxemia": [
                  {
                    "text": "Cardiac failureAcute myocardial infarction or cardiac surgery",
                    "sub_points": [
                      "Acute myocardial infarction or cardiac surgery"
                    ]
                  },
                  {
                    "text": "Circulatory shock due to sepsis, hypovolemia, severe trauma, burns, and other causes"
                  }
                ],
                "Vascular Obstruction": [
                  {
                    "text": "Caused by stasis, endothelial injury, and hypercoagulable state1 or more vessels may be involved",
                    "sub_points": [
                      "1 or more vessels may be involved"
                    ]
                  },
                  {
                    "text": "In transplant patients, anastomotic complications lead to vascular thromboses"
                  },
                  {
                    "text": "In native livers, usually require obstruction of 2 vessels to result in clinically significant ischemiaGreater collateralization present in native livers, but allografts subject to injury with single vessel obstruction",
                    "sub_points": [
                      "Greater collateralization present in native livers, but allografts subject to injury with single vessel obstruction"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Presentation": [
                  {
                    "text": "Often asymptomatic"
                  },
                  {
                    "text": "Severely affected patients may present with acute liver failure"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Rapid and extreme rise in serum aminotransferases, often identified by screening laboratory testsMay be followed by liver failureIf patient survives, enzymes then normalize rapidly",
                    "sub_points": [
                      "May be followed by liver failure",
                      "If patient survives, enzymes then normalize rapidly"
                    ]
                  },
                  {
                    "text": "Marked elevation of lactate dehydrogenase (LDH)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Treat underlying cause of ischemia"
                  },
                  {
                    "text": "Supportive care"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on duration and extent of liver injuryIn severe cases, often accompanied by multisystem organ failure and poor prognosis",
                    "sub_points": [
                      "In severe cases, often accompanied by multisystem organ failure and poor prognosis"
                    ]
                  },
                  {
                    "text": "Most cases are brief and followed by recoveryMany cases are likely subclinical",
                    "sub_points": [
                      "Many cases are likely subclinical"
                    ]
                  },
                  {
                    "text": "Hepatic abscess may occur if necrotic tissue is colonized by organisms"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Variably present gross abnormalities"
                  },
                  {
                    "text": "Infarcts evident as hyperemic areas"
                  },
                  {
                    "text": "\"Nutmeg liver\"Serpiginous, red discoloration representing zones of necrosis and hemorrhageCommon autopsy finding",
                    "sub_points": [
                      "Serpiginous, red discoloration representing zones of necrosis and hemorrhage",
                      "Common autopsy finding"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Range of  findings, depending on location and extent of ischemic insultDifferent regions of liver can be variably affectedNeedle biopsies may not be representative of extent or severity of ischemic injury",
                    "sub_points": [
                      "Different regions of liver can be variably affected",
                      "Needle biopsies may not be representative of extent or severity of ischemic injury"
                    ]
                  },
                  {
                    "text": "Sharply demarcated zones of coagulative hepatocyte necrosisCollapse of liver cell plates seen on reticulin stainSinusoidal congestionMay see cholestasis at periphery of necrotic areasWith cardiac failure or shock, zone 3/perivenular hepatocytes most often affectedMay extend into zone 2Zone 1 necrosis more typical of diseases with intravascular fibrin depositionDisseminated intravascular coagulation, toxemia of pregnancy",
                    "sub_points": [
                      "Collapse of liver cell plates seen on reticulin stain",
                      "Sinusoidal congestion",
                      "May see cholestasis at periphery of necrotic areas",
                      "With cardiac failure or shock, zone 3/perivenular hepatocytes most often affectedMay extend into zone 2",
                      "May extend into zone 2",
                      "Zone 1 necrosis more typical of diseases with intravascular fibrin depositionDisseminated intravascular coagulation, toxemia of pregnancy",
                      "Disseminated intravascular coagulation, toxemia of pregnancy"
                    ]
                  },
                  {
                    "text": "Hepatic infarctIschemic necrosis of 2 or more contiguous and complete acini",
                    "sub_points": [
                      "Ischemic necrosis of 2 or more contiguous and complete acini"
                    ]
                  },
                  {
                    "text": "Hepatocyte swelling"
                  },
                  {
                    "text": "Minimal inflammation"
                  },
                  {
                    "text": "Aggregates of ceroid pigment-laden macrophages in hepatic lobules following resolution"
                  },
                  {
                    "text": "Dystrophic calcification may eventually develop"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Infection": [
                  {
                    "text": "Also causes confluent hepatocyte necrosis"
                  },
                  {
                    "text": "In infection, necrotic areas are nonzonal (\"geographic\" necrosis)Herpes simplex and adenovirus hepatitis cause nonzonal confluent necrosisViral inclusions can usually be foundImmunohistochemical stains may be helpful",
                    "sub_points": [
                      "Herpes simplex and adenovirus hepatitis cause nonzonal confluent necrosis",
                      "Viral inclusions can usually be foundImmunohistochemical stains may be helpful",
                      "Immunohistochemical stains may be helpful"
                    ]
                  }
                ],
                "Drug-induced Liver Injury": [
                  {
                    "text": "Acetaminophen and cocaine also cause zone 3 hepatocyte necrosis"
                  },
                  {
                    "text": "Distinction based on history and other clinical findings"
                  }
                ],
                "Chronic Passive Congestion": [
                  {
                    "text": "Causes hepatocyte atrophy and sinusoidal dilatation"
                  },
                  {
                    "text": "Usually lacks zonal ischemic necrosis, infarcts"
                  },
                  {
                    "text": "History and laboratory values may be helpful"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Consider in systemically ill patients or those at risk for thrombosis with rapid, extreme rise in aminotransferases"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Graft-vs.-Host Disease": {
            "name": "Graft-vs.-Host Disease",
            "url": "https://app.pathprimer.com/document/74417b74-c780-42b5-9ae5-4f5e76a9fa4f/lesson/63ed988e-12c5-487a-8a64-944068749545",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Donor lymphocytes attack and damage recipient tissues after allogeneic transplant"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Skin, gut, and liver are all common sites of GVHDGut 2nd most common after skin",
                    "sub_points": [
                      "Gut 2nd most common after skin"
                    ]
                  },
                  {
                    "text": "Triad of nausea, vomiting, and diarrhea present in up to 63% of patients"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Apoptosis is hallmark of GVHD but is not specific"
                  },
                  {
                    "text": "May end up with marked crypt distortion resembling inflammatory bowel disease"
                  },
                  {
                    "text": "Usually has paucity of lamina propria inflammation"
                  },
                  {
                    "text": "Can totally denude mucosa; endocrine cells more resistant"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Chemotherapy (conditioning)Cannot reliably distinguish from GVHD until 21st day post transplant",
                    "sub_points": [
                      "Cannot reliably distinguish from GVHD until 21st day post transplant"
                    ]
                  },
                  {
                    "text": "Mycophenolate mofetil damage> 15 eosinophils/ 10 HPF in the lamina propria favors mycophenolate over GVHDResidual endocrine cell nests favors GVHD",
                    "sub_points": [
                      "> 15 eosinophils/ 10 HPF in the lamina propria favors mycophenolate over GVHD",
                      "Residual endocrine cell nests favors GVHD"
                    ]
                  },
                  {
                    "text": "InfectionsCMV, adenovirus, and cryptosporidiosis all induce apoptosisIf many neutrophils are present, worry about bacterial infection",
                    "sub_points": [
                      "CMV, adenovirus, and cryptosporidiosis all induce apoptosis",
                      "If many neutrophils are present, worry about bacterial infection"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Histologic grading scheme (1-4) does not always correlate well with clinical outcome, but in general grade 4 does not respond well to therapy"
                  },
                  {
                    "text": "NIH consensus panel recommends just stating whether GVHD is absent or possibly, probably, or unequivocally present"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Graft-vs.-host disease (GVHD)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Donor lymphocytes attack and damage recipient tissues after allogeneic transplant"
                  },
                  {
                    "text": "Initially divided into acute and chronic forms based on time< 100 days = acute GVHD> 100 days = chronic GVHD",
                    "sub_points": [
                      "< 100 days = acute GVHD",
                      "> 100 days = chronic GVHD"
                    ]
                  },
                  {
                    "text": "Now defined along clinicopathologic features rather than time post transplantOther than esophageal webs, no consensus on what constitutes chronic GVHD in gutChronic features, such as fibrosis/stenosis, Paneth cell metaplasia, and crypt distortion, can all occur secondary to acute GVHDScleroderma-like changes most often considered chronic GVHDBetter terms would be active and active chronic GVHD",
                    "sub_points": [
                      "Other than esophageal webs, no consensus on what constitutes chronic GVHD in gut",
                      "Chronic features, such as fibrosis/stenosis, Paneth cell metaplasia, and crypt distortion, can all occur secondary to acute GVHD",
                      "Scleroderma-like changes most often considered chronic GVHD",
                      "Better terms would be active and active chronic GVHD"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Type of Transplant": [
                  {
                    "text": "Hematopoietic cell transplants most likely to lead to GVHD40-80%",
                    "sub_points": [
                      "40-80%"
                    ]
                  },
                  {
                    "text": "Solid organ transplants can also lead to GVHDSmall bowel transplant ~ 5%Other solid organs ~ 1%",
                    "sub_points": [
                      "Small bowel transplant ~ 5%",
                      "Other solid organs ~ 1%"
                    ]
                  },
                  {
                    "text": "Blood transfusions can rarely lead to GVHD in immunosuppressed patients"
                  }
                ],
                "Immunopathology": [
                  {
                    "text": "T cells responsible for GVHD"
                  },
                  {
                    "text": "Decreasing number of T cells in transplants has reduced GVHD mortalityConcern that completely depleting T cells in bone marrow transplants will lead to higher likelihood of disease recurrence",
                    "sub_points": [
                      "Concern that completely depleting T cells in bone marrow transplants will lead to higher likelihood of disease recurrence"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Site": [
                  {
                    "text": "Skin, gut, and liver are all common sites of GVHDGut 2nd most common after skinAny site from oral mucosa to anus may be involvedBest diagnostic yield comes from colon and duodenal biopsy specimensAutopsy studies indicate small bowel is often most severely damagedSome institutions avoid biopsying small bowel due to bleeding; others prefer this siteSeveral studies suggest sigmoidoscopy with biopsy is most cost effective way to diagnose GVHD",
                    "sub_points": [
                      "Gut 2nd most common after skin",
                      "Any site from oral mucosa to anus may be involvedBest diagnostic yield comes from colon and duodenal biopsy specimensAutopsy studies indicate small bowel is often most severely damagedSome institutions avoid biopsying small bowel due to bleeding; others prefer this siteSeveral studies suggest sigmoidoscopy with biopsy is most cost effective way to diagnose GVHD",
                      "Best diagnostic yield comes from colon and duodenal biopsy specimens",
                      "Autopsy studies indicate small bowel is often most severely damaged",
                      "Some institutions avoid biopsying small bowel due to bleeding; others prefer this site",
                      "Several studies suggest sigmoidoscopy with biopsy is most cost effective way to diagnose GVHD"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Triad of nausea, vomiting, and diarrhea present in up to 63% of patients"
                  },
                  {
                    "text": "Abdominal pain"
                  },
                  {
                    "text": "GI bleeding"
                  }
                ],
                "Endoscopic Findings": [
                  {
                    "text": "Quite variableSome studies report good correlation between endoscopy and histology and outcome; others do not> 40% of endoscopically normal-appearing mucosa showed histologic GVHD in 1 study",
                    "sub_points": [
                      "Some studies report good correlation between endoscopy and histology and outcome; others do not> 40% of endoscopically normal-appearing mucosa showed histologic GVHD in 1 study",
                      "> 40% of endoscopically normal-appearing mucosa showed histologic GVHD in 1 study"
                    ]
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "Mainstay of treatment is immunosuppressionSteroidsMycophenolate mofetilCan induce GVHD-like damage to gutTacrolimusCyclosporineInfliximabDacluzimab",
                    "sub_points": [
                      "Steroids",
                      "Mycophenolate mofetilCan induce GVHD-like damage to gut",
                      "Can induce GVHD-like damage to gut",
                      "Tacrolimus",
                      "Cyclosporine",
                      "Infliximab",
                      "Dacluzimab"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "50% of patients develop chronic problems secondary to GVHDBiggest cause of morbidity and mortality in long-term hematopoietic cell transplant patients",
                    "sub_points": [
                      "Biggest cause of morbidity and mortality in long-term hematopoietic cell transplant patients"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Apoptosis is hallmark of GVHD but is not specificSome studies suggest a minimum of 6 apoptotic bodies per 10 contiguous crypts to reliably diagnose grade 1 GVHDMay have a few lymphocytes or eosinophils in damaged crypts",
                    "sub_points": [
                      "Some studies suggest a minimum of 6 apoptotic bodies per 10 contiguous crypts to reliably diagnose grade 1 GVHD",
                      "May have a few lymphocytes or eosinophils in damaged crypts"
                    ]
                  },
                  {
                    "text": "Usually has paucity of lamina propria inflammation"
                  },
                  {
                    "text": "Can totally denude mucosaEndocrine cell nests may be only residual cells seen",
                    "sub_points": [
                      "Endocrine cell nests may be only residual cells seen"
                    ]
                  },
                  {
                    "text": "May end up with marked crypt distortion resembling chronic inflammatory bowel disease"
                  }
                ],
                "Predominant Pattern/Injury Type": [
                  {
                    "text": "Inflammatory"
                  }
                ],
                "Predominant Cell/Compartment Type": [
                  {
                    "text": "Epithelial, glandular"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Chemotherapy (Conditioning)": [
                  {
                    "text": "Damages mucosa within first 2-3 weeks of transplant"
                  },
                  {
                    "text": "Cannot reliably distinguish from GVHD until 21st day post transplant"
                  }
                ],
                "Mycophenolate Mofetil Damage": [
                  {
                    "text": "Can be identical to GVHD"
                  },
                  {
                    "text": "Typically has more eosinophils in lamina propria> 15 eosinophils/10 high-power field (HPF) found only in mycophenolate colitis and not GVHD in 1 study",
                    "sub_points": [
                      "> 15 eosinophils/10 high-power field (HPF) found only in mycophenolate colitis and not GVHD in 1 study"
                    ]
                  },
                  {
                    "text": "Presence of preserved endocrine cell nests in severe damage favors GVHD"
                  },
                  {
                    "text": "Usually does not have entire crypts with apoptosis"
                  }
                ],
                "Infections": [
                  {
                    "text": "Cytomegalovirus, adenovirus, and cryptosporidiosis all induce apoptosis"
                  },
                  {
                    "text": "If lots of neutrophils, worry about bacterial infection"
                  }
                ],
                "Cord Colitis Syndrome": [
                  {
                    "text": "Persistent diarrheal illness that responds to antibioticsInfection due toBradyrhizobium enterica",
                    "sub_points": [
                      "Infection due toBradyrhizobium enterica"
                    ]
                  },
                  {
                    "text": "Presence of granulomatous inflammation with neutrophilic infiltratesMay have crypt distortion and Paneth cell metaplasia, mimicking chronic inflammatory bowel disease",
                    "sub_points": [
                      "May have crypt distortion and Paneth cell metaplasia, mimicking chronic inflammatory bowel disease"
                    ]
                  }
                ],
                "Oral Sodium Phosphate Bowel Preparation": [
                  {
                    "text": "Causes apoptosis at bases of colonic crypts identical to grade 1 GVHD"
                  },
                  {
                    "text": "May also see neutrophils in crypt base epithelium \"focal active colitis\""
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Lerner histologic grading scheme (1-4) does not always correlate with clinical outcome, but in general grade 4 GVHD (totally denuded mucosa) is less likely to respond to therapyStudy by Levine et al found that the number of Paneth cells per HPF in duodenum predicted outcomePatients who had < 4 Paneth cells per HPF had 2x the mortality rate from GVHD as those that had > 4 per HPF",
                    "sub_points": [
                      "Study by Levine et al found that the number of Paneth cells per HPF in duodenum predicted outcomePatients who had < 4 Paneth cells per HPF had 2x the mortality rate from GVHD as those that had > 4 per HPF",
                      "Patients who had < 4 Paneth cells per HPF had 2x the mortality rate from GVHD as those that had > 4 per HPF"
                    ]
                  },
                  {
                    "text": "NIH currently recommends just stating whether GVHD is absent or possibly, probably, or unequivocally present"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Inflammation and Repair": {
        "name": "Inflammation and Repair",
        "url": "https://app.pathprimer.com/lesson/9752129a-a100-4e55-be4a-c0d8ec6f50f9",
        "topics": {
          "Acute Pancreatitis": {
            "name": "Acute Pancreatitis",
            "url": "https://app.pathprimer.com/document/59479b7e-6972-4624-bb60-020f1c481c63/lesson/9752129a-a100-4e55-be4a-c0d8ec6f50f9",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Acute inflammation of pancreas"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Gallstone and alcoholic pancreatitis account for 70-80% of cases"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Abdominal pain"
                  },
                  {
                    "text": "Elevated serum amylase"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Severe acute pancreatitisLarge areas of fat necrosis along with variable parenchymal necrosisHemorrhage, vascular thrombosis",
                    "sub_points": [
                      "Large areas of fat necrosis along with variable parenchymal necrosis",
                      "Hemorrhage, vascular thrombosis"
                    ]
                  },
                  {
                    "text": "Mild acute pancreatitis is most often a clinical diagnosis"
                  }
                ]
              },
              "Terminology": {
                "Definitions": [
                  {
                    "text": "Acute inflammatory process of pancreas"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Mechanical": [
                  {
                    "text": "Gallstones, biliary sludge, periampullary diverticulum, neoplasms, duodenal stricture or obstructionMost common cause is gallstones, accounting for 35-60% of cases",
                    "sub_points": [
                      "Most common cause is gallstones, accounting for 35-60% of cases"
                    ]
                  }
                ],
                "Toxic": [
                  {
                    "text": "Ethanol, methanol, scorpion venom, organophosphate poisoning2nd most common cause is alcoholism",
                    "sub_points": [
                      "2nd most common cause is alcoholism"
                    ]
                  }
                ],
                "Trauma": [
                  {
                    "text": "Blunt or penetrating abdominal injury, iatrogenic injury during procedure"
                  }
                ],
                "Metabolic": [
                  {
                    "text": "Hyperlipidemia type V and hypercalcemia"
                  }
                ],
                "Vascular": [
                  {
                    "text": "Ischemia, intraoperative hypotension, hemorrhagic shock, atheroembolism, vasculitis"
                  }
                ],
                "Genetic": [
                  {
                    "text": "Mutations of serine protease 1 gene (PRSS1), serine protease inhibitor Kazal type 1 (SPINK1), and cystic fibrosis transmembrane conductance regulator (CFTR)"
                  }
                ],
                "Drug-induced": [
                  {
                    "text": "Numerous drugs implicated"
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "Virus: Mumps, Coxsackievirus, CMV, varicella-zoster, HSV, HIV"
                  },
                  {
                    "text": "Bacteria:Mycoplasma,Legionella,Leptospira,Salmonella"
                  },
                  {
                    "text": "Parasites:Toxoplasma,Cryptosporidium,Ascaris"
                  }
                ],
                "Congenital": [
                  {
                    "text": "Choledochocele type V"
                  }
                ],
                "Miscellaneous": [
                  {
                    "text": "Post ERCP, pregnancy, renal transplant, α-1-antitrypsin deficiency"
                  }
                ],
                "Idiopathic": [
                  {
                    "text": "10-25% of patients have no identifiable cause"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Occurs at any ageMost common in adults in 3rd to 6th decade of life1st decade suggests hereditary cause, infection, or trauma",
                    "sub_points": [
                      "Most common in adults in 3rd to 6th decade of life",
                      "1st decade suggests hereditary cause, infection, or trauma"
                    ]
                  }
                ],
                "Gender": [
                  {
                    "text": "Gallstone pancreatitis more common in women between 50-60 years of age"
                  },
                  {
                    "text": "Alcoholic pancreatitis more common in men"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Acute upper abdominal pain, nausea, vomiting"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated amylase and lipase"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Mild cases usually recover within 5-7 days"
                  },
                  {
                    "text": "Severe necrotizing pancreatitis is associated with high rate of complication and significant mortalityCommon sequelae are pancreatic abscess and pseudocyst",
                    "sub_points": [
                      "Common sequelae are pancreatic abscess and pseudocyst"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Supportive care, infection prevention"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Mortality in USA ranges from 2-10%Severe disease has higher mortality of 17%",
                    "sub_points": [
                      "Severe disease has higher mortality of 17%"
                    ]
                  }
                ],
                "Atlanta Classification": [
                  {
                    "text": "Clinical classification; utility somewhat controversialMild (edematous and interstitial)Severe (necrotizing)",
                    "sub_points": [
                      "Mild (edematous and interstitial)",
                      "Severe (necrotizing)"
                    ]
                  }
                ]
              },
              "Macroscopic Features": {
                "Mild Acute Pancreatitis": [
                  {
                    "text": "Enlarged and swollen"
                  },
                  {
                    "text": "Foci of fat necrosis (yellow-white, waxy or chalky consistency)"
                  },
                  {
                    "text": "Hemorrhagic necrosis often absent"
                  }
                ],
                "Severe Acute Pancreatitis": [
                  {
                    "text": "Larger confluent areas of fat necrosis and parenchymal necrosis"
                  },
                  {
                    "text": "Hemorrhage can encase pancreas and simulate hematoma"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Mild acute pancreatitisSpotty peripancreatic or perilobular fat necrosisInterstitial acute inflammationUsually clinical rather than morphologic diagnosis",
                    "sub_points": [
                      "Spotty peripancreatic or perilobular fat necrosis",
                      "Interstitial acute inflammation",
                      "Usually clinical rather than morphologic diagnosis"
                    ]
                  },
                  {
                    "text": "Severe acute pancreatitisLarge areas of fat necrosis along with variable pancreatic parenchymal necrosisNecrotic areas may have abundant neutrophils that can involve duct lumensViable acinar lumens may be widened and contain secretory materialSaponificationFat necrosis may extend to omentum, retroperitoneum, bone marrow, subcutaneous tissueHemorrhage and usually venous thrombosis",
                    "sub_points": [
                      "Large areas of fat necrosis along with variable pancreatic parenchymal necrosisNecrotic areas may have abundant neutrophils that can involve duct lumensViable acinar lumens may be widened and contain secretory materialSaponification",
                      "Necrotic areas may have abundant neutrophils that can involve duct lumens",
                      "Viable acinar lumens may be widened and contain secretory material",
                      "Saponification",
                      "Fat necrosis may extend to omentum, retroperitoneum, bone marrow, subcutaneous tissue",
                      "Hemorrhage and usually venous thrombosis"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Chronic Pancreatitis": [
                  {
                    "text": "Fibrosis, chronic inflammation, lacks inflammatory component"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Acute Pyelonephritis": {
            "name": "Acute Pyelonephritis",
            "url": "https://app.pathprimer.com/document/737ac97f-61ca-4959-b43a-5f1bbd0b4ff5/lesson/9752129a-a100-4e55-be4a-c0d8ec6f50f9",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Acute renal parenchymal inflammation due to bacterial or fungal infection"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Retrograde infection via urethra, bladder, and uretersEscherichia colicommon organism",
                    "sub_points": [
                      "Escherichia colicommon organism"
                    ]
                  },
                  {
                    "text": "Hematogenous infection in septicemiaStaphylococcus aureuscommon organism",
                    "sub_points": [
                      "Staphylococcus aureuscommon organism"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Associated with lower tract problems, obstruction, reflux, pregnancy, diabetesInfants, elderly males and women at risk",
                    "sub_points": [
                      "Infants, elderly males and women at risk"
                    ]
                  },
                  {
                    "text": "Fever"
                  },
                  {
                    "text": "Costovertebral angle tenderness"
                  },
                  {
                    "text": "Leukocyte casts"
                  },
                  {
                    "text": "Acute uncomplicated pyelonephritis responds to antimicrobial therapy in > 90% of cases"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Neutrophilic infiltrate and casts in tubules"
                  },
                  {
                    "text": "Abscesses and papillary necrosis may arise"
                  },
                  {
                    "text": "Glomeruli and blood vessels relatively spared"
                  },
                  {
                    "text": "Early infection in medulla and collecting ducts"
                  },
                  {
                    "text": "Pelvic inflammation in ascending infection"
                  },
                  {
                    "text": "Special variantsEmphysematous pyelonephritisAcute lobar nephronia mimics mass lesion",
                    "sub_points": [
                      "Emphysematous pyelonephritis",
                      "Acute lobar nephronia mimics mass lesion"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Drug-induced interstitial nephritis"
                  },
                  {
                    "text": "Glomerulonephritis with severe tubulointerstitial inflammation"
                  },
                  {
                    "text": "Myeloma cast nephropathy"
                  },
                  {
                    "text": "Ischemic or toxic tubular injury"
                  },
                  {
                    "text": "Acute humoral rejection in transplants"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Acute pyelonephritis (APN)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Upper urinary tract infection (UTI)"
                  },
                  {
                    "text": "Acute bacterial nephritis (used when no pyelitis)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Acute inflammation of kidney parenchyma due to bacterial infection"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Ascending Infection": [
                  {
                    "text": "Retrograde infection via urethra, bladder, and ureters"
                  },
                  {
                    "text": "Most common route of infection (95%)"
                  },
                  {
                    "text": "Usually associated with predisposing factorObstructionRefluxInstrumentationUrolithiasisDiabetesPregnancyRenal transplantation immunosuppressionAPN is the most common bacterial complicationTreatment with Cyclosporine A may compromise the host defenses againstEscherichia coli",
                    "sub_points": [
                      "Obstruction",
                      "Reflux",
                      "Instrumentation",
                      "Urolithiasis",
                      "Diabetes",
                      "Pregnancy",
                      "Renal transplantation immunosuppressionAPN is the most common bacterial complicationTreatment with Cyclosporine A may compromise the host defenses againstEscherichia coli",
                      "APN is the most common bacterial complication",
                      "Treatment with Cyclosporine A may compromise the host defenses againstEscherichia coli"
                    ]
                  },
                  {
                    "text": "Gram-negative bacteria from gastrointestinal tract (fecal flora) most commonE. colimost common organismUropathogenic and virulence factors include fimbriae/pili and serotypes O, K, and HCan colonize urinary bladder efficientlyP fimbriae (mannose resistant)Attach to digalactoside residue on urothelial cells and facilitate persistent infectionEnhance host innate inflammatory response by interaction with Toll-like receptor 4 (TLR4), resulting in IL-6 and IL-8 productionAlpha intercalated cells of the collecting ducts may defend againstE. coliby acidifying the urine and secreting bacteriostatic protein lipocalin 2 (NGAL)Most important for renal involvementType 1 fimbriae (mannose sensitive)Binds to Tamm-Horsfall proteinProteus,Klebsiella,Enterobacter,Pseudomonas,Streptococcus faecalis",
                    "sub_points": [
                      "E. colimost common organismUropathogenic and virulence factors include fimbriae/pili and serotypes O, K, and HCan colonize urinary bladder efficiently",
                      "Uropathogenic and virulence factors include fimbriae/pili and serotypes O, K, and H",
                      "Can colonize urinary bladder efficiently",
                      "P fimbriae (mannose resistant)Attach to digalactoside residue on urothelial cells and facilitate persistent infectionEnhance host innate inflammatory response by interaction with Toll-like receptor 4 (TLR4), resulting in IL-6 and IL-8 productionAlpha intercalated cells of the collecting ducts may defend againstE. coliby acidifying the urine and secreting bacteriostatic protein lipocalin 2 (NGAL)Most important for renal involvement",
                      "Attach to digalactoside residue on urothelial cells and facilitate persistent infection",
                      "Enhance host innate inflammatory response by interaction with Toll-like receptor 4 (TLR4), resulting in IL-6 and IL-8 productionAlpha intercalated cells of the collecting ducts may defend againstE. coliby acidifying the urine and secreting bacteriostatic protein lipocalin 2 (NGAL)",
                      "Alpha intercalated cells of the collecting ducts may defend againstE. coliby acidifying the urine and secreting bacteriostatic protein lipocalin 2 (NGAL)",
                      "Most important for renal involvement",
                      "Type 1 fimbriae (mannose sensitive)Binds to Tamm-Horsfall protein",
                      "Binds to Tamm-Horsfall protein",
                      "Proteus,Klebsiella,Enterobacter,Pseudomonas,Streptococcus faecalis"
                    ]
                  },
                  {
                    "text": "Fungal organisms can produce similar pathology"
                  }
                ],
                "Hematogenous Infection": [
                  {
                    "text": "In septicemia or bacterial endocarditisStaphylococcus aureuscommon pathogenFungal organisms in immunocompromised hosts",
                    "sub_points": [
                      "Staphylococcus aureuscommon pathogen",
                      "Fungal organisms in immunocompromised hosts"
                    ]
                  },
                  {
                    "text": "No obstruction or reflux required for pathogenesis"
                  }
                ],
                "Asymptomatic Bacteriuria": [
                  {
                    "text": "Bacterial counts of > 100,000 colony forming units/mL of urine in relatively asymptomatic patient"
                  },
                  {
                    "text": "Frequently encountered in pregnant womenAntimicrobial therapy recommended as it can progress to overt bacteriuria and pyelonephritis",
                    "sub_points": [
                      "Antimicrobial therapy recommended as it can progress to overt bacteriuria and pyelonephritis"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "InfantsOften have anatomic abnormalities of urinary tract",
                    "sub_points": [
                      "Often have anatomic abnormalities of urinary tract"
                    ]
                  },
                  {
                    "text": "Elderly malesProstatic hypertrophy is risk factor",
                    "sub_points": [
                      "Prostatic hypertrophy is risk factor"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "Women more susceptible, especially during pregnancy"
                  }
                ],
                "Site": [
                  {
                    "text": "Pelvic urothelium (pyelitis)"
                  },
                  {
                    "text": "Renal tubules and interstitium (pyelonephritis)"
                  },
                  {
                    "text": "Renal cortical abscesses (bacterial nephritis)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Fever and chills"
                  },
                  {
                    "text": "Flank pain"
                  },
                  {
                    "text": "Nausea and vomiting"
                  },
                  {
                    "text": "Costovertebral angle tenderness"
                  },
                  {
                    "text": "May be subclinical"
                  },
                  {
                    "text": "If lower UTI is presentDysuria, frequency of micturitionSuprapubic tenderness may be present",
                    "sub_points": [
                      "Dysuria, frequency of micturition",
                      "Suprapubic tenderness may be present"
                    ]
                  },
                  {
                    "text": "Acute renal failureSevere and bilateral casesEmphysematous pyelonephritisSingle kidneyTransplant kidney",
                    "sub_points": [
                      "Severe and bilateral cases",
                      "Emphysematous pyelonephritis",
                      "Single kidney",
                      "Transplant kidney"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Urine microscopyPyuria (white blood cells in urine)Leukocyte castsGram stain may be positive",
                    "sub_points": [
                      "Pyuria (white blood cells in urine)",
                      "Leukocyte casts",
                      "Gram stain may be positive"
                    ]
                  },
                  {
                    "text": "Urine culturesMidstream urine needed to minimize contamination",
                    "sub_points": [
                      "Midstream urine needed to minimize contamination"
                    ]
                  },
                  {
                    "text": "Blood examinationLeukocytosis with shift to leftBlood cultures positive in septicemia",
                    "sub_points": [
                      "Leukocytosis with shift to left",
                      "Blood cultures positive in septicemia"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Correction of anatomical defect or source of obstruction"
                  },
                  {
                    "text": "Most respond to antibiotics and avoid nephrectomy"
                  },
                  {
                    "text": "Nephrectomy may be required in emphysematous pyelonephritis"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Antimicrobials"
                  },
                  {
                    "text": "Empiric antimicrobial therapy with Gram-negative coverage until culture results are obtained"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Severe complications more common in patients with diabetes mellitus and urinary obstructionPapillary necrosis: Coagulative necrosis of papillary tipsPyonephrosis: Pus accumulates in pyelocalyceal systemPerinephric abscess: Suppurative inflammation extends beyond kidney into perinephric fatEmphysematous pyelonephritis: Gas within renal parenchyma, collecting system or perinephritic spaceSepticemia",
                    "sub_points": [
                      "Papillary necrosis: Coagulative necrosis of papillary tips",
                      "Pyonephrosis: Pus accumulates in pyelocalyceal system",
                      "Perinephric abscess: Suppurative inflammation extends beyond kidney into perinephric fat",
                      "Emphysematous pyelonephritis: Gas within renal parenchyma, collecting system or perinephritic space",
                      "Septicemia"
                    ]
                  },
                  {
                    "text": "Scarring ensues in 30% of children with APN"
                  },
                  {
                    "text": "Acute uncomplicated pyelonephritis responds to antimicrobial therapy in > 90% of casesLack of response inDrug-resistant bacterial strainsPresence of anatomic abnormality (reflux, etc.)Urinary tract obstruction",
                    "sub_points": [
                      "Lack of response inDrug-resistant bacterial strainsPresence of anatomic abnormality (reflux, etc.)Urinary tract obstruction",
                      "Drug-resistant bacterial strains",
                      "Presence of anatomic abnormality (reflux, etc.)",
                      "Urinary tract obstruction"
                    ]
                  },
                  {
                    "text": "Recurrent episodes of pyelonephritis can lead to chronic pyelonephritis and chronic renal failure"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Imaging is indicated in select casesPatients with recurrent UTI, especially adult males and children < 5 years of agePatients with diabetes mellitus",
                    "sub_points": [
                      "Patients with recurrent UTI, especially adult males and children < 5 years of age",
                      "Patients with diabetes mellitus"
                    ]
                  },
                  {
                    "text": "Tests includeCystoscopyRetrograde pyelogramVoiding cystourethrogramAbdominal CT scan and plain radiographTechnetium-99m dimercaptosuccinic acid (DMSA) renal scintigraphy",
                    "sub_points": [
                      "Cystoscopy",
                      "Retrograde pyelogram",
                      "Voiding cystourethrogram",
                      "Abdominal CT scan and plain radiograph",
                      "Technetium-99m dimercaptosuccinic acid (DMSA) renal scintigraphy"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Enlarged and edematous kidney"
                  },
                  {
                    "text": "Ascending pyelonephritisCharacteristic straight yellow streaks seen in medullaCorrespond to collecting ducts filled with pusTypical of ascending APNPyelitis usualPyelocalyceal dilatation in obstruction or refluxScarred areas represent residua of prior episodesCortical scars in ascending APN overlie pelvic calycesInflammation may extend into perirenal fat with perinephric abscessCalculi or strictures may be seen in pelvis or ureters",
                    "sub_points": [
                      "Characteristic straight yellow streaks seen in medullaCorrespond to collecting ducts filled with pusTypical of ascending APN",
                      "Correspond to collecting ducts filled with pus",
                      "Typical of ascending APN",
                      "Pyelitis usual",
                      "Pyelocalyceal dilatation in obstruction or reflux",
                      "Scarred areas represent residua of prior episodesCortical scars in ascending APN overlie pelvic calyces",
                      "Cortical scars in ascending APN overlie pelvic calyces",
                      "Inflammation may extend into perirenal fat with perinephric abscess",
                      "Calculi or strictures may be seen in pelvis or ureters"
                    ]
                  },
                  {
                    "text": "Hematogenous bacterial nephritisSmall subcapsular yellow abscesses measuring a few millimeters in diameterTypical of hematogenous APN",
                    "sub_points": [
                      "Small subcapsular yellow abscesses measuring a few millimeters in diameterTypical of hematogenous APN",
                      "Typical of hematogenous APN"
                    ]
                  },
                  {
                    "text": "Emphysematous pyelonephritisEmpty (gas-filled) rounded spaces in cortex and perirenal fat; dissection planes under capsule have abscesses",
                    "sub_points": [
                      "Empty (gas-filled) rounded spaces in cortex and perirenal fat; dissection planes under capsule have abscesses"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Patchy neutrophilic infiltrate in tubules and interstitium, typically with spared areasNeutrophil casts in tubular lumina, sometimes with associated bacteriaAbscesses with tubular destruction in severe cases",
                    "sub_points": [
                      "Neutrophil casts in tubular lumina, sometimes with associated bacteria",
                      "Abscesses with tubular destruction in severe cases"
                    ]
                  },
                  {
                    "text": "Lymphocytes, plasma cells, eosinophils, and macrophages are seen within a few days"
                  },
                  {
                    "text": "Acute tubular injuryLoss of proximal tubule brush borderSimplified tubular epitheliumSloughed epithelial cells in tubular lumens",
                    "sub_points": [
                      "Loss of proximal tubule brush border",
                      "Simplified tubular epithelium",
                      "Sloughed epithelial cells in tubular lumens"
                    ]
                  },
                  {
                    "text": "Tubular basement membranes disrupted"
                  },
                  {
                    "text": "Severe cases may have papillary necrosisUsually tip of papilla unlike that in analgesic abuse",
                    "sub_points": [
                      "Usually tip of papilla unlike that in analgesic abuse"
                    ]
                  },
                  {
                    "text": "Glomeruli and blood vessels relatively spared"
                  },
                  {
                    "text": "Bacterial and fungal stains often useful"
                  }
                ],
                "Variants": [
                  {
                    "text": "Ascending infectionAcute inflammation of pelvis usualEarly infection in medulla and collecting ductsOrganisms invade via fornix of calyx and intrarenal reflux through collecting ducts",
                    "sub_points": [
                      "Acute inflammation of pelvis usual",
                      "Early infection in medulla and collecting ducts",
                      "Organisms invade via fornix of calyx and intrarenal reflux through collecting ducts"
                    ]
                  },
                  {
                    "text": "Hematogenous infectionRandomly scattered abscesses in cortexOccasionally, septic emboli in glomeruli containing organisms in endocarditisLittle or no inflammation of pelvis",
                    "sub_points": [
                      "Randomly scattered abscesses in cortex",
                      "Occasionally, septic emboli in glomeruli containing organisms in endocarditis",
                      "Little or no inflammation of pelvis"
                    ]
                  },
                  {
                    "text": "Emphysematous pyelonephritisRound empty spaces and planes of dissection in tissue due to gas-forming organisms",
                    "sub_points": [
                      "Round empty spaces and planes of dissection in tissue due to gas-forming organisms"
                    ]
                  },
                  {
                    "text": "Acute lobar nephroniaVariant that suggests mass lesions in imaging studiesFocal areas of intense inflammation and edema in cortex",
                    "sub_points": [
                      "Variant that suggests mass lesions in imaging studies",
                      "Focal areas of intense inflammation and edema in cortex"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Tissue Gram stain (Brown-Brenn)Reactivity: Detects gram-positive & -negative organismsBacteria typically not conspicuous in tubules but can be detected in abscesses",
                    "sub_points": [
                      "Reactivity: Detects gram-positive & -negative organisms",
                      "Bacteria typically not conspicuous in tubules but can be detected in abscesses"
                    ]
                  },
                  {
                    "text": "Grocott methenamine silverPositive in tubules and abscesses if fungal organisms present",
                    "sub_points": [
                      "Positive in tubules and abscesses if fungal organisms present"
                    ]
                  }
                ],
                "Immunofluorescence": [
                  {
                    "text": "Glomeruli and tubular basement membranes negative for immunoglobulins and complement"
                  },
                  {
                    "text": "C4d binds to bacterial surfaces in APN via activation of lectin pathway in ring pattern"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Glomerular and tubular basement membranes negative for electron-dense deposits"
                  },
                  {
                    "text": "Bacteria rarely encountered"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Drug-Induced Interstitial Nephritis": [
                  {
                    "text": "Clinical history of drug exposureNeutrophilic infiltrate less prominentUrine and blood cultures are negative",
                    "sub_points": [
                      "Neutrophilic infiltrate less prominent",
                      "Urine and blood cultures are negative"
                    ]
                  }
                ],
                "Myeloma Cast Nephropathy": [
                  {
                    "text": "Neutrophilic infiltrate associated with myeloma casts"
                  },
                  {
                    "text": "Tubular casts are typically fractured and weakly PAS(+)"
                  },
                  {
                    "text": "To be excluded in elderly patients with acute renal failure"
                  },
                  {
                    "text": "Tubular casts are light chain restricted on immunofluorescence microscopy"
                  }
                ],
                "Glomerulonephritis-Associated Severe Tubulointerstitial Inflammation": [
                  {
                    "text": "Glomerular hypercellularity seen in primary glomerular process"
                  },
                  {
                    "text": "Neutrophilic infiltrate less prominent"
                  },
                  {
                    "text": "No abscesses"
                  },
                  {
                    "text": "Immunofluorescence and electron microscopy may indicate presence of immune complexes"
                  }
                ],
                "Ischemic or Toxic Tubular Injury": [
                  {
                    "text": "Less neutrophilic infiltrate"
                  },
                  {
                    "text": "No abscesses"
                  },
                  {
                    "text": "Tubular injury in area without inflammation"
                  }
                ],
                "Acute Humoral Rejection in Transplants": [
                  {
                    "text": "Neutrophils in tubules sometimes mimic APN"
                  },
                  {
                    "text": "C4d in peritubular capillaries"
                  },
                  {
                    "text": "Abscesses not seen"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Abscess formation"
                  },
                  {
                    "text": "Papillary necrosis"
                  },
                  {
                    "text": "Histological evidence of chronic pyelonephritisNumerous hyaline casts in atrophic tubules reminiscent of thyroidizationCan indicate prior episodes of APN or presence of urinary outflow obstruction",
                    "sub_points": [
                      "Numerous hyaline casts in atrophic tubules reminiscent of thyroidization",
                      "Can indicate prior episodes of APN or presence of urinary outflow obstruction"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Neutrophils occasionally seen in end-stage kidneys without other evidence of APN, likely due to sterile tubular injury"
                  },
                  {
                    "text": "Fungal infections can be missed (check PAS and silver stain)"
                  },
                  {
                    "text": "Persistent infection may have abundant eosinophils"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Bronchopneumonia": {
            "name": "Bronchopneumonia",
            "url": "https://app.pathprimer.com/document/e3678f66-a791-43e1-abf6-c1eed2cd9440/lesson/9752129a-a100-4e55-be4a-c0d8ec6f50f9",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Pathologic definition of bronchopneumonia based on anatomic distribution of acute inflammatory changes"
                  },
                  {
                    "text": "Distribution can be appreciated grossly as patchy foci of airway-centered consolidation with intervening areas of normal lung parenchyma (lobular distribution)"
                  },
                  {
                    "text": "Lobular pattern is in contrast to lobar pneumonia (consolidation of an entire lobe)"
                  },
                  {
                    "text": "Pneumonia is classified by specific etiologic agent"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Most often result of inhalation of microorganisms or aspiration"
                  },
                  {
                    "text": "A preceding viral pneumonia increases susceptibility to secondary infection (bronchopneumonia)"
                  },
                  {
                    "text": "Nosocomial pneumonia is leading cause of death from hospital-acquired infection"
                  },
                  {
                    "text": "Gram-negative organisms predominate in ICU-acquired infections and ventilator-associated pneumonia"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "May involve 1 or multiple lobes and is frequently bilateral"
                  },
                  {
                    "text": "Most pronounced changes often in basilar regions"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Airway-centered acute inflammation with contiguous involvement of peribronchial/peribronchiolar alveolated parenchyma"
                  },
                  {
                    "text": "Focal or extensive organization may be present"
                  }
                ]
              },
              "Terminology": {
                "Definitions": [
                  {
                    "text": "Pneumonia is classified by specific etiologic agent; however, if no pathogen can be isolated, clinical setting in which infection occurs is used as a guide for therapyCommunity-acquired pneumonia (CAP): Pneumonia acquired outside of health care settingMost common type of pneumonia↑ incidence in winter~ 20% of patients with CAP will require hospitalizationUp to 50% of CAP have no pathogen identifiedAtypical Pneumonia: Old terminology for CAP with milder symptoms, scant sputum, and lack of response to penicillinHospital-acquired pneumonia: Acquired while in hospital for another illness (synonym: Nosocomial pneumonia)Patients tend to be sicker due to underlying illness↑ risk of antibiotic-resistant bacteriaHealth care-associated pneumonia: Acquired in a nonhospital health care setting such as nursing home, dialysis center, outpatient clinic",
                    "sub_points": [
                      "Community-acquired pneumonia (CAP): Pneumonia acquired outside of health care settingMost common type of pneumonia↑ incidence in winter~ 20% of patients with CAP will require hospitalizationUp to 50% of CAP have no pathogen identifiedAtypical Pneumonia: Old terminology for CAP with milder symptoms, scant sputum, and lack of response to penicillin",
                      "Most common type of pneumonia",
                      "↑ incidence in winter",
                      "~ 20% of patients with CAP will require hospitalization",
                      "Up to 50% of CAP have no pathogen identified",
                      "Atypical Pneumonia: Old terminology for CAP with milder symptoms, scant sputum, and lack of response to penicillin",
                      "Hospital-acquired pneumonia: Acquired while in hospital for another illness (synonym: Nosocomial pneumonia)Patients tend to be sicker due to underlying illness↑ risk of antibiotic-resistant bacteria",
                      "Patients tend to be sicker due to underlying illness",
                      "↑ risk of antibiotic-resistant bacteria",
                      "Health care-associated pneumonia: Acquired in a nonhospital health care setting such as nursing home, dialysis center, outpatient clinic"
                    ]
                  },
                  {
                    "text": "Pathologic definition of bronchopneumonia is based on anatomic distribution of acute inflammatory changesPathologic changes can be appreciated grossly as patchy foci of airway-centered consolidation with intervening areas of normal lung parenchyma (lobular distribution)This lobular pattern is in contrast to lobar pneumonia, which is consolidation of an entire lobePathologic changes can be appreciated microscopically as foci of airway-centered inflammation with contiguous involvement of peribronchial/peribronchiolar alveolated parenchyma",
                    "sub_points": [
                      "Pathologic changes can be appreciated grossly as patchy foci of airway-centered consolidation with intervening areas of normal lung parenchyma (lobular distribution)This lobular pattern is in contrast to lobar pneumonia, which is consolidation of an entire lobe",
                      "This lobular pattern is in contrast to lobar pneumonia, which is consolidation of an entire lobe",
                      "Pathologic changes can be appreciated microscopically as foci of airway-centered inflammation with contiguous involvement of peribronchial/peribronchiolar alveolated parenchyma"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Pathogenesis": [
                  {
                    "text": "Microorganisms reach lung by 4 basic mechanismsInhalationAspiration (primarily from a previously colonized oropharynx)Hematogenous spreadDirect extension from an adjacent focus of infection",
                    "sub_points": [
                      "Inhalation",
                      "Aspiration (primarily from a previously colonized oropharynx)",
                      "Hematogenous spread",
                      "Direct extension from an adjacent focus of infection"
                    ]
                  },
                  {
                    "text": "In most circumstances, pathologic entity of bronchopneumonia is result of inhalation and aspiration"
                  },
                  {
                    "text": "Endotracheal tube placement further compromises host defenses by impairing mucociliary function, injuring mucosa, and allowing secretions to pool"
                  },
                  {
                    "text": "More likely in patients with other comorbidities"
                  },
                  {
                    "text": "More common in patients with an impaired immune response (due to immunosuppressive medications, underlying immunodeficiency disease, or critical illness)"
                  },
                  {
                    "text": "More common with a large inoculum (such as occurs with massive aspiration)"
                  },
                  {
                    "text": "More common in patients with genetic differences, which are a focus of ongoing research"
                  },
                  {
                    "text": "A preceding viral pneumonia increases susceptibility to bacterial pneumonia"
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "BacteriaGram positive:Staphylococcus aureus,Streptococcus pneumoniae(most common cause of lobar pneumonia)Gram negative:Haemophilus influenzae, Moraxella catarrhalis, Escherichia coli, Legionella pneumophila, Pseudomonas aeruginosa, Klebsiella pneumoniae",
                    "sub_points": [
                      "Gram positive:Staphylococcus aureus,Streptococcus pneumoniae(most common cause of lobar pneumonia)",
                      "Gram negative:Haemophilus influenzae, Moraxella catarrhalis, Escherichia coli, Legionella pneumophila, Pseudomonas aeruginosa, Klebsiella pneumoniae"
                    ]
                  },
                  {
                    "text": "Gram-negative organisms predominate in ICU-acquired infections and ventilator-associated pneumonia, particularlyP. aeruginosa,Acinetobacter baumannii, and Enterobacteriaceae"
                  },
                  {
                    "text": "Viruses and fungal organisms can cause bronchopneumonia, mainly in immunocompromised patientsHerpes viruses,Candidaspp, andAspergillusspp most common",
                    "sub_points": [
                      "Herpes viruses,Candidaspp, andAspergillusspp most common"
                    ]
                  },
                  {
                    "text": "Agents associated with community-acquired \"atypical pneumonia\" includeBacteria:Mycoplasma pneumoniae,Legionellaspp.,Chlamydiaspp.,Coxiella burnetiiViruses: Respiratory syncytial virus, adenovirus, and influenzas A and B",
                    "sub_points": [
                      "Bacteria:Mycoplasma pneumoniae,Legionellaspp.,Chlamydiaspp.,Coxiella burnetii",
                      "Viruses: Respiratory syncytial virus, adenovirus, and influenzas A and B"
                    ]
                  },
                  {
                    "text": "Progressive primary pulmonary tuberculosis can resemble an acute bacterial pneumonia"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Only a small percentage of those patients requiring hospitalization for CAP will die, usually of complications related to pneumonia (such as empyema, meningitis, or endocarditis) or because of a debilitated stateNosocomial pneumonia: 2nd most common cause of nosocomial infection and leading cause of death from hospital-acquired infection",
                    "sub_points": [
                      "Nosocomial pneumonia: 2nd most common cause of nosocomial infection and leading cause of death from hospital-acquired infection"
                    ]
                  },
                  {
                    "text": "Mechanical ventilation is the leading risk factor for development of nosocomial pneumonia"
                  }
                ],
                "Age": [
                  {
                    "text": "Very young and elderly are more susceptible than other patient populations"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Shortness of breath, fever, productive cough, malaise, and pleuritic chest pain"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Check premortem sputum and blood culture results"
                  },
                  {
                    "text": "Elevated WBC with left shift and ↑ bands (low WBC in patients who have underlying neutropenia and sometimes with severe infection)"
                  },
                  {
                    "text": "Thrombocytopenia, elevated fibrin degradation products (sepsis, DIC)"
                  },
                  {
                    "text": "Cold agglutinins: Not specific for Mycoplasma but if high titer cold agglutinin (> 1:64) in CAP = high likelihood of mycoplasma"
                  },
                  {
                    "text": "Increased liver function tests and elevated creatinine (organ system injury from sepsis/shock) and lactic acid (shock)"
                  },
                  {
                    "text": "Serologic evidence of infection: Paired sera to look for antibodies toMycoplasma,Chlamydiainfluenza A and B, adenovirus, and respiratory syncytial virusBeing replaced by more specific and rapid PCR techniques for organism isolation",
                    "sub_points": [
                      "Being replaced by more specific and rapid PCR techniques for organism isolation"
                    ]
                  },
                  {
                    "text": "Legionella urine antigen test"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Patients with healthcare-acquired pneumonia (HCAP) typically have a worse clinical course and outcome than those of patients with CAP"
                  },
                  {
                    "text": "Patients developing necrotizing pneumonia usually have concomitant medical illness, most common being diabetes mellitus and alcohol abuse"
                  }
                ]
              },
              "Image Findings": {
                "Radiographic Findings": [
                  {
                    "text": "Multifocal, heterogeneous opacities distributed along course of airways and centered in distal airways"
                  }
                ]
              },
              "Macroscopic Features": {
                "External Examination": [
                  {
                    "text": "Signs of treatment: Endotracheal tube, chest tube (empyema, parapneumonic effusion), central and peripheral intravenous linesChest radiograph prior to autopsy may indicate placement of endotracheal tube, chest tube, presence of effusion, empyema, central line placementFollow radiologic safety precautions: Leave room during x-ray procedure if performed in autopsy suite",
                    "sub_points": [
                      "Chest radiograph prior to autopsy may indicate placement of endotracheal tube, chest tube, presence of effusion, empyema, central line placement",
                      "Follow radiologic safety precautions: Leave room during x-ray procedure if performed in autopsy suite"
                    ]
                  },
                  {
                    "text": "Signs of sepsis/shock: Petechiae (DIC), jaundice, pallor"
                  }
                ],
                "Internal Examination": [
                  {
                    "text": "Acute pleuritis and fibrinous adhesions may be present in addition to frank empyema"
                  },
                  {
                    "text": "Fresh lung and spleen tissue should be procured for microbiology cultures before excessive organ manipulationCulture technique: Use sterile equipment (scalpel, forceps), sterilize pleural or capsular surface of organ with either heat (hot spatula or scalpel blade used to sear surface) or iodine and alcohol decontamination of surfaceUse sterile container for transport to microbiology labFollow safety precautions if using heat source, check with safety engineers prior to using, and use flame retardant glovesUse universal precautions for all pneumonia autopsies: Personal protective equipment and particulate respirators",
                    "sub_points": [
                      "Culture technique: Use sterile equipment (scalpel, forceps), sterilize pleural or capsular surface of organ with either heat (hot spatula or scalpel blade used to sear surface) or iodine and alcohol decontamination of surfaceUse sterile container for transport to microbiology lab",
                      "Use sterile container for transport to microbiology lab",
                      "Follow safety precautions if using heat source, check with safety engineers prior to using, and use flame retardant gloves",
                      "Use universal precautions for all pneumonia autopsies: Personal protective equipment and particulate respirators"
                    ]
                  },
                  {
                    "text": "Look for evidence of bacteremic dissemination to other organs"
                  }
                ],
                "Organ Examination": [
                  {
                    "text": "Respiratory System: Bronchopneumonia may involve 1 or multiple lobes and is frequently bilateralMost pronounced changes are often in basilar regionsFoci of consolidation are centered on airway and are typically 1-3 cm in diameter, poorly circumscribed, and yellow to gray-red in colorConsolidation is best appreciated following formalin perfusionFoci of consolidation can expand to near confluence, thereby mimicking lobar pneumoniaGross description should include distribution of consolidated areas as well as complications of pneumonia, such as prominent necrosis (necrotizing pneumonia) and abscess formationSection adequately to document distribution of disease, areas of necrosis or abscess, and noninvolved lung parenchyma",
                    "sub_points": [
                      "Most pronounced changes are often in basilar regions",
                      "Foci of consolidation are centered on airway and are typically 1-3 cm in diameter, poorly circumscribed, and yellow to gray-red in colorConsolidation is best appreciated following formalin perfusion",
                      "Consolidation is best appreciated following formalin perfusion",
                      "Foci of consolidation can expand to near confluence, thereby mimicking lobar pneumoniaGross description should include distribution of consolidated areas as well as complications of pneumonia, such as prominent necrosis (necrotizing pneumonia) and abscess formationSection adequately to document distribution of disease, areas of necrosis or abscess, and noninvolved lung parenchyma",
                      "Gross description should include distribution of consolidated areas as well as complications of pneumonia, such as prominent necrosis (necrotizing pneumonia) and abscess formation",
                      "Section adequately to document distribution of disease, areas of necrosis or abscess, and noninvolved lung parenchyma"
                    ]
                  },
                  {
                    "text": "Other organsSepsis/shock changes: Pallor of renal cortex (acute tubular injury), softening of liver (shock liver), Ischemic bowel (shock)Disseminated Infection: Vegetations on cardiac valves, disseminated abscessesCause for underlying immunosuppression: Malignancy, transplantation, etc.",
                    "sub_points": [
                      "Sepsis/shock changes: Pallor of renal cortex (acute tubular injury), softening of liver (shock liver), Ischemic bowel (shock)",
                      "Disseminated Infection: Vegetations on cardiac valves, disseminated abscesses",
                      "Cause for underlying immunosuppression: Malignancy, transplantation, etc."
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Respiratory systemAcute bronchitis: Neutrophil-rich suppurative exudate within lumen, and mucosal ulceration/necrosisAcute pneumonia involving peribronchial/peribronchiolar alveolated parenchymaNeutrophil-rich intraalveolar fibrinous exudate and active capillary congestionDepending on time course of infection and effectiveness of therapy, focal or extensive organization may be presentIt is not uncommon in patients with a protracted hospital course to see evidence of multiple episodes of infection, with acute inflammation in 1 region and more advanced organizing pneumonia in othersOrganizing pneumonia: Polypoid accumulation of granulation tissue in alveolar spaces, ducts, and sometimes in bronchioles",
                    "sub_points": [
                      "Acute bronchitis: Neutrophil-rich suppurative exudate within lumen, and mucosal ulceration/necrosis",
                      "Acute pneumonia involving peribronchial/peribronchiolar alveolated parenchymaNeutrophil-rich intraalveolar fibrinous exudate and active capillary congestion",
                      "Neutrophil-rich intraalveolar fibrinous exudate and active capillary congestion",
                      "Depending on time course of infection and effectiveness of therapy, focal or extensive organization may be presentIt is not uncommon in patients with a protracted hospital course to see evidence of multiple episodes of infection, with acute inflammation in 1 region and more advanced organizing pneumonia in othersOrganizing pneumonia: Polypoid accumulation of granulation tissue in alveolar spaces, ducts, and sometimes in bronchioles",
                      "It is not uncommon in patients with a protracted hospital course to see evidence of multiple episodes of infection, with acute inflammation in 1 region and more advanced organizing pneumonia in others",
                      "Organizing pneumonia: Polypoid accumulation of granulation tissue in alveolar spaces, ducts, and sometimes in bronchioles"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Histochemistry": [
                  {
                    "text": "Tissue gram, silver, PAS, mucicarmine or acid-fast/modified acid-fast stains as appropriate"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Immunohistochemical stains for microorganisms as appropriate"
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "In situ hybridization for microorganisms as appropriate"
                  }
                ],
                "Microbiology": [
                  {
                    "text": "Tissue culture procured in sterile fashion"
                  },
                  {
                    "text": "Molecular diagnostic tests, as appropriate"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Processes That Mimic Gross Consolidation": [
                  {
                    "text": "Pulmonary hemorrhage"
                  },
                  {
                    "text": "Diffuse alveolar damage"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Chronic Pancreatitis": {
            "name": "Chronic Pancreatitis",
            "url": "https://app.pathprimer.com/document/78edcb6c-43d7-4deb-9085-42f495de60b8/lesson/9752129a-a100-4e55-be4a-c0d8ec6f50f9",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Progressive inflammatory disorder of pancreas resulting in scarring, gland destruction, and functional impairment"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Alcohol is by far the most common cause of CP in developed countries"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Chronic progressive disease leading to permanent loss of pancreatic function"
                  },
                  {
                    "text": "Steatorrhea"
                  },
                  {
                    "text": "Diabetes mellitus"
                  },
                  {
                    "text": "Weight loss"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Grossly affected area should be thoroughly sampled to exclude pancreatic adenocarcinoma, which can mimic CP grossly"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Irregular atrophy and obliteration of pancreatic acini and ducts"
                  },
                  {
                    "text": "Variable extent and distribution of fibrosis"
                  },
                  {
                    "text": "Retention of normal lobular pancreatic architecture"
                  },
                  {
                    "text": "Pancreatic duct alterations related to fibrosis and destruction"
                  },
                  {
                    "text": "Islets of Langerhans usually preserved"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Pancreatic adenocarcinoma"
                  },
                  {
                    "text": "Autoimmune pancreatitis"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Chronic pancreatitis (CP)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Progressive inflammatory disorder of pancreas resulting in scarring, gland destruction, and functional impairment"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Alcoholic": [
                  {
                    "text": "By far the most common cause of CP in developed countries"
                  }
                ],
                "Anatomic": [
                  {
                    "text": "ObstructivePancreatic duct obstruction leads to proximal duct dilatation, gland atrophy, and scarringObstruction may be due to stones or tumors involving head of pancreas",
                    "sub_points": [
                      "Pancreatic duct obstruction leads to proximal duct dilatation, gland atrophy, and scarring",
                      "Obstruction may be due to stones or tumors involving head of pancreas"
                    ]
                  },
                  {
                    "text": "Paraduodenal or \"groove\" pancreatitis"
                  }
                ],
                "Metabolic": [
                  {
                    "text": "Occurs in patients with hypercalcemia"
                  },
                  {
                    "text": "Hyperlipidemia is risk factor for CP"
                  }
                ],
                "Hereditary": [
                  {
                    "text": "Autosomal dominant form of pancreatitis"
                  },
                  {
                    "text": "Several associated gene mutations describedTrypsinogen gene (PRSS1)Cystic fibrosis transmembrane conductance regulator gene (CFTR)Serine protease inhibitor Kazal type 1 gene (SPINK1)",
                    "sub_points": [
                      "Trypsinogen gene (PRSS1)",
                      "Cystic fibrosis transmembrane conductance regulator gene (CFTR)",
                      "Serine protease inhibitor Kazal type 1 gene (SPINK1)"
                    ]
                  },
                  {
                    "text": "Presents during childhood with recurrent attacks of acute pancreatitis"
                  },
                  {
                    "text": "Affected patients develop complications similar to those seen in alcohol-related CP but at younger age"
                  }
                ],
                "Eosinophilic": [
                  {
                    "text": "Rare form of chronic pancreatitis with prominent eosinophilic infiltrate"
                  },
                  {
                    "text": "May present as mass-forming process or with biliary obstruction"
                  },
                  {
                    "text": "Patients often have systemic process with blood eosinophilia and eosinophilias in other organs"
                  },
                  {
                    "text": "May occur as primary disease or with other processesParasitic infectionAllergic process or hypersensitivity reactionAssociated with pancreatic carcinoma or inflammatory myofibroblastic tumorPancreatic allograft rejection",
                    "sub_points": [
                      "Parasitic infection",
                      "Allergic process or hypersensitivity reaction",
                      "Associated with pancreatic carcinoma or inflammatory myofibroblastic tumor",
                      "Pancreatic allograft rejection"
                    ]
                  }
                ],
                "Tropical": [
                  {
                    "text": "Aggressive form of juvenile pancreatitis occurring in tropical developing countries"
                  },
                  {
                    "text": "May be related to malnutrition, toxin exposure, &/or genetic predisposition"
                  }
                ],
                "Idiopathic": [
                  {
                    "text": "Up to 25% of cases for which no cause can be identified"
                  }
                ],
                "Other": [
                  {
                    "text": "Miscellaneous forms related to trauma, radiation injury, or medications"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Alcohol-related CP usually affects adults > 40 years of age"
                  },
                  {
                    "text": "Hereditary and tropical forms of CP present during childhood"
                  }
                ],
                "Gender": [
                  {
                    "text": "Alcohol-related CP is more common in males than in females"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Often follows recurrent attacks of acute pancreatitis"
                  }
                ],
                "Abdominal pain": [
                  {
                    "text": "Most common presenting symptom"
                  }
                ],
                "Steatorrhea": [
                  {
                    "text": "Associated with malabsorption due to impaired pancreatic enzyme secretion"
                  }
                ],
                "Diabetes mellitus": [
                  {
                    "text": "Occurs with advanced disease"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "May see elevated CA19-9"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Chronic, progressive disease leading to permanent loss of pancreatic functionLoss of pancreatic enzyme secretions leads to malabsorption and steatorrheaPancreatic endocrine insufficiencyDiabetes more common in late disease",
                    "sub_points": [
                      "Loss of pancreatic enzyme secretions leads to malabsorption and steatorrhea",
                      "Pancreatic endocrine insufficiencyDiabetes more common in late disease",
                      "Diabetes more common in late disease"
                    ]
                  },
                  {
                    "text": "Symptoms may wax and wane over course of disease"
                  },
                  {
                    "text": "Complications of advanced diseasePortal vein thrombosisSplenic vein thrombosisJaundicePancreatic ascitesPancreatic pseudocysts",
                    "sub_points": [
                      "Portal vein thrombosis",
                      "Splenic vein thrombosis",
                      "Jaundice",
                      "Pancreatic ascites",
                      "Pancreatic pseudocysts"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Pain managementMedical therapyCeliac nerve block",
                    "sub_points": [
                      "Medical therapy",
                      "Celiac nerve block"
                    ]
                  },
                  {
                    "text": "Diabetes treatment as needed with insulin and diet"
                  },
                  {
                    "text": "Dietary managementLow-fat mealsFrequent small meals may be better tolerated than less frequent, larger meals",
                    "sub_points": [
                      "Low-fat meals",
                      "Frequent small meals may be better tolerated than less frequent, larger meals"
                    ]
                  },
                  {
                    "text": "Stop offending agent (if identifiable)Discontinue alcohol useIf obstructive CP, remove source of obstructionGallstones may be removed by endoscopic retrograde cholangiopancreatography (ERCP)Sphincterotomy or balloon dilatation can relieve duct obstructionStent may be placed to maintain pancreatic duct opening",
                    "sub_points": [
                      "Discontinue alcohol use",
                      "If obstructive CP, remove source of obstructionGallstones may be removed by endoscopic retrograde cholangiopancreatography (ERCP)Sphincterotomy or balloon dilatation can relieve duct obstructionStent may be placed to maintain pancreatic duct opening",
                      "Gallstones may be removed by endoscopic retrograde cholangiopancreatography (ERCP)",
                      "Sphincterotomy or balloon dilatation can relieve duct obstruction",
                      "Stent may be placed to maintain pancreatic duct opening"
                    ]
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Whipple pancreaticoduodenectomy"
                  },
                  {
                    "text": "Pancreatic duct drainage procedure"
                  },
                  {
                    "text": "Local or duodenum-preserving resection of pancreatic head"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Pancreatic enzyme replacement aids intestinal absorption"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "CP is risk factor for pancreatic cancerLifetime risk variesPatients with hereditary pancreatitis have 40% lifetime risk of pancreatic cancer",
                    "sub_points": [
                      "Lifetime risk varies",
                      "Patients with hereditary pancreatitis have 40% lifetime risk of pancreatic cancer"
                    ]
                  }
                ]
              },
              "Image Findings": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Pancreatic stones evident"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Intrapancreatic calcifications"
                  }
                ],
                "ERCP Findings": [
                  {
                    "text": "Irregular, dilated pancreatic duct and branches"
                  },
                  {
                    "text": "May reveal source of obstructive pancreatitis"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Findings may be diffuse, focal, or segmentalUsually, affected area is enlarged but may be shrunken in advanced CP",
                    "sub_points": [
                      "Usually, affected area is enlarged but may be shrunken in advanced CP"
                    ]
                  },
                  {
                    "text": "Firm, indurated, and fibrotic pancreas"
                  },
                  {
                    "text": "Cystically dilated pancreatic ductsMay contain calcified protein concretions",
                    "sub_points": [
                      "May contain calcified protein concretions"
                    ]
                  },
                  {
                    "text": "Pseudocysts may be evidentVariably sized, thick-walled cysts containing blood and necrotic debris",
                    "sub_points": [
                      "Variably sized, thick-walled cysts containing blood and necrotic debris"
                    ]
                  }
                ],
                "Sections to Be Submitted": [
                  {
                    "text": "Grossly affected area should be thoroughly sampled to exclude pancreatic adenocarcinoma, which can appear similar grossly"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Irregular atrophy and obliteration of pancreatic acini and ductsResults in overall loss of acinar tissue",
                    "sub_points": [
                      "Results in overall loss of acinar tissue"
                    ]
                  },
                  {
                    "text": "Retention of normal lobular pancreatic architectureRounded configuration of lobules is preserved",
                    "sub_points": [
                      "Rounded configuration of lobules is preserved"
                    ]
                  },
                  {
                    "text": "Pancreatic duct alterations related to fibrosis and destructionResults in duct ectasia and saccular dilatationsDuct epithelium may show atrophy, reactive, or hyperplastic changesReactive epithelial cells show mild nuclear enlargementDucts may show spectrum of reactive alterations or metaplasiaSquamous metaplasiaMucous cell metaplasiaPyloric gland metaplasia",
                    "sub_points": [
                      "Results in duct ectasia and saccular dilatations",
                      "Duct epithelium may show atrophy, reactive, or hyperplastic changesReactive epithelial cells show mild nuclear enlargement",
                      "Reactive epithelial cells show mild nuclear enlargement",
                      "Ducts may show spectrum of reactive alterations or metaplasiaSquamous metaplasiaMucous cell metaplasiaPyloric gland metaplasia",
                      "Squamous metaplasia",
                      "Mucous cell metaplasia",
                      "Pyloric gland metaplasia"
                    ]
                  },
                  {
                    "text": "Variable extent and distribution of fibrosisOccurs around ducts and within & between lobules",
                    "sub_points": [
                      "Occurs around ducts and within & between lobules"
                    ]
                  },
                  {
                    "text": "Chronic inflammation usually mild"
                  },
                  {
                    "text": "Islets of Langerhans usually relatively well preservedIslets may become lost or atrophic in advanced CPMay also show \"pseudohyperplasia\" as result of parenchymal loss",
                    "sub_points": [
                      "Islets may become lost or atrophic in advanced CP",
                      "May also show \"pseudohyperplasia\" as result of parenchymal loss"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Pancreatic Adenocarcinoma": [
                  {
                    "text": "Invasive growth pattern indicative of malignancyMalignant glands demonstrate infiltrative growth patternIn adenocarcinoma, glands are more irregularly distributedCP retains lobular pancreatic architecturePerineural invasion is feature of malignancyAngiolymphatic space invasion",
                    "sub_points": [
                      "Malignant glands demonstrate infiltrative growth patternIn adenocarcinoma, glands are more irregularly distributed",
                      "In adenocarcinoma, glands are more irregularly distributed",
                      "CP retains lobular pancreatic architecture",
                      "Perineural invasion is feature of malignancy",
                      "Angiolymphatic space invasion"
                    ]
                  },
                  {
                    "text": "Gland architecture more irregular in adenocarcinomaIn CP, glands are rounded or tubular with minimal branchingIndividual malignant-appearing cells are feature of adenocarcinomaResidual islet cells may appear singly and should not be overinterpreted as evidence of cancerNecrotic debris may be seen in malignant glands but not in ducts in CP",
                    "sub_points": [
                      "In CP, glands are rounded or tubular with minimal branching",
                      "Individual malignant-appearing cells are feature of adenocarcinomaResidual islet cells may appear singly and should not be overinterpreted as evidence of cancer",
                      "Residual islet cells may appear singly and should not be overinterpreted as evidence of cancer",
                      "Necrotic debris may be seen in malignant glands but not in ducts in CP"
                    ]
                  },
                  {
                    "text": "Cytologic features of malignancy are seen in adenocarcinomaNuclei are larger, more irregular, and more hyperchromatic in adenocarcinoma than in CPAdenocarcinoma shows greater variation in nuclear size than does CPMitotic activity and atypical mitotic features are features of adenocarcinoma but not of CP",
                    "sub_points": [
                      "Nuclei are larger, more irregular, and more hyperchromatic in adenocarcinoma than in CP",
                      "Adenocarcinoma shows greater variation in nuclear size than does CP",
                      "Mitotic activity and atypical mitotic features are features of adenocarcinoma but not of CP"
                    ]
                  },
                  {
                    "text": "Areas of CP are often present in association with pancreatic adenocarcinoma"
                  }
                ],
                "Autoimmune Pancreatitis": [
                  {
                    "text": "More densely cellular inflammatory infiltrates than CPPeriductal inflammation consisting of large numbers of lymphocytes and plasma cellsInflammatory infiltrates associated with injury and destruction of duct epitheliumPlasma cells are IgG4 positiveLymphoid follicles may be seenObliterative phlebitis of small to medium-sized veinsPresent in most casesCan be highlighted with elastic stain",
                    "sub_points": [
                      "Periductal inflammation consisting of large numbers of lymphocytes and plasma cellsInflammatory infiltrates associated with injury and destruction of duct epitheliumPlasma cells are IgG4 positive",
                      "Inflammatory infiltrates associated with injury and destruction of duct epithelium",
                      "Plasma cells are IgG4 positive",
                      "Lymphoid follicles may be seen",
                      "Obliterative phlebitis of small to medium-sized veinsPresent in most casesCan be highlighted with elastic stain",
                      "Present in most cases",
                      "Can be highlighted with elastic stain"
                    ]
                  },
                  {
                    "text": "Serum IgG4 level elevated in most patients with autoimmune pancreatitis"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Abdominal pain is most common presenting symptom"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Dense parenchymal fibrosis may mimic neoplasm"
                  },
                  {
                    "text": "Lobular architecture aids histologic distinction from pancreatic adenocarcinoma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Chronic Pyelonephritis": {
            "name": "Chronic Pyelonephritis",
            "url": "https://app.pathprimer.com/document/aff4f5cc-7cf6-49e3-b8f2-5f2e26943ac0/lesson/9752129a-a100-4e55-be4a-c0d8ec6f50f9",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Renal damage due to repeated bacterial infection and scarring"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Urinary tract obstruction"
                  },
                  {
                    "text": "Reflux nephropathy"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Insidious onset of renal insufficiency if bilateral"
                  },
                  {
                    "text": "Progression to end-stage kidney disease"
                  },
                  {
                    "text": "Hypertension"
                  },
                  {
                    "text": "Proteinuria due to secondary FSGS"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Plain radiographs, CT scan of abdomen for obstruction"
                  },
                  {
                    "text": "Voiding cystourethrogram for reflux nephropathy"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Large irregular scars on cortical surface"
                  },
                  {
                    "text": "Dilated pelvis; calyces blunted or deformed"
                  },
                  {
                    "text": "Cortical scars overlie deformed calyces"
                  },
                  {
                    "text": "Calculi may be seen in pelvis"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Patchy chronic tubulointerstitial inflammationLymphocytes, plasma cells, and monocytes predominate",
                    "sub_points": [
                      "Lymphocytes, plasma cells, and monocytes predominate"
                    ]
                  },
                  {
                    "text": "Thyroidization of tubules"
                  },
                  {
                    "text": "Inflammation and scarring involves pelvis and calyces"
                  },
                  {
                    "text": "Sharp demarcation between inflamed and preserved parenchyma"
                  },
                  {
                    "text": "Glomeruli relatively spared but often with periglomerular fibrosisSecondary FSGS may be present",
                    "sub_points": [
                      "Secondary FSGS may be present"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Chronic tubulointerstitial nephritis"
                  },
                  {
                    "text": "Primary FSGS"
                  },
                  {
                    "text": "Hypertensive renal disease"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Chronic pyelonephritis (CPN)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Renal damage due to repeated bacterial infection and scarring"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Urinary Outflow Tract Obstruction or Urinary Reflux": [
                  {
                    "text": "Prostatic disease"
                  },
                  {
                    "text": "Nephrolithiasis"
                  },
                  {
                    "text": "Neurogenic bladder"
                  },
                  {
                    "text": "Ureteral stenosis or dysfunction"
                  },
                  {
                    "text": "Vesicoureteral reflux, congenital or acquiredRole of infection debated",
                    "sub_points": [
                      "Role of infection debated"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Sex": [
                  {
                    "text": "F > M"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Chronic renal failure if bilateralLoss of urinary concentration abilityProteinuria, hypertension (HTN)",
                    "sub_points": [
                      "Loss of urinary concentration ability",
                      "Proteinuria, hypertension (HTN)"
                    ]
                  },
                  {
                    "text": "Silent clinical course if unilateral; presents as HTN"
                  },
                  {
                    "text": "Repeated episodes of acute pyelonephritisFever, chills, flank pain",
                    "sub_points": [
                      "Fever, chills, flank pain"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated BUN, serum creatinine"
                  },
                  {
                    "text": "Urinalysis: Proteinuria, pyuria"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Correct anatomic defect"
                  },
                  {
                    "text": "Nephrectomy in unilateral disease to control HTN"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Antimicrobial therapy if bacterial infection"
                  },
                  {
                    "text": "Antihypertensives"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Progression slowed only if detected early"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Plain radiographs, CT scan of abdomen for obstruction"
                  },
                  {
                    "text": "Voiding cystourethrogram for reflux nephropathy"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Large irregular scars on cortical surfaceAdjacent cortical surface can be smooth or granular if associated with arterionephrosclerosisCortical scars common in upper and lower polesThickness of cortex can be reduced to 2-3 mmCortical scars overlie deformed calycesIndicative of ascending infection",
                    "sub_points": [
                      "Adjacent cortical surface can be smooth or granular if associated with arterionephrosclerosis",
                      "Cortical scars common in upper and lower poles",
                      "Thickness of cortex can be reduced to 2-3 mm",
                      "Cortical scars overlie deformed calycesIndicative of ascending infection",
                      "Indicative of ascending infection"
                    ]
                  },
                  {
                    "text": "Dilated pelvis and calycesBlunted or deformed calycesCalculi may be in pelvis",
                    "sub_points": [
                      "Blunted or deformed calyces",
                      "Calculi may be in pelvis"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Patchy chronic tubulointerstitial inflammationLymphocytes, plasma cells, and monocytesSharp demarcation between inflamed and preserved parenchyma",
                    "sub_points": [
                      "Lymphocytes, plasma cells, and monocytes",
                      "Sharp demarcation between inflamed and preserved parenchyma"
                    ]
                  },
                  {
                    "text": "Tubular atrophy and interstitial fibrosisAtrophic tubules with attenuated epithelium and luminal colloid-like hyaline casts (thyroidization)Not specific for chronic pyelonephritis",
                    "sub_points": [
                      "Atrophic tubules with attenuated epithelium and luminal colloid-like hyaline casts (thyroidization)Not specific for chronic pyelonephritis",
                      "Not specific for chronic pyelonephritis"
                    ]
                  },
                  {
                    "text": "Inflammation and scarring of pelvis and calyces"
                  },
                  {
                    "text": "Neutrophil casts in setting of acute pyelonephritis"
                  },
                  {
                    "text": "Extravasated Tamm-Horsfall protein may be abundant"
                  },
                  {
                    "text": "Glomeruli relatively sparedPeriglomerular fibrosis commonWith progression, focal segmental glomerulosclerosis (FSGS) may develop due to loss of renal mass",
                    "sub_points": [
                      "Periglomerular fibrosis common",
                      "With progression, focal segmental glomerulosclerosis (FSGS) may develop due to loss of renal mass"
                    ]
                  },
                  {
                    "text": "Arteriosclerosis, if hypertension"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunofluorescence": [
                  {
                    "text": "Segmental glomerular IgM and C3 if FSGS present"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Mild foot process effacement if secondary FSGS"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Chronic Tubulointerstitial Nephritis": [
                  {
                    "text": "Pelvicalyceal inflammation and thyroidization more prominent in CPN"
                  },
                  {
                    "text": "No selective destruction of medulla or evidence of obstruction"
                  },
                  {
                    "text": "Uniform involvement; no spared lobes"
                  }
                ],
                "Primary FSGS": [
                  {
                    "text": "No pelvicalyceal inflammation or medullary destruction"
                  }
                ],
                "Hypertensive Renal Disease": [
                  {
                    "text": "No pelvicalyceal inflammation or medullary destruction"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Diagnosis almost impossible on biopsy alone; clinical and radiographic correlations needed"
                  },
                  {
                    "text": "Sterile reflux produces similar pathologyDifficult to be certain if infection played role",
                    "sub_points": [
                      "Difficult to be certain if infection played role"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Keloid and Cellular Scar": {
            "name": "Keloid and Cellular Scar",
            "url": "https://app.pathprimer.com/document/cf739fc6-2527-4de7-b0a0-54ec42d1f03f/lesson/9752129a-a100-4e55-be4a-c0d8ec6f50f9",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Scar with prominent thickened and eosinophilic bundles of collagen"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Persistence and recurrence are common, but no risk of malignancy"
                  },
                  {
                    "text": "Scar that grows beyond original wound"
                  },
                  {
                    "text": "Often erythematous, pruritic lesions with predilection for earlobe in African-American patients"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Dense proliferation of thickened, hyalinized collagen bundles in dermis"
                  },
                  {
                    "text": "Decreased vessels compared to conventional and hypertrophic scars"
                  },
                  {
                    "text": "Increased fibroblasts, lymphocytes, and mast cells usually present"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Hypertrophic scar"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Scar with keloidal collagen"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Scar with prominent thickened and eosinophilic bundles of collagen extending beyond original wound"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Unknown, Possibly Genetic": [
                  {
                    "text": "Fibroblasts from keloids show decreased apoptosis"
                  },
                  {
                    "text": "Many cytokines implicated in stimulating fibroblasts, including TGF-B and IL-15"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Most common in patients < 30 years"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "More common in African-American patients; least common in Caucasians"
                  }
                ],
                "Site": [
                  {
                    "text": "Earlobe is most common siteTypically follows ear piercing or other trauma",
                    "sub_points": [
                      "Typically follows ear piercing or other trauma"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Nodule/mass lesion is most common"
                  },
                  {
                    "text": "Scar that grows beyond confines of original wound"
                  },
                  {
                    "text": "Often erythematous, pruritic lesions with predilection for earlobe"
                  }
                ],
                "Treatment": [],
                "Options, risks, complications": [
                  {
                    "text": "Potentially disfiguring with high risk of recurrence"
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Complete excision, accompanied by concurrent steroid injections or radiotherapy to decrease risk of recurrence"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Direct injection of steroids is often first-line treatment"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Persistence and recurrence are common, but no risk of malignancy"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Large, nodular, dermal-based lesion with firm, white cut surface"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Dense proliferation of thickened, hyalinized collagen bundles in dermis"
                  },
                  {
                    "text": "May be background of conventional or hypertrophic scar with smaller collagen bundles and perpendicular vessels"
                  },
                  {
                    "text": "Decreased vessels compared to conventional and hypertrophic scarsSuperficial telangiectatic vessels often presentAssociated with mild chronic inflammation",
                    "sub_points": [
                      "Superficial telangiectatic vessels often present",
                      "Associated with mild chronic inflammation"
                    ]
                  },
                  {
                    "text": "Overlying epidermis shows atrophy in most cases, may show hyperplasia in some cases"
                  },
                  {
                    "text": "Increased fibroblasts, lymphocytes, and mast cells usually present"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Hypertrophic Scar": [
                  {
                    "text": "Lacks characteristic hyalinized collagen bundles of keloid"
                  },
                  {
                    "text": "Has more small, perpendicularly oriented vessels; lacks telangiectasia"
                  },
                  {
                    "text": "Overlapping cases may be seen and may be diagnosed as \"hypertrophic scar with focal keloidal collagen\""
                  },
                  {
                    "text": "Clinically not as elevated as keloid"
                  }
                ],
                "Nodular Fasciitis": [
                  {
                    "text": "May rarely show focal keloidal collagen"
                  },
                  {
                    "text": "Background shows classic features of nodular fasciitis with loose, tissue culture appearance"
                  },
                  {
                    "text": "Zonation with cellular, myxoid, and more fibrous areas"
                  }
                ],
                "Desmoplastic Melanoma": [
                  {
                    "text": "Unlikely, but rarely may enter differential diagnosis if no history of trauma or previous biopsy/surgery"
                  },
                  {
                    "text": "Reexcision specimens of desmoplastic melanoma may show keloidal collagen"
                  },
                  {
                    "text": "S100 immunohistochemical stain should be positiveIncreased numbers of dermal dendritic cells may be seen in scarsShould not show spindled morphology of desmoplastic melanoma cells",
                    "sub_points": [
                      "Increased numbers of dermal dendritic cells may be seen in scars",
                      "Should not show spindled morphology of desmoplastic melanoma cells"
                    ]
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Nodular, elevated lesion compared to adjacent skin"
                  },
                  {
                    "text": "Thickened, hyalinized eosinophilic collagen bundles"
                  },
                  {
                    "text": "Often see background of hypertrophic scar"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Ischemic Heart Disease": {
            "name": "Ischemic Heart Disease",
            "url": "https://app.pathprimer.com/document/21a16ae6-3e0b-457d-bf38-a7a6efa5f3c9/lesson/9752129a-a100-4e55-be4a-c0d8ec6f50f9",
            "content": {
              "Key Facts": {
                "Clinical Issues": [
                  {
                    "text": "Most common cause of heart failure overall and 2nd most common etiology of heart failure in transplantation"
                  },
                  {
                    "text": "5-year survival post transplant (> 70%) is lower than for nonischemic cardiomyopathy but higher than for congenital heart disease or valvular cardiomyopathy"
                  },
                  {
                    "text": "Metabolic risk factors that increase risk for CAD are also independent risk factors for post-transplant mortality and decreased 5-year survival"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Large areas of fibrosis are often present and may be subendocardial or transmural, consistent with healed myocardial infarctionsDistribution corresponds to coronary artery lesions",
                    "sub_points": [
                      "Distribution corresponds to coronary artery lesions"
                    ]
                  },
                  {
                    "text": "Usually multifocal obstruction of multiple coronary arteriesPathologic exam typically overestimates extent of stenosis due to remodeling of entire arterial wall and collapse of arterial lumen",
                    "sub_points": [
                      "Pathologic exam typically overestimates extent of stenosis due to remodeling of entire arterial wall and collapse of arterial lumen"
                    ]
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "In areas of old myocardial infarction, fibrosis replaces myocytes"
                  },
                  {
                    "text": "Myocytes immediately subjacent to endocardium are typically spared due to oxygen supply received from ventricular blood"
                  },
                  {
                    "text": "Patchy interstitial or replacement fibrosis and myocyte hypertrophy are often seen but not specific"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Ischemic heart disease (IHD)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Ischemic cardiomyopathy, coronary artery disease (CAD), coronary heart disease (CHD)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Heart failure due to coronary artery diseaseAlmost always due to atherosclerotic coronary arteries, but may rarely be due to anomalous coronary arteries or fibromuscular dysplasia",
                    "sub_points": [
                      "Almost always due to atherosclerotic coronary arteries, but may rarely be due to anomalous coronary arteries or fibromuscular dysplasia"
                    ]
                  },
                  {
                    "text": "Includes stable and unstable angina, myocardial infarctions, and sudden cardiac deathExplanted hearts most commonly show chronic ischemic disease",
                    "sub_points": [
                      "Explanted hearts most commonly show chronic ischemic disease"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Environmental Exposure": [
                  {
                    "text": "Tobacco"
                  }
                ],
                "Additional Clinical Risk Factors": [
                  {
                    "text": "Hypertension, diabetes mellitus, obesity, dyslipidemia, and physical inactivity"
                  },
                  {
                    "text": "Family history of CAD is a strong risk factor but specific mechanisms for this polygenic trait have not been elucidated"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Most common cause of heart failure overall and 2nd most common etiology in transplantation"
                  },
                  {
                    "text": "Leading cause of death worldwide"
                  },
                  {
                    "text": "Mortality rates are falling in many economically developed countries due to advances in medical treatment and changes in risk factors"
                  }
                ],
                "Age": [
                  {
                    "text": "Typically presents in middle-aged to older adults"
                  },
                  {
                    "text": "Incidence increases with age"
                  }
                ],
                "Gender": [
                  {
                    "text": "More common in males overall but risk increases for women after menopause"
                  }
                ],
                "Presentation": [
                  {
                    "text": "\"Silent\" (asymptomatic) ischemia commonly precedes presentation of CAD"
                  },
                  {
                    "text": "At time of transplantation, patients often have long history of chest pain, shortness of breath, and heart failure"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Once medical management, percutaneous coronary balloon angioplasty with stenting, and coronary bypass surgery have failed, patients are eligible for orthotopic heart transplant"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "5-year survival post transplant (> 70%) is lower than for nonischemic cardiomyopathy but higher than for congenital heart disease or valvular cardiomyopathy"
                  },
                  {
                    "text": "Metabolic risk factors that increase risk for CAD are also independent risk factors for post-transplant mortality and decreased 5-year survival"
                  }
                ]
              },
              "Image Findings": {
                "General Features": [
                  {
                    "text": "Coronary artery stenosis on coronary angiogram"
                  }
                ],
                "Ultrasonographic Findings": [
                  {
                    "text": "Regional wall motion abnormalities"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Hypertrophy with left ventricular dilation"
                  },
                  {
                    "text": "Large areas of fibrosis are often present and may be subendocardial or transmural, consistent with healed myocardial infarctions"
                  },
                  {
                    "text": "In large areas of scar, there is often thinning and aneurysm formation as well as patchy endocardial fibrosis"
                  },
                  {
                    "text": "Usually multifocal obstruction of coronary arteriesDegree of occlusion of each vessel and any grafts should be determined during gross examinationSignificant ischemia occurs with 75% reduction in cross-sectional area (50% reduction in diameter) as determined by angiographyPathologic exam typically overestimates extent of stenosis due to remodeling of entire arterial wall and collapse of arterial lumen",
                    "sub_points": [
                      "Degree of occlusion of each vessel and any grafts should be determined during gross examination",
                      "Significant ischemia occurs with 75% reduction in cross-sectional area (50% reduction in diameter) as determined by angiography",
                      "Pathologic exam typically overestimates extent of stenosis due to remodeling of entire arterial wall and collapse of arterial lumen"
                    ]
                  }
                ],
                "Sections to Be Submitted": [
                  {
                    "text": "Left main, left circumflex, and right coronary arteries should be sectioned every 2 mm, and areas demonstrating most severe occlusion submittedDecalcification of coronary arteries prior to sectioning is often helpfulBypass grafts &/or stents may be present and should be evaluated",
                    "sub_points": [
                      "Decalcification of coronary arteries prior to sectioning is often helpful",
                      "Bypass grafts &/or stents may be present and should be evaluated"
                    ]
                  },
                  {
                    "text": "Areas of fibrosis, discoloration, and grossly uninvolved myocardium should be submitted"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Coronary arteriesEccentric lumen obstruction due to atherosclerotic plaques (which are often calcified)Simple plaques have an overlying fibrous cap with subjacent extracellular lipid (cholesterol crystals), intracellular lipid (foamy macrophages), and inflammatory cellsComplex plaques may have multiple cores or solid fibrosis and may be concentricRecanalized thrombi may be present in either native coronary arteries or grafted vesselsAcute plaque changes (thrombosis, hemorrhage) are typically not present in explanted specimens",
                    "sub_points": [
                      "Eccentric lumen obstruction due to atherosclerotic plaques (which are often calcified)",
                      "Simple plaques have an overlying fibrous cap with subjacent extracellular lipid (cholesterol crystals), intracellular lipid (foamy macrophages), and inflammatory cells",
                      "Complex plaques may have multiple cores or solid fibrosis and may be concentric",
                      "Recanalized thrombi may be present in either native coronary arteries or grafted vessels",
                      "Acute plaque changes (thrombosis, hemorrhage) are typically not present in explanted specimens"
                    ]
                  },
                  {
                    "text": "In areas of old infarction, fibrosis replaces myocytesReplacement fibrosis may be subendocardial or transmuralMyocytes immediately subjacent to endocardium are typically spared due to oxygen supply received from ventricular blood",
                    "sub_points": [
                      "Replacement fibrosis may be subendocardial or transmural",
                      "Myocytes immediately subjacent to endocardium are typically spared due to oxygen supply received from ventricular blood"
                    ]
                  },
                  {
                    "text": "Cytoplasmic vacuolization (\"myocytolysis\") is a sublethal ischemic change that can be seen adjacent to infarcts or in subendocardium"
                  },
                  {
                    "text": "Nonspecific changes in the noninfarcted areas include interstitial fibrosis and myocyte hypertrophy"
                  },
                  {
                    "text": "Areas of acute or organizing infarction that have occurred within 4 hours to several weeks may be present but are less common"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Healed Inflammation in Other Types of Heart Disease": [
                  {
                    "text": "Myocarditis, sarcoidosis"
                  },
                  {
                    "text": "No marked occlusion of coronary arteries"
                  },
                  {
                    "text": "Location of fibrosis does not correspond to vascular distribution patterns"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Hemodynamic Disorders": {
        "name": "Hemodynamic Disorders",
        "url": "https://app.pathprimer.com/lesson/31d58b63-a3da-42c0-a630-edacbda642a3",
        "topics": {
          "Pulmonary Edema": {
            "name": "Pulmonary Edema",
            "url": "https://app.pathprimer.com/document/830d4d55-a850-484a-9928-d0f4a0d97c4d/lesson/31d58b63-a3da-42c0-a630-edacbda642a3",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Pulmonary edema is accumulation of fluid in alveolar spaces"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Pulmonary edema divided into cardiogenic and noncardiogenic causes"
                  },
                  {
                    "text": "Diffuse alveolar damage is the prototypical example of noncardiogenic, permeability edemaMajor histologic pattern associated with clinical syndrome of acute respiratory distress syndrome",
                    "sub_points": [
                      "Major histologic pattern associated with clinical syndrome of acute respiratory distress syndrome"
                    ]
                  },
                  {
                    "text": "In hospitalized patients, etiology of pulmonary edema or diffuse alveolar damage is often multifactorial"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Significant cause of morbidity and mortality in hospitalized patients and is a common finding at autopsy"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Heavy and fluid-filled lungs"
                  },
                  {
                    "text": "Diffuse alveolar damage results in airless and firm lungs"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Nonpermeability pulmonary edemaFluid accumulation within alveolar spaces",
                    "sub_points": [
                      "Fluid accumulation within alveolar spaces"
                    ]
                  },
                  {
                    "text": "Diffuse alveolar damageHyaline membranes (early) and fibroblastic proliferation (late)",
                    "sub_points": [
                      "Hyaline membranes (early) and fibroblastic proliferation (late)"
                    ]
                  }
                ]
              },
              "Terminology": {
                "Definitions": [
                  {
                    "text": "Accumulation of fluid in alveolar spaces2 main etiologic categoriesCardiogenic pulmonary edema (CPE) (also referred to as hemodynamic edema)Noncardiogenic pulmonary edemaPathogenetic classification based on integrity of alveolar-capillary unit and intrinsic permeability of microvasculatureNonpermeability edema of intact alveolar-capillary unit, usually seen with ↑ hydrostatic pressure; may also be due to ↓ oncotic pressure, lymphatic obstruction, and other less well understood factorsPermeability edema: Disruption of alveolar-capillary unit due to endothelial &/or epithelial damageDiffuse alveolar damage (DAD) is classic noncardiogenic permeability edema and usual pathology seen in clinical acute respiratory distress syndrome (ARDS)\"Diffuse\" refers to damage to all parts of alveolus, but not to widespread lung injuryDAD may be localized, but when clinically significant is usually widespread throughout lung",
                    "sub_points": [
                      "2 main etiologic categoriesCardiogenic pulmonary edema (CPE) (also referred to as hemodynamic edema)Noncardiogenic pulmonary edema",
                      "Cardiogenic pulmonary edema (CPE) (also referred to as hemodynamic edema)",
                      "Noncardiogenic pulmonary edema",
                      "Pathogenetic classification based on integrity of alveolar-capillary unit and intrinsic permeability of microvasculatureNonpermeability edema of intact alveolar-capillary unit, usually seen with ↑ hydrostatic pressure; may also be due to ↓ oncotic pressure, lymphatic obstruction, and other less well understood factorsPermeability edema: Disruption of alveolar-capillary unit due to endothelial &/or epithelial damage",
                      "Nonpermeability edema of intact alveolar-capillary unit, usually seen with ↑ hydrostatic pressure; may also be due to ↓ oncotic pressure, lymphatic obstruction, and other less well understood factors",
                      "Permeability edema: Disruption of alveolar-capillary unit due to endothelial &/or epithelial damage",
                      "Diffuse alveolar damage (DAD) is classic noncardiogenic permeability edema and usual pathology seen in clinical acute respiratory distress syndrome (ARDS)\"Diffuse\" refers to damage to all parts of alveolus, but not to widespread lung injuryDAD may be localized, but when clinically significant is usually widespread throughout lung",
                      "\"Diffuse\" refers to damage to all parts of alveolus, but not to widespread lung injury",
                      "DAD may be localized, but when clinically significant is usually widespread throughout lung"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Pathogenesis": [
                  {
                    "text": "Lung fluid exchange based on Starling Law (balance of intra- and extravascular hydrostatic and oncotic pressures), normal permeability of  microvasculature, and reserve capacity of lymphaticsNormal alveolar wall (alveolar/capillary unit) highly specialized to facilitate gas exchangeNormally, capillary endothelium is semipermeable to protein; allows escape of fluid and low molecular weight substancesType I alveolar epithelial cells and endothelial cells are very thin and susceptible to damageDirect injury to endothelium allows for escape of fibrin-rich exudates into interstitium and airspacesEpithelial damage → epithelial necrosis, ↓ surfactant due to type II alveolar pneumocyte injury and alveolar collapseCPE: Cardiac disease → accumulation of blood in pulmonary vasculature (passive congestion) → increased hydrostatic pressure → transudation of fluid from microvasculature into alveolar spacesAcute passive congestion → small endothelial breaks → some release of red blood cells (alveolar microhemorrhage) in addition to fluidChronic passive congestion → repetitive alveolar microhemorrhage, ↑ hemosiderin-laden macrophages (\"heart failure cells\")Noncardiogenic pulmonary edema: Mechanism of injury that → transudation/exudation of fluid varies according to etiologyIn all cases, fluid in alveoli impairs gas exchange and can be fatal",
                    "sub_points": [
                      "Normal alveolar wall (alveolar/capillary unit) highly specialized to facilitate gas exchangeNormally, capillary endothelium is semipermeable to protein; allows escape of fluid and low molecular weight substancesType I alveolar epithelial cells and endothelial cells are very thin and susceptible to damageDirect injury to endothelium allows for escape of fibrin-rich exudates into interstitium and airspacesEpithelial damage → epithelial necrosis, ↓ surfactant due to type II alveolar pneumocyte injury and alveolar collapse",
                      "Normally, capillary endothelium is semipermeable to protein; allows escape of fluid and low molecular weight substances",
                      "Type I alveolar epithelial cells and endothelial cells are very thin and susceptible to damage",
                      "Direct injury to endothelium allows for escape of fibrin-rich exudates into interstitium and airspaces",
                      "Epithelial damage → epithelial necrosis, ↓ surfactant due to type II alveolar pneumocyte injury and alveolar collapse",
                      "CPE: Cardiac disease → accumulation of blood in pulmonary vasculature (passive congestion) → increased hydrostatic pressure → transudation of fluid from microvasculature into alveolar spacesAcute passive congestion → small endothelial breaks → some release of red blood cells (alveolar microhemorrhage) in addition to fluidChronic passive congestion → repetitive alveolar microhemorrhage, ↑ hemosiderin-laden macrophages (\"heart failure cells\")",
                      "Acute passive congestion → small endothelial breaks → some release of red blood cells (alveolar microhemorrhage) in addition to fluid",
                      "Chronic passive congestion → repetitive alveolar microhemorrhage, ↑ hemosiderin-laden macrophages (\"heart failure cells\")",
                      "Noncardiogenic pulmonary edema: Mechanism of injury that → transudation/exudation of fluid varies according to etiology",
                      "In all cases, fluid in alveoli impairs gas exchange and can be fatal"
                    ]
                  }
                ],
                "Etiology": [
                  {
                    "text": "Cardiogenic pulmonary edemaIschemic and valvular heart disease, cardiomyopathy, myocarditis, cardiotoxic drugs and systemic toxins, hypertension and diabetes",
                    "sub_points": [
                      "Ischemic and valvular heart disease, cardiomyopathy, myocarditis, cardiotoxic drugs and systemic toxins, hypertension and diabetes"
                    ]
                  },
                  {
                    "text": "Noncardiogenic pulmonary edema including etiologies associated with diffuse alveolar damageInfectionsPulmonary viral infections and sepsis (often with associated disseminated intravascular coagulation)TraumaMajor trauma and burns (burns often associated with smoke injury), fat embolism subsequent to trauma, near drowningChemical, toxin, drug, radiation exposureGastric acid (aspiration), smoke and other inhaled toxins (gases and chemicals), adverse drug reaction (including recreational drugs, oxygen toxicity, radiation injury, uremia)Hypoalbuminemic statesNephrotic syndrome, protein-losing enteropathies, chronic liver diseaseIatrogenicVolume overloadUnknown exact mechanism of injuryTransfusion-related acute lung injury (TRALI), pancreatitis, high altitude pulmonary edemaDisseminated intravascular coagulation (DIC)Cardiopulmonary bypassMultifactorial, and in some cases may be associated with adverse reaction to protamine used to reverse heparin anticoagulationMultifactorial/unknownPulmonary thromboembolismRenal artery stenosis (often bilateral)EclampsiaNeurogenicLymphatic obstructionPulmonary vein obstruction",
                    "sub_points": [
                      "InfectionsPulmonary viral infections and sepsis (often with associated disseminated intravascular coagulation)",
                      "Pulmonary viral infections and sepsis (often with associated disseminated intravascular coagulation)",
                      "TraumaMajor trauma and burns (burns often associated with smoke injury), fat embolism subsequent to trauma, near drowning",
                      "Major trauma and burns (burns often associated with smoke injury), fat embolism subsequent to trauma, near drowning",
                      "Chemical, toxin, drug, radiation exposureGastric acid (aspiration), smoke and other inhaled toxins (gases and chemicals), adverse drug reaction (including recreational drugs, oxygen toxicity, radiation injury, uremia)",
                      "Gastric acid (aspiration), smoke and other inhaled toxins (gases and chemicals), adverse drug reaction (including recreational drugs, oxygen toxicity, radiation injury, uremia)",
                      "Hypoalbuminemic statesNephrotic syndrome, protein-losing enteropathies, chronic liver disease",
                      "Nephrotic syndrome, protein-losing enteropathies, chronic liver disease",
                      "IatrogenicVolume overload",
                      "Volume overload",
                      "Unknown exact mechanism of injuryTransfusion-related acute lung injury (TRALI), pancreatitis, high altitude pulmonary edema",
                      "Transfusion-related acute lung injury (TRALI), pancreatitis, high altitude pulmonary edema",
                      "Disseminated intravascular coagulation (DIC)",
                      "Cardiopulmonary bypassMultifactorial, and in some cases may be associated with adverse reaction to protamine used to reverse heparin anticoagulation",
                      "Multifactorial, and in some cases may be associated with adverse reaction to protamine used to reverse heparin anticoagulation",
                      "Multifactorial/unknownPulmonary thromboembolismRenal artery stenosis (often bilateral)EclampsiaNeurogenic",
                      "Pulmonary thromboembolism",
                      "Renal artery stenosis (often bilateral)",
                      "Eclampsia",
                      "Neurogenic",
                      "Lymphatic obstruction",
                      "Pulmonary vein obstruction"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Presentation": [],
                "Depending on etiology, symptoms of pulmonary edema may appear suddenly or develop over time": [
                  {
                    "text": "Symptoms include shortness of breath, dyspnea, wheezing, cough, anxiety, chest pain, and rapid weight gain from build-up of fluid in body"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Effect of formalin perfusion of lung on evaluation of pulmonary edema has long been debatedCutting lungs in a fresh state enhances appreciation of pulmonary edema and might be appropriate in some circumstances and is favored by some pathologistsHowever, perfusion of lung allows for better overall appreciation of many other pathologic processes such as infection, parenchymal disease, and malignancy (many of which coexist in a hospital autopsy population), and perfusion is therefore recommendedEven with perfusion, it is still possible to satisfactorily document pulmonary edema by observation, pre-perfusion lung weights, and microscopic sections",
                    "sub_points": [
                      "Cutting lungs in a fresh state enhances appreciation of pulmonary edema and might be appropriate in some circumstances and is favored by some pathologistsHowever, perfusion of lung allows for better overall appreciation of many other pathologic processes such as infection, parenchymal disease, and malignancy (many of which coexist in a hospital autopsy population), and perfusion is therefore recommendedEven with perfusion, it is still possible to satisfactorily document pulmonary edema by observation, pre-perfusion lung weights, and microscopic sections",
                      "However, perfusion of lung allows for better overall appreciation of many other pathologic processes such as infection, parenchymal disease, and malignancy (many of which coexist in a hospital autopsy population), and perfusion is therefore recommended",
                      "Even with perfusion, it is still possible to satisfactorily document pulmonary edema by observation, pre-perfusion lung weights, and microscopic sections"
                    ]
                  }
                ],
                "External Examination": [
                  {
                    "text": "Pulmonary edema often occurs in setting of congestive heart failurePitting edema and venous stasis changes may be presentSevere edema (anasarca) noted in hypoalbuminemic states",
                    "sub_points": [
                      "Pitting edema and venous stasis changes may be present",
                      "Severe edema (anasarca) noted in hypoalbuminemic states"
                    ]
                  },
                  {
                    "text": "Rapid infusion of fluids may result in iatrogenic volume overload and subsequent acute pulmonary edemaNote IV access and other central lines and correlate with clinical history of fluid administration as well as transfusions",
                    "sub_points": [
                      "Note IV access and other central lines and correlate with clinical history of fluid administration as well as transfusions"
                    ]
                  },
                  {
                    "text": "Sternal incision from recent coronary artery bypass graft surgery, valve surgery, ventricular assist device"
                  },
                  {
                    "text": "Burns (not encountered in hospital autopsy practice)"
                  },
                  {
                    "text": "Gastric contents in mouth (aspiration)"
                  },
                  {
                    "text": "Recent cesarean section scar (eclampsia-related pulmonary edema)"
                  }
                ],
                "Internal Examination": [
                  {
                    "text": "Absence or presence and character/quantitation of pleural effusionsPleural effusion occurs when reserve capacity of lymphatic system to drain fluid from pulmonary extravascular spaces is exceeded and it is a good indicator of excess fluid in lungs",
                    "sub_points": [
                      "Pleural effusion occurs when reserve capacity of lymphatic system to drain fluid from pulmonary extravascular spaces is exceeded and it is a good indicator of excess fluid in lungs"
                    ]
                  },
                  {
                    "text": "Cardiac disease is the major cause of nonpermeability pulmonary edemaSpecial attention should be paid to examination of the 4 heart chambers, cardiac valves, coronary vessels, and major vessels for any abnormality",
                    "sub_points": [
                      "Special attention should be paid to examination of the 4 heart chambers, cardiac valves, coronary vessels, and major vessels for any abnormality"
                    ]
                  },
                  {
                    "text": "Renal disease or renal artery stenosis can also cause noncardiogenic, nonpermeability pulmonary edema"
                  }
                ],
                "Organ Examination": [
                  {
                    "text": "Increased lung weights are a sensitive indicator of pulmonary disease and, in absence of another etiology such as infection or malignancy, reflect severity of fluid accumulation within lung"
                  },
                  {
                    "text": "Prominent interstitial markings are often present on pleural surface and reflect accumulation of fluid within lobular interstitium"
                  },
                  {
                    "text": "Sectioning of unfixed lung will result in exudation of fluid from cut surfaceAssuming no other underlying pulmonary disease or longstanding cardiac disease resulting in chronic passive congestion, lungs in cardiogenic and noncardiogenic, nonpermeability pulmonary edema are fairly compliantBy contrast, lungs with evolving diffuse alveolar damage are airless and firm",
                    "sub_points": [
                      "Assuming no other underlying pulmonary disease or longstanding cardiac disease resulting in chronic passive congestion, lungs in cardiogenic and noncardiogenic, nonpermeability pulmonary edema are fairly compliant",
                      "By contrast, lungs with evolving diffuse alveolar damage are airless and firm"
                    ]
                  },
                  {
                    "text": "Presence of frothy fluid exuding into trachea and bronchi prior to fixation is another indication of pulmonary edema"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Nonpermeability pulmonary edemaFluid-filled alveolar spaces with pale granular eosinophilic precipitate, even with prior formalin perfusionMost prominent changes are often in lower lobe sections where hydrostatic pressure is most increasedAlveolar capillaries are often distended reflecting antecedent capillary congestionAdditional finding of increased hemosiderin-laden macrophages supports a diagnosis of chronic passive congestion in appropriate clinical setting",
                    "sub_points": [
                      "Fluid-filled alveolar spaces with pale granular eosinophilic precipitate, even with prior formalin perfusion",
                      "Most prominent changes are often in lower lobe sections where hydrostatic pressure is most increased",
                      "Alveolar capillaries are often distended reflecting antecedent capillary congestionAdditional finding of increased hemosiderin-laden macrophages supports a diagnosis of chronic passive congestion in appropriate clinical setting",
                      "Additional finding of increased hemosiderin-laden macrophages supports a diagnosis of chronic passive congestion in appropriate clinical setting"
                    ]
                  },
                  {
                    "text": "Permeability pulmonary edema (diffuse alveolar damage)Early phase (also referred to as acute or exudative phase)Hyaline membranes (formed by escape of fibrin-rich exudates and epithelial cell necrosis)Interstitial edemaAlveolar collapse secondary to loss of surfactantFibrin thrombi reflecting endothelial damageLate phase (also referred to as proliferative or organizing phase)Fibroblastic proliferation and type II pneumocyte hyperplasia predominateSquamous metaplasia",
                    "sub_points": [
                      "Early phase (also referred to as acute or exudative phase)Hyaline membranes (formed by escape of fibrin-rich exudates and epithelial cell necrosis)Interstitial edemaAlveolar collapse secondary to loss of surfactantFibrin thrombi reflecting endothelial damage",
                      "Hyaline membranes (formed by escape of fibrin-rich exudates and epithelial cell necrosis)",
                      "Interstitial edema",
                      "Alveolar collapse secondary to loss of surfactant",
                      "Fibrin thrombi reflecting endothelial damage",
                      "Late phase (also referred to as proliferative or organizing phase)Fibroblastic proliferation and type II pneumocyte hyperplasia predominateSquamous metaplasia",
                      "Fibroblastic proliferation and type II pneumocyte hyperplasia predominate",
                      "Squamous metaplasia"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Acute Fibrinous and Organizing Pneumonia (AFOP)": [
                  {
                    "text": "Alveolar spaces filled with organizing balls of fibrin rather than classic hyaline membranes found in diffuse alveolar damage"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "In cardiogenic pulmonary edema, etiology is often directly attributable to a specific injury such as acute myocardial infarction"
                  },
                  {
                    "text": "In hospitalized patients, particularly within an intensive care setting, etiology of pulmonary edema or diffuse alveolar damage is often multifactorialInclude major contributory causes when multifactorial",
                    "sub_points": [
                      "Include major contributory causes when multifactorial"
                    ]
                  }
                ]
              },
              "Reporting Criteria": {
                "Pulmonary Edema as Primary or Contributory Cause of Death": [
                  {
                    "text": "Example: Patient maintained on life support after major intracerebral hemorrhage eventually sustains cerebral herniation and expires, lungs with permeability pulmonary edemaPermeability edema is a contributory cause of death",
                    "sub_points": [
                      "Permeability edema is a contributory cause of death"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Pulmonary Thromboembolism": {
            "name": "Pulmonary Thromboembolism",
            "url": "https://app.pathprimer.com/document/21a0ac10-41e3-48c6-8cc0-42c069924ac2/lesson/31d58b63-a3da-42c0-a630-edacbda642a3",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Thromboemboli in pulmonary arterial circulation, virtually all arising from deep veins of lower extremity"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Signs of deep venous thrombosis include swollen red lower extremity; measure bilateral calf circumference to reveal subtle swelling"
                  },
                  {
                    "text": "Risk factors: Recent surgery, hip fracture, atrophy of lower extremities suggesting paralysis, trauma"
                  },
                  {
                    "text": "Remove heart and lung block together to avoid disruption of pulmonary thromboembolus, open pulmonary artery anteriorly"
                  },
                  {
                    "text": "Check for presence of thromboembolus either proximal within bifurcation (saddle embolus) or distal vasculature"
                  },
                  {
                    "text": "True thromboembolus has shape of vessel of origin, has venous valve markings on exterior"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Pulmonary thromboembolism (PTE)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Venous thromboembolism (VTE)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Embolus: Solid, gaseous, or liquid mass that travels in circulation from its point of origin to distant location (usually an end artery)Thromboembolus: Composed of thrombus materialPTE: Thromboemboli in pulmonary arterial circulation, virtually all arising from deep veins of lower extremity",
                    "sub_points": [
                      "Thromboembolus: Composed of thrombus material",
                      "PTE: Thromboemboli in pulmonary arterial circulation, virtually all arising from deep veins of lower extremity"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Presentation": [
                  {
                    "text": "Wells criteria: Clinical risk score for PTE (0-1 = low, 2-6 = intermediate, > 6 = high)Clinical signs/symptoms of PTE (3)PTE/VTE favored clinical diagnosis (3)Heart rate > 100 (1.5)Surgery/immobilization in last 30 days (1.5)Prior VTE (1)Hemoptysis (1)Active or treated malignancy in last 6 months (1)",
                    "sub_points": [
                      "Clinical signs/symptoms of PTE (3)",
                      "PTE/VTE favored clinical diagnosis (3)",
                      "Heart rate > 100 (1.5)",
                      "Surgery/immobilization in last 30 days (1.5)",
                      "Prior VTE (1)",
                      "Hemoptysis (1)",
                      "Active or treated malignancy in last 6 months (1)"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "D dimer elevationHigh negative predictive valueNonspecificPostmortem utility not proven",
                    "sub_points": [
                      "High negative predictive value",
                      "Nonspecific",
                      "Postmortem utility not proven"
                    ]
                  }
                ]
              },
              "Macroscopic Features": {
                "External Examination": [
                  {
                    "text": "Deep venous thrombosisSwollen red lower extremityBilateral calf and thigh circumference",
                    "sub_points": [
                      "Swollen red lower extremityBilateral calf and thigh circumference",
                      "Bilateral calf and thigh circumference"
                    ]
                  }
                ],
                "Internal Examination": [
                  {
                    "text": "Often unremarkable or findings related to trauma, recent surgery, underlying malignancy"
                  },
                  {
                    "text": "After incising iliac veins, lower extremities elevated and \"milked\"Free-flowing blood from iliacs = no obstruction",
                    "sub_points": [
                      "Free-flowing blood from iliacs = no obstruction"
                    ]
                  }
                ],
                "Organ Examination": [
                  {
                    "text": "Cardiovascular systemRemove heart and lung block together to avoid disruption of pulmonary thromboembolusOpen pulmonary artery along anterior aspect of bifurcationCheck for PTE proximally  (\"saddle\") or distallyThromboembolus has shape of vessel of origin, has venous valve markingsRight ventricular dilatation, thromboembolus in transitPatent foramen ovale (potential for paradoxical embolization)IVC filter (postmortem radiograph helpful)",
                    "sub_points": [
                      "Remove heart and lung block together to avoid disruption of pulmonary thromboembolusOpen pulmonary artery along anterior aspect of bifurcationCheck for PTE proximally  (\"saddle\") or distallyThromboembolus has shape of vessel of origin, has venous valve markings",
                      "Open pulmonary artery along anterior aspect of bifurcation",
                      "Check for PTE proximally  (\"saddle\") or distally",
                      "Thromboembolus has shape of vessel of origin, has venous valve markings",
                      "Right ventricular dilatation, thromboembolus in transit",
                      "Patent foramen ovale (potential for paradoxical embolization)",
                      "IVC filter (postmortem radiograph helpful)"
                    ]
                  },
                  {
                    "text": "Respiratory systemPulmonary vasculature opened completely to identify PTE (may be multiple)Webs within pulmonary artery indicate organized and recanalized thromboemboliPulmonary edema may indicate preexistent congestive heart failure, a contributory cause of PTE",
                    "sub_points": [
                      "Pulmonary vasculature opened completely to identify PTE (may be multiple)Webs within pulmonary artery indicate organized and recanalized thromboemboli",
                      "Webs within pulmonary artery indicate organized and recanalized thromboemboli",
                      "Pulmonary edema may indicate preexistent congestive heart failure, a contributory cause of PTE"
                    ]
                  },
                  {
                    "text": "Hepatobiliary systemLiver congestion from acute cor pulmonale",
                    "sub_points": [
                      "Liver congestion from acute cor pulmonale"
                    ]
                  },
                  {
                    "text": "Malignancy: Occult tumor"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "ThromboembolusRecentRed blood cells layered with fibrin and platelets (lines of Zahn)May be subtle, thin, peripheralOrganizingCellular infiltration (macrophages and neovessels)Starting at edges and progressing inward",
                    "sub_points": [
                      "RecentRed blood cells layered with fibrin and platelets (lines of Zahn)May be subtle, thin, peripheral",
                      "Red blood cells layered with fibrin and platelets (lines of Zahn)",
                      "May be subtle, thin, peripheral",
                      "OrganizingCellular infiltration (macrophages and neovessels)Starting at edges and progressing inward",
                      "Cellular infiltration (macrophages and neovessels)",
                      "Starting at edges and progressing inward"
                    ]
                  },
                  {
                    "text": "LungCongestion ± edemaInfarction: Coagulative necrosis with hemorrhage (red infarct)",
                    "sub_points": [
                      "Congestion ± edema",
                      "Infarction: Coagulative necrosis with hemorrhage (red infarct)"
                    ]
                  },
                  {
                    "text": "HepatobiliaryCentrilobular congestion ± necrosis",
                    "sub_points": [
                      "Centrilobular congestion ± necrosis"
                    ]
                  },
                  {
                    "text": "MalignancyTumor emboli",
                    "sub_points": [
                      "Tumor emboli"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Postmortem Blood Clot": [
                  {
                    "text": "\"Chicken fat\" (yellow gelatinous)"
                  },
                  {
                    "text": "\"Currant jelly\" (dark red)"
                  },
                  {
                    "text": "Random arrangement of coagulated serum and red blood cells"
                  },
                  {
                    "text": "Not adherent to wall"
                  }
                ]
              },
              "Reporting Criteria": {
                "Presence and Location of Thromboembolus": [
                  {
                    "text": "Cause of death or contributor?"
                  },
                  {
                    "text": "Underlying risk factors identified from chart review or postmortem"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Atheromatous Emboli": {
            "name": "Atheromatous Emboli",
            "url": "https://app.pathprimer.com/document/d330cb32-85b5-404c-bb09-5fbcc322be28/lesson/31d58b63-a3da-42c0-a630-edacbda642a3",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Vascular disease caused by embolization of dislodged components, atheromatous plaques"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Severe atherosclerosis"
                  },
                  {
                    "text": "Precipitating causesInvasive vascular procedureCardiopulmonary resuscitationAnticoagulant or thrombolytic therapyTrauma~ 24% spontaneous",
                    "sub_points": [
                      "Invasive vascular procedure",
                      "Cardiopulmonary resuscitation",
                      "Anticoagulant or thrombolytic therapy",
                      "Trauma",
                      "~ 24% spontaneous"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Clinical presentationAcute renal failureHypertensionProteinuria, hematuriaEosinophilia",
                    "sub_points": [
                      "Acute renal failure",
                      "Hypertension",
                      "Proteinuria, hematuria",
                      "Eosinophilia"
                    ]
                  },
                  {
                    "text": "TreatmentHMG-CoA reductase inhibitorsAvoidance of anticoagulation",
                    "sub_points": [
                      "HMG-CoA reductase inhibitors",
                      "Avoidance of anticoagulation"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Nobbled surface due to vascular scars"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "AtheroembolusCholesterol clefts: Crystals dissolved by formalin fixationAcute lesion surrounded by red blood cells, fibrin, or leukocytesChronic lesion embedded within intimal fibrosisMultinucleated giant cell reaction may be present",
                    "sub_points": [
                      "Cholesterol clefts: Crystals dissolved by formalin fixation",
                      "Acute lesion surrounded by red blood cells, fibrin, or leukocytes",
                      "Chronic lesion embedded within intimal fibrosis",
                      "Multinucleated giant cell reaction may be present"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Thrombotic microangiopathy"
                  },
                  {
                    "text": "Arteriosclerosis"
                  },
                  {
                    "text": "Vasculitis"
                  },
                  {
                    "text": "Tissue artifact"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Atheroembolic renal disease"
                  },
                  {
                    "text": "Atheroemboli"
                  },
                  {
                    "text": "Cholesterol crystal emboli"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Vascular disease caused by embolization of dislodged components, atheromatous plaques"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Risk Factors": [
                  {
                    "text": "Severe atherosclerosisHypertension, diabetes mellitus, smoking, hypercholesterolemia",
                    "sub_points": [
                      "Hypertension, diabetes mellitus, smoking, hypercholesterolemia"
                    ]
                  }
                ],
                "Precipitating Event: Plaque Disruption": [
                  {
                    "text": "Iatrogenic (~ 76% of cases)Invasive vascular procedureCoronary artery bypassAortic aneurysm repairAngioplasty or angiographyCardiopulmonary resuscitationAnticoagulant or thrombolytic therapy",
                    "sub_points": [
                      "Invasive vascular procedureCoronary artery bypassAortic aneurysm repairAngioplasty or angiography",
                      "Coronary artery bypass",
                      "Aortic aneurysm repair",
                      "Angioplasty or angiography",
                      "Cardiopulmonary resuscitation",
                      "Anticoagulant or thrombolytic therapy"
                    ]
                  },
                  {
                    "text": "Spontaneous (~ 24% of cases)"
                  },
                  {
                    "text": "Trauma"
                  }
                ],
                "Embolization": [
                  {
                    "text": "Elicits inflammatory response, thrombosis, ischemia"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "5-10% of acute renal failure cases"
                  },
                  {
                    "text": "77% of abdominal aortic aneurysm repairs"
                  },
                  {
                    "text": "1.8-2.4% of coronary artery catheterization"
                  },
                  {
                    "text": "0.5-2% of tumor nephrectomies"
                  },
                  {
                    "text": "0.8-4.4% of autopsies"
                  }
                ],
                "Age": [
                  {
                    "text": "> 60 years old"
                  }
                ],
                "Sex": [
                  {
                    "text": "Male predominance"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Caucasian predilection"
                  }
                ],
                "Site": [
                  {
                    "text": "Kidneys"
                  },
                  {
                    "text": "Extremities, gastrointestinal (GI) tract, central nervous system (CNS)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Acute renal failure (20-30%)"
                  },
                  {
                    "text": "Subacute or chronic renal failure (70-80%)"
                  },
                  {
                    "text": "Skin lesions (35-90%)Livedo reticularis, blue toe, gangrene, palpable purpura",
                    "sub_points": [
                      "Livedo reticularis, blue toe, gangrene, palpable purpura"
                    ]
                  },
                  {
                    "text": "Eosinophilia (22-73%), transient"
                  },
                  {
                    "text": "GI signs (10-33%)"
                  },
                  {
                    "text": "Retinal emboli (7-25%); Hollenhorst plaques"
                  },
                  {
                    "text": "Proteinuria usually minimalMay be nephrotic range in association with diabetes or focal segmental glomerulosclerosis",
                    "sub_points": [
                      "May be nephrotic range in association with diabetes or focal segmental glomerulosclerosis"
                    ]
                  },
                  {
                    "text": "Fever, myalgia, weight loss"
                  },
                  {
                    "text": "Hypertension"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "None"
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "HMG-CoA reductase inhibitors to stabilize plaques"
                  },
                  {
                    "text": "Steroids controversial"
                  },
                  {
                    "text": "Avoidance of anticoagulation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "33-61% require dialysis; 21-39% recover function"
                  },
                  {
                    "text": "13-81% 1-year mortality"
                  },
                  {
                    "text": "Hypertension or preexisting renal disease predict poor outcome"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Nobbled surface due to vascular scars, infarcts"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "GlomeruliIschemic global or segmental glomerulosclerosisRare cholesterol emboli",
                    "sub_points": [
                      "Ischemic global or segmental glomerulosclerosis",
                      "Rare cholesterol emboli"
                    ]
                  },
                  {
                    "text": "Tubules and interstitiumAcute tubular injuryInterstitial fibrosis and tubular atrophy",
                    "sub_points": [
                      "Acute tubular injury",
                      "Interstitial fibrosis and tubular atrophy"
                    ]
                  },
                  {
                    "text": "Arteries/arteriolesAtheroemboliSlit-like cholesterol cleftsCrystals dissolved by formalin fixationAcute lesion surrounded by red blood cells, fibrin, neutrophils, eosinophilsChronic lesion embedded within cellular intimal fibrosisMultinucleated giant cell reaction often presentRecanalization of vessels may occurIntimal fibrosis/elastosis",
                    "sub_points": [
                      "AtheroemboliSlit-like cholesterol cleftsCrystals dissolved by formalin fixationAcute lesion surrounded by red blood cells, fibrin, neutrophils, eosinophilsChronic lesion embedded within cellular intimal fibrosisMultinucleated giant cell reaction often presentRecanalization of vessels may occur",
                      "Slit-like cholesterol cleftsCrystals dissolved by formalin fixation",
                      "Crystals dissolved by formalin fixation",
                      "Acute lesion surrounded by red blood cells, fibrin, neutrophils, eosinophils",
                      "Chronic lesion embedded within cellular intimal fibrosis",
                      "Multinucleated giant cell reaction often present",
                      "Recanalization of vessels may occur",
                      "Intimal fibrosis/elastosis"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunofluorescence": [
                  {
                    "text": "Fibrin in arteries affected"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Podocyte foot process effacement may be present"
                  },
                  {
                    "text": "Rare cholesterol crystals in glomerular capillaries"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Artifact": [
                  {
                    "text": "Arterioles and small arteries may have slit-like lumen that mimic cholesterol clefts"
                  },
                  {
                    "text": "Artifact due to compression, forceps, or tissue processing"
                  }
                ],
                "Renal Artery Stenosis": [
                  {
                    "text": "Hypertension"
                  },
                  {
                    "text": "Ischemic glomerulopathy, diffuse interstitial fibrosis, and tubular atrophy"
                  }
                ],
                "Arteriosclerosis": [
                  {
                    "text": "Severe intimal fibrosis"
                  },
                  {
                    "text": "No cholesterol clefts in severely narrowed lumen"
                  }
                ],
                "Thrombotic Microangiopathy": [
                  {
                    "text": "Thrombi without cholesterol clefts"
                  }
                ],
                "Vasculitis": [
                  {
                    "text": "Clinical presentation can suggest vasculitis"
                  },
                  {
                    "text": "Inflammation extends through wall"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Shock and Sepsis": {
            "name": "Shock and Sepsis",
            "url": "https://app.pathprimer.com/document/4788da55-163d-4ebe-a19b-52cd688235b2/lesson/31d58b63-a3da-42c0-a630-edacbda642a3",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Shock: Inability to meet cellular metabolic requirements due to inadequate circulating blood or plasma volume"
                  },
                  {
                    "text": "MODS: Physiologic dysfunction of ≥ 2 organ or physiologic systems not directly related to primary cause of shock"
                  },
                  {
                    "text": "SIRS: Systemic activation of innate immune response, regardless of cause"
                  },
                  {
                    "text": "Sepsis: Probable or documented infection plus SIRS manifestations"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Shock: Hypovolemic, cardiogenic, systemic inflammation"
                  },
                  {
                    "text": "SIRS: Sepsis, massive tissue injury, metabolic derangements, malignancy, neurologic trauma"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Evidence of specific cause of shock"
                  },
                  {
                    "text": "Macroscopic stigmata of shock: e.g., diffuse petechia, pallor, edema, serosal effusions, \"nutmeg\" liver"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Shock: Diffuse vascular congestion, hemorrhage, fibrin thrombi of microvasculature involving any organ system"
                  },
                  {
                    "text": "Sepsis: Evidence of primary infection, septic emboli to any organ, widespread bacterial overgrowth"
                  },
                  {
                    "text": "Microscopic stigmata of shock: e.g., subendocardial demand ischemia, diffuse alveolar damage, hepatic centrilobular hemorrhagic necrosis, acute tubular necrosis"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Systemic inflammatory response syndrome (SIRS)"
                  },
                  {
                    "text": "Multiple organ dysfunction syndrome (MODS)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "MODS: Multi-organ failure, multiple systems organ failure"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Shock: Inability to meet cellular metabolic requirements due to global hypoperfusion from inadequate circulating blood or plasma volume"
                  },
                  {
                    "text": "MODS: Physiologic dysfunction of ≥ 2 organ or physiologic systems not directly related to primary cause of shocke.g., acute tubular injury and coagulopathy following cardiogenic shock due to acute myocardial infarction",
                    "sub_points": [
                      "e.g., acute tubular injury and coagulopathy following cardiogenic shock due to acute myocardial infarction"
                    ]
                  },
                  {
                    "text": "SIRS: Systemic activation of innate immune response, regardless of cause, clinically manifested as 2 or more of the followingTemperature > 38°C or < 36°C; heart rate (HR) > 90 beats/min; hyperventilation (respiratory rate > 20 breaths/min or PaCO₂ < 32mmHg); white blood cell (WBC) count > 12,000/μL or < 4,000/μL or 10% bands",
                    "sub_points": [
                      "Temperature > 38°C or < 36°C; heart rate (HR) > 90 beats/min; hyperventilation (respiratory rate > 20 breaths/min or PaCO₂ < 32mmHg); white blood cell (WBC) count > 12,000/μL or < 4,000/μL or 10% bands"
                    ]
                  },
                  {
                    "text": "Sepsis: Probable or documented infection plus SIRS manifestations"
                  },
                  {
                    "text": "Severe sepsis: Sepsis plus infection-induced organ dysfunction, tissue hypoperfusion, or hypotensionOrgan dysfunction: Altered mental status, generalized edema, acute lung injury, acute renal injury, oliguria, edema, coagulopathy, hyperbilirubinemia, hyperglycemia, ileus, thrombocytopeniaTissue hypoperfusion: Lactate > 1mmol/L, ↓ capillary refill, or mottlingHypotension: Systolic blood pressure (BP) < 90mmHg or mean arterial pressure < 70mmHg",
                    "sub_points": [
                      "Organ dysfunction: Altered mental status, generalized edema, acute lung injury, acute renal injury, oliguria, edema, coagulopathy, hyperbilirubinemia, hyperglycemia, ileus, thrombocytopenia",
                      "Tissue hypoperfusion: Lactate > 1mmol/L, ↓ capillary refill, or mottling",
                      "Hypotension: Systolic blood pressure (BP) < 90mmHg or mean arterial pressure < 70mmHg"
                    ]
                  },
                  {
                    "text": "Septic shock: Sepsis plus hypotension persisting despite administration of adequate fluid resuscitation"
                  },
                  {
                    "text": "Stigmata of shock: Nonspecific pathologic findings reflecting pattern of organ injury due to tissue hypoperfusion"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Causes of Shock": [
                  {
                    "text": "Hypovolemic: Massive loss of blood or plasma volumee.g., hemorrhage, burns, massive vomiting or diarrhea, anaphylaxis",
                    "sub_points": [
                      "e.g., hemorrhage, burns, massive vomiting or diarrhea, anaphylaxis"
                    ]
                  },
                  {
                    "text": "Cardiogenic: Inability of heart to pump blood due to intrinsic failure (e.g., infarction, arrhythmia, cardiomyopathy) or external factors (e.g., cardiac tamponade, pulmonary embolism, tension pneumothorax)"
                  }
                ],
                "Pathogenesis of Shock": [
                  {
                    "text": "Initial phase: ↓ tissue perfusion → sympathetic nervous system activation → ↑ HR, ↑ myocardial contractility, ↑ arterial & venous tone; activation of renin-angiotensin system → BP maintained with blood preferentially shunted to heart & brain"
                  },
                  {
                    "text": "Progressive phase: ↓ BP & tissue perfusion → global tissue hypoxia, ↑ lactic acid, ↓ pH → arteriolar dilation, venous constriction, ↑ capillary permeability → loss of intravascular volume → organ dysfunction"
                  },
                  {
                    "text": "Irreversible phase: Refractory hypotension, multiple system organ failure, and death"
                  }
                ],
                "Causes of SIRS": [
                  {
                    "text": "Overwhelming microbial infection or release of microbial toxinsDeaths due to sepsis: Gram negative bacteria > Gram positive bacteria > fungal >> opportunistic bacteria & fungi, viruses",
                    "sub_points": [
                      "Deaths due to sepsis: Gram negative bacteria > Gram positive bacteria > fungal >> opportunistic bacteria & fungi, viruses"
                    ]
                  },
                  {
                    "text": "Tissue injury: Massive trauma, severe burns, surgery, ischemia/reperfusion injury, transplant rejection, pancreatitis, erythroderma"
                  },
                  {
                    "text": "Metabolic: Thyroid storm, acute adrenal insufficiency"
                  },
                  {
                    "text": "Therapy related: Blood products, granulocyte-macrophage colony-stimulating factor, anesthesia-related malignant hyperpyrexia, neuroleptic malignant syndrome, opiates, benzodiazepines"
                  },
                  {
                    "text": "Malignancy: Lymphoma, tumor lysis syndrome"
                  },
                  {
                    "text": "Neurologic: Subarachnoid hemorrhage"
                  }
                ],
                "Predisposing Factors to SIRS": [
                  {
                    "text": "Inherited or acquired defects in innate or adaptive immune system"
                  },
                  {
                    "text": "Age (↑ risk neonates & elderly)"
                  }
                ],
                "Pathogenesis of SIRS": [
                  {
                    "text": "Systemic activation of innate immune responseActivation of neutrophils, monocytes/macrophages, & endotheliumEarly phase: Excessive pro-inflammatory cytokines release → vasodilation, edemaLate phase: Diminished innate immune function → diminished adaptive immune functionPro-oxidant state: ↑ reactive oxygen & nitrogen species, ↓ free radical scavengers → vasodilation, edemaPro-coagulation state: Complement, coagulation cascade, & endothelial activation  → disseminated intravascular coagulation (DIC)→ metabolic derangements, organ dysfunction, and shock",
                    "sub_points": [
                      "Activation of neutrophils, monocytes/macrophages, & endotheliumEarly phase: Excessive pro-inflammatory cytokines release → vasodilation, edemaLate phase: Diminished innate immune function → diminished adaptive immune function",
                      "Early phase: Excessive pro-inflammatory cytokines release → vasodilation, edema",
                      "Late phase: Diminished innate immune function → diminished adaptive immune function",
                      "Pro-oxidant state: ↑ reactive oxygen & nitrogen species, ↓ free radical scavengers → vasodilation, edema",
                      "Pro-coagulation state: Complement, coagulation cascade, & endothelial activation  → disseminated intravascular coagulation (DIC)",
                      "→ metabolic derangements, organ dysfunction, and shock"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "SIRS: Most critically ill patients meet criteria"
                  },
                  {
                    "text": "Sepsis: Most common cause of death in noncoronary intensive care unit (ICU)600,000 cases annually in USAIncidence and number of deaths increasing in USA and worldwide",
                    "sub_points": [
                      "600,000 cases annually in USA",
                      "Incidence and number of deaths increasing in USA and worldwide"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Shock: Varies with etiology; most common clinical manifestations are hypotension, tachycardia, cyanosis, and evidence of organ dysfunction"
                  },
                  {
                    "text": "Sepsis: Most common primary sites of infection (in ↓ frequency) are lung, bloodstream, abdomen, skin and soft tissue, urinary tract, and central nervous system"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Shock: Identify and treat underlying cause"
                  },
                  {
                    "text": "Sepsis: Supportive therapy only"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Mortality rate of shock: Varies according to severity and etiology"
                  },
                  {
                    "text": "Mortality rate of sepsis:Average: 20-30%; range: 5-50%Varies according to predisposing factors, degree of organ dysfunction, type and site of infectious agent",
                    "sub_points": [
                      "Average: 20-30%; range: 5-50%",
                      "Varies according to predisposing factors, degree of organ dysfunction, type and site of infectious agent"
                    ]
                  }
                ],
                "Clinical Organ Dysfunction Scoring Systems": [
                  {
                    "text": "Commonly used scoring systems for assessing severity of illness and predicting mortality in ICU patientsGeneral prognostication scores: Acute physiology and chronic health evaluation (APACHE), simplified acute physiology score (SAPS), mortality probability models (MPM)Organ dysfunction scores: Sequential organ failure assessment (SOFA), multiple organ dysfunction score (MODS), logistic organ dysfunction system (LODS)",
                    "sub_points": [
                      "General prognostication scores: Acute physiology and chronic health evaluation (APACHE), simplified acute physiology score (SAPS), mortality probability models (MPM)",
                      "Organ dysfunction scores: Sequential organ failure assessment (SOFA), multiple organ dysfunction score (MODS), logistic organ dysfunction system (LODS)"
                    ]
                  }
                ]
              },
              "Image Findings": {
                "Radiographic Findings": [
                  {
                    "text": "Lungs: Diffuse bilateral infiltrates (\"white out\")"
                  }
                ],
                "Ultrasonographic Findings": [
                  {
                    "text": "Heart: Systolic and diastolic ventricular dysfunctionLow ejection fraction is predictor of mortality in septic shock",
                    "sub_points": [
                      "Low ejection fraction is predictor of mortality in septic shock"
                    ]
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Brain: Hypodensities in bilateral watershed areas progressing to whole brain edema"
                  },
                  {
                    "text": "Other: Evidence of specific underlying cause of shock &/or sepsis"
                  }
                ]
              },
              "Macroscopic Features": {
                "External Examination": [
                  {
                    "text": "Extensive petechia &/or ecchymoses"
                  },
                  {
                    "text": "Pallor of conjunctiva &/or nailbeds"
                  },
                  {
                    "text": "Cyanosis of distal extremities"
                  },
                  {
                    "text": "Severe peripheral edema"
                  },
                  {
                    "text": "Jaundice"
                  }
                ],
                "Internal Examination": [
                  {
                    "text": "Evidence of specific cause of shock such as massive acute myocardial infarction, gastrointestinal hemorrhage, perforated viscus with fecopurulent exudate"
                  },
                  {
                    "text": "Macroscopic stigmata of shockSoft tissue edema &/or hemorrhageSerous effusionsBrain: Diffuse cerebral swelling ± uncal or cerebellar herniationLungs: Firm, heavy, wet ± hemorrhage, frothy fluid within airwaysHeart: Epicardial &/or endocardial petechia, acute subendocardial ischemiaLiver: Mottled cut surface (\"nutmeg\" appearance)Pancreas: Fat saponificationGastrointestinal tract: Serosal and mucosal petechia, mucosal erosionsKidneys: Cortical pallor with medullary congestion",
                    "sub_points": [
                      "Soft tissue edema &/or hemorrhage",
                      "Serous effusions",
                      "Brain: Diffuse cerebral swelling ± uncal or cerebellar herniation",
                      "Lungs: Firm, heavy, wet ± hemorrhage, frothy fluid within airways",
                      "Heart: Epicardial &/or endocardial petechia, acute subendocardial ischemia",
                      "Liver: Mottled cut surface (\"nutmeg\" appearance)",
                      "Pancreas: Fat saponification",
                      "Gastrointestinal tract: Serosal and mucosal petechia, mucosal erosions",
                      "Kidneys: Cortical pallor with medullary congestion"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Shock: Diffuse vascular congestion, hemorrhage, fibrin thrombi of microvasculature involving any organ system"
                  },
                  {
                    "text": "Sepsis: Evidence of primary infection (e.g., acute bronchopneumonia, meningitis), septic emboli to any organ (highly specific), widespread bacterial overgrowth disproportional to postmortem interval"
                  }
                ],
                "Organ Examination": [
                  {
                    "text": "Microscopic stigmata of shockBrain: Hypoxic nerve cell change, cerebritis (sepsis)Heart: Subendocardial ischemia (demand ischemia)Lungs: Alveolar edema, capillary congestion, diffuse alveolar damageLiver: Centrolobular hemorrhagic necrosis, canalicular or ductal cholestasis, steatosisGastrointestinal tract: Submucosal hemorrhages, erosions, or ulcerationsKidneys: Acute tubular necrosis, pigmented casts (hemoglobin, myoglobin, or bile)Spleen: Acute splenitis, congestionBone marrow: Reactive hypercellularityAdrenal glands:  Cortical cell lipid depletion, microscopic foci of hemorrhage within cortex",
                    "sub_points": [
                      "Brain: Hypoxic nerve cell change, cerebritis (sepsis)",
                      "Heart: Subendocardial ischemia (demand ischemia)",
                      "Lungs: Alveolar edema, capillary congestion, diffuse alveolar damage",
                      "Liver: Centrolobular hemorrhagic necrosis, canalicular or ductal cholestasis, steatosis",
                      "Gastrointestinal tract: Submucosal hemorrhages, erosions, or ulcerations",
                      "Kidneys: Acute tubular necrosis, pigmented casts (hemoglobin, myoglobin, or bile)",
                      "Spleen: Acute splenitis, congestion",
                      "Bone marrow: Reactive hypercellularity",
                      "Adrenal glands:  Cortical cell lipid depletion, microscopic foci of hemorrhage within cortex"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Histochemistry": [
                  {
                    "text": "GMS (Gomori methenamine silver)"
                  },
                  {
                    "text": "Gram"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Supporting evidence of organ dysfunction (if antemortem samples not available)e.g., troponin level, CBC, chemistry panel",
                    "sub_points": [
                      "e.g., troponin level, CBC, chemistry panel"
                    ]
                  },
                  {
                    "text": "Postmortem blood cultures: High false positive rate due to agonal bacteremia, postmortem bacterial transmigrationPositive postmortem blood cultures should correlate with gross and histologic evidence of infection",
                    "sub_points": [
                      "Positive postmortem blood cultures should correlate with gross and histologic evidence of infection"
                    ]
                  }
                ],
                "Specialty Consultation": [
                  {
                    "text": "Centers for Disease Control and Prevention Infectious Diseases Pathology BranchProvides important information and guidelines related to  transport of pathology materials and clinical samples for ancillary testing",
                    "sub_points": [
                      "Provides important information and guidelines related to  transport of pathology materials and clinical samples for ancillary testing"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Septicemia/Shock": {
            "name": "Septicemia/Shock",
            "url": "https://app.pathprimer.com/document/915a0b42-5d76-4202-91ed-a71371438510/lesson/31d58b63-a3da-42c0-a630-edacbda642a3",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Sepsis defined as systemic inflammatory response associated with infection, commonly associated with acute kidney injury (AKI)"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Septic kidney injury is multifactorial"
                  },
                  {
                    "text": "Hemodynamic instability, inflammatory mediators, DIC, tubular obstruction, drug toxicity"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "20 million cases of sepsis per year worldwide"
                  },
                  {
                    "text": "Renal insufficiency occurs in 30-60% of septic patients"
                  },
                  {
                    "text": "When kidney injury occurs in sepsis, mortality is high"
                  },
                  {
                    "text": "Sepsis is leading cause of death in noncoronary intensive care units"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Tubules show dilatation, epithelial simplification, cytoplasmic blebbing"
                  },
                  {
                    "text": "Proximal tubular coarse vacuolization is common and associated with mitochondrial damage"
                  },
                  {
                    "text": "Isometric tubular vacuolization may be seen and correlates with swollen lysosomes"
                  },
                  {
                    "text": "Coagulative-type tubular necrosis rare and typically focal, when occurs"
                  },
                  {
                    "text": "Interstitial chronic inflammation common, but typically mild"
                  },
                  {
                    "text": "Circulating nucleated red blood cells may be seen in medulla, associated with poor prognosis"
                  },
                  {
                    "text": "Glomeruli may show intracapillary fibrin thrombi (DIC)"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "KIM-1 IHC assists in assessing tubular injury and distinguishing injury from autolysis"
                  },
                  {
                    "text": "Ki-67 labeling index increased in corticomedullary junction tubular cells"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Acute tubular injury from other causes"
                  },
                  {
                    "text": "Autolysis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Sepsis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Sepsis defined as systemic inflammatory response associated with infection, commonly associated with acute kidney injury (AKI)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Pathophysiology": [
                  {
                    "text": "Initial proinflammatory response results in hypotension and organ dysfunction"
                  },
                  {
                    "text": "Followed by anti-inflammatory response resulting in immune depression"
                  },
                  {
                    "text": "Multifactorial kidney injuryHemodynamic instabilityDiffuse intravascular coagulation (DIC)Inflammatory mediatorsTubular obstructionIatrogenic causes (drugs, intravenous contrast, etc.)",
                    "sub_points": [
                      "Hemodynamic instability",
                      "Diffuse intravascular coagulation (DIC)",
                      "Inflammatory mediators",
                      "Tubular obstruction",
                      "Iatrogenic causes (drugs, intravenous contrast, etc.)"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "20 million cases of sepsis per year worldwide1 million cases per year in USA",
                    "sub_points": [
                      "1 million cases per year in USA"
                    ]
                  },
                  {
                    "text": "Sepsis is leading cause of death in noncoronary intensive care units> 210,000 deaths/year in USA",
                    "sub_points": [
                      "> 210,000 deaths/year in USA"
                    ]
                  },
                  {
                    "text": "Renal insufficiency occurs in 30-60% of septic patients"
                  },
                  {
                    "text": "Septic kidney injury patients with ~ 70% mortality"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Systemic inflammatory response in setting of confirmed infectionHypothermiaTachycardiaTachypneaHypocapniaLeukopenia or leukocytosis",
                    "sub_points": [
                      "Hypothermia",
                      "Tachycardia",
                      "Tachypnea",
                      "Hypocapnia",
                      "Leukopenia or leukocytosis"
                    ]
                  },
                  {
                    "text": "Severe sepsis occurs with systemic inflammatory response syndrome (SIRS) plus organ dysfunction"
                  },
                  {
                    "text": "Septic shock occurs in setting of sepsis withPersistent arterial hypotensionHypoperfusion despite fluid administration",
                    "sub_points": [
                      "Persistent arterial hypotension",
                      "Hypoperfusion despite fluid administration"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "GlomeruliCapillary loop thrombi, rare and focalMay occur in cases with DIC",
                    "sub_points": [
                      "Capillary loop thrombi, rare and focalMay occur in cases with DIC",
                      "May occur in cases with DIC"
                    ]
                  },
                  {
                    "text": "TubulesMild degree of tubular injuryDisproportionate to degree of renal dysfunctionDilatation/epithelial simplificationCell sloughing/detachmentCytoplasmic blebbingCoarse vacuolizationProximal tubule cytoplasmic fine isometric vacuolization in cases complicated by osmotic nephrosisCalcium phosphate and calcium oxalate crystals, focal",
                    "sub_points": [
                      "Mild degree of tubular injuryDisproportionate to degree of renal dysfunction",
                      "Disproportionate to degree of renal dysfunction",
                      "Dilatation/epithelial simplification",
                      "Cell sloughing/detachment",
                      "Cytoplasmic blebbing",
                      "Coarse vacuolization",
                      "Proximal tubule cytoplasmic fine isometric vacuolization in cases complicated by osmotic nephrosis",
                      "Calcium phosphate and calcium oxalate crystals, focal"
                    ]
                  },
                  {
                    "text": "InterstitiumPatchy, mild, chronic interstitial inflammation in majority of cases",
                    "sub_points": [
                      "Patchy, mild, chronic interstitial inflammation in majority of cases"
                    ]
                  },
                  {
                    "text": "VesselsCirculating nucleated red blood cells may be in medullary capillaries",
                    "sub_points": [
                      "Circulating nucleated red blood cells may be in medullary capillaries"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Increased kidney injury molecule-1 (KIM-1) expression in proximal tubule cells"
                  },
                  {
                    "text": "Increased Ki-67 labeling of corticomedullary junction tubular cells"
                  }
                ],
                "Immunofluorescence": [
                  {
                    "text": "Negative"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Proximal tubulesEnlarged, hydropic mitochondriaIncreased numbers of lysosomes and autophagosomes",
                    "sub_points": [
                      "Enlarged, hydropic mitochondria",
                      "Increased numbers of lysosomes and autophagosomes"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Autolysis": [
                  {
                    "text": "Tubular epithelial cells appear detached from underlying basement membrane"
                  },
                  {
                    "text": "KIM-1 immunohistochemistry is negative"
                  }
                ],
                "Acute Tubular Injury Due to Other Etiologies": [
                  {
                    "text": "Similar histopathologic findings"
                  },
                  {
                    "text": "Requires clinical correlation"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Glomerular fibrin thrombi may rarely occur in setting of DIC"
                  },
                  {
                    "text": "Coarse tubular vacuolization correlates with mitochondrial damage"
                  },
                  {
                    "text": "Tubular injury typically mild and focal, despite severe renal functional impairment"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Genetic Disorders": {
        "name": "Genetic Disorders",
        "url": "https://app.pathprimer.com/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
        "topics": {
          "Dementia and Neurodegenerative Disease": {
            "name": "Dementia and Neurodegenerative Disease",
            "url": "https://app.pathprimer.com/document/9557d473-d11c-4655-b67c-f28ae3093486/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Key Facts": {
                "Clinical Issues": [
                  {
                    "text": "Common causes of deathAspiration pneumonia, other infections, choking, or respiratory failureOther infectionsPulmonary thromboembolismFalls due to extrapyramidal symptoms, weakness, orthostatic hypotension, and deconditioning from immobilityDecreased nutritional intake, generalized deconditioning contribute to comorbidity",
                    "sub_points": [
                      "Aspiration pneumonia, other infections, choking, or respiratory failure",
                      "Other infections",
                      "Pulmonary thromboembolism",
                      "Falls due to extrapyramidal symptoms, weakness, orthostatic hypotension, and deconditioning from immobility",
                      "Decreased nutritional intake, generalized deconditioning contribute to comorbidity"
                    ]
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Routine samplingFrontal, temporal, anterior cingulate, parietal (ink the precentral gyrus before sectioning), occipital cortexHippocampus, amygdalaCaudate, putamen, globus pallidus, subthalamic nucleusMidbrain (with substantia nigra), pons (with locus ceruleus), medullaCerebellar vermis, dentateTarget to suspected disorder based on clinical signs and symptoms",
                    "sub_points": [
                      "Frontal, temporal, anterior cingulate, parietal (ink the precentral gyrus before sectioning), occipital cortex",
                      "Hippocampus, amygdala",
                      "Caudate, putamen, globus pallidus, subthalamic nucleus",
                      "Midbrain (with substantia nigra), pons (with locus ceruleus), medulla",
                      "Cerebellar vermis, dentate",
                      "Target to suspected disorder based on clinical signs and symptoms"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Alzheimer: Plaque frequency does not correlate well with clinical dementia, but tangle frequency and distribution does"
                  },
                  {
                    "text": "Parkinson: Most of the loss of pigmented neurons in pars compacta of substantia nigra occurs laterally and ventrally, whereas in normal aging, what loss there is occurs medially and dorsally"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Alzheimer Disease (AD)": [
                  {
                    "text": "Most common neurodegenerative disease, incidence ↑ with age"
                  }
                ],
                "Tauopathies": [
                  {
                    "text": "AD, Pick disease, corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), argyrophilic grain disease"
                  }
                ],
                "Multi-Infarct Dementia": [
                  {
                    "text": "Shared risk factors for atherosclerosis"
                  }
                ],
                "Frontotemporal Dementias (FTD)": [
                  {
                    "text": "Pick disease, FTD with inclusions (positive for tdp-43, neurofilament, fused in sarcoma protein [FUS], p62, ubiquitin)"
                  }
                ],
                "Amyotrophic Lateral Sclerosis (ALS) With Dementia": [
                  {
                    "text": "Spectrum from ALS only to ALS with frontotemporal dementia to pure frontotemporal dementia with ubiquitin positive inclusions"
                  }
                ],
                "Synucleinopathies": [
                  {
                    "text": "Parkinson disease (PD), Lewy body dementia (LBD), multisystem atrophy (MSA)"
                  }
                ],
                "Other Heritable Conditions": [
                  {
                    "text": "Huntington disease (HD), spinocerebellar ataxias, Friedrich ataxia, inherited amyloidoses"
                  }
                ],
                "Other Acquired Conditions": [
                  {
                    "text": "Acquired-B12 deficiency, chronic traumatic encephalopathy, Wernicke-Korsakoff"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "AD is most common neurodegenerative diseaseNot a normal part of aging but incidence ↑ with advancing age: Incidence 1/100 in 65-59 year oldsPrevalence doubles with 5-year increments after age 70Younger onset with inherited AD (mutations in amyloid precursor protein [APP], pre-senilin 1, pre-senilin 2; all autosomal dominant)Down syndrome (APP gene on chromosome 21)",
                    "sub_points": [
                      "Not a normal part of aging but incidence ↑ with advancing age: Incidence 1/100 in 65-59 year olds",
                      "Prevalence doubles with 5-year increments after age 70",
                      "Younger onset with inherited AD (mutations in amyloid precursor protein [APP], pre-senilin 1, pre-senilin 2; all autosomal dominant)",
                      "Down syndrome (APP gene on chromosome 21)"
                    ]
                  },
                  {
                    "text": "Multi-infarct dementia occurs with other risk factors for and manifestations of cardiovascular disease"
                  },
                  {
                    "text": "Note that patients with autosomal dominant inherited diseases with trinucleotide repeats (e.g., HD) may show earlier onset in successive generation"
                  },
                  {
                    "text": "PD also increases with increasing age but has early-onset heritable forms in 10% of casesHeritable forms may be autosomal dominant or recessive",
                    "sub_points": [
                      "Heritable forms may be autosomal dominant or recessive"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "AD: Insidious onset, disturbances in recent memory function, visuospatial disorders, behavioral change"
                  },
                  {
                    "text": "Multi-infarct dementia: Stepwise deterioration"
                  },
                  {
                    "text": "FTD: Progressive aphasia, behavioral change, semantic dementia (language difficulties)"
                  },
                  {
                    "text": "Movement disordersPD: Tremor, rigidity, responsive to L-dopaLBD: Tremor, rigidity, not responsive to L-dopa, with visual hallucinationHD: ChoreaCorticobasilar degeneration: \"Alien limb\"",
                    "sub_points": [
                      "PD: Tremor, rigidity, responsive to L-dopa",
                      "LBD: Tremor, rigidity, not responsive to L-dopa, with visual hallucination",
                      "HD: Chorea",
                      "Corticobasilar degeneration: \"Alien limb\""
                    ]
                  },
                  {
                    "text": "Prion diseases: Rapidly progressive dementia (< 1 year), ataxia, myoclonus, sleep disturbances"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Genetic testing:SNCA(synucleinopathies),PSEN1(AD), huntingtin (HD)"
                  },
                  {
                    "text": "Autonomic testing: Impaired in PD, MSA"
                  },
                  {
                    "text": "Cerebrospinal fluid testing for prion disease (14-3-3 protein and tau)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Aspiration pneumonia, infections, respiratory failure are common causes of death"
                  },
                  {
                    "text": "Decreased nutritional intake, general deconditioning contribute to comorbidity"
                  },
                  {
                    "text": "Falls due to extrapyramidal symptoms, weakness, orthostatic hypotension, and deconditioning from immobility"
                  }
                ]
              },
              "Image Findings": {
                "CT Findings": [
                  {
                    "text": "ADEnlarged ventriclesMay be lobar hemorrhage if associated amyloid angiopathy",
                    "sub_points": [
                      "Enlarged ventricles",
                      "May be lobar hemorrhage if associated amyloid angiopathy"
                    ]
                  },
                  {
                    "text": "Cerebellar, pontine atrophy in MSA"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "AD: Hippocampal atrophy; frontal, temporal, and parietal atrophy"
                  },
                  {
                    "text": "MSA: Atrophy of putamen, pons, (\"hot cross bun\" hyperintensity of pons), cerebellum"
                  },
                  {
                    "text": "FTD: Severe focal frontal and temporal atrophy"
                  },
                  {
                    "text": "Creutzfeldt-Jakob disease (CJD): Hyperintensity of cortical ribbon, caudate, putamen"
                  }
                ]
              },
              "Macroscopic Features": {
                "External Examination": [
                  {
                    "text": "Cachexia, features of Down syndrome, muscle atrophy indicating denervation, contractures"
                  },
                  {
                    "text": "Evidence of deep vein thrombosis (asymmetrical calf swelling), decubitus ulcers, fractures from recent falls, tongue biting from seizures"
                  }
                ],
                "Internal Examination": [
                  {
                    "text": "Aspiration pneumonia"
                  },
                  {
                    "text": "Atherosclerotic disease (multi-infarct dementia)"
                  }
                ],
                "Brain Examination": [
                  {
                    "text": "Pattern of atrophyAD: May be thinning of cortical ribbon, ventricular enlargement, diffuse atrophyHD: Flattening or concavity of caudate nucleusFTD: \"Knife edge\" atrophy of temporal lobes, frontal atrophyMSA: Atrophy of putamen, inferior olivary nuclei, pons, and cerebellumSCA: Pontine, olivary, or cerebellar atrophyCBD: Asymmetrical frontal and parietal atrophy, sometimes caudate and thalamusPSP: Atrophy of subthalamic nucleus, superior cerebellar peduncleALS: May be atrophy of motor cortex (precentral gyrus); may be frontal and temporal atrophy if coexisting FTD",
                    "sub_points": [
                      "AD: May be thinning of cortical ribbon, ventricular enlargement, diffuse atrophy",
                      "HD: Flattening or concavity of caudate nucleus",
                      "FTD: \"Knife edge\" atrophy of temporal lobes, frontal atrophy",
                      "MSA: Atrophy of putamen, inferior olivary nuclei, pons, and cerebellum",
                      "SCA: Pontine, olivary, or cerebellar atrophy",
                      "CBD: Asymmetrical frontal and parietal atrophy, sometimes caudate and thalamus",
                      "PSP: Atrophy of subthalamic nucleus, superior cerebellar peduncle",
                      "ALS: May be atrophy of motor cortex (precentral gyrus); may be frontal and temporal atrophy if coexisting FTD"
                    ]
                  },
                  {
                    "text": "PigmentationDiscoloration of putamen in MSA, globus pallidus in PSP and CBDLoss of pigment in substantia nigra in PD, LBD, MSA, PSP, CBDPallor of locus ceruleus in PD, LBD, MSA, and AD",
                    "sub_points": [
                      "Discoloration of putamen in MSA, globus pallidus in PSP and CBD",
                      "Loss of pigment in substantia nigra in PD, LBD, MSA, PSP, CBD",
                      "Pallor of locus ceruleus in PD, LBD, MSA, and AD"
                    ]
                  },
                  {
                    "text": "SamplingTarget to suspected disorder based on clinical signs and symptomsCortex: Frontal, temporal, anterior cingulate, parietal, occipitalInk precentral gyrus (motor cortex) before serially sectioningHippocampus, amygdalaBasal ganglia and thalamus: Caudate, putamen, globus pallidus, subthalamic nucleus, mamillary bodiesBrainstem: Midbrain (with substantia nigra), pons (with locus ceruleus), medullaCerebellum: Vermis, dentateCervical, thoracic, and lumbar cord (esp. in ALS, spinocerebellar ataxias, Friedrich ataxia, B12 deficiency)",
                    "sub_points": [
                      "Target to suspected disorder based on clinical signs and symptoms",
                      "Cortex: Frontal, temporal, anterior cingulate, parietal, occipitalInk precentral gyrus (motor cortex) before serially sectioning",
                      "Ink precentral gyrus (motor cortex) before serially sectioning",
                      "Hippocampus, amygdala",
                      "Basal ganglia and thalamus: Caudate, putamen, globus pallidus, subthalamic nucleus, mamillary bodies",
                      "Brainstem: Midbrain (with substantia nigra), pons (with locus ceruleus), medulla",
                      "Cerebellum: Vermis, dentate",
                      "Cervical, thoracic, and lumbar cord (esp. in ALS, spinocerebellar ataxias, Friedrich ataxia, B12 deficiency)"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Amyloid plaques, neurofibrillary tangles (AD)"
                  },
                  {
                    "text": "Neuronal inclusionsPD, LBD: Lewy bodies (alpha synuclein [+])PSP, CBD: Balloon neuronsALS: Skein-like inclusions",
                    "sub_points": [
                      "PD, LBD: Lewy bodies (alpha synuclein [+])",
                      "PSP, CBD: Balloon neurons",
                      "ALS: Skein-like inclusions"
                    ]
                  },
                  {
                    "text": "Glial inclusionsMSA: Cytoplasmic in oligodendrocytesPSP: Tufted/\"thorny\" astrocytesCBD: Astrocytic plaques",
                    "sub_points": [
                      "MSA: Cytoplasmic in oligodendrocytes",
                      "PSP: Tufted/\"thorny\" astrocytes",
                      "CBD: Astrocytic plaques"
                    ]
                  },
                  {
                    "text": "Spongiotic degenerationPrion disease: Throughout cortex, thalamus, &/or cerebellumAD, LBD: Superficial cortex only (in severe forms)",
                    "sub_points": [
                      "Prion disease: Throughout cortex, thalamus, &/or cerebellum",
                      "AD, LBD: Superficial cortex only (in severe forms)"
                    ]
                  },
                  {
                    "text": "Neuronal lossPD: Atrophy and loss in substantia nigra (midbrain)",
                    "sub_points": [
                      "PD: Atrophy and loss in substantia nigra (midbrain)"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Histochemistry": [
                  {
                    "text": "Silver stains: Bielschowsky, Gallyas, or BodianStain plaques and wide variety of inclusions with varying sensitivities",
                    "sub_points": [
                      "Stain plaques and wide variety of inclusions with varying sensitivities"
                    ]
                  }
                ],
                "Congo red (or beta amyloid IHC)": [],
                "Immunohistochemistry": [
                  {
                    "text": "Ubiquitin: Highlights intraneuronal inclusions (e.g., SCA, Huntington, and ALS)"
                  },
                  {
                    "text": "Α-synuclein: Lewy bodies and Lewy neurits in neuronal processes, glial cytoplasmic inclusions in MSA"
                  },
                  {
                    "text": "Tau: Hyperphosphorylated tau seen in neurofibrillary tangles of AD, Pick bodies in Pick disease, inclusions of CBD, PSP"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Normal agingBoth diffuse plaques and varying number of neuritic plaques (amyloid plaques with a core of dystrophic neurites)Hippocampal neurofibrillary tangles found in normal aging (but cortical tangles specific for dementia)",
                    "sub_points": [
                      "Both diffuse plaques and varying number of neuritic plaques (amyloid plaques with a core of dystrophic neurites)",
                      "Hippocampal neurofibrillary tangles found in normal aging (but cortical tangles specific for dementia)"
                    ]
                  },
                  {
                    "text": "ADOnly neuritic plaques relevant to a diagnosis of AD; must be interpreted in context (patient age, signs and symptoms)Plaque frequency does not correlate well with clinical dementia severity, but tangle frequency and distribution doesβ-amyloid plaques are extracellular; neurofibrillary tangles are intracellular",
                    "sub_points": [
                      "Only neuritic plaques relevant to a diagnosis of AD; must be interpreted in context (patient age, signs and symptoms)",
                      "Plaque frequency does not correlate well with clinical dementia severity, but tangle frequency and distribution does",
                      "β-amyloid plaques are extracellular; neurofibrillary tangles are intracellular"
                    ]
                  },
                  {
                    "text": "PDLewy bodies are never a normal finding in agingLoss of pigmented neurons in pars compacta of substantia nigra (lateral and ventral), whereas in normal aging, loss is medial and dorsal",
                    "sub_points": [
                      "Lewy bodies are never a normal finding in aging",
                      "Loss of pigmented neurons in pars compacta of substantia nigra (lateral and ventral), whereas in normal aging, loss is medial and dorsal"
                    ]
                  }
                ]
              },
              "Reporting Criteria": {
                "Cause of Death": [
                  {
                    "text": "Generally secondary effect of dementia rather than neurodegeneration aloneAspiration, sepsis, or other systemic findings",
                    "sub_points": [
                      "Aspiration, sepsis, or other systemic findings"
                    ]
                  }
                ],
                "Clinicopathologic Correlation": [
                  {
                    "text": "AD diagnosis requires clinical history of dementia, and absence of another cause of dementia"
                  },
                  {
                    "text": "Findings of AD frequently coexist with LBD"
                  },
                  {
                    "text": "Multiple vascular subcortical lesions are more suggestive of multiinfarct dementia than lacunar infarcts"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Neurofibromatosis Type 1": {
            "name": "Neurofibromatosis Type 1",
            "url": "https://app.pathprimer.com/document/aa75fe66-80b0-46e7-9168-5ffce78b24c5/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Neurofibromatosis type 1 (NF1)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "von Recklinghausen disease"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Genetic syndrome resulting from germline mutations inNF1gene encoding for neurofibromin"
                  }
                ]
              },
              "Epidemiology": {
                "Incidence": [
                  {
                    "text": "~ 1 in 2,500-3,000 births (1 of the most common inherited syndromes)"
                  },
                  {
                    "text": "Occurs in all races and geographic regions"
                  }
                ]
              },
              "Genetics": {
                "NF1Gene": [
                  {
                    "text": "Located in chromosome region 17q11.2"
                  },
                  {
                    "text": "Ubiquitously expressed, but levels highest in nervous system"
                  },
                  {
                    "text": "Encodes for neurofibromin, a tumor suppressor GTPase-activating protein that negatively regulates RASConstitutive activation of MAPK and AKT/mTOR signaling pathwaysAlso may regulate cAMP levels, which affect central nervous system manifestations",
                    "sub_points": [
                      "Constitutive activation of MAPK and AKT/mTOR signaling pathways",
                      "Also may regulate cAMP levels, which affect central nervous system manifestations"
                    ]
                  },
                  {
                    "text": "Mosaicism or \"segmental\" neurofibromatosis manifests as involvement of an isolated anatomical region"
                  },
                  {
                    "text": "Penetrance is ~ 100% with appropriate follow-up although manifestations are variable between individuals and within families"
                  }
                ],
                "Genetic Modifiers": [
                  {
                    "text": "Modifier genes identified in mice and families with NF1Associated with disease severityAffect predisposition to peripheral nerve and central nervous system tumors",
                    "sub_points": [
                      "Associated with disease severity",
                      "Affect predisposition to peripheral nerve and central nervous system tumors"
                    ]
                  }
                ],
                "NF1-Associated Tumors": [
                  {
                    "text": "Loss of heterozygosity inNF1is a feature of associated tumors"
                  },
                  {
                    "text": "Haploinsufficient cells in tumor microenvironment (macrophages/microglia, mast cells) also contribute to tumorigenesis"
                  }
                ]
              },
              "Clinical Implications and Ancillary Tests": {
                "Diagnostic Criteria (NIH 1991)": [
                  {
                    "text": "2 or more of the following featuresCafé au lait macules (≥ 6), with a diameter of 0.5 cm in children, or 1.5 cm after pubertyCutaneous or subcutaneous neurofibromas (≥ 2) or plexiform neurofibromaFreckling of the axillary or groin regionGlioma of the optic pathwaysLisch nodules identified by slit-lamp examination (≥ 2)Dysplasias of skeletal system (sphenoid wing, long bone bowing, pseudoarthrosis)Diagnosis of NF1 in a 1st-degree relative",
                    "sub_points": [
                      "Café au lait macules (≥ 6), with a diameter of 0.5 cm in children, or 1.5 cm after puberty",
                      "Cutaneous or subcutaneous neurofibromas (≥ 2) or plexiform neurofibroma",
                      "Freckling of the axillary or groin region",
                      "Glioma of the optic pathways",
                      "Lisch nodules identified by slit-lamp examination (≥ 2)",
                      "Dysplasias of skeletal system (sphenoid wing, long bone bowing, pseudoarthrosis)",
                      "Diagnosis of NF1 in a 1st-degree relative"
                    ]
                  }
                ]
              },
              "Nonneoplastic Manifestations": {
                "Ophthalmic": [
                  {
                    "text": "Lisch nodules: Nodular, hamartomatous aggregates of melanin-containing cells on surface of iris, usually asymptomatic"
                  }
                ],
                "Central Nervous System": [
                  {
                    "text": "Unknown bright objects (UBOs): Asymptomatic focal areas of ↑ T2 signal on MRMay represent localized myelin abnormalities/edema",
                    "sub_points": [
                      "May represent localized myelin abnormalities/edema"
                    ]
                  },
                  {
                    "text": "Macrocephaly, cognitive disabilities, developmental delays, and behavioral disturbances"
                  }
                ],
                "Skin": [
                  {
                    "text": "Café au lait spots: One of the earliest manifestations"
                  },
                  {
                    "text": "Axillary/inguinal (intertriginous skin) freckling"
                  }
                ],
                "Musculoskeletal": [
                  {
                    "text": "Sphenoid wing dysplasia/hypoplasia, scoliosis, pseudoarthrosis, bowing of long bones"
                  }
                ],
                "Cardiovascular System": [
                  {
                    "text": "Cerebral arteriopathy (Moyamoya disease)"
                  },
                  {
                    "text": "Pulmonary artery stenosis"
                  }
                ]
              },
              "Associated Neoplasms": {
                "Central Nervous System": [
                  {
                    "text": "Pilocytic astrocytomaMost frequent central nervous system neoplasm in NF1Predilection for optic pathways (15-20% of children with NF1)May also occur in brainstem and anywhere along neuraxis",
                    "sub_points": [
                      "Most frequent central nervous system neoplasm in NF1",
                      "Predilection for optic pathways (15-20% of children with NF1)",
                      "May also occur in brainstem and anywhere along neuraxis"
                    ]
                  },
                  {
                    "text": "Diffuse astrocytomasGrades II-IVUsually develop after childhood yearsAggressive as sporadic counterparts",
                    "sub_points": [
                      "Grades II-IV",
                      "Usually develop after childhood years",
                      "Aggressive as sporadic counterparts"
                    ]
                  },
                  {
                    "text": "Indeterminate astrocytomasSubset of low-grade astrocytomas in patients with NF1 difficult to classifyMay demonstrate phenotypic or ultrastructural evidence of neuronal differentiation",
                    "sub_points": [
                      "Subset of low-grade astrocytomas in patients with NF1 difficult to classify",
                      "May demonstrate phenotypic or ultrastructural evidence of neuronal differentiation"
                    ]
                  },
                  {
                    "text": "Glioneuronal tumorsGangliogliomas and dysembryoplastic neuroepithelial tumors previously reported in NF1",
                    "sub_points": [
                      "Gangliogliomas and dysembryoplastic neuroepithelial tumors previously reported in NF1"
                    ]
                  }
                ],
                "Peripheral Nervous System": [
                  {
                    "text": "NeurofibromaLocalized neurofibromaCutaneous, soft tissue or intraneuralLow cellularityVariable contents of Schwann cells, perineurial cells, fibroblasts, mast cells, and axonsDiffuse neurofibromaMay develop in patients with NF1 but is not exclusive for the syndromeUsually large cutaneous plaques infiltrating dermis &/or subcutisMay arise in internal organsCellular neurofibromaAreas of increased cellularity and even limited fascicular architectureLack pronounced atypia and mitotic activityDifferential diagnosis with low-grade MPNST challenging, particularly when associated with plexiform neurofibromaAtypical neurofibromaDegenerative nuclear atypiaLacks hypercellularity and mitotic activityPlexiform neurofibromaComplex neoplasms that by definition involve multiple peripheral nerve fascicles or a large plexusCharacteristic \"worm-like\" gross appearanceDeep/large plexiform neurofibromas essentially restricted to patients with NF1Propensity for malignant degenerationMassive soft tissue neurofibromaLarge neoplasm displaying prominent soft tissue infiltration, often containing hypercellular, round cell areas, and pseudo-meissnerian corpusclesUsually benign, but some contain a plexiform neurofibroma component with a propensity for malignant degenerationArises only in patients with NF1Rare findings in neurofibroma include presence of melanin pigment, metaplastic bone, and glandular differentiation",
                    "sub_points": [
                      "Localized neurofibromaCutaneous, soft tissue or intraneuralLow cellularityVariable contents of Schwann cells, perineurial cells, fibroblasts, mast cells, and axons",
                      "Cutaneous, soft tissue or intraneural",
                      "Low cellularity",
                      "Variable contents of Schwann cells, perineurial cells, fibroblasts, mast cells, and axons",
                      "Diffuse neurofibromaMay develop in patients with NF1 but is not exclusive for the syndromeUsually large cutaneous plaques infiltrating dermis &/or subcutisMay arise in internal organs",
                      "May develop in patients with NF1 but is not exclusive for the syndrome",
                      "Usually large cutaneous plaques infiltrating dermis &/or subcutis",
                      "May arise in internal organs",
                      "Cellular neurofibromaAreas of increased cellularity and even limited fascicular architectureLack pronounced atypia and mitotic activityDifferential diagnosis with low-grade MPNST challenging, particularly when associated with plexiform neurofibroma",
                      "Areas of increased cellularity and even limited fascicular architecture",
                      "Lack pronounced atypia and mitotic activity",
                      "Differential diagnosis with low-grade MPNST challenging, particularly when associated with plexiform neurofibroma",
                      "Atypical neurofibromaDegenerative nuclear atypiaLacks hypercellularity and mitotic activity",
                      "Degenerative nuclear atypia",
                      "Lacks hypercellularity and mitotic activity",
                      "Plexiform neurofibromaComplex neoplasms that by definition involve multiple peripheral nerve fascicles or a large plexusCharacteristic \"worm-like\" gross appearanceDeep/large plexiform neurofibromas essentially restricted to patients with NF1Propensity for malignant degeneration",
                      "Complex neoplasms that by definition involve multiple peripheral nerve fascicles or a large plexus",
                      "Characteristic \"worm-like\" gross appearance",
                      "Deep/large plexiform neurofibromas essentially restricted to patients with NF1",
                      "Propensity for malignant degeneration",
                      "Massive soft tissue neurofibromaLarge neoplasm displaying prominent soft tissue infiltration, often containing hypercellular, round cell areas, and pseudo-meissnerian corpusclesUsually benign, but some contain a plexiform neurofibroma component with a propensity for malignant degenerationArises only in patients with NF1",
                      "Large neoplasm displaying prominent soft tissue infiltration, often containing hypercellular, round cell areas, and pseudo-meissnerian corpuscles",
                      "Usually benign, but some contain a plexiform neurofibroma component with a propensity for malignant degeneration",
                      "Arises only in patients with NF1",
                      "Rare findings in neurofibroma include presence of melanin pigment, metaplastic bone, and glandular differentiation"
                    ]
                  },
                  {
                    "text": "Malignant peripheral nerve sheath tumor (MPNST)Afflicts 8-13% of patients with NF1Usually aggressive, high-grade spindle cell neoplasmsDifferentiation is predominantly schwannian but may also be perineurialPresence of heterologous elements relatively more common in NF1 setting (skeletal muscle, cartilaginous, osseous, angiosarcomatous, glandular or smooth muscle)\"Low-grade MPNST\" applied to tumors arising in transition from neurofibroma, usually in patients with NF1Hypercellularity, nuclear enlargement (~ 3x the size of a neurofibroma nucleus), and hyperchromasiaMitotic activity may also be present but is not required for diagnosis",
                    "sub_points": [
                      "Afflicts 8-13% of patients with NF1",
                      "Usually aggressive, high-grade spindle cell neoplasms",
                      "Differentiation is predominantly schwannian but may also be perineurial",
                      "Presence of heterologous elements relatively more common in NF1 setting (skeletal muscle, cartilaginous, osseous, angiosarcomatous, glandular or smooth muscle)",
                      "\"Low-grade MPNST\" applied to tumors arising in transition from neurofibroma, usually in patients with NF1Hypercellularity, nuclear enlargement (~ 3x the size of a neurofibroma nucleus), and hyperchromasiaMitotic activity may also be present but is not required for diagnosis",
                      "Hypercellularity, nuclear enlargement (~ 3x the size of a neurofibroma nucleus), and hyperchromasia",
                      "Mitotic activity may also be present but is not required for diagnosis"
                    ]
                  }
                ],
                "Other": [
                  {
                    "text": "Pheochromocytoma: Usually unilateral but may be bilateral in NF1"
                  },
                  {
                    "text": "Glomus tumorRecently recognized component of NF1NF1-biallelic inactivation, mitotic recombination not uncommon",
                    "sub_points": [
                      "Recently recognized component of NF1",
                      "NF1-biallelic inactivation, mitotic recombination not uncommon"
                    ]
                  },
                  {
                    "text": "Intestinal ganglioneuromatosis (involving primarily the submucosal plexus)"
                  },
                  {
                    "text": "Gastrointestinal stromal tumor (GIST)LacksKITmutations in contrast to sporadic GIST",
                    "sub_points": [
                      "LacksKITmutations in contrast to sporadic GIST"
                    ]
                  },
                  {
                    "text": "Gastrointestinal schwannomaMore common in NF1 than NF2Loss of heterozygosity inNF1gene",
                    "sub_points": [
                      "More common in NF1 than NF2",
                      "Loss of heterozygosity inNF1gene"
                    ]
                  },
                  {
                    "text": "Neuroendocrine neoplasms (carcinoid tumors)"
                  },
                  {
                    "text": "Juvenile myelomonocytic leukemia (JMML)100x < risk in children with NF1",
                    "sub_points": [
                      "100x < risk in children with NF1"
                    ]
                  },
                  {
                    "text": "Breast carcinomaIncreased risk and earlier age of occurrence in women with NF1",
                    "sub_points": [
                      "Increased risk and earlier age of occurrence in women with NF1"
                    ]
                  },
                  {
                    "text": "Rhabdomyosarcoma"
                  }
                ]
              },
              "Molecular biology": {
                "Central Nervous System": [
                  {
                    "text": "NF1-associated gliomas demonstrate completeNF1inactivation"
                  },
                  {
                    "text": "Haploinsufficient stromal components (e.g., microglia) also required in mouse models of NF1-associated low-grade glioma"
                  },
                  {
                    "text": "Development of high-grade glioma requires losses in additional tumor suppressors (e.g.,TP53,PTEN)"
                  }
                ],
                "Peripheral Nerve": [
                  {
                    "text": "Haploinsufficient microenvironment cell components (e.g., mast cells) important for neurofibroma formation in some NF1 mouse models"
                  },
                  {
                    "text": "Nonmyelinating Schwann cell progenitors and Dsh(+) Schwann cell precursors are candidate cells of origin of plexiform neurofibromas in mouse models"
                  },
                  {
                    "text": "Neural crest-derived cutaneous neural stem cell/progenitor candidate cell of origin for cutaneous neurofibroma"
                  },
                  {
                    "text": "Malignant peripheral nerve sheath tumors in addition toNF1loss develop oncogene amplification (e.g.,EGFR) and tumor suppressor loss (e.g.,P16,TP53)"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Neurofibromatosis Type 2 (NF2)": [
                  {
                    "text": "Mutations in theNF2gene encoding for merlin/schwannomin"
                  },
                  {
                    "text": "Gliomas, café au lait spots, and neurofibromas may present in patients with NF2 although at a lower frequency and number than in those with NF1"
                  },
                  {
                    "text": "Ependymoma, meningioma, and multiple schwannomas are not a feature of NF1"
                  }
                ],
                "Noonan Syndrome": [
                  {
                    "text": "Results from mutations in various components of the RAS/MAPK signaling pathwayPTPN11,KRAS,SOS1,NRAS, andRAF1",
                    "sub_points": [
                      "PTPN11,KRAS,SOS1,NRAS, andRAF1"
                    ]
                  },
                  {
                    "text": "Distinctive facial features, developmental delay, short stature, congenital heart disease, café au lait spots"
                  },
                  {
                    "text": "Tumor predisposition lower than NF1"
                  }
                ],
                "Legius Syndrome": [
                  {
                    "text": "Results from loss-of-functionSPRED1mutations leading to ↑ RAS-MAPK pathway activity"
                  },
                  {
                    "text": "Mild NF1-like phenotypeCafé au lait spots, macrocephalyLack Lisch nodules, bone abnormalities, gliomas, and peripheral nerve sheath tumors",
                    "sub_points": [
                      "Café au lait spots, macrocephaly",
                      "Lack Lisch nodules, bone abnormalities, gliomas, and peripheral nerve sheath tumors"
                    ]
                  }
                ],
                "Constitutional Mismatch Repair-Deficiency Syndrome": [
                  {
                    "text": "Homozygous or compound heterozygous mutations in mismatch repair genes"
                  },
                  {
                    "text": "Multiple cancers, including gliomas, colon cancer"
                  },
                  {
                    "text": "May be associated with clinical features of NF1 (e.g., café au lait spots)"
                  }
                ],
                "McCune-Albright Syndrome": [
                  {
                    "text": "Somatic mutations inGNAS1gene resulting in increased cAMP signaling"
                  },
                  {
                    "text": "May have café au lait spots (unilateral) but no axillary freckling"
                  },
                  {
                    "text": "Polyostotic fibrous dysplasia"
                  }
                ],
                "Proteus Syndrome": [
                  {
                    "text": "Somatic (mosaic) activating mutations inAKT1in most cases"
                  },
                  {
                    "text": "Localized tissue overgrowth clinically mimicking plexiform neurofibroma; scoliosis, hyperostoses, \"cerebriform\" connective tissue nevus, and epidermal nevi; monomorphic parotid gland adenomas, ovarian cystadenomas"
                  }
                ],
                "Familial Café Au Lait Spots": [
                  {
                    "text": "Rare autosomal dominant disorder"
                  },
                  {
                    "text": "Lack neurofibromas and noncutaneous manifestations of NF1"
                  }
                ],
                "Multiple Endocrine Neoplasia Type 2B (MEN2B)": [
                  {
                    "text": "Caused by genetic alterations inRETproto-oncogene"
                  },
                  {
                    "text": "Develop pheochromocytomas but also mucosal neuromas (notneurofibromas)Diffuse and extensive involvement of all intestinal layers by ganglioneuromatosis is relatively specific to MEN2B",
                    "sub_points": [
                      "Diffuse and extensive involvement of all intestinal layers by ganglioneuromatosis is relatively specific to MEN2B"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Neurofibromatosis Type 2": {
            "name": "Neurofibromatosis Type 2",
            "url": "https://app.pathprimer.com/document/9bb13a91-f478-428d-b36e-8857b7fe4439/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Neurofibromatosis type 2 (NF2)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Inherited tumor predisposition syndrome caused by germline mutations in theNF2gene encoding for merlin/schwannomin"
                  }
                ]
              },
              "Epidemiology": {
                "Incidence": [
                  {
                    "text": "1 in  33,000 to 40,000 births"
                  },
                  {
                    "text": "Similar proportion of male and female patients"
                  }
                ]
              },
              "Genetics and Molecular Biology": {
                "NF2Gene Encodes for Merlin": [
                  {
                    "text": "Inherited in 1/2 of patients and new germline mutation in remaining 1/2"
                  },
                  {
                    "text": "Located in chromosomal region 22q12.2"
                  },
                  {
                    "text": "Merlin associates with cell junctional complexes and participates in contact-dependent inhibition"
                  },
                  {
                    "text": "More severe phenotype in patients with frameshift or nonsense mutations"
                  },
                  {
                    "text": "Germline mosaicism occurs in 20-30% of patients without family history"
                  }
                ]
              },
              "Clinical Implications and Ancillary Tests": {
                "Nonneoplastic Manifestations": [
                  {
                    "text": "Ophthalmic: Posterior subcapsular cataracts, retinal hamartomas, and epiretinal membranes"
                  },
                  {
                    "text": "Central nervous system: Glial microhamartomas"
                  },
                  {
                    "text": "Peripheral nervous system: Polyneuropathy"
                  },
                  {
                    "text": "Skin: Café au lait spots but at a lesser frequency than NF1; also hairy cutaneous plaques"
                  },
                  {
                    "text": "Musculoskeletal: Scoliosis"
                  }
                ],
                "Classification Criteria": [
                  {
                    "text": "Manchester criteria (1992)Bilateral vestibular schwannomaorNF2 in 1st-degree relative plus unilateral vestibular schwannoma or any 2 of the following: Neurofibroma, meningioma, glioma, schwannoma, posterior subcapsular lens opacityorUnilateral vestibular schwannoma plus any 2 of the following: Neurofibroma, meningioma, glioma, schwannoma, posterior subscapular lens opacityor≥ 2 meningiomas plus unilateral vestibular schwannoma or any 2 of the following: Neurofibroma, glioma, schwannoma, or cataract",
                    "sub_points": [
                      "Bilateral vestibular schwannomaor",
                      "NF2 in 1st-degree relative plus unilateral vestibular schwannoma or any 2 of the following: Neurofibroma, meningioma, glioma, schwannoma, posterior subcapsular lens opacityor",
                      "Unilateral vestibular schwannoma plus any 2 of the following: Neurofibroma, meningioma, glioma, schwannoma, posterior subscapular lens opacityor",
                      "≥ 2 meningiomas plus unilateral vestibular schwannoma or any 2 of the following: Neurofibroma, glioma, schwannoma, or cataract"
                    ]
                  },
                  {
                    "text": "Baser criteria (2011)Manifests an effort to incorporate genetic information into clinical classifications",
                    "sub_points": [
                      "Manifests an effort to incorporate genetic information into clinical classifications"
                    ]
                  }
                ]
              },
              "Associated Neoplasms": {
                "Schwannoma": [
                  {
                    "text": "Similar histologic features as sporadic tumorsCompact Antoni A areas alternating with loose Antoni B areasVerocay bodies, hyalinized vessels, hemosiderin depositionS100, SOX10, and pericellular collagen IV immunoreactivity; EMA limited to perineurium and neurofilament protein to rare entrapped axons",
                    "sub_points": [
                      "Compact Antoni A areas alternating with loose Antoni B areas",
                      "Verocay bodies, hyalinized vessels, hemosiderin deposition",
                      "S100, SOX10, and pericellular collagen IV immunoreactivity; EMA limited to perineurium and neurofilament protein to rare entrapped axons"
                    ]
                  },
                  {
                    "text": "Features occurring more frequently in NF2-associated schwannomas include whorl formation, multiple tumors involving a single nerve, and juxtaposition to meningiomaMosaic pattern of INI1 immunostaining in majority of syndrome-associated schwannomas",
                    "sub_points": [
                      "Mosaic pattern of INI1 immunostaining in majority of syndrome-associated schwannomas"
                    ]
                  },
                  {
                    "text": "Bilateral vestibular schwannomas are a hallmark of NF2 (90-95% of patients)"
                  },
                  {
                    "text": "Plexiform schwannomas may occur in NF2 but are not specific to the syndromeNodular Schwann cell proliferation favoring cutaneous and mucosal sitesMay be multiple",
                    "sub_points": [
                      "Nodular Schwann cell proliferation favoring cutaneous and mucosal sites",
                      "May be multiple"
                    ]
                  }
                ],
                "Neurofibroma": [
                  {
                    "text": "Relatively rare in NF2 compared to NF1 but may contribute to clinical diagnosis if other criteria present"
                  }
                ],
                "Meningioma": [
                  {
                    "text": "Intracranial meningiomas found in ~ 1/2 of NF2 patients"
                  },
                  {
                    "text": "Skull base involvement is less frequent than in sporadic tumors"
                  },
                  {
                    "text": "\"Saltatory growth\": Periods of growth followed by quiescence"
                  },
                  {
                    "text": "Relatively high frequency of fibroblastic, transitional, and grade II meningiomas in NF2 patients but also histologic heterogeneity"
                  },
                  {
                    "text": "MeningioangiomatosisGrowth of meningothelial-like cells into superficial cortical vessels and leptomeningesAssociated with seizuresEMA(+) or  EMA(-), collagen rich (Masson trichrome)",
                    "sub_points": [
                      "Growth of meningothelial-like cells into superficial cortical vessels and leptomeninges",
                      "Associated with seizures",
                      "EMA(+) or  EMA(-), collagen rich (Masson trichrome)"
                    ]
                  }
                ],
                "Ependymoma": [
                  {
                    "text": "Cervical cord and cervicomedullary junction are favored sites in NF2"
                  },
                  {
                    "text": "Majority of NF2-associated ependymomas are low grade and asymptomatic"
                  },
                  {
                    "text": "Associated with a relatively high rate of truncatingNF2mutations"
                  }
                ],
                "Other": [
                  {
                    "text": "Conventional MPNST and MPNST ex-schwannomas reported in NF2 but very rare"
                  },
                  {
                    "text": "Some malignant neoplasms may be irradiation-induced"
                  },
                  {
                    "text": "Nonependymal glial neoplasms may occur"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Tuberous Sclerosis Complex": {
            "name": "Tuberous Sclerosis Complex",
            "url": "https://app.pathprimer.com/document/cf7926d2-086f-4861-ac36-7527b8e9f595/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Tuberous sclerosis complex (TSC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Inherited tumor predisposition syndrome resulting from mutations inTSC1orTSC2genes leading to mTOR pathway activation"
                  }
                ]
              },
              "Epidemiology": {
                "Incidence": [
                  {
                    "text": "~ 1:5,000-10,0002nd most common hereditary tumor syndrome involving the CNS",
                    "sub_points": [
                      "2nd most common hereditary tumor syndrome involving the CNS"
                    ]
                  }
                ]
              },
              "Genetics": {
                "Germline Mutations inTSC1orTSC2": [
                  {
                    "text": "Encode for tumor suppressor part of protein complex that inhibits RHEB and regulates mTOR activationTSC1located in chromosome region 9q34 (encodes for hamartin)TSC2located in chromosome region 16p13.3 (encodes for tuberin)RHEB is a small GTPase/homolog ofRASand is kept in an inactive state byTSC1/TSC2complex",
                    "sub_points": [
                      "TSC1located in chromosome region 9q34 (encodes for hamartin)",
                      "TSC2located in chromosome region 16p13.3 (encodes for tuberin)",
                      "RHEB is a small GTPase/homolog ofRASand is kept in an inactive state byTSC1/TSC2complex"
                    ]
                  },
                  {
                    "text": "mTOR is a key downstream mediator of PI3K/AKT activation"
                  },
                  {
                    "text": "Protein mTOR exists as part of 2 different multiprotein complexesmTORC1 contains PRAS40, RAPTOR, and mLST8/GBLIncreases protein translation, cell growth, and survivalmTORC2 contains RICTOR, mSIN1,  PROTOR, and mLST8Functional role less understood than mTORC1 complexRegulates metabolism and survival through activation of AKTPlays a role in cytoskeletal organizationActivation leads to increased protein translationEffective pharmacologic inhibition by rapamycin and analogs",
                    "sub_points": [
                      "mTORC1 contains PRAS40, RAPTOR, and mLST8/GBLIncreases protein translation, cell growth, and survival",
                      "Increases protein translation, cell growth, and survival",
                      "mTORC2 contains RICTOR, mSIN1,  PROTOR, and mLST8Functional role less understood than mTORC1 complexRegulates metabolism and survival through activation of AKTPlays a role in cytoskeletal organization",
                      "Functional role less understood than mTORC1 complex",
                      "Regulates metabolism and survival through activation of AKT",
                      "Plays a role in cytoskeletal organization",
                      "Activation leads to increased protein translation",
                      "Effective pharmacologic inhibition by rapamycin and analogs"
                    ]
                  },
                  {
                    "text": "Majority of patients (70-80%) have new \"spontaneous\" mutations and lack a family historyTSC1andTSC2mutation frequency similar in familial casesMutations inTSC2more frequent thanTSC1in nonfamilial cases",
                    "sub_points": [
                      "TSC1andTSC2mutation frequency similar in familial cases",
                      "Mutations inTSC2more frequent thanTSC1in nonfamilial cases"
                    ]
                  }
                ]
              },
              "Clinical Implications and Ancillary Tests": {
                "Diagnostic Criteria": [
                  {
                    "text": "Definite TSC: 2 major features or 1 major + 2 minor"
                  },
                  {
                    "text": "Probable TSC: 1 major + 1 minor"
                  },
                  {
                    "text": "Possible TSC: 1 major or  > 1 minor"
                  },
                  {
                    "text": "Major features: Cortical tuber, subependymal nodule, subependymal giant cell astrocytoma (SEGA), facial angiofibroma/forehead plaque, ungual/periungual fibroma, > 3 hypomelanotic macules, Shagreen patch, multiple retinal hamartomas, cardiac rhabdomyoma, renal angiomyolipoma/lymphangioleiomyomatosis (LAM)"
                  },
                  {
                    "text": "Minor features: White matter migration lines, transmantle cortical dysplasia, retinal patch, hamartomatous rectal polyps, gingival fibroma, dental pits, hypomelanotic clustered skin lesions, bone cysts, renal cysts, nonrenal hamartomas"
                  }
                ]
              },
              "Nonneoplastic Manifestations": {
                "Skin": [
                  {
                    "text": "Hypomelanotic macules (\"ash leaf spot\")"
                  },
                  {
                    "text": "Shagreen patch"
                  }
                ],
                "Nervous System": [
                  {
                    "text": "Epilepsy and mental retardation"
                  },
                  {
                    "text": "Cortical tubersLocalized cortical areas with abnormal developmentAbnormal lamination, dysmorphic neurons, microcalcificationsGiant/balloon cells: Pale cytoplasm, variably immunoreactive with glial (S100, GFAP) and neuronal markers (synaptophysin, neurofilament)",
                    "sub_points": [
                      "Localized cortical areas with abnormal developmentAbnormal lamination, dysmorphic neurons, microcalcifications",
                      "Abnormal lamination, dysmorphic neurons, microcalcifications",
                      "Giant/balloon cells: Pale cytoplasm, variably immunoreactive with glial (S100, GFAP) and neuronal markers (synaptophysin, neurofilament)"
                    ]
                  },
                  {
                    "text": "Cortical cytoarchitectural abnormalities may also be present outside tubers"
                  },
                  {
                    "text": "Subependymal nodules (\"candle guttering lesions\")Giant cells arranged in clusters and fascicles with mixed glial/neuronal phenotype",
                    "sub_points": [
                      "Giant cells arranged in clusters and fascicles with mixed glial/neuronal phenotype"
                    ]
                  }
                ],
                "Retinal Hamartoma/Astrocytoma": [
                  {
                    "text": "Small lesions involving nerve fiber layer of retina in ~ 50% of TSC patients"
                  },
                  {
                    "text": "Larger lesions may grow and cause retinal detachment"
                  },
                  {
                    "text": "Histologically similar to SEGA"
                  }
                ],
                "Renal Cysts": [
                  {
                    "text": "Usually asymptomatic"
                  },
                  {
                    "text": "TSC2/PKD1contiguous gene syndrome: Coexisting TSC and autosomal dominant polycystic kidney disease (severe)"
                  }
                ],
                "Micronodular Pneumocyte Hyperplasia": [
                  {
                    "text": "Small nodules of bland type II pneumocytes"
                  }
                ]
              },
              "Associated Neoplasms": {
                "Cutaneous Angiofibroma": [
                  {
                    "text": "Previously known by misnomer \"adenoma sebaceum\""
                  },
                  {
                    "text": "Dermal sclerosis"
                  },
                  {
                    "text": "Dilatation/proliferation of small vessels"
                  },
                  {
                    "text": "Stellate fibroblasts/multinucleated cells"
                  }
                ],
                "Subependymal Giant Cell Astrocytoma": [
                  {
                    "text": "Slow growth"
                  },
                  {
                    "text": "WHO grade I"
                  },
                  {
                    "text": "Mitotic activity rare to absent"
                  },
                  {
                    "text": "Microcalcifications in a subset, necrosis rare"
                  },
                  {
                    "text": "Pseudorosettes may be present and simulate ependymal neoplasms"
                  },
                  {
                    "text": "Composed of large cells with eosinophilic cytoplasm and macronucleoli"
                  },
                  {
                    "text": "Evidence of glial and neuronal differentiation by immunohistochemistry and electron microscopyConsistent S100 expression, GFAP variableVariable expression of synaptophysin, chromogranin, and neurofilament protein",
                    "sub_points": [
                      "Consistent S100 expression, GFAP variable",
                      "Variable expression of synaptophysin, chromogranin, and neurofilament protein"
                    ]
                  },
                  {
                    "text": "Excellent response to mTOR inhibitors in clinical trials"
                  }
                ],
                "Angiomyolipoma": [
                  {
                    "text": "Usually benign, but large tumors associated with risk for life-threatening bleeding"
                  },
                  {
                    "text": "Most common cause of mortality in TSC adult patients"
                  },
                  {
                    "text": "May be classic or epithelioid subtype"
                  },
                  {
                    "text": "May be a cause of LAM"
                  },
                  {
                    "text": "Partial response to mTOR inhibitors in some studies"
                  }
                ],
                "Lymphangioleiomyomatosis": [
                  {
                    "text": "Occurs in 30% of women with tuberous sclerosis"
                  },
                  {
                    "text": "Progressive pulmonary disorder involving lung"
                  },
                  {
                    "text": "Cystic changes, respiratory failure"
                  },
                  {
                    "text": "Lung biopsies demonstrate smooth muscle cells involving lymphatics, vessels, airways, and alveolar septa"
                  },
                  {
                    "text": "SMA(+), HMB-45(+)"
                  },
                  {
                    "text": "Majority of cases associated with tuberous sclerosis haveTSC2mutations (rather thanTSC1) and loss of heterozygosity"
                  },
                  {
                    "text": "Loss of heterozygosity inTSC2also frequent in sporadic LAM"
                  }
                ],
                "Cardiac Rhabdomyoma": [
                  {
                    "text": "~ 50% of patients with TSC"
                  },
                  {
                    "text": "Most frequent initial imaging finding in TSC patients"
                  },
                  {
                    "text": "May cause cardiac arrhythmias but also may regress with age"
                  }
                ],
                "Pancreatic Neuroendocrine Tumor": [
                  {
                    "text": "Not part of diagnostic criteria, but recognized in rare TSC patients"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Autosomal Dominant Polycystic Kidney Disease": {
            "name": "Autosomal Dominant Polycystic Kidney Disease",
            "url": "https://app.pathprimer.com/document/3a5ea44c-b93e-4622-97cc-5cbfceae4c80/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Autosomal dominant polycystic kidney disease (ADPKD)"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Autosomal dominant inheritance pattern"
                  },
                  {
                    "text": "Ciliopathy involving proteins of primary ciliumPKD1(polycystin-1): 85%PKD2(polycystin-2): 15%",
                    "sub_points": [
                      "PKD1(polycystin-1): 85%",
                      "PKD2(polycystin-2): 15%"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "1 in 500 live births"
                  },
                  {
                    "text": "SymptomsHypertensionRenal failureAbdominal pain/discomfortHematuria, infections",
                    "sub_points": [
                      "Hypertension",
                      "Renal failure",
                      "Abdominal pain/discomfort",
                      "Hematuria, infections"
                    ]
                  },
                  {
                    "text": "No known preventive treatment"
                  },
                  {
                    "text": "~ 50% require dialysis or kidney transplant by age 50"
                  },
                  {
                    "text": "Risk factors for disease progressionPKD1, particularly truncating mutationMenEarly onset of hypertension &/or gross hematuriaFor women, ≥ 3 pregnancies",
                    "sub_points": [
                      "PKD1, particularly truncating mutation",
                      "Men",
                      "Early onset of hypertension &/or gross hematuria",
                      "For women, ≥ 3 pregnancies"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Numerous cysts throughout both kidneysKidneys weigh up to 4 kg each",
                    "sub_points": [
                      "Kidneys weigh up to 4 kg each"
                    ]
                  },
                  {
                    "text": "Cysts in multiple other organsLiver, pancreas, arachnoid, pineal, seminal vesicle",
                    "sub_points": [
                      "Liver, pancreas, arachnoid, pineal, seminal vesicle"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Numerous cysts involving all levels of nephron"
                  },
                  {
                    "text": "Renal cell tumors may be present"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Autosomal recessive PKD"
                  },
                  {
                    "text": "Acquired cystic disease"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Autosomal dominant polycystic kidney disease (ADPKD)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Adult-type PKD"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Disease": [
                  {
                    "text": "Classified as \"ciliopathy\""
                  },
                  {
                    "text": "Autosomal dominantRandom somatic mutation of normal allele in individual cells",
                    "sub_points": [
                      "Random somatic mutation of normal allele in individual cells"
                    ]
                  }
                ],
                "PKD1(Polycystin-1) Mutation": [
                  {
                    "text": "Located on chromosome 16"
                  },
                  {
                    "text": "Accounts for 85% of ADPKD"
                  },
                  {
                    "text": "Component of primary ciliumInteracts with and regulates polycystin-2Mechanosensor for flow",
                    "sub_points": [
                      "Interacts with and regulates polycystin-2",
                      "Mechanosensor for flow"
                    ]
                  }
                ],
                "PKD2(Polycystin-2) Mutation": [
                  {
                    "text": "Located on chromosome 4"
                  },
                  {
                    "text": "Accounts for 15% of ADPKD"
                  },
                  {
                    "text": "May act as cation channel for calcium entry into cell"
                  }
                ],
                "Possible Pathogenic Mechanisms Related to Cilium": [
                  {
                    "text": "Abnormal cell proliferation"
                  },
                  {
                    "text": "Deregulated apoptosis"
                  },
                  {
                    "text": "Defective cellular polarity"
                  },
                  {
                    "text": "Increased secretion of fluids into tubular lumina"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1 in 500 live births"
                  }
                ],
                "Age": [
                  {
                    "text": "Usually presents at 30-40 years of age"
                  },
                  {
                    "text": "Rarely presents in childhood"
                  },
                  {
                    "text": "Cysts develop progressively"
                  }
                ],
                "Sex": [
                  {
                    "text": "Earlier onset of hypertension and end-stage renal disease in men compared to women at any given age"
                  },
                  {
                    "text": "Women have more cysts in liver and develop them at earlier age than men do"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Hematuria"
                  },
                  {
                    "text": "Abdominal pain/discomfort"
                  },
                  {
                    "text": "Urinary tract infections"
                  },
                  {
                    "text": "HypertensionCerebral arterial aneurysms with intracranial hemorrhage in 5-10%",
                    "sub_points": [
                      "Cerebral arterial aneurysms with intracranial hemorrhage in 5-10%"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Genetic tests forPKD1orPKD2mutationsMutation detection rate: 65-70% forPKD1Mutation detection rate: Nearly 90% forPKD2",
                    "sub_points": [
                      "Mutation detection rate: 65-70% forPKD1",
                      "Mutation detection rate: Nearly 90% forPKD2"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "None effective to slow progressionClinical trials of mTOR inhibitors, vasopressin receptor antagonists",
                    "sub_points": [
                      "Clinical trials of mTOR inhibitors, vasopressin receptor antagonists"
                    ]
                  },
                  {
                    "text": "Bilateral nephrectomy if kidneys are too enlarged or if recurrent episodes of pyelonephritis"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "~ 50% of patients will require dialysis or kidney transplant by age 50"
                  },
                  {
                    "text": "PKD2mutations result in milder clinical course compared toPKD1mutations"
                  },
                  {
                    "text": "Risk factors for disease progressionPKD1, particularly truncating mutationMenEarly onset of hypertension &/or gross hematuriaFor women, ≥ 3 pregnancies",
                    "sub_points": [
                      "PKD1, particularly truncating mutation",
                      "Men",
                      "Early onset of hypertension &/or gross hematuria",
                      "For women, ≥ 3 pregnancies"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Numerous cysts throughout kidney"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Numerous cysts throughout both kidneysRare cases of \"1-sided\" ADPKD",
                    "sub_points": [
                      "Rare cases of \"1-sided\" ADPKD"
                    ]
                  },
                  {
                    "text": "Kidneys weigh up to 4 kg each"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Cysts in cortex and medulla up to several cm in diameterArises from any nephron segment or collecting ductGlomerular, tubular cystsLined by single layer of flattened to cuboidal epitheliumNormal intervening parenchyma may be present, depending on stageHemorrhage may be present",
                    "sub_points": [
                      "Arises from any nephron segment or collecting duct",
                      "Glomerular, tubular cysts",
                      "Lined by single layer of flattened to cuboidal epithelium",
                      "Normal intervening parenchyma may be present, depending on stage",
                      "Hemorrhage may be present"
                    ]
                  },
                  {
                    "text": "Diffuse interstitial fibrosis and tubular atrophy"
                  },
                  {
                    "text": "Renal cell tumors sometimes present"
                  }
                ],
                "Extrarenal Pathology": [
                  {
                    "text": "Liver cysts (> 90%)Termed polycystic liver diseaseRarely predominates over renal disease",
                    "sub_points": [
                      "Termed polycystic liver disease",
                      "Rarely predominates over renal disease"
                    ]
                  },
                  {
                    "text": "Cysts in pancreas (10%), seminal vesicles (39%), pineal gland (< 5%), arachnoid, and ovaries"
                  },
                  {
                    "text": "Mitral valve prolapse or aortic regurgitation in 25%"
                  },
                  {
                    "text": "Cerebral (berry) aneurysms"
                  },
                  {
                    "text": "Inguinal, ventral, hiatal hernias"
                  },
                  {
                    "text": "Diverticulosis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Autosomal Recessive PKD": [
                  {
                    "text": "Congenital or childhood onset"
                  },
                  {
                    "text": "Ectatic collecting ducts and bile ducts"
                  }
                ],
                "Acquired Cystic Disease": [
                  {
                    "text": "Usually < 1 kg, cysts not as widespread"
                  },
                  {
                    "text": "Underlying renal disease evident"
                  },
                  {
                    "text": "Hyperplastic tubular epithelium"
                  },
                  {
                    "text": "May be present in ADPKD"
                  }
                ],
                "Simple Cysts": [
                  {
                    "text": "Isolated cysts and much normal parenchyma"
                  },
                  {
                    "text": "Difficult to distinguish from early stage ADPKD"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Bread loaf nephrectomy specimens at 1 cm to exclude neoplasia"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Familial Adenomatous Polyposis": {
            "name": "Familial Adenomatous Polyposis",
            "url": "https://app.pathprimer.com/document/2297b31e-4183-465a-aa01-ec0b55c33776/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Familial adenomatous polyposis (FAP)"
                  },
                  {
                    "text": "Attenuated familial adenomatous polyposis (AFAP)"
                  },
                  {
                    "text": "Congenital hypertrophy of retinal pigment epithelium (CHRPE)"
                  },
                  {
                    "text": "Colorectal carcinoma (CRC)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Adenomatous polyposis coli (APC), familial polyposis coli, Gardner syndrome, Turcot syndrome, Crail syndrome, Bussey-Gardner polyposis"
                  }
                ]
              },
              "Epidemiology": {
                "Age Range": [
                  {
                    "text": "1st adenomas detected between ages 10 and 20 years"
                  },
                  {
                    "text": "Mean age of diagnosis: 34-36 years if not in a known kindred undergoing screening"
                  },
                  {
                    "text": "Mean age of CRC: 40-42 years, but can occur in teenagers"
                  }
                ],
                "Incidence": [
                  {
                    "text": "0.003-0.015% of population"
                  },
                  {
                    "text": "Most common genetic polyposis syndromeFAP accounts for < 1% of all CRCs",
                    "sub_points": [
                      "FAP accounts for < 1% of all CRCs"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Adenomas increase in size and number with agePolyp count and patient age predict cancer riskAs in sporadic adenomas, only a small percentage progress to cancer",
                    "sub_points": [
                      "Polyp count and patient age predict cancer risk",
                      "As in sporadic adenomas, only a small percentage progress to cancer"
                    ]
                  },
                  {
                    "text": "AFAP: Fewer adenomas at a later onset (~ 15 years later than FAP)Upper GI lesions almost always present, but extraintestinal manifestations rareLower risk of developing CRCPhenotype identical toMYH-associated polyposis, which is autosomal recessiveRequires genetic testing to differentiate the 2",
                    "sub_points": [
                      "Upper GI lesions almost always present, but extraintestinal manifestations rare",
                      "Lower risk of developing CRC",
                      "Phenotype identical toMYH-associated polyposis, which is autosomal recessiveRequires genetic testing to differentiate the 2",
                      "Requires genetic testing to differentiate the 2"
                    ]
                  }
                ],
                "Gender": [
                  {
                    "text": "M = F"
                  }
                ]
              },
              "Genetics": {
                "Germline Mutation inAPCGene": [
                  {
                    "text": "Tumor suppressor gene that downregulates β-catenin (Wnt signaling pathway)Controls cell cycle and stabilizes microtubules",
                    "sub_points": [
                      "Controls cell cycle and stabilizes microtubules"
                    ]
                  },
                  {
                    "text": "Located on chromosome 5q21-22"
                  },
                  {
                    "text": "SpecificAPCmutations correlate with phenotypesAFAP associated with mutations at 3' and 5' ends ofAPCgene, whereas CHRPEs, osteomas, desmoids, and epidermal cysts are associated with mutations in middle of geneHot spot for severe polyposis phenotype at codon 1309More polyps and earlier onset of CRC in families with mutations near this hot spot",
                    "sub_points": [
                      "AFAP associated with mutations at 3' and 5' ends ofAPCgene, whereas CHRPEs, osteomas, desmoids, and epidermal cysts are associated with mutations in middle of gene",
                      "Hot spot for severe polyposis phenotype at codon 1309More polyps and earlier onset of CRC in families with mutations near this hot spot",
                      "More polyps and earlier onset of CRC in families with mutations near this hot spot"
                    ]
                  },
                  {
                    "text": "30-40% of FAP cases arise de novo (no family history)Cause of these spontaneous mutations unknown",
                    "sub_points": [
                      "Cause of these spontaneous mutations unknown"
                    ]
                  },
                  {
                    "text": "APCI1307K mutationAutosomal dominant mutation that imparts a 10-20% lifetime CRC riskNo polyposis or extracolonic manifestationsAffects 6% of Ashkenazi JewsRendersAPCgene susceptible to further mutations that lead to CRC",
                    "sub_points": [
                      "Autosomal dominant mutation that imparts a 10-20% lifetime CRC risk",
                      "No polyposis or extracolonic manifestations",
                      "Affects 6% of Ashkenazi Jews",
                      "RendersAPCgene susceptible to further mutations that lead to CRC"
                    ]
                  }
                ]
              },
              "Clinical Implications": {
                "Clinical Presentation": [
                  {
                    "text": "Rectal bleeding, diarrhea, colicky abdominal pain, mucous discharge, intussusception"
                  },
                  {
                    "text": "Rarely, severe electrolyte depletion can occur with diffuse polyposis"
                  },
                  {
                    "text": "Acute pancreatitis due to adenoma obstructing ampulla/pancreatic duct"
                  }
                ],
                "Imaging Findings": [
                  {
                    "text": "Polyps can be detected in both upper GI and lower GI locations, especially with fluoroscopic-guided barium enema"
                  },
                  {
                    "text": "Osteomas of jaw in Gardner syndrome can be identified on radiographs"
                  },
                  {
                    "text": "Desmoid tumors in Gardner syndrome can be identified on CT"
                  }
                ]
              },
              "Macroscopic Findings": {
                "General Features": [
                  {
                    "text": "Diagnostic criteria for FAP (any of the following)≥ 100 colorectal adenomas (classical FAP)< 100 colorectal adenomas in AFAPGermlineAPCmutationFamily history of FAP plus at least 1 of the followingEpidermoid cyst, osteoma, desmoid",
                    "sub_points": [
                      "≥ 100 colorectal adenomas (classical FAP)",
                      "< 100 colorectal adenomas in AFAP",
                      "GermlineAPCmutation",
                      "Family history of FAP plus at least 1 of the followingEpidermoid cyst, osteoma, desmoid",
                      "Epidermoid cyst, osteoma, desmoid"
                    ]
                  }
                ],
                "Endoscopic Findings": [
                  {
                    "text": "Hundreds of small sessile adenomas carpet the colonSimilar location as in sporadic adenomas with predilection for rectosigmoidSome larger pedunculated polypsMay have rectal sparing in AFAP",
                    "sub_points": [
                      "Similar location as in sporadic adenomas with predilection for rectosigmoid",
                      "Some larger pedunculated polyps",
                      "May have rectal sparing in AFAP"
                    ]
                  },
                  {
                    "text": "CRC distribution follows adenomas (70-80% left-sided)Often multiple CRCs, either synchronous or metachronous",
                    "sub_points": [
                      "Often multiple CRCs, either synchronous or metachronous"
                    ]
                  }
                ],
                "Specimen Handling": [
                  {
                    "text": "Total resectionAside from taking sections of all large polyps to look for invasive carcinoma, face-down sections of the flat mucosa can be taken to show unicryptal adenomas that are pathognomonic of FAP (so-called Bussey section)",
                    "sub_points": [
                      "Aside from taking sections of all large polyps to look for invasive carcinoma, face-down sections of the flat mucosa can be taken to show unicryptal adenomas that are pathognomonic of FAP (so-called Bussey section)"
                    ]
                  }
                ]
              },
              "Microscopic Findings": {
                "General Features": [
                  {
                    "text": "Colonic adenomas look identical to sporadic counterparts"
                  },
                  {
                    "text": "Presence of unicryptal adenomas in flat mucosa diagnostic of FAP"
                  }
                ]
              },
              "Associated Neoplasms": {
                "Other GI (Extracolonic Lesions)": [
                  {
                    "text": "Small intestineMostly duodenal/ampullary adenomasPossible cocarcinogenic effect of bile10-15 years later than colonic adenomas but 30 years earlier than general population50-100% of FAP patients have these on routine screening (50-100%)Cumulative cancer risk: 2-10%Common cause of death in patients who have had a prophylactic colectomy (20%)",
                    "sub_points": [
                      "Mostly duodenal/ampullary adenomasPossible cocarcinogenic effect of bile10-15 years later than colonic adenomas but 30 years earlier than general population50-100% of FAP patients have these on routine screening (50-100%)Cumulative cancer risk: 2-10%Common cause of death in patients who have had a prophylactic colectomy (20%)",
                      "Possible cocarcinogenic effect of bile",
                      "10-15 years later than colonic adenomas but 30 years earlier than general population",
                      "50-100% of FAP patients have these on routine screening (50-100%)",
                      "Cumulative cancer risk: 2-10%",
                      "Common cause of death in patients who have had a prophylactic colectomy (20%)"
                    ]
                  },
                  {
                    "text": "StomachMostly fundic gland polyps (40-60%)More numerous, occurring at a younger age, and more likely to have dysplasia (up to 25%) than sporadicAntral adenomas (6%)Gastric cancer is rare, but cases have been reported",
                    "sub_points": [
                      "Mostly fundic gland polyps (40-60%)More numerous, occurring at a younger age, and more likely to have dysplasia (up to 25%) than sporadic",
                      "More numerous, occurring at a younger age, and more likely to have dysplasia (up to 25%) than sporadic",
                      "Antral adenomas (6%)",
                      "Gastric cancer is rare, but cases have been reported"
                    ]
                  },
                  {
                    "text": "LiverIncreasing rate of hepatoblastomas in male infantsRare hepatic adenomas and hepatocellular carcinomasRare malignant embryonal tumor",
                    "sub_points": [
                      "Increasing rate of hepatoblastomas in male infants",
                      "Rare hepatic adenomas and hepatocellular carcinomas",
                      "Rare malignant embryonal tumor"
                    ]
                  },
                  {
                    "text": "PancreasAdenocarcinomaRare reports of intraductal mucinous neoplasms",
                    "sub_points": [
                      "Adenocarcinoma",
                      "Rare reports of intraductal mucinous neoplasms"
                    ]
                  },
                  {
                    "text": "Biliary tractAdenocarcinoma and dysplasia of bile ducts and gallbladder",
                    "sub_points": [
                      "Adenocarcinoma and dysplasia of bile ducts and gallbladder"
                    ]
                  }
                ],
                "Extraintestinal Manifestations": [
                  {
                    "text": "Soft tissue (10-30% of FAP patients)Fibromatosis (desmoid tumors)Locally aggressive (even fatal) but \"benign\" tumors: Do not metastasize2nd most common cause of death in FAP patients (after CRC)UnencapsulatedHereditary desmoid disease: RareAPCmutation that causes multiple desmoids and other extraintestinal manifestations without colonic diseaseMost common in small bowel mesenteryOften post surgery/traumaHormones may affect growth (pregnancy, estrogen); tamoxifen sometimes used for treatment",
                    "sub_points": [
                      "Fibromatosis (desmoid tumors)Locally aggressive (even fatal) but \"benign\" tumors: Do not metastasize2nd most common cause of death in FAP patients (after CRC)UnencapsulatedHereditary desmoid disease: RareAPCmutation that causes multiple desmoids and other extraintestinal manifestations without colonic diseaseMost common in small bowel mesenteryOften post surgery/traumaHormones may affect growth (pregnancy, estrogen); tamoxifen sometimes used for treatment",
                      "Locally aggressive (even fatal) but \"benign\" tumors: Do not metastasize",
                      "2nd most common cause of death in FAP patients (after CRC)",
                      "Unencapsulated",
                      "Hereditary desmoid disease: RareAPCmutation that causes multiple desmoids and other extraintestinal manifestations without colonic disease",
                      "Most common in small bowel mesentery",
                      "Often post surgery/trauma",
                      "Hormones may affect growth (pregnancy, estrogen); tamoxifen sometimes used for treatment"
                    ]
                  },
                  {
                    "text": "BonesMultiple osteomas of the skull, long bones, and mandible",
                    "sub_points": [
                      "Multiple osteomas of the skull, long bones, and mandible"
                    ]
                  },
                  {
                    "text": "Teeth (70-80% of FAP patients)Impaction, supernumerary/absent, abnormal roots",
                    "sub_points": [
                      "Impaction, supernumerary/absent, abnormal roots"
                    ]
                  },
                  {
                    "text": "Eye (75-90% of FAP patients)Congenital hypertrophy of retinal pigment epithelium (CHRPE)Pigmented fundus lesionEarliest manifestation of FAP; can be seen in young infants",
                    "sub_points": [
                      "Congenital hypertrophy of retinal pigment epithelium (CHRPE)Pigmented fundus lesionEarliest manifestation of FAP; can be seen in young infants",
                      "Pigmented fundus lesion",
                      "Earliest manifestation of FAP; can be seen in young infants"
                    ]
                  },
                  {
                    "text": "SkinMultiple epidermal inclusion cysts of face and scalpLipomas, fibromas, sebaceous cysts",
                    "sub_points": [
                      "Multiple epidermal inclusion cysts of face and scalp",
                      "Lipomas, fibromas, sebaceous cysts"
                    ]
                  },
                  {
                    "text": "Endocrine systemPapillary thyroid carcinoma, cribriform morular variant, in womenAdrenal cortical neoplasmsPancreatic islet cell neoplasmsRare reports of parathyroid and pituitary adenomas",
                    "sub_points": [
                      "Papillary thyroid carcinoma, cribriform morular variant, in women",
                      "Adrenal cortical neoplasms",
                      "Pancreatic islet cell neoplasms",
                      "Rare reports of parathyroid and pituitary adenomas"
                    ]
                  },
                  {
                    "text": "Brain (Turcot syndrome)Hereditary CRC & brain tumorFAP patients: MedulloblastomasLynch patients: Gliomas",
                    "sub_points": [
                      "Hereditary CRC & brain tumorFAP patients: MedulloblastomasLynch patients: Gliomas",
                      "FAP patients: Medulloblastomas",
                      "Lynch patients: Gliomas"
                    ]
                  },
                  {
                    "text": "Head and neckNasopharyngeal angiofibroma",
                    "sub_points": [
                      "Nasopharyngeal angiofibroma"
                    ]
                  }
                ]
              },
              "Cancer Risk Management": {
                "Surgery": [
                  {
                    "text": "Prophylactic colectomy with ileoanal pouch anastomosis is surgical treatment of choice"
                  },
                  {
                    "text": "Goal is to do this when patient is in their teens (if diagnosis can be established this early)"
                  },
                  {
                    "text": "Patients will still require surveillance of pouch to remove adenomas"
                  },
                  {
                    "text": "Upper endoscopy with biopsy of gastric and duodenal polypsMost duodenal/ampullary adenomas can be excised endoscopically, but some may require a Whipple procedure",
                    "sub_points": [
                      "Most duodenal/ampullary adenomas can be excised endoscopically, but some may require a Whipple procedure"
                    ]
                  },
                  {
                    "text": "Surgical excision of desmoids (when possible)"
                  }
                ],
                "Medical Management": [
                  {
                    "text": "Chemoprevention of polyps with indomethacin and other NSAIDs"
                  },
                  {
                    "text": "Medical treatment of desmoids includes hormonal therapy, imatinib, and NSAIDs"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Protein truncation test (PTT)Looks for abnormally shortened APC protein in exon 15",
                    "sub_points": [
                      "Looks for abnormally shortened APC protein in exon 15"
                    ]
                  },
                  {
                    "text": "Gene sequencingAPCgene is very large; hence, sequencing is difficultSequencing is done to try and predict phenotype of affected family members (likelihood of desmoids or severe phenotype)Latest techniques are about 95% sensitive in detecting mutations in classic FAP, < 30% in AFAPImportant to test forMYH-associated polyposis if these tests are negativeMultiplex ligation probe amplification (MLPA) is used to look for large deletions and duplications",
                    "sub_points": [
                      "APCgene is very large; hence, sequencing is difficultSequencing is done to try and predict phenotype of affected family members (likelihood of desmoids or severe phenotype)",
                      "Sequencing is done to try and predict phenotype of affected family members (likelihood of desmoids or severe phenotype)",
                      "Latest techniques are about 95% sensitive in detecting mutations in classic FAP, < 30% in AFAPImportant to test forMYH-associated polyposis if these tests are negative",
                      "Important to test forMYH-associated polyposis if these tests are negative",
                      "Multiplex ligation probe amplification (MLPA) is used to look for large deletions and duplications"
                    ]
                  },
                  {
                    "text": "Sequencing of exons 1-14 coupled with PTT of exon 15 is one commonly used testing strategyIf PTT is positive, then exon 15 can be sequenced",
                    "sub_points": [
                      "If PTT is positive, then exon 15 can be sequenced"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hereditary Spherocytosis": {
            "name": "Hereditary Spherocytosis",
            "url": "https://app.pathprimer.com/document/8c713287-d564-45bd-9d96-d0d878b5f006/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Most common congenital hemolytic anemia in Caucasians: Estimated prevalence of 1:2,000"
                  },
                  {
                    "text": "Group of hemolytic anemias characterized by dense, spherically shaped red blood cells without central pallor"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "HS is clinically, biochemically, and genetically heterogeneous~ 75% of cases are AD with 1 parent affectedAnkyrin-1 gene mutation is most common",
                    "sub_points": [
                      "~ 75% of cases are AD with 1 parent affected",
                      "Ankyrin-1 gene mutation is most common"
                    ]
                  },
                  {
                    "text": "Defects in membrane proteins ankyrin-1, band 3, β spectrin, α spectrin, or protein 4.2 lead to loss of membrane surface area"
                  },
                  {
                    "text": "Abnormal spherocytes are sequestered and destroyed in spleen"
                  },
                  {
                    "text": "An intact spleen is required for pathophysiological effects of HS"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Evidence of hemolysis with anemia, reticulocytosis, splenomegaly, jaundice, gallstonesMild disease may not be discovered until adulthoodModerate-severe disease: Excellent prognosis after splenectomy, unless complications",
                    "sub_points": [
                      "Mild disease may not be discovered until adulthood",
                      "Moderate-severe disease: Excellent prognosis after splenectomy, unless complications"
                    ]
                  },
                  {
                    "text": "Diagnose HS if family history, typical clinical features including hemolysis, and increased spherocytes in blood film"
                  },
                  {
                    "text": "If diagnosis is equivocal, perform screening testFlow cytometry for eosin-5-maleimide (EMA) has high predictive valueNo single test identifies all cases of HS",
                    "sub_points": [
                      "Flow cytometry for eosin-5-maleimide (EMA) has high predictive value",
                      "No single test identifies all cases of HS"
                    ]
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Hereditary spherocytosis (HS)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Group of hemolytic anemias characterized by presence of dense, spherically shaped red blood cells without central pallor"
                  },
                  {
                    "text": "Shape abnormality renders erythrocyte susceptible to premature removal by spleen"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Developmental Anomaly": [
                  {
                    "text": "Autosomal dominant (AD), autosomal recessive (AR), and de novo types described"
                  },
                  {
                    "text": "Red blood cell membrane loss due to defective vertical protein linkages between membrane skeleton and lipid bilayer"
                  },
                  {
                    "text": "Proteins stabilize red blood cell membranesTransmembrane proteinsBand 3 and RhAG (ankyrin complex)4.1R, band 3-adducin (junctional complex)Anchoring proteinsAnkyrin-1 and protein 4.2Proteins providing membrane cohesionα spectrin and β spectrin",
                    "sub_points": [
                      "Transmembrane proteinsBand 3 and RhAG (ankyrin complex)4.1R, band 3-adducin (junctional complex)",
                      "Band 3 and RhAG (ankyrin complex)",
                      "4.1R, band 3-adducin (junctional complex)",
                      "Anchoring proteinsAnkyrin-1 and protein 4.2",
                      "Ankyrin-1 and protein 4.2",
                      "Proteins providing membrane cohesionα spectrin and β spectrin",
                      "α spectrin and β spectrin"
                    ]
                  },
                  {
                    "text": "Molecular defects in the membrane proteins are heterogeneous and often family specific"
                  },
                  {
                    "text": "Most common molecular defects involveAnkyrin-1ANK1gene mutations (> 55 distinct mutations in AD disease)Most common defect in CaucasiansPresent in 50-60% of HS patientsInheritance: AD, AR, de novo (15-20%)Mild-severe HSDecreased ankyrin protein leads to defective spectrin assemblyReduction of ankyrin &/or spectrin membrane proteins (despite normal spectrin synthesis)Combined reduction in ankyrin and spectrin proteins present in 15-50% of casesRare patients have deletions or translocations of chromosome 8p ankyrin gene locus insteadBand 3SLC4A1gene mutationsPresent in 20% of HS patientsInheritance: ADMild-moderate HSReduced band 3 protein (20-35% of patients) or reduced protein 4.2β spectrinSPTBgene defectsPresent in 15-30% of Caucasians with HSInheritance: AD, de novoMild-moderate HSα spectrinSPTA1gene defectsPresent in < 5% of HS patientsInheritance: ARSevere HSα spectrin is normally produced at 3-4x greater amount than β spectrinHS has mutations of both α spectrin allelesProtein 4.2HomozygousEPB42gene mutationsPresent in < 5% of HS patientsCommon in Japan (45-50% of HS)Rare in other ethnic groupsInheritance: ARMild-moderate HSTotal absence of protein 4.2 membrane proteins with secondary reduction of CD47 (member of Rh complex)Rh deficiencyExtremely rareMild to moderate anemiaDecreased or absent Rh antigen expression",
                    "sub_points": [
                      "Ankyrin-1ANK1gene mutations (> 55 distinct mutations in AD disease)Most common defect in CaucasiansPresent in 50-60% of HS patientsInheritance: AD, AR, de novo (15-20%)Mild-severe HSDecreased ankyrin protein leads to defective spectrin assemblyReduction of ankyrin &/or spectrin membrane proteins (despite normal spectrin synthesis)Combined reduction in ankyrin and spectrin proteins present in 15-50% of casesRare patients have deletions or translocations of chromosome 8p ankyrin gene locus instead",
                      "ANK1gene mutations (> 55 distinct mutations in AD disease)",
                      "Most common defect in Caucasians",
                      "Present in 50-60% of HS patients",
                      "Inheritance: AD, AR, de novo (15-20%)",
                      "Mild-severe HS",
                      "Decreased ankyrin protein leads to defective spectrin assembly",
                      "Reduction of ankyrin &/or spectrin membrane proteins (despite normal spectrin synthesis)",
                      "Combined reduction in ankyrin and spectrin proteins present in 15-50% of cases",
                      "Rare patients have deletions or translocations of chromosome 8p ankyrin gene locus instead",
                      "Band 3SLC4A1gene mutationsPresent in 20% of HS patientsInheritance: ADMild-moderate HSReduced band 3 protein (20-35% of patients) or reduced protein 4.2",
                      "SLC4A1gene mutations",
                      "Present in 20% of HS patients",
                      "Inheritance: AD",
                      "Mild-moderate HS",
                      "Reduced band 3 protein (20-35% of patients) or reduced protein 4.2",
                      "β spectrinSPTBgene defectsPresent in 15-30% of Caucasians with HSInheritance: AD, de novoMild-moderate HS",
                      "SPTBgene defects",
                      "Present in 15-30% of Caucasians with HS",
                      "Inheritance: AD, de novo",
                      "Mild-moderate HS",
                      "α spectrinSPTA1gene defectsPresent in < 5% of HS patientsInheritance: ARSevere HSα spectrin is normally produced at 3-4x greater amount than β spectrinHS has mutations of both α spectrin alleles",
                      "SPTA1gene defects",
                      "Present in < 5% of HS patients",
                      "Inheritance: AR",
                      "Severe HS",
                      "α spectrin is normally produced at 3-4x greater amount than β spectrin",
                      "HS has mutations of both α spectrin alleles",
                      "Protein 4.2HomozygousEPB42gene mutationsPresent in < 5% of HS patientsCommon in Japan (45-50% of HS)Rare in other ethnic groupsInheritance: ARMild-moderate HSTotal absence of protein 4.2 membrane proteins with secondary reduction of CD47 (member of Rh complex)",
                      "HomozygousEPB42gene mutations",
                      "Present in < 5% of HS patients",
                      "Common in Japan (45-50% of HS)",
                      "Rare in other ethnic groups",
                      "Inheritance: AR",
                      "Mild-moderate HS",
                      "Total absence of protein 4.2 membrane proteins with secondary reduction of CD47 (member of Rh complex)",
                      "Rh deficiencyExtremely rareMild to moderate anemiaDecreased or absent Rh antigen expression",
                      "Extremely rare",
                      "Mild to moderate anemia",
                      "Decreased or absent Rh antigen expression"
                    ]
                  },
                  {
                    "text": "Molecular phenotype is not strictly linked to biochemical phenotype (i.e., ankyrin-1 gene defect may manifest as spectrin protein deficiency)Combined ankyrin and spectrin protein deficiency is most commonUSA and Europe: 40-65% of patients with HSJapan: 5-10% of patients with HSSpectrin deficiency is most prevalent among individuals diagnosed in childhood",
                    "sub_points": [
                      "Combined ankyrin and spectrin protein deficiency is most commonUSA and Europe: 40-65% of patients with HSJapan: 5-10% of patients with HS",
                      "USA and Europe: 40-65% of patients with HS",
                      "Japan: 5-10% of patients with HS",
                      "Spectrin deficiency is most prevalent among individuals diagnosed in childhood"
                    ]
                  }
                ],
                "General": [
                  {
                    "text": "Intact spleen is required for pathophysiological effectsMembrane protein defects lead to dyscohesion between lipid bilayer and membrane skeletonSkeleton-free lipid vesicles are released during membrane destabilization, leading to reduced membrane surface areaReduction in red blood cell surface area to volume causes formation of spherocytesSpherocyte shape leads to reduced deformabilityIneffective passage through splenic basement membrane gapsRed cell sequestration within spleenFurther loss of membrane surface area due to low pH, low glucose concentration, high oxidant concentrationDelayed RBC transit through spleen leads toIncreased contact with splenic macrophagesErythrophagocytosis and hemosiderin deposition",
                    "sub_points": [
                      "Membrane protein defects lead to dyscohesion between lipid bilayer and membrane skeleton",
                      "Skeleton-free lipid vesicles are released during membrane destabilization, leading to reduced membrane surface area",
                      "Reduction in red blood cell surface area to volume causes formation of spherocytes",
                      "Spherocyte shape leads to reduced deformabilityIneffective passage through splenic basement membrane gapsRed cell sequestration within spleen",
                      "Ineffective passage through splenic basement membrane gaps",
                      "Red cell sequestration within spleen",
                      "Further loss of membrane surface area due to low pH, low glucose concentration, high oxidant concentration",
                      "Delayed RBC transit through spleen leads toIncreased contact with splenic macrophagesErythrophagocytosis and hemosiderin deposition",
                      "Increased contact with splenic macrophages",
                      "Erythrophagocytosis and hemosiderin deposition"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Most common congenital hemolytic anemia in Caucasians with estimated prevalence of 1:2,000"
                  }
                ],
                "Age": [
                  {
                    "text": "Majority of individuals experience jaundice at birth with subsequent mild to moderate anemia"
                  },
                  {
                    "text": "If HS is extremely mild, may not be identified until adulthood when exacerbated by infection"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Present in all ethnic groups"
                  },
                  {
                    "text": "Most commonly seen in Northern European, Northern American, and Japanese populations"
                  },
                  {
                    "text": "Least commonly found in African American and southeast Asian populations"
                  }
                ],
                "Presentation": [
                  {
                    "text": "~ 75% of cases have AD pattern of inheritanceFamily history of anemia, jaundice, gallstones, splenomegaly &/or splenectomy common",
                    "sub_points": [
                      "Family history of anemia, jaundice, gallstones, splenomegaly &/or splenectomy common"
                    ]
                  },
                  {
                    "text": "Remaining cases are AR or have de novo mutationsRecessive forms of HS tend to have more severe clinical symptoms",
                    "sub_points": [
                      "Recessive forms of HS tend to have more severe clinical symptoms"
                    ]
                  },
                  {
                    "text": "Anemia is most common presenting complaint in childhoodCheck for scleral icterus, jaundice (often intermittent), and splenomegaly",
                    "sub_points": [
                      "Check for scleral icterus, jaundice (often intermittent), and splenomegaly"
                    ]
                  },
                  {
                    "text": "Disease severity varies widely as classified below for the non-neonatal period (% of HS patients)Mild (~ 20%): Compensated hemolysis, minimal spherocytosis, minimal anemia, slight reticulocytosis (< 6%), mild splenomegalyModerate (~ 60%): Hemoglobin 8.0-11.0 g/dL, reticulocytes generally > 8%Moderately severe (~ 10%): Hemoglobin 6.0-8.0 g/dL, reticulocytes generally > 15%Severe (3-5%): Transfusions required to maintain hemoglobin > 6.0 g/dL, almost always AR",
                    "sub_points": [
                      "Mild (~ 20%): Compensated hemolysis, minimal spherocytosis, minimal anemia, slight reticulocytosis (< 6%), mild splenomegaly",
                      "Moderate (~ 60%): Hemoglobin 8.0-11.0 g/dL, reticulocytes generally > 8%",
                      "Moderately severe (~ 10%): Hemoglobin 6.0-8.0 g/dL, reticulocytes generally > 15%",
                      "Severe (3-5%): Transfusions required to maintain hemoglobin > 6.0 g/dL, almost always AR"
                    ]
                  },
                  {
                    "text": "Some neonates have more severe anemiaUnable to mount an adequate erythropoietic response until > 1 year of age",
                    "sub_points": [
                      "Unable to mount an adequate erythropoietic response until > 1 year of age"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Infant or child with family history of HS and typical clinical features requiresTests for hemolysisReticulocyte count to evaluate degree of bone marrow compensationIndirect bilirubin level to assess hemolysisLactate dehydrogenase (LDH)Complete blood countAssess for anemia, may be minimal to markedIncreased RDW (usually normal MCV)Increased MCHC (due to relative cellular dehydration)Peripheral blood smear review for spherocytesMorphology may be unclear in neonatesIf child is well, may postpone evaluation until child is ≥ 6 months of age when morphology may be less confusingAdditional screening tests for equivocable diagnosis",
                    "sub_points": [
                      "Tests for hemolysisReticulocyte count to evaluate degree of bone marrow compensationIndirect bilirubin level to assess hemolysisLactate dehydrogenase (LDH)",
                      "Reticulocyte count to evaluate degree of bone marrow compensation",
                      "Indirect bilirubin level to assess hemolysis",
                      "Lactate dehydrogenase (LDH)",
                      "Complete blood countAssess for anemia, may be minimal to markedIncreased RDW (usually normal MCV)Increased MCHC (due to relative cellular dehydration)",
                      "Assess for anemia, may be minimal to marked",
                      "Increased RDW (usually normal MCV)",
                      "Increased MCHC (due to relative cellular dehydration)",
                      "Peripheral blood smear review for spherocytesMorphology may be unclear in neonatesIf child is well, may postpone evaluation until child is ≥ 6 months of age when morphology may be less confusing",
                      "Morphology may be unclear in neonates",
                      "If child is well, may postpone evaluation until child is ≥ 6 months of age when morphology may be less confusing",
                      "Additional screening tests for equivocable diagnosis"
                    ]
                  },
                  {
                    "text": "Patient without family history of HS or lacking diagnostic criteriaExclude other causes of hemolysisNegative direct antiglobulin test (DAT)",
                    "sub_points": [
                      "Exclude other causes of hemolysisNegative direct antiglobulin test (DAT)",
                      "Negative direct antiglobulin test (DAT)"
                    ]
                  },
                  {
                    "text": "Additional screening testsFlow cytometric analysis for eosin-5-maleimide (EMA)EMA interacts with band 3, Rh protein, Rh glycoprotein, and CD47Decreased fluorescence in HS is independent of type of membrane protein deficiencySensitivity > 90%, specificity > 95%Cryohemolysis testMeasures susceptibility of HS red cells to coolingRecommended for screening but controversialAcidified glycerol lysis testBetter detection rate for asymptomatic relatives of affected individualsSensitivity and specificity > 90% (laboratory dependent)NaCl osmotic fragility testRequires incubation of blood at 37°C for 24 hours to adequately detect spherocytesTesting is normal in 1/4 of HS patientsHigher incidence of positive results if Northern European descent or family history of anemiaSensitivity > 80% and specificity > 60% on incubated bloodOsmotic gradient ektacytometryMeasures deformability of red blood cells",
                    "sub_points": [
                      "Flow cytometric analysis for eosin-5-maleimide (EMA)EMA interacts with band 3, Rh protein, Rh glycoprotein, and CD47Decreased fluorescence in HS is independent of type of membrane protein deficiencySensitivity > 90%, specificity > 95%",
                      "EMA interacts with band 3, Rh protein, Rh glycoprotein, and CD47",
                      "Decreased fluorescence in HS is independent of type of membrane protein deficiency",
                      "Sensitivity > 90%, specificity > 95%",
                      "Cryohemolysis testMeasures susceptibility of HS red cells to coolingRecommended for screening but controversial",
                      "Measures susceptibility of HS red cells to cooling",
                      "Recommended for screening but controversial",
                      "Acidified glycerol lysis testBetter detection rate for asymptomatic relatives of affected individualsSensitivity and specificity > 90% (laboratory dependent)",
                      "Better detection rate for asymptomatic relatives of affected individuals",
                      "Sensitivity and specificity > 90% (laboratory dependent)",
                      "NaCl osmotic fragility testRequires incubation of blood at 37°C for 24 hours to adequately detect spherocytesTesting is normal in 1/4 of HS patientsHigher incidence of positive results if Northern European descent or family history of anemiaSensitivity > 80% and specificity > 60% on incubated blood",
                      "Requires incubation of blood at 37°C for 24 hours to adequately detect spherocytes",
                      "Testing is normal in 1/4 of HS patients",
                      "Higher incidence of positive results if Northern European descent or family history of anemia",
                      "Sensitivity > 80% and specificity > 60% on incubated blood",
                      "Osmotic gradient ektacytometryMeasures deformability of red blood cells",
                      "Measures deformability of red blood cells"
                    ]
                  },
                  {
                    "text": "Confirmatory tests for membrane protein defectPolyacrylamide gel electrophoresis in presence of sodium dodecyl sulphate (SDS-PAGE)Identifies abnormality in 70-80% of HS patientsRecommended if clinical phenotype is more severe than predicted by morphologyRecommended if red cell morphology is more severe than predicted by parent blood filmsPerform if diagnosis not clear prior to splenectomyMolecular studies for gene mutations not required for diagnosisDNA-cDNA analysis in patients with normal parents",
                    "sub_points": [
                      "Polyacrylamide gel electrophoresis in presence of sodium dodecyl sulphate (SDS-PAGE)Identifies abnormality in 70-80% of HS patientsRecommended if clinical phenotype is more severe than predicted by morphologyRecommended if red cell morphology is more severe than predicted by parent blood filmsPerform if diagnosis not clear prior to splenectomy",
                      "Identifies abnormality in 70-80% of HS patients",
                      "Recommended if clinical phenotype is more severe than predicted by morphology",
                      "Recommended if red cell morphology is more severe than predicted by parent blood films",
                      "Perform if diagnosis not clear prior to splenectomy",
                      "Molecular studies for gene mutations not required for diagnosisDNA-cDNA analysis in patients with normal parents",
                      "DNA-cDNA analysis in patients with normal parents"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Gallstones common5% of children < 10 years oldMore common in children with band 3 deficiencyIncreased incidence if coinheritance of Gilbert syndrome",
                    "sub_points": [
                      "5% of children < 10 years old",
                      "More common in children with band 3 deficiency",
                      "Increased incidence if coinheritance of Gilbert syndrome"
                    ]
                  },
                  {
                    "text": "Hemolytic crisis in childhoodTriggered by viral infectionSecondary enlargement of spleen with activation of reticuloendothelial (RE) systemUsually mild; supportive care adequate",
                    "sub_points": [
                      "Triggered by viral infection",
                      "Secondary enlargement of spleen with activation of reticuloendothelial (RE) system",
                      "Usually mild; supportive care adequate"
                    ]
                  },
                  {
                    "text": "Aplastic crisisLess common, usually only arises once in lifetimeMost common cause is Parvovirus B19 infectionMay not have characteristic rashIncreased serum ironUsually lasts 10-14 days",
                    "sub_points": [
                      "Less common, usually only arises once in lifetime",
                      "Most common cause is Parvovirus B19 infectionMay not have characteristic rash",
                      "May not have characteristic rash",
                      "Increased serum iron",
                      "Usually lasts 10-14 days"
                    ]
                  },
                  {
                    "text": "Megaloblastic crisisOccurs during times of increased folate demandGrowing children or recovering from aplastic crisis",
                    "sub_points": [
                      "Occurs during times of increased folate demand",
                      "Growing children or recovering from aplastic crisis"
                    ]
                  },
                  {
                    "text": "Additional clinical characteristicsNeuromuscular disordersCardiovascular diseaseRare cases of concurrent Kallmann syndrome if 8p11.21 deletion",
                    "sub_points": [
                      "Neuromuscular disorders",
                      "Cardiovascular disease",
                      "Rare cases of concurrent Kallmann syndrome if 8p11.21 deletion"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Special considerations for neonatesHemoglobin concentration is usually normal at birth but declines during first 3 weeks of lifeSevere anemia may be transient and improve by 1 year of ageRequires red blood cell transfusions (preferably genotyped) in interimRecombinant human erythropoietin is being evaluated as alternative to transfusion",
                    "sub_points": [
                      "Hemoglobin concentration is usually normal at birth but declines during first 3 weeks of life",
                      "Severe anemia may be transient and improve by 1 year of ageRequires red blood cell transfusions (preferably genotyped) in interimRecombinant human erythropoietin is being evaluated as alternative to transfusion",
                      "Requires red blood cell transfusions (preferably genotyped) in interim",
                      "Recombinant human erythropoietin is being evaluated as alternative to transfusion"
                    ]
                  },
                  {
                    "text": "General approach during childhoodUnsplenectomized children with moderate-severe HS require folate supplementation< 5 years of age: 2-3 mg per day> 5 years of age: 5 mg per day",
                    "sub_points": [
                      "Unsplenectomized children with moderate-severe HS require folate supplementation< 5 years of age: 2-3 mg per day> 5 years of age: 5 mg per day",
                      "< 5 years of age: 2-3 mg per day",
                      "> 5 years of age: 5 mg per day"
                    ]
                  }
                ],
                "Options, risks, complications": [
                  {
                    "text": "Children with moderate-severe HS benefit from splenectomy"
                  },
                  {
                    "text": "Immunize patients prior to splenectomyStreptococcus pneumoniae,Haemophilus influenzaetype b,Neisseria meningitidis",
                    "sub_points": [
                      "Streptococcus pneumoniae,Haemophilus influenzaetype b,Neisseria meningitidis"
                    ]
                  },
                  {
                    "text": "Post-splenectomy infection with encapsulated bacteria is serious long-term complication"
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Splenectomy: Laparoscopic is the method of choiceMore beneficial for ankyrin or spectrin deficiency than for band 3 deficiencyIf possible, delay until > 6 years of age due to high secondary infection rate",
                    "sub_points": [
                      "More beneficial for ankyrin or spectrin deficiency than for band 3 deficiency",
                      "If possible, delay until > 6 years of age due to high secondary infection rate"
                    ]
                  },
                  {
                    "text": "CholecystectomyPerform during splenectomy if patient has symptomatic gallstones",
                    "sub_points": [
                      "Perform during splenectomy if patient has symptomatic gallstones"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Patients with mild HS have relatively normal lifespan"
                  },
                  {
                    "text": "Moderate-severe disease: Excellent prognosis after splenectomy unless complicationsCareful assessment of risks vs. benefits is required, particularly in younger childrenEarly complications include local infection, bleeding, pancreatitisSerious long-term complications include infections with encapsulated bacteria or parasites",
                    "sub_points": [
                      "Careful assessment of risks vs. benefits is required, particularly in younger children",
                      "Early complications include local infection, bleeding, pancreatitis",
                      "Serious long-term complications include infections with encapsulated bacteria or parasites"
                    ]
                  },
                  {
                    "text": "Long-term outcome of partial splenectomy is being assessedGoal to reduce hemolysis but retain resistance to encapsulated bacteria",
                    "sub_points": [
                      "Goal to reduce hemolysis but retain resistance to encapsulated bacteria"
                    ]
                  }
                ]
              },
              "Image Findings": {
                "Ultrasonographic Findings": [
                  {
                    "text": "GallstonesAbdominal scan evaluation recommended at least every 3-5 years (prior to splenectomy)",
                    "sub_points": [
                      "Abdominal scan evaluation recommended at least every 3-5 years (prior to splenectomy)"
                    ]
                  },
                  {
                    "text": "Enlarged spleen"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Key Microscopic Findings": [
                  {
                    "text": "Spherocytes are dense, round, and hyperchromatic red blood cells that lack central pallorMild forms of HS have < 10% circulating spherocytesSevere forms of HS have numerous spherocytes",
                    "sub_points": [
                      "Mild forms of HS have < 10% circulating spherocytes",
                      "Severe forms of HS have numerous spherocytes"
                    ]
                  },
                  {
                    "text": "Increased polychromatophilic red blood cells reflect increase in reticulocytes"
                  },
                  {
                    "text": "Molecular defects are associated with additional red blood cell findings as followsAnkyrin-1: Prominent spherocytes onlyBand 3: Spherocytes, mushroom-shaped, or pincered erythrocytesβ spectrin: Spherocytes, 5-10% acanthocytes, spherostomatocytesα spectrin: Spherocytes, numerous microspherocytes, contracted erythrocytes, abnormal poikilocytesProtein 4.2: Few spherocytes, ovalocytes, stomatocytesRh deficiency: Spherocytes, stomatocytes",
                    "sub_points": [
                      "Ankyrin-1: Prominent spherocytes only",
                      "Band 3: Spherocytes, mushroom-shaped, or pincered erythrocytes",
                      "β spectrin: Spherocytes, 5-10% acanthocytes, spherostomatocytes",
                      "α spectrin: Spherocytes, numerous microspherocytes, contracted erythrocytes, abnormal poikilocytes",
                      "Protein 4.2: Few spherocytes, ovalocytes, stomatocytes",
                      "Rh deficiency: Spherocytes, stomatocytes"
                    ]
                  },
                  {
                    "text": "Bone marrowErythroid hyperplasia (effective erythropoiesis)Megaloblastic erythroid lineage if megaloblastic crisisErythroid hypoplasia during aplastic crisis; possible parvoviral inclusions",
                    "sub_points": [
                      "Erythroid hyperplasia (effective erythropoiesis)",
                      "Megaloblastic erythroid lineage if megaloblastic crisis",
                      "Erythroid hypoplasia during aplastic crisis; possible parvoviral inclusions"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Immune-Mediated Hemolytic Anemia": [
                  {
                    "text": "ABO incompatibility in neonatal periodDAT is sometimes negative",
                    "sub_points": [
                      "DAT is sometimes negative"
                    ]
                  },
                  {
                    "text": "Autoimmune uncommon in childrenPositive DAT",
                    "sub_points": [
                      "Positive DAT"
                    ]
                  }
                ],
                "Hereditary Stomatocytosis and Related Disorders": [
                  {
                    "text": "Characterized by abnormal permeability to sodium and potassium ions"
                  },
                  {
                    "text": "Macrocytosis common, stomatocytes and possible target cells, spherocytes"
                  }
                ],
                "Congenital Dyserythropoietic Anemia Type II (CDA-II)": [
                  {
                    "text": "Bone marrow erythroid hyperplasia with 10-40% binucleate or multinucleate erythroid precursors"
                  },
                  {
                    "text": "Screening tests for HS cannot exclude this entity (requires SDS-PAGE analysis)"
                  }
                ],
                "Disorders With Spherocytes on Peripheral Blood Smear": [
                  {
                    "text": "Acute oxidant injury; Heinz body anemias"
                  },
                  {
                    "text": "Thermal injuries"
                  },
                  {
                    "text": "Hemolytic transfusion reactions"
                  },
                  {
                    "text": "Microangiopathic hemolytic anemias"
                  },
                  {
                    "text": "Hypersplenism, liver disease"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Evaluate patient for HSIf marked anemia after viral infection (especially Parvovirus B19 or influenza)If patient is anemic and has family history suggestive of HS",
                    "sub_points": [
                      "If marked anemia after viral infection (especially Parvovirus B19 or influenza)",
                      "If patient is anemic and has family history suggestive of HS"
                    ]
                  },
                  {
                    "text": "Detection of HS is often more difficult in neonatal period than later in life"
                  },
                  {
                    "text": "Spherocytes are common artifact on blood smearsRequires high-quality smears to assessNeed well-separated red blood cells and cells with central pallor to confirm",
                    "sub_points": [
                      "Requires high-quality smears to assess",
                      "Need well-separated red blood cells and cells with central pallor to confirm"
                    ]
                  },
                  {
                    "text": "~ 25% of HS patients have normal osmotic fragilityOther screening tests have better predictive value",
                    "sub_points": [
                      "Other screening tests have better predictive value"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Osteogenesis Imperfecta": {
            "name": "Osteogenesis Imperfecta",
            "url": "https://app.pathprimer.com/document/63e60c2e-9ccd-4941-b997-795ac28f2e6f/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Osteogenesis imperfecta (OI)Inherited disorder of bone fragility resulting from abnormal quantity &/or quality of collagen type I",
                    "sub_points": [
                      "Inherited disorder of bone fragility resulting from abnormal quantity &/or quality of collagen type I"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Most cases are thought to be caused by point mutation affecting glycine residue in eitherCOL1A1orCOL1A2"
                  },
                  {
                    "text": "Collagen type I is a major constituent of bone, dentin, sclerae, ligaments, and skinTherefore, mutations inCOL1Aresult in abnormalities of these structures",
                    "sub_points": [
                      "Therefore, mutations inCOL1Aresult in abnormalities of these structures"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "7 types described, each with a different degree of severity"
                  },
                  {
                    "text": "Bone fragility increases in severity as followsType I < types IV, V, VI, VII < type III < type II",
                    "sub_points": [
                      "Type I < types IV, V, VI, VII < type III < type II"
                    ]
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Shortened extremities with severe deformity and crumpling due to multiple fracturesFractures sustained in utero",
                    "sub_points": [
                      "Fractures sustained in utero"
                    ]
                  },
                  {
                    "text": "Blue or black sclera"
                  },
                  {
                    "text": "Short, curved femora with deformity due to multiple fractures"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Normal cartilage zones with preserved alignment of chondrocyte columns at epiphyseal plate"
                  },
                  {
                    "text": "Thin trabeculae with severely deficient ossification"
                  },
                  {
                    "text": "Excessive callus formation at fracture sites"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Osteogenesis imperfecta (OI)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Brittle bone disease"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Inherited disorder of bone fragility resulting from abnormal quantity &/or quality of collagen type I"
                  },
                  {
                    "text": "Nosolology Group of International Skeletal Dysplasia Society classification of OIType II collagen group",
                    "sub_points": [
                      "Type II collagen group"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Pathogenesis": [
                  {
                    "text": "Most cases are thought to be caused by point mutation affecting glycine residue in eitherCOL1A1orCOL1A2Glycine residue at every 3rd position is required for proper collagen trihelix intertwiningMutations inCOL1Agenes alter the triple helix structure of collagen, resulting in decreased synthesis or structurally abnormal collagenOI types with decreased synthesis of structurally normal collagen are milder than those resulting from synthesis of structurally abnormal collagen",
                    "sub_points": [
                      "Glycine residue at every 3rd position is required for proper collagen trihelix intertwining",
                      "Mutations inCOL1Agenes alter the triple helix structure of collagen, resulting in decreased synthesis or structurally abnormal collagenOI types with decreased synthesis of structurally normal collagen are milder than those resulting from synthesis of structurally abnormal collagen",
                      "OI types with decreased synthesis of structurally normal collagen are milder than those resulting from synthesis of structurally abnormal collagen"
                    ]
                  },
                  {
                    "text": "Collagen type I is a major constituent of bone, dentin, sclerae, ligaments, and skinMutations inCOL1Aresult in abnormalities of these structures",
                    "sub_points": [
                      "Mutations inCOL1Aresult in abnormalities of these structures"
                    ]
                  },
                  {
                    "text": "Not all patients with clinical features consistent with OI harbor aCOL1A1orCOL1A2mutationTherefore, the definition of OI should remain a clinical one",
                    "sub_points": [
                      "Therefore, the definition of OI should remain a clinical one"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1 per 10,000 births"
                  }
                ],
                "Presentation": [
                  {
                    "text": "7 types described, each with different degree of severityBone fragility increases in severity as followsType I < types IV, V, VI, VII < type III < type IIType I: Mild; autosomal dominant (AD)Most common typeDistinctly blue scleraePresenile hearing loss or impairment (or family history)Onset and frequency of fractures variable: Most occur during preschool years and decrease after pubertyNormal or near-normal statureType II: Perinatal lethal form; AD, rarely ARIntrauterine growth retardationIntrauterine fracturesType III: Severe, progressive deformity; ADMost severe type compatible with survival beyond neonatal periodMost cases result from new mutationsFeatures present at birth in > 50% of casesMarkedly short stature and severe growth retardationDentinogenesis imperfecta (DI) and hearing loss are commonType IV: Mild to moderate; autosomal recessiveVariable deformities of long bones and spineHearing impairment can occurNumber and frequency of fractures is variable but decrease after pubertyType V: Moderate to severe; ADModerate to severe bony fragilityHypertrophic callus formation is the hallmarkMesh-like appearance of bony lamellaeType VI: Moderate to severe; ARPatients do not have blue sclerae or DIFish scale-like appearance of bony lamellaeType VII: Moderate to severe; ARRhizomelia and coxa vara",
                    "sub_points": [
                      "Bone fragility increases in severity as followsType I < types IV, V, VI, VII < type III < type II",
                      "Type I < types IV, V, VI, VII < type III < type II",
                      "Type I: Mild; autosomal dominant (AD)Most common typeDistinctly blue scleraePresenile hearing loss or impairment (or family history)Onset and frequency of fractures variable: Most occur during preschool years and decrease after pubertyNormal or near-normal stature",
                      "Most common type",
                      "Distinctly blue sclerae",
                      "Presenile hearing loss or impairment (or family history)",
                      "Onset and frequency of fractures variable: Most occur during preschool years and decrease after puberty",
                      "Normal or near-normal stature",
                      "Type II: Perinatal lethal form; AD, rarely ARIntrauterine growth retardationIntrauterine fractures",
                      "Intrauterine growth retardation",
                      "Intrauterine fractures",
                      "Type III: Severe, progressive deformity; ADMost severe type compatible with survival beyond neonatal periodMost cases result from new mutationsFeatures present at birth in > 50% of casesMarkedly short stature and severe growth retardationDentinogenesis imperfecta (DI) and hearing loss are common",
                      "Most severe type compatible with survival beyond neonatal period",
                      "Most cases result from new mutations",
                      "Features present at birth in > 50% of cases",
                      "Markedly short stature and severe growth retardation",
                      "Dentinogenesis imperfecta (DI) and hearing loss are common",
                      "Type IV: Mild to moderate; autosomal recessiveVariable deformities of long bones and spineHearing impairment can occurNumber and frequency of fractures is variable but decrease after puberty",
                      "Variable deformities of long bones and spine",
                      "Hearing impairment can occur",
                      "Number and frequency of fractures is variable but decrease after puberty",
                      "Type V: Moderate to severe; ADModerate to severe bony fragilityHypertrophic callus formation is the hallmarkMesh-like appearance of bony lamellae",
                      "Moderate to severe bony fragility",
                      "Hypertrophic callus formation is the hallmark",
                      "Mesh-like appearance of bony lamellae",
                      "Type VI: Moderate to severe; ARPatients do not have blue sclerae or DIFish scale-like appearance of bony lamellae",
                      "Patients do not have blue sclerae or DI",
                      "Fish scale-like appearance of bony lamellae",
                      "Type VII: Moderate to severe; ARRhizomelia and coxa vara",
                      "Rhizomelia and coxa vara"
                    ]
                  },
                  {
                    "text": "Skin laxity and joint hyperlaxity are present in all types"
                  },
                  {
                    "text": "Blue or gray sclerae are noted in OI types I through IV"
                  },
                  {
                    "text": "DI is seen in OI types II and III"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Bisphosphonate therapy: Cyclical intravenous pamidronateOI type VI patients do not respond as well as those with other types",
                    "sub_points": [
                      "OI type VI patients do not respond as well as those with other types"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on type"
                  }
                ]
              },
              "Image Findings": {
                "Radiographic Findings": [
                  {
                    "text": "General featuresOsteopeniaBowing, angulation, deformity of long bonesMultiple fractures",
                    "sub_points": [
                      "Osteopenia",
                      "Bowing, angulation, deformity of long bones",
                      "Multiple fractures"
                    ]
                  },
                  {
                    "text": "Type IICrumpled femoraMultiple long bone fracturesUndermineralized calvarium with Wormian bonesMultiple rib fractures (\"beaded\" ribs)",
                    "sub_points": [
                      "Crumpled femora",
                      "Multiple long bone fractures",
                      "Undermineralized calvarium with Wormian bones",
                      "Multiple rib fractures (\"beaded\" ribs)"
                    ]
                  },
                  {
                    "text": "Type IIIShort, curved femora with multiple fracturesMineralized calvarium",
                    "sub_points": [
                      "Short, curved femora with multiple fractures",
                      "Mineralized calvarium"
                    ]
                  }
                ]
              },
              "Macroscopic Features": {
                "Type II": [
                  {
                    "text": "Shortened extremities with severe deformity and crumpling due to multiple fracturesFractures sustained in utero",
                    "sub_points": [
                      "Fractures sustained in utero"
                    ]
                  },
                  {
                    "text": "Disproportionately large head"
                  },
                  {
                    "text": "Small nose with depressed nasal bridge"
                  },
                  {
                    "text": "Small chest"
                  },
                  {
                    "text": "Blue or black sclera"
                  }
                ],
                "Type III": [
                  {
                    "text": "Short, curved femora with deformity due to multiple fracturesNot to the degree seen in type II",
                    "sub_points": [
                      "Not to the degree seen in type II"
                    ]
                  },
                  {
                    "text": "Multiple rib fractures"
                  },
                  {
                    "text": "Triangular facies"
                  },
                  {
                    "text": "Dark sclerae"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Normal cartilage zones with preserved alignment of chondrocyte columns at epiphyseal plateHypertrophic chondrocytes contain PAS-positive and argyrophilic material resembling procollagenNormal calcification of chondral cartilage",
                    "sub_points": [
                      "Hypertrophic chondrocytes contain PAS-positive and argyrophilic material resembling procollagen",
                      "Normal calcification of chondral cartilage"
                    ]
                  },
                  {
                    "text": "Alignment of cartilaginous struts"
                  },
                  {
                    "text": "Thin trabeculae with severely deficient ossificationOsteoid is scanty or absent",
                    "sub_points": [
                      "Osteoid is scanty or absent"
                    ]
                  },
                  {
                    "text": "Excessive callus formation at fracture sites"
                  },
                  {
                    "text": "Normal lamellar organizationException: OI types V and VIBone has irregular mesh-like appearance in type VFish scale-like appearance of bony lamellae in type VI",
                    "sub_points": [
                      "Exception: OI types V and VIBone has irregular mesh-like appearance in type VFish scale-like appearance of bony lamellae in type VI",
                      "Bone has irregular mesh-like appearance in type V",
                      "Fish scale-like appearance of bony lamellae in type VI"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Molecular Genetics": [
                  {
                    "text": "Performed on cultured fibroblasts or amniocytesOI types II, III, and IVCOL1A1andCOL1A2glycine substitutions",
                    "sub_points": [
                      "OI types II, III, and IVCOL1A1andCOL1A2glycine substitutions",
                      "COL1A1andCOL1A2glycine substitutions"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Juvenile Idiopathic Osteoporosis": [
                  {
                    "text": "Transient, nonhereditary"
                  },
                  {
                    "text": "Collagen studies negative"
                  }
                ],
                "Idiopathic Autosomal Recessive Hypophosphatasia": [
                  {
                    "text": "Extremely high serum alkaline phosphatase activity"
                  }
                ],
                "Child Abuse": [
                  {
                    "text": "Negative collagen mutation tests do not rule out OI"
                  },
                  {
                    "text": "Bone mineral density tests may be helpful"
                  },
                  {
                    "text": "Blue sclerae and hearing loss/family history of hearing loss suggestive of OI type I"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Approach to Autopsy Work-Up of Skeletal Dysplasias": [
                  {
                    "text": "Multidisciplinary approach is critical (similar to the diagnostic approach to bone tumors)Bone histology must be evaluated in conjunction with radiographic, gross, and molecular/genetic findingsHistologic spectrum of each disease may vary widely, and overlap between entities may existRadiographic diagnosis may be sufficient for diagnosis in some casesSkeletal survey is recommended over \"babygram\"Both AP and lateral views are recommended (AP views to evaluate spine)Radiographs of dilatation and curretage specimens can provide valuable information",
                    "sub_points": [
                      "Bone histology must be evaluated in conjunction with radiographic, gross, and molecular/genetic findingsHistologic spectrum of each disease may vary widely, and overlap between entities may exist",
                      "Histologic spectrum of each disease may vary widely, and overlap between entities may exist",
                      "Radiographic diagnosis may be sufficient for diagnosis in some casesSkeletal survey is recommended over \"babygram\"Both AP and lateral views are recommended (AP views to evaluate spine)Radiographs of dilatation and curretage specimens can provide valuable information",
                      "Skeletal survey is recommended over \"babygram\"",
                      "Both AP and lateral views are recommended (AP views to evaluate spine)",
                      "Radiographs of dilatation and curretage specimens can provide valuable information"
                    ]
                  },
                  {
                    "text": "Pertinent clinical information to obtainShort stature, consanguinity, early osteoarthritis",
                    "sub_points": [
                      "Short stature, consanguinity, early osteoarthritis"
                    ]
                  },
                  {
                    "text": "Fresh skin or placental tissue should be obtained for fibroblast cultures"
                  },
                  {
                    "text": "External exam should includeLimb or head disproportion, limb shortening or asymmetry, skeletal deformitiesChest diameterEvaluation for natal teethScleral examinationMeasurementsArm span and length, upper to lower segment ratio, long bone lengthDetermination of type of long bone shorteningRhizomelic (proximal segment), mesomelic (middle segment), or acromelic (distal segment)",
                    "sub_points": [
                      "Limb or head disproportion, limb shortening or asymmetry, skeletal deformities",
                      "Chest diameter",
                      "Evaluation for natal teeth",
                      "Scleral examination",
                      "MeasurementsArm span and length, upper to lower segment ratio, long bone length",
                      "Arm span and length, upper to lower segment ratio, long bone length",
                      "Determination of type of long bone shorteningRhizomelic (proximal segment), mesomelic (middle segment), or acromelic (distal segment)",
                      "Rhizomelic (proximal segment), mesomelic (middle segment), or acromelic (distal segment)"
                    ]
                  },
                  {
                    "text": "Histologic sections should includeSections of femur and rib at costochondral junctionSections of vertebral boneCartilage for electron microscopy",
                    "sub_points": [
                      "Sections of femur and rib at costochondral junction",
                      "Sections of vertebral bone",
                      "Cartilage for electron microscopy"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Sickle Cell Anemia": {
            "name": "Sickle Cell Anemia",
            "url": "https://app.pathprimer.com/document/72ef1205-165e-40e4-8f38-bb73309f7cbd/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Autosomal recessive inherited genetic disease resulting from homozygous point mutation (valine to glutamine at codon 6) of β globin gene"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Abnormal hemoglobin (HbS) polymerizes under low oxygen tension, resulting in RBC sickling"
                  },
                  {
                    "text": "RBC sickling and adhesion result in chronic anemia, microinfarcts, and painful vascular crisis"
                  },
                  {
                    "text": "Heterozygous state provides protection againstPlasmodium falciparuminfection"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "EthnicityAfrican ancestry most common",
                    "sub_points": [
                      "African ancestry most common"
                    ]
                  },
                  {
                    "text": "Signs, symptoms, and natural historyChronic anemiaAcute pain crises most commonly precipitated by infection, dehydration, and high altitude",
                    "sub_points": [
                      "Chronic anemia",
                      "Acute pain crises most commonly precipitated by infection, dehydration, and high altitude"
                    ]
                  },
                  {
                    "text": "Diagnostic laboratory testingHemoglobin electrophoresis shows single band of hemoglobin S",
                    "sub_points": [
                      "Hemoglobin electrophoresis shows single band of hemoglobin S"
                    ]
                  },
                  {
                    "text": "TreatmentHydroxycarbamide (hydroxyurea) is standardBone marrow transplantation considered using criteria related to donor availability and severity of disease",
                    "sub_points": [
                      "Hydroxycarbamide (hydroxyurea) is standard",
                      "Bone marrow transplantation considered using criteria related to donor availability and severity of disease"
                    ]
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Chronic normocytic normochromic anemia"
                  },
                  {
                    "text": "Peripheral blood smear shows sickle cells during acute crisis"
                  },
                  {
                    "text": "Howell-Jolly bodies indicate functional asplenism"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Sickle cell anemia (SCA)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Sickle cell disease"
                  },
                  {
                    "text": "Hemoglobin (Hb) SS disease"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Autosomal recessive inherited genetic disease"
                  },
                  {
                    "text": "Results from homozygous point mutation in β globin gene resulting in abnormal hemoglobin (HbS)Mutation at codon 6 of β globin geneValine substituted for glutamineDespite identical mutation, marked interindividual variability in clinical manifestations",
                    "sub_points": [
                      "Mutation at codon 6 of β globin gene",
                      "Valine substituted for glutamine",
                      "Despite identical mutation, marked interindividual variability in clinical manifestations"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Environmental Exposure": [
                  {
                    "text": "Although a genetic disease, acute episodes are precipitated by environmental factorsCold temperatureFever or infectionDehydrationLow oxygen (e.g., high altitude)",
                    "sub_points": [
                      "Cold temperature",
                      "Fever or infection",
                      "Dehydration",
                      "Low oxygen (e.g., high altitude)"
                    ]
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "Heterozygous state provides protection againstPlasmodium falciparuminfectionProtective mechanisms poorly understoodErythrocyte apoptosis may help eliminate organisms in infected cells through phagocytosis",
                    "sub_points": [
                      "Protective mechanisms poorly understood",
                      "Erythrocyte apoptosis may help eliminate organisms in infected cells through phagocytosis"
                    ]
                  }
                ],
                "Pathophysiology": [
                  {
                    "text": "HbS abnormally polymerizes when deoxygenated"
                  },
                  {
                    "text": "Polymerization of Hb results in distorted, stiffened sickle shapeReduced red blood cell deformability",
                    "sub_points": [
                      "Reduced red blood cell deformability"
                    ]
                  },
                  {
                    "text": "Other disease features not directly related to erythrocyte sicklingRed cell adhesion to vascular endotheliumIncreased blood viscosityChronic inflammationIschemia reperfusion injuryDysregulated nitric oxide homeostasis",
                    "sub_points": [
                      "Red cell adhesion to vascular endothelium",
                      "Increased blood viscosity",
                      "Chronic inflammation",
                      "Ischemia reperfusion injury",
                      "Dysregulated nitric oxide homeostasis"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "250,000 born each year with SCA worldwide"
                  },
                  {
                    "text": "60,000 people in USA have SCA"
                  }
                ],
                "Age": [
                  {
                    "text": "Usually presents in 1st year of life after fetal hemoglobin (HbF) levels from infancy are reduced and hemoglobin S becomes predominant type"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "African ancestry most commonSickle cell trait (heterozygous carriers) conveys protection againstPlasmodium falciparum",
                    "sub_points": [
                      "Sickle cell trait (heterozygous carriers) conveys protection againstPlasmodium falciparum"
                    ]
                  },
                  {
                    "text": "Also found at much lower frequency in Mediterranean and Middle Eastern populations"
                  }
                ],
                "Site": [
                  {
                    "text": "HbS protein present only in red blood cellsResults in anemia and other widespread vascular problems related to adhesion and viscosityComplications can result in damage to multiple organs",
                    "sub_points": [
                      "Results in anemia and other widespread vascular problems related to adhesion and viscosity",
                      "Complications can result in damage to multiple organs"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Usually in early childhoodInfants protected by high HbF levels until about 6 months of age",
                    "sub_points": [
                      "Infants protected by high HbF levels until about 6 months of age"
                    ]
                  },
                  {
                    "text": "Chronic hemolytic anemia"
                  },
                  {
                    "text": "Pain"
                  },
                  {
                    "text": "Dactylitis"
                  },
                  {
                    "text": "Leukocytosis without infection"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Complete blood count (CBC)Chronic anemiaUsually normochromic normocyticCan be macrocytic if concurrent folate deficiency is present from rapid cell turnoverLeukocytosis &/or thrombocytosisFrequently seen with acute infection or stress from acute crisis",
                    "sub_points": [
                      "Chronic anemiaUsually normochromic normocyticCan be macrocytic if concurrent folate deficiency is present from rapid cell turnover",
                      "Usually normochromic normocytic",
                      "Can be macrocytic if concurrent folate deficiency is present from rapid cell turnover",
                      "Leukocytosis &/or thrombocytosisFrequently seen with acute infection or stress from acute crisis",
                      "Frequently seen with acute infection or stress from acute crisis"
                    ]
                  },
                  {
                    "text": "Reticulocyte countElevated, producing polychromasiaIndicates intact bone marrow response",
                    "sub_points": [
                      "Elevated, producing polychromasia",
                      "Indicates intact bone marrow response"
                    ]
                  },
                  {
                    "text": "Peripheral blood smear reviewSickled erythrocytesHowell-Jolly bodiesNucleated red blood cellsPolychromasia",
                    "sub_points": [
                      "Sickled erythrocytes",
                      "Howell-Jolly bodies",
                      "Nucleated red blood cells",
                      "Polychromasia"
                    ]
                  },
                  {
                    "text": "Hb electrophoresisNecessary for definitive diagnosisSingle band of HbS in homozygotesAbsence of HbACombination of HbS and HbA indicates sickle cell trait (asymptomatic)May show other abnormal Hb in compound heterozygotes",
                    "sub_points": [
                      "Necessary for definitive diagnosis",
                      "Single band of HbS in homozygotes",
                      "Absence of HbACombination of HbS and HbA indicates sickle cell trait (asymptomatic)",
                      "Combination of HbS and HbA indicates sickle cell trait (asymptomatic)",
                      "May show other abnormal Hb in compound heterozygotes"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Acute complicationsAcute painful (vaso-occlusive) crisisPrecipitating event may or may not be identifiedSevere pain in long bones &/or abdomenLasts several hours to daysAcute febrile illnessAcute splenic sequestrationParvovirus infectionParvovirus B19 infects early erythroid precursorsLeads to red cell aplasiaRapid drop in hemoglobinResults from combined aplasia and shortened RBC lifespanResolves in about a week with supportive care and treatmentAcute chest syndromeSystemic embolization of necrotic bone marrowLungs are major target organFrequency of acute complications highly variable between individuals but stays roughly constant in a given person",
                    "sub_points": [
                      "Acute painful (vaso-occlusive) crisisPrecipitating event may or may not be identifiedSevere pain in long bones &/or abdomenLasts several hours to days",
                      "Precipitating event may or may not be identified",
                      "Severe pain in long bones &/or abdomen",
                      "Lasts several hours to days",
                      "Acute febrile illness",
                      "Acute splenic sequestration",
                      "Parvovirus infectionParvovirus B19 infects early erythroid precursorsLeads to red cell aplasiaRapid drop in hemoglobinResults from combined aplasia and shortened RBC lifespanResolves in about a week with supportive care and treatment",
                      "Parvovirus B19 infects early erythroid precursors",
                      "Leads to red cell aplasia",
                      "Rapid drop in hemoglobin",
                      "Results from combined aplasia and shortened RBC lifespan",
                      "Resolves in about a week with supportive care and treatment",
                      "Acute chest syndromeSystemic embolization of necrotic bone marrowLungs are major target organ",
                      "Systemic embolization of necrotic bone marrow",
                      "Lungs are major target organ",
                      "Frequency of acute complications highly variable between individuals but stays roughly constant in a given person"
                    ]
                  },
                  {
                    "text": "Chronic complicationsNocturnal enuresisGrowth delayAvascular necrosis of hipGallstonesLearning difficultiesMay be associated with occult cerebral infarctsLeg ulcersPriapismSplenic hypofunctionStroke (cerebrovascular accident)Invasive pneumococcal disease",
                    "sub_points": [
                      "Nocturnal enuresis",
                      "Growth delay",
                      "Avascular necrosis of hip",
                      "Gallstones",
                      "Learning difficultiesMay be associated with occult cerebral infarcts",
                      "May be associated with occult cerebral infarcts",
                      "Leg ulcers",
                      "Priapism",
                      "Splenic hypofunction",
                      "Stroke (cerebrovascular accident)",
                      "Invasive pneumococcal disease"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Pneumococcal vaccination"
                  },
                  {
                    "text": "Penicillin prophylaxis"
                  },
                  {
                    "text": "Transfusion of blood products"
                  },
                  {
                    "text": "Bone marrow transplantationNot used in most casesLimited to cases with severe, persistent complicationsDifficulty finding HLA-matched sibling donor without disease",
                    "sub_points": [
                      "Not used in most casesLimited to cases with severe, persistent complications",
                      "Limited to cases with severe, persistent complications",
                      "Difficulty finding HLA-matched sibling donor without disease"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "Hydroxycarbamide (hydroxyurea)Only FDA-approved drug for SCAAntimetabolite chemotherapeutic agentStimulates HbF production, which is resistant to sicklingUnwanted side effects include reduced white blood cell and platelet numbersDecreases RBC adhesiveness to endotheliumWhen used from early age, may have protective effects against long-term complications of SCASuspected risk of carcinogenesis has not been proven in any major studies",
                    "sub_points": [
                      "Only FDA-approved drug for SCA",
                      "Antimetabolite chemotherapeutic agent",
                      "Stimulates HbF production, which is resistant to sickling",
                      "Unwanted side effects include reduced white blood cell and platelet numbers",
                      "Decreases RBC adhesiveness to endothelium",
                      "When used from early age, may have protective effects against long-term complications of SCA",
                      "Suspected risk of carcinogenesis has not been proven in any major studies"
                    ]
                  },
                  {
                    "text": "DecitabineAlternative or adjuvant to those with inadequate response to hydroxycarbamide5-azacytidine analogue that hypomethylates DNAResults in increased HbF production",
                    "sub_points": [
                      "Alternative or adjuvant to those with inadequate response to hydroxycarbamide",
                      "5-azacytidine analogue that hypomethylates DNA",
                      "Results in increased HbF production"
                    ]
                  },
                  {
                    "text": "Recombinant human erythropoietinAlso augments HbF productionOften used synergistically with hydroxycarbamidePossible ↑ risk of thrombosis under investigation",
                    "sub_points": [
                      "Also augments HbF production",
                      "Often used synergistically with hydroxycarbamide",
                      "Possible ↑ risk of thrombosis under investigation"
                    ]
                  },
                  {
                    "text": "Antisickling agentsPrevent RBC dehydration",
                    "sub_points": [
                      "Prevent RBC dehydration"
                    ]
                  },
                  {
                    "text": "VasodilatorsAid in prevention of vaso-occlusive complicationsInhaled nitric oxideArginineSildenafilStatins",
                    "sub_points": [
                      "Aid in prevention of vaso-occlusive complications",
                      "Inhaled nitric oxide",
                      "Arginine",
                      "Sildenafil",
                      "Statins"
                    ]
                  },
                  {
                    "text": "Other agents included in SCA managementAnti-adhesivesAntithromboticsSteroidsImmunomodulators",
                    "sub_points": [
                      "Anti-adhesives",
                      "Antithrombotics",
                      "Steroids",
                      "Immunomodulators"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Favorable indicatorsElevated HbF (> 20%) associated with fewer clinical events",
                    "sub_points": [
                      "Elevated HbF (> 20%) associated with fewer clinical events"
                    ]
                  },
                  {
                    "text": "Poor indicatorsLow HbF concentrationDactylitis in infantsHemoglobin < 7 g/dLLeukocytosis in absence of infection",
                    "sub_points": [
                      "Low HbF concentration",
                      "Dactylitis in infants",
                      "Hemoglobin < 7 g/dL",
                      "Leukocytosis in absence of infection"
                    ]
                  }
                ]
              },
              "Image Findings": {
                "Radiographic Findings": [
                  {
                    "text": "\"Fish vertebra\" sign"
                  },
                  {
                    "text": "Infarcts of bone"
                  },
                  {
                    "text": "Avascular necrosis"
                  },
                  {
                    "text": "Marrow expansion due to pervasive erythropoiesis"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Bone marrow biopsy generally not indicated"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Peripheral blood smearSickle cellsHowell-Jolly bodies indicate functional asplenismNucleated red blood cellsIncreased polychromasiaMay see other types of cells in compound heterozygotesTarget cells and boat-shaped cells in SC disease",
                    "sub_points": [
                      "Sickle cells",
                      "Howell-Jolly bodies indicate functional asplenism",
                      "Nucleated red blood cells",
                      "Increased polychromasia",
                      "May see other types of cells in compound heterozygotesTarget cells and boat-shaped cells in SC disease",
                      "Target cells and boat-shaped cells in SC disease"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Hemoglobin S/β Thalassemia": [
                  {
                    "text": "Microcytic hypochromic anemia"
                  },
                  {
                    "text": "Abundant target cells on peripheral blood smear"
                  },
                  {
                    "text": "Hemoglobin electrophoresis is definitiveProminent HbS and HbA bandsUnlike sickle cell trait, HbS > HbASmall components of HbA₂ and HbF are also present",
                    "sub_points": [
                      "Prominent HbS and HbA bandsUnlike sickle cell trait, HbS > HbA",
                      "Unlike sickle cell trait, HbS > HbA",
                      "Small components of HbA₂ and HbF are also present"
                    ]
                  }
                ],
                "Hemoglobin SC Disease": [
                  {
                    "text": "Peripheral blood smearAbundant target cellsBoat-shaped cells vary slightly from typical sickle cells",
                    "sub_points": [
                      "Abundant target cells",
                      "Boat-shaped cells vary slightly from typical sickle cells"
                    ]
                  },
                  {
                    "text": "Hb electrophoresisProminent bands in HbS and HbC positionsNo HbA is observed",
                    "sub_points": [
                      "Prominent bands in HbS and HbC positions",
                      "No HbA is observed"
                    ]
                  },
                  {
                    "text": "Clinical syndrome often milder than HbSS disease"
                  }
                ],
                "Microangiopathic Hemolytic Anemia": [
                  {
                    "text": "Subtypes include disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura (TTP)"
                  },
                  {
                    "text": "Features include anemia, thrombocytopenia, and schistocytes that could be confused with sickle cells"
                  },
                  {
                    "text": "Different clinical presentation from sickle cell anemia"
                  },
                  {
                    "text": "Normal results on Hb electrophoresis"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Sickle cells on peripheral blood smear"
                  },
                  {
                    "text": "HbS as major component on Hb electrophoresis"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Sickle cells should be distinguished from schistocytes of microangiopathic hemolytic anemiaCorrelate with clinical history and other laboratory findings",
                    "sub_points": [
                      "Correlate with clinical history and other laboratory findings"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Congenital Adrenal Hyperplasia": {
            "name": "Congenital Adrenal Hyperplasia",
            "url": "https://app.pathprimer.com/document/4ce295d2-b6ef-464b-aa32-7f43ac0369be/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Beckwith-Wiedemann syndromeCharacterized by adrenal cytomegalyAssociated with adrenal cortical neoplasms",
                    "sub_points": [
                      "Characterized by adrenal cytomegaly",
                      "Associated with adrenal cortical neoplasms"
                    ]
                  },
                  {
                    "text": "Li-Fraumeni syndrome"
                  },
                  {
                    "text": "Congenital adrenal hyperplasiaACA and ACC have been associated with adrenogenital syndrome",
                    "sub_points": [
                      "ACA and ACC have been associated with adrenogenital syndrome"
                    ]
                  },
                  {
                    "text": "HemihypertrophyAdrenal cortical neoplasms have been associated with hemihypertrophy in children",
                    "sub_points": [
                      "Adrenal cortical neoplasms have been associated with hemihypertrophy in children"
                    ]
                  },
                  {
                    "text": "Multiple endocrine neoplasia type 1"
                  },
                  {
                    "text": "Carney complex"
                  },
                  {
                    "text": "Familial adenomatous polyposis; Lynch syndrome"
                  },
                  {
                    "text": "Neurofibromatosis type 1 (NF1)"
                  },
                  {
                    "text": "McCune-Albright syndrome"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Annual incidence is 3:1,000,000 patients < 20 years old"
                  },
                  {
                    "text": "Females have higher incidence until 5 years of age, after which sex difference disappears"
                  },
                  {
                    "text": "Most cases occur in patients < 5 years old"
                  },
                  {
                    "text": "> 90% of children with adrenal cortical neoplasms present with symptoms of endocrine syndrome"
                  },
                  {
                    "text": "Most common presentation is virilization"
                  },
                  {
                    "text": "Adrenal cortical tumors in children more frequently show adverse histologic features in clinically benign tumors as compared to adult tumors"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Mostly unilateral; bilateral tumors are extremely rare"
                  },
                  {
                    "text": "Tumors with better prognoses have average size of 6 cm, while those with worse prognosis have average size of 12 cm"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Pediatric tumors differ from adult adrenal cortical neoplasms in that those features associated with malignancy in adults can sometimes be seen in clinically benign tumors in children"
                  },
                  {
                    "text": "Different architectural patterns are seenAlveolar: Most common pattern in ACATrabecular: Commonly seen in ACCSolid",
                    "sub_points": [
                      "Alveolar: Most common pattern in ACA",
                      "Trabecular: Commonly seen in ACC",
                      "Solid"
                    ]
                  },
                  {
                    "text": "Confluent necrosis is a histologic feature; adverse prognostic finding if > 25%"
                  },
                  {
                    "text": "Capsular and vascular invasion"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Adrenal cortical neoplasm (ACN)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Adrenal cortical adenoma (ACA)"
                  },
                  {
                    "text": "Adrenal cortical carcinoma (ACC)"
                  },
                  {
                    "text": "Adrenal cortical tumor"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Neoplasms arising from the adrenal cortical cells"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Beckwith-Wiedemann Syndrome (BWS)": [
                  {
                    "text": "Involves chromosome 11p15.5 in ~ 80% of casesIGF2andKCNQ1OT1are normally expressed from paternal alleleH19,CDKN1C, andKCNQ1are normally expressed from maternal allele",
                    "sub_points": [
                      "IGF2andKCNQ1OT1are normally expressed from paternal allele",
                      "H19,CDKN1C, andKCNQ1are normally expressed from maternal allele"
                    ]
                  },
                  {
                    "text": "Characterized by adrenal cytomegaly"
                  },
                  {
                    "text": "Associated with adrenal cortical neoplasms"
                  },
                  {
                    "text": "Characterized by embryonal tumor in childhoodMain tumors associated with BWS are nephroblastoma, ACC, and hepatoblastoma",
                    "sub_points": [
                      "Main tumors associated with BWS are nephroblastoma, ACC, and hepatoblastoma"
                    ]
                  },
                  {
                    "text": "Characteristic facies in early childhood (often normal by adulthood)"
                  },
                  {
                    "text": "Somatic overgrowth"
                  },
                  {
                    "text": "Classic triadExomphalosGigantismMacroglossia",
                    "sub_points": [
                      "Exomphalos",
                      "Gigantism",
                      "Macroglossia"
                    ]
                  }
                ],
                "Li-Fraumeni Syndrome": [
                  {
                    "text": "A.k.a.  SBLA syndrome:Sarcoma;breast andbrain tumors;leukemia,laryngeal carcinoma, andlung cancer;adrenal cortical carcinoma"
                  },
                  {
                    "text": "Endometrial carcinoma"
                  },
                  {
                    "text": "Autosomal dominant mode of inheritance"
                  },
                  {
                    "text": "Alterations inP53tumor suppressor gene have been detected"
                  },
                  {
                    "text": "Most common associated neoplasms are soft tissue sarcomas, bone sarcomas, and breast carcinoma"
                  }
                ],
                "Congenital Adrenal Hyperplasia": [
                  {
                    "text": "ACA and ACC have been associated with congenital adrenal hyperplasia (CAH)(adrenogenital syndrome)"
                  },
                  {
                    "text": "Associated with testicular tumors of adrenal cortical type"
                  }
                ],
                "Hemihypertrophy": [
                  {
                    "text": "Adrenal cortical neoplasms have been associated with hemihypertrophy in children"
                  },
                  {
                    "text": "Adrenal neoplasms are not necessarily located ipsilateral to hemihypertrophy"
                  },
                  {
                    "text": "Other associated tumors are Wilms tumor, hepatoblastoma, and pheochromocytoma"
                  }
                ],
                "Other Syndromes": [
                  {
                    "text": "Multiple endocrine neoplasia type 1 (MEN1)"
                  },
                  {
                    "text": "Carney complex"
                  },
                  {
                    "text": "McCune-Albright syndrome"
                  },
                  {
                    "text": "Neurofibromatosis type 1 (NF1)"
                  },
                  {
                    "text": "Familial adenomatous polyposis; Lynch syndrome"
                  },
                  {
                    "text": "Hereditary nonpolyposis colorectal cancer (HNPCC)"
                  }
                ],
                "Sporadic": [
                  {
                    "text": "Rare cases in children are nonsyndromic"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "~ 20 new ACC cases per year"
                  },
                  {
                    "text": "~ 25 new cases of ACA per year in United States in patients < 20 years of age"
                  },
                  {
                    "text": "Annual incidence is 3:1,000,000 patients < 20 years old"
                  },
                  {
                    "text": "Females have higher incidence until 5 years of age, after which sex difference disappears"
                  },
                  {
                    "text": "Adrenal cortical neoplasms constitute 0.2% of all malignancies observed in children"
                  }
                ],
                "Age": [
                  {
                    "text": "Average at presentation: 8 years oldMost cases occur in patients < 5 years old",
                    "sub_points": [
                      "Most cases occur in patients < 5 years old"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "> 90% of children with adrenal cortical neoplasms present with symptoms of endocrine syndrome"
                  },
                  {
                    "text": "Functionally active tumors account for > 80%"
                  },
                  {
                    "text": "Most common presentation is virilizationExpressed in femalesIncreased muscle mass, clitoromegaly, facial hair, pubic hair, deepening of voiceExpressed in malesPenile enlargement, pubic hair",
                    "sub_points": [
                      "Expressed in femalesIncreased muscle mass, clitoromegaly, facial hair, pubic hair, deepening of voice",
                      "Increased muscle mass, clitoromegaly, facial hair, pubic hair, deepening of voice",
                      "Expressed in malesPenile enlargement, pubic hair",
                      "Penile enlargement, pubic hair"
                    ]
                  },
                  {
                    "text": "May present with Cushing syndromeIf so, syndrome is usually associated with virilization",
                    "sub_points": [
                      "If so, syndrome is usually associated with virilization"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Adrenal cortical tumors in children more frequently show adverse histologic features in clinically benign tumors vs. adult tumors"
                  },
                  {
                    "text": "Adverse prognostic factors in pediatric tumorsOlder age at diagnosis: > 5 years of ageAverage tumor size: 12 cmTumor weight: > 400 gMitotic count: > 30 per 50 HPFAverage tumor necrosis: 60%Vascular &/or capsular invasionTumor ploidy has been shownnotto correlate with outcome",
                    "sub_points": [
                      "Older age at diagnosis: > 5 years of age",
                      "Average tumor size: 12 cm",
                      "Tumor weight: > 400 g",
                      "Mitotic count: > 30 per 50 HPF",
                      "Average tumor necrosis: 60%",
                      "Vascular &/or capsular invasion",
                      "Tumor ploidy has been shownnotto correlate with outcome"
                    ]
                  },
                  {
                    "text": "Most frequent sites of metastases are lung and liver; other places are peritoneum, pleura/diaphragm, abdominal lymph nodes, and kidneys"
                  }
                ],
                "Associated Neoplasms": [
                  {
                    "text": "BWSWilms tumorHepatoblastomaRhabdomyosarcomaNeuroblastoma",
                    "sub_points": [
                      "Wilms tumor",
                      "Hepatoblastoma",
                      "Rhabdomyosarcoma",
                      "Neuroblastoma"
                    ]
                  },
                  {
                    "text": "Li-Fraumeni syndrome (a.k.a. SBLA syndrome)Endometrial carcinoma",
                    "sub_points": [
                      "Endometrial carcinoma"
                    ]
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Mostly unilateral; bilateral tumors are extremely rare"
                  }
                ],
                "Size": [
                  {
                    "text": "Wide range: 2.5-20 cm"
                  },
                  {
                    "text": "Tumors with better prognosis have average size of 6 cm, whereas those with worse prognosis have average size of 12 cm"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Pediatric tumors differ from adult adrenal cortical neoplasms in that those features associated with malignancy in adults can sometimes be seen in clinically benign tumors in childrenCapsular invasionConfluent necrosis (adverse prognostic finding if > 25%)Vascular invasion",
                    "sub_points": [
                      "Capsular invasion",
                      "Confluent necrosis (adverse prognostic finding if > 25%)",
                      "Vascular invasion"
                    ]
                  },
                  {
                    "text": "Different architectural patterns are seenAlveolar pattern is most common pattern in ACATrabecular (commonly seen in malignant neoplasms)Solid",
                    "sub_points": [
                      "Alveolar pattern is most common pattern in ACA",
                      "Trabecular (commonly seen in malignant neoplasms)",
                      "Solid"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Nuclear pleomorphism"
                  },
                  {
                    "text": "Some can have oncocytic features"
                  },
                  {
                    "text": "Nuclear hyperchromasia"
                  },
                  {
                    "text": "Mitosis: Few figures can be seen in clinically benign tumors; sign of malignancy if numerous (> 30 per 50 HPF)"
                  },
                  {
                    "text": "Intracytoplasmic hyaline globules"
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "Positive for adrenal cortical markers such as inhibin, synaptophysin, chromogranin, and Melan-A"
                  },
                  {
                    "text": "Negative for cytokeratin (rarely may be positive)"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Pheochromocytoma": [
                  {
                    "text": "Positive for chromogranin; negative for inhibin and MART-1"
                  }
                ],
                "Renal Cell Carcinoma": [
                  {
                    "text": "Negative for chromogranin"
                  }
                ],
                "Other Primary or Metastatic Neoplasms": [
                  {
                    "text": "Neuroblastoma, Wilms tumor, hepatoblastoma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Spinal Muscular Atrophy": {
            "name": "Spinal Muscular Atrophy",
            "url": "https://app.pathprimer.com/document/0b7b9b2a-f1e8-4e4a-8afe-6be0d92198f1/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Spinal muscular atrophy (SMA) types I-IV, including infantile SMA type I, or Werdnig-Hoffmann disease"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Most often a deletion or truncation ofSMN1gene at chromosome 5q 11.2-13.3"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "2nd most common lethal, autosomal recessive disease in Caucasians after cystic fibrosis"
                  },
                  {
                    "text": "Tongue fasciculations are seen in all types of SMA"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "SMA type I: Classic pattern of variable atrophy of types I and II fibers and clusters of enlarged type I fibers"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Spinal muscular atrophy (SMA)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Wide range of mostly autosomal recessive neuromuscular disorders due to degeneration of spinal anterior horn motor neuronsLeads to symmetrical muscle weakness and atrophy",
                    "sub_points": [
                      "Leads to symmetrical muscle weakness and atrophy"
                    ]
                  },
                  {
                    "text": "4 types describedSMA type ISevere infantile acute SMA, or Werdnig-Hoffmann diseaseSMA type IIInfantile chronic SMASMA type IIIJuvenile SMA, or Wohlfart-Kugelberg-Welander diseaseSMA type IVAdult-onset SMA",
                    "sub_points": [
                      "SMA type ISevere infantile acute SMA, or Werdnig-Hoffmann disease",
                      "Severe infantile acute SMA, or Werdnig-Hoffmann disease",
                      "SMA type IIInfantile chronic SMA",
                      "Infantile chronic SMA",
                      "SMA type IIIJuvenile SMA, or Wohlfart-Kugelberg-Welander disease",
                      "Juvenile SMA, or Wohlfart-Kugelberg-Welander disease",
                      "SMA type IVAdult-onset SMA",
                      "Adult-onset SMA"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Deletion or Truncation ofSMN1": [
                  {
                    "text": "At chromosome 5q 11.2-13.3 leads to enhanced neuronal death in anterior horns of spinal cord"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "2nd most common lethal, autosomal recessive disease in Caucasians after cystic fibrosis"
                  },
                  {
                    "text": "5-7 per 100,000 live births in United States"
                  },
                  {
                    "text": "Carrier rate: 1 in 80"
                  }
                ],
                "Gender": [
                  {
                    "text": "M:F ratio is 1:1, favoring males as age of disease onset increases"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Proximal weakness"
                  },
                  {
                    "text": "Diaphragm, cardiac, and smooth muscles spared"
                  },
                  {
                    "text": "Tongue fasciculations due to degeneration of the hypoglossal nucleus are seen in all types of SMA, but rarely in SMA type III"
                  },
                  {
                    "text": "SMA type IOnset: Birth to age 6 monthsFloppy infant, never able to roll over or sit",
                    "sub_points": [
                      "Onset: Birth to age 6 months",
                      "Floppy infant, never able to roll over or sit"
                    ]
                  },
                  {
                    "text": "SMA type IIOnset: 6-12 monthsMuscular weakness greater in legs; never ambulate",
                    "sub_points": [
                      "Onset: 6-12 months",
                      "Muscular weakness greater in legs; never ambulate"
                    ]
                  },
                  {
                    "text": "SMA type IIIOnset: 2-15 yearsDifficulty climbing stairs, standing up from floor/seated position",
                    "sub_points": [
                      "Onset: 2-15 years",
                      "Difficulty climbing stairs, standing up from floor/seated position"
                    ]
                  },
                  {
                    "text": "SMA type IVOnset: Young/middle adulthood",
                    "sub_points": [
                      "Onset: Young/middle adulthood"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "SMA type IRespiratory failure with pneumonia is most frequent cause of death, usually before age of 2 years",
                    "sub_points": [
                      "Respiratory failure with pneumonia is most frequent cause of death, usually before age of 2 years"
                    ]
                  },
                  {
                    "text": "SMA type IIMost patients live into adulthood barring respiratory complications",
                    "sub_points": [
                      "Most patients live into adulthood barring respiratory complications"
                    ]
                  },
                  {
                    "text": "SMA types III and IVLife expectancy is normal or near normal",
                    "sub_points": [
                      "Life expectancy is normal or near normal"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "SMA types I and IISMA type IEarly: May only be subtle variation in fiber sizesMore advanced cases display characteristic appearance with variable rounding of atrophic types I and II fibers and clusters of markedly enlarged type I fibersSMA type IIShows similar findings with grouped atrophy and type 1 fiber predominanceSMA types III and IVShows variable denervation atrophy and fiber type grouping",
                    "sub_points": [
                      "SMA type IEarly: May only be subtle variation in fiber sizesMore advanced cases display characteristic appearance with variable rounding of atrophic types I and II fibers and clusters of markedly enlarged type I fibers",
                      "Early: May only be subtle variation in fiber sizes",
                      "More advanced cases display characteristic appearance with variable rounding of atrophic types I and II fibers and clusters of markedly enlarged type I fibers",
                      "SMA type IIShows similar findings with grouped atrophy and type 1 fiber predominance",
                      "Shows similar findings with grouped atrophy and type 1 fiber predominance",
                      "SMA types III and IVShows variable denervation atrophy and fiber type grouping",
                      "Shows variable denervation atrophy and fiber type grouping"
                    ]
                  },
                  {
                    "text": "Autopsy spinal cord examinationShows loss of spinal anterior horn motor neurons and atrophy of anterior roots and degeneration of motor neurons in cranial nerve nuclei V to XII in severe SMA",
                    "sub_points": [
                      "Shows loss of spinal anterior horn motor neurons and atrophy of anterior roots and degeneration of motor neurons in cranial nerve nuclei V to XII in severe SMA"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Genetic Testing": [
                  {
                    "text": "Most cases of SMA type I are diagnosed by genetic testing of hypotonic infants"
                  },
                  {
                    "text": "95% of SMA patients have a homozygous deletion ofSMN1exon 7"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Diseases Causing Degeneration of Anterior Horn Motor Neurons": [
                  {
                    "text": "Autosomal recessive distal spinal muscular atrophy 1 (DSMA1)a.k.a. SMA with respiratory distress (SMARD1), chromosome 11q13",
                    "sub_points": [
                      "a.k.a. SMA with respiratory distress (SMARD1), chromosome 11q13"
                    ]
                  },
                  {
                    "text": "SCO2 deficiency with cytochrome oxidase negative myofibers"
                  },
                  {
                    "text": "Pontocerebellar hypoplasia with infantile SMA"
                  },
                  {
                    "text": "SMA type I with congenital bone fractures"
                  },
                  {
                    "text": "Neuronal storage diseases affecting spinal anterior horn motor neurons"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Neurogenic atrophy with small rounded fibers with marked hypertrophy of type I fibers in absence of myopathic changes should suggest SMA type I"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "X-Linked Muscular Dystrophies": {
            "name": "X-Linked Muscular Dystrophies",
            "url": "https://app.pathprimer.com/document/39be708b-fdcc-4b1c-b2f9-d677539de86a/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD)Affect males and rarely females through X-inactivation1/3 of cases are result of new mutations",
                    "sub_points": [
                      "Affect males and rarely females through X-inactivation",
                      "1/3 of cases are result of new mutations"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Young boy with progressive proximal weakness, calf hypertrophy, and raised creatine kinase (CK) levels often results in a diagnosis of DMD"
                  },
                  {
                    "text": "Multisystem disease with muscle, cardiac, gastrointestinal, and cognitive abnormalities"
                  },
                  {
                    "text": "Gowers sign: Nonspecific manifestation of proximal leg weakness, with patient rising from floor with buttocks up 1st, using arms to climb up legs while buttocks remain elevated"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "No histologic features specific for DMD or BMD"
                  },
                  {
                    "text": "Diagnosis by immunohistochemistry in muscle biopsies"
                  },
                  {
                    "text": "BMD may be missed if anti-rod antibody does not recognize absent portion of rod domain"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Most cases are diagnosed by blood genetic studies"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Other X-linked myopathiesEmery-Dreifuss muscular dystrophy and Danon diseaseMale involvement in severe autosomal dominant and recessive limb girdle muscular dystrophies",
                    "sub_points": [
                      "Emery-Dreifuss muscular dystrophy and Danon disease",
                      "Male involvement in severe autosomal dominant and recessive limb girdle muscular dystrophies"
                    ]
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Duchenne muscular dystrophy (DMD)"
                  },
                  {
                    "text": "Becker muscular dystrophy (BMD)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "DMD and BMD: Hereditary diseases caused by mutations of dystrophin gene at locus Xp21"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "DMD1 per 3,300 boys",
                    "sub_points": [
                      "1 per 3,300 boys"
                    ]
                  },
                  {
                    "text": "BMD1 per ≤ 10,000 male births",
                    "sub_points": [
                      "1 per ≤ 10,000 male births"
                    ]
                  },
                  {
                    "text": "1/3 of DMD cases are result of new mutation"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Usually asymptomatic at birth"
                  },
                  {
                    "text": "DMDEarly ageGross motor delayDifficulty running and climbingFrequent fallsEnlarged calf muscles3-6 yearsWaddling gaitGowers sign: Nonspecific manifestation of proximal leg weakness, with patients rising from the floor with buttocks up 1st, using arms to climb up legs while buttocks remain elevatedProximal weaknessGreater in legsAverage IQ of 80–90, 1 standard deviation below meanVerbal IQ more impaired than performance IQ6-11 yearsSteady decline in strength with sparing of extraocular and facial muscles2nd decadeLoss of ambulationProgressive kyphoscoliosisRespiratory muscle weaknessDeath usually due to respiratory failure and infectionFrequent cardiac involvementAbnormal rate, rhythm, conduction, and EKG",
                    "sub_points": [
                      "Early ageGross motor delayDifficulty running and climbingFrequent fallsEnlarged calf muscles",
                      "Gross motor delay",
                      "Difficulty running and climbing",
                      "Frequent falls",
                      "Enlarged calf muscles",
                      "3-6 yearsWaddling gaitGowers sign: Nonspecific manifestation of proximal leg weakness, with patients rising from the floor with buttocks up 1st, using arms to climb up legs while buttocks remain elevatedProximal weaknessGreater in legsAverage IQ of 80–90, 1 standard deviation below meanVerbal IQ more impaired than performance IQ",
                      "Waddling gait",
                      "Gowers sign: Nonspecific manifestation of proximal leg weakness, with patients rising from the floor with buttocks up 1st, using arms to climb up legs while buttocks remain elevated",
                      "Proximal weakness",
                      "Greater in legs",
                      "Average IQ of 80–90, 1 standard deviation below mean",
                      "Verbal IQ more impaired than performance IQ",
                      "6-11 yearsSteady decline in strength with sparing of extraocular and facial muscles",
                      "Steady decline in strength with sparing of extraocular and facial muscles",
                      "2nd decadeLoss of ambulationProgressive kyphoscoliosisRespiratory muscle weaknessDeath usually due to respiratory failure and infection",
                      "Loss of ambulation",
                      "Progressive kyphoscoliosis",
                      "Respiratory muscle weakness",
                      "Death usually due to respiratory failure and infection",
                      "Frequent cardiac involvementAbnormal rate, rhythm, conduction, and EKG",
                      "Abnormal rate, rhythm, conduction, and EKG"
                    ]
                  },
                  {
                    "text": "BMDMean age at onset: 12 yearsRange: 1-70 yearsMean age at loss of ambulation: 4th decadeRange: 10-78 yearsCardiac involvement common, including X-linked dilated cardiomyopathyInfertility varies with severitySpectrum also includes asymptomatic hyper-CKemia, cramps and myalgia, quadriceps myopathy",
                    "sub_points": [
                      "Mean age at onset: 12 yearsRange: 1-70 years",
                      "Range: 1-70 years",
                      "Mean age at loss of ambulation: 4th decadeRange: 10-78 years",
                      "Range: 10-78 years",
                      "Cardiac involvement common, including X-linked dilated cardiomyopathy",
                      "Infertility varies with severity",
                      "Spectrum also includes asymptomatic hyper-CKemia, cramps and myalgia, quadriceps myopathy"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Glucocorticoids prolong ambulation"
                  },
                  {
                    "text": "Gene therapy approachesGene replacementExon skipping with antisense oligonucleotidesUpregulation of genes that act as dystrophin surrogates",
                    "sub_points": [
                      "Gene replacement",
                      "Exon skipping with antisense oligonucleotides",
                      "Upregulation of genes that act as dystrophin surrogates"
                    ]
                  },
                  {
                    "text": "Cell therapy-based treatments augment muscle progenitor cell potential"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "DMD and BMDMyofiber necrosisRegenerationEndomysial fibrosis and fiber \"splitting\"Marked variation in fiber sizesIncrease in internally placed nucleiFiber-type distinction by myosin ATPase enzyme histochemistry is diminishedDMD and severe BMD may show similar features, but DMD generally shows greater degree of acute dystrophic features, such asMyofibers necrosisMyophagocytosis by macrophagesMild BMD may show only subtle increases in endomysial fibrosis, focal inflammation, or regenerating clusters",
                    "sub_points": [
                      "Myofiber necrosis",
                      "Regeneration",
                      "Endomysial fibrosis and fiber \"splitting\"",
                      "Marked variation in fiber sizes",
                      "Increase in internally placed nuclei",
                      "Fiber-type distinction by myosin ATPase enzyme histochemistry is diminished",
                      "DMD and severe BMD may show similar features, but DMD generally shows greater degree of acute dystrophic features, such asMyofibers necrosisMyophagocytosis by macrophages",
                      "Myofibers necrosis",
                      "Myophagocytosis by macrophages",
                      "Mild BMD may show only subtle increases in endomysial fibrosis, focal inflammation, or regenerating clusters"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "DMD and BMD may be diagnosed and distinguished by immunohistochemistry for components of dystrophin moleculeDMDVariable preservation of N-terminus and extensive loss of C-terminus staining, except for revertant fibersRod domain staining is generally absentBMDPreservation of or mildly diminished N- and C-terminus staining and absence of rod domain staining if antigenic determinant is missingMay be missed if anti-rod domain antibody recognizes preserved portion of rod domain when separate portion is missing",
                    "sub_points": [
                      "DMDVariable preservation of N-terminus and extensive loss of C-terminus staining, except for revertant fibersRod domain staining is generally absent",
                      "Variable preservation of N-terminus and extensive loss of C-terminus staining, except for revertant fibers",
                      "Rod domain staining is generally absent",
                      "BMDPreservation of or mildly diminished N- and C-terminus staining and absence of rod domain staining if antigenic determinant is missingMay be missed if anti-rod domain antibody recognizes preserved portion of rod domain when separate portion is missing",
                      "Preservation of or mildly diminished N- and C-terminus staining and absence of rod domain staining if antigenic determinant is missing",
                      "May be missed if anti-rod domain antibody recognizes preserved portion of rod domain when separate portion is missing"
                    ]
                  }
                ],
                "Molecular Genetics": [
                  {
                    "text": "Majority of cases may be diagnosed by molecular genetic testing using peripheral blood leukocytes"
                  },
                  {
                    "text": "Chorionic villi and amniotic fluid samples may also be tested"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Other X-linked Myopathies": [
                  {
                    "text": "Emery-Dreifuss muscular dystrophy and Danon disease"
                  }
                ],
                "Severe Autosomal Dominant and Recessive Limb Girdle Muscular Dystrophies": [
                  {
                    "text": "With male involvement, considered in the differential diagnosis of DMD and BMD"
                  },
                  {
                    "text": "Normal dystrophin levels"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Dystrophic muscle changes in boysImmunohistochemistry should be performed for abnormalities in dystrophin",
                    "sub_points": [
                      "Immunohistochemistry should be performed for abnormalities in dystrophin"
                    ]
                  },
                  {
                    "text": "BMD may show only subtle increases in connective tissue, a few regenerative fibers, or focal inflammation"
                  },
                  {
                    "text": "Focal dystrophic changes in female muscle biopsiesMay reflect regional X-inactivation and will show concomitant loss of dystrophin immunostaining",
                    "sub_points": [
                      "May reflect regional X-inactivation and will show concomitant loss of dystrophin immunostaining"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Chronic Granulomatous Disease": {
            "name": "Chronic Granulomatous Disease",
            "url": "https://app.pathprimer.com/document/28510650-a7e1-4bc3-bdeb-6eec0c70bb54/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Disease in which leukocytes cannot eliminate phagocytosed microorganisms, resulting in recurrent infections and granulomas"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Prevalence: 1 in 1 million people; 1 in 250,000 births"
                  },
                  {
                    "text": "Recurrent infections presenting as pneumonia, abscesses, osteomyelitis, and bacteremia"
                  },
                  {
                    "text": "Usually detected by 5 years of age"
                  },
                  {
                    "text": "More common in boys since it is often X-linked"
                  },
                  {
                    "text": "Testing includes nitroblue tetrazolium reduction test, flow cytometry, and others"
                  },
                  {
                    "text": "Antibiotic treatment for active infections as well as prophylactically"
                  },
                  {
                    "text": "Improving prognosisPatients can live until adulthood",
                    "sub_points": [
                      "Patients can live until adulthood"
                    ]
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Necrotizing granulomas with abscesses in white pulp or red pulp"
                  },
                  {
                    "text": "± abscess formation"
                  },
                  {
                    "text": "Organisms may be difficult to identify in spleen"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Special stains (e.g., Fite, GMS, Brown-Hopp, Warthin-Starry) used to detect organisms"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Bacterial infections and fungal infections show necrotizing granulomas"
                  },
                  {
                    "text": "Crohn disease can have granulomas"
                  },
                  {
                    "text": "Other defects in leukocyte function, e.g., Chédiak-Higashi syndrome"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Chronic granulomatous disease (CGD)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Bridges–Good syndrome, Quie syndrome, fatal granulomatosis of childhood"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Genetically determined enzymatic deficiency in a component of phagocyte NADPH oxidase characterized by impaired destruction of phagocytosed microorganismsPhagocytes in CGD patients engulf microorganisms but cannot destroy them, because they do not activate oxygen-dependent killing mechanismsPatients cannot form reactive oxygen compoundsMicroorganisms are surrounded by macrophages, forming granulomas",
                    "sub_points": [
                      "Phagocytes in CGD patients engulf microorganisms but cannot destroy them, because they do not activate oxygen-dependent killing mechanismsPatients cannot form reactive oxygen compoundsMicroorganisms are surrounded by macrophages, forming granulomas",
                      "Patients cannot form reactive oxygen compounds",
                      "Microorganisms are surrounded by macrophages, forming granulomas"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Defective Phagocyte NADPH Oxidase": [
                  {
                    "text": "Defect can be in any component of NADPH oxidase"
                  },
                  {
                    "text": "NADPH has membrane-bound componentsgp91-phox, p22-phox, rap1a",
                    "sub_points": [
                      "gp91-phox, p22-phox, rap1a"
                    ]
                  },
                  {
                    "text": "NADPH has cytoplasmic componentsp47-phox, p40-phox, p67-phox, rac2",
                    "sub_points": [
                      "p47-phox, p40-phox, p67-phox, rac2"
                    ]
                  },
                  {
                    "text": "Mutations can be deletions, frame shift, nonsense, and missense"
                  },
                  {
                    "text": "~ 65% of patients have defect in gp91-phox, which presents as X-linked disease"
                  },
                  {
                    "text": "~ 35% of patients have cytoplasmic component defect, which presents as autosomal recessive defectMost common autosomal recessive defect is in p47-phox",
                    "sub_points": [
                      "Most common autosomal recessive defect is in p47-phox"
                    ]
                  },
                  {
                    "text": "Low levels of NADPH can also cause CGDWomen homozygous for glucose-6-phosphate dehydrogenase deficiency (G6PD) can have decreased NADPH levels",
                    "sub_points": [
                      "Women homozygous for glucose-6-phosphate dehydrogenase deficiency (G6PD) can have decreased NADPH levels"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1 per 200,000 people in United States"
                  },
                  {
                    "text": "~ 20 new cases diagnosed each year"
                  }
                ],
                "Age": [
                  {
                    "text": "Onset: Usually < 1 year of age"
                  },
                  {
                    "text": "Diagnosis: Usually ~ 5 years of ageMild disease may not be diagnosed until teen years or adulthood",
                    "sub_points": [
                      "Mild disease may not be diagnosed until teen years or adulthood"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Severe, recurrent infections in any organ systemPresenting as pneumonia, abscesses, osteomyelitis, and bacteremiaInfection by catalase-producing organismsOftenStaphylococcus aureus,Serratia marcescens,Salmonella,Klebsiella,Pseudomonas cepacia,Nocardia,Aspergillus,Candida",
                    "sub_points": [
                      "Presenting as pneumonia, abscesses, osteomyelitis, and bacteremia",
                      "Infection by catalase-producing organismsOftenStaphylococcus aureus,Serratia marcescens,Salmonella,Klebsiella,Pseudomonas cepacia,Nocardia,Aspergillus,Candida",
                      "OftenStaphylococcus aureus,Serratia marcescens,Salmonella,Klebsiella,Pseudomonas cepacia,Nocardia,Aspergillus,Candida"
                    ]
                  },
                  {
                    "text": "Frequent lymphadenopathy, impetigo, abscesses, pneumonia, and osteomyelitisLymphadenopathy is most common finding",
                    "sub_points": [
                      "Lymphadenopathy is most common finding"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Nitroblue tetrazolium (NBT) reduction test is standardTests oxidase-producing capacity of neutrophilsNegative in CGD due to impaired NADPH oxidaseCells in males with CGD: All negativeCells in females with CGD: Some positive (normal), some negative (abnormal)",
                    "sub_points": [
                      "Tests oxidase-producing capacity of neutrophils",
                      "Negative in CGD due to impaired NADPH oxidaseCells in males with CGD: All negativeCells in females with CGD: Some positive (normal), some negative (abnormal)",
                      "Cells in males with CGD: All negative",
                      "Cells in females with CGD: Some positive (normal), some negative (abnormal)"
                    ]
                  },
                  {
                    "text": "Newer alternative tests exist"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Antibiotics and antifungals to treat active infectionAlso taken prophylactically to prevent infection",
                    "sub_points": [
                      "Also taken prophylactically to prevent infection"
                    ]
                  },
                  {
                    "text": "Interferon"
                  },
                  {
                    "text": "Hematopoietic stem cell transplant possibly curative"
                  },
                  {
                    "text": "Abscesses treated surgically"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Improving, with early death usually due to infectionAnnual mortality rate: 2-5%Average survival: ~ 20 yearsMost common cause of death:Aspergillus",
                    "sub_points": [
                      "Annual mortality rate: 2-5%",
                      "Average survival: ~ 20 years",
                      "Most common cause of death:Aspergillus"
                    ]
                  },
                  {
                    "text": "X-linked cases: 20% of patients die by 10 years of age"
                  },
                  {
                    "text": "Autosomal recessive: Patients live until ~ 35 years old"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Splenomegaly with varying numbers of caseating granulomas"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Splenic architecture is often distorted but not effacedInvolves red pulp and white pulp",
                    "sub_points": [
                      "Involves red pulp and white pulp"
                    ]
                  },
                  {
                    "text": "Necrotizing granulomas ± giant cellsPalisading epithelioid histiocytesOval nuclei with folded nuclear membranePale pink cytoplasmYellow lipofuscin-like pigment in some histiocytesNecrosisCan be caseous or coagulativeGiant cells≤ 50 μm in diameter≥ 20 nuclei can be seen in periphery or randomlyOrganisms may be difficult to identify in spleen± abscess formation",
                    "sub_points": [
                      "Palisading epithelioid histiocytesOval nuclei with folded nuclear membranePale pink cytoplasmYellow lipofuscin-like pigment in some histiocytes",
                      "Oval nuclei with folded nuclear membrane",
                      "Pale pink cytoplasm",
                      "Yellow lipofuscin-like pigment in some histiocytes",
                      "NecrosisCan be caseous or coagulative",
                      "Can be caseous or coagulative",
                      "Giant cells≤ 50 μm in diameter≥ 20 nuclei can be seen in periphery or randomly",
                      "≤ 50 μm in diameter",
                      "≥ 20 nuclei can be seen in periphery or randomly",
                      "Organisms may be difficult to identify in spleen",
                      "± abscess formation"
                    ]
                  },
                  {
                    "text": "White cells in peripheral blood are morphologically normal"
                  }
                ]
              },
              "Ancillary Tests": {
                "Histochemistry": [
                  {
                    "text": "Used to detect organismsExamples: Fite, GMS, Brown-Hopp, Warthin-Starry",
                    "sub_points": [
                      "Examples: Fite, GMS, Brown-Hopp, Warthin-Starry"
                    ]
                  }
                ],
                "Flow Cytometry": [
                  {
                    "text": "Measures fluorescence of laser-sensitive dye responding to stimulus of oxidative burst in neutrophil"
                  },
                  {
                    "text": "In CGD, oxidative burst is absent, so there is no increase in fluorescence"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Other Disorders With Necrotizing Granulomas": [
                  {
                    "text": "Bacterial infections, fungal infectionsGranulomas can look identical to CGDNo NADPH defects, normal NBT",
                    "sub_points": [
                      "Granulomas can look identical to CGDNo NADPH defects, normal NBT",
                      "No NADPH defects, normal NBT"
                    ]
                  },
                  {
                    "text": "Crohn diseaseGranulomatous inflammation with abscess and necrosis",
                    "sub_points": [
                      "Granulomatous inflammation with abscess and necrosis"
                    ]
                  },
                  {
                    "text": "Granulomatosis with polyangiitis (Wegener disease)Has necrosis and granulomas (like CGD)Has vasculitis; necrosis is basophilic (unlike CGD)",
                    "sub_points": [
                      "Has necrosis and granulomas (like CGD)",
                      "Has vasculitis; necrosis is basophilic (unlike CGD)"
                    ]
                  }
                ],
                "Other Defects in Leukocyte Function": [
                  {
                    "text": "Leukocyte adhesion deficiencies 1 and 2, Chédiak-Higashi syndromeCan present with recurrent infectionsDo not have defective NAPDH oxidase (unlike CGD)Have normal NBTOften have abnormal neutrophils in peripheral blood (unlike CGD)",
                    "sub_points": [
                      "Can present with recurrent infections",
                      "Do not have defective NAPDH oxidase (unlike CGD)",
                      "Have normal NBT",
                      "Often have abnormal neutrophils in peripheral blood (unlike CGD)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Wiskott-Aldrich Syndrome": {
            "name": "Wiskott-Aldrich Syndrome",
            "url": "https://app.pathprimer.com/document/9511e59d-ea97-4251-8aeb-3b6c43fe44ca/lesson/c35d9ccb-b4ff-4be3-98e4-c888d565fd2d",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "WAS-related disorders include 3 distinct clinical entities"
                  },
                  {
                    "text": "Wiskott-Aldrich syndromeMicrothrombocytopeniaEczemaImmunodeficiency and immune dysregulation",
                    "sub_points": [
                      "Microthrombocytopenia",
                      "Eczema",
                      "Immunodeficiency and immune dysregulation"
                    ]
                  },
                  {
                    "text": "X-linked thrombocytopeniaIsolated microthrombocytopenia",
                    "sub_points": [
                      "Isolated microthrombocytopenia"
                    ]
                  },
                  {
                    "text": "X-linked congenital neutropeniaIsolated neutropenia (and monocytopenia)",
                    "sub_points": [
                      "Isolated neutropenia (and monocytopenia)"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "WAS protein regulates actin polymerization, which is important in migration and adhesion activities necessary for proper leukocyte function"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "WAS-related disorders are X-linked and thus affect males but not female carriers"
                  },
                  {
                    "text": "Autoimmune phenomena develop in up to ~ 70% of WAS patients over time"
                  },
                  {
                    "text": "WAS patients have increased risk of developing lymphoma"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Patients with XLT are often initially misdiagnosed as having ITP"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "WAS and XLT should be entertained as possible diagnoses whenever very significant decrease in MPV is observed in a thrombocytopenic patient"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Wiskott-Aldrich syndrome (WAS)"
                  },
                  {
                    "text": "X-linked thrombocytopenia (XLT)"
                  },
                  {
                    "text": "X-linked neutropenia (XLN)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "WAS-related disorders include 3 distinct clinical entities"
                  },
                  {
                    "text": "Loss of function mutations inWASare associated withWiskott-Aldrich syndrome (WAS)MicrothrombocytopeniaEczemaImmunodeficiency and immune dysregulationX-linked thrombocytopenia (XLT)Isolated microthrombocytopenia is predominant symptom, with absent or minimal additional findingsIn practice, it can be difficult to clearly distinguish between XLT and mild WAS in some cases",
                    "sub_points": [
                      "Wiskott-Aldrich syndrome (WAS)MicrothrombocytopeniaEczemaImmunodeficiency and immune dysregulation",
                      "Microthrombocytopenia",
                      "Eczema",
                      "Immunodeficiency and immune dysregulation",
                      "X-linked thrombocytopenia (XLT)Isolated microthrombocytopenia is predominant symptom, with absent or minimal additional findingsIn practice, it can be difficult to clearly distinguish between XLT and mild WAS in some cases",
                      "Isolated microthrombocytopenia is predominant symptom, with absent or minimal additional findings",
                      "In practice, it can be difficult to clearly distinguish between XLT and mild WAS in some cases"
                    ]
                  },
                  {
                    "text": "Gain of function mutations inWASare associated withX-linked congenital neutropenia (XLN)Isolated neutropenia (and monocytopenia) without eczema or other findingsHowever, abnormalities of lymphocyte number or function may also be present in XLN",
                    "sub_points": [
                      "X-linked congenital neutropenia (XLN)Isolated neutropenia (and monocytopenia) without eczema or other findingsHowever, abnormalities of lymphocyte number or function may also be present in XLN",
                      "Isolated neutropenia (and monocytopenia) without eczema or other findings",
                      "However, abnormalities of lymphocyte number or function may also be present in XLN"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Normal Function of WAS Protein": [
                  {
                    "text": "WAS protein regulates actin polymerization, which is important in migration and adhesion activities necessary for proper leukocyte functionIn T cells, WAS protein is recruited to immunologic synapseIn NK cells, WAS protein is concentrated at immunologic synapse and is thought to mediate target-directed cytotoxicityB cells with decreased WAS protein do not migrate normally to blood or secondary lymphoid organsWAS protein permits dendritic cell migration and antigen presentation",
                    "sub_points": [
                      "In T cells, WAS protein is recruited to immunologic synapse",
                      "In NK cells, WAS protein is concentrated at immunologic synapse and is thought to mediate target-directed cytotoxicity",
                      "B cells with decreased WAS protein do not migrate normally to blood or secondary lymphoid organs",
                      "WAS protein permits dendritic cell migration and antigen presentation"
                    ]
                  },
                  {
                    "text": "WAS protein also participates in signal transduction pathways, independent of its cytoskeletal function"
                  }
                ],
                "WASMutations": [
                  {
                    "text": "Absence of WAS protein deregulates actin polymerization in hematopoietic cells, resulting in profound immune abnormalities"
                  },
                  {
                    "text": "For inactivating mutations, severity of phenotype may partially depend on type of mutation and effect on residual WAS protein functionMissense mutations leading to expression of full-length, though defective, WAS protein tend to be associated with XLT or attenuated form of WASTruncating mutations or mutations leading to severely decreased expression tend to be associated with more severe WASHowever, direct prediction of phenotype from genotype is difficult",
                    "sub_points": [
                      "Missense mutations leading to expression of full-length, though defective, WAS protein tend to be associated with XLT or attenuated form of WAS",
                      "Truncating mutations or mutations leading to severely decreased expression tend to be associated with more severe WAS",
                      "However, direct prediction of phenotype from genotype is difficult"
                    ]
                  },
                  {
                    "text": "Gain of function (XLN-associated) mutationsAutoinhibitory domain of protein is disabled, resulting in increased activity",
                    "sub_points": [
                      "Autoinhibitory domain of protein is disabled, resulting in increased activity"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Gender": [
                  {
                    "text": "WAS-related disorders are X-linked and thus affect males but not female carriersFemale carriers may occasionally manifest very mild, clinically insignificant thrombocytopenia",
                    "sub_points": [
                      "Female carriers may occasionally manifest very mild, clinically insignificant thrombocytopenia"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "WASPatients typically present as infantsBleeding due to thrombocytopeniaMucosal bleedingGastrointestinal bleedingPetechiaeIntracranial bleedingLife-threatening bleeds occur in up to 30% of patients before diagnosisRecurrent bacterial and viral infectionsEspecially otitis mediaEczemaOther skin changes may also occur (impetigo, abscesses, cellulitis)",
                    "sub_points": [
                      "Patients typically present as infants",
                      "Bleeding due to thrombocytopeniaMucosal bleedingGastrointestinal bleedingPetechiaeIntracranial bleedingLife-threatening bleeds occur in up to 30% of patients before diagnosis",
                      "Mucosal bleeding",
                      "Gastrointestinal bleeding",
                      "Petechiae",
                      "Intracranial bleeding",
                      "Life-threatening bleeds occur in up to 30% of patients before diagnosis",
                      "Recurrent bacterial and viral infectionsEspecially otitis media",
                      "Especially otitis media",
                      "EczemaOther skin changes may also occur (impetigo, abscesses, cellulitis)",
                      "Other skin changes may also occur (impetigo, abscesses, cellulitis)"
                    ]
                  },
                  {
                    "text": "XLTBleeding due to thrombocytopeniaThrombocytopenia may be intermittent",
                    "sub_points": [
                      "Bleeding due to thrombocytopenia",
                      "Thrombocytopenia may be intermittent"
                    ]
                  },
                  {
                    "text": "XLNRecurrent infections due to neutropenia",
                    "sub_points": [
                      "Recurrent infections due to neutropenia"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "WAS protein analysisWestern blotting or flow cytometric analysis may reveal decreased WAS protein in WAS and XLTHowever, WAS protein expression is normal in XLN",
                    "sub_points": [
                      "Western blotting or flow cytometric analysis may reveal decreased WAS protein in WAS and XLTHowever, WAS protein expression is normal in XLN",
                      "However, WAS protein expression is normal in XLN"
                    ]
                  },
                  {
                    "text": "Molecular analysisSequencing ofWASidentifies mutations in almost all patients withWAS-related disordersOften used as confirmatory test after WAS protein analysis",
                    "sub_points": [
                      "Sequencing ofWASidentifies mutations in almost all patients withWAS-related disorders",
                      "Often used as confirmatory test after WAS protein analysis"
                    ]
                  },
                  {
                    "text": "Lymphocyte subset analysisGeneralized lymphopenia may be presentCD8 positive T cells may be especially decreased in number in WASIn contrast, increased activated CD8 positive T cells are present in XLNNK cells are increased in number in WAS",
                    "sub_points": [
                      "Generalized lymphopenia may be present",
                      "CD8 positive T cells may be especially decreased in number in WAS",
                      "In contrast, increased activated CD8 positive T cells are present in XLN",
                      "NK cells are increased in number in WAS"
                    ]
                  },
                  {
                    "text": "Lymphocyte functional assaysIn particular, NK-cell function and cell-mediated immunity activities may be abnormal in WAS",
                    "sub_points": [
                      "In particular, NK-cell function and cell-mediated immunity activities may be abnormal in WAS"
                    ]
                  },
                  {
                    "text": "Immunoglobulin subset analysisVarious abnormalities of specific immunoglobulin subsets may be present in WASDecreased IgMDecreased IgG2Increased IgEIncreased IgA",
                    "sub_points": [
                      "Various abnormalities of specific immunoglobulin subsets may be present in WASDecreased IgMDecreased IgG2Increased IgEIncreased IgA",
                      "Decreased IgM",
                      "Decreased IgG2",
                      "Increased IgE",
                      "Increased IgA"
                    ]
                  },
                  {
                    "text": "SerologyImpaired titer response to polysaccharide-based vaccinations (e.g., Pneumovax) in WAS",
                    "sub_points": [
                      "Impaired titer response to polysaccharide-based vaccinations (e.g., Pneumovax) in WAS"
                    ]
                  },
                  {
                    "text": "IsohemagluttininsAntibodies naturally produced by individuals with blood types A, B, and O against A or B antigens that they lackWAS patients may have significantly decreased titers of isohemagglutinins",
                    "sub_points": [
                      "Antibodies naturally produced by individuals with blood types A, B, and O against A or B antigens that they lack",
                      "WAS patients may have significantly decreased titers of isohemagglutinins"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Supportive and prophylactic careAntibiotics to reduce incidence and severity of infectionsIntravenous immunoglobulin (IVIG) to replace missing immunoglobulin subsetsPlatelet transfusions as necessary for active bleedsCellular immune defect in WAS renders these patients susceptible to graft-vs.-host disease from transfused lymphocytesTransfused products should be irradiated before administration to WAS patientsImmunosuppression or rituximab if autoimmune phenomena ariseG-CSF for XLNTopical or systemic steroids for eczema",
                    "sub_points": [
                      "Antibiotics to reduce incidence and severity of infections",
                      "Intravenous immunoglobulin (IVIG) to replace missing immunoglobulin subsets",
                      "Platelet transfusions as necessary for active bleedsCellular immune defect in WAS renders these patients susceptible to graft-vs.-host disease from transfused lymphocytesTransfused products should be irradiated before administration to WAS patients",
                      "Cellular immune defect in WAS renders these patients susceptible to graft-vs.-host disease from transfused lymphocytes",
                      "Transfused products should be irradiated before administration to WAS patients",
                      "Immunosuppression or rituximab if autoimmune phenomena arise",
                      "G-CSF for XLN",
                      "Topical or systemic steroids for eczema"
                    ]
                  },
                  {
                    "text": "Hematopoietic stem cell transplantationIndicated in some patients with WAS, but not usually in XLT or XLNEarly transplantation (< age 5) is associated with cure rate of ~ 85%Closeness of HLA allele matching is especially important for successful transplantation in setting of WAS",
                    "sub_points": [
                      "Indicated in some patients with WAS, but not usually in XLT or XLNEarly transplantation (< age 5) is associated with cure rate of ~ 85%Closeness of HLA allele matching is especially important for successful transplantation in setting of WAS",
                      "Early transplantation (< age 5) is associated with cure rate of ~ 85%",
                      "Closeness of HLA allele matching is especially important for successful transplantation in setting of WAS"
                    ]
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "SplenectomyResults in increased platelet count but greater susceptibility to infection",
                    "sub_points": [
                      "Results in increased platelet count but greater susceptibility to infection"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "WASAutoimmune phenomena develop in up to ~ 70% of WAS patients over timeAutoimmune hemolytic anemiaVasculitisRheumatoid arthritisNephropathyAutoimmune neutropeniaImmune thrombocytopenic purpuraInflammatory bowel diseaseOther autoimmune syndromesWAS patients have increased risk (13%) of developing lymphomaOften EBV-relatedOften extranodalUsually B-cell lymphoma, though EBV-related T-cell lymphoma and Hodgkin disease have been describedAverage onset is ~ 10 years of ageAmong WAS patients, risk for development of lymphoma is highest in those with autoimmune phenomenaIncreased incidence of myelodysplastic syndrome has also been described in WASAverage survival in patients without bone marrow transplant is between 8 and 15 years of ageInfections, malignancy, and bleeding all contribute significantly to mortality in WAS",
                    "sub_points": [
                      "Autoimmune phenomena develop in up to ~ 70% of WAS patients over timeAutoimmune hemolytic anemiaVasculitisRheumatoid arthritisNephropathyAutoimmune neutropeniaImmune thrombocytopenic purpuraInflammatory bowel diseaseOther autoimmune syndromes",
                      "Autoimmune hemolytic anemia",
                      "Vasculitis",
                      "Rheumatoid arthritis",
                      "Nephropathy",
                      "Autoimmune neutropenia",
                      "Immune thrombocytopenic purpura",
                      "Inflammatory bowel disease",
                      "Other autoimmune syndromes",
                      "WAS patients have increased risk (13%) of developing lymphomaOften EBV-relatedOften extranodalUsually B-cell lymphoma, though EBV-related T-cell lymphoma and Hodgkin disease have been describedAverage onset is ~ 10 years of ageAmong WAS patients, risk for development of lymphoma is highest in those with autoimmune phenomena",
                      "Often EBV-related",
                      "Often extranodal",
                      "Usually B-cell lymphoma, though EBV-related T-cell lymphoma and Hodgkin disease have been described",
                      "Average onset is ~ 10 years of age",
                      "Among WAS patients, risk for development of lymphoma is highest in those with autoimmune phenomena",
                      "Increased incidence of myelodysplastic syndrome has also been described in WAS",
                      "Average survival in patients without bone marrow transplant is between 8 and 15 years of ageInfections, malignancy, and bleeding all contribute significantly to mortality in WAS",
                      "Infections, malignancy, and bleeding all contribute significantly to mortality in WAS"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Peripheral Blood": [
                  {
                    "text": "WAS and XLTThrombocytopeniaUsually < 70 x 10⁹/LPlatelets are small in size (mean platelet volume often ~ 50% of normal controls)",
                    "sub_points": [
                      "ThrombocytopeniaUsually < 70 x 10⁹/LPlatelets are small in size (mean platelet volume often ~ 50% of normal controls)",
                      "Usually < 70 x 10⁹/L",
                      "Platelets are small in size (mean platelet volume often ~ 50% of normal controls)"
                    ]
                  },
                  {
                    "text": "XLNNeutropenia with no morphologic abnormalitiesMonocytopenia may also be presentNormal platelet number and size",
                    "sub_points": [
                      "Neutropenia with no morphologic abnormalities",
                      "Monocytopenia may also be present",
                      "Normal platelet number and size"
                    ]
                  }
                ],
                "Bone Marrow": [
                  {
                    "text": "WAS and XLTNormal (or occasionally mildly increased) number of megakaryocytesMegakaryocyte morphology is normal in most cases, though increased small immature forms may sometimes be present",
                    "sub_points": [
                      "Normal (or occasionally mildly increased) number of megakaryocytes",
                      "Megakaryocyte morphology is normal in most cases, though increased small immature forms may sometimes be present"
                    ]
                  },
                  {
                    "text": "XLNMyeloid \"maturation arrest\" picture with decreased to absent mature granulocytes",
                    "sub_points": [
                      "Myeloid \"maturation arrest\" picture with decreased to absent mature granulocytes"
                    ]
                  },
                  {
                    "text": "Given increased risk of lymphoma in WAS, especially critical to rule out involvement by lymphoma in all bone marrows from WAS patients"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Immune Thrombocytopenic Purpura (ITP)": [
                  {
                    "text": "XLT is often initially misdiagnosed as ITP"
                  },
                  {
                    "text": "Platelets in ITP are typically large in size, not small as in WAS and XLT"
                  }
                ],
                "Other Inherited Immunodeficiency Syndromes": [
                  {
                    "text": "X-linked severe combined immunodeficiency and X-linked hyper-IgM syndromes, in particular, may mimic inheritance pattern of WAS"
                  },
                  {
                    "text": "Usually lack microthrombocytopenia"
                  }
                ],
                "HIV Infection": [
                  {
                    "text": "Vertical transmission of HIV can mimic typical presentation of WAS in early childhood"
                  },
                  {
                    "text": "Some patients with HIV may present with immunodeficiency and thrombocytopenia though platelet size is not usually small"
                  }
                ],
                "Other Inherited Thrombocytopenia Syndromes": [
                  {
                    "text": "These usually lack immune dysregulation seen in WAS but could mimic XLT"
                  },
                  {
                    "text": "Platelets in WAS and XLT, but not in most other inherited thrombocytopenias, are small in size"
                  },
                  {
                    "text": "Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii show decreased bone marrow megakaryocytes, which is not seen in WAS or XLT"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "WAS and XLT should be entertained as possible diagnoses whenever very significant decrease in mean platelet volume (MPV) is observed in a thrombocytopenic patient"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Immune System Diseases": {
        "name": "Immune System Diseases",
        "url": "https://app.pathprimer.com/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
        "topics": {
          "Asthma": {
            "name": "Asthma",
            "url": "https://app.pathprimer.com/document/b5c089f6-090a-4734-ba30-22eac85107fa/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Chronic inflammatory disorder of airways with bronchoconstriction"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "One of the most common chronic disorders in childhood"
                  },
                  {
                    "text": "Atopy is strongest identifiable predisposing factor for developing asthma"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Mucus plugging with overinflation"
                  },
                  {
                    "text": "Bronchiectasis"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Goblet cell metaplasia &/or hyperplasia"
                  },
                  {
                    "text": "Epithelial sloughing"
                  },
                  {
                    "text": "Eosinophilic infiltrate of bronchial wall"
                  },
                  {
                    "text": "Smooth muscle hyperplasia"
                  },
                  {
                    "text": "Luminal mucus stasis"
                  }
                ]
              },
              "Terminology": {
                "Definitions": [
                  {
                    "text": "Chronic inflammatory disorder of airways with bronchoconstriction"
                  },
                  {
                    "text": "Caused by increased reaction of airways to various stimuli"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Has increased greatly over the last 20 yearsNearly 50% increase in asthma rates were documented in black children from 2001 through 2009",
                    "sub_points": [
                      "Nearly 50% increase in asthma rates were documented in black children from 2001 through 2009"
                    ]
                  },
                  {
                    "text": "One of the most common chronic disorders in childhood~ 1 in 10 children suffers from asthma",
                    "sub_points": [
                      "~ 1 in 10 children suffers from asthma"
                    ]
                  },
                  {
                    "text": "Atopy is strongest identifiable predisposing factor for developing asthma"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asthma typically develops in childhood"
                  },
                  {
                    "text": "Causes of recurrent inflammation in asthmaticsEpisodes of wheezingChest tightnessNight-time and early morning coughBreathlessness",
                    "sub_points": [
                      "Episodes of wheezing",
                      "Chest tightness",
                      "Night-time and early morning cough",
                      "Breathlessness"
                    ]
                  },
                  {
                    "text": "TriggersRespiratory infectionsIndoor and outdoor air pollutantsExposure to cold airExcitement &/or stressExerciseAllergic reactions toPollenDustMoldAnimal danderFeathersFoodCockroaches",
                    "sub_points": [
                      "Respiratory infections",
                      "Indoor and outdoor air pollutants",
                      "Exposure to cold air",
                      "Excitement &/or stress",
                      "Exercise",
                      "Allergic reactions toPollenDustMoldAnimal danderFeathersFoodCockroaches",
                      "Pollen",
                      "Dust",
                      "Mold",
                      "Animal dander",
                      "Feathers",
                      "Food",
                      "Cockroaches"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Bronchial thermoplasty"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Long-term asthma control medicationsInhaled corticosteroidsLeukotriene modifiersLong-acting β-agonists",
                    "sub_points": [
                      "Inhaled corticosteroids",
                      "Leukotriene modifiers",
                      "Long-acting β-agonists"
                    ]
                  },
                  {
                    "text": "Quick-relief (rescue) medicationsShort-acting β-agonistsIpratropiumOral and intravenous corticosteroids",
                    "sub_points": [
                      "Short-acting β-agonists",
                      "Ipratropium",
                      "Oral and intravenous corticosteroids"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Airflow obstruction is reversibleMay happen spontaneously or with treatment",
                    "sub_points": [
                      "May happen spontaneously or with treatment"
                    ]
                  },
                  {
                    "text": "Bronchi become hyperresponsive to various stimuli"
                  },
                  {
                    "text": "Can be life-threatening disease if not properly managedStatus asthmaticusAcute respiratory failure due to inflammation, edema, and mucus pluggingSudden asphyxic asthmaAirflow obstruction due to bronchospasmDeaths due to asthma are rare in pediatric age group",
                    "sub_points": [
                      "Status asthmaticusAcute respiratory failure due to inflammation, edema, and mucus plugging",
                      "Acute respiratory failure due to inflammation, edema, and mucus plugging",
                      "Sudden asphyxic asthmaAirflow obstruction due to bronchospasm",
                      "Airflow obstruction due to bronchospasm",
                      "Deaths due to asthma are rare in pediatric age group"
                    ]
                  }
                ]
              },
              "Macroscopic Features": {
                "Gross Findings": [
                  {
                    "text": "Mucus plugging with overinflation"
                  },
                  {
                    "text": "Bronchiectasis"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "BronchiGoblet cell metaplasia &/or hyperplasiaSquamous metaplasiaEpithelial sloughingBasal membrane thickeningEosinophilic infiltrate of bronchial wallAirway wall edemaSmooth muscle hyperplasiaBronchial mucus gland hyperplasiaLuminal mucus stasis (mucus plugs)Airway mucus may contain inclusionsCurschmann spiralsCreola bodiesCharcot-Leyden crystals",
                    "sub_points": [
                      "Goblet cell metaplasia &/or hyperplasia",
                      "Squamous metaplasia",
                      "Epithelial sloughing",
                      "Basal membrane thickening",
                      "Eosinophilic infiltrate of bronchial wall",
                      "Airway wall edema",
                      "Smooth muscle hyperplasia",
                      "Bronchial mucus gland hyperplasia",
                      "Luminal mucus stasis (mucus plugs)",
                      "Airway mucus may contain inclusionsCurschmann spiralsCreola bodiesCharcot-Leyden crystals",
                      "Curschmann spirals",
                      "Creola bodies",
                      "Charcot-Leyden crystals"
                    ]
                  },
                  {
                    "text": "Small airwaysLuminal mucus pluggingBronchiolar lesions are less prominent",
                    "sub_points": [
                      "Luminal mucus plugging",
                      "Bronchiolar lesions are less prominent"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Allergic Bronchopulmonary Fungal Disease": [
                  {
                    "text": "Presence of \"allergic mucin\""
                  },
                  {
                    "text": "Allergic mucin contains eosinophils and eosinophil cytoplasmic granular debris"
                  },
                  {
                    "text": "Asthmatics are predisposed to fungal colonization of respiratory tract"
                  }
                ],
                "Mucoid Impaction of Bronchi": [
                  {
                    "text": "Distinctive clinicopathologic syndrome"
                  },
                  {
                    "text": "Mucus has laminated appearance"
                  }
                ],
                "Eosinophilic Pneumonia": [
                  {
                    "text": "Eosinophils, macrophages, and fibrin fill alveolar spaces"
                  }
                ],
                "Bronchocentric Granulomatosis": [
                  {
                    "text": "Granulomatous inflammation surrounds and replaces bronchial walls and mucosa"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Goodpasture Syndrome": {
            "name": "Goodpasture Syndrome",
            "url": "https://app.pathprimer.com/document/7d26834d-ecdc-483f-bbc5-76797c61ccaf/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Disease caused by autoantibody to glomerular basement membrane collagen, typically manifested by necrotizing, crescentic GN, and sometimes lung hemorrhage"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Autoantibody targets neoepitope in noncollagenous-1 (NC1) domain of α-3 chain of collagen IV (Goodpasture antigen)Distinct from epitope recognized by anti-GBM antibodies post-transplant Alport patients",
                    "sub_points": [
                      "Distinct from epitope recognized by anti-GBM antibodies post-transplant Alport patients"
                    ]
                  },
                  {
                    "text": "Risk factorsHydrocarbon exposure &/or cigarette smokingCertain HLA-DR and DQ antigens",
                    "sub_points": [
                      "Hydrocarbon exposure &/or cigarette smoking",
                      "Certain HLA-DR and DQ antigens"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Rare: 1 case per 1 million per year in United States"
                  },
                  {
                    "text": "Peak incidence in 2nd and 6th decades of age"
                  },
                  {
                    "text": "Presents with acute kidney injury (> 90%)"
                  },
                  {
                    "text": "25-50% pulmonary hemorrhage"
                  },
                  {
                    "text": "Treatment: Plasmapheresis, immunosuppression"
                  },
                  {
                    "text": "Rare renal function recovery if ≥ 75% crescents"
                  },
                  {
                    "text": "Poor prognostic factors include Cr > 5 mg/dL at time of diagnosis and anuria"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Cellular crescent formation ± segmental fibrinoid necrosisOften involves > 75% of glomeruli",
                    "sub_points": [
                      "Often involves > 75% of glomeruli"
                    ]
                  },
                  {
                    "text": "Linear IgG and C3 staining of GBMIgG4 staining reported in cases with mild or no renal involvementRare monoclonal IgG, IgA, or IgM staining reported",
                    "sub_points": [
                      "IgG4 staining reported in cases with mild or no renal involvement",
                      "Rare monoclonal IgG, IgA, or IgM staining reported"
                    ]
                  },
                  {
                    "text": "EM: Breaks in GBM, but otherwise normal (no deposits)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Pauci-immune crescentic glomerulonephritis"
                  },
                  {
                    "text": "Atypical forms of anti-GBM disease"
                  },
                  {
                    "text": "Immune complex-mediated GN"
                  },
                  {
                    "text": "Membranous GN and anti-GBM disease"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Anti-glomerular basement membrane glomerulonephritis (anti-GBM GN)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Anti-GBM disease"
                  },
                  {
                    "text": "Goodpasture syndrome"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Disease caused by autoantibody to glomerular basement membrane collagen, typically manifested by necrotizing, crescentic GN, and sometimes lung hemorrhage"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Autoantibody Deposition": [
                  {
                    "text": "Autoantibody targets noncollagenous-1 (NC1) domain of α-3 chain of collagen IV (Goodpasture antigen)"
                  },
                  {
                    "text": "Autoantibody targeting noncollagenous-1 (NC1) domain of α-5 chain of collagen IV may also be presentAutoantibodies reactive to α-3 NC1 and α-5 NC1 are nonreactive to normal collagenConformational changes allow formation of neoepitopes for autoantibodiesDissociation of α-3 chain of collagen IV in both kidney and lung increases binding affinity of autoantibodies",
                    "sub_points": [
                      "Autoantibodies reactive to α-3 NC1 and α-5 NC1 are nonreactive to normal collagen",
                      "Conformational changes allow formation of neoepitopes for autoantibodies",
                      "Dissociation of α-3 chain of collagen IV in both kidney and lung increases binding affinity of autoantibodies"
                    ]
                  },
                  {
                    "text": "Anti-GBM antibody response is typically transient (2-3 months)"
                  }
                ],
                "Genetic Predisposition": [
                  {
                    "text": "Strong association with certain HLA class II antigens: DRB1-1501 and DQB1-0602"
                  }
                ],
                "Precipitating Events": [
                  {
                    "text": "Pulmonary injuryHydrocarbon exposureInhibition of putative enzyme that catalyzes formation of sulfilimine bonds between collagen hexamersMay trigger neoepitope formation for Goodpasture autoantibody developmentCigarette smokingIncreases risk of pulmonary hemorrhage",
                    "sub_points": [
                      "Hydrocarbon exposureInhibition of putative enzyme that catalyzes formation of sulfilimine bonds between collagen hexamersMay trigger neoepitope formation for Goodpasture autoantibody development",
                      "Inhibition of putative enzyme that catalyzes formation of sulfilimine bonds between collagen hexamers",
                      "May trigger neoepitope formation for Goodpasture autoantibody development",
                      "Cigarette smokingIncreases risk of pulmonary hemorrhage",
                      "Increases risk of pulmonary hemorrhage"
                    ]
                  },
                  {
                    "text": "Infectious agent postulatedFlu-like symptoms prior to onset in some patientsMini-epidemics documented (4-7 cases over a few months)1971 (winter): 4 cases in Connecticut, USA1985 (June-October): 7 cases in Mersey region, England2005 (April-June): 7 cases in Chicago, IL, USA2013 (March-April): 4 cases in Seattle, WA, USACausative agent not identified",
                    "sub_points": [
                      "Flu-like symptoms prior to onset in some patients",
                      "Mini-epidemics documented (4-7 cases over a few months)1971 (winter): 4 cases in Connecticut, USA1985 (June-October): 7 cases in Mersey region, England2005 (April-June): 7 cases in Chicago, IL, USA2013 (March-April): 4 cases in Seattle, WA, USACausative agent not identified",
                      "1971 (winter): 4 cases in Connecticut, USA",
                      "1985 (June-October): 7 cases in Mersey region, England",
                      "2005 (April-June): 7 cases in Chicago, IL, USA",
                      "2013 (March-April): 4 cases in Seattle, WA, USA",
                      "Causative agent not identified"
                    ]
                  },
                  {
                    "text": "Sequelae of glomerular injury, including ANCA disease, membranous glomerulonephritis"
                  },
                  {
                    "text": "Exposure to allogeneic GBM antigens3-5% of Alport syndrome patients develop de novo anti-GBM GN after transplantationAssociated with largeCOL4A3deletionsAntibodies to α345 NC1 hexamer (X-linked form)",
                    "sub_points": [
                      "3-5% of Alport syndrome patients develop de novo anti-GBM GN after transplantation",
                      "Associated with largeCOL4A3deletions",
                      "Antibodies to α345 NC1 hexamer (X-linked form)"
                    ]
                  }
                ],
                "Inflammatory Mediators": [
                  {
                    "text": "FcγRIII, classic and alternative complement pathway"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare: 1 case per 1 million per year in United States"
                  }
                ],
                "Age": [
                  {
                    "text": "Bimodal distribution with peaks in 2nd and 6th decades of age; rare in children < 11 years old"
                  }
                ],
                "Sex": [
                  {
                    "text": "Male predilection in 2nd decadePulmonary and renal involvement common",
                    "sub_points": [
                      "Pulmonary and renal involvement common"
                    ]
                  },
                  {
                    "text": "Female predilection in 6th decadeCrescentic GN without pulmonary involvement common",
                    "sub_points": [
                      "Crescentic GN without pulmonary involvement common"
                    ]
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Rare in African Americans"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Acute kidney injury in > 90%Rare cases with renal sparing",
                    "sub_points": [
                      "Rare cases with renal sparing"
                    ]
                  },
                  {
                    "text": "Hematuria"
                  },
                  {
                    "text": "ProteinuriaRarely nephrotic range",
                    "sub_points": [
                      "Rarely nephrotic range"
                    ]
                  },
                  {
                    "text": "Pulmonary hemorrhage (25-50%)Hemoptysis, dyspnea, rales, rhonchi5-10% lung only involved",
                    "sub_points": [
                      "Hemoptysis, dyspnea, rales, rhonchi",
                      "5-10% lung only involved"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Anti-GBM titerWestern blot and ELISATiters do not correlate with severityIgG1 and IgG3Some female patients have high IgG4 titers associated with pulmonary hemorrhageFalse-negative immunoassay",
                    "sub_points": [
                      "Western blot and ELISATiters do not correlate with severity",
                      "Titers do not correlate with severity",
                      "IgG1 and IgG3",
                      "Some female patients have high IgG4 titers associated with pulmonary hemorrhageFalse-negative immunoassay",
                      "False-negative immunoassay"
                    ]
                  },
                  {
                    "text": "Antineutrophil cytoplasmic antibodies (ANCA)Present in 1/3 of anti-GBM disease patients",
                    "sub_points": [
                      "Present in 1/3 of anti-GBM disease patients"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Plasmapheresis/plasma exchange"
                  },
                  {
                    "text": "Renal transplantationRecurrence uncommon if negative anti-GBM antibodies",
                    "sub_points": [
                      "Recurrence uncommon if negative anti-GBM antibodies"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "Cyclophosphamide and high-dose corticosteroids"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Poor prognostic factorsDialysis requirement at presentation or Cr > 5 mg/dLOligoanuriaExtensive crescents on biopsyIf ≥ 75% crescents, all dialysis dependent by 3 months (15/15) vs. 38% with < 75% crescents (7/12)",
                    "sub_points": [
                      "Dialysis requirement at presentation or Cr > 5 mg/dL",
                      "Oligoanuria",
                      "Extensive crescents on biopsyIf ≥ 75% crescents, all dialysis dependent by 3 months (15/15) vs. 38% with < 75% crescents (7/12)",
                      "If ≥ 75% crescents, all dialysis dependent by 3 months (15/15) vs. 38% with < 75% crescents (7/12)"
                    ]
                  },
                  {
                    "text": "Rarely recurs if anti-GBM alone (no ANCA)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Petechiae on cortical surface (\"flea-bitten\")Due to blood within tubular lumina or Bowman space",
                    "sub_points": [
                      "Due to blood within tubular lumina or Bowman space"
                    ]
                  },
                  {
                    "text": "Normal to slightly enlarged kidneys"
                  },
                  {
                    "text": "Lung: Airless alveoli filled with red/brown blood diffusely"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "GlomeruliCellular crescents ± segmental fibrinoid necrosisOften involves > 75% of glomeruliRupture or GBM breaks in PAS or silver stainsDisruption of Bowman capsulePeriglomerular granulomatous inflammation with multinucleated giant cellsNot specific for anti-GBM GNUninvolved glomerular tufts without significant endocapillary or mesangial hypercellularityNeutrophils may be present adjacent to crescents or fibrinoid necrosisContrasts with immune complex-mediated GN with crescentsThrombotic microangiopathy involving glomerular capillariesPresent in subset of anti-GBM GNAtypical, mild forms with lobular mesangial expansion or minimal glomerular lesions and few crescents",
                    "sub_points": [
                      "Cellular crescents ± segmental fibrinoid necrosisOften involves > 75% of glomeruliRupture or GBM breaks in PAS or silver stainsDisruption of Bowman capsulePeriglomerular granulomatous inflammation with multinucleated giant cellsNot specific for anti-GBM GN",
                      "Often involves > 75% of glomeruli",
                      "Rupture or GBM breaks in PAS or silver stains",
                      "Disruption of Bowman capsule",
                      "Periglomerular granulomatous inflammation with multinucleated giant cellsNot specific for anti-GBM GN",
                      "Not specific for anti-GBM GN",
                      "Uninvolved glomerular tufts without significant endocapillary or mesangial hypercellularityNeutrophils may be present adjacent to crescents or fibrinoid necrosisContrasts with immune complex-mediated GN with crescents",
                      "Neutrophils may be present adjacent to crescents or fibrinoid necrosis",
                      "Contrasts with immune complex-mediated GN with crescents",
                      "Thrombotic microangiopathy involving glomerular capillariesPresent in subset of anti-GBM GN",
                      "Present in subset of anti-GBM GN",
                      "Atypical, mild forms with lobular mesangial expansion or minimal glomerular lesions and few crescents"
                    ]
                  },
                  {
                    "text": "TubulesRed blood cell castsAggregates of red blood cells in tubular luminaTubulitis",
                    "sub_points": [
                      "Red blood cell castsAggregates of red blood cells in tubular lumina",
                      "Aggregates of red blood cells in tubular lumina",
                      "Tubulitis"
                    ]
                  },
                  {
                    "text": "InterstitiumInterstitial inflammationConsists of lymphocytes, plasma cells, neutrophils, and macrophagesMore prominent with TBM IgGProminent eosinophilic infiltrate may suggest Churg-Strauss syndrome",
                    "sub_points": [
                      "Interstitial inflammationConsists of lymphocytes, plasma cells, neutrophils, and macrophagesMore prominent with TBM IgGProminent eosinophilic infiltrate may suggest Churg-Strauss syndrome",
                      "Consists of lymphocytes, plasma cells, neutrophils, and macrophages",
                      "More prominent with TBM IgG",
                      "Prominent eosinophilic infiltrate may suggest Churg-Strauss syndrome"
                    ]
                  },
                  {
                    "text": "VesselsNecrotizing vasculitis rare (8%)May be due to presence of ANCA",
                    "sub_points": [
                      "Necrotizing vasculitis rare (8%)May be due to presence of ANCA",
                      "May be due to presence of ANCA"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunofluorescence": [
                  {
                    "text": "Bright linear IgG in GBM (99%)Predominately IgG3 by IHC (Qu); IgG1 and IgG4 by IF (Noël)",
                    "sub_points": [
                      "Predominately IgG3 by IHC (Qu); IgG1 and IgG4 by IF (Noël)"
                    ]
                  },
                  {
                    "text": "Linear staining with IgM (~ 50%), IgA (~ 10%), C3 (~ 90%) or C1q (~ 20%)Rare strong linear IgA without IgG",
                    "sub_points": [
                      "Rare strong linear IgA without IgG"
                    ]
                  },
                  {
                    "text": "Both light chains, kappa > lambda in ~ 95%Rare light chain restriction with IgG, IgA, or IgM reported",
                    "sub_points": [
                      "Rare light chain restriction with IgG, IgA, or IgM reported"
                    ]
                  },
                  {
                    "text": "Linear TBM IgG staining in 10-67%Distal tubules express α-3 chainIgG3 by IHC correlated with increased interstitial inflammation",
                    "sub_points": [
                      "Distal tubules express α-3 chain",
                      "IgG3 by IHC correlated with increased interstitial inflammation"
                    ]
                  },
                  {
                    "text": "Rare IgG4 predominance with mild or no renal involvementMay be due to inability of IgG4 to fix complement",
                    "sub_points": [
                      "May be due to inability of IgG4 to fix complement"
                    ]
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Break or disruption of GBM"
                  },
                  {
                    "text": "Neutrophils and monocytes in capillary loops"
                  },
                  {
                    "text": "Fibrin tactoids present where fibrinoid necrosis occurs"
                  },
                  {
                    "text": "Absence of immune complex deposition"
                  },
                  {
                    "text": "Crescents contain leukocytes, fibrin, parietal epithelium"
                  },
                  {
                    "text": "Ultrastructural findings not specific for anti-GBM GN"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pauci-Immune Crescentic GN": [
                  {
                    "text": "Lacks strong linear immunoglobulin deposition in GBM"
                  },
                  {
                    "text": "Presence of fibrocellular to fibrous crescents favors pauci-immune GN"
                  }
                ],
                "Membranous GN and Anti-GBM GN": [
                  {
                    "text": "Anti-GBM disease superimposed upon very small subset of membranous GN patients"
                  },
                  {
                    "text": "Careful evaluation of immunofluorescence and serologic test for anti-GBM necessary to establish diagnosis"
                  }
                ],
                "Atypical Forms of Anti-GBM Disease": [
                  {
                    "text": "Mild forms with lobular glomerular pattern or minimal glomerular lesionsFew cases associated with nodular glomerulosclerosis and cigarette smoking",
                    "sub_points": [
                      "Few cases associated with nodular glomerulosclerosis and cigarette smoking"
                    ]
                  },
                  {
                    "text": "Some associated with IgG4 anti-GBM antibodies"
                  }
                ],
                "Monoclonal Immunoglobulin Deposition Disease": [
                  {
                    "text": "Light chain restricted linear deposits along GBM and TBM"
                  },
                  {
                    "text": "Cellular crescents rare"
                  }
                ],
                "Diabetic Nephropathy": [
                  {
                    "text": "Linear immunofluorescence of GBM for albumin and IgGSegmental sclerosis or collapsed tufts with prominent overlying podocytesnotto be mistaken as crescentsSuperimposed pauci-immune crescentic GN observed in small subset of diabetic patients",
                    "sub_points": [
                      "Segmental sclerosis or collapsed tufts with prominent overlying podocytesnotto be mistaken as crescents",
                      "Superimposed pauci-immune crescentic GN observed in small subset of diabetic patients"
                    ]
                  }
                ],
                "Alport Syndrome After Kidney Transplantation": [
                  {
                    "text": "Up to 15% develop anti-GBM antibodies3-5% of Alport syndrome patients develop de novo anti-GBM disease",
                    "sub_points": [
                      "3-5% of Alport syndrome patients develop de novo anti-GBM disease"
                    ]
                  }
                ],
                "Immune Complex-Mediated GN": [
                  {
                    "text": "Includes lupus nephritis, membranoproliferative GN, postinfectious GN, and IgA nephropathy"
                  },
                  {
                    "text": "Typically, glomeruli demonstrate significant endocapillary hypercellularity"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Cellular crescents typically involve most glomeruliExtent correlates with serum CrFibrocellular or fibrous crescents are not prominentRarely recover if ≥ 75% crescents",
                    "sub_points": [
                      "Extent correlates with serum Cr",
                      "Fibrocellular or fibrous crescents are not prominent",
                      "Rarely recover if ≥ 75% crescents"
                    ]
                  },
                  {
                    "text": "Uninvolved glomerular tufts lack endocapillary hypercellularity, in contrast to other forms of GN, except pauci-immune GN"
                  },
                  {
                    "text": "Anti-GBM autoantibodies may complicate other renal diseases, such as membranous GN, ANCA-related GN"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Systemic Lupus Erythematosus": {
            "name": "Systemic Lupus Erythematosus",
            "url": "https://app.pathprimer.com/document/56bd1f17-f041-458c-931d-e97ee6a64b18/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Systemic autoimmune disease manifested by inflammation of skin, joints, kidneys and central nervous systemIgG autoantibodies to DNA, RNA, proteins, phospholipids",
                    "sub_points": [
                      "IgG autoantibodies to DNA, RNA, proteins, phospholipids"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Autoantibodies cause immune complex deposition, vasculitis, thrombotic microangiopathy"
                  },
                  {
                    "text": "Multiple genetic risk factors"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Glomerular pathology is quite varied and is basis of ISN/RPS classificationMesangial proliferationThickened GBM (extreme is wire loop)Endocapillary hypercellularityNecrosis, crescentsThrombotic microangiopathy may dominate",
                    "sub_points": [
                      "Mesangial proliferation",
                      "Thickened GBM (extreme is wire loop)",
                      "Endocapillary hypercellularity",
                      "Necrosis, crescents",
                      "Thrombotic microangiopathy may dominate"
                    ]
                  },
                  {
                    "text": "Tubulointerstitial inflammation common"
                  },
                  {
                    "text": "IF: IgG deposits in glomeruli are essential for diagnosisUsually accompanied by IgM, IgA, C1q, and C3 (full house)TBM deposits in ~ 60%",
                    "sub_points": [
                      "Usually accompanied by IgM, IgA, C1q, and C3 (full house)",
                      "TBM deposits in ~ 60%"
                    ]
                  },
                  {
                    "text": "EM: Amorphous and structured depositsMesangial, subendothelial, and subepithelial deposits",
                    "sub_points": [
                      "Mesangial, subendothelial, and subepithelial deposits"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "MPGN with immune complexes"
                  },
                  {
                    "text": "Cryoglobulinemia"
                  },
                  {
                    "text": "Drug-induced lupus nephritis"
                  },
                  {
                    "text": "Postinfectious GN"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Important diagnostic clues include heterogeneity of glomerular lesions; \"full house\" pattern (IgG, IgA, IgM, C3, C1q) and TBM deposits of IgG; and endothelial tubuloreticular inclusions and thumbprint pattern in deposits"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Systemic lupus erythematosus (SLE)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Lupus nephritis (LN), lupus glomerulonephritis (GN)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Systemic autoimmune disease manifested by inflammation of skin, joints, kidneys, and central nervous system, with pathogenic IgG autoantibodies targeting nuclear, cell surface, and plasma protein self-antigens"
                  },
                  {
                    "text": "Diagnostic criteria (Systemic Lupus Collaborating Clinics, SLICC): Biopsy-confirmed nephritis (ISN/RPS classification) and anti-nuclear or anti-dsDNA antibodies; if not, must meet 4/17 clinical and immunologic criteriaClinical: Acute or chronic cutaneous lesions, oral ulcers, nonscarring alopecia, synovitis, serositis, renal, neurologic, hemolytic anemia, leukopenia, thrombocytopeniaImmunologic: Antinuclear antibodies (ANA), anti-dsDNA, anti-Sm, antiphospholipid antibody, low complement, direct Coombs test",
                    "sub_points": [
                      "Clinical: Acute or chronic cutaneous lesions, oral ulcers, nonscarring alopecia, synovitis, serositis, renal, neurologic, hemolytic anemia, leukopenia, thrombocytopenia",
                      "Immunologic: Antinuclear antibodies (ANA), anti-dsDNA, anti-Sm, antiphospholipid antibody, low complement, direct Coombs test"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Autoimmune Disease": [
                  {
                    "text": "AutoantibodiesANA in 95%Double-stranded (ds) DNA (nucleosomes), Ro/SSA (ribonucleoprotein), La (RNA binding protein), Sm (ribonucleoprotein)Occasional LN with negative ANA, especially class VCardiolipin (false-positive test for syphilis)Phospholipids, ADAMTS13, lupus anticoagulantC1q, laminin, heparan sulfate proteoglycans, podocyte antigens, and others",
                    "sub_points": [
                      "ANA in 95%Double-stranded (ds) DNA (nucleosomes), Ro/SSA (ribonucleoprotein), La (RNA binding protein), Sm (ribonucleoprotein)Occasional LN with negative ANA, especially class V",
                      "Double-stranded (ds) DNA (nucleosomes), Ro/SSA (ribonucleoprotein), La (RNA binding protein), Sm (ribonucleoprotein)",
                      "Occasional LN with negative ANA, especially class V",
                      "Cardiolipin (false-positive test for syphilis)",
                      "Phospholipids, ADAMTS13, lupus anticoagulant",
                      "C1q, laminin, heparan sulfate proteoglycans, podocyte antigens, and others"
                    ]
                  },
                  {
                    "text": "Autoantibodies may be detectable years before disease"
                  },
                  {
                    "text": "Breakdown of tolerance to self-antigens, trigger unknown\"Waste disposal\" hypothesisDefective phagocytosis of apoptotic cells exposures immune system to intracellular sequestered antigensActivation of self-reactive T and B cells and development of autoantibodies",
                    "sub_points": [
                      "\"Waste disposal\" hypothesisDefective phagocytosis of apoptotic cells exposures immune system to intracellular sequestered antigensActivation of self-reactive T and B cells and development of autoantibodies",
                      "Defective phagocytosis of apoptotic cells exposures immune system to intracellular sequestered antigens",
                      "Activation of self-reactive T and B cells and development of autoantibodies"
                    ]
                  }
                ],
                "Environmental Triggers and Aggravating Factors": [
                  {
                    "text": "Sunlight (UV)"
                  },
                  {
                    "text": "Estrogens"
                  },
                  {
                    "text": "Drugs: Hydralazine, procainamide, quinidine"
                  }
                ],
                "Genetic Factors": [
                  {
                    "text": "10% have relatives with SLE"
                  },
                  {
                    "text": "Higher concordance in monozygotic twins (25-69%) than dizygotic twins (1-2%)"
                  },
                  {
                    "text": "Deficiencies in complement or nuclease enzymesC1q, C2, or C4; rarely other complement componentsNuclease genesTREX1,DNASE1",
                    "sub_points": [
                      "C1q, C2, or C4; rarely other complement components",
                      "Nuclease genesTREX1,DNASE1"
                    ]
                  },
                  {
                    "text": "Polymorphisms (SNPs) of > 25 genes increase risk in genome-wide association studiesFcγ receptor IIB (inhibitory receptor on B cells)Toll-like receptors (TLR 7 and 9)Interferon and tumor necrosis factor signalingHLA-DR2 and 3",
                    "sub_points": [
                      "Fcγ receptor IIB (inhibitory receptor on B cells)",
                      "Toll-like receptors (TLR 7 and 9)",
                      "Interferon and tumor necrosis factor signaling",
                      "HLA-DR2 and 3"
                    ]
                  }
                ],
                "Pathogenesis of Renal Disease": [
                  {
                    "text": "Immune complex (IC) formation and deposition in kidneyCirculating IC trapped in capillaries and mesangiumIn situ formation of IC due to planted or intrinsic antigenHistone-rich nucleosomal antigens trapped in glomeruli, may initiate IC formationComplement fixation: C3a and C5a attract neutrophils and macrophagesInflammatory cells bind IC via Fc and complement receptors and are activatedPersistent or recurrent inflammation leads to changes in intrinsic glomerular cell numbers and function, and matrix homeostasis",
                    "sub_points": [
                      "Circulating IC trapped in capillaries and mesangium",
                      "In situ formation of IC due to planted or intrinsic antigenHistone-rich nucleosomal antigens trapped in glomeruli, may initiate IC formation",
                      "Histone-rich nucleosomal antigens trapped in glomeruli, may initiate IC formation",
                      "Complement fixation: C3a and C5a attract neutrophils and macrophages",
                      "Inflammatory cells bind IC via Fc and complement receptors and are activated",
                      "Persistent or recurrent inflammation leads to changes in intrinsic glomerular cell numbers and function, and matrix homeostasis"
                    ]
                  },
                  {
                    "text": "Thrombotic microangiopathyDue to lupus anticoagulant, antiphospholipid antibodies, or antibodies to ADAMTS13May arise independently of immune complex LN",
                    "sub_points": [
                      "Due to lupus anticoagulant, antiphospholipid antibodies, or antibodies to ADAMTS13",
                      "May arise independently of immune complex LN"
                    ]
                  },
                  {
                    "text": "Vasculitic GN: Necrosis with little or no IC deposition and endothelial damage by uncertain mechanism"
                  },
                  {
                    "text": "Podocytopathy: Minimal change lesion, FSGS, or collapsing glomerulopathy"
                  },
                  {
                    "text": "T-cell-mediated autoimmune reactivity particularly in tubulointerstitial disease"
                  }
                ],
                "Insights From Animal Studies": [
                  {
                    "text": "NZB/NZW F1, MRL/lpr, and BSXB mice develop lupus-like GNMultigenic risk factorsPromoted by deficiency of C4, C3, FcγRIIB, CD19, fas, Ro",
                    "sub_points": [
                      "Multigenic risk factors",
                      "Promoted by deficiency of C4, C3, FcγRIIB, CD19, fas, Ro"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Prevalence7-159/100,000 worldwide; varied methodologiesAsians 30-50/100000; blacks 9-30/100000; whites 5-10/1000001/1,400 females of European ancestry in USA~ 80% have LN during course of disease20% have nephritis at onset, > 90% at autopsy",
                    "sub_points": [
                      "7-159/100,000 worldwide; varied methodologiesAsians 30-50/100000; blacks 9-30/100000; whites 5-10/1000001/1,400 females of European ancestry in USA",
                      "Asians 30-50/100000; blacks 9-30/100000; whites 5-10/100000",
                      "1/1,400 females of European ancestry in USA",
                      "~ 80% have LN during course of disease20% have nephritis at onset, > 90% at autopsy",
                      "20% have nephritis at onset, > 90% at autopsy"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Peak incidence of LN: ~ 34 years (range: < 5 to > 75)"
                  }
                ],
                "Sex": [
                  {
                    "text": "F:M ~ 9:1"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Gradual or sudden onset"
                  },
                  {
                    "text": "Presentation correlates partially with ISN/RPS classificationAcute renal failure: Class IV (~ 85%)Nephrotic syndrome: Class V (~ 45%); IV (~ 35%); non-LN (~ 10%)Isolated proteinuria: Class V (~ 45%); IV (~ 35%); II (~ 15%); III (~ 15%)Isolated hematuria: Class II (~ 40%), V (~ 30%); non-LN (~ 30%)Nephritic syndrome: Class III and IVChronic renal failure: Class VI",
                    "sub_points": [
                      "Acute renal failure: Class IV (~ 85%)",
                      "Nephrotic syndrome: Class V (~ 45%); IV (~ 35%); non-LN (~ 10%)",
                      "Isolated proteinuria: Class V (~ 45%); IV (~ 35%); II (~ 15%); III (~ 15%)",
                      "Isolated hematuria: Class II (~ 40%), V (~ 30%); non-LN (~ 30%)",
                      "Nephritic syndrome: Class III and IV",
                      "Chronic renal failure: Class VI"
                    ]
                  },
                  {
                    "text": "Can have subclinical (\"silent\") LN, even with class IV"
                  },
                  {
                    "text": "Nonrenal manifestations: Serositis, synovitis, skin rash (malar, butterfly), oral ulcers, non-scarring alopecia, hemolytic anemia, leukopenia/lymphopenia, thrombocytopenia, lymphadenopathy, thrombosis, neuropathy, seizures, psychosis"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Autoantibodies95% have antinuclear antibodies (ANA)> 95% ANA (speckled pattern)~ 5% in general population have positive ANA30-80% anti-dsDNA; 20-30% anti-Sm (99% have SLE); 30-50% anti-Ro (SSA); 30-40% anti-U1RNP; ~ 60% anti-histone40-50% anticardiolipin; 15% antiphospholipid; 30-50% anti-C1qNephritis associated with anti-dsDNA and anti-C1q",
                    "sub_points": [
                      "95% have antinuclear antibodies (ANA)> 95% ANA (speckled pattern)~ 5% in general population have positive ANA30-80% anti-dsDNA; 20-30% anti-Sm (99% have SLE); 30-50% anti-Ro (SSA); 30-40% anti-U1RNP; ~ 60% anti-histone",
                      "> 95% ANA (speckled pattern)~ 5% in general population have positive ANA",
                      "~ 5% in general population have positive ANA",
                      "30-80% anti-dsDNA; 20-30% anti-Sm (99% have SLE); 30-50% anti-Ro (SSA); 30-40% anti-U1RNP; ~ 60% anti-histone",
                      "40-50% anticardiolipin; 15% antiphospholipid; 30-50% anti-C1q",
                      "Nephritis associated with anti-dsDNA and anti-C1q"
                    ]
                  },
                  {
                    "text": "Complement levels30-50% ↓ C3, 67-80% ↓ C4, association with active disease",
                    "sub_points": [
                      "30-50% ↓ C3, 67-80% ↓ C4, association with active disease"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "TransplantationClinical recurrence ~ 2%; subclinical recurrence ~ 40%",
                    "sub_points": [
                      "Clinical recurrence ~ 2%; subclinical recurrence ~ 40%"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "Immunosuppressive therapy to decrease or arrest IC deposits, inflammation, and necrosisGlucocorticoids, mycophenolate mofetil, cyclophosphamide, chlorambucil and azathioprine",
                    "sub_points": [
                      "Glucocorticoids, mycophenolate mofetil, cyclophosphamide, chlorambucil and azathioprine"
                    ]
                  },
                  {
                    "text": "Antibodies targeting CD20 (rituximab) and BLys (Belimumab) under evaluation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Typically remitting and recurring course"
                  },
                  {
                    "text": "20-25% develop end-stage renal disease (ESRD)ESRD or doubling of Cr at 10 years by ISN/RPS classClass I, II: 0%Class III: 0-8%Class IV: 8-50%Class V: 0-10%Risk factors for ESRD: Class III or IV biopsy: Male gender, hypertension, proteinuria",
                    "sub_points": [
                      "ESRD or doubling of Cr at 10 years by ISN/RPS classClass I, II: 0%Class III: 0-8%Class IV: 8-50%Class V: 0-10%",
                      "Class I, II: 0%",
                      "Class III: 0-8%",
                      "Class IV: 8-50%",
                      "Class V: 0-10%",
                      "Risk factors for ESRD: Class III or IV biopsy: Male gender, hypertension, proteinuria"
                    ]
                  },
                  {
                    "text": "Common causes of deathInfection, especially pneumonia; chronic renal failure; B-cell lymphomas, lung carcinoma",
                    "sub_points": [
                      "Infection, especially pneumonia; chronic renal failure; B-cell lymphomas, lung carcinoma"
                    ]
                  },
                  {
                    "text": "Delay in biopsy (> 6 mo) correlates with development of ESRD"
                  }
                ],
                "Systemic Lupus Collaborating Clinics (SLICC) Diagnostic Criteria": [
                  {
                    "text": "Biopsy confirmed nephritis compatible with SLE in presence of SLE autoantibodies is sufficient for diagnosisOtherwise need 4/17 criteria, including at least 1 clinical and 1 immunologicCompared with American College of Rheumatology (ACR) criteria, SLICC is more sensitive (97% vs. 83%) but less specific (84% vs. 96%)",
                    "sub_points": [
                      "Otherwise need 4/17 criteria, including at least 1 clinical and 1 immunologic",
                      "Compared with American College of Rheumatology (ACR) criteria, SLICC is more sensitive (97% vs. 83%) but less specific (84% vs. 96%)"
                    ]
                  },
                  {
                    "text": "Clinical criteriaAcute cutaneous lupusMalar rashBullous lupusToxic epidermal necrolysis variant of lupusMaculopapular lupus rash in absence of dermatomyositisSubacute cutaneous lupus (nonindurated psoriasiform &/or annular polycyclic lesions)Chronic cutaneous lupusClassical discoid rashHypertrophic (verrucous) lupusLupus panniculitis (profundus)Mucosal lupusLupus erythematosus tumidusChilblains lupusDiscoid lupus/lichen planus overlapOral ulcersPalate, buccal, tongue, or nasal ulcersIn absence of other causes (e.g., vasculitis, Behçet, infection)Nonscarring alopeciaDiffuse thinning or hair fragility with visible broken hairsIn absence of other causes (e.g., drugs, iron deficiency, alopecia areata, androgenic alopecia)SynovitisSwelling or effusion in 2 or more jointsTenderness in 2 or more joints and 30 minutes or more of morning stiffnessSerositisPleurisy for > 1 dayPleural effusionsPleural rubPericardial pain with recumbency, improved by sitting forward for > 1 dayPericardial effusionPericardial rubPericarditis by EKGIn absence of other causes (e.g., uremia, infection, Dressler syndrome)RenalUrine protein/creatinine (or 24 hr urine protein) representing 500 mg of protein/24 hrRed blood cell castsNeurologicSeizuresPsychosisMononeuritis multiplexIn absence of other causes such as primary vasculitisMyelitisPeripheral or cranial neuropathyIn absence of other known causes such as primary vasculitis, infection, and diabetes mellitusAcute confusional stateIn absence of other causes, including toxic-metabolic, uremia, drugsHemolytic anemiaLeukopenia(< 4000/mm3) orlymphopenia(< 1,000/mm3)In absence of other known causes such as Felty, drugs, portal hypertension, and infectionThrombocytopenia(<100,000/mm3)In absence of other known causes such as drugs, portal hypertension, and TTP",
                    "sub_points": [
                      "Acute cutaneous lupusMalar rashBullous lupusToxic epidermal necrolysis variant of lupusMaculopapular lupus rash in absence of dermatomyositisSubacute cutaneous lupus (nonindurated psoriasiform &/or annular polycyclic lesions)",
                      "Malar rash",
                      "Bullous lupus",
                      "Toxic epidermal necrolysis variant of lupus",
                      "Maculopapular lupus rash in absence of dermatomyositis",
                      "Subacute cutaneous lupus (nonindurated psoriasiform &/or annular polycyclic lesions)",
                      "Chronic cutaneous lupusClassical discoid rashHypertrophic (verrucous) lupusLupus panniculitis (profundus)Mucosal lupusLupus erythematosus tumidusChilblains lupusDiscoid lupus/lichen planus overlap",
                      "Classical discoid rash",
                      "Hypertrophic (verrucous) lupus",
                      "Lupus panniculitis (profundus)",
                      "Mucosal lupus",
                      "Lupus erythematosus tumidus",
                      "Chilblains lupus",
                      "Discoid lupus/lichen planus overlap",
                      "Oral ulcersPalate, buccal, tongue, or nasal ulcersIn absence of other causes (e.g., vasculitis, Behçet, infection)",
                      "Palate, buccal, tongue, or nasal ulcersIn absence of other causes (e.g., vasculitis, Behçet, infection)",
                      "In absence of other causes (e.g., vasculitis, Behçet, infection)",
                      "Nonscarring alopeciaDiffuse thinning or hair fragility with visible broken hairsIn absence of other causes (e.g., drugs, iron deficiency, alopecia areata, androgenic alopecia)",
                      "Diffuse thinning or hair fragility with visible broken hairsIn absence of other causes (e.g., drugs, iron deficiency, alopecia areata, androgenic alopecia)",
                      "In absence of other causes (e.g., drugs, iron deficiency, alopecia areata, androgenic alopecia)",
                      "SynovitisSwelling or effusion in 2 or more jointsTenderness in 2 or more joints and 30 minutes or more of morning stiffness",
                      "Swelling or effusion in 2 or more joints",
                      "Tenderness in 2 or more joints and 30 minutes or more of morning stiffness",
                      "SerositisPleurisy for > 1 dayPleural effusionsPleural rubPericardial pain with recumbency, improved by sitting forward for > 1 dayPericardial effusionPericardial rubPericarditis by EKGIn absence of other causes (e.g., uremia, infection, Dressler syndrome)",
                      "Pleurisy for > 1 day",
                      "Pleural effusions",
                      "Pleural rub",
                      "Pericardial pain with recumbency, improved by sitting forward for > 1 day",
                      "Pericardial effusion",
                      "Pericardial rub",
                      "Pericarditis by EKGIn absence of other causes (e.g., uremia, infection, Dressler syndrome)",
                      "In absence of other causes (e.g., uremia, infection, Dressler syndrome)",
                      "RenalUrine protein/creatinine (or 24 hr urine protein) representing 500 mg of protein/24 hrRed blood cell casts",
                      "Urine protein/creatinine (or 24 hr urine protein) representing 500 mg of protein/24 hr",
                      "Red blood cell casts",
                      "NeurologicSeizuresPsychosisMononeuritis multiplexIn absence of other causes such as primary vasculitisMyelitisPeripheral or cranial neuropathyIn absence of other known causes such as primary vasculitis, infection, and diabetes mellitusAcute confusional stateIn absence of other causes, including toxic-metabolic, uremia, drugs",
                      "Seizures",
                      "Psychosis",
                      "Mononeuritis multiplexIn absence of other causes such as primary vasculitis",
                      "In absence of other causes such as primary vasculitis",
                      "Myelitis",
                      "Peripheral or cranial neuropathyIn absence of other known causes such as primary vasculitis, infection, and diabetes mellitus",
                      "In absence of other known causes such as primary vasculitis, infection, and diabetes mellitus",
                      "Acute confusional stateIn absence of other causes, including toxic-metabolic, uremia, drugs",
                      "In absence of other causes, including toxic-metabolic, uremia, drugs",
                      "Hemolytic anemia",
                      "Leukopenia(< 4000/mm3) orlymphopenia(< 1,000/mm3)In absence of other known causes such as Felty, drugs, portal hypertension, and infection",
                      "In absence of other known causes such as Felty, drugs, portal hypertension, and infection",
                      "Thrombocytopenia(<100,000/mm3)In absence of other known causes such as drugs, portal hypertension, and TTP",
                      "In absence of other known causes such as drugs, portal hypertension, and TTP"
                    ]
                  },
                  {
                    "text": "Immunologic criteriaANAAbove laboratory reference rangeAnti-dsDNAAbove laboratory reference range, except ELISA: 2x above laboratory reference rangeAnti-SmAntiphospholipid antibodyLupus anticoagulantFalse-positive RPRMedium or high titer anticardiolipin (IgA, IgG or IgM)Anti-β2 glycoprotein I (IgA, IgG or IgM)Low complementLow C3Low C4Low CH50Direct Coombs testIn absence of hemolytic anemia",
                    "sub_points": [
                      "ANAAbove laboratory reference range",
                      "Above laboratory reference range",
                      "Anti-dsDNAAbove laboratory reference range, except ELISA: 2x above laboratory reference range",
                      "Above laboratory reference range, except ELISA: 2x above laboratory reference range",
                      "Anti-Sm",
                      "Antiphospholipid antibodyLupus anticoagulantFalse-positive RPRMedium or high titer anticardiolipin (IgA, IgG or IgM)Anti-β2 glycoprotein I (IgA, IgG or IgM)",
                      "Lupus anticoagulant",
                      "False-positive RPR",
                      "Medium or high titer anticardiolipin (IgA, IgG or IgM)",
                      "Anti-β2 glycoprotein I (IgA, IgG or IgM)",
                      "Low complementLow C3Low C4Low CH50",
                      "Low C3",
                      "Low C4",
                      "Low CH50",
                      "Direct Coombs testIn absence of hemolytic anemia",
                      "In absence of hemolytic anemia"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Lupus nephritis affects glomeruli, peritubular capillaries, muscular blood vessels, tubules, and interstitium with a spectrum of lesions"
                  },
                  {
                    "text": "GlomeruliGlomerular lesions determine ISN/RPS classification (classes I-VI)Lesions can be active (acute) or chronic (sclerosing)Focal (< 50% of glomeruli affected; III) or diffuse (≥ 50% of glomeruli affected; IV)Segmental (part of a glomerulus) or global (> 50% of a glomerulus)Distinction between III and IV is by extent of glomerular lesions (< or ≥ 50%, respectively)Normal (class I)Requires mesangial IgG to diagnose lupus class IClass I is seen in < 1% of biopsies for causeMesangial hypercellularity (class II)By itself is not considered an active lesionClass II is seen in 8-17% of biopsiesEndocapillary hypercellularity (class III, IV)Proliferation of intrinsic glomerular cells and accumulation of leukocytes with capillary luminal reductionClass III is seen in 9-24% of biopsiesClass IV is seen in 37-66% of biopsiesSegmental glomerulonephritis designated IV-S (10-20%); global glomerulonephritis as IV-G (21-46%)Extracapillary hypercellularity (crescents) (class III, IV)Proliferation of parietal epithelium and accumulation of leukocytes, especially macrophagesDefined as ≥ 2 cells thick, > 25% of circumference of capsuleKaryorrhexis, fibrinoid necrosis ± GBM rupture (class III, IV)Prominent subendothelial deposits (\"wire loops\") (class III, IV)Trichrome stain highlights bright red wire loopsHyaline \"pseudothrombi\" (class III, IV)Hematoxylin bodies specific but rare (class III, IV): In vivo LE cellMembranous lesions (class V)Diffuse thickening of GBM with granular subepithelial deposits (trichrome) with silver-positive \"spikes\"Class V is seen in 8-29% of biopsies; often mixed with other classes (II, III, IV)Chronic glomerular lesionsIncluded in count of involved glomeruli for III vs. IV, if believed to be due to LNGlomerular sclerosis, segmental or global and fibrous adhesionsFibrous crescentsGBM duplicationEnd stage (class VI); ≥ 90% global glomerulosclerosis; 1-3% of biopsiesVariantsSome patients with minimal lupus (I-II) have podocytopathy (minimal change disease and focal segmental glomerulosclerosis)Focal segmental glomerular sclerosis can also be late scarring phase of lupus nephritis or maladaptive/hemodynamic secondary to loss of nephronsRarely thrombotic microangiopathy with little immune complex disease",
                    "sub_points": [
                      "Glomerular lesions determine ISN/RPS classification (classes I-VI)Lesions can be active (acute) or chronic (sclerosing)Focal (< 50% of glomeruli affected; III) or diffuse (≥ 50% of glomeruli affected; IV)Segmental (part of a glomerulus) or global (> 50% of a glomerulus)Distinction between III and IV is by extent of glomerular lesions (< or ≥ 50%, respectively)",
                      "Lesions can be active (acute) or chronic (sclerosing)",
                      "Focal (< 50% of glomeruli affected; III) or diffuse (≥ 50% of glomeruli affected; IV)",
                      "Segmental (part of a glomerulus) or global (> 50% of a glomerulus)",
                      "Distinction between III and IV is by extent of glomerular lesions (< or ≥ 50%, respectively)",
                      "Normal (class I)Requires mesangial IgG to diagnose lupus class IClass I is seen in < 1% of biopsies for cause",
                      "Requires mesangial IgG to diagnose lupus class I",
                      "Class I is seen in < 1% of biopsies for cause",
                      "Mesangial hypercellularity (class II)By itself is not considered an active lesionClass II is seen in 8-17% of biopsies",
                      "By itself is not considered an active lesion",
                      "Class II is seen in 8-17% of biopsies",
                      "Endocapillary hypercellularity (class III, IV)Proliferation of intrinsic glomerular cells and accumulation of leukocytes with capillary luminal reductionClass III is seen in 9-24% of biopsiesClass IV is seen in 37-66% of biopsiesSegmental glomerulonephritis designated IV-S (10-20%); global glomerulonephritis as IV-G (21-46%)",
                      "Proliferation of intrinsic glomerular cells and accumulation of leukocytes with capillary luminal reduction",
                      "Class III is seen in 9-24% of biopsies",
                      "Class IV is seen in 37-66% of biopsiesSegmental glomerulonephritis designated IV-S (10-20%); global glomerulonephritis as IV-G (21-46%)",
                      "Segmental glomerulonephritis designated IV-S (10-20%); global glomerulonephritis as IV-G (21-46%)",
                      "Extracapillary hypercellularity (crescents) (class III, IV)Proliferation of parietal epithelium and accumulation of leukocytes, especially macrophagesDefined as ≥ 2 cells thick, > 25% of circumference of capsule",
                      "Proliferation of parietal epithelium and accumulation of leukocytes, especially macrophages",
                      "Defined as ≥ 2 cells thick, > 25% of circumference of capsule",
                      "Karyorrhexis, fibrinoid necrosis ± GBM rupture (class III, IV)",
                      "Prominent subendothelial deposits (\"wire loops\") (class III, IV)Trichrome stain highlights bright red wire loops",
                      "Trichrome stain highlights bright red wire loops",
                      "Hyaline \"pseudothrombi\" (class III, IV)",
                      "Hematoxylin bodies specific but rare (class III, IV): In vivo LE cell",
                      "Membranous lesions (class V)Diffuse thickening of GBM with granular subepithelial deposits (trichrome) with silver-positive \"spikes\"Class V is seen in 8-29% of biopsies; often mixed with other classes (II, III, IV)",
                      "Diffuse thickening of GBM with granular subepithelial deposits (trichrome) with silver-positive \"spikes\"",
                      "Class V is seen in 8-29% of biopsies; often mixed with other classes (II, III, IV)",
                      "Chronic glomerular lesionsIncluded in count of involved glomeruli for III vs. IV, if believed to be due to LNGlomerular sclerosis, segmental or global and fibrous adhesionsFibrous crescentsGBM duplicationEnd stage (class VI); ≥ 90% global glomerulosclerosis; 1-3% of biopsies",
                      "Included in count of involved glomeruli for III vs. IV, if believed to be due to LN",
                      "Glomerular sclerosis, segmental or global and fibrous adhesions",
                      "Fibrous crescents",
                      "GBM duplication",
                      "End stage (class VI); ≥ 90% global glomerulosclerosis; 1-3% of biopsies",
                      "VariantsSome patients with minimal lupus (I-II) have podocytopathy (minimal change disease and focal segmental glomerulosclerosis)Focal segmental glomerular sclerosis can also be late scarring phase of lupus nephritis or maladaptive/hemodynamic secondary to loss of nephronsRarely thrombotic microangiopathy with little immune complex disease",
                      "Some patients with minimal lupus (I-II) have podocytopathy (minimal change disease and focal segmental glomerulosclerosis)",
                      "Focal segmental glomerular sclerosis can also be late scarring phase of lupus nephritis or maladaptive/hemodynamic secondary to loss of nephrons",
                      "Rarely thrombotic microangiopathy with little immune complex disease"
                    ]
                  },
                  {
                    "text": "Tubules and interstitiumTubulointerstitial lesions most commonly seen in association with class III and IV GNMay be active or chronic; ± IgG and C3 positive tubulointerstitial immune depositsTubulointerstitial immune deposits strongly correlated with interstitial lymphoid folliclesAnti-vimentin autoantibody titers commonly found and correlate with degree of interstitial inflammationActive lesions have T cells, macrophages, B cells, plasma cells, neutrophils, edema and tubulitisChronic lesions are characterized by interstitial fibrosis and tubular atrophyTubulointerstitial disease with little or no glomerular disease (e.g., class I and II) occurs rarely (15 cases reported); beware of unsampled class III.",
                    "sub_points": [
                      "Tubulointerstitial lesions most commonly seen in association with class III and IV GNMay be active or chronic; ± IgG and C3 positive tubulointerstitial immune depositsTubulointerstitial immune deposits strongly correlated with interstitial lymphoid folliclesAnti-vimentin autoantibody titers commonly found and correlate with degree of interstitial inflammation",
                      "May be active or chronic; ± IgG and C3 positive tubulointerstitial immune deposits",
                      "Tubulointerstitial immune deposits strongly correlated with interstitial lymphoid follicles",
                      "Anti-vimentin autoantibody titers commonly found and correlate with degree of interstitial inflammation",
                      "Active lesions have T cells, macrophages, B cells, plasma cells, neutrophils, edema and tubulitis",
                      "Chronic lesions are characterized by interstitial fibrosis and tubular atrophy",
                      "Tubulointerstitial disease with little or no glomerular disease (e.g., class I and II) occurs rarely (15 cases reported); beware of unsampled class III."
                    ]
                  },
                  {
                    "text": "Vessels: 6 patterns observedNormal (negative IF)Uncomplicated vascular immune deposits: Normal-looking vessels with Ig and C by IFNoninflammatory lupus vasculopathy: Hyaline deposits with Ig and C by IFNecrotizing lupus vasculitis: Fibrinoid necrosis and leukocytoclasis ± immune depositsThrombotic microangiopathy: ± class III or IV glomerular lesionsArterial and arteriolar sclerosis: Nonlupus vasculopathy without immune deposits",
                    "sub_points": [
                      "Normal (negative IF)",
                      "Uncomplicated vascular immune deposits: Normal-looking vessels with Ig and C by IF",
                      "Noninflammatory lupus vasculopathy: Hyaline deposits with Ig and C by IF",
                      "Necrotizing lupus vasculitis: Fibrinoid necrosis and leukocytoclasis ± immune deposits",
                      "Thrombotic microangiopathy: ± class III or IV glomerular lesions",
                      "Arterial and arteriolar sclerosis: Nonlupus vasculopathy without immune deposits"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunofluorescence": [
                  {
                    "text": "Detection of IgG deposits in glomeruli essential for diagnosisUsually accompanied by IgA, IgM, C3, and C1q (\"full house\")Kappa and lambda equalIgG1 and IgG3 are predominate subclassesFibrin in necrotizing lesions, thrombi and crescents",
                    "sub_points": [
                      "Usually accompanied by IgA, IgM, C3, and C1q (\"full house\")",
                      "Kappa and lambda equal",
                      "IgG1 and IgG3 are predominate subclasses",
                      "Fibrin in necrotizing lesions, thrombi and crescents"
                    ]
                  },
                  {
                    "text": "Glomerular patternsMesangial only (class I, II)Capillary wall, focal or diffuse, coarse granular, elongated (class III, IV)Capillary wall, diffuse, finely granular (class V)",
                    "sub_points": [
                      "Mesangial only (class I, II)",
                      "Capillary wall, focal or diffuse, coarse granular, elongated (class III, IV)",
                      "Capillary wall, diffuse, finely granular (class V)"
                    ]
                  },
                  {
                    "text": "Tubules focal granular IgG in ~ 60% of cases, ± other components (Ig, C3, C1q)IgG subclass distribution different from those in glomerulus in 70%No strong correlation with interstitial inflammationRare case with linear IgG",
                    "sub_points": [
                      "IgG subclass distribution different from those in glomerulus in 70%",
                      "No strong correlation with interstitial inflammation",
                      "Rare case with linear IgG"
                    ]
                  },
                  {
                    "text": "Vessels: Granular IgG in small arteries &/or arterioles (~ 48%) &/or peritubular capillaries (6%) along with various other components"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Amorphous electron-dense deposits present in glomeruli in varied locations and extentMesangium, subendothelium, subepitheliumSubepithelial deposits sometimes penetrate GBMSubstructure may be focally manifested as \"fingerprint\" pattern",
                    "sub_points": [
                      "Mesangium, subendothelium, subepithelium",
                      "Subepithelial deposits sometimes penetrate GBM",
                      "Substructure may be focally manifested as \"fingerprint\" pattern"
                    ]
                  },
                  {
                    "text": "Extraglomerular deposits of similar natureTubular basement membrane, Bowman capsule, peritubular capillaries, interstitium, small arteries",
                    "sub_points": [
                      "Tubular basement membrane, Bowman capsule, peritubular capillaries, interstitium, small arteries"
                    ]
                  },
                  {
                    "text": "Endothelial cells have tubuloreticular inclusionsClusters of vesicles and tubules of diameter 20-25 nm in endoplasmic reticulumConsequence of elevated levels of interferon: So-called \"interferon footprints\"",
                    "sub_points": [
                      "Clusters of vesicles and tubules of diameter 20-25 nm in endoplasmic reticulum",
                      "Consequence of elevated levels of interferon: So-called \"interferon footprints\""
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Type II Mixed Cryoglobulinemia": [
                  {
                    "text": "Cryoglobulins in serum"
                  },
                  {
                    "text": "Microtubular substructure of deposits"
                  },
                  {
                    "text": "Usually no subepithelial deposits"
                  },
                  {
                    "text": "Deposits can be sparse, macrophages prominent, IgM dominant"
                  },
                  {
                    "text": "Often associated with hepatitis C virus"
                  }
                ],
                "Membranoproliferative GN With Immune Deposits": [
                  {
                    "text": "Little or no C1q"
                  },
                  {
                    "text": "Negative lupus serologies"
                  }
                ],
                "Idiopathic Membranous GN": [
                  {
                    "text": "Absence of subendothelial, mesangial, and TBM deposits or tubuloreticular inclusions"
                  },
                  {
                    "text": "Deposits typically do not penetrate the GBM"
                  },
                  {
                    "text": "Antibodies to phospholipase A2 receptors in~70%"
                  }
                ],
                "Lupus-Like GN in HIV": [
                  {
                    "text": "Negative or low titer ANA and negative dsDNA antibodies by definition"
                  },
                  {
                    "text": "50% diffuse, 45% focal, and 5% membranous pattern"
                  },
                  {
                    "text": "~ 20% of renal biopsies in HIV-infected patients"
                  }
                ],
                "C1q Nephropathy": [
                  {
                    "text": "No clinical or serologic evidence of lupus (by definition)"
                  },
                  {
                    "text": "Abundant mesangial immune deposits, with predominance of C1q"
                  }
                ],
                "Drug-Induced LN": [
                  {
                    "text": "Propylthiouracil, isoniazid, hydralazine, procainamide, chlorpromazine"
                  },
                  {
                    "text": "Usually no dsDNA antibodies or renal disease (5%)High frequency of antihistone antibodiesMay also have antineutrophil cytoplasmic autoantibodies (ANCA) and antiphospholipid antibodies",
                    "sub_points": [
                      "High frequency of antihistone antibodies",
                      "May also have antineutrophil cytoplasmic autoantibodies (ANCA) and antiphospholipid antibodies"
                    ]
                  },
                  {
                    "text": "Proof requires improvement after drug withdrawal and absence of SLE prior to drug exposure"
                  }
                ],
                "Postinfectious GN": [
                  {
                    "text": "IgG and C3 in a characteristic coarse granular (\"lumpy-bumpy\") pattern, with hump-like deposits along subepithelium; usually little C1q"
                  },
                  {
                    "text": "Deposits in subepithelium (\"humps\") do not have \"spikes\""
                  }
                ],
                "ANCA-Related GN": [
                  {
                    "text": "Little or no endocapillary hypercellularity or Ig or complement deposition"
                  }
                ],
                "IgA Nephropathy": [
                  {
                    "text": "IgA-dominant deposits without tubuloreticular inclusions or extraglomerular immune deposits"
                  }
                ],
                "Sjögren Syndrome": [
                  {
                    "text": "Distinction based on serology and clinical features"
                  },
                  {
                    "text": "Tubulointerstitial nephritis may be present before glomerular disease"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Kidneys are biopsied in SLE to determine type of renal disease, acute inflammatory activity, and extent of glomerular and tubulointerstitial scarring"
                  },
                  {
                    "text": "Histologic predictors of poor renal outcomeISN/RPS class of LN broadly correlates with outcome but tendency for class changes in follow-up biopsies reduces predictive valueMesangial and membranous lesions have better prognosis than focal or diffuse GNAmount of subendothelial depositsCrescents (cellular and fibrous)Glomerulosclerosis, tubular atrophyActivity and chronicity index",
                    "sub_points": [
                      "ISN/RPS class of LN broadly correlates with outcome but tendency for class changes in follow-up biopsies reduces predictive valueMesangial and membranous lesions have better prognosis than focal or diffuse GN",
                      "Mesangial and membranous lesions have better prognosis than focal or diffuse GN",
                      "Amount of subendothelial deposits",
                      "Crescents (cellular and fibrous)",
                      "Glomerulosclerosis, tubular atrophy",
                      "Activity and chronicity index"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Lupus nephritis is in differential diagnosis of almost every renal biopsy"
                  },
                  {
                    "text": "Heterogeneity of glomerular lesions, extraglomerular IgG, and endothelial tubuloreticular inclusions are most important diagnostic clues to LN"
                  },
                  {
                    "text": "Hematoxylin bodies are pathognomonic but rare"
                  }
                ]
              },
              "GRADING": {
                "ISN/RPS Classification of Lupus Glomerulonephritis (2004)": [
                  {
                    "text": "Based on light and immunofluorescence microscopy; electron microscopy not required≥ 20 glomeruli should be sampled for accurate classificationClassification requires distinction of active and chronic lesions and determination of extent of glomerular involvement by these injury processesOne glomerulus may have both acute/active lesions and chronic/sclerosing lesionsHeterogeneity of interglomerular and intraglomerular changes makes classification difficultMajority of reported cases have no change of class in follow-up biopsiesClass III and IV lesions rarely downgrade to class IIClassification upgrades reported in repeat biopsies over months to yearsClass II upgrades to class III, IV, and V lesions in ~ 33%Class III upgrades to class IV and V in ~ 50%Class IV upgrades to class V and VI lesions in ~ 15%Class V develop proliferative (class III or IV) lesions in ~ 45% of cases",
                    "sub_points": [
                      "≥ 20 glomeruli should be sampled for accurate classification",
                      "Classification requires distinction of active and chronic lesions and determination of extent of glomerular involvement by these injury processesOne glomerulus may have both acute/active lesions and chronic/sclerosing lesionsHeterogeneity of interglomerular and intraglomerular changes makes classification difficult",
                      "One glomerulus may have both acute/active lesions and chronic/sclerosing lesions",
                      "Heterogeneity of interglomerular and intraglomerular changes makes classification difficult",
                      "Majority of reported cases have no change of class in follow-up biopsiesClass III and IV lesions rarely downgrade to class II",
                      "Class III and IV lesions rarely downgrade to class II",
                      "Classification upgrades reported in repeat biopsies over months to yearsClass II upgrades to class III, IV, and V lesions in ~ 33%Class III upgrades to class IV and V in ~ 50%Class IV upgrades to class V and VI lesions in ~ 15%Class V develop proliferative (class III or IV) lesions in ~ 45% of cases",
                      "Class II upgrades to class III, IV, and V lesions in ~ 33%",
                      "Class III upgrades to class IV and V in ~ 50%",
                      "Class IV upgrades to class V and VI lesions in ~ 15%",
                      "Class V develop proliferative (class III or IV) lesions in ~ 45% of cases"
                    ]
                  },
                  {
                    "text": "Classes broadly correlate with outcomeClass I and II: Best survivalClass IV: Worse survival than III in many studiesLittle or no difference in outcome of (G) vs. (S)Class V: Good long-term survivalClass VI: End-stage disease",
                    "sub_points": [
                      "Class I and II: Best survival",
                      "Class IV: Worse survival than III in many studiesLittle or no difference in outcome of (G) vs. (S)",
                      "Little or no difference in outcome of (G) vs. (S)",
                      "Class V: Good long-term survival",
                      "Class VI: End-stage disease"
                    ]
                  }
                ],
                "Activity and Chronicity Indices": [
                  {
                    "text": "Histologic lesions scored 0 (none), 1 (mild), 2 (moderate), 3 (severe), and summed"
                  },
                  {
                    "text": "Activity index (AI) (range 0-24)Components: Endocapillary hypercellularity, neutrophils, fibrinoid necrosis/karyorrhexis, cellular crescents, \"pseudothrombi\"/\"wire loops\"Scores for necrosis/karyorrhexis and cellular crescents are doubled",
                    "sub_points": [
                      "Components: Endocapillary hypercellularity, neutrophils, fibrinoid necrosis/karyorrhexis, cellular crescents, \"pseudothrombi\"/\"wire loops\"Scores for necrosis/karyorrhexis and cellular crescents are doubled",
                      "Scores for necrosis/karyorrhexis and cellular crescents are doubled"
                    ]
                  },
                  {
                    "text": "Chronicity index (CI) (range 0-12)Components: Glomerular sclerosis, fibrous crescents, interstitial fibrosis, and tubular atrophy",
                    "sub_points": [
                      "Components: Glomerular sclerosis, fibrous crescents, interstitial fibrosis, and tubular atrophy"
                    ]
                  },
                  {
                    "text": "Thresholds for componentsEndocapillary hypercellularity, fibrinoid necrosis/karyorrhexis, cellular crescents, \"pseudothrombi\"/\"wire loops,\" glomerular sclerosis, fibrous crescents% of affected glomeruli (0 = 0%, 1 = < 25%, 2 = 25-50%, 3 = > 50%)Neutrophils in glomeruli0 ≤ 2/glomerulus, 1 = mild, 2 = moderate, 3 = severeInterstitial fibrosis, and tubular atrophy0 = absent, 1 = mild, 2 = moderate, 3 = severe",
                    "sub_points": [
                      "Endocapillary hypercellularity, fibrinoid necrosis/karyorrhexis, cellular crescents, \"pseudothrombi\"/\"wire loops,\" glomerular sclerosis, fibrous crescents% of affected glomeruli (0 = 0%, 1 = < 25%, 2 = 25-50%, 3 = > 50%)",
                      "% of affected glomeruli (0 = 0%, 1 = < 25%, 2 = 25-50%, 3 = > 50%)",
                      "Neutrophils in glomeruli0 ≤ 2/glomerulus, 1 = mild, 2 = moderate, 3 = severe",
                      "0 ≤ 2/glomerulus, 1 = mild, 2 = moderate, 3 = severe",
                      "Interstitial fibrosis, and tubular atrophy0 = absent, 1 = mild, 2 = moderate, 3 = severe",
                      "0 = absent, 1 = mild, 2 = moderate, 3 = severe"
                    ]
                  },
                  {
                    "text": "Activity scores generally go down with treatment and chronicity scores persist or increase"
                  },
                  {
                    "text": "Limited reproducibility and correlation with outcome, however widely used by nephrologists as a guide and particularly for comparing repeat biopsies"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Multiple Sclerosis": {
            "name": "Multiple Sclerosis",
            "url": "https://app.pathprimer.com/document/797a6904-876d-4b30-9054-bafa83ef1b1a/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Acute demyelinating disease prompting biopsy due to enhancement, prominent surrounding edema, and tumor or abscess-like appearance"
                  },
                  {
                    "text": "Most patients with demyelinating disease prompting biopsy eventually develop relapsing-remitting multiple sclerosis (MS)"
                  },
                  {
                    "text": "Disease course in most patients, once MS diagnosis is made by clinical/neuroimaging criteria, similar to that of \"ordinary\" MS"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Open ring sign is characteristic MR enhancement feature"
                  },
                  {
                    "text": "Inconsistent with pathological diagnosis of grade II infiltrating gliomas"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Sharp border"
                  },
                  {
                    "text": "Numerous foamy macrophages"
                  },
                  {
                    "text": "Admixed reactive astrocytes with long processes"
                  },
                  {
                    "text": "Loss of myelin on special stains"
                  },
                  {
                    "text": "Relatively greater preservation of axons than myelin"
                  },
                  {
                    "text": "Variable perivascular lymphocytic cuffing"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Astrocytoma, oligodendroglioma"
                  },
                  {
                    "text": "Glioblastoma"
                  },
                  {
                    "text": "Lymphocytic vasculitis"
                  },
                  {
                    "text": "Infarct"
                  },
                  {
                    "text": "Acute disseminated encephalomyelitis"
                  },
                  {
                    "text": "Steroid-treated CNS lymphoma"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "May closely resemble astrocytoma or oligodendroglioma in H&E sections"
                  },
                  {
                    "text": "Recognition of macrophages on touch and smear preparations during intraoperative consultation aids in diagnosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Multiple sclerosis (MS)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Large, usually solitary, lesion > 2 cm in size or lesion with significant mass effect, edema, or ring enhancementMay be mistaken on neuroimaging studies for tumor or abscess",
                    "sub_points": [
                      "May be mistaken on neuroimaging studies for tumor or abscess"
                    ]
                  },
                  {
                    "text": "Most patients with acute demyelinating disease prompting biopsy eventually develop relapsing-remitting MS (Pittock et al)Clinical course of MS in most patients with tumefactive-like lesions similar to that of \"ordinary\" MS patients, i.e., not more severe or monophasic",
                    "sub_points": [
                      "Clinical course of MS in most patients with tumefactive-like lesions similar to that of \"ordinary\" MS patients, i.e., not more severe or monophasic"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Median age at onset: 30-40 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "Slightly more common in females"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Patients polysymptomaticMotor, cognitive, sensory symptoms",
                    "sub_points": [
                      "Motor, cognitive, sensory symptoms"
                    ]
                  },
                  {
                    "text": "Symptom onset-biopsy interval usually about 2 monthsClinical expressions prompting biopsy initial neurological events in majority of cases",
                    "sub_points": [
                      "Clinical expressions prompting biopsy initial neurological events in majority of cases"
                    ]
                  },
                  {
                    "text": "Prior history of relapsing remitting MS (in some cases)"
                  },
                  {
                    "text": "History of progressive disease (rare)"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Stereotactic biopsy (most cases)"
                  },
                  {
                    "text": "Open biopsyAggressive resection potentially associated with new or increased neurological deficit",
                    "sub_points": [
                      "Aggressive resection potentially associated with new or increased neurological deficit"
                    ]
                  }
                ],
                "Adjuvant therapy": [
                  {
                    "text": "Plasma exchange (PLEX)Ring-enhancing lesions &/or mass effect associated with beneficial response to PLEX",
                    "sub_points": [
                      "Ring-enhancing lesions &/or mass effect associated with beneficial response to PLEX"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Good, but variable"
                  },
                  {
                    "text": "Does not portend aggressive subsequent downhill clinical course"
                  },
                  {
                    "text": "Median time to 2nd attack of demyelination ~ 5 years"
                  },
                  {
                    "text": "Large lesions (> 5 cm) associated with slightly more clinical dysfunction"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Large, confluent lesion(s), often periventricular or subcortical"
                  },
                  {
                    "text": "Contrast enhancementCommon in acute phase\"Open ring\" or horseshoe-shaped configuration highly suggestiveInconsistent with pathological diagnosis of grade II infiltrating gliomas",
                    "sub_points": [
                      "Common in acute phase",
                      "\"Open ring\" or horseshoe-shaped configuration highly suggestive",
                      "Inconsistent with pathological diagnosis of grade II infiltrating gliomas"
                    ]
                  },
                  {
                    "text": "Perilesional edemaVariable, but may be prominent with larger lesions",
                    "sub_points": [
                      "Variable, but may be prominent with larger lesions"
                    ]
                  },
                  {
                    "text": "Multiple lesions on prebiopsy scan in ~ 70%"
                  },
                  {
                    "text": "Rare variant, Balo sclerosis, shows concentric globe appearance with alternating bands of myelin loss and preservation"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Acute plaques with somewhat ill-defined margins, tan-yellow, granular"
                  },
                  {
                    "text": "Chronic inactive plaques usually have sharply defined margins, gray, glistening, depressed"
                  },
                  {
                    "text": "Often periventricular, gray-white junction, or deep white matterPerivenular orientation at angles of lateral ventricles, with extension along veins: \"Dawson fingers\"",
                    "sub_points": [
                      "Perivenular orientation at angles of lateral ventricles, with extension along veins: \"Dawson fingers\""
                    ]
                  },
                  {
                    "text": "Balo sclerosis not easily detected on gross tissue examinationDiagnosis requires correlation with MR imaging",
                    "sub_points": [
                      "Diagnosis requires correlation with MR imaging"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "BordersUsually discrete in chronic inactive plaquesSomewhat more irregular, but still microscopically well defined, in acute/active plaques",
                    "sub_points": [
                      "Usually discrete in chronic inactive plaques",
                      "Somewhat more irregular, but still microscopically well defined, in acute/active plaques"
                    ]
                  },
                  {
                    "text": "Perivenular orientationMore obvious in autopsy specimens",
                    "sub_points": [
                      "More obvious in autopsy specimens"
                    ]
                  },
                  {
                    "text": "MacrophagesPrincipal componentFrequent perivascular concentrationContentsFoamy to granularLuxol fast blue (LFB) (+), acutePeriodic acid-Schiff (+), subacute to chronic",
                    "sub_points": [
                      "Principal component",
                      "Frequent perivascular concentration",
                      "ContentsFoamy to granularLuxol fast blue (LFB) (+), acutePeriodic acid-Schiff (+), subacute to chronic",
                      "Foamy to granular",
                      "Luxol fast blue (LFB) (+), acute",
                      "Periodic acid-Schiff (+), subacute to chronic"
                    ]
                  },
                  {
                    "text": "Reactive astrocytesEvenly dispersedLong tapering cytoplasmic processesLarge nuclei, prominent nucleoli, and vesicular nuclei when highly reactiveMultinucleate (Creutzfeldt cell)Common but not specific",
                    "sub_points": [
                      "Evenly dispersed",
                      "Long tapering cytoplasmic processes",
                      "Large nuclei, prominent nucleoli, and vesicular nuclei when highly reactive",
                      "Multinucleate (Creutzfeldt cell)Common but not specific",
                      "Common but not specific"
                    ]
                  },
                  {
                    "text": "Loss of myelinLFB/H&E, LFB/PAS",
                    "sub_points": [
                      "LFB/H&E, LFB/PAS"
                    ]
                  },
                  {
                    "text": "Axonal lossAxonal swellings in acute examplesProportionally less than that of myelin",
                    "sub_points": [
                      "Axonal swellings in acute examples",
                      "Proportionally less than that of myelin"
                    ]
                  },
                  {
                    "text": "Perivascular inflammationVariable, not always presentT cells predominate",
                    "sub_points": [
                      "Variable, not always present",
                      "T cells predominate"
                    ]
                  },
                  {
                    "text": "Little if any cavitation"
                  },
                  {
                    "text": "MitosesGranularExploding pattern of chromosomes in cells with copious cytoplasmPresumed precursor of Creutzfeldt cellConventionalOccasional",
                    "sub_points": [
                      "GranularExploding pattern of chromosomes in cells with copious cytoplasmPresumed precursor of Creutzfeldt cell",
                      "Exploding pattern of chromosomes in cells with copious cytoplasm",
                      "Presumed precursor of Creutzfeldt cell",
                      "ConventionalOccasional",
                      "Occasional"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "MacrophagesSharp cell bordersFoamy or granular cytoplasmCytologically bland",
                    "sub_points": [
                      "Sharp cell borders",
                      "Foamy or granular cytoplasm",
                      "Cytologically bland"
                    ]
                  },
                  {
                    "text": "Reactive astrocytesConventional, can simulate astrocytomaMultinucleated (Creutzfeldt cell)",
                    "sub_points": [
                      "Conventional, can simulate astrocytoma",
                      "Multinucleated (Creutzfeldt cell)"
                    ]
                  },
                  {
                    "text": "Granular mitoses"
                  }
                ],
                "Histochemistry": [
                  {
                    "text": "Modified Bielschowsky, Bodian stainsReactivity: AxonsStaining Pattern: Preservation relative to myelin loss",
                    "sub_points": [
                      "Reactivity: Axons",
                      "Staining Pattern: Preservation relative to myelin loss"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "GFAPReactive astrocytes strongly (+)",
                    "sub_points": [
                      "Reactive astrocytes strongly (+)"
                    ]
                  },
                  {
                    "text": "Macrophage markersHAM56Specific macrophage markerQualitatively and quantitatively less staining than with CD68CD68Lysosomal, rather than specific macrophage, markerAll phagocytes (+)",
                    "sub_points": [
                      "HAM56Specific macrophage markerQualitatively and quantitatively less staining than with CD68",
                      "Specific macrophage marker",
                      "Qualitatively and quantitatively less staining than with CD68",
                      "CD68Lysosomal, rather than specific macrophage, markerAll phagocytes (+)",
                      "Lysosomal, rather than specific macrophage, marker",
                      "All phagocytes (+)"
                    ]
                  },
                  {
                    "text": "Axonal markersNeurofilament protein, especially phosphorylated, e.g., SMI-31Axons generally preservedSome reduction and fragmentation but less than in infarcts",
                    "sub_points": [
                      "Neurofilament protein, especially phosphorylated, e.g., SMI-31Axons generally preservedSome reduction and fragmentation but less than in infarcts",
                      "Axons generally preserved",
                      "Some reduction and fragmentation but less than in infarcts"
                    ]
                  },
                  {
                    "text": "Antibodies directed against myelin basic protein (MBP), proteolipid protein (PLP)"
                  },
                  {
                    "text": "Aquaporin-4 IHC recently recognized as method to identify acute demyelinative lesions related to neuromyelitis optica (NMO)/NMO spectrum disorderShould be followed up with subsequent AQP4-IgG testing to confirm NMO/NMO spectrum disorder",
                    "sub_points": [
                      "Should be followed up with subsequent AQP4-IgG testing to confirm NMO/NMO spectrum disorder"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Astrocytoma, Oligodendroglioma": [
                  {
                    "text": "Few if any macrophages"
                  },
                  {
                    "text": "Cytoplasm of neoplastic oligodendrocytes artifactually clear, not foamy or granular"
                  },
                  {
                    "text": "Little if any perivascular inflammation, except for gemistocytic astrocytomas"
                  },
                  {
                    "text": "IDH-1 and Olig2(+), almost all cases"
                  }
                ],
                "Glioblastoma": [
                  {
                    "text": "More variable nuclear size, shape, and hyperchromatism"
                  },
                  {
                    "text": "Often more variable cell distribution, greater cellularity"
                  },
                  {
                    "text": "Pseudopalisading necrosis"
                  },
                  {
                    "text": "Microvascular proliferation"
                  },
                  {
                    "text": "Macrophages and microglia, but not in large numbers or sheets"
                  },
                  {
                    "text": "EGFR, EGFRVIII(+), in some cases"
                  },
                  {
                    "text": "IDH-1(+), in secondary glioblastoma (GBM), small subset of all GBMs"
                  }
                ],
                "Lymphocytic Vasculitis": [
                  {
                    "text": "Transmural, not perivascular, lymphocytes"
                  },
                  {
                    "text": "Vessel wall distortion, destruction"
                  },
                  {
                    "text": "Associated infarction in some cases"
                  },
                  {
                    "text": "Angiographic features of vasculitis in some cases"
                  }
                ],
                "Infarct": [
                  {
                    "text": "Loss of axons and myelin in near equal proportions"
                  },
                  {
                    "text": "Cavitation in subacute and chronic phases"
                  },
                  {
                    "text": "Lesions in vessel distribution"
                  },
                  {
                    "text": "Little if any perivascular chronic inflammation"
                  }
                ],
                "Acute Disseminated Encephalomyelitis": [
                  {
                    "text": "Perivenous, rather than confluent, demyelination"
                  },
                  {
                    "text": "Microglial activation and aggregation without cortical demyelination"
                  },
                  {
                    "text": "Depressed level of consciousness, headache, meningismus, cerebrospinal fluid pleocytosis, or multifocal enhancing magnetic resonance imaging abnormalities more common"
                  }
                ],
                "Steroid-Treated Central Nervous System Lymphoma": [
                  {
                    "text": "Sheets of macrophages, reactive astrocytes, variable numbers of nonneoplastic lymphocytesResidual lymphocytes often nonneoplastic CD3(+) T cellsGreater disruption of background neuropil, \"empty bed\"",
                    "sub_points": [
                      "Residual lymphocytes often nonneoplastic CD3(+) T cells",
                      "Greater disruption of background neuropil, \"empty bed\""
                    ]
                  },
                  {
                    "text": "Apoptosis, acutely prominent post steroids"
                  }
                ],
                "Neuromyelitis Optica/Neuromyelitis Spectrum Disorder": [
                  {
                    "text": "Can present as acute demyelinative lesion"
                  },
                  {
                    "text": "May have eosinophils in biopsy (rare in MS)"
                  },
                  {
                    "text": "AQP4 immunoreactivity  lost"
                  },
                  {
                    "text": "AQP4-IgG serum test (+), unlike multiple sclerosis"
                  },
                  {
                    "text": "Myelin vacuolation, vascular hyalinization, macrophages containing GFAP(+) debris may be present"
                  }
                ],
                "Balo Sclerosis": [
                  {
                    "text": "Considered rare variant of MS, not fully separate disorder"
                  },
                  {
                    "text": "May present acutely, prompting biopsy"
                  },
                  {
                    "text": "Diagnosis requires correlation with MR imaging of \"concentric globe\" appearance"
                  },
                  {
                    "text": "Requires histochemistry for LFB/PAS or IHC for MBP, PLP to detect concentric myelin loss and preservation"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "May closely resemble astrocytoma or oligodendroglioma in H&E sections due to hypercellularity"
                  },
                  {
                    "text": "Recognition of macrophages on touch and smear preparations during intraoperative consultation aids in diagnosis"
                  },
                  {
                    "text": "Absence of inflammation does not negate diagnosis"
                  },
                  {
                    "text": "Periventricular, perivenular location typical"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Tuberculosis": {
            "name": "Tuberculosis",
            "url": "https://app.pathprimer.com/document/44e1144b-9efd-4e0a-b288-135ca4e1ea4a/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Members of MTB complex are rod-shaped, acid-fast, aerobic, slow-growing intracellular pathogens that subvert phagosomal cells in order to persist and evade immune system"
                  },
                  {
                    "text": "Humans are the only natural reservoir for mycobacterial speciesM. tuberculosis,M. africanum, andM. canetti"
                  },
                  {
                    "text": "Most common in developing world"
                  },
                  {
                    "text": "Drug resistance is a serious problem and some infections are virtually untreatable"
                  },
                  {
                    "text": "Transmission is mainly by inhalation of contaminated droplets, thoughM. bovisinfection can be transmitted from cattle via undercooked meat or unpasteurized milk"
                  },
                  {
                    "text": "May establish itself in a subclinical, latent state, or immediately progress to active disease (~ 10%)"
                  },
                  {
                    "text": "Latent disease may reactivate in old age, in periods of stress or nutrient deprivation, or upon immunosuppression or HIV infection"
                  },
                  {
                    "text": "Pulmonary tuberculosis is most common manifestationUsually presents with nonspecific constitutional symptoms and productive cough",
                    "sub_points": [
                      "Usually presents with nonspecific constitutional symptoms and productive cough"
                    ]
                  },
                  {
                    "text": "Extrapulmonary tuberculosis can affect virtually any organ system and result from contiguous or lymphohematogenous spread"
                  },
                  {
                    "text": "Histopathologic hallmark is a necrotizing granuloma with giant cells and epithelioid histiocytes"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Mycobacterium tuberculosis(MTB)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Tubercle bacillus, Koch bacillus"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Greek: \"Myco\" (fungi, for similarity of mycobacteria to fungal growth on liquid media surfaces)"
                  },
                  {
                    "text": "Latin: \"Tuber\" (lump or swelling)"
                  }
                ],
                "Manifestations": [
                  {
                    "text": "Phthisis, consumption"
                  },
                  {
                    "text": "Tuberculosis"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Environmental Exposure": [
                  {
                    "text": "Humans are the only natural reservoir for mycobacterial speciesM. tuberculosis,Mycobacterium africanum, andMycobacterium canetti"
                  },
                  {
                    "text": "Most common in developing world"
                  },
                  {
                    "text": "Cattle are also reservoirs of mycobacterial speciesMycobacterium bovisandMycobacterium caprae"
                  },
                  {
                    "text": "Seals are reservoir forMycobacterium pinnipedii"
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "Mycobacterium tuberculosiscomplex comprises several species with > 99.9% identityMembers pertinent for human disease includeM. tuberculosis,M. africanum,M. canetti,M. bovis,M. caprae, andM.pinnipedii",
                    "sub_points": [
                      "Members pertinent for human disease includeM. tuberculosis,M. africanum,M. canetti,M. bovis,M. caprae, andM.pinnipedii"
                    ]
                  },
                  {
                    "text": "Transmission is mainly by inhalation of contaminated droplets, thoughM. bovisinfection can be transmitted from cattle via undercooked meat or unpasteurized milk"
                  },
                  {
                    "text": "MTB are intracellular pathogens that subvert phagosomal cell in order to persist and evade immune system"
                  },
                  {
                    "text": "Immunomodulatory components include cell wall, which contains a unique complement of glycolipid moietiesIncludes lipomannan, lipoarabinomannan and mycolic acids, responsible for acid-fastness of organism",
                    "sub_points": [
                      "Includes lipomannan, lipoarabinomannan and mycolic acids, responsible for acid-fastness of organism"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Presentation": [
                  {
                    "text": "Upon infection, MTB may establish itself in a subclinical, latent state or immediately progress to active disease (~ 10%)"
                  },
                  {
                    "text": "Latent disease may reactivate in old age, in periods of stress or nutrient deprivation, or upon immunosuppression or HIV infection"
                  },
                  {
                    "text": "Risk factors for active disease include extremes of age, immunosuppression, and coinfection with HIV"
                  },
                  {
                    "text": "Pulmonary tuberculosisTypically, very early disease is asymptomaticProgresses to nonspecific constitutional symptomsUsually includes productive coughHemoptysis usually indicates endobronchial erosion in advanced diseaseOften diagnosed upon chest imaging that shows infiltrates in lung apices or cavitation (CT or MR) in advanced disease",
                    "sub_points": [
                      "Typically, very early disease is asymptomaticProgresses to nonspecific constitutional symptomsUsually includes productive coughHemoptysis usually indicates endobronchial erosion in advanced disease",
                      "Progresses to nonspecific constitutional symptoms",
                      "Usually includes productive cough",
                      "Hemoptysis usually indicates endobronchial erosion in advanced disease",
                      "Often diagnosed upon chest imaging that shows infiltrates in lung apices or cavitation (CT or MR) in advanced disease"
                    ]
                  },
                  {
                    "text": "Extrapulmonary tuberculosis can result from contiguous or lymphohematogenous spreadMiliary tuberculosis: Progressive, widely disseminated disease (foci resemble \"millet seeds\")Central nervous system (CNS) tuberculosisCommon complication of childhood diseaseSymptoms range widely, include headache, vomiting, mental status changes, meningismus, focal neurologic signs, and comaCSF usually shows lymphocytic predominance, high protein, and low glucoseAcid-fast bacilli (AFB) may be present on Gram stainPleurisy: Most common in young childrenPericarditis: Most common in HIV(+) patientsSkeletal tuberculosis (Pott disease)Occurs in 1/3 of casesTypically begins on anterior aspect of vertebral bodySpreads to disks and other vertebraTends to affect lower thoracic or lumbar spine (also hips and knees)Commonly progresses to paraspinal abscess (can be extensive)Lymphadenitis (scrofula)Most common form of extrapulmonary tuberculosisHIV negative: Usually unilateral and cervical; no systemic symptomsHIV positive and AIDS: Often multifocal and marked systemic symptomsCommonly complicated by suppuration, sinus formation, and enlargement of surrounding nodes (which may represent immune activation rather than spread)RenalAsymptomatic lesions common in pulmonary TBUsually sterile pyuriaAdvanced disease includes papillar necrosis, uretal stricture, hydronephrosis, cavitation, and autonephrectomyGenitourinaryMales: Often a tender scrotal mass with draining sinus; may have calcified foci in prostateFemales: Hematogenous spread commonly involves endometrium and ovaries; may mimic carcinoma in cervix or peritoneal carcinomatosisOther extrapulmonary manifestationsGastrointestinal: Can affect any part of GI tract (also hepatic and pancreatic inflammation and masses)Peritoneal: Plastic and serous typesCutaneous: Lupus vulgaris (most common form), scrofuloderma",
                    "sub_points": [
                      "Miliary tuberculosis: Progressive, widely disseminated disease (foci resemble \"millet seeds\")",
                      "Central nervous system (CNS) tuberculosisCommon complication of childhood diseaseSymptoms range widely, include headache, vomiting, mental status changes, meningismus, focal neurologic signs, and comaCSF usually shows lymphocytic predominance, high protein, and low glucoseAcid-fast bacilli (AFB) may be present on Gram stain",
                      "Common complication of childhood disease",
                      "Symptoms range widely, include headache, vomiting, mental status changes, meningismus, focal neurologic signs, and coma",
                      "CSF usually shows lymphocytic predominance, high protein, and low glucose",
                      "Acid-fast bacilli (AFB) may be present on Gram stain",
                      "Pleurisy: Most common in young children",
                      "Pericarditis: Most common in HIV(+) patients",
                      "Skeletal tuberculosis (Pott disease)Occurs in 1/3 of casesTypically begins on anterior aspect of vertebral bodySpreads to disks and other vertebraTends to affect lower thoracic or lumbar spine (also hips and knees)Commonly progresses to paraspinal abscess (can be extensive)",
                      "Occurs in 1/3 of cases",
                      "Typically begins on anterior aspect of vertebral body",
                      "Spreads to disks and other vertebra",
                      "Tends to affect lower thoracic or lumbar spine (also hips and knees)",
                      "Commonly progresses to paraspinal abscess (can be extensive)",
                      "Lymphadenitis (scrofula)Most common form of extrapulmonary tuberculosisHIV negative: Usually unilateral and cervical; no systemic symptomsHIV positive and AIDS: Often multifocal and marked systemic symptomsCommonly complicated by suppuration, sinus formation, and enlargement of surrounding nodes (which may represent immune activation rather than spread)",
                      "Most common form of extrapulmonary tuberculosis",
                      "HIV negative: Usually unilateral and cervical; no systemic symptoms",
                      "HIV positive and AIDS: Often multifocal and marked systemic symptoms",
                      "Commonly complicated by suppuration, sinus formation, and enlargement of surrounding nodes (which may represent immune activation rather than spread)",
                      "RenalAsymptomatic lesions common in pulmonary TBUsually sterile pyuriaAdvanced disease includes papillar necrosis, uretal stricture, hydronephrosis, cavitation, and autonephrectomy",
                      "Asymptomatic lesions common in pulmonary TB",
                      "Usually sterile pyuria",
                      "Advanced disease includes papillar necrosis, uretal stricture, hydronephrosis, cavitation, and autonephrectomy",
                      "GenitourinaryMales: Often a tender scrotal mass with draining sinus; may have calcified foci in prostateFemales: Hematogenous spread commonly involves endometrium and ovaries; may mimic carcinoma in cervix or peritoneal carcinomatosis",
                      "Males: Often a tender scrotal mass with draining sinus; may have calcified foci in prostate",
                      "Females: Hematogenous spread commonly involves endometrium and ovaries; may mimic carcinoma in cervix or peritoneal carcinomatosis",
                      "Other extrapulmonary manifestationsGastrointestinal: Can affect any part of GI tract (also hepatic and pancreatic inflammation and masses)Peritoneal: Plastic and serous typesCutaneous: Lupus vulgaris (most common form), scrofuloderma",
                      "Gastrointestinal: Can affect any part of GI tract (also hepatic and pancreatic inflammation and masses)",
                      "Peritoneal: Plastic and serous types",
                      "Cutaneous: Lupus vulgaris (most common form), scrofuloderma"
                    ]
                  },
                  {
                    "text": "Other MTB complex organismsM. africanumCauses a tuberculosis-like (clinically and histologically equivalent) disease predominantly in West AfricaPatients affected with symptoms are usually immunocompromisedLacks \"region of difference 9,\" which may be related to differences in pathogenesisM. canettiCauses a tuberculosis-like (clinically and histologically equivalent) disease predominantly in Horn of AfricaPatients affected with symptoms may be immunocompetent or immunocompromisedSpecies has a novel phenolic glycolipid and lipo-oligosaccharideM. bovisCauses a tuberculosis-like (clinically and histologically equivalent) disease after animal exposureControl is primarily through culling of affected animalsInherently resistant to pyrazinamideM. capraeCauses a tuberculosis-like (clinically and histologically equivalent) disease after animal exposure in Eastern EuropeControl is primarily through culling of affected animalsDistinguished by molecular genotyping techniquesM. pinnipediiCauses a tuberculosis-like (clinically and histologically equivalent) disease after exposure to seals, guinea pigs, rabbits, or tapirsDistinguished by molecular genotyping techniques",
                    "sub_points": [
                      "M. africanumCauses a tuberculosis-like (clinically and histologically equivalent) disease predominantly in West AfricaPatients affected with symptoms are usually immunocompromisedLacks \"region of difference 9,\" which may be related to differences in pathogenesis",
                      "Causes a tuberculosis-like (clinically and histologically equivalent) disease predominantly in West Africa",
                      "Patients affected with symptoms are usually immunocompromised",
                      "Lacks \"region of difference 9,\" which may be related to differences in pathogenesis",
                      "M. canettiCauses a tuberculosis-like (clinically and histologically equivalent) disease predominantly in Horn of AfricaPatients affected with symptoms may be immunocompetent or immunocompromisedSpecies has a novel phenolic glycolipid and lipo-oligosaccharide",
                      "Causes a tuberculosis-like (clinically and histologically equivalent) disease predominantly in Horn of Africa",
                      "Patients affected with symptoms may be immunocompetent or immunocompromised",
                      "Species has a novel phenolic glycolipid and lipo-oligosaccharide",
                      "M. bovisCauses a tuberculosis-like (clinically and histologically equivalent) disease after animal exposureControl is primarily through culling of affected animalsInherently resistant to pyrazinamide",
                      "Causes a tuberculosis-like (clinically and histologically equivalent) disease after animal exposure",
                      "Control is primarily through culling of affected animals",
                      "Inherently resistant to pyrazinamide",
                      "M. capraeCauses a tuberculosis-like (clinically and histologically equivalent) disease after animal exposure in Eastern EuropeControl is primarily through culling of affected animalsDistinguished by molecular genotyping techniques",
                      "Causes a tuberculosis-like (clinically and histologically equivalent) disease after animal exposure in Eastern Europe",
                      "Control is primarily through culling of affected animals",
                      "Distinguished by molecular genotyping techniques",
                      "M. pinnipediiCauses a tuberculosis-like (clinically and histologically equivalent) disease after exposure to seals, guinea pigs, rabbits, or tapirsDistinguished by molecular genotyping techniques",
                      "Causes a tuberculosis-like (clinically and histologically equivalent) disease after exposure to seals, guinea pigs, rabbits, or tapirs",
                      "Distinguished by molecular genotyping techniques"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Tuberculin skin testingUsed screen to detect exposure by reaction to an intradermal dose of purified protein derivative (PPD)",
                    "sub_points": [
                      "Used screen to detect exposure by reaction to an intradermal dose of purified protein derivative (PPD)"
                    ]
                  },
                  {
                    "text": "Interferon release assaysELISA-based assay to determine the release of interferon gamma in response to multiple, purified MTB productsDoes not cross-react with BCG, though may with other mycobacterial species",
                    "sub_points": [
                      "ELISA-based assay to determine the release of interferon gamma in response to multiple, purified MTB products",
                      "Does not cross-react with BCG, though may with other mycobacterial species"
                    ]
                  },
                  {
                    "text": "SputumAcid-fast staining, culture, and direct detection or organisms by PCRIn a suspected patient, 3 sputa are required to rule out/rule in infection",
                    "sub_points": [
                      "Acid-fast staining, culture, and direct detection or organisms by PCR",
                      "In a suspected patient, 3 sputa are required to rule out/rule in infection"
                    ]
                  },
                  {
                    "text": "Lumbar punctureMay demonstrate organisms (by culture or AFB stain) in meningitisHigh protein, low glucose, lymphocytic predominance",
                    "sub_points": [
                      "May demonstrate organisms (by culture or AFB stain) in meningitis",
                      "High protein, low glucose, lymphocytic predominance"
                    ]
                  },
                  {
                    "text": "Fine-needle aspirationMay show organisms in lymphadenitisOften smear positive in HIV(+)May need biopsy and culture to detect in HIV(-)",
                    "sub_points": [
                      "May show organisms in lymphadenitis",
                      "Often smear positive in HIV(+)",
                      "May need biopsy and culture to detect in HIV(-)"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Mycobacterial lymphadenitis may have to be surgically excised"
                  },
                  {
                    "text": "Large lesions of any organ may be resected to prevent catastrophic erosions (e.g., aorta)"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Several possible months-long, multi-drug regimens available for active diseaseUsually some combination of isoniazid, rifampin, pyrazinamide, and ethambutolDrug resistance is a serious problem in MTB therapy and some or all commonly used agents may be ineffective",
                    "sub_points": [
                      "Usually some combination of isoniazid, rifampin, pyrazinamide, and ethambutol",
                      "Drug resistance is a serious problem in MTB therapy and some or all commonly used agents may be ineffective"
                    ]
                  },
                  {
                    "text": "Standard treatment for latent MTB infection consists of 9 months of daily isoniazid"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent in immunocompetent individuals with drug-susceptible infections"
                  },
                  {
                    "text": "Outcomes can be quite poor in ill/immunocompromised patients, particularly if infected with resistant strains"
                  }
                ]
              },
              "Image Findings": {
                "Radiographic Findings": [
                  {
                    "text": "Classically, MTB will show upper lobe involvement with apical scarring"
                  },
                  {
                    "text": "Miliary TB, pleural effusions, lobar pneumonias, and hilar masses are also possible"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Pulmonary sites may show cavitation"
                  },
                  {
                    "text": "Nonpulmonary sites may show small (miliary) disseminated nodules up to large solid or cavitary lesions with variable calcification"
                  }
                ]
              },
              "Microbiology": {
                "Morphologic and Biochemical Characteristics": [
                  {
                    "text": "Acid-fast, aerobic rods"
                  }
                ],
                "Culture": [
                  {
                    "text": "Slow growingDoubling time may be > 20 hoursTime to detection is 2-8 weeks",
                    "sub_points": [
                      "Doubling time may be > 20 hours",
                      "Time to detection is 2-8 weeks"
                    ]
                  },
                  {
                    "text": "Agar is usually composed of salt base and amino acids with glycerol, Tween 80, and malachite greenMalachite green will inhibit rapidly growing contaminants",
                    "sub_points": [
                      "Malachite green will inhibit rapidly growing contaminants"
                    ]
                  },
                  {
                    "text": "Colonies can be beige to yellowish, and have a \"piled up\" or \"crinkled\" appearance"
                  },
                  {
                    "text": "Commonly cultured in liquid media as part of automated BACTEC mycobacterial growth indicator tube (MGIT) systemTime to detection is 1-3 weeks",
                    "sub_points": [
                      "Time to detection is 1-3 weeks"
                    ]
                  }
                ],
                "Molecular Microbiologic Identification": [
                  {
                    "text": "Commonly by nucleic acid amplification test (NAAT)Gen-Probe (ribosomal RNA)AMPLICOR (DNA)GeneXpert MTB/RIF (real-time PCR, also assays rifampin resistance)",
                    "sub_points": [
                      "Gen-Probe (ribosomal RNA)",
                      "AMPLICOR (DNA)",
                      "GeneXpert MTB/RIF (real-time PCR, also assays rifampin resistance)"
                    ]
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "LungsCavities, caseating (necrotic) zones, and old calcified fociCommonly involves hilar and mediastinal lymph nodesLung lesions and hilar foci may both heal and calcify (Ghon foci)",
                    "sub_points": [
                      "Cavities, caseating (necrotic) zones, and old calcified foci",
                      "Commonly involves hilar and mediastinal lymph nodes",
                      "Lung lesions and hilar foci may both heal and calcify (Ghon foci)"
                    ]
                  },
                  {
                    "text": "Extrapulmonary featuresWidespread caseating granulomasPeripheral involved lymph nodes tend to be in supraclavicular fossa or posterior cervical triangleIntestinal ulcers may be transversal, granular, and punched out against smooth, hyperemic mucosa (tubercles may proliferate along edges)Peritoneal tuberculosis can develop from miliary tubercles in omental fat or propagate from infected abdominal lymph nodes or intestinal ulcersSkeletal involvement commonly in lower thoracic and lumbar vertebrae (Pott disease)Also knees and hips",
                    "sub_points": [
                      "Widespread caseating granulomas",
                      "Peripheral involved lymph nodes tend to be in supraclavicular fossa or posterior cervical triangle",
                      "Intestinal ulcers may be transversal, granular, and punched out against smooth, hyperemic mucosa (tubercles may proliferate along edges)",
                      "Peritoneal tuberculosis can develop from miliary tubercles in omental fat or propagate from infected abdominal lymph nodes or intestinal ulcers",
                      "Skeletal involvement commonly in lower thoracic and lumbar vertebrae (Pott disease)Also knees and hips",
                      "Also knees and hips"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "PulmonaryMost common site of both primary and reactivation tuberculosisCan involve airways, parenchyma, and pleuraPrimary tuberculosisMost commonly self-limitedLung lesions and hilar foci heal and calcify (Ghon foci)Can be progressiveHallmark lesion is caseating granulomaContain Langerhans giant cells with nuclei in a horseshoe arrangement, as well as activated epithelioid macrophagesAs granulomas progress, center becomes necrotic (caseous necrosis, coagulative necrosis speckled with basophilic particles of hydroxyapatite)With erosion into airways, exudative material is available to be expressed and transmitted to othersWith erosion into blood vessels, may spread widely",
                    "sub_points": [
                      "Most common site of both primary and reactivation tuberculosis",
                      "Can involve airways, parenchyma, and pleura",
                      "Primary tuberculosisMost commonly self-limitedLung lesions and hilar foci heal and calcify (Ghon foci)Can be progressiveHallmark lesion is caseating granulomaContain Langerhans giant cells with nuclei in a horseshoe arrangement, as well as activated epithelioid macrophagesAs granulomas progress, center becomes necrotic (caseous necrosis, coagulative necrosis speckled with basophilic particles of hydroxyapatite)With erosion into airways, exudative material is available to be expressed and transmitted to othersWith erosion into blood vessels, may spread widely",
                      "Most commonly self-limited",
                      "Lung lesions and hilar foci heal and calcify (Ghon foci)",
                      "Can be progressive",
                      "Hallmark lesion is caseating granuloma",
                      "Contain Langerhans giant cells with nuclei in a horseshoe arrangement, as well as activated epithelioid macrophages",
                      "As granulomas progress, center becomes necrotic (caseous necrosis, coagulative necrosis speckled with basophilic particles of hydroxyapatite)",
                      "With erosion into airways, exudative material is available to be expressed and transmitted to others",
                      "With erosion into blood vessels, may spread widely"
                    ]
                  },
                  {
                    "text": "ExtrapulmonaryPericardialConstrictive, constrictive-effusive, or effusive pericarditisAbdominalCan spread via propagation to abdominal lymph nodesIntestinal tuberculosis may demonstrate clubbing of villi, inflammatory infiltrates, and necrosis of lamina propria and submucosaTuberculous hepatitis can manifest as caseating granulomas as well as diffuse inflammatory and fibrous lesions (usually in context of miliary TB)Can involve virtually any other organLymphadenitisMay occur in isolation from pulmonary or miliary tuberculosisUsually demonstrates well-formed granulomas with scarce AFBCNSCaseating granulomas of brain parenchymaLeptomeningitisAFB are normally scarce except in AIDS patients; can have dramatic, exudative CNS lesions with dense colonies of AFBDermatologicLupus vulgaris: Rare, focal, chronic, granulomatous dermatitisScrofuloderma: Ulcerative lesions arising from contiguous spread of underlying affected lymph nodesErythema induratum: Granulomatous panniculitis with necrosis and vasculitis on posterior aspect of legsSkeletalGranulomatous lesions with degeneration of bone and disksCommonly spreads into contiguous soft tissue with abscess formation",
                    "sub_points": [
                      "PericardialConstrictive, constrictive-effusive, or effusive pericarditis",
                      "Constrictive, constrictive-effusive, or effusive pericarditis",
                      "AbdominalCan spread via propagation to abdominal lymph nodesIntestinal tuberculosis may demonstrate clubbing of villi, inflammatory infiltrates, and necrosis of lamina propria and submucosaTuberculous hepatitis can manifest as caseating granulomas as well as diffuse inflammatory and fibrous lesions (usually in context of miliary TB)Can involve virtually any other organ",
                      "Can spread via propagation to abdominal lymph nodes",
                      "Intestinal tuberculosis may demonstrate clubbing of villi, inflammatory infiltrates, and necrosis of lamina propria and submucosa",
                      "Tuberculous hepatitis can manifest as caseating granulomas as well as diffuse inflammatory and fibrous lesions (usually in context of miliary TB)",
                      "Can involve virtually any other organ",
                      "LymphadenitisMay occur in isolation from pulmonary or miliary tuberculosisUsually demonstrates well-formed granulomas with scarce AFB",
                      "May occur in isolation from pulmonary or miliary tuberculosis",
                      "Usually demonstrates well-formed granulomas with scarce AFB",
                      "CNSCaseating granulomas of brain parenchymaLeptomeningitisAFB are normally scarce except in AIDS patients; can have dramatic, exudative CNS lesions with dense colonies of AFB",
                      "Caseating granulomas of brain parenchyma",
                      "Leptomeningitis",
                      "AFB are normally scarce except in AIDS patients; can have dramatic, exudative CNS lesions with dense colonies of AFB",
                      "DermatologicLupus vulgaris: Rare, focal, chronic, granulomatous dermatitisScrofuloderma: Ulcerative lesions arising from contiguous spread of underlying affected lymph nodesErythema induratum: Granulomatous panniculitis with necrosis and vasculitis on posterior aspect of legs",
                      "Lupus vulgaris: Rare, focal, chronic, granulomatous dermatitis",
                      "Scrofuloderma: Ulcerative lesions arising from contiguous spread of underlying affected lymph nodes",
                      "Erythema induratum: Granulomatous panniculitis with necrosis and vasculitis on posterior aspect of legs",
                      "SkeletalGranulomatous lesions with degeneration of bone and disksCommonly spreads into contiguous soft tissue with abscess formation",
                      "Granulomatous lesions with degeneration of bone and disks",
                      "Commonly spreads into contiguous soft tissue with abscess formation"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Necrotizing Granulomatous Disease": [
                  {
                    "text": "Fungal infectionsNegative AFB stain, positive stain for fungi on silver or periodic acid-Schiff stain",
                    "sub_points": [
                      "Negative AFB stain, positive stain for fungi on silver or periodic acid-Schiff stain"
                    ]
                  },
                  {
                    "text": "Atypical mycobacteriaPositive AFB stain, must be differentiated using PCR &/or culture methods",
                    "sub_points": [
                      "Positive AFB stain, must be differentiated using PCR &/or culture methods"
                    ]
                  },
                  {
                    "text": "SarcoidosisGenerally small, tightly circumscribed granulomas, not necrotizingMay contain asteroid bodies or small calcifications",
                    "sub_points": [
                      "Generally small, tightly circumscribed granulomas, not necrotizing",
                      "May contain asteroid bodies or small calcifications"
                    ]
                  },
                  {
                    "text": "Granulomatosis with polyangiitisTends to feature more mixed inflammation, e.g., neutrophils, eosinophilsHas collagenolytic debris and evidence of hemorrhage and small vessel vasculitis",
                    "sub_points": [
                      "Tends to feature more mixed inflammation, e.g., neutrophils, eosinophils",
                      "Has collagenolytic debris and evidence of hemorrhage and small vessel vasculitis"
                    ]
                  },
                  {
                    "text": "Crohn diseaseGranulomas tend to be small and nonnecrotizing, confined to gastrointestinal tractOther features of chronic colitis should be present",
                    "sub_points": [
                      "Granulomas tend to be small and nonnecrotizing, confined to gastrointestinal tract",
                      "Other features of chronic colitis should be present"
                    ]
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "History of foreign birth, known exposures (prisons, homeless, affected family member), or positive sputum AFB should prompt AFB staining of tissue samples and PCR/culture"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Mycobacteria on a standard AFB stain cannot be reliably distinguished on morphology alone"
                  },
                  {
                    "text": "Confirmation with culture &/or PCR is required for definitive diagnosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Graves Disease": {
            "name": "Graves Disease",
            "url": "https://app.pathprimer.com/document/2b88cd14-5e89-488d-9cf4-7e2ac554e7d0/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Autoimmune disease characterized by diffuse goiter, thyrotoxicosis, infiltrative ophthalmopathy, and occasionally infiltrative dermopathology"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most common cause of hyperthyroidism in USA"
                  },
                  {
                    "text": "Most common cause of spontaneous hyperthyroidism in patients younger than 40"
                  },
                  {
                    "text": "Female to male ratio of 8:1"
                  },
                  {
                    "text": "Diffuse goiter with thyrotoxicosis, eye disease, and possible skin manifestations"
                  },
                  {
                    "text": "TSH receptor antibody is most specific for Graves disease, however, these may be seen in other thyroiditides such as Hashimoto"
                  },
                  {
                    "text": "Strongly associated with haplotypes HLA-B8 and HLA-DR3"
                  },
                  {
                    "text": "Prognosis is good with treatment, however if left untreated patients may develop thyroid storm, which can be deadly"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Diffuse symmetric enlargement"
                  },
                  {
                    "text": "Beefy, deep red parenchyma"
                  },
                  {
                    "text": "Prominent vascular pattern"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Preserved follicular architecture with prominent stromal vessels and hyperplasia of tall columnar cells in the follicle"
                  },
                  {
                    "text": "Iodine treatment may diminish vascularity of the gland, causing involution of the follicle, causing follicular cells to be cuboidal rather than columnar"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Graves disease (GD)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Diffuse hyperplasia"
                  },
                  {
                    "text": "Diffuse toxic goiter"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Autoimmune disease characterized by diffuse goiter, thyrotoxicosis, infiltrative ophthalmopathy, and occasionally infiltrative dermopathology"
                  },
                  {
                    "text": "Named after Irish clinician Robert Graves, who described a syndrome of cardiac palpitations, thyroid enlargement, and exophthalmos in 1835"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Environmental Exposure": [
                  {
                    "text": "Iodine replacement in previously deficient patients can cause a reactive hyperthyroid state and unmask an underlying autoimmune process"
                  },
                  {
                    "text": "Smoking increases risk of Graves 2-3x and is significantly associated with ophthalmopathy"
                  }
                ],
                "General": [
                  {
                    "text": "Stronger familial predisposition than Hashimoto (monozygotic twin concordance rate may be as high as 60%)"
                  },
                  {
                    "text": "Strongly associated with haplotypes HLA-B8 and HLA-DR3"
                  },
                  {
                    "text": "Hyperthyroidism is caused by antibodiesAntibodies directed toward extracellular domain of thyroid stimulating hormone receptor (TSHR) on follicular cellsSerum of patient with Graves disease has been found to stimulate thyroid activity in animals in controlled experimentThese antibodies activate receptor and stimulate hormone synthesis and secretion as well as proliferation of follicular cells",
                    "sub_points": [
                      "Antibodies directed toward extracellular domain of thyroid stimulating hormone receptor (TSHR) on follicular cellsSerum of patient with Graves disease has been found to stimulate thyroid activity in animals in controlled experimentThese antibodies activate receptor and stimulate hormone synthesis and secretion as well as proliferation of follicular cells",
                      "Serum of patient with Graves disease has been found to stimulate thyroid activity in animals in controlled experiment",
                      "These antibodies activate receptor and stimulate hormone synthesis and secretion as well as proliferation of follicular cells"
                    ]
                  },
                  {
                    "text": "Possible triggers include infectious etiology as well as physiological and psychological stressTriggered disturbance of immune system confers an imbalance that begets autoimmunity",
                    "sub_points": [
                      "Triggered disturbance of immune system confers an imbalance that begets autoimmunity"
                    ]
                  },
                  {
                    "text": "Role of gonadal steroids has been suggested because of higher incidence in women, particularly in times of hormonal change such as puberty, pregnancy, and menopause6x increased risk of Graves disease in postpartum women",
                    "sub_points": [
                      "6x increased risk of Graves disease in postpartum women"
                    ]
                  },
                  {
                    "text": "In men, Graves disease occurs later in life with more severe symptoms and greater incidence of ophthalmopathy"
                  },
                  {
                    "text": "Autoimmunity is triggered by genetic susceptibility and environmental factors"
                  }
                ],
                "Ophthalmopathy": [
                  {
                    "text": "Has not been fully elucidated"
                  },
                  {
                    "text": "Thought to be related to expression of HLA class II antigens by orbital muscles, to which activated T cells react"
                  },
                  {
                    "text": "TSH receptor mRNA has been detected in retroorbital fibroblasts"
                  }
                ],
                "Dermopathy": [
                  {
                    "text": "Has not been fully elucidated"
                  },
                  {
                    "text": "Thought to be a mechanism involving fibroblasts in skin, similar to that of Graves ophthalmopathy"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Most common cause of hyperthyroidism in USA"
                  },
                  {
                    "text": "Most common cause of spontaneous hyperthyroidism in patients younger than 40"
                  },
                  {
                    "text": "One of the most common autoimmune diseasesAnnual incidence is 20-25 per 100,000",
                    "sub_points": [
                      "Annual incidence is 20-25 per 100,000"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Usually presents in 3rd or 4th decade of life"
                  }
                ],
                "Gender": [
                  {
                    "text": "Female to male ratio of 8:1"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Diffuse goiter with thyrotoxicosis, eye disease, and possible skin manifestations"
                  },
                  {
                    "text": "Most common symptoms include anxiety, hyperhydrosis, heat intolerance, palpitations, fatigue, tachycardia, muscle wasting, and weight loss"
                  },
                  {
                    "text": "Patients have goiter, tachycardia, tremors, and warm, moist skin"
                  },
                  {
                    "text": "Exophthalmos may be present"
                  },
                  {
                    "text": "Usually presents at later age in men and with more severe symptoms"
                  },
                  {
                    "text": "Often presents in women undergoing states of hormonal changes such as pregnancy or menopause"
                  },
                  {
                    "text": "Increased radioiodine uptake on imaging"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Serum antibodies against thyroid peroxidase or microsomal antibodies, thyroglobulin, and TSH receptor"
                  },
                  {
                    "text": "TSH receptor antibody is most specific for Graves disease, however these may be seen in other thyroiditides such as Hashimoto"
                  },
                  {
                    "text": "Strongly associated with haplotypes HLA-B8 and HLA-DR3"
                  },
                  {
                    "text": "Patients have diminished levels of circulating CD8 T cells"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Thyroidectomy"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Methimazole, propylthiouracil, carbimazoleInhibit thyroid hormone synthesis through interference with peroxidase-mediated iodination of tyrosine residues",
                    "sub_points": [
                      "Inhibit thyroid hormone synthesis through interference with peroxidase-mediated iodination of tyrosine residues"
                    ]
                  },
                  {
                    "text": "Non-radioactive iodine inhibits release of thyroid hormones and peripheral conversion of T4 to T3Additionally iodine promotes colloid storage, reduces vascularity, and promotes involution of folliclesDiminished activity attenuates hyperthyroid symptoms",
                    "sub_points": [
                      "Additionally iodine promotes colloid storage, reduces vascularity, and promotes involution of follicles",
                      "Diminished activity attenuates hyperthyroid symptoms"
                    ]
                  },
                  {
                    "text": "RadiationRadioactive iodine ablation may be used in patients with refractory symptoms or in those whose thyroid function is difficult to manageAfter radioactive ablation, patients need to be supplemented with T4 and followed clinically",
                    "sub_points": [
                      "Radioactive iodine ablation may be used in patients with refractory symptoms or in those whose thyroid function is difficult to manage",
                      "After radioactive ablation, patients need to be supplemented with T4 and followed clinically"
                    ]
                  },
                  {
                    "text": "Beta blockers relieve symptoms but do not affect physiology of thyroid gland"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Untreated patients may develop thyroid storm, which can be deadlyHowever, if patients are followed, prognosis is usually excellent",
                    "sub_points": [
                      "However, if patients are followed, prognosis is usually excellent"
                    ]
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Diffuse symmetric enlargement with vague nodularity"
                  }
                ],
                "Size": [
                  {
                    "text": "50-150 g"
                  }
                ],
                "Gross Features": [
                  {
                    "text": "Prominent vascular patternFollicular cells may promote vascularity by secreting vascular endothelial growth factor in response to stimulation by TSHR",
                    "sub_points": [
                      "Follicular cells may promote vascularity by secreting vascular endothelial growth factor in response to stimulation by TSHR"
                    ]
                  },
                  {
                    "text": "Beefy, deep red parenchymaResembles skeletal muscleParenchyma has a spongy to firm consistency",
                    "sub_points": [
                      "Resembles skeletal muscle",
                      "Parenchyma has a spongy to firm consistency"
                    ]
                  },
                  {
                    "text": "Treated Graves disease has less vascularity and a lighter pink color than untreated Graves"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Preserved follicular architecture with prominent stromal vessels and hyperplasia of tall columnar cells in the follicleTall columnar cells with eosinophilic to amphophilic cytoplasmNuclei are basally located, round to regular, and with coarse to granular cytoplasmUnlike Hashimoto disease, fibrosis is limited and usually absentFibrosis may be present in treated cases",
                    "sub_points": [
                      "Tall columnar cells with eosinophilic to amphophilic cytoplasm",
                      "Nuclei are basally located, round to regular, and with coarse to granular cytoplasm",
                      "Unlike Hashimoto disease, fibrosis is limited and usually absentFibrosis may be present in treated cases",
                      "Fibrosis may be present in treated cases"
                    ]
                  },
                  {
                    "text": "Signs of hyperthyroidism in the follicle, such as small follicular size and scalloping of the colloid"
                  },
                  {
                    "text": "Papillae with fibrovascular core may be present, mimicking papillary thyroid carcinoma"
                  },
                  {
                    "text": "Mixed inflammatory infiltrate with lymphocytic infiltrate within stroma surrounding follicles"
                  },
                  {
                    "text": "Iodine treatment may diminish vascularity of gland, causing involution of follicle, causing follicular cells to be cuboidal rather than columnar"
                  },
                  {
                    "text": "Radioactive iodine can lead to nuclear pleomorphism, follicular destruction, fibrosis, and oncocytic metaplasia"
                  },
                  {
                    "text": "Treatment with propylthiouracil can cause hyperplastic changes"
                  },
                  {
                    "text": "Dendritic cells are increased in number"
                  }
                ],
                "Ophthalmic Muscles": [
                  {
                    "text": "Edema, loss of striation, fragmentation of fibers, diffuse lymphocytic infiltrationAccumulation of excessive hydrophilic glycosaminoglycansAdvanced stages will demonstrate atrophy with associated fibrosis",
                    "sub_points": [
                      "Accumulation of excessive hydrophilic glycosaminoglycans",
                      "Advanced stages will demonstrate atrophy with associated fibrosis"
                    ]
                  }
                ],
                "Skin": [
                  {
                    "text": "Mucopolysaccharides within dermis and thickening of skin (5-10% of Graves patients)"
                  }
                ],
                "Treatment Effects": [
                  {
                    "text": "Hyperplastic effects are diminished and regressed but are still present"
                  },
                  {
                    "text": "Colloid is increased"
                  },
                  {
                    "text": "Radiative therapy causes follicular atrophy, fibrosis, Hürthle cell changes, nuclear atypia, hyperplastic nodules, and persistence of lymphocytic infiltrate"
                  }
                ]
              },
              "Ancillary Tests": {
                "Cytology": [
                  {
                    "text": "Low to moderately cellular specimen"
                  },
                  {
                    "text": "Sheets of follicular cells with peripherally located nuclei and marginal vacuoles adjacent to nucleiVacuoles are clear on Papanicolaou stain, pink on Diff-QuikThese cells with marginal vacuolization are called \"flame cells\"Nuclei contain small nucleoli",
                    "sub_points": [
                      "Vacuoles are clear on Papanicolaou stain, pink on Diff-Quik",
                      "These cells with marginal vacuolization are called \"flame cells\"",
                      "Nuclei contain small nucleoli"
                    ]
                  },
                  {
                    "text": "Hürthle cell changes may be present in up to 1/2 of cytologic specimens of patients with Graves disease"
                  },
                  {
                    "text": "Post-treatment specimens can demonstrate atypia"
                  },
                  {
                    "text": "Lymphocytes may be present in specimen"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "HLA-DR is positive in thyroid cells as well as lymphoid cells"
                  },
                  {
                    "text": "Hematolymphoid markers demonstrate a mixed inflammatory infiltrate"
                  },
                  {
                    "text": "TTF-1 and thyroglobulin are positive"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Increased activity of follicular cells and in some cases immune complex deposition within basement membrane"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Papillary Thyroid Carcinoma": [
                  {
                    "text": "Graves disease may have papillary structures with fibrovascular cores and psammoma bodies"
                  },
                  {
                    "text": "Inflammatory response of Graves disease may cause adherence to adjacent skeletal muscle mimicking invasive PTC"
                  },
                  {
                    "text": "These features can make distinction between Graves disease and papillary carcinoma difficult"
                  },
                  {
                    "text": "Look closely for nuclear features of papillary thyroid carcinoma in these instances, and always consider clinical history"
                  },
                  {
                    "text": "Papillary thyroid carcinoma can be found in 1-4% of cases"
                  }
                ],
                "Hashimoto Thyroiditis": [
                  {
                    "text": "Distinction from early Hashimoto may be difficult clinically as Hashimoto may present initially with hypothyroid symptoms"
                  },
                  {
                    "text": "However, Hashimoto will inevitably convert to hypothyroid symptoms"
                  },
                  {
                    "text": "Autoantibody panel may be similar, but TSH is more specific for Graves"
                  },
                  {
                    "text": "Hashimoto will have more prominent oncocytic metaplasia"
                  },
                  {
                    "text": "More lymphocytic infiltrate and germinal centers"
                  },
                  {
                    "text": "Fibrous bands coursing through parenchyma favors diagnosis of Hashimoto over Graves"
                  }
                ],
                "Toxic Multinodular Goiter": [
                  {
                    "text": "Gross findings demonstrate marked nodularity"
                  },
                  {
                    "text": "Majority of gland with follicles having abundant colloid"
                  },
                  {
                    "text": "Patients will be hyperthyroidCharacteristic antibody panel of Graves will be absent",
                    "sub_points": [
                      "Characteristic antibody panel of Graves will be absent"
                    ]
                  }
                ],
                "Adenomatous Nodule": [
                  {
                    "text": "Clinically resembles multinodular goiter"
                  },
                  {
                    "text": "Patients are euthyroid"
                  },
                  {
                    "text": "Nodules of multiple sizes with background of normal-appearing thyroid"
                  },
                  {
                    "text": "Colloid deposition is normal"
                  },
                  {
                    "text": "Cytologically benign"
                  }
                ],
                "Dyshormonogenetic Goiter": [
                  {
                    "text": "Family history is often identified, as this is an inherited disorder"
                  },
                  {
                    "text": "Patients are younger than those with Graves disease"
                  },
                  {
                    "text": "Thyroid is diffusely affected with multiple nodules"
                  },
                  {
                    "text": "Absent, watery colloid"
                  },
                  {
                    "text": "Marked nuclear atypia"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Signs of hyperthyroidism in the follicle, such as small follicular size and scalloping of colloid during active Graves diseaseDegree of histologic signs of hyperthyroidism will change with treatment",
                    "sub_points": [
                      "Degree of histologic signs of hyperthyroidism will change with treatment"
                    ]
                  },
                  {
                    "text": "Patients with Graves disease generally undergo treatment before thyroidectomySurgical specimen will almost always have some treatment effect",
                    "sub_points": [
                      "Surgical specimen will almost always have some treatment effect"
                    ]
                  },
                  {
                    "text": "Treatment can dramatically change histology of gland; therefore, clinical history is essential to signing out cases of suspected Graves diseaseHistological changes are dependent upon selected treatment modalityRadiation, iodine, propylthiouracil",
                    "sub_points": [
                      "Histological changes are dependent upon selected treatment modalityRadiation, iodine, propylthiouracil",
                      "Radiation, iodine, propylthiouracil"
                    ]
                  },
                  {
                    "text": "Be aware of other conditions associated with enlarged thyroid, altered hormone status, and antibodies associated with that conditionHashimoto will be hypothyroidToxic multinodular goiter will be hyperthyroidAdenomatoid nodules will be euthyroid",
                    "sub_points": [
                      "Hashimoto will be hypothyroid",
                      "Toxic multinodular goiter will be hyperthyroid",
                      "Adenomatoid nodules will be euthyroid"
                    ]
                  },
                  {
                    "text": "Clinical history is essential in diagnosisFamily history, antibodies, hormone status",
                    "sub_points": [
                      "Family history, antibodies, hormone status"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Morphea/Scleroderma": {
            "name": "Morphea/Scleroderma",
            "url": "https://app.pathprimer.com/document/75125a68-eae8-4168-bfda-e59072f11f02/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Morphea is mainly limited to skin and subcutaneous tissue and, occasionally, underlying muscle and bone"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Presumably, microvascular injury in the genetically predisposed launches cytokine-driven profibrotic cascade following an environmental trigger"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Classified into 5 subtypes with varying clinical presentations (extracutaneous findings possible)"
                  },
                  {
                    "text": "May cause physical deformity (e.g., muscular atrophy, joint contractures, and limb length discrepancies)"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Smooth, indurated plaques with variable postinflammatory pigmentary alteration"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Early superficial and deep perivascular predominantly lymphocytic infiltrate"
                  },
                  {
                    "text": "Obliterative sclerotic dermal collagen bundles follow resolution of inflammation"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Systemic scleroderma"
                  },
                  {
                    "text": "Scleredema"
                  },
                  {
                    "text": "Graft-vs.-host disease (GVHD), sclerodermiform chronic variant"
                  },
                  {
                    "text": "Scleromyxedema"
                  },
                  {
                    "text": "Radiation dermatitis"
                  },
                  {
                    "text": "Nephrogenic fibrosing dermopathy"
                  },
                  {
                    "text": "Lichen sclerosus et atrophicus"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Morphea: Juvenile localized scleroderma (JLS)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Most common form of scleroderma (group of fibrosing disorders that result in an imbalance between collagen production and destruction) in childhoodClinically heterogeneous disease process that is predominantly localized to the skin and subcutaneous tissues with possible involvement of underlying muscle and boneImportant to note: Numerous extracutaneous features are now recognized to be a part of JLS",
                    "sub_points": [
                      "Clinically heterogeneous disease process that is predominantly localized to the skin and subcutaneous tissues with possible involvement of underlying muscle and boneImportant to note: Numerous extracutaneous features are now recognized to be a part of JLS",
                      "Important to note: Numerous extracutaneous features are now recognized to be a part of JLS"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Multifactorial": [
                  {
                    "text": "Precise etiology remains unclear"
                  },
                  {
                    "text": "Prevailing theory implicates the release of profibrotic cytokines following microvascular injury in genetically predisposed patientsReleased cytokines induce fibroblasts to increase synthesis of collagen, resulting in excessive fibrosis",
                    "sub_points": [
                      "Released cytokines induce fibroblasts to increase synthesis of collagen, resulting in excessive fibrosis"
                    ]
                  },
                  {
                    "text": "GeneticAutoimmunity and microchimerism may play a role",
                    "sub_points": [
                      "Autoimmunity and microchimerism may play a role"
                    ]
                  },
                  {
                    "text": "EnvironmentalLocal mechanical factors such as accidental trauma, insect bite, and vaccination have been proposed in 7.3-12.7% of patients",
                    "sub_points": [
                      "Local mechanical factors such as accidental trauma, insect bite, and vaccination have been proposed in 7.3-12.7% of patients"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Relatively rare pediatric malady; however, the most common connective tissue disease of childhood"
                  },
                  {
                    "text": "JLS is at least 10x more common than juvenile systemic sclerosis (JSS)"
                  }
                ],
                "Age": [
                  {
                    "text": "Mean age at disease onset is 7.3 years"
                  },
                  {
                    "text": "Cases of congenital localized scleroderma with disease onset at birth have been reported"
                  }
                ],
                "Gender": [
                  {
                    "text": "Mild female predilection with a female to male ratio of 2.4:1"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Newer classification scheme divides JLS into 5 subtypes"
                  },
                  {
                    "text": "Circumscribed morpheaRound or oval circumscribed area of induration with a violaceous haloTypically confined to the dermis but may involve the superficial panniculusDeeper involvement results in thickened, taut, and bound-down skin",
                    "sub_points": [
                      "Round or oval circumscribed area of induration with a violaceous halo",
                      "Typically confined to the dermis but may involve the superficial panniculus",
                      "Deeper involvement results in thickened, taut, and bound-down skin"
                    ]
                  },
                  {
                    "text": "Generalized morpheaDefined as 4 or more plaques (often confluent) measuring > 3 cm each and involving at least 2 of 7 anatomic sites (head/neck, extremities, anterior trunk, posterior trunk)Uncommon unilateral variant beginning in childhood has been proposed",
                    "sub_points": [
                      "Defined as 4 or more plaques (often confluent) measuring > 3 cm each and involving at least 2 of 7 anatomic sites (head/neck, extremities, anterior trunk, posterior trunk)",
                      "Uncommon unilateral variant beginning in childhood has been proposed"
                    ]
                  },
                  {
                    "text": "Linear sclerodermaMost common subtype in children and adolescentsLimb variant: 1 or more linear streaks involving dermis of extremities with possible extension through subcutaneous tissue and muscle into underlying boneMay cause significant deformity (e.g., limb length discrepancies and flexion contractures)En coup de sabre variant (ECDS): Linear induration involves the face or scalpLesions may extend into the ocular and central nervous systems, causing sequelaeParry-Romberg variant: Considered a severe manifestation of ECDS by many; hemifacial atrophy of the skin and tissue deep to the forehead with absent or mild involvement of the superficial skin",
                    "sub_points": [
                      "Most common subtype in children and adolescents",
                      "Limb variant: 1 or more linear streaks involving dermis of extremities with possible extension through subcutaneous tissue and muscle into underlying boneMay cause significant deformity (e.g., limb length discrepancies and flexion contractures)",
                      "May cause significant deformity (e.g., limb length discrepancies and flexion contractures)",
                      "En coup de sabre variant (ECDS): Linear induration involves the face or scalpLesions may extend into the ocular and central nervous systems, causing sequelae",
                      "Lesions may extend into the ocular and central nervous systems, causing sequelae",
                      "Parry-Romberg variant: Considered a severe manifestation of ECDS by many; hemifacial atrophy of the skin and tissue deep to the forehead with absent or mild involvement of the superficial skin"
                    ]
                  },
                  {
                    "text": "Pansclerotic morpheaExceedingly rare but serious subtype that is more common in children than in adultsFull-thickness (skin and subcutaneous tissue, muscle, and bone) involvement of the trunk, extremities, face, and scalp with sparing of the fingertips and toesMay be complicated by chronic ulcers, which may progress to squamous cell carcinoma",
                    "sub_points": [
                      "Exceedingly rare but serious subtype that is more common in children than in adults",
                      "Full-thickness (skin and subcutaneous tissue, muscle, and bone) involvement of the trunk, extremities, face, and scalp with sparing of the fingertips and toes",
                      "May be complicated by chronic ulcers, which may progress to squamous cell carcinoma"
                    ]
                  },
                  {
                    "text": "MixedPatient has a combination of 2 or more of the previous subtypes",
                    "sub_points": [
                      "Patient has a combination of 2 or more of the previous subtypes"
                    ]
                  },
                  {
                    "text": "Extracutaneous manifestations of JLS are seen in ~ 20% of pediatric patients and are most commonly associated with linear sclerodermaOrgan impairment is mild and usually not life-threateningFeatures include arthritis, neurological findings, other autoimmune conditions, vascular disturbances, ocular changes, GI abnormalities, and respiratory findingsArthritis is the most common extracutaneous pathology and manifests as asymmetric joint involvement without erosions",
                    "sub_points": [
                      "Organ impairment is mild and usually not life-threatening",
                      "Features include arthritis, neurological findings, other autoimmune conditions, vascular disturbances, ocular changes, GI abnormalities, and respiratory findingsArthritis is the most common extracutaneous pathology and manifests as asymmetric joint involvement without erosions",
                      "Arthritis is the most common extracutaneous pathology and manifests as asymmetric joint involvement without erosions"
                    ]
                  },
                  {
                    "text": "Distinct from JSS, which has an onset in children and adolescents < 16 years of age and results in varying degrees of fibrosis of the skin and visceraPer provisional criteria set forth by the collaborative efforts of multiple international organizations, diagnosis requires the presence of proximal sclerosis or induration of the skin plus 2 minor criteria spanning various organ systemsSuch restrictive requirements helps exclude other pediatric maladies such as eosinophilic fasciitis, progeria, phenylketonuria, and pansclerotic morpheaThese criteria do not adequately distinguish diffuse cutaneous JSS from the limited cutaneous form of JSSSuch a limitation may not be of great consequence given the relatively low prevalence of the latter in patients < 16 years of ageAt time of diagnosis, children usually have significantly less frequent visceral involvement than adultsArthritis and myositis are more common in children than in adults, but Raynaud phenomenon, skin necrosis, interstitial lung disease, gastroesophageal dysmotility, renal involvement, and arterial hypertension are less common in children",
                    "sub_points": [
                      "Per provisional criteria set forth by the collaborative efforts of multiple international organizations, diagnosis requires the presence of proximal sclerosis or induration of the skin plus 2 minor criteria spanning various organ systemsSuch restrictive requirements helps exclude other pediatric maladies such as eosinophilic fasciitis, progeria, phenylketonuria, and pansclerotic morphea",
                      "Such restrictive requirements helps exclude other pediatric maladies such as eosinophilic fasciitis, progeria, phenylketonuria, and pansclerotic morphea",
                      "These criteria do not adequately distinguish diffuse cutaneous JSS from the limited cutaneous form of JSSSuch a limitation may not be of great consequence given the relatively low prevalence of the latter in patients < 16 years of age",
                      "Such a limitation may not be of great consequence given the relatively low prevalence of the latter in patients < 16 years of age",
                      "At time of diagnosis, children usually have significantly less frequent visceral involvement than adults",
                      "Arthritis and myositis are more common in children than in adults, but Raynaud phenomenon, skin necrosis, interstitial lung disease, gastroesophageal dysmotility, renal involvement, and arterial hypertension are less common in children"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Due to the relative rarity and self-limiting tendency of JLS, most data on treatment have been extrapolated from studies on adult patients"
                  },
                  {
                    "text": "Level of functional &/or cosmetic deformity is weighed against the toxicity of therapy"
                  },
                  {
                    "text": "No single therapy has shown absolute benefit in children with JLS or JSS, and treatment must be modified according to the stage of the lesion"
                  },
                  {
                    "text": "Physiotherapy, anti-inflammatories, vitamin D analogues, and UV irradiation have been the focus in the treatment of localized disease"
                  },
                  {
                    "text": "Treatment of more advanced disease mainly includes antifibrotics, immunosuppressants, and vasodilators"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "JLS is typically self-limited, with an initial inflammatory stage that is followed by a period of stabilization and, ultimately, resolutionAverage duration of disease is ~ 3-5 years, but much longer disease activity has been reportedProlonged activity is usually associated with deep variants of circumscribed morphea and linear sclerodermaSignificant disfigurement and disability can result",
                    "sub_points": [
                      "Average duration of disease is ~ 3-5 years, but much longer disease activity has been reported",
                      "Prolonged activity is usually associated with deep variants of circumscribed morphea and linear scleroderma",
                      "Significant disfigurement and disability can result"
                    ]
                  },
                  {
                    "text": "JSS has a better prognosis than its adult counterpart, with less severe organ involvement and better long-term survival"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Skin lesions typically present with an inflammatory stage characterized by erythematous patches and plaques"
                  },
                  {
                    "text": "With resolution of inflammation, cutaneous lesions develop a white, sclerotic center and violaceous peripheral border (\"lilac ring\")"
                  },
                  {
                    "text": "Adnexal structures are eventually destroyed by excess collagen deposition resulting in smooth, indurated plaques with variable postinflammatory hyperpigmentation"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "In early lesionsReticular dermis shows a predominantly lymphocytic infiltrate with occasional plasma cells and eosinophils in a superficial and deep perivascular patternEndothelial cells may seem swollenThickening of collagen bundles may be appreciated",
                    "sub_points": [
                      "Reticular dermis shows a predominantly lymphocytic infiltrate with occasional plasma cells and eosinophils in a superficial and deep perivascular pattern",
                      "Endothelial cells may seem swollen",
                      "Thickening of collagen bundles may be appreciated"
                    ]
                  },
                  {
                    "text": "In developed lesionsNotable inflammatory infiltrate is no longer seenCollagen bundles are prominently eosinophilic, thickened, and crowdedHypertrophic collagen bundles replace adipose tissue surrounding eccrine glands and pilosebaceous units, both of which appear entrapped and atrophicDermal blood vessels are similarly scarceAdipose tissue of subcutis appears entrapped within dermis as collagen bundles extend deep",
                    "sub_points": [
                      "Notable inflammatory infiltrate is no longer seen",
                      "Collagen bundles are prominently eosinophilic, thickened, and crowdedHypertrophic collagen bundles replace adipose tissue surrounding eccrine glands and pilosebaceous units, both of which appear entrapped and atrophicDermal blood vessels are similarly scarce",
                      "Hypertrophic collagen bundles replace adipose tissue surrounding eccrine glands and pilosebaceous units, both of which appear entrapped and atrophic",
                      "Dermal blood vessels are similarly scarce",
                      "Adipose tissue of subcutis appears entrapped within dermis as collagen bundles extend deep"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Serologic Testing": [
                  {
                    "text": "~ 42% of children with JLS have been shown to harbor antinuclear antibodies"
                  },
                  {
                    "text": "Rheumatoid factor is seen in low titers in ~ 16% of JLS patients and has significant correlation with arthritisSignificant correlation with arthritis",
                    "sub_points": [
                      "Significant correlation with arthritis"
                    ]
                  },
                  {
                    "text": "~ 2-3% of those with JLS have anti-topoisomerase I antibodies (anti-Scl 70)"
                  },
                  {
                    "text": "Nearly 2% of pediatric JLS patients have anticentromere antibodies"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Systemic Scleroderma": [
                  {
                    "text": "Cannot be differentiated from morphea on histopathology alone"
                  }
                ],
                "Scleredema": [
                  {
                    "text": "Interfibrous spaces containing mucopolysaccharides are seen among hypertrophied collagen bundles"
                  },
                  {
                    "text": "Inflammation is not a significant component of the histopathology at any stage of the lesion"
                  }
                ],
                "Graft-vs.-Host Disease (GVHD), Sclerodermiform Chronic Variant": [
                  {
                    "text": "Pertinent clinical history of transplantation"
                  },
                  {
                    "text": "Involvement of papillary and upper reticular dermis typically seen at an earlier stage"
                  }
                ],
                "Scleromyxedema": [
                  {
                    "text": "Prominent mucin deposition in upper and mid-reticular dermis"
                  },
                  {
                    "text": "Irregularly arranged fibroblasts markedly increased"
                  }
                ],
                "Radiation Dermatitis": [
                  {
                    "text": "Clinical examination reveals presence of surface changes (xerosis, scale, hyperkeratosis, and telangiectasias) and absence of violaceous ring"
                  },
                  {
                    "text": "Atypical radiation cells, radiation-induced elastosis, and dilated superficial vessels characterize histopathology"
                  }
                ],
                "Nephrogenic Fibrosing Dermopathy": [
                  {
                    "text": "Clinical history of renal insufficiency"
                  },
                  {
                    "text": "Histopathology identical to that of scleromyxedema"
                  }
                ],
                "Lichen Sclerosus Et Atrophicus": [
                  {
                    "text": "Considered a variant of morphea by some"
                  },
                  {
                    "text": "Sclerosis is limited to papillary dermis, with a band-like lymphoid infiltrate present between sclerotic and nonsclerotic areas"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Extracutaneous organ impairment is mild and not life-threatening in comparison to that seen in JSSMany believe the 2 disease processes represent opposite ends of a continuous spectrum",
                    "sub_points": [
                      "Many believe the 2 disease processes represent opposite ends of a continuous spectrum"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Features at low magnificationPunch biopsy shows \"cookie cutter\" appearance with rigid, squared edgesFollicles at junction of cutis and subcutisDemarcation between dermis and subcutis is abrupt",
                    "sub_points": [
                      "Punch biopsy shows \"cookie cutter\" appearance with rigid, squared edges",
                      "Follicles at junction of cutis and subcutis",
                      "Demarcation between dermis and subcutis is abrupt"
                    ]
                  },
                  {
                    "text": "Features at medium and high magnificationFocal perivascular infiltrate in inflammatory stageDiminished space between collagen bundlesAbsence of perieccrine adipose tissueSome increase in mast cells",
                    "sub_points": [
                      "Focal perivascular infiltrate in inflammatory stage",
                      "Diminished space between collagen bundles",
                      "Absence of perieccrine adipose tissue",
                      "Some increase in mast cells"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Sjögren Syndrome": {
            "name": "Sjögren Syndrome",
            "url": "https://app.pathprimer.com/document/c4089602-56d1-4bbc-846e-05c064dda236/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Reactive, focal to diffuse lymphoid infiltrate of salivary glands leading to parenchymal atrophy and degeneration of glandular elements into irregular epithelial complexes"
                  },
                  {
                    "text": "PrimarySjögren syndrome (SS): Chronic, systemic autoimmune disease primarily affecting parotid and lacrimal glands"
                  },
                  {
                    "text": "Secondary SS: Above in association with another autoimmune disorder"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Mean age: 5th-7th decades"
                  },
                  {
                    "text": "Female > > > male (9:1)"
                  },
                  {
                    "text": "Lacrimal and parotid glands most severely affected, commonly bilateral"
                  },
                  {
                    "text": "Recurrent, firm, diffuse parotid enlargement lasting weeks to months, with occasional remissionTypically painless, bilateral swellings of lateral orbital margin",
                    "sub_points": [
                      "Typically painless, bilateral swellings of lateral orbital margin"
                    ]
                  },
                  {
                    "text": "Diagnosis based upon results of multiple testsPositive anti-SSA (RO) &/or anti-SSB (LA)Rheumatoid factor positive in up to 95%",
                    "sub_points": [
                      "Positive anti-SSA (RO) &/or anti-SSB (LA)",
                      "Rheumatoid factor positive in up to 95%"
                    ]
                  },
                  {
                    "text": "Treatment mostly supportive44x increased risk of developing lymphoma",
                    "sub_points": [
                      "44x increased risk of developing lymphoma"
                    ]
                  }
                ],
                "Imaging": [
                  {
                    "text": "MR sialography is best diagnostic study"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Minor salivary glands with lymphocytic and plasma cell infiltrate"
                  },
                  {
                    "text": "Focus score: Number of lymphoid aggregates per 4 mm² of salivary gland tissueLymphoid aggregate ≥ 50 lymphocytes",
                    "sub_points": [
                      "Lymphoid aggregate ≥ 50 lymphocytes"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Benign lymphoepithelial cyst, chronic sialadenitis, tumor-associated lymphoid proliferation (TALP), extranodal marginal zone B-cell lymphoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Sjögren syndrome (SS)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Mikulicz disease, Sicca syndrome"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Primary SS: Chronic, systemic autoimmune disease primarily affecting parotid and lacrimal excretory glands, leading to xerostomia and xerophthalmia, respectively"
                  },
                  {
                    "text": "Secondary SS: Above in association with another autoimmune, connective tissue disorderTypically rheumatoid arthritis or systemic lupus erythematosus",
                    "sub_points": [
                      "Typically rheumatoid arthritis or systemic lupus erythematosus"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Primary Sjögren Syndrome": [
                  {
                    "text": "Etiology unknown, yet likely multifactorial and complexEndocrine: Systemic and local androgen deficienciesGenetics1° SS associated withHLA-B8andHLA-Dw32° SS associated withHLA-DRw4Viral infection: EBV, Coxsackievirus, and HTLV-1Autonomic nervous systemBlockage of receptor sites by antimuscarinic antibodies (anti-M3R)Upregulation of INFα and β-cell activating factor",
                    "sub_points": [
                      "Endocrine: Systemic and local androgen deficiencies",
                      "Genetics1° SS associated withHLA-B8andHLA-Dw32° SS associated withHLA-DRw4",
                      "1° SS associated withHLA-B8andHLA-Dw3",
                      "2° SS associated withHLA-DRw4",
                      "Viral infection: EBV, Coxsackievirus, and HTLV-1",
                      "Autonomic nervous systemBlockage of receptor sites by antimuscarinic antibodies (anti-M3R)",
                      "Blockage of receptor sites by antimuscarinic antibodies (anti-M3R)",
                      "Upregulation of INFα and β-cell activating factor"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "0.5-3% of populationMay be undiagnosed in nearly half of affected patients",
                    "sub_points": [
                      "May be undiagnosed in nearly half of affected patients"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Mean: 5th-7th decadesPeaks at menarche and menopause",
                    "sub_points": [
                      "Peaks at menarche and menopause"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "Female > > > male (9:1)Males may be more common in juvenile presentation",
                    "sub_points": [
                      "Males may be more common in juvenile presentation"
                    ]
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "No racial predilection"
                  }
                ],
                "Site": [
                  {
                    "text": "Lacrimal and parotid glands most severely affectedCommonly bilateral",
                    "sub_points": [
                      "Commonly bilateral"
                    ]
                  },
                  {
                    "text": "Submandibular, sublingual, and minor salivary glands affected to lesser degree"
                  },
                  {
                    "text": "Upper respiratory tractSinonasal mucosa, eustachian tube, and larynx",
                    "sub_points": [
                      "Sinonasal mucosa, eustachian tube, and larynx"
                    ]
                  },
                  {
                    "text": "Multiple other organ systems uncommonly affected"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Fatigue and musculoskeletal pain with dry mouth and dry eyes is classical"
                  },
                  {
                    "text": "Xerostomia (dry mouth)Typically noted after saliva production falls below 50% of normalTaste alterationsDifficulties in speech and masticationPossible burning sensationLess frequently associated withDental cariesDry, cracked lips, angular cheilitisFissured or depapillated tongueChronic candidiasisOral ulcerations",
                    "sub_points": [
                      "Typically noted after saliva production falls below 50% of normal",
                      "Taste alterations",
                      "Difficulties in speech and mastication",
                      "Possible burning sensation",
                      "Less frequently associated withDental cariesDry, cracked lips, angular cheilitisFissured or depapillated tongueChronic candidiasisOral ulcerations",
                      "Dental caries",
                      "Dry, cracked lips, angular cheilitis",
                      "Fissured or depapillated tongue",
                      "Chronic candidiasis",
                      "Oral ulcerations"
                    ]
                  },
                  {
                    "text": "Xerophthalmia (dry eyes, keratoconjunctivitis sicca)Pain and foreign body sensationPhotosensitivity, ocular fatigueRedness, loss of visual acuity, filamentary keratitis",
                    "sub_points": [
                      "Pain and foreign body sensation",
                      "Photosensitivity, ocular fatigue",
                      "Redness, loss of visual acuity, filamentary keratitis"
                    ]
                  },
                  {
                    "text": "Parotid glandRecurrent, firm, diffuse parotid enlargement lasting weeks to months, with occasional remissionEnlargement correlated with increased disease severityPersistent swelling may indicate transformation into low-grade lymphomaPossible discomfort/pain, which may increase with eatingPotential retrograde infections with suppuration from Stensen duct",
                    "sub_points": [
                      "Recurrent, firm, diffuse parotid enlargement lasting weeks to months, with occasional remissionEnlargement correlated with increased disease severityPersistent swelling may indicate transformation into low-grade lymphoma",
                      "Enlargement correlated with increased disease severity",
                      "Persistent swelling may indicate transformation into low-grade lymphoma",
                      "Possible discomfort/pain, which may increase with eating",
                      "Potential retrograde infections with suppuration from Stensen duct"
                    ]
                  },
                  {
                    "text": "Lacrimal glandTypically painless, bilateral swellings of lateral orbital marginAssociated with chronic dacryoadenitisAssociated with infection (especially viral), sarcoidosis, Graves disease, and orbital inflammatory syndrome",
                    "sub_points": [
                      "Typically painless, bilateral swellings of lateral orbital margin",
                      "Associated with chronic dacryoadenitis",
                      "Associated with infection (especially viral), sarcoidosis, Graves disease, and orbital inflammatory syndrome"
                    ]
                  },
                  {
                    "text": "Other presentations based upon affected system"
                  },
                  {
                    "text": "Many patients have other connective tissue, autoimmune, or rheumatologic disordersDiabetes, sarcoidosis, malnutrition, infection, alcoholism, bulimiaMedications can be related to disorder development",
                    "sub_points": [
                      "Diabetes, sarcoidosis, malnutrition, infection, alcoholism, bulimia",
                      "Medications can be related to disorder development"
                    ]
                  },
                  {
                    "text": "Extraglandular manifestationsAutoimmune thyroiditis; primary biliary cirrhosis; lung interstitial fibrosis; glomerulonephritis and interstitial nephritisSkin with dryness and vasculitis; peripheral neuropathy; carpal tunnel syndrome; dysphagia; reflux; pernicious anemia; arthritis",
                    "sub_points": [
                      "Autoimmune thyroiditis; primary biliary cirrhosis; lung interstitial fibrosis; glomerulonephritis and interstitial nephritis",
                      "Skin with dryness and vasculitis; peripheral neuropathy; carpal tunnel syndrome; dysphagia; reflux; pernicious anemia; arthritis"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Examinations should be performed in sequential order: Anti-SSA antibody, lip biopsy, and parotid gland sialography"
                  },
                  {
                    "text": "SerologyPositive anti-Ro/SS-A and anti-La/SS-BSSA: Sjögren syndrome-AAlso autoantibodies for muscarinic receptor M3, IFI16, KLHL12, or KLHL7Rheumatoid factor positive in up to 95%Antinuclear antibody (ANA) positive in up to 80%Erythrocyte sedimentation rate (ESR) usually elevatedImmunoglobulins: Usually elevated in SS patients",
                    "sub_points": [
                      "Positive anti-Ro/SS-A and anti-La/SS-BSSA: Sjögren syndrome-A",
                      "SSA: Sjögren syndrome-A",
                      "Also autoantibodies for muscarinic receptor M3, IFI16, KLHL12, or KLHL7",
                      "Rheumatoid factor positive in up to 95%",
                      "Antinuclear antibody (ANA) positive in up to 80%",
                      "Erythrocyte sedimentation rate (ESR) usually elevated",
                      "Immunoglobulins: Usually elevated in SS patients"
                    ]
                  },
                  {
                    "text": "Salivary flow tests (sialography)"
                  },
                  {
                    "text": "OcularSchirmer test: Decreased tear secretionRose bengal and lissamine green: Dyes used to examine eye surface for dry spots",
                    "sub_points": [
                      "Schirmer test: Decreased tear secretion",
                      "Rose bengal and lissamine green: Dyes used to examine eye surface for dry spots"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Treatment mostly supportive"
                  },
                  {
                    "text": "Xerostomia: Adequate hydration and stimulation of salivary flowTopical stimulation: Sugar-free gum, candies, or lozengesSystemic stimulation: Pilocarpine, cevimeline, bromhexine, tiboloneOral hygiene instruction, topical fluoride, and chlorhexidine rinses",
                    "sub_points": [
                      "Topical stimulation: Sugar-free gum, candies, or lozenges",
                      "Systemic stimulation: Pilocarpine, cevimeline, bromhexine, tibolone",
                      "Oral hygiene instruction, topical fluoride, and chlorhexidine rinses"
                    ]
                  },
                  {
                    "text": "XerophthalmiaTopical: Artificial tears, including eye drops or ointmentsSystemic: Androgens (methyltestosterone) or cyclosporine",
                    "sub_points": [
                      "Topical: Artificial tears, including eye drops or ointments",
                      "Systemic: Androgens (methyltestosterone) or cyclosporine"
                    ]
                  },
                  {
                    "text": "Antifungal therapy for chronic candidiasis"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Slowly progressive, evolving over decades, waxing and waning"
                  },
                  {
                    "text": "Most serious complication is lymphoma development44x increased risk of developing lymphoma~ 4-10% of SS patientsTypically low gradeExtranodal marginal zone B-cell lymphoma (EMZBCL) of mucosa-associated lymphoid tissue (MALT) is most commonRepresents ~ 85% of lymphomas in SS patientsGood prognosis unless transformation into diffuse large B-cell lymphoma",
                    "sub_points": [
                      "44x increased risk of developing lymphoma~ 4-10% of SS patients",
                      "~ 4-10% of SS patients",
                      "Typically low gradeExtranodal marginal zone B-cell lymphoma (EMZBCL) of mucosa-associated lymphoid tissue (MALT) is most commonRepresents ~ 85% of lymphomas in SS patientsGood prognosis unless transformation into diffuse large B-cell lymphoma",
                      "Extranodal marginal zone B-cell lymphoma (EMZBCL) of mucosa-associated lymphoid tissue (MALT) is most common",
                      "Represents ~ 85% of lymphomas in SS patients",
                      "Good prognosis unless transformation into diffuse large B-cell lymphoma"
                    ]
                  },
                  {
                    "text": "Juvenile cases may resolve spontaneously at puberty"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "SialographyDilation of ducts (sialodochiectasis) and punctate collections of contrast medium\"Fruit-laden branchless tree\"",
                    "sub_points": [
                      "Dilation of ducts (sialodochiectasis) and punctate collections of contrast medium",
                      "\"Fruit-laden branchless tree\""
                    ]
                  },
                  {
                    "text": "ScintigraphyNoninvasive nuclear medicine technique measuring salivary gland functionUptake and secretion of (Tc-99m) pertechnetateLow values in keeping with loss of salivary gland function",
                    "sub_points": [
                      "Noninvasive nuclear medicine technique measuring salivary gland functionUptake and secretion of (Tc-99m) pertechnetateLow values in keeping with loss of salivary gland function",
                      "Uptake and secretion of (Tc-99m) pertechnetate",
                      "Low values in keeping with loss of salivary gland function"
                    ]
                  }
                ],
                "MR Findings": [
                  {
                    "text": "MR sialography is best diagnostic studyPunctate, globular, cavitary, or destructive parotid distal duct changes show high T2 signal",
                    "sub_points": [
                      "Punctate, globular, cavitary, or destructive parotid distal duct changes show high T2 signal"
                    ]
                  },
                  {
                    "text": "STIR MR sequence makes findings more conspicuous"
                  },
                  {
                    "text": "T1WI: Discrete collections of low signal intensity"
                  },
                  {
                    "text": "T2WI: Diffuse, bilateral high T2 1-2 mm up to > 2 mm foci"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Bilateral enlarged parotids with multiple cystic and solid intraparotid lesions ± punctate calcificationsLacrimal glands frequently involved",
                    "sub_points": [
                      "Lacrimal glands frequently involved"
                    ]
                  },
                  {
                    "text": "\"Miliary pattern\" of small cysts diffusely throughout both parotids seen in intermediate stage"
                  },
                  {
                    "text": "Cysts and solid masses (lymphoid aggregates) in late stage"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Overall gland enlargement with intact capsule"
                  },
                  {
                    "text": "Multinodular to diffuse with or without micronodules"
                  }
                ],
                "Size": [
                  {
                    "text": "Variable gland size, although overall enlargement"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Major salivary glands with lymphocytic infiltration, acinar atrophy, and formation of epimyoepithelial islandsi.e., benign lymphoepithelial lesion",
                    "sub_points": [
                      "i.e., benign lymphoepithelial lesion"
                    ]
                  },
                  {
                    "text": "Labial minor salivary gland biopsyMinor salivary glands with focal lymphocytic infiltrationInfiltrate adjacent to normal appearing aciniParenchymal acinar atrophy, fibrosis, duct ectasia (chronic sclerosing sialadenitis), or acute inflammation not in keeping with SSLymphoid aggregate is defined as ≥ 50 lymphocytesPeriductal lymphoid aggregates (sialodochitis) not countedMinimum of 4 mm² of minor salivary gland parenchyma required (5-10 minor salivary glands)Focus score: Number of lymphoid aggregates per 4 mm² of salivary gland tissueFocus score of ≥ 1 supportive of SSCorrelation increases with greater focus score",
                    "sub_points": [
                      "Minor salivary glands with focal lymphocytic infiltrationInfiltrate adjacent to normal appearing aciniParenchymal acinar atrophy, fibrosis, duct ectasia (chronic sclerosing sialadenitis), or acute inflammation not in keeping with SS",
                      "Infiltrate adjacent to normal appearing acini",
                      "Parenchymal acinar atrophy, fibrosis, duct ectasia (chronic sclerosing sialadenitis), or acute inflammation not in keeping with SS",
                      "Lymphoid aggregate is defined as ≥ 50 lymphocytesPeriductal lymphoid aggregates (sialodochitis) not counted",
                      "Periductal lymphoid aggregates (sialodochitis) not counted",
                      "Minimum of 4 mm² of minor salivary gland parenchyma required (5-10 minor salivary glands)",
                      "Focus score: Number of lymphoid aggregates per 4 mm² of salivary gland tissueFocus score of ≥ 1 supportive of SSCorrelation increases with greater focus score",
                      "Focus score of ≥ 1 supportive of SS",
                      "Correlation increases with greater focus score"
                    ]
                  },
                  {
                    "text": "Lacrimal gland with lymphocytic and plasma cell infiltrate"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Cellular smears with mixed inflammatory infiltrate and histiocytes"
                  },
                  {
                    "text": "Myoepithelial and ductal epithelial cells interspersed with lymphoid infiltrate"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Mixed population of B and T lymphocytesCD4(+) T-cell lymphocytes",
                    "sub_points": [
                      "CD4(+) T-cell lymphocytes"
                    ]
                  },
                  {
                    "text": "Clonal studies (κ and λ) show polyclonal population"
                  }
                ],
                "Flow Cytometry": [
                  {
                    "text": "Fresh tissue (at initial biopsy) for flow cytometryPolyclonal population helps exclude possibility of lymphoma",
                    "sub_points": [
                      "Polyclonal population helps exclude possibility of lymphoma"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Gene rearrangement studies to exclude lymphoma"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Benign Lymphoepithelial Lesion (BLEL)": [
                  {
                    "text": "Highly suggestive of SS, especially if bilateral"
                  },
                  {
                    "text": "Ocular and oral signs and symptoms, when combined with SS-A/SS-B autoantibodies, support SS rather than BLEL"
                  }
                ],
                "Benign Lymphoepithelial Cyst": [
                  {
                    "text": "Benign, cystic epithelial lesion intimately associated with lymphocytic proliferation within cyst wall"
                  },
                  {
                    "text": "Unilocular and unicystic lesion that is typically well demarcated within parotid gland"
                  },
                  {
                    "text": "Cysts are ordinarily lined by stratified squamous epitheliumCuboidal, columnar, or pseudostratified epithelium may line cyst",
                    "sub_points": [
                      "Cuboidal, columnar, or pseudostratified epithelium may line cyst"
                    ]
                  },
                  {
                    "text": "Dense lymphoid component within cyst wallGerminal center formation is regularly identified",
                    "sub_points": [
                      "Germinal center formation is regularly identified"
                    ]
                  }
                ],
                "Chronic Sialadenitis": [
                  {
                    "text": "Mixed chronic inflammatory infiltrate containing plasma cells, lymphocytes, and neutrophils"
                  },
                  {
                    "text": "Prominent periductal and acinar fibrosis"
                  },
                  {
                    "text": "Parenchymal acinar atrophy"
                  },
                  {
                    "text": "Duct ectasia (sialodochitis) or acute inflammation not in keeping with SS"
                  },
                  {
                    "text": "Lobular architecture is maintained"
                  },
                  {
                    "text": "Lack of lymphoepithelial lesions"
                  }
                ],
                "Sarcoidosis": [
                  {
                    "text": "Tight, well-formed, epithelioid histiocyte aggregatesPalisade of histiocytes at periphery",
                    "sub_points": [
                      "Palisade of histiocytes at periphery"
                    ]
                  },
                  {
                    "text": "Giant cells may be present"
                  },
                  {
                    "text": "Noncaseating for most cases"
                  },
                  {
                    "text": "Lymphocytes and plasma cells usually present"
                  }
                ],
                "Warthin Tumor": [
                  {
                    "text": "Defined tumor with capsule &/or circumscription"
                  },
                  {
                    "text": "Papillary, oncocytic epithelium arranged with cyst"
                  },
                  {
                    "text": "Lymphoid aggregates around periphery, often with germinal center formation"
                  }
                ],
                "Tumor-Associated Lymphoid Proliferation": [
                  {
                    "text": "Secondary lymphoid infiltrate associated with epithelial malignancies"
                  },
                  {
                    "text": "Present at advancing edge or within tumor"
                  }
                ],
                "Extranodal Marginal Zone B-Cell Lymphoma": [
                  {
                    "text": "Loss of lobular architecture with destroyed fibrous septa"
                  },
                  {
                    "text": "Extension beyond gland capsule into adjacent tissues"
                  },
                  {
                    "text": "Sheets of medium-sized atypical B cellsInvasion of epithelial complexes by clonal monocytoid B cells",
                    "sub_points": [
                      "Invasion of epithelial complexes by clonal monocytoid B cells"
                    ]
                  },
                  {
                    "text": "Sheets of plasma cells"
                  }
                ],
                "Metastatic Carcinoma": [
                  {
                    "text": "Destructive growth of cytologic atypical cells without myoepithelial islands"
                  }
                ]
              },
              "STAGING": {
                "Based on MR Sialography": [
                  {
                    "text": "I: Punctate contrast/high signal ≤ 1 mm"
                  },
                  {
                    "text": "II: Globular contrast/high signal 1-2 mm"
                  },
                  {
                    "text": "III: Cavitary contrast/high signal > 2 mm"
                  },
                  {
                    "text": "IV: Complete destruction of parotid parenchyma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Polyarteritis Nodosa": {
            "name": "Polyarteritis Nodosa",
            "url": "https://app.pathprimer.com/document/d90ee28e-f80c-4749-87d7-bf6a2fd05c8e/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Necrotizing inflammation of medium-sized or small arteries without glomerulonephritis or vasculitis in arterioles, capillaries, or venules"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Idiopathic in majority"
                  },
                  {
                    "text": "Hepatitis B virus, hepatitis C virus"
                  },
                  {
                    "text": "Mutation inCECR1(autosomal recessive)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "HBV association in ~ 36% of PAN cases, endemic areas"
                  },
                  {
                    "text": "Adult: Peak at 3rd to 6th decade; children: 7-11 years"
                  },
                  {
                    "text": "Multisystemic involvement"
                  },
                  {
                    "text": "ANCA negative"
                  },
                  {
                    "text": "Kidney frequently involved (70-80%)"
                  },
                  {
                    "text": "New-onset hypertension, sometimes malignant range"
                  },
                  {
                    "text": "Cyclophosphamide and steroids, 90% remission rate"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Angiography localizes microaneurysms and stenosis"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Intralobar, arcuate, and, rarely, interlobular arteries affected (medium-sized vessels)"
                  },
                  {
                    "text": "Fibrinoid necrosis and transmural and periarterial inflammation"
                  },
                  {
                    "text": "Neutrophilic and mononuclear inflammatory infiltrate"
                  },
                  {
                    "text": "Late arterial lesions include aneurysms and stenosis"
                  },
                  {
                    "text": "Normal glomeruli located away from vasculitis"
                  },
                  {
                    "text": "Disruption of internal and external elastic laminae"
                  },
                  {
                    "text": "Intravascular thrombosis with occlusion"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Kawasaki disease"
                  },
                  {
                    "text": "ANCA-related small vessel vasculitides"
                  },
                  {
                    "text": "Systemic lupus erythematosus"
                  },
                  {
                    "text": "Fibromuscular dysplasia"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Focal and patchy involvement of medium-sized or (rarely) small arteries with necrotizing inflammation"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Polyarteritis nodosa (PAN)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Macroscopic polyarteritis"
                  },
                  {
                    "text": "Classic polyarteritis nodosa"
                  },
                  {
                    "text": "Kussmaul and Maier periarteritis nodosa"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Chapel Hill Consensus Conference criteria 2012Necrotizing arteritis of medium-sized or small arteries without GN or vasculitis in arterioles, capillaries, or venulesNot associated with antineutrophil cytoplasmic antibodies",
                    "sub_points": [
                      "Necrotizing arteritis of medium-sized or small arteries without GN or vasculitis in arterioles, capillaries, or venulesNot associated with antineutrophil cytoplasmic antibodies",
                      "Not associated with antineutrophil cytoplasmic antibodies"
                    ]
                  },
                  {
                    "text": "American College of Rheumatology criteriaWeight loss ≥ 4 kg, livedo reticularis, testicular pain or tenderness, myalgias, weakness or leg tenderness, mono- or polyneuropathy, diastolic BP > 90 mm Hg, elevated BUN or creatinine, hepatitis B virus, biopsy diagnosis of small or medium-sized arteries, arteriography with aneurysms or occlusions in visceral arteries≥ 3 of above criteria have high sensitivity and specificity for diagnosis",
                    "sub_points": [
                      "Weight loss ≥ 4 kg, livedo reticularis, testicular pain or tenderness, myalgias, weakness or leg tenderness, mono- or polyneuropathy, diastolic BP > 90 mm Hg, elevated BUN or creatinine, hepatitis B virus, biopsy diagnosis of small or medium-sized arteries, arteriography with aneurysms or occlusions in visceral arteries≥ 3 of above criteria have high sensitivity and specificity for diagnosis",
                      "≥ 3 of above criteria have high sensitivity and specificity for diagnosis"
                    ]
                  },
                  {
                    "text": "EULAR/PRINTO/PRES criteria for childhood PANNecrotizing vasculitis, angiographic abnormalities, and either skin involvement, myalgia/muscle tenderness, hypertension, peripheral neuropathy, or renal involvement",
                    "sub_points": [
                      "Necrotizing vasculitis, angiographic abnormalities, and either skin involvement, myalgia/muscle tenderness, hypertension, peripheral neuropathy, or renal involvement"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "Hepatitis B virus (HBV)"
                  },
                  {
                    "text": "Possibly other viral infectionsHepatitis C virus (HCV)Most also infected with HBV~ 20% of HCV(+) vasculitis is PANRarely HIV, parvovirus B-19, cytomegalovirus",
                    "sub_points": [
                      "Hepatitis C virus (HCV)Most also infected with HBV~ 20% of HCV(+) vasculitis is PAN",
                      "Most also infected with HBV",
                      "~ 20% of HCV(+) vasculitis is PAN",
                      "Rarely HIV, parvovirus B-19, cytomegalovirus"
                    ]
                  }
                ],
                "Genetic": [
                  {
                    "text": "Mutation inCECR1(autosomal recessive)"
                  },
                  {
                    "text": "Encodes adenosine deaminase 2Major extracellular enzyme for inactivating adenosineAlso acts as growth factor",
                    "sub_points": [
                      "Major extracellular enzyme for inactivating adenosine",
                      "Also acts as growth factor"
                    ]
                  },
                  {
                    "text": "Israeli (Georgian heritage), Germans, and Turks10% carrier frequency in Georgian Jews in Israel",
                    "sub_points": [
                      "10% carrier frequency in Georgian Jews in Israel"
                    ]
                  }
                ],
                "Other Triggers": [
                  {
                    "text": "Exposure to silica-containing compounds"
                  },
                  {
                    "text": "In majority, etiology unknown"
                  }
                ],
                "Pathogenesis": [
                  {
                    "text": "Immunologically mediatedChronic immune-complex-mediated disease with HBVAntigen-specific T-cell-mediated immune mechanisms with CD4 T cells and dendritic cellsMay be microbial or autoantigen in vessel wall",
                    "sub_points": [
                      "Chronic immune-complex-mediated disease with HBV",
                      "Antigen-specific T-cell-mediated immune mechanisms with CD4 T cells and dendritic cells",
                      "May be microbial or autoantigen in vessel wall"
                    ]
                  },
                  {
                    "text": "Participation of neutrophils and macrophagesWeakness in vessel wall leads to thrombosis or fibrosis and microaneurysm formation",
                    "sub_points": [
                      "Weakness in vessel wall leads to thrombosis or fibrosis and microaneurysm formation"
                    ]
                  },
                  {
                    "text": "Chronic, cyclic insults support presence of different stages of vasculitis in tissue and relapses"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1-2/million in Europe and USAPrevalence: Up to 31/million",
                    "sub_points": [
                      "Prevalence: Up to 31/million"
                    ]
                  },
                  {
                    "text": "Up to 77/million in endemic areas for HBV infection, accounting for 36% of PAN cases"
                  },
                  {
                    "text": "< 5% of PAN patients HBV(+) in developed countries"
                  }
                ],
                "Age": [
                  {
                    "text": "Adults: Peak at 3rd to 6th decade"
                  },
                  {
                    "text": "Children: 7-11 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "Male predilection (M:F = 2:1)"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Involves all ethnic groups"
                  },
                  {
                    "text": "HLA B27, B39 associated"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Multisystemic clinical symptoms related to ischemia and dependent on organ involved and disease severity"
                  },
                  {
                    "text": "Constitutional symptoms: Fever, malaise, weight loss, myalgia, abdominal pain, arthralgia"
                  },
                  {
                    "text": "RenalKidney frequently involved (70-80%)Focal renal infarction (~ 30%)Microaneurysms (~ 65%)Hematuria, proteinuria (~ 20%)Loin painAcute renal failureNew-onset hypertension, sometimes malignant rangeRare: Rupture of kidney with perirenal hematomaMassive retroperitoneal and peritoneal hemorrhage",
                    "sub_points": [
                      "Kidney frequently involved (70-80%)Focal renal infarction (~ 30%)Microaneurysms (~ 65%)Hematuria, proteinuria (~ 20%)Loin painAcute renal failure",
                      "Focal renal infarction (~ 30%)",
                      "Microaneurysms (~ 65%)",
                      "Hematuria, proteinuria (~ 20%)",
                      "Loin pain",
                      "Acute renal failure",
                      "New-onset hypertension, sometimes malignant range",
                      "Rare: Rupture of kidney with perirenal hematoma",
                      "Massive retroperitoneal and peritoneal hemorrhage"
                    ]
                  },
                  {
                    "text": "HeartIschemic heart disease",
                    "sub_points": [
                      "Ischemic heart disease"
                    ]
                  },
                  {
                    "text": "Neurologic (10%)Hemiplegia, visual loss, mononeuritis multiplex",
                    "sub_points": [
                      "Hemiplegia, visual loss, mononeuritis multiplex"
                    ]
                  },
                  {
                    "text": "SkinVaried lesions: Palpable purpura, necrotic with peripheral gangrene, livedo reticularis, ulcersSubcutaneous nodules",
                    "sub_points": [
                      "Varied lesions: Palpable purpura, necrotic with peripheral gangrene, livedo reticularis, ulcers",
                      "Subcutaneous nodules"
                    ]
                  },
                  {
                    "text": "Skeletal muscle and mesentery (30%)"
                  },
                  {
                    "text": "Gastrointestinal, peripheral nerves (50%)"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Anemia, leukocytosis, thrombocytosis"
                  },
                  {
                    "text": "Elevation of ESR and C-reactive protein"
                  },
                  {
                    "text": "Positive HBV serology in some cases"
                  },
                  {
                    "text": "No specific serologic tests"
                  },
                  {
                    "text": "No significant association with ANCA"
                  },
                  {
                    "text": "Rarely, ANCA positive (usually perinuclear) by indirect IF only, when overlap with microscopic polyangiitis"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Steroids are 1st-line therapy; remission in 50%"
                  },
                  {
                    "text": "Cyclophosphamide/steroids for severe cases; remission in 90%"
                  },
                  {
                    "text": "Plasma exchange/plasmapheresis in refractory cases"
                  },
                  {
                    "text": "HBV-associated PAN needs antiviral therapy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Fulminant disease with < 5-year survival"
                  },
                  {
                    "text": "40% of patients relapse"
                  },
                  {
                    "text": "5 factor score (FFS) estimates prognosisScores renal (Cr > 1.6 mg/dL, proteinuria > 1 gm/24 hr), GI, cardiac, and CNS involvementLower score correlates with better 5-year survival3x risk of mortality with renal involvement",
                    "sub_points": [
                      "Scores renal (Cr > 1.6 mg/dL, proteinuria > 1 gm/24 hr), GI, cardiac, and CNS involvement",
                      "Lower score correlates with better 5-year survival",
                      "3x risk of mortality with renal involvement"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Pulsed and color Doppler ultrasonographyLocalization of microaneurysm (seen in 50-60%)",
                    "sub_points": [
                      "Localization of microaneurysm (seen in 50-60%)"
                    ]
                  }
                ],
                "Computed Tomography Angiography": [
                  {
                    "text": "Microaneurysms (1-5 mm) at artery bifurcations"
                  },
                  {
                    "text": "Stenotic lesions"
                  },
                  {
                    "text": "Tc-99m DMSA uptake scanning detects patchy renal parenchymal disease"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "GlomeruliMostly varying degrees of ischemic collapseGlobal glomerulosclerosis in cortical scarsNormal glomeruli located away from vasculitisRarely, focal crescentic GN (pauci-immune type)Suggests overlap of PAN and microscopic polyangiitis",
                    "sub_points": [
                      "Mostly varying degrees of ischemic collapse",
                      "Global glomerulosclerosis in cortical scars",
                      "Normal glomeruli located away from vasculitis",
                      "Rarely, focal crescentic GN (pauci-immune type)Suggests overlap of PAN and microscopic polyangiitis",
                      "Suggests overlap of PAN and microscopic polyangiitis"
                    ]
                  },
                  {
                    "text": "Tubules and interstitiumAcute ischemic infarction along distribution of affected arteryTubular injury, atrophy, and mild interstitial fibrosisActive &/or chronic interstitial and periarterial inflammationGranulomatous inflammation absent",
                    "sub_points": [
                      "Acute ischemic infarction along distribution of affected artery",
                      "Tubular injury, atrophy, and mild interstitial fibrosis",
                      "Active &/or chronic interstitial and periarterial inflammation",
                      "Granulomatous inflammation absent"
                    ]
                  },
                  {
                    "text": "ArteriesIntralobar, arcuate, and, rarely interlobular artery (medium-sized vessels)Small arterioles and capillaries lacking muscular coat not affectedObliterative arteritis (acute, subacute, or chronic)Transmural fibrinoid necrosis and inflammationFuchsinophilic/eosinophilic amorphous fibrinoid material in areas of necrosisDestruction of medial smooth muscleDisruption of internal and external elastic laminaeModerate to intense inflammatory infiltrateNeutrophils, eosinophils with karyorrhexisActivated T lymphocytes and macrophagesIncreased expression of matrix metalloproteinase-1, tumor necrosis factor α, and decreased smoothelinVarying degrees of luminal narrowing, neoangiogenesisIntravascular thrombosis with occlusionAcute and chronic/healed lesions can coexist in same vesselHealed lesions show progressive fibrotic change, obliterative arteriopathy, and intimal hyperplasiaLate lesions include arterial aneurysmsProgressive scarring can lead to stenosis",
                    "sub_points": [
                      "Intralobar, arcuate, and, rarely interlobular artery (medium-sized vessels)Small arterioles and capillaries lacking muscular coat not affected",
                      "Small arterioles and capillaries lacking muscular coat not affected",
                      "Obliterative arteritis (acute, subacute, or chronic)",
                      "Transmural fibrinoid necrosis and inflammationFuchsinophilic/eosinophilic amorphous fibrinoid material in areas of necrosisDestruction of medial smooth muscleDisruption of internal and external elastic laminae",
                      "Fuchsinophilic/eosinophilic amorphous fibrinoid material in areas of necrosis",
                      "Destruction of medial smooth muscle",
                      "Disruption of internal and external elastic laminae",
                      "Moderate to intense inflammatory infiltrateNeutrophils, eosinophils with karyorrhexisActivated T lymphocytes and macrophagesIncreased expression of matrix metalloproteinase-1, tumor necrosis factor α, and decreased smoothelin",
                      "Neutrophils, eosinophils with karyorrhexis",
                      "Activated T lymphocytes and macrophages",
                      "Increased expression of matrix metalloproteinase-1, tumor necrosis factor α, and decreased smoothelin",
                      "Varying degrees of luminal narrowing, neoangiogenesis",
                      "Intravascular thrombosis with occlusion",
                      "Acute and chronic/healed lesions can coexist in same vessel",
                      "Healed lesions show progressive fibrotic change, obliterative arteriopathy, and intimal hyperplasiaLate lesions include arterial aneurysmsProgressive scarring can lead to stenosis",
                      "Late lesions include arterial aneurysms",
                      "Progressive scarring can lead to stenosis"
                    ]
                  },
                  {
                    "text": "Low yield of renal biopsyIncreased risk of bleeding in acute casesRare: Formation of arteriovenous fistulae",
                    "sub_points": [
                      "Increased risk of bleeding in acute cases",
                      "Rare: Formation of arteriovenous fistulae"
                    ]
                  }
                ],
                "Other Organs": [
                  {
                    "text": "Lung, skeletal muscle, liver, pancreas, others"
                  },
                  {
                    "text": "Obliterative arteritis, fibrinoid necrosis, transmural and periarterial inflammation, thrombosis, and aneurysm"
                  },
                  {
                    "text": "Spares aorta and its major branches"
                  },
                  {
                    "text": "Localized PAN lesion, e.g., appendix, gallbladder, testicles"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunofluorescence": [
                  {
                    "text": "Immunoglobulins (IgG, IgM, IgA), complement C3 (nonspecific) staining in areas of fibrinoid necrosis"
                  },
                  {
                    "text": "Strong staining for fibrinogen in same distribution"
                  },
                  {
                    "text": "No immune complex deposits in glomeruli"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "No glomerular deposits"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Kawasaki Disease": [
                  {
                    "text": "Mucocutaneous lymph node syndrome"
                  },
                  {
                    "text": "Mononuclear infiltrate"
                  },
                  {
                    "text": "Less fibrinoid necrosis"
                  }
                ],
                "ANCA-Related Small Vessel Vasculitides": [
                  {
                    "text": "Multisystemic microscopic polyangiitis"
                  },
                  {
                    "text": "Granulomatosis with polyangiitis (Wegener)"
                  },
                  {
                    "text": "Churg-Strauss syndrome (CSS)"
                  }
                ],
                "Fibromuscular Dysplasia": [
                  {
                    "text": "Lesions lack fibrinoid necrosis"
                  },
                  {
                    "text": "No inflammation"
                  },
                  {
                    "text": "Disorganized media"
                  }
                ],
                "Systemic Lupus Erythematosus": [
                  {
                    "text": "Eosinophils in CSS"
                  },
                  {
                    "text": "Immune-complex mediated"
                  },
                  {
                    "text": "PAN-like pauci-immune vasculitis"
                  },
                  {
                    "text": "Positive serology for SLE"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Arkin classificationStages I and II: Acute arterial inflammatory lesionStages III and IV: Chronic arterial lesions",
                    "sub_points": [
                      "Stages I and II: Acute arterial inflammatory lesion",
                      "Stages III and IV: Chronic arterial lesions"
                    ]
                  },
                  {
                    "text": "Medium artery aneurysm seen on imaging studies"
                  },
                  {
                    "text": "Focal and patchy involvement of medium-sized or (rarely) small arteries with necrotizing inflammation"
                  },
                  {
                    "text": "No ANCA or crescentic GN"
                  },
                  {
                    "text": "Biopsy from affected area (e.g., skin, skeletal muscle) or organ improves diagnostic yield"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Absence of vasculitic lesion (usually larger vessel) does not exclude diagnosis due to sampling"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "IgG4-Related Disease": {
            "name": "IgG4-Related Disease",
            "url": "https://app.pathprimer.com/document/cf7818b4-f168-4bfc-a867-758495bc1257/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "IgG4-related disease (IgG4-RD) refers to systemic fibroinflammatory disease that can affect nearly any organ"
                  },
                  {
                    "text": "IgG4-related kidney disease (IgG4-RKD) refers to any pattern of kidney involvement by IgG4-RDMay include IgG4-TIN, IgG4-related membranous glomerulonephritis, and IgG4 plasma cell arteritisIgG4-TIN is immune-mediated TIN with increased IgG4(+) plasma cells and often tubulointerstitial immune complex deposits",
                    "sub_points": [
                      "May include IgG4-TIN, IgG4-related membranous glomerulonephritis, and IgG4 plasma cell arteritis",
                      "IgG4-TIN is immune-mediated TIN with increased IgG4(+) plasma cells and often tubulointerstitial immune complex deposits"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Renal involvement by systemic immune-mediated disease, now called IgG4-related disease"
                  },
                  {
                    "text": "Immune-mediated systemic disease, unknown antigen"
                  },
                  {
                    "text": "IgG4 is anti-inflammatory IgG subclass"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Renal mass(es)"
                  },
                  {
                    "text": "Acute or chronic renal failure"
                  },
                  {
                    "text": "Steroid therapy usually effective"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Plasma cell-rich interstitial inflammationIncreased IgG4(+) plasma cells (polyclonal)",
                    "sub_points": [
                      "Increased IgG4(+) plasma cells (polyclonal)"
                    ]
                  },
                  {
                    "text": "Granular TBM immune complex deposits by IFContain IgG, IgG4, C3, kappa and lambda light chains",
                    "sub_points": [
                      "Contain IgG, IgG4, C3, kappa and lambda light chains"
                    ]
                  },
                  {
                    "text": "Glomeruli negative by IF unless concurrent immune complex glomerulonephritis"
                  },
                  {
                    "text": "Amorphous electron-dense deposits within tubular basement membranes and in interstitium by EM"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Granulomatosis with polyangiitis (Wegener)"
                  },
                  {
                    "text": "Drug-induced acute interstitial nephritis"
                  },
                  {
                    "text": "Lymphoma or leukemia"
                  },
                  {
                    "text": "Inflammation may be misinterpreted as nondiagnostic in biopsy taken for \"mass\""
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "IgG4-related tubulointerstitial nephritis (IgG4-TIN)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "IgG4-related disease (IgG4-RD)Systemic immune-mediated disease that can affect nearly any organ",
                    "sub_points": [
                      "Systemic immune-mediated disease that can affect nearly any organ"
                    ]
                  },
                  {
                    "text": "IgG4-related kidney disease (IgG4-RKD)Refers to any renal manifestation of IgG4-RDIncludes IgG4-TIN, IgG4-related membranous glomerulonephritis, and IgG4 plasma cell arteritis",
                    "sub_points": [
                      "Refers to any renal manifestation of IgG4-RD",
                      "Includes IgG4-TIN, IgG4-related membranous glomerulonephritis, and IgG4 plasma cell arteritis"
                    ]
                  }
                ],
                "Definitions": [
                  {
                    "text": "Immune-mediated TIN with increased IgG4(+) plasma cells and often tubulointerstitial immune complex deposits; usually associated with systemic fibroinflammatory disease"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Systemic Autoimmune Disease": [
                  {
                    "text": "Renal involvement by systemic immune-mediated disease, now called IgG4-related disease"
                  },
                  {
                    "text": "Affected organs include pancreas, liver, kidney, lung, salivary glands, thyroid, lymph nodes"
                  }
                ],
                "Proposed Etiology/Autoantigens": [
                  {
                    "text": "Clonal expansion of CD19(+), CD27(+), CD20(-), CD38(hi) plasmablasts in peripheral blood of active IgG4-RD patients"
                  },
                  {
                    "text": "No definite antigen identified; some antigens proposedPlasminogen-binding protein (PBP) peptideHomologue of PBP ofHelicobacter pyloriand of ubiquitin-protein ligase E3 component n-recognin 2Enzyme expressed in pancreatic acinar cellsPBP peptide antibodies in 95% of autoimmune pancreatitis (AIP) patientsMay include patients with other forms of AIP, not only IgG4-related AIP (type 1)Carbonic anhydrase-II and -IVLactoferrinPancreatic secretory trypsin inhibitorα-fodrin",
                    "sub_points": [
                      "Plasminogen-binding protein (PBP) peptideHomologue of PBP ofHelicobacter pyloriand of ubiquitin-protein ligase E3 component n-recognin 2Enzyme expressed in pancreatic acinar cellsPBP peptide antibodies in 95% of autoimmune pancreatitis (AIP) patientsMay include patients with other forms of AIP, not only IgG4-related AIP (type 1)",
                      "Homologue of PBP ofHelicobacter pyloriand of ubiquitin-protein ligase E3 component n-recognin 2Enzyme expressed in pancreatic acinar cells",
                      "Enzyme expressed in pancreatic acinar cells",
                      "PBP peptide antibodies in 95% of autoimmune pancreatitis (AIP) patientsMay include patients with other forms of AIP, not only IgG4-related AIP (type 1)",
                      "May include patients with other forms of AIP, not only IgG4-related AIP (type 1)",
                      "Carbonic anhydrase-II and -IV",
                      "Lactoferrin",
                      "Pancreatic secretory trypsin inhibitor",
                      "α-fodrin"
                    ]
                  },
                  {
                    "text": "In IgG4-MGN, negative phospholipase A2 receptor (PLA2R) staining, implying secondary MGN"
                  }
                ],
                "IgG4 Distinctive Subclass of IgG": [
                  {
                    "text": "Weaker interchain disulfide bridgesIgG4 immunoglobulin half-molecules dissociate and reassociate with other IgG4 half-molecules, including those with different antigen specificities",
                    "sub_points": [
                      "IgG4 immunoglobulin half-molecules dissociate and reassociate with other IgG4 half-molecules, including those with different antigen specificities"
                    ]
                  },
                  {
                    "text": "Does not fix complementServe as anti-inflammatory antibodiesMay block antigen binding site for more pathogenic IgG1 or IgE",
                    "sub_points": [
                      "Serve as anti-inflammatory antibodies",
                      "May block antigen binding site for more pathogenic IgG1 or IgE"
                    ]
                  },
                  {
                    "text": "Rheumatoid factor activity via Fc-Fc interactions"
                  }
                ],
                "Propensity to Form Mass Lesions": [
                  {
                    "text": "May be due to anti-inflammatory cytokines, including IL-10, tumor necrosis factor-α, and fibrogenic IL-13, and resultant expansion of IgG4-secreting plasma cells"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Renal mass(es), enlarged kidneys, or heterogeneous appearance on CT scan"
                  },
                  {
                    "text": "Acute or chronic renal failure"
                  },
                  {
                    "text": "Other organ involvement may be present concurrently, previously, or may emerge in futureAIP type 1, IgG4-related AIPSclerosing cholangitisSialadenitis/Mikulicz diseaseInflammatory aortic aneurysmRetroperitoneal fibrosisLymphadenopathyOrbital pseudolymphomaInflammatory masses in liver, lung, breast, heart, prostate, pituitary, other organsOften patients have history of allergy",
                    "sub_points": [
                      "AIP type 1, IgG4-related AIP",
                      "Sclerosing cholangitis",
                      "Sialadenitis/Mikulicz disease",
                      "Inflammatory aortic aneurysm",
                      "Retroperitoneal fibrosis",
                      "Lymphadenopathy",
                      "Orbital pseudolymphoma",
                      "Inflammatory masses in liver, lung, breast, heart, prostate, pituitary, other organs",
                      "Often patients have history of allergy"
                    ]
                  },
                  {
                    "text": "Not all cases of IgG4-TIN have extrarenal involvement"
                  },
                  {
                    "text": "ProteinuriaDue to IgG4-related membranous glomerulonephritis (IgG4-MGN)",
                    "sub_points": [
                      "Due to IgG4-related membranous glomerulonephritis (IgG4-MGN)"
                    ]
                  },
                  {
                    "text": "Obstruction due to IgG4-related retroperitoneal fibrosis"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "HypergammaglobulinemiaTypically no monoclonal protein",
                    "sub_points": [
                      "Typically no monoclonal protein"
                    ]
                  },
                  {
                    "text": "Elevated serum IgG4 or total IgG in ~ 80%Elevated serum IgG4 in 70-75% of AIP patientsProzone effect in ~ 30% of IgG4-RD patients by routine IgG4 serum laboratory testNeed dilutions with nephelometry or mass spectrometry to evaluate for IgG4 serum excess",
                    "sub_points": [
                      "Elevated serum IgG4 in 70-75% of AIP patients",
                      "Prozone effect in ~ 30% of IgG4-RD patients by routine IgG4 serum laboratory testNeed dilutions with nephelometry or mass spectrometry to evaluate for IgG4 serum excess",
                      "Need dilutions with nephelometry or mass spectrometry to evaluate for IgG4 serum excess"
                    ]
                  },
                  {
                    "text": "Increased circulating plasmablasts by flow cytometry in patients with active IgG4-RD"
                  },
                  {
                    "text": "Hypocomplementemia (50%)"
                  },
                  {
                    "text": "Eosinophilia (~ 30%)"
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "SteroidsGlucocorticoids are 1st-line treatment unless contraindicated~ 90% sensitive to steroid therapy but high rate of relapseSteroid responsiveness is 1 diagnostic criterion for AIP",
                    "sub_points": [
                      "Glucocorticoids are 1st-line treatment unless contraindicated",
                      "~ 90% sensitive to steroid therapy but high rate of relapse",
                      "Steroid responsiveness is 1 diagnostic criterion for AIP"
                    ]
                  },
                  {
                    "text": "RituximabAnti-CD20 drug used with success in IgG4-RD and IgG4-TIN",
                    "sub_points": [
                      "Anti-CD20 drug used with success in IgG4-RD and IgG4-TIN"
                    ]
                  },
                  {
                    "text": "Mycophenolate mofetilUsed with steroids in some IgG4-TIN cases",
                    "sub_points": [
                      "Used with steroids in some IgG4-TIN cases"
                    ]
                  },
                  {
                    "text": "Optimal treatment for IgG4-related MGN may differ from inflammatory manifestations of IgG4-RD"
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Enlarged kidneys in some IgG4-TIN"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Radiographic abnormalities in some IgG4-TINSingle or multiple low-attenuation lesions, usually bilateral, in renal cortexFindings suggestive of vasculitis, lymphoma, or other tumor mass(es)Inflammatory lesions may extend beyond kidney",
                    "sub_points": [
                      "Single or multiple low-attenuation lesions, usually bilateral, in renal cortex",
                      "Findings suggestive of vasculitis, lymphoma, or other tumor mass(es)",
                      "Inflammatory lesions may extend beyond kidney"
                    ]
                  },
                  {
                    "text": "Masses in other organs (e.g., pancreas, liver, lung) may give clue to renal diagnosis"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "GlomeruliMembranous glomerulonephritis (MGN)~ 8% of cases in one IgG4-TIN seriesMay be present without or with little interstitial inflammationSubepithelial deposits also IgG4 dominantIgA nephropathyMay be coincidental, particularly in reports of IgG4-RD from AsiaMild mesangial immune complex glomerulonephritisMild mesangial proliferation in some cases with IgG deposits, no specific diagnosisDiabetic glomerulosclerosisMay be coincidental, or diabetes may be secondary to IgG4-related autoimmune pancreatitis (AIP) with resultant kidney diseaseMinimal change disease",
                    "sub_points": [
                      "Membranous glomerulonephritis (MGN)~ 8% of cases in one IgG4-TIN seriesMay be present without or with little interstitial inflammationSubepithelial deposits also IgG4 dominant",
                      "~ 8% of cases in one IgG4-TIN series",
                      "May be present without or with little interstitial inflammation",
                      "Subepithelial deposits also IgG4 dominant",
                      "IgA nephropathyMay be coincidental, particularly in reports of IgG4-RD from Asia",
                      "May be coincidental, particularly in reports of IgG4-RD from Asia",
                      "Mild mesangial immune complex glomerulonephritisMild mesangial proliferation in some cases with IgG deposits, no specific diagnosis",
                      "Mild mesangial proliferation in some cases with IgG deposits, no specific diagnosis",
                      "Diabetic glomerulosclerosisMay be coincidental, or diabetes may be secondary to IgG4-related autoimmune pancreatitis (AIP) with resultant kidney disease",
                      "May be coincidental, or diabetes may be secondary to IgG4-related autoimmune pancreatitis (AIP) with resultant kidney disease",
                      "Minimal change disease"
                    ]
                  },
                  {
                    "text": "Tubules and interstitiumPlasma cell-rich interstitial inflammationEosinophils often present and may be prominentPaucity of neutrophilsTubulitis with mononuclear cells, plasma cells, and eosinophilsInterstitial fibroinflammatory process, expansile interstitial fibrosisTubular atrophy and destruction of tubules by interstitial fibrosisThickened tubular basement membranesRange of appearancesSome show more interstitial inflammation and less fibrosisAcute interstitial nephritis pattern may be present but unusualOther cases show more fibrosis and less inflammationCases with less inflammation often show fewer IgG4(+) plasma cells, but still > 10/HPF in most concentrated areasIgG4/IgG(+) plasma cell ratio useful for cases with less inflammation and more fibrosisFibroinflammatory process may extend outside of kidney and involve surrounding organsPresence of granulomatous inflammation or necrosisexcludesdiagnosis of IgG4-TIN",
                    "sub_points": [
                      "Plasma cell-rich interstitial inflammationEosinophils often present and may be prominentPaucity of neutrophils",
                      "Eosinophils often present and may be prominent",
                      "Paucity of neutrophils",
                      "Tubulitis with mononuclear cells, plasma cells, and eosinophils",
                      "Interstitial fibroinflammatory process, expansile interstitial fibrosis",
                      "Tubular atrophy and destruction of tubules by interstitial fibrosis",
                      "Thickened tubular basement membranes",
                      "Range of appearancesSome show more interstitial inflammation and less fibrosisAcute interstitial nephritis pattern may be present but unusualOther cases show more fibrosis and less inflammationCases with less inflammation often show fewer IgG4(+) plasma cells, but still > 10/HPF in most concentrated areasIgG4/IgG(+) plasma cell ratio useful for cases with less inflammation and more fibrosis",
                      "Some show more interstitial inflammation and less fibrosisAcute interstitial nephritis pattern may be present but unusual",
                      "Acute interstitial nephritis pattern may be present but unusual",
                      "Other cases show more fibrosis and less inflammationCases with less inflammation often show fewer IgG4(+) plasma cells, but still > 10/HPF in most concentrated areasIgG4/IgG(+) plasma cell ratio useful for cases with less inflammation and more fibrosis",
                      "Cases with less inflammation often show fewer IgG4(+) plasma cells, but still > 10/HPF in most concentrated areas",
                      "IgG4/IgG(+) plasma cell ratio useful for cases with less inflammation and more fibrosis",
                      "Fibroinflammatory process may extend outside of kidney and involve surrounding organs",
                      "Presence of granulomatous inflammation or necrosisexcludesdiagnosis of IgG4-TIN"
                    ]
                  },
                  {
                    "text": "VesselsIgG4 plasma cell arteritisTransmural inflammation with plasma cells (many IgG4[+])Absence of fibrinoid necrosisObliterative phlebitis present in other organs affected by IgG4-RD, but not observed yet in kidneysVeins often not present in kidney biopsies",
                    "sub_points": [
                      "IgG4 plasma cell arteritisTransmural inflammation with plasma cells (many IgG4[+])Absence of fibrinoid necrosis",
                      "Transmural inflammation with plasma cells (many IgG4[+])",
                      "Absence of fibrinoid necrosis",
                      "Obliterative phlebitis present in other organs affected by IgG4-RD, but not observed yet in kidneysVeins often not present in kidney biopsies",
                      "Veins often not present in kidney biopsies"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Increased IgG4(+) plasma cellsAt least moderate increase: > 10 IgG4(+) cells/40x field in most concentrated areaSome cases show marked increase, > 30 IgG4(+) cells/40x fieldIgG4 staining ~ 100% sensitive and ~ 92% specific for detecting TIN related to IgG4(+) TIN vs. other types of plasma cell-rich interstitial nephritisFalse-positives in interstitial infiltrate associated with pauci-immune necrotizing and crescentic glomerulonephritis",
                    "sub_points": [
                      "At least moderate increase: > 10 IgG4(+) cells/40x field in most concentrated area",
                      "Some cases show marked increase, > 30 IgG4(+) cells/40x field",
                      "IgG4 staining ~ 100% sensitive and ~ 92% specific for detecting TIN related to IgG4(+) TIN vs. other types of plasma cell-rich interstitial nephritisFalse-positives in interstitial infiltrate associated with pauci-immune necrotizing and crescentic glomerulonephritis",
                      "False-positives in interstitial infiltrate associated with pauci-immune necrotizing and crescentic glomerulonephritis"
                    ]
                  },
                  {
                    "text": "Increased IgG4/IgG(+) plasma cell ratioRatio typically > 30% in IgG4-RDUseful when fewer plasma cells present with more fibrosis or in treated patients",
                    "sub_points": [
                      "Ratio typically > 30% in IgG4-RDUseful when fewer plasma cells present with more fibrosis or in treated patients",
                      "Useful when fewer plasma cells present with more fibrosis or in treated patients"
                    ]
                  },
                  {
                    "text": "Increased IgG4(+) plasma cells or high IgG4/IgG(+) plasma cell ratio not necessary for diagnosis, however, in presence of typical diagnostic histologic features"
                  },
                  {
                    "text": "Kappa and lambda immunoperoxidase or in situ hybridization reveal polytypic plasma cell population"
                  }
                ],
                "Immunofluorescence": [
                  {
                    "text": "Granular tubular basement membrane (TBM) immune complex deposits in > 80% of casesIgG, C3, kappa and lambda light chains; accompanying IgM, IgA, &/or C1q present in ~ 10% of casesIgG4(+) deposits; other IgG subclasses also variably presentDeposits may be focal; present in most but not all casesDeposits present in areas of interstitial inflammation and fibrosisTBM deposits typicallynotpresent in cases with histologic pattern of acute interstitial nephritis",
                    "sub_points": [
                      "IgG, C3, kappa and lambda light chains; accompanying IgM, IgA, &/or C1q present in ~ 10% of cases",
                      "IgG4(+) deposits; other IgG subclasses also variably present",
                      "Deposits may be focal; present in most but not all cases",
                      "Deposits present in areas of interstitial inflammation and fibrosis",
                      "TBM deposits typicallynotpresent in cases with histologic pattern of acute interstitial nephritis"
                    ]
                  },
                  {
                    "text": "Granular interstitial deposits may be present"
                  },
                  {
                    "text": "Glomeruli usually negative by IF unless concurrent MGN or other immune complex glomerulonephritis"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Amorphous electron-dense deposits within tubular basement membranes and in interstitium"
                  },
                  {
                    "text": "Thickened and laminated TBM"
                  },
                  {
                    "text": "Normal glomeruli unless concurrent immune complex glomerulonephritis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pauci-Immune Necrotizing and Crescentic Glomerulonephritis/Granulomatosis With Polyangiitis": [
                  {
                    "text": "May be mass-forming"
                  },
                  {
                    "text": "25% of cases show at least moderate increase in IgG4(+) plasma cells in interstitial infiltrate"
                  },
                  {
                    "text": "Areas of necrosis in interstitial infiltrate may be present in granulomatosis with polyangiitis (Wegener)Necrosis not present in IgG4-associated TIN",
                    "sub_points": [
                      "Necrosis not present in IgG4-associated TIN"
                    ]
                  },
                  {
                    "text": "Most cases ANCA(+)"
                  },
                  {
                    "text": "Absence of tubulointerstitial immune complex deposits"
                  }
                ],
                "Drug-Induced Acute Interstitial Nephritis": [
                  {
                    "text": "Both IgG4-TIN and allergic TIN can show numerous eosinophils"
                  },
                  {
                    "text": "IgG4-TIN shows more plasma cells and characteristic storiform fibrosis"
                  }
                ],
                "Idiopathic Hypocomplementemic Tubulointerstitial Nephritis With Deposits": [
                  {
                    "text": "Most cases of this entity represent IgG4-TIN and show increased IgG4(+) plasma cells"
                  }
                ],
                "Sjögren Syndrome-Associated Tubulointerstitial Nephritis": [
                  {
                    "text": "May be related to IgG4-associated autoimmune disease"
                  },
                  {
                    "text": "Usually no increase in IgG4(+) plasma cells"
                  },
                  {
                    "text": "Tubulointerstitial immune complex deposits"
                  },
                  {
                    "text": "Both IgG4-TIN and TIN secondary to Sjögren syndrome may have salivary gland involvement"
                  }
                ],
                "Giant Cell Tubulitis With Tubular Basement Membrane Immune Deposits": [
                  {
                    "text": "Probably represents allergic drug reaction"
                  },
                  {
                    "text": "Giant cells surrounding tubules"
                  },
                  {
                    "text": "TBM deposits"
                  }
                ],
                "Tubulointerstitial Lupus Nephritis": [
                  {
                    "text": "Usually biopsies show glomerular disease with glomerular immune deposits along with TBM or interstitial immune deposits"
                  },
                  {
                    "text": "Many IgG4-RD patients have low-titer positive ANA"
                  }
                ],
                "Chronic Pyelonephritis": [
                  {
                    "text": "May have appearance of mass on imaging studies"
                  },
                  {
                    "text": "Neutrophils in infiltrate in addition to plasma cells; neutrophilic casts may also be present"
                  },
                  {
                    "text": "Evidence of urinary tract bacterial infection"
                  }
                ],
                "Lymphoma": [
                  {
                    "text": "May be mass on radiographic studies"
                  },
                  {
                    "text": "Atypical and monotypic cellular infiltrate"
                  },
                  {
                    "text": "Rare cases show TBM immune complex deposits by IF"
                  },
                  {
                    "text": "Immunohistochemical studies can confirm monoclonal infiltrate"
                  }
                ],
                "Interstitial Inflammation With TBM Deposits Associated With Glomerular Disease": [
                  {
                    "text": "Minority of MGN or other immune complex GN show TBM immune complex deposits"
                  }
                ],
                "Monoclonal Immunoglobulin Deposition Disease (MIDD)": [
                  {
                    "text": "Linear vs. granular TBM deposits in MIDD"
                  },
                  {
                    "text": "Monoclonal immune deposits by IF"
                  }
                ],
                "Renal Neoplasm": [
                  {
                    "text": "Imaging studies often suggest neoplasm"
                  },
                  {
                    "text": "Inflammation may be misinterpreted as missing the tumor"
                  }
                ],
                "Membranous Glomerulonephritis (Primary or Secondary)": [
                  {
                    "text": "MGN may be secondary to systemic lupus erythematosus or other autoimmune diseases"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Needle biopsy sometimes performed for renal massInflammatory process may be misinterpreted as reaction around tumor, and specimen considered inadequate for diagnosis",
                    "sub_points": [
                      "Inflammatory process may be misinterpreted as reaction around tumor, and specimen considered inadequate for diagnosis"
                    ]
                  },
                  {
                    "text": "Exclusion of ANCA-related inflammation necessary"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Classification of Transplant Rejection": {
            "name": "Classification of Transplant Rejection",
            "url": "https://app.pathprimer.com/document/79c1c649-9082-496e-9d78-2086809a4181/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
            "content": {
              "Terminology": {
                "Definitions": [
                  {
                    "text": "Alloimmune response: Recipient recognition of donor antigens"
                  },
                  {
                    "text": "International Society for Heart and Lung Transplantation (ISHLT)Publishes guidelines for pathologic grading of acute rejection",
                    "sub_points": [
                      "Publishes guidelines for pathologic grading of acute rejection"
                    ]
                  },
                  {
                    "text": "Acute cellular rejection (ACR)Grade A: Perivascular inflammationGrade A0: No acute rejectionGrade A1: Minimal acute rejectionGrade A2: Mild acute rejectionGrade A3: Moderate acute rejectionGrade A4: Severe acute rejectionGrade AX: Ungradeable specimenGrade B: Small airway inflammation, lymphocytic bronchiolitis (LB)Grade B0: No airway inflammationGrade B1R: Low-grade small airway inflammationGrade B2R: High-grade small airway inflammationGrade B1: Minimal airway inflammationGrade B2: Mild airway inflammationGrade B3: Moderate airway inflammationGrade B4: Severe airway inflammationGrade BX: Ungradeable specimen",
                    "sub_points": [
                      "Grade A: Perivascular inflammationGrade A0: No acute rejectionGrade A1: Minimal acute rejectionGrade A2: Mild acute rejectionGrade A3: Moderate acute rejectionGrade A4: Severe acute rejectionGrade AX: Ungradeable specimen",
                      "Grade A0: No acute rejection",
                      "Grade A1: Minimal acute rejection",
                      "Grade A2: Mild acute rejection",
                      "Grade A3: Moderate acute rejection",
                      "Grade A4: Severe acute rejection",
                      "Grade AX: Ungradeable specimen",
                      "Grade B: Small airway inflammation, lymphocytic bronchiolitis (LB)Grade B0: No airway inflammationGrade B1R: Low-grade small airway inflammationGrade B2R: High-grade small airway inflammationGrade B1: Minimal airway inflammationGrade B2: Mild airway inflammationGrade B3: Moderate airway inflammationGrade B4: Severe airway inflammationGrade BX: Ungradeable specimen",
                      "Grade B0: No airway inflammation",
                      "Grade B1R: Low-grade small airway inflammation",
                      "Grade B2R: High-grade small airway inflammation",
                      "Grade B1: Minimal airway inflammation",
                      "Grade B2: Mild airway inflammation",
                      "Grade B3: Moderate airway inflammation",
                      "Grade B4: Severe airway inflammation",
                      "Grade BX: Ungradeable specimen"
                    ]
                  },
                  {
                    "text": "Chronic airway rejection: Grade C (bronchiolitis obliterans [BO])Bronchiolitis obliterans syndrome (BOS) is clinical correlate",
                    "sub_points": [
                      "Bronchiolitis obliterans syndrome (BOS) is clinical correlate"
                    ]
                  },
                  {
                    "text": "Chronic vascular rejection: Grade D (accelerated graft vascular sclerosis)"
                  },
                  {
                    "text": "Antibody-mediated rejection (AMR): Humoral rejectionAlloantibodies targeting microvasculature and capillaries",
                    "sub_points": [
                      "Alloantibodies targeting microvasculature and capillaries"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "IncidenceBetween 2004 and 2011, 34% of adult lung transplant recipients had ≥ 1 episode of acute rejection within 1 yearAcute rejection is less common in pediatric lung recipients, occurring in only 4.5% of recipients within 1st yearBOS occurs in ~ 50% of lung transplant recipients within 5 years and in 75% within 10 years",
                    "sub_points": [
                      "Between 2004 and 2011, 34% of adult lung transplant recipients had ≥ 1 episode of acute rejection within 1 year",
                      "Acute rejection is less common in pediatric lung recipients, occurring in only 4.5% of recipients within 1st year",
                      "BOS occurs in ~ 50% of lung transplant recipients within 5 years and in 75% within 10 years"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Immunologic Basis of Lung Allograft Rejection": [
                  {
                    "text": "Recipient T cells recognize donor major histocompatibility complex (MHC) or human leukocyte antigen (HLA) peptidesHLA peptides presented initially by donor antigen presenting cells (APCs) and later by recipient APCsDirect pathway: Donor APCs present donor MHC-peptide complexes to recipient T cellsIndirect pathway: Recipient APCs present donor peptides to recipient T cellsRecipient T cells recognize these antigens as foreign through T-cell receptor, and a response is triggeredDonor allograft cells targeted by host immune system for destruction, resulting in graft injuryBoth CD4(+) and CD8(+) T cells are found in perivascular cuff, diagnostic of ACR grade A on biopsy specimens",
                    "sub_points": [
                      "HLA peptides presented initially by donor antigen presenting cells (APCs) and later by recipient APCsDirect pathway: Donor APCs present donor MHC-peptide complexes to recipient T cellsIndirect pathway: Recipient APCs present donor peptides to recipient T cells",
                      "Direct pathway: Donor APCs present donor MHC-peptide complexes to recipient T cells",
                      "Indirect pathway: Recipient APCs present donor peptides to recipient T cells",
                      "Recipient T cells recognize these antigens as foreign through T-cell receptor, and a response is triggeredDonor allograft cells targeted by host immune system for destruction, resulting in graft injuryBoth CD4(+) and CD8(+) T cells are found in perivascular cuff, diagnostic of ACR grade A on biopsy specimens",
                      "Donor allograft cells targeted by host immune system for destruction, resulting in graft injury",
                      "Both CD4(+) and CD8(+) T cells are found in perivascular cuff, diagnostic of ACR grade A on biopsy specimens"
                    ]
                  },
                  {
                    "text": "Local innate immunity is also activated, which contributes to allograft injuryMechanisms of innate immune system activation includeTissue injury associated with transplantation procedureAutoimmune response to self-antigens, which may become exposed during ischemia-reperfusion injuryInfection",
                    "sub_points": [
                      "Mechanisms of innate immune system activation includeTissue injury associated with transplantation procedureAutoimmune response to self-antigens, which may become exposed during ischemia-reperfusion injuryInfection",
                      "Tissue injury associated with transplantation procedure",
                      "Autoimmune response to self-antigens, which may become exposed during ischemia-reperfusion injury",
                      "Infection"
                    ]
                  },
                  {
                    "text": "HLA matching not routinely performed for lung transplantation"
                  },
                  {
                    "text": "Lung is thought to be primary site of T-cell activationAcute rejection can occur in immediate postoperative periodLymphatics not yet functioning to drain donor APCs to lymph nodesLung lymphoid tissue, or bronchial-associated lymphoid tissue (BALT), functions similarly to lymph node as a site of T-cell activation",
                    "sub_points": [
                      "Acute rejection can occur in immediate postoperative periodLymphatics not yet functioning to drain donor APCs to lymph nodesLung lymphoid tissue, or bronchial-associated lymphoid tissue (BALT), functions similarly to lymph node as a site of T-cell activation",
                      "Lymphatics not yet functioning to drain donor APCs to lymph nodes",
                      "Lung lymphoid tissue, or bronchial-associated lymphoid tissue (BALT), functions similarly to lymph node as a site of T-cell activation"
                    ]
                  },
                  {
                    "text": "In AMR, alloantibodies deposit within graft vasculature, leading to complement activation, endothelial cell damage, and cell death"
                  },
                  {
                    "text": "In BOS, immune response to airway epithelial antigens leads to Th17/IL-17 activationIncreased IL-17(+) CD8(+) T cells have also been found in inflammatory infiltrates in LB",
                    "sub_points": [
                      "Increased IL-17(+) CD8(+) T cells have also been found in inflammatory infiltrates in LB"
                    ]
                  }
                ]
              },
              "Clinical Implications": {
                "Prognosis": [
                  {
                    "text": "Frequency and severity of acute rejection is one of the most important risk factors for development of BOS"
                  },
                  {
                    "text": "BOS is most common cause of death in all lung transplant recipients after 1 year post transplant"
                  }
                ],
                "Clinical Presentation": [
                  {
                    "text": "Presenting signs and symptoms of ACR, when present, are nonspecific"
                  },
                  {
                    "text": "Surveillance biopsies are routinely performed to identify ACR and AMRHistologic assessment is gold standard for diagnosis of rejection",
                    "sub_points": [
                      "Histologic assessment is gold standard for diagnosis of rejection"
                    ]
                  },
                  {
                    "text": "BOS can occur anytime after transplant and presents with declining pulmonary function tests, dyspnea, and cough"
                  }
                ],
                "ISHLT Guidelines": [
                  {
                    "text": "Because grade B1R (ISHLT 2007 classification) is a broader category including grades B1 and B2 (ISHLT 1996 classification), this may contribute to treatment differences for these patients"
                  },
                  {
                    "text": "Clarification needed regarding utilization of terms grade AX and grade BX, as pathologists and pulmonologists may interpret differently"
                  }
                ],
                "Interobserver Variability": [
                  {
                    "text": "Interobserver variability exists in grading lung allograft biopsiesRecently, moderate agreement has been reported for both grade A and grade B rejection",
                    "sub_points": [
                      "Recently, moderate agreement has been reported for both grade A and grade B rejection"
                    ]
                  }
                ]
              },
              "Macroscopic Findings": {
                "Specimen Adequacy": [
                  {
                    "text": "≥ 5 fragments of alveolated lung from transbronchial biopsy"
                  }
                ],
                "Specimen Handling": [
                  {
                    "text": "Gently agitate in formalin to ensure expansion of alveoli"
                  },
                  {
                    "text": "Avoid forceps use to minimize crush artifact"
                  }
                ]
              },
              "Microscopic Findings": {
                "Specimen Adequacy": [
                  {
                    "text": "Minimum of 3 levels of H&E-stained sections"
                  },
                  {
                    "text": "Connective tissue stains may aid in identifyingSubmucosal airway fibrosis in BO (grade C, chronic airways rejection)Arteriosclerosis in chronic vascular rejection (grade D)",
                    "sub_points": [
                      "Submucosal airway fibrosis in BO (grade C, chronic airways rejection)",
                      "Arteriosclerosis in chronic vascular rejection (grade D)"
                    ]
                  },
                  {
                    "text": "Silver stains may help identify fungal elements"
                  },
                  {
                    "text": "Grade AX &/or BX may be reported if specimen is not adequate for grading≥ 100 alveolar spaces total≥ 1 bronchioleAbsence of tangential cutting and processing artifact",
                    "sub_points": [
                      "≥ 100 alveolar spaces total",
                      "≥ 1 bronchiole",
                      "Absence of tangential cutting and processing artifact"
                    ]
                  }
                ],
                "ISHLT Guidelines": [
                  {
                    "text": "First published in 1990; revised in 1996 and 2007Some centers use 1996 system, although most use 2007 system",
                    "sub_points": [
                      "Some centers use 1996 system, although most use 2007 system"
                    ]
                  },
                  {
                    "text": "Major changes in 2007 from 1996Grade BGrade B1R is combination of grade B1 and grade B2 from 1996 classificationGrade B2R is combination of grade B3 and grade B4 from 1996 classification1996 classification allowed for 5 grades of LB (B0-B4) or just stating the presence or absence of LB, depending on transplant clinician's preferenceGrade C2007 classification has no requirement to report inflammation associated with BOReported as grade C1a (active) or C1b (no inflammation) in 1996 classification",
                    "sub_points": [
                      "Grade BGrade B1R is combination of grade B1 and grade B2 from 1996 classificationGrade B2R is combination of grade B3 and grade B4 from 1996 classification1996 classification allowed for 5 grades of LB (B0-B4) or just stating the presence or absence of LB, depending on transplant clinician's preference",
                      "Grade B1R is combination of grade B1 and grade B2 from 1996 classification",
                      "Grade B2R is combination of grade B3 and grade B4 from 1996 classification",
                      "1996 classification allowed for 5 grades of LB (B0-B4) or just stating the presence or absence of LB, depending on transplant clinician's preference",
                      "Grade C2007 classification has no requirement to report inflammation associated with BOReported as grade C1a (active) or C1b (no inflammation) in 1996 classification",
                      "2007 classification has no requirement to report inflammation associated with BO",
                      "Reported as grade C1a (active) or C1b (no inflammation) in 1996 classification"
                    ]
                  },
                  {
                    "text": "Nonrejection biopsy findings that should be reportedInfectionPresence of numerous neutrophils, fungal hyphae or yeast, viral inclusionsMicroaspirationExogenous lipoid pneumonia and multinucleated giant cellsOrganizing pneumoniaMay be subacute infection, ischemia-reperfusion injury, or idiopathicBALTImmunohistochemical stain for CD21 can highlight follicular dendritic network",
                    "sub_points": [
                      "InfectionPresence of numerous neutrophils, fungal hyphae or yeast, viral inclusions",
                      "Presence of numerous neutrophils, fungal hyphae or yeast, viral inclusions",
                      "MicroaspirationExogenous lipoid pneumonia and multinucleated giant cells",
                      "Exogenous lipoid pneumonia and multinucleated giant cells",
                      "Organizing pneumoniaMay be subacute infection, ischemia-reperfusion injury, or idiopathic",
                      "May be subacute infection, ischemia-reperfusion injury, or idiopathic",
                      "BALTImmunohistochemical stain for CD21 can highlight follicular dendritic network",
                      "Immunohistochemical stain for CD21 can highlight follicular dendritic network"
                    ]
                  },
                  {
                    "text": "Many issues related to lung allograft biopsy interpretation remain unresolvedDegree of inflammation in grade B rejectionLarge airway submucosal inflammationInflammation associated with BOSpecific definitions of grades AX and BXHistologic features of AMRDistinguishing signs of infectionDistinguishing features of BALT",
                    "sub_points": [
                      "Degree of inflammation in grade B rejection",
                      "Large airway submucosal inflammation",
                      "Inflammation associated with BO",
                      "Specific definitions of grades AX and BX",
                      "Histologic features of AMR",
                      "Distinguishing signs of infection",
                      "Distinguishing features of BALT"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Amyloidosis": {
            "name": "Amyloidosis",
            "url": "https://app.pathprimer.com/document/967511f1-3799-47cd-a34d-2de4f776b960/lesson/593f0823-e25e-4da6-abb5-c8b88123771b",
            "content": {
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Protein folding diseases characterized by accumulation of 7-12 nm diameter fibrils with β-pleated sheet structure that confers birefringence after staining with Congo red"
                  }
                ]
              },
              "EPIDEMIOLOGY": {
                "Age Range": [
                  {
                    "text": "AL & AA amyloid: Typically 50-70 years old"
                  },
                  {
                    "text": "Familial forms: < 40 years old; AFib older"
                  }
                ],
                "Gender": [
                  {
                    "text": "M:F = 2:1 overall"
                  }
                ],
                "Incidence": [
                  {
                    "text": "1.4/100,000 per person/year; all types (France)"
                  },
                  {
                    "text": "About 10% of cases are familial"
                  },
                  {
                    "text": "1-5% of adult patients with nephrotic syndrome have some form of amyloidosis"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Amyloidogenic Proteins": [
                  {
                    "text": "> 30 different precursor proteinsClonal proliferation of plasma cells (AL/AH types)Chronic inflammation (AA type)Genetic (multiple proteins)Failure of excretion (β2 microglobulin)Localized formsIslet amyloid polypeptide (AIAPP) in islets of Langerhans (type 2 diabetes mellitus)Semenogelin 1 (ASem) in seminal vesicles (↑ with aging)Lactadherin (AMed) in aortic media (↑ with aging)Neoplasm (e.g., calcitonin [ACal] associated with medullary thyroid carcinoma)",
                    "sub_points": [
                      "Clonal proliferation of plasma cells (AL/AH types)",
                      "Chronic inflammation (AA type)",
                      "Genetic (multiple proteins)",
                      "Failure of excretion (β2 microglobulin)",
                      "Localized formsIslet amyloid polypeptide (AIAPP) in islets of Langerhans (type 2 diabetes mellitus)Semenogelin 1 (ASem) in seminal vesicles (↑ with aging)Lactadherin (AMed) in aortic media (↑ with aging)Neoplasm (e.g., calcitonin [ACal] associated with medullary thyroid carcinoma)",
                      "Islet amyloid polypeptide (AIAPP) in islets of Langerhans (type 2 diabetes mellitus)",
                      "Semenogelin 1 (ASem) in seminal vesicles (↑ with aging)",
                      "Lactadherin (AMed) in aortic media (↑ with aging)",
                      "Neoplasm (e.g., calcitonin [ACal] associated with medullary thyroid carcinoma)"
                    ]
                  },
                  {
                    "text": "~ 90% of renal amyloidosis cases are AL or AA"
                  }
                ],
                "Pathogenesis": [
                  {
                    "text": "Amyloidogenic proteins have antiparallel, β-pleated sheet tertiary structure (also termed cross β-sheets)Structure determined by x-ray diffraction, which shows 2 reflections: Sharp one at ~ 4.7 Å & more diffuse one at ~ 8-12 ÅCross-β motif forms central structural spine of amyloid protofilamentsStructure accounts for Congo red staining & apple-green birefringence under polarized light since it enables anisotropic binding of Congo red moleculesResistance to metabolic processing leads to accumulation & interference with physiologic functioning",
                    "sub_points": [
                      "Structure determined by x-ray diffraction, which shows 2 reflections: Sharp one at ~ 4.7 Å & more diffuse one at ~ 8-12 Å",
                      "Cross-β motif forms central structural spine of amyloid protofilaments",
                      "Structure accounts for Congo red staining & apple-green birefringence under polarized light since it enables anisotropic binding of Congo red molecules",
                      "Resistance to metabolic processing leads to accumulation & interference with physiologic functioning"
                    ]
                  },
                  {
                    "text": "Amyloid deposits composed of amyloidogenic protein nonfibrillary glycoproteins serum amyloid P (SAP), apolipoprotein E, & glycosaminoglycansNormal plasma proteins that bind all amyloid proteinsSAP present early & promotes depositsLabeled SAP used to image amyloid in vivo",
                    "sub_points": [
                      "Normal plasma proteins that bind all amyloid proteins",
                      "SAP present early & promotes deposits",
                      "Labeled SAP used to image amyloid in vivo"
                    ]
                  }
                ],
                "Renal Deposits": [
                  {
                    "text": "Certain forms typically involve kidney (AL, AA, fibrinogen, Apo AI & AII, Alys)"
                  },
                  {
                    "text": "Glomerular mesangial amyloid accumulation often occurs 1st as mesangial cells lose usual smooth muscle phenotype & acquire macrophage phenotypeMesangial cells engage in endocytosis & deliver amyloidogenic light chains to lysosomal compartment, where fibril formation takes place",
                    "sub_points": [
                      "Mesangial cells engage in endocytosis & deliver amyloidogenic light chains to lysosomal compartment, where fibril formation takes place"
                    ]
                  },
                  {
                    "text": "Fibrils penetrate & aggregate in GBM, suggesting that they may be locally formed"
                  }
                ]
              },
              "CLINICAL IMPLICATIONS": {
                "Clinical Presentation": [
                  {
                    "text": "ProteinuriaPresent in virtually all with renal involvement~ 5% of adult cases of nephrotic syndrome",
                    "sub_points": [
                      "Present in virtually all with renal involvement",
                      "~ 5% of adult cases of nephrotic syndrome"
                    ]
                  },
                  {
                    "text": "HematuriaRarely a presenting feature",
                    "sub_points": [
                      "Rarely a presenting feature"
                    ]
                  },
                  {
                    "text": "Extrarenal manifestationsCongestive heart failure, arrhythmias, orthostatic hypotensionDysesthesiasBladder dysfunction↑ organ size: Hepatomegaly/splenomegaly, macroglossiaCarpal tunnel syndrome",
                    "sub_points": [
                      "Congestive heart failure, arrhythmias, orthostatic hypotension",
                      "DysesthesiasBladder dysfunction",
                      "Bladder dysfunction",
                      "↑ organ size: Hepatomegaly/splenomegaly, macroglossia",
                      "Carpal tunnel syndrome"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Enlarged, pale, firm, & with waxy appearance"
                  },
                  {
                    "text": "Cut surfaces remain firm & flat in contrast to normal kidney, which bulges after sectioning"
                  },
                  {
                    "text": "Lugol iodine stains glomeruli dark brown in cut surfaces (like starch)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "General Features": [
                  {
                    "text": "GlomeruliExpansion of mesangium & thickening of capillary walls by amorphous eosinophilic materialAmorphous deposits are acidophilic, \"salmon orange\"Usually less acidophilic than collagen (i.e., mesangial sclerosis, interstitial fibrosis)Normal mesangial matrix, presumably destroyed by activated metalloproteinases, is replaced by amyloid fibrilsNodular mesangial expansion can often be seenLittle or no hypercellularityAmyloid is weakly PAS positive, less than GBMAmyloid deposition can 1st be seen in mesangium & blood vessel wallsEarly mesangial deposits may be quite small & subject to being overlooked, resulting in erroneous diagnosis of minimal change disease/glomerulopathyRare cases of AL & AA amyloid with crescentsSilver stains: Expanded mesangial areas but ↓ or no silver staining (i.e., \"loss of argyrophilia\")GBMs also may be engulfed by the material, showing up as areas of complete GBM discontinuitySubepithelial spikes in capillary loops (\"cock's comb\")Eventually, ESRD kidneys with glomerulosclerosis from amyloid can be suspected by pale staining on JMS or PAS stainsMesangial & subendothelial deposits eventually obliterate glomeruliTrichrome stains blue in amyloid, usually paler than trichrome staining of collagen",
                    "sub_points": [
                      "Expansion of mesangium & thickening of capillary walls by amorphous eosinophilic materialAmorphous deposits are acidophilic, \"salmon orange\"Usually less acidophilic than collagen (i.e., mesangial sclerosis, interstitial fibrosis)Normal mesangial matrix, presumably destroyed by activated metalloproteinases, is replaced by amyloid fibrilsNodular mesangial expansion can often be seenLittle or no hypercellularityAmyloid is weakly PAS positive, less than GBM",
                      "Amorphous deposits are acidophilic, \"salmon orange\"",
                      "Usually less acidophilic than collagen (i.e., mesangial sclerosis, interstitial fibrosis)",
                      "Normal mesangial matrix, presumably destroyed by activated metalloproteinases, is replaced by amyloid fibrils",
                      "Nodular mesangial expansion can often be seen",
                      "Little or no hypercellularity",
                      "Amyloid is weakly PAS positive, less than GBM",
                      "Amyloid deposition can 1st be seen in mesangium & blood vessel wallsEarly mesangial deposits may be quite small & subject to being overlooked, resulting in erroneous diagnosis of minimal change disease/glomerulopathy",
                      "Early mesangial deposits may be quite small & subject to being overlooked, resulting in erroneous diagnosis of minimal change disease/glomerulopathy",
                      "Rare cases of AL & AA amyloid with crescents",
                      "Silver stains: Expanded mesangial areas but ↓ or no silver staining (i.e., \"loss of argyrophilia\")GBMs also may be engulfed by the material, showing up as areas of complete GBM discontinuitySubepithelial spikes in capillary loops (\"cock's comb\")",
                      "GBMs also may be engulfed by the material, showing up as areas of complete GBM discontinuity",
                      "Subepithelial spikes in capillary loops (\"cock's comb\")",
                      "Eventually, ESRD kidneys with glomerulosclerosis from amyloid can be suspected by pale staining on JMS or PAS stainsMesangial & subendothelial deposits eventually obliterate glomeruli",
                      "Mesangial & subendothelial deposits eventually obliterate glomeruli",
                      "Trichrome stains blue in amyloid, usually paler than trichrome staining of collagen"
                    ]
                  },
                  {
                    "text": "TubulointerstitiumCongo red staining useful in identifying vascular & interstitial amyloidHelps distinguish from interstitial fibrosis (IF)Interstitial involvement often contiguous with involvement of TBMs & vesselsEventually, IF & tubular atrophy (TA) may be extensive, admixed with interstitial inflammationTubular casts containing amyloid are sometimes present and, in rare case reports, are the only manifestation of amyloidosisMaterial has fibrillar appearance characteristic of amyloid material on EMInterstitium may be expanded by amyloid materialMast cells may lead to IF in AA type",
                    "sub_points": [
                      "Congo red staining useful in identifying vascular & interstitial amyloidHelps distinguish from interstitial fibrosis (IF)",
                      "Helps distinguish from interstitial fibrosis (IF)",
                      "Interstitial involvement often contiguous with involvement of TBMs & vesselsEventually, IF & tubular atrophy (TA) may be extensive, admixed with interstitial inflammation",
                      "Eventually, IF & tubular atrophy (TA) may be extensive, admixed with interstitial inflammation",
                      "Tubular casts containing amyloid are sometimes present and, in rare case reports, are the only manifestation of amyloidosisMaterial has fibrillar appearance characteristic of amyloid material on EM",
                      "Material has fibrillar appearance characteristic of amyloid material on EM",
                      "Interstitium may be expanded by amyloid materialMast cells may lead to IF in AA type",
                      "Mast cells may lead to IF in AA type"
                    ]
                  }
                ],
                "Immunofluorescence": [
                  {
                    "text": "Pattern depends on type of amyloid"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "FibrilsNonbranching, nonperiodic, ~ 7-12 nm in diameterAccurate measurement necessaryAmorphous \"cottony\" appearance at ~ 5,000xElectron-lucent core at ~ 100,000xInternal references: Cell membrane 8.5 nm; actin: 5 nmRandomly distributed in mesangium & GBMFibrils sometimes extend transmurally, replacing entire glomerular basement membraneIn subepithelial zone, fibrils align roughly perpendicular to GBM, producing \"spike\" formation or \"cock's comb\" (also called \"spicular amyloid\")Podocyte foot processes often effaced, & cytoplasm has condensation of actin filaments",
                    "sub_points": [
                      "Nonbranching, nonperiodic, ~ 7-12 nm in diameterAccurate measurement necessaryAmorphous \"cottony\" appearance at ~ 5,000xElectron-lucent core at ~ 100,000xInternal references: Cell membrane 8.5 nm; actin: 5 nm",
                      "Accurate measurement necessary",
                      "Amorphous \"cottony\" appearance at ~ 5,000x",
                      "Electron-lucent core at ~ 100,000x",
                      "Internal references: Cell membrane 8.5 nm; actin: 5 nm",
                      "Randomly distributed in mesangium & GBM",
                      "Fibrils sometimes extend transmurally, replacing entire glomerular basement membraneIn subepithelial zone, fibrils align roughly perpendicular to GBM, producing \"spike\" formation or \"cock's comb\" (also called \"spicular amyloid\")",
                      "In subepithelial zone, fibrils align roughly perpendicular to GBM, producing \"spike\" formation or \"cock's comb\" (also called \"spicular amyloid\")",
                      "Podocyte foot processes often effaced, & cytoplasm has condensation of actin filaments"
                    ]
                  },
                  {
                    "text": "Immunoelectron microscopy can be used for various amyloids, usually employing antibody probes conjugated with gold particles (immunogold)"
                  }
                ],
                "Special Stains": [
                  {
                    "text": "Congo redOrangeophilic material on brightfield examination that has apple-green birefringence when examined with polarized light (i.e., crossed polars)In contrast to fibrillar collagen, amyloid fibrils are only birefringent after Congo red stainImportant to have simultaneous positive controlRather than \"apple-green\" birefringence, some advocate the term \"anomalous colors\"Red without polarization (called \"congophilia\")Elastic fibers are congophilic but not birefringentSmall amyloid quantities may make it difficult to demonstrate apple-green birefringenceHigher quality polarizing microscope will have greater sensitivity9 μm sections recommended for Congo red staining to maximize detection of small quantities of amyloidPlacing Congo red stains under green fluorescent light makes amyloid deposits appear bright red; sensitive but not specific",
                    "sub_points": [
                      "Orangeophilic material on brightfield examination that has apple-green birefringence when examined with polarized light (i.e., crossed polars)In contrast to fibrillar collagen, amyloid fibrils are only birefringent after Congo red stainImportant to have simultaneous positive controlRather than \"apple-green\" birefringence, some advocate the term \"anomalous colors\"",
                      "In contrast to fibrillar collagen, amyloid fibrils are only birefringent after Congo red stain",
                      "Important to have simultaneous positive control",
                      "Rather than \"apple-green\" birefringence, some advocate the term \"anomalous colors\"",
                      "Red without polarization (called \"congophilia\")Elastic fibers are congophilic but not birefringent",
                      "Elastic fibers are congophilic but not birefringent",
                      "Small amyloid quantities may make it difficult to demonstrate apple-green birefringenceHigher quality polarizing microscope will have greater sensitivity9 μm sections recommended for Congo red staining to maximize detection of small quantities of amyloidPlacing Congo red stains under green fluorescent light makes amyloid deposits appear bright red; sensitive but not specific",
                      "Higher quality polarizing microscope will have greater sensitivity",
                      "9 μm sections recommended for Congo red staining to maximize detection of small quantities of amyloid",
                      "Placing Congo red stains under green fluorescent light makes amyloid deposits appear bright red; sensitive but not specific"
                    ]
                  },
                  {
                    "text": "Thioflavine T & SThioflavin T activated by blue light to emit yellow fluorescence; sensitive, not specificReports of ↑ sensitivity vs. Congo red if small quantities of amyloid presentRarely used currently",
                    "sub_points": [
                      "Thioflavin T activated by blue light to emit yellow fluorescence; sensitive, not specific",
                      "Reports of ↑ sensitivity vs. Congo red if small quantities of amyloid present",
                      "Rarely used currently"
                    ]
                  },
                  {
                    "text": "Crystal violetMetachromatic stain not usually used in routine diagnostic work",
                    "sub_points": [
                      "Metachromatic stain not usually used in routine diagnostic work"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "SAP (does not discriminate between types)Used to compare with stains for specific protein",
                    "sub_points": [
                      "Used to compare with stains for specific protein"
                    ]
                  },
                  {
                    "text": "Antibodies available for a variety of amyloid types"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Quality of polarizing microscope is crucial determinant of sensitivity"
                  }
                ]
              },
              "Ancillary Tests for Amyloid Detection": {
                "Mass Spectrometry (MS) & Proteomics": [
                  {
                    "text": "Laser microdissection (LMD) & tandem mass spectrometry (MS)-based proteomic analysis useful in typing amyloidosis"
                  },
                  {
                    "text": "Microextraction followed by amino acid sequencing can be used in select cases"
                  }
                ],
                "Abdominal Fat Pad Fine-Needle Aspiration": [
                  {
                    "text": "Sensitivity ~ 20-60%; specificity ~ 100%"
                  },
                  {
                    "text": "Core biopsy probably more sensitive"
                  }
                ],
                "Rectal Biopsy": [
                  {
                    "text": "Sensitivity & specificity likely varies based on amyloid formFor example: FMF biopsy studies indicate following sensitivities for amyloidosis: Renal (88%), testicular (87%), bone marrow (80%), rectal (75%), liver (48%), gingival (19%)",
                    "sub_points": [
                      "For example: FMF biopsy studies indicate following sensitivities for amyloidosis: Renal (88%), testicular (87%), bone marrow (80%), rectal (75%), liver (48%), gingival (19%)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Neoplastic Disorders": {
        "name": "Neoplastic Disorders",
        "url": "https://app.pathprimer.com/lesson/77119f90-6e7d-4033-ab21-1264e916bcec",
        "topics": {
          "Colorectal Adenocarcinoma and Precancerous Lesions": {
            "name": "Colorectal Adenocarcinoma and Precancerous Lesions",
            "url": "https://app.pathprimer.com/document/bffd349b-d7e1-4bfd-9eb2-b33e679b870c/lesson/77119f90-6e7d-4033-ab21-1264e916bcec",
            "content": {
              "Key Facts": {
                "Clinical Issues": [
                  {
                    "text": "Molecular subtyping of CRC helps define patient prognosisMSI-H, CRC shows most favorable outcome, regardless ofBRAFstatusMSI-H,BRAF,andKRASwild-type CRC also shows favorable outcomeMSS,BRAF-mutated CRC shows worst prognosisMSI status appears to be the most clinically relevant prognostic molecular marker",
                    "sub_points": [
                      "MSI-H, CRC shows most favorable outcome, regardless ofBRAFstatus",
                      "MSI-H,BRAF,andKRASwild-type CRC also shows favorable outcome",
                      "MSS,BRAF-mutated CRC shows worst prognosis",
                      "MSI status appears to be the most clinically relevant prognostic molecular marker"
                    ]
                  },
                  {
                    "text": "Effectiveness of EGFR inhibition for advanced-stage disease depends on downstream mutationsKRASmutationsconfer resistance to anti-EGFR therapyBRAFandNRASmutationsconfer reduced sensitivity to anti-EGFR therapy",
                    "sub_points": [
                      "KRASmutationsconfer resistance to anti-EGFR therapy",
                      "BRAFandNRASmutationsconfer reduced sensitivity to anti-EGFR therapy"
                    ]
                  }
                ],
                "Molecular Pathology": [
                  {
                    "text": "Sporadic MSI-H CRCMLH1promoter hypermethylated,BRAFmutated",
                    "sub_points": [
                      "MLH1promoter hypermethylated,BRAFmutated"
                    ]
                  },
                  {
                    "text": "LS-associated MSI-H CRCGermline MMR genes mutated,MLH1promoter nonmethylated,BRAFwild type",
                    "sub_points": [
                      "Germline MMR genes mutated,MLH1promoter nonmethylated,BRAFwild type"
                    ]
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Features characteristic of MSI-H CRCMucinous, medullary, poorly differentiated, and signet ring cell phenotypesAbundant tumor-infiltrating lymphocytesCrohn-like peritumoral lymphoid aggregates",
                    "sub_points": [
                      "Mucinous, medullary, poorly differentiated, and signet ring cell phenotypes",
                      "Abundant tumor-infiltrating lymphocytes",
                      "Crohn-like peritumoral lymphoid aggregates"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "LS screening recommended in all patients with newly diagnosed CRC"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Colorectal adenocarcinoma (CRC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Colorectal adenocarcinoma is a malignant epithelial-derived neoplasm of the colonSporadic with chromosomal instability or microsatellite instabilityHereditary with multiple pathways",
                    "sub_points": [
                      "Sporadic with chromosomal instability or microsatellite instability",
                      "Hereditary with multiple pathways"
                    ]
                  },
                  {
                    "text": "Colorectal precancerous lesions are epithelial-derived dysplastic changes that typically present as adenomatous polyps or flat dysplastic lesions"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Chromosomal Instability Pathway": [
                  {
                    "text": "Adenoma-carcinoma sequenceAccount for ~ 60-70% of sporadic CRCInactivationAPCgene(initial mutation)Activating mutations inKRASgene (early event)Mutually exclusiveBRAFmutations in some18q loss of heterozygosityDCCandSMAD4genes mapped to this regionInactivation ofTP53gene",
                    "sub_points": [
                      "Account for ~ 60-70% of sporadic CRC",
                      "InactivationAPCgene(initial mutation)",
                      "Activating mutations inKRASgene (early event)",
                      "Mutually exclusiveBRAFmutations in some",
                      "18q loss of heterozygosityDCCandSMAD4genes mapped to this region",
                      "DCCandSMAD4genes mapped to this region",
                      "Inactivation ofTP53gene"
                    ]
                  }
                ],
                "Sessile Serrated Pathway": [
                  {
                    "text": "CpG island hypermethylation in tumor suppressor genes in sporadic cases"
                  },
                  {
                    "text": "Sessile serrated adenomas are precursor lesions that progress to CRCAccounts for up to 20% of CRCs",
                    "sub_points": [
                      "Accounts for up to 20% of CRCs"
                    ]
                  },
                  {
                    "text": "BRAFV600E mutation in majority of cases"
                  },
                  {
                    "text": "KRASmutations occur, but less commonKRASandBRAFmutations are mutually exclusive",
                    "sub_points": [
                      "KRASandBRAFmutations are mutually exclusive"
                    ]
                  }
                ],
                "Microsatellite Instability Pathway": [
                  {
                    "text": "Seen in both sporadic and hereditary nonpolyposis CRC (Lynch syndrome)"
                  },
                  {
                    "text": "Hypermethylation of promoterMLH1genein sporadic CRC cases leads to mismatch repair (MMR) protein deficiency and subsequent MSI-H CRCResults in loss of MMR via gene silencing",
                    "sub_points": [
                      "Results in loss of MMR via gene silencing"
                    ]
                  },
                  {
                    "text": "Account for ~ 12-15% of CRCs"
                  }
                ],
                "Hereditary CRC": [
                  {
                    "text": "Lynch syndrome (LS)Germline mutation in MMR genes, includingMSH2(50%),MLH1(30-40%),MSH6(7-10%),PMS2(< 5%)2nd-hit somatic mutation leads to MMR deficiency and subsequent MSI-H CRCConventional adenomatous polyps are precursors for LS-associated CRCLacksBRAFmutationsDeletions of 3' end ofEPCAMgene in 1-3% of LSGermlineMSH2mutation analysis usually includes testing forEPCAMdeletions",
                    "sub_points": [
                      "Germline mutation in MMR genes, includingMSH2(50%),MLH1(30-40%),MSH6(7-10%),PMS2(< 5%)",
                      "2nd-hit somatic mutation leads to MMR deficiency and subsequent MSI-H CRC",
                      "Conventional adenomatous polyps are precursors for LS-associated CRC",
                      "LacksBRAFmutations",
                      "Deletions of 3' end ofEPCAMgene in 1-3% of LS",
                      "GermlineMSH2mutation analysis usually includes testing forEPCAMdeletions"
                    ]
                  },
                  {
                    "text": "Serratedpolyposis syndrome (SPS)~ 25-40% risk of development of CRCGenetic alterations similar to serrated pathway CRC",
                    "sub_points": [
                      "~ 25-40% risk of development of CRC",
                      "Genetic alterations similar to serrated pathway CRC"
                    ]
                  },
                  {
                    "text": "Familialadenomatous polyposis (FAP)GermlineAPCmutation with 2nd-hit somatic mutation~ 90-100% risk of developing CRCOften thousands of colonic tubular adenomasAttenuated FAP has < 100 adenomas with ~ 70% risk for development of CRC",
                    "sub_points": [
                      "GermlineAPCmutation with 2nd-hit somatic mutation",
                      "~ 90-100% risk of developing CRC",
                      "Often thousands of colonic tubular adenomas",
                      "Attenuated FAP has < 100 adenomas with ~ 70% risk for development of CRC"
                    ]
                  },
                  {
                    "text": "MUTYH-associated polyposisMUTYHmutations result in heritable predisposition to colon and gastric cancerBiallelic mutations inMUTYHgene with  35-53% risk of CRC in adulthood",
                    "sub_points": [
                      "MUTYHmutations result in heritable predisposition to colon and gastric cancer",
                      "Biallelic mutations inMUTYHgene with  35-53% risk of CRC in adulthood"
                    ]
                  },
                  {
                    "text": "Juvenilepolyposis (JP)Inherited forms have an autosomal dominant patternGermline mutations inSMAD4orBMPR1APolyps appear benign, but patient has ~ 40% risk of developing CRC",
                    "sub_points": [
                      "Inherited forms have an autosomal dominant patternGermline mutations inSMAD4orBMPR1A",
                      "Germline mutations inSMAD4orBMPR1A",
                      "Polyps appear benign, but patient has ~ 40% risk of developing CRC"
                    ]
                  },
                  {
                    "text": "Peutz-Jegherssyndrome (PJS)Autosomal dominant disorder with germline mutations inSTK11gene~ 40% risk of developing CRC",
                    "sub_points": [
                      "Autosomal dominant disorder with germline mutations inSTK11gene",
                      "~ 40% risk of developing CRC"
                    ]
                  },
                  {
                    "text": "PTENhamartoma tumor syndromesGermline mutations inPTENassociated with a variety of syndromes, including Cowden, Bannayan-Riley-Ruvalcaba, and others~ 13-16% risk of developing CRC",
                    "sub_points": [
                      "Germline mutations inPTENassociated with a variety of syndromes, including Cowden, Bannayan-Riley-Ruvalcaba, and others",
                      "~ 13-16% risk of developing CRC"
                    ]
                  }
                ],
                "Environmental Exposure": [
                  {
                    "text": "Western-type dietHighly caloric food, rich in animal fat",
                    "sub_points": [
                      "Highly caloric food, rich in animal fat"
                    ]
                  }
                ],
                "Modifiable Risk Factors": [
                  {
                    "text": "Alcohol"
                  },
                  {
                    "text": "Smoking"
                  },
                  {
                    "text": "Obesity/sedentary lifestyle"
                  }
                ],
                "Chronic Inflammation": [
                  {
                    "text": "Increased incidence in inflammatory bowel disease"
                  }
                ],
                "Inverse Associations": [
                  {
                    "text": "Diet high in fruits, vegetables, and whole grains (high fiber, low fat)"
                  },
                  {
                    "text": "Prolonged use of NSAIDs"
                  },
                  {
                    "text": "Physical activity"
                  }
                ]
              },
              "Clinical Issues": {
                "Presentation": [
                  {
                    "text": "Often asymptomatic, identified on screening"
                  },
                  {
                    "text": "Change in bowel habits"
                  },
                  {
                    "text": "Iron-deficiency anemia (right sided tumors)"
                  },
                  {
                    "text": "Hematochezia (left-sided tumors)"
                  },
                  {
                    "text": "Tenesmus (rectal tumors)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection for stage I tumors"
                  },
                  {
                    "text": "Adjuvant chemotherapy after surgical resection for stage III CRC and high-risk stage II tumors withLymphovascular invasionPerineural invasionPoor differentiationT4 classificationObstructing or perforating tumorInadequate lymph node samplingTumor buddingPositive margins",
                    "sub_points": [
                      "Lymphovascular invasion",
                      "Perineural invasion",
                      "Poor differentiation",
                      "T4 classification",
                      "Obstructing or perforating tumor",
                      "Inadequate lymph node sampling",
                      "Tumor budding",
                      "Positive margins"
                    ]
                  },
                  {
                    "text": "Patients with stage II MSI-H CRC may not benefit from adjuvant 5-fluorouracil (5-FU)-based chemotherapy"
                  },
                  {
                    "text": "Targeted EGFR antibodies in advanced-stage disease with wild-typeKRASgene"
                  },
                  {
                    "text": "Anti-programmed death 1 (PD-1) checkpoint inhibitor (pembrolizumab) therapyMismatch repair-deficient CRC appear responsive to therapeutic blockade of PD-1",
                    "sub_points": [
                      "Mismatch repair-deficient CRC appear responsive to therapeutic blockade of PD-1"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Association of molecular subtypes and patient survivalMSI-H, CRC shows most favorable outcome, regardless ofBRAFstatusMSI-H,BRAF,andKRASwild-type CRC also shows favorable outcomeMSS,BRAF-mutated CRC shows worst prognosis",
                    "sub_points": [
                      "MSI-H, CRC shows most favorable outcome, regardless ofBRAFstatus",
                      "MSI-H,BRAF,andKRASwild-type CRC also shows favorable outcome",
                      "MSS,BRAF-mutated CRC shows worst prognosis"
                    ]
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Exophytic, fungating mass"
                  },
                  {
                    "text": "Annular mass with circumferential mural growth (apple core lesion)"
                  },
                  {
                    "text": "Diffusely infiltrative (least common)"
                  },
                  {
                    "text": "MSI-H and MSS/CpG island methylator phenotype (CIMP) tumors are frequently located in right colon"
                  },
                  {
                    "text": "MSS/non-CIMP tumors are frequently located in left colon"
                  }
                ]
              },
              "Molecular Pathology": {
                "Sporadic Polyps": [
                  {
                    "text": "Tubular/tubulovillous adenomaPrecursor polyp to conventional CRCInactivatingAPCgene mutationLeads to development of dysplasia in aberrant crypt foci and early adenomasSequential accumulation of mutations inKRAS, DCC, SMAD4,andTP53drives progression to CRC",
                    "sub_points": [
                      "Precursor polyp to conventional CRC",
                      "InactivatingAPCgene mutationLeads to development of dysplasia in aberrant crypt foci and early adenomas",
                      "Leads to development of dysplasia in aberrant crypt foci and early adenomas",
                      "Sequential accumulation of mutations inKRAS, DCC, SMAD4,andTP53drives progression to CRC"
                    ]
                  },
                  {
                    "text": "Sessileserrated adenoma (SSA)Precursor polyp to CIMP, MSI-H CRCInitiatingBRAFmutation in sporadic casesProgressive CpG island hypermethylationMLH1promoter hypermethylation commonly seen with progression to cytologic dysplasiaLoss of MMR proteins results in rapid accumulation of other mutations that drive progression to CRC",
                    "sub_points": [
                      "Precursor polyp to CIMP, MSI-H CRC",
                      "InitiatingBRAFmutation in sporadic cases",
                      "Progressive CpG island hypermethylation",
                      "MLH1promoter hypermethylation commonly seen with progression to cytologic dysplasia",
                      "Loss of MMR proteins results in rapid accumulation of other mutations that drive progression to CRC"
                    ]
                  },
                  {
                    "text": "Traditionalserrated adenoma (TSA)Poorly characterized compared to tubular adenoma and SSAMolecularly diverseMay harborKRASorBRAFmutations, or neitherMay show low or high CIMP, or non-CIMPAssociated withMGMTpromoter methylationTypically do not showMLH1promoter hypermethylation or loss of MLH1 protein expression, and not associated with MSI-H CRCProposed to give rise toBRAF-orKRAS-mutated MSS CRC",
                    "sub_points": [
                      "Poorly characterized compared to tubular adenoma and SSA",
                      "Molecularly diverseMay harborKRASorBRAFmutations, or neitherMay show low or high CIMP, or non-CIMP",
                      "May harborKRASorBRAFmutations, or neither",
                      "May show low or high CIMP, or non-CIMP",
                      "Associated withMGMTpromoter methylation",
                      "Typically do not showMLH1promoter hypermethylation or loss of MLH1 protein expression, and not associated with MSI-H CRC",
                      "Proposed to give rise toBRAF-orKRAS-mutated MSS CRC"
                    ]
                  },
                  {
                    "text": "Microvesicularhyperplastic polypBRAFmutations present in ~ 70%~ 47-73% are CIMP positiveSpeculation that these may be precursors to SSAs",
                    "sub_points": [
                      "BRAFmutations present in ~ 70%",
                      "~ 47-73% are CIMP positive",
                      "Speculation that these may be precursors to SSAs"
                    ]
                  },
                  {
                    "text": "Gobletcell-rich hyperplastic polypHarborKRASmutations in ~ 50%",
                    "sub_points": [
                      "HarborKRASmutations in ~ 50%"
                    ]
                  }
                ],
                "Chromosomal Instability Pathway CRC": [
                  {
                    "text": "KRASmutationsActivating mutations in 40%-50% of CRC85-90% occur in codons 12 and 13Codons 61 and 146 are less commonMutations in codons 12, 13, and 61 render targeted EGFR inhibition ineffectiveKRASmutation testing mandatory for all patients with stage IV CRC who are candidates for anti-EGFR therapyPresence of a mutation precludes treatment with anti-EGFR monoclonal antibodies",
                    "sub_points": [
                      "Activating mutations in 40%-50% of CRC85-90% occur in codons 12 and 13Codons 61 and 146 are less common",
                      "85-90% occur in codons 12 and 13",
                      "Codons 61 and 146 are less common",
                      "Mutations in codons 12, 13, and 61 render targeted EGFR inhibition ineffective",
                      "KRASmutation testing mandatory for all patients with stage IV CRC who are candidates for anti-EGFR therapyPresence of a mutation precludes treatment with anti-EGFR monoclonal antibodies",
                      "Presence of a mutation precludes treatment with anti-EGFR monoclonal antibodies"
                    ]
                  },
                  {
                    "text": "BRAFmutationsMutually exclusive ofKRASmutationAssociated with reduced response toanti-EGFR targeted therapyIndicates poor prognosis in MSS or MSI-L CRC, but has no prognostic impact on MSI-H tumors",
                    "sub_points": [
                      "Mutually exclusive ofKRASmutation",
                      "Associated with reduced response toanti-EGFR targeted therapy",
                      "Indicates poor prognosis in MSS or MSI-L CRC, but has no prognostic impact on MSI-H tumors"
                    ]
                  },
                  {
                    "text": "NRASmutationsActivating mutations in 1-6% of CRCMajority occur in codons 12 and 13Reduced response to EGFR blockadeNRAStesting is recommended by NCCN",
                    "sub_points": [
                      "Activating mutations in 1-6% of CRCMajority occur in codons 12 and 13",
                      "Majority occur in codons 12 and 13",
                      "Reduced response to EGFR blockade",
                      "NRAStesting is recommended by NCCN"
                    ]
                  },
                  {
                    "text": "PIK3CAActivating mutations in 10-30% of all CRCsOccur in exons 1, 2, 9, and 20 (9 and 20 are most common)Unclear whether mutations are of prognostic significance, though poor survival reported in resectable stage I-III CRCNot mutually exclusive ofKRASorBRAFmutationsAdverse effect potentially limited toKRASwild-type CRCClinical effect ofPIK3CAmutations on response to anti-EGFR therapy has shown conflicting results",
                    "sub_points": [
                      "Activating mutations in 10-30% of all CRCsOccur in exons 1, 2, 9, and 20 (9 and 20 are most common)",
                      "Occur in exons 1, 2, 9, and 20 (9 and 20 are most common)",
                      "Unclear whether mutations are of prognostic significance, though poor survival reported in resectable stage I-III CRC",
                      "Not mutually exclusive ofKRASorBRAFmutationsAdverse effect potentially limited toKRASwild-type CRC",
                      "Adverse effect potentially limited toKRASwild-type CRC",
                      "Clinical effect ofPIK3CAmutations on response to anti-EGFR therapy has shown conflicting results"
                    ]
                  }
                ],
                "MSI Pathway CRC": [
                  {
                    "text": "MSI testing by PCRUsed as a screening test for Lynch syndrome (LS)Also used for prognostication in sporadic CRCIs an alternative test to MMR protein testing by IHCLaboratories may choose either or both as a first-line screening testMSI-H≥ 30% of the National Cancer Institute (NCI)-designated microsatellite markers (3 dinucleotide and 2 mononucleotide repeats) show instabilityMononucleotide markers have a higher sensitivity and specificity than dinucleotide markersMSI-L< 30% of NCI or commercially available mononucleotide markers show instability",
                    "sub_points": [
                      "Used as a screening test for Lynch syndrome (LS)",
                      "Also used for prognostication in sporadic CRC",
                      "Is an alternative test to MMR protein testing by IHC",
                      "Laboratories may choose either or both as a first-line screening test",
                      "MSI-H≥ 30% of the National Cancer Institute (NCI)-designated microsatellite markers (3 dinucleotide and 2 mononucleotide repeats) show instabilityMononucleotide markers have a higher sensitivity and specificity than dinucleotide markers",
                      "≥ 30% of the National Cancer Institute (NCI)-designated microsatellite markers (3 dinucleotide and 2 mononucleotide repeats) show instability",
                      "Mononucleotide markers have a higher sensitivity and specificity than dinucleotide markers",
                      "MSI-L< 30% of NCI or commercially available mononucleotide markers show instability",
                      "< 30% of NCI or commercially available mononucleotide markers show instability"
                    ]
                  },
                  {
                    "text": "MLH1gene promoter methylation assayReflexive test performed if CRC is MSI-H &/or IHC shows MMR protein lossPresence ofMLH1promoter hypermethylation indicatesMLH1gene silencingTypically seen in MSI-H sporadic CRCLack of significant promoter methylation suggests germline mutations in MMR genesTypically seen in Lynch syndromeReflexive test in MSI-H tumors to differentiate sporadic vs LS-associated CRC",
                    "sub_points": [
                      "Reflexive test performed if CRC is MSI-H &/or IHC shows MMR protein loss",
                      "Presence ofMLH1promoter hypermethylation indicatesMLH1gene silencingTypically seen in MSI-H sporadic CRC",
                      "Typically seen in MSI-H sporadic CRC",
                      "Lack of significant promoter methylation suggests germline mutations in MMR genesTypically seen in Lynch syndrome",
                      "Typically seen in Lynch syndrome",
                      "Reflexive test in MSI-H tumors to differentiate sporadic vs LS-associated CRC"
                    ]
                  },
                  {
                    "text": "ReflexiveBRAFtesting in MSI-H CRCPresence ofBRAFmutation indicates a sporadic tumorLess sensitive thanMLH1promoter methylation assay",
                    "sub_points": [
                      "Presence ofBRAFmutation indicates a sporadic tumor",
                      "Less sensitive thanMLH1promoter methylation assay"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Conventional CRCMost are well- to moderately differentiated glandular tumors~ 15% are poorly differentiated and may grow in solid massesGrowth patterns include expansile and infiltrative",
                    "sub_points": [
                      "Most are well- to moderately differentiated glandular tumors",
                      "~ 15% are poorly differentiated and may grow in solid masses",
                      "Growth patterns include expansile and infiltrative"
                    ]
                  },
                  {
                    "text": "Microscopic features characteristic of MSI-H CRCMucinous, medullary, poorly differentiated, and signet ring cell phenotypesIntratumoral morphologic heterogeneity (mixed phenotypes)Abundant tumor-infiltrating lymphocytesCrohn-like peritumoral lymphoid aggregates",
                    "sub_points": [
                      "Mucinous, medullary, poorly differentiated, and signet ring cell phenotypes",
                      "Intratumoral morphologic heterogeneity (mixed phenotypes)",
                      "Abundant tumor-infiltrating lymphocytes",
                      "Crohn-like peritumoral lymphoid aggregates"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "MMRprotein expression in CRCImmunohistochemical stains show intact nuclear expression of MLH1, PMS2, MSH2, and MSH6 in MMR-proficient tumorsNegative staining with positive internal control (mononuclear cells and stomal cells) indicates MMR deficiencyNegative staining with negative internal control is uninterpretable (repeat IHC)Mutated or methylatedMLH1leads to loss of MLH1 and PMS2 nuclear expression, but not vice versa for mutatedPMS2MutatedMSH2leads to loss of MSH2 and MSH6 nuclear expression, but not vice versa for mutatedMSH6Lack of MLH1 expression cannot differentiate LS-associated CRC from sporadic CRCBRAFmutation analysis &/orMLH1hypermethylation testing is necessary to make this distinctionLack of MSH2, MSH6, or isolated PMS2 expression is usually associated with LS-associated CRCGenetic counseling with targeted germline mutation testing is indicated~ 30-60% of patients with loss of MSH2 expression may have biallelic somatic mutations (not LS)False-positive loss of MSH6 expression can occur in neoadjuvant-treated CRCRepeat IHC on pretreatment diagnostic biopsy",
                    "sub_points": [
                      "Immunohistochemical stains show intact nuclear expression of MLH1, PMS2, MSH2, and MSH6 in MMR-proficient tumors",
                      "Negative staining with positive internal control (mononuclear cells and stomal cells) indicates MMR deficiency",
                      "Negative staining with negative internal control is uninterpretable (repeat IHC)Mutated or methylatedMLH1leads to loss of MLH1 and PMS2 nuclear expression, but not vice versa for mutatedPMS2MutatedMSH2leads to loss of MSH2 and MSH6 nuclear expression, but not vice versa for mutatedMSH6",
                      "Mutated or methylatedMLH1leads to loss of MLH1 and PMS2 nuclear expression, but not vice versa for mutatedPMS2",
                      "MutatedMSH2leads to loss of MSH2 and MSH6 nuclear expression, but not vice versa for mutatedMSH6",
                      "Lack of MLH1 expression cannot differentiate LS-associated CRC from sporadic CRCBRAFmutation analysis &/orMLH1hypermethylation testing is necessary to make this distinction",
                      "BRAFmutation analysis &/orMLH1hypermethylation testing is necessary to make this distinction",
                      "Lack of MSH2, MSH6, or isolated PMS2 expression is usually associated with LS-associated CRCGenetic counseling with targeted germline mutation testing is indicated~ 30-60% of patients with loss of MSH2 expression may have biallelic somatic mutations (not LS)",
                      "Genetic counseling with targeted germline mutation testing is indicated",
                      "~ 30-60% of patients with loss of MSH2 expression may have biallelic somatic mutations (not LS)",
                      "False-positive loss of MSH6 expression can occur in neoadjuvant-treated CRCRepeat IHC on pretreatment diagnostic biopsy",
                      "Repeat IHC on pretreatment diagnostic biopsy"
                    ]
                  },
                  {
                    "text": "MMRprotein expression in adenomasLost MMR proteins can identify potential LS patientsIntact MMR proteins cannot be used to exclude LS in an individual patientSome LS derived adenomas will not have acquired the 2nd-hit somatic mutation and will thus show intact MMR protein expression",
                    "sub_points": [
                      "Lost MMR proteins can identify potential LS patients",
                      "Intact MMR proteins cannot be used to exclude LS in an individual patientSome LS derived adenomas will not have acquired the 2nd-hit somatic mutation and will thus show intact MMR protein expression",
                      "Some LS derived adenomas will not have acquired the 2nd-hit somatic mutation and will thus show intact MMR protein expression"
                    ]
                  },
                  {
                    "text": "BRAFV600E mutation-specific antibodyAlternative to molecular testing, with good sensitivity and specificityCannot detect other variant mutations in codon 600",
                    "sub_points": [
                      "Alternative to molecular testing, with good sensitivity and specificity",
                      "Cannot detect other variant mutations in codon 600"
                    ]
                  },
                  {
                    "text": "EGFRIHC can demonstrate EGFR overexpression but does not predict response to anti-EGFR therapyNot useful in clinical practice",
                    "sub_points": [
                      "IHC can demonstrate EGFR overexpression but does not predict response to anti-EGFR therapy",
                      "Not useful in clinical practice"
                    ]
                  },
                  {
                    "text": "PTENLoss of PTEN protein expression may predict lack of response to anti-EGFR therapy in metastaticKRASwild-type tumorsNo recommendations at this time for routine analysis of PTEN protein expression",
                    "sub_points": [
                      "Loss of PTEN protein expression may predict lack of response to anti-EGFR therapy in metastaticKRASwild-type tumors",
                      "No recommendations at this time for routine analysis of PTEN protein expression"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Metastatic Carcinomas": [
                  {
                    "text": "May be confused with primary CRC"
                  },
                  {
                    "text": "Lack or only weakly express CRC markers such as CK20, CDX2, and SATB2"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "LS Screening Recommendations": [
                  {
                    "text": "Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group recommends screening all patients with newly diagnosed CRCRevised Bethesda criteria may miss up to 25% of LS patientsMSI PCR has an 80-90% sensitivity for identifying LSMMR IHC has an 85% sensitivity for identifying LSNear 100% sensitivity for combined MSI PCR and MMR IHC testingMLH1promoter hypermethylation testing &/orBRAFmutation analysis help to differentiate possible LS from sporadic MSI-H CRCGenetic counseling is crucial in all suspected LS cases",
                    "sub_points": [
                      "Revised Bethesda criteria may miss up to 25% of LS patients",
                      "MSI PCR has an 80-90% sensitivity for identifying LS",
                      "MMR IHC has an 85% sensitivity for identifying LS",
                      "Near 100% sensitivity for combined MSI PCR and MMR IHC testing",
                      "MLH1promoter hypermethylation testing &/orBRAFmutation analysis help to differentiate possible LS from sporadic MSI-H CRC",
                      "Genetic counseling is crucial in all suspected LS cases"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Colorectal Adenocarcinoma": {
            "name": "Colorectal Adenocarcinoma",
            "url": "https://app.pathprimer.com/document/a876a2f8-f86b-42df-9ad6-f75263b086a1/lesson/77119f90-6e7d-4033-ab21-1264e916bcec",
            "content": {
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Colorectal cancer (CRC)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Colorectal carcinoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Adenocarcinoma arising in colon or rectum"
                  },
                  {
                    "text": "Must be present in submucosa to diagnose invasive carcinoma"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "High-fat, low-fiber diet linked to increased risk, though not straightforwardStudies have failed to show decreased risk with increased dietary fiberRole of red meat controversial; depends on population studied and method of cookingHotter cooking temperature = higher risk",
                    "sub_points": [
                      "Studies have failed to show decreased risk with increased dietary fiber",
                      "Role of red meat controversial; depends on population studied and method of cookingHotter cooking temperature = higher risk",
                      "Hotter cooking temperature = higher risk"
                    ]
                  },
                  {
                    "text": "Cigarette smoking increases risk and worsens outcomeStrongest association with sporadic microsatellite unstable carcinomas/serrated pathway in older women",
                    "sub_points": [
                      "Strongest association with sporadic microsatellite unstable carcinomas/serrated pathway in older women"
                    ]
                  },
                  {
                    "text": "NSAIDs and calcium associated with lower risk of CRC"
                  }
                ],
                "Other Risk Factors/Syndromes": [
                  {
                    "text": "Familial adenomatous polyposis (FAP)Gardner syndromeTurcot syndrome",
                    "sub_points": [
                      "Gardner syndrome",
                      "Turcot syndrome"
                    ]
                  },
                  {
                    "text": "Lynch syndrome, a.k.a. hereditary nonpolyposis colorectal cancer syndrome (HNPCC)"
                  },
                  {
                    "text": "MYH polyposis"
                  },
                  {
                    "text": "Polymerase proofreading-associated polyposisGermline mutations in DNA polymerase ε and DNA polymerase δ",
                    "sub_points": [
                      "Germline mutations in DNA polymerase ε and DNA polymerase δ"
                    ]
                  },
                  {
                    "text": "Juvenile polyposis"
                  },
                  {
                    "text": "Peutz-Jeghers syndrome"
                  },
                  {
                    "text": "Chronic inflammatory bowel diseaseRisk increases after 8-10 years duration of colitis",
                    "sub_points": [
                      "Risk increases after 8-10 years duration of colitis"
                    ]
                  },
                  {
                    "text": "Previous radiation therapy"
                  },
                  {
                    "text": "Schistosomiasis"
                  }
                ],
                "Molecular Genetics": [
                  {
                    "text": "Majority of CRCs have eitherKRASorBRAFmutation (mutually exclusive)"
                  },
                  {
                    "text": "CpG island methylation is also an important pathway in CRC development, usually associated withBRAFmutation (CIMP high)"
                  },
                  {
                    "text": "85-88% of CRCs are microsatellite stable (MSS) tumors, many arise via mutations in Wnt signaling pathwayAdenoma-carcinoma sequenceProcess takes ~ 10 years, hence current time intervals used for surveillance colonoscopy",
                    "sub_points": [
                      "Adenoma-carcinoma sequenceProcess takes ~ 10 years, hence current time intervals used for surveillance colonoscopy",
                      "Process takes ~ 10 years, hence current time intervals used for surveillance colonoscopy"
                    ]
                  },
                  {
                    "text": "12-15% of CRCs are microsatellite unstable (MSI-H) tumors that arise due to errors in DNA mismatch repairSerrated pathway: Sessile serrated adenomas give rise to sporadic MSI-H cancersMethylation of MLH1 key molecular eventOften haveBRAFmutationCpG island methylator phenotype (CIMP) high",
                    "sub_points": [
                      "Serrated pathway: Sessile serrated adenomas give rise to sporadic MSI-H cancersMethylation of MLH1 key molecular eventOften haveBRAFmutationCpG island methylator phenotype (CIMP) high",
                      "Methylation of MLH1 key molecular event",
                      "Often haveBRAFmutation",
                      "CpG island methylator phenotype (CIMP) high"
                    ]
                  },
                  {
                    "text": "10% of MSI-H tumors arise via germline mutations in mismatch repair genes (Lynch syndrome/HNPCC)Appear to arise from adenomas (rather than serrated lesions)Lynch tumors are thought to arise much faster than MSS tumors; hence yearly surveillance needed",
                    "sub_points": [
                      "Appear to arise from adenomas (rather than serrated lesions)",
                      "Lynch tumors are thought to arise much faster than MSS tumors; hence yearly surveillance needed"
                    ]
                  },
                  {
                    "text": "MSI-H tumors have better prognosis than MSS tumors (stage for stage)This is in part due to prominent host response found in most MSI-H tumors",
                    "sub_points": [
                      "This is in part due to prominent host response found in most MSI-H tumors"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Incidence150,000-160,000 new cases per year in USA3rd leading cause of cancer death in USA20x difference in incidence between high-risk areas (Europe, Americas, Australia) and low-risk regions (Asia, Africa)",
                    "sub_points": [
                      "150,000-160,000 new cases per year in USA",
                      "3rd leading cause of cancer death in USA",
                      "20x difference in incidence between high-risk areas (Europe, Americas, Australia) and low-risk regions (Asia, Africa)"
                    ]
                  },
                  {
                    "text": "AgeIncidence increases with age1-2% of patients with CRC are under 40 years old, often have IBD or genetic syndromeMost patients are middle-aged or elderlyIn low-risk countries, age of onset is younger and tumors are more aggressive",
                    "sub_points": [
                      "Incidence increases with age1-2% of patients with CRC are under 40 years old, often have IBD or genetic syndromeMost patients are middle-aged or elderlyIn low-risk countries, age of onset is younger and tumors are more aggressive",
                      "1-2% of patients with CRC are under 40 years old, often have IBD or genetic syndrome",
                      "Most patients are middle-aged or elderly",
                      "In low-risk countries, age of onset is younger and tumors are more aggressive"
                    ]
                  },
                  {
                    "text": "SexMale predominance (M:F is not quite 2:1)",
                    "sub_points": [
                      "Male predominance (M:F is not quite 2:1)"
                    ]
                  },
                  {
                    "text": "EthnicityIn USA, highest incidence in African Americans, lowest in Hispanics and Native Americans",
                    "sub_points": [
                      "In USA, highest incidence in African Americans, lowest in Hispanics and Native Americans"
                    ]
                  }
                ],
                "Site": [
                  {
                    "text": "Shift over time to more right-sided tumors and to younger age of onset"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Anemia"
                  },
                  {
                    "text": "Constipation"
                  },
                  {
                    "text": "Diarrhea"
                  },
                  {
                    "text": "Hematochezia"
                  },
                  {
                    "text": "Weight loss"
                  }
                ],
                "Endoscopic Findings": [
                  {
                    "text": "Classically seen as mass lesion with raised edges and central ulceration"
                  },
                  {
                    "text": "Right-sided lesions may be missed on colonoscopy"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "CEA elevated in serum of patients with metastatic diseaseFollow levels over time to gauge treatment efficacy",
                    "sub_points": [
                      "Follow levels over time to gauge treatment efficacy"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical approachesSurgical resection is typically first-line treatmentLow-stage rectal tumors may be amenable to local excisionPatients with high-stage rectal tumors typically have chemoradiation prior to surgeryIsolated liver and lung metastasis often resected, may have > 5-year survival",
                    "sub_points": [
                      "Surgical resection is typically first-line treatmentLow-stage rectal tumors may be amenable to local excisionPatients with high-stage rectal tumors typically have chemoradiation prior to surgery",
                      "Low-stage rectal tumors may be amenable to local excision",
                      "Patients with high-stage rectal tumors typically have chemoradiation prior to surgery",
                      "Isolated liver and lung metastasis often resected, may have > 5-year survival"
                    ]
                  },
                  {
                    "text": "Adjuvant therapyFluorouracil (5-FU)-based chemotherapy is standardNode (-) tumors don't require chemotherapyT3 and T4 node (-) tumors may benefit from adjuvant chemo; individualized based on riskEvidence mounting that 5-FU is not effective (and is perhaps harmful) in MSI-H tumorsIrinotecan or oxaliplatin added for advanced diseaseIf 5-FU-based therapy fails, cetuximab and panitumumab (anti-EGFR) have both shown some efficacyCetuximab and panitumumab only given to patients with wild typeKRAS(ineffective if tumor hasKRASmutation)Growing evidence thatBRAF,NRAS,andPIK3CAmutations also render anti-EGFR ineffectiveHepatic artery infusion pump used to deliver chemo to liver lesions directlyAvoids systemic toxicityPD-1/PD-L1 checkpoint blockade has shown promise in treating metastatic MSI-H tumors",
                    "sub_points": [
                      "Fluorouracil (5-FU)-based chemotherapy is standardNode (-) tumors don't require chemotherapyT3 and T4 node (-) tumors may benefit from adjuvant chemo; individualized based on riskEvidence mounting that 5-FU is not effective (and is perhaps harmful) in MSI-H tumors",
                      "Node (-) tumors don't require chemotherapy",
                      "T3 and T4 node (-) tumors may benefit from adjuvant chemo; individualized based on risk",
                      "Evidence mounting that 5-FU is not effective (and is perhaps harmful) in MSI-H tumors",
                      "Irinotecan or oxaliplatin added for advanced disease",
                      "If 5-FU-based therapy fails, cetuximab and panitumumab (anti-EGFR) have both shown some efficacyCetuximab and panitumumab only given to patients with wild typeKRAS(ineffective if tumor hasKRASmutation)Growing evidence thatBRAF,NRAS,andPIK3CAmutations also render anti-EGFR ineffective",
                      "Cetuximab and panitumumab only given to patients with wild typeKRAS(ineffective if tumor hasKRASmutation)Growing evidence thatBRAF,NRAS,andPIK3CAmutations also render anti-EGFR ineffective",
                      "Growing evidence thatBRAF,NRAS,andPIK3CAmutations also render anti-EGFR ineffective",
                      "Hepatic artery infusion pump used to deliver chemo to liver lesions directlyAvoids systemic toxicity",
                      "Avoids systemic toxicity",
                      "PD-1/PD-L1 checkpoint blockade has shown promise in treating metastatic MSI-H tumors"
                    ]
                  },
                  {
                    "text": "RadiationOften used in combination with chemotherapy for advanced diseaseUsed preoperatively in rectal cancers to downstage tumor",
                    "sub_points": [
                      "Often used in combination with chemotherapy for advanced diseaseUsed preoperatively in rectal cancers to downstage tumor",
                      "Used preoperatively in rectal cancers to downstage tumor"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends largely on depth of invasion and lymph node status"
                  },
                  {
                    "text": "Other markers of poorer prognosis includeLack of host response to tumor (Crohn-like reaction)Infiltrative growth pattern/tumor buddingVascular invasionPerineural invasionColonic perforationMicrosatellite stable tumors as compared to unstable tumorsStable tumors that are CIMP high and haveBRAFmutations have the lowest survival",
                    "sub_points": [
                      "Lack of host response to tumor (Crohn-like reaction)",
                      "Infiltrative growth pattern/tumor budding",
                      "Vascular invasion",
                      "Perineural invasion",
                      "Colonic perforation",
                      "Microsatellite stable tumors as compared to unstable tumorsStable tumors that are CIMP high and haveBRAFmutations have the lowest survival",
                      "Stable tumors that are CIMP high and haveBRAFmutations have the lowest survival"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Typically has raised edge with ulcerated center"
                  },
                  {
                    "text": "Sporadic MSI-H tumors tend to be large bulky right-sided lesionsMore common in older women",
                    "sub_points": [
                      "More common in older women"
                    ]
                  }
                ],
                "Sections to be Submitted": [
                  {
                    "text": "Multiple sections of tumor to assess deepest point of invasion and tumor characteristics at advancing edgeExtensive dissection of pericolic fat to identify all lymph nodes is criticalFat clearing techniques can greatly increase yield of nodes found",
                    "sub_points": [
                      "Extensive dissection of pericolic fat to identify all lymph nodes is criticalFat clearing techniques can greatly increase yield of nodes found",
                      "Fat clearing techniques can greatly increase yield of nodes found"
                    ]
                  },
                  {
                    "text": "For rectal resections, assessment of radial margin is criticalIf post therapy, may need numerous sections to identify residual carcinoma",
                    "sub_points": [
                      "If post therapy, may need numerous sections to identify residual carcinoma"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Presence of desmoplasia on biopsy specimen indicative of invasive carcinomaStroma pushing apart dysplastic glands is helpful in making diagnosis",
                    "sub_points": [
                      "Stroma pushing apart dysplastic glands is helpful in making diagnosis"
                    ]
                  },
                  {
                    "text": "Histology of MSI-H tumorsWell or poorly differentiatedMucinous or focally mucinousSignet ring cellCircumscribed growth patternCrohn-like reactionProminent tumor infiltrating lymphocytes (> 2/HPF), single best morphologic predictor of MSI-HLack of dirty necrosis (may be focal)Histologic heterogeneitySerrated precursor lesion (in sporadic setting)More often right sided",
                    "sub_points": [
                      "Well or poorly differentiated",
                      "Mucinous or focally mucinous",
                      "Signet ring cell",
                      "Circumscribed growth pattern",
                      "Crohn-like reaction",
                      "Prominent tumor infiltrating lymphocytes (> 2/HPF), single best morphologic predictor of MSI-H",
                      "Lack of dirty necrosis (may be focal)",
                      "Histologic heterogeneity",
                      "Serrated precursor lesion (in sporadic setting)",
                      "More often right sided"
                    ]
                  },
                  {
                    "text": "Histology of MSS tumorsLack of tumor infiltrating lymphocytes and Crohn-like reactionPresence of abundant dirty necrosisInfiltrative growth pattern/tumor buddingModerately differentiated",
                    "sub_points": [
                      "Lack of tumor infiltrating lymphocytes and Crohn-like reaction",
                      "Presence of abundant dirty necrosis",
                      "Infiltrative growth pattern/tumor budding",
                      "Moderately differentiated"
                    ]
                  }
                ],
                "Predominant Pattern/Injury Type": [
                  {
                    "text": "Neoplastic"
                  }
                ],
                "Predominant Cell/Compartment Type": [
                  {
                    "text": "Epithelial, glandular"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Immunohistochemical stains for the 4 mismatch repair proteins are now done fairly routinely on all newly diagnosed CRCs to screen for Lynch syndrome"
                  }
                ],
                "PCR": [
                  {
                    "text": "General commentsMicrosatellite instability testingSome centers test all CRCsSome centers only test tumors in patients younger than 50Some centers test tumors that have histologic features suggestive of MSI-HGruber Labs (University of Michigan Health System) website can help predict likelihood of MSI-H based on histology: http://sitemaker.umich.edu/gruber.lab/files/msi_pre.htmMSI testing is often combined with immunohistochemistry for mismatch repair proteins to screen for Lynch syndrome",
                    "sub_points": [
                      "Microsatellite instability testingSome centers test all CRCsSome centers only test tumors in patients younger than 50Some centers test tumors that have histologic features suggestive of MSI-HGruber Labs (University of Michigan Health System) website can help predict likelihood of MSI-H based on histology: http://sitemaker.umich.edu/gruber.lab/files/msi_pre.htmMSI testing is often combined with immunohistochemistry for mismatch repair proteins to screen for Lynch syndrome",
                      "Some centers test all CRCs",
                      "Some centers only test tumors in patients younger than 50",
                      "Some centers test tumors that have histologic features suggestive of MSI-HGruber Labs (University of Michigan Health System) website can help predict likelihood of MSI-H based on histology: http://sitemaker.umich.edu/gruber.lab/files/msi_pre.htm",
                      "Gruber Labs (University of Michigan Health System) website can help predict likelihood of MSI-H based on histology: http://sitemaker.umich.edu/gruber.lab/files/msi_pre.htm",
                      "MSI testing is often combined with immunohistochemistry for mismatch repair proteins to screen for Lynch syndrome"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Adenoma With Pseudoinvasion": [
                  {
                    "text": "Presence of lamina propria-like inflammation surrounding dysplastic glands within polyp stalk = pseudoinvasion"
                  },
                  {
                    "text": "Hemosiderin-laden macrophages more often in pseudoinvasion"
                  },
                  {
                    "text": "Prolapse-type changes with smooth muscle proliferation rather than true desmoplasia = pseudoinvasion"
                  },
                  {
                    "text": "Grade of dysplasia of polyp matches grade of dysplasia within stalk polyp = pseudoinvasion"
                  },
                  {
                    "text": "Be wary of diagnosing pseudoinvasion in right-sided polyps; this is usually true invasion"
                  }
                ],
                "Metastatic Adenocarcinoma": [
                  {
                    "text": "Lack of adenoma at edge of tumorNot always helpful as tumor may overgrow preexisting adenoma",
                    "sub_points": [
                      "Not always helpful as tumor may overgrow preexisting adenoma"
                    ]
                  },
                  {
                    "text": "Immunostains for CK7, CK20, and CDX-2 may be helpful"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Invasive pattern"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Presence of desmoplasia key for diagnosis in biopsy/polypectomy specimens"
                  }
                ]
              },
              "GRADING": {
                "Low Grade": [
                  {
                    "text": "Well differentiatedComplex or simple tubules, uniform nuclei that maintain polarity",
                    "sub_points": [
                      "Complex or simple tubules, uniform nuclei that maintain polarity"
                    ]
                  }
                ],
                "Intermediate Grade": [
                  {
                    "text": "Moderately differentiatedDecrease in or loss of nuclear polarity, more irregular tubules",
                    "sub_points": [
                      "Decrease in or loss of nuclear polarity, more irregular tubules"
                    ]
                  }
                ],
                "High Grade": [
                  {
                    "text": "Poorly differentiatedHighly irregular glands or absent glands, loss of nuclear polarity",
                    "sub_points": [
                      "Highly irregular glands or absent glands, loss of nuclear polarity"
                    ]
                  }
                ],
                "Importance of Grading": [
                  {
                    "text": "Vast majority of tumors are moderately differentiated approximately 70%"
                  },
                  {
                    "text": "Probably not as important as MSI status"
                  }
                ]
              },
              "REPORTING": {
                "Key Elements to Report": [
                  {
                    "text": "Depth of invasion"
                  },
                  {
                    "text": "Number of positive lymph nodesTry to distinguish extranodal tumor deposits in mesenteric fat from totally replaced lymph nodes (N1c)Presence of capsule and some lymphoid tissue with germinal centers can be helpful, but sometimes this is very difficult",
                    "sub_points": [
                      "Try to distinguish extranodal tumor deposits in mesenteric fat from totally replaced lymph nodes (N1c)Presence of capsule and some lymphoid tissue with germinal centers can be helpful, but sometimes this is very difficult",
                      "Presence of capsule and some lymphoid tissue with germinal centers can be helpful, but sometimes this is very difficult"
                    ]
                  },
                  {
                    "text": "Presence of angiolymphatic invasionExtramural venous invasionIrregularly contoured tumor deposits in mesenteric fatV1 = microscopic evidence of venous invasionV2 = gross evidence of venous invasion",
                    "sub_points": [
                      "Extramural venous invasionIrregularly contoured tumor deposits in mesenteric fatV1 = microscopic evidence of venous invasionV2 = gross evidence of venous invasion",
                      "Irregularly contoured tumor deposits in mesenteric fat",
                      "V1 = microscopic evidence of venous invasion",
                      "V2 = gross evidence of venous invasion"
                    ]
                  },
                  {
                    "text": "Status of proximal and distal marginsRadial margin status in rectal cancers",
                    "sub_points": [
                      "Radial margin status in rectal cancers"
                    ]
                  },
                  {
                    "text": "Host responseCrohn-like reactionTumor infiltrating lymphocytes",
                    "sub_points": [
                      "Crohn-like reaction",
                      "Tumor infiltrating lymphocytes"
                    ]
                  },
                  {
                    "text": "Growth pattern of tumorTumor budding or infiltrative growth vs. circumscribed growth",
                    "sub_points": [
                      "Tumor budding or infiltrative growth vs. circumscribed growth"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Familial Cancer Syndromes in Colorectal Carcinoma": {
            "name": "Familial Cancer Syndromes in Colorectal Carcinoma",
            "url": "https://app.pathprimer.com/document/022be60f-af14-4583-b1db-19311b43083d/lesson/77119f90-6e7d-4033-ab21-1264e916bcec",
            "content": {
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Familial adenomatous polyposis (FAP)"
                  },
                  {
                    "text": "Hereditary nonpolyposis colorectal cancer (HNPCC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Familial cancer syndromes = germline mutations associated with increased incidence of specific cancer typesMany syndromes are related to more than 1 cancer type",
                    "sub_points": [
                      "Many syndromes are related to more than 1 cancer type"
                    ]
                  },
                  {
                    "text": "Mismatch repair genes = genes that promote genomic stability by initiating DNA repair at time of mitosis"
                  },
                  {
                    "text": "Microsatellites = short DNA repeats in introns that can be detected as stable or unstable as way of predicting mismatch repair of DNA"
                  }
                ]
              },
              "Syndromes": {
                "FAP": [
                  {
                    "text": "Autosomal dominantGermline mutation inAPC1/3 at codon 1061-1309Severe polyposis has mutations at codons 1250-1464Attenuated polyposis has mutations at 5' and 3' ends of geneDesmoid tumors associate with mutations at codons 1403-1578APCI1307K makes somatic mutations more likely",
                    "sub_points": [
                      "Germline mutation inAPC1/3 at codon 1061-1309Severe polyposis has mutations at codons 1250-1464Attenuated polyposis has mutations at 5' and 3' ends of geneDesmoid tumors associate with mutations at codons 1403-1578APCI1307K makes somatic mutations more likely",
                      "1/3 at codon 1061-1309",
                      "Severe polyposis has mutations at codons 1250-1464",
                      "Attenuated polyposis has mutations at 5' and 3' ends of gene",
                      "Desmoid tumors associate with mutations at codons 1403-1578",
                      "APCI1307K makes somatic mutations more likely"
                    ]
                  },
                  {
                    "text": "Incidence: 1 in 5,000"
                  },
                  {
                    "text": "Hundreds of adenomas in childhood or adolescence"
                  },
                  {
                    "text": "Associated with other tumor formationGardner syndromeOsteomas of jaw, epidermoid cysts, thyroid carcinomas, and desmoid tumorsTurcot syndromeMedulloblastomaPeriampullary carcinomaDesmoid tumorsFundic gland polyps (often with dysplasia)",
                    "sub_points": [
                      "Gardner syndromeOsteomas of jaw, epidermoid cysts, thyroid carcinomas, and desmoid tumors",
                      "Osteomas of jaw, epidermoid cysts, thyroid carcinomas, and desmoid tumors",
                      "Turcot syndromeMedulloblastoma",
                      "Medulloblastoma",
                      "Periampullary carcinoma",
                      "Desmoid tumors",
                      "Fundic gland polyps (often with dysplasia)"
                    ]
                  }
                ],
                "MYH-Associated Polyposis": [
                  {
                    "text": "Autosomal recessive"
                  },
                  {
                    "text": "Biallelic inactivation ofMUTYHgeneNormally this enzyme repairs oxidative damage to guanineFailure of enzyme leads to multiple G-C to T-A transversions in DNA2 common sites of mutation in gene associated with most casesImmunostain for gene product is now commercially availableLack of nuclear staining may be potential screening test; needs to be validatedIncidence: 1 in 5,000Clinically and pathologically looks identical to attenuated FAP",
                    "sub_points": [
                      "Normally this enzyme repairs oxidative damage to guanine",
                      "Failure of enzyme leads to multiple G-C to T-A transversions in DNA",
                      "2 common sites of mutation in gene associated with most cases",
                      "Immunostain for gene product is now commercially availableLack of nuclear staining may be potential screening test; needs to be validated",
                      "Lack of nuclear staining may be potential screening test; needs to be validated",
                      "Incidence: 1 in 5,000",
                      "Clinically and pathologically looks identical to attenuated FAP"
                    ]
                  }
                ],
                "Lynch Syndrome (HNPCC)": [
                  {
                    "text": "Autosomal dominant"
                  },
                  {
                    "text": "Germline mutation in DNA mismatch repair genes (MSH2,MLH1,MSH6,PMS2)Biallelic mutations lead to multiple cancers at young agesDetected by sequelae of mismatch repair; instability in short DNA repeats called microsatellites (MS) in introns2 of 5 MS regions must be unstable for positive diagnosisImmunohistochemistry for products ofMLH1,MSH2,MSH6,andPMS2can also be performedSpecific gene testing may be indicated if either of these tests is positive",
                    "sub_points": [
                      "Biallelic mutations lead to multiple cancers at young ages",
                      "Detected by sequelae of mismatch repair; instability in short DNA repeats called microsatellites (MS) in introns2 of 5 MS regions must be unstable for positive diagnosis",
                      "2 of 5 MS regions must be unstable for positive diagnosis",
                      "Immunohistochemistry for products ofMLH1,MSH2,MSH6,andPMS2can also be performed",
                      "Specific gene testing may be indicated if either of these tests is positive"
                    ]
                  },
                  {
                    "text": "Incidence: 1 in 1,000"
                  },
                  {
                    "text": "2-4% of all colorectal carcinomaLifetime risk of colon cancer is up to 80%Endometrial cancer: 55% lifetime riskOvarian cancer: 15% lifetime riskSmall bowel and biliary tract carcinomasTransitional cell carcinomas of renal pelvis and ureterGliomasSebaceous neoplasms and keratoacanthomas = Muir-Torre syndromeAdrenal cortical carcinomaA subset of adenocarcinomas of the prostate",
                    "sub_points": [
                      "Lifetime risk of colon cancer is up to 80%Endometrial cancer: 55% lifetime riskOvarian cancer: 15% lifetime riskSmall bowel and biliary tract carcinomasTransitional cell carcinomas of renal pelvis and ureterGliomasSebaceous neoplasms and keratoacanthomas = Muir-Torre syndromeAdrenal cortical carcinomaA subset of adenocarcinomas of the prostate",
                      "Endometrial cancer: 55% lifetime risk",
                      "Ovarian cancer: 15% lifetime risk",
                      "Small bowel and biliary tract carcinomas",
                      "Transitional cell carcinomas of renal pelvis and ureter",
                      "Gliomas",
                      "Sebaceous neoplasms and keratoacanthomas = Muir-Torre syndrome",
                      "Adrenal cortical carcinoma",
                      "A subset of adenocarcinomas of the prostate"
                    ]
                  },
                  {
                    "text": "Familial colorectal cancer type X is closely related syndromePatients have appropriate family history without MSI-H tumorsAs common as HNPCCTreated and screened like HNPCC",
                    "sub_points": [
                      "Patients have appropriate family history without MSI-H tumors",
                      "As common as HNPCC",
                      "Treated and screened like HNPCC"
                    ]
                  },
                  {
                    "text": "Lynch-like syndrome patients have all features of Lynch but no identifiable mutations"
                  }
                ],
                "Hereditary Mixed Polyposis": [
                  {
                    "text": "Autosomal dominantMutation ofGREM1geneIncidence unknown",
                    "sub_points": [
                      "Mutation ofGREM1gene",
                      "Incidence unknown"
                    ]
                  },
                  {
                    "text": "Mixture of adenomas, serrated polyps, mixed polyps, and atypical juvenile polyps"
                  },
                  {
                    "text": "Risk of tumors outside colon not documented"
                  }
                ],
                "Serrated (Giant Hyperplastic) Polyposis Syndrome": [
                  {
                    "text": "Genetic basis currently unknown"
                  },
                  {
                    "text": "Incidence: 1 in 100,000"
                  },
                  {
                    "text": "Initially described as giant hyperplastic polyps, they are now known to be sessile serrated adenomas> 4 proximal serrated polyps of which 2 are > 1 cm or at least 20 pancolonic serrated polypsMany have adenomas as wellUltimately this may prove to be several different syndromes with different genetic loci",
                    "sub_points": [
                      "> 4 proximal serrated polyps of which 2 are > 1 cm or at least 20 pancolonic serrated polyps",
                      "Many have adenomas as well",
                      "Ultimately this may prove to be several different syndromes with different genetic loci"
                    ]
                  },
                  {
                    "text": "Risk of tumors outside colon not documented"
                  }
                ],
                "Peutz-Jeghers Syndrome": [
                  {
                    "text": "Autosomal dominantMutations inSTK11gene (a.k.a.LKB1), which encodes serine/threonine kinase",
                    "sub_points": [
                      "Mutations inSTK11gene (a.k.a.LKB1), which encodes serine/threonine kinase"
                    ]
                  },
                  {
                    "text": "Incidence: 1 in 8,300-120,000"
                  },
                  {
                    "text": "Multiple hamartomatous polyps throughout GI tractPolyps have characteristic bundles of arborizing smooth muscleMuscularis mucosae appears hyperplasticMimics mucosal prolapseMucocutaneous pigmentationFreckles on lips, oral and anal mucosaIncreased risk of cancer throughout GI tract, pancreas, ovary, and breast",
                    "sub_points": [
                      "Polyps have characteristic bundles of arborizing smooth muscleMuscularis mucosae appears hyperplasticMimics mucosal prolapse",
                      "Muscularis mucosae appears hyperplastic",
                      "Mimics mucosal prolapse",
                      "Mucocutaneous pigmentationFreckles on lips, oral and anal mucosa",
                      "Freckles on lips, oral and anal mucosa",
                      "Increased risk of cancer throughout GI tract, pancreas, ovary, and breast"
                    ]
                  }
                ],
                "Juvenile Polyposis": [
                  {
                    "text": "Autosomal dominantMutation ofSMAD4gene in 30% of cases andBMPR1Agene in 30% of cases",
                    "sub_points": [
                      "Mutation ofSMAD4gene in 30% of cases andBMPR1Agene in 30% of cases"
                    ]
                  },
                  {
                    "text": "Incidence: 1 in 100,000"
                  },
                  {
                    "text": "Multiple hamartomatous polyps (need > 5 unless positive family history)Confined to colon in some patients/familiesInvolves entire GI tract in some patients/familiesPolyps identical to inflammatory pseudopolyps, especially when smallLarger polyps have dilated cysts characteristic of juvenile polypsPolyps can develop dysplasia/carcinoma",
                    "sub_points": [
                      "Confined to colon in some patients/families",
                      "Involves entire GI tract in some patients/families",
                      "Polyps identical to inflammatory pseudopolyps, especially when smallLarger polyps have dilated cysts characteristic of juvenile polyps",
                      "Larger polyps have dilated cysts characteristic of juvenile polyps",
                      "Polyps can develop dysplasia/carcinoma"
                    ]
                  },
                  {
                    "text": "Increased risk of cancer in stomach, small bowel, and pancreas"
                  }
                ],
                "PTEN Hamartoma Syndrome (Cowden/Bannayan-Riley-Ruvalcaba)": [
                  {
                    "text": "Autosomal dominantMutation inPTENgene",
                    "sub_points": [
                      "Mutation inPTENgene"
                    ]
                  },
                  {
                    "text": "Incidence: 1 in 200,000"
                  },
                  {
                    "text": "Multiple hamartomatous polyps throughout GI tract"
                  },
                  {
                    "text": "Increased risk of breast and thyroid cancers"
                  },
                  {
                    "text": "Increased risk of colon cancer is debatable (only 1 study shows increase)"
                  }
                ],
                "Li-Fraumeni Syndrome": [
                  {
                    "text": "Autosomal dominantMutation inTP53Some families have mutation inCHEK2",
                    "sub_points": [
                      "Mutation inTP53Some families have mutation inCHEK2",
                      "Some families have mutation inCHEK2"
                    ]
                  },
                  {
                    "text": "Incidence: 1 in 500,000"
                  },
                  {
                    "text": "Increased risk of soft tissue sarcomas, melanomas, leukemias, brain tumors, and carcinomas of breast, colon, pancreas, and adrenal cortexUncertain if risk of stomach and lung cancer is increased",
                    "sub_points": [
                      "Uncertain if risk of stomach and lung cancer is increased"
                    ]
                  }
                ],
                "DNA Polymerase ε and δ Polyposis": [
                  {
                    "text": "Increased risk of colon and endometrial cancers"
                  },
                  {
                    "text": "Mutations in proof reading polymerases lead to transversions in DNA"
                  },
                  {
                    "text": "Autosomal dominant inheritance with microsatellite stable tumors"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer Syndrome)": {
            "name": "Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer Syndrome)",
            "url": "https://app.pathprimer.com/document/bfb3142d-dadf-48c8-bd8e-14f31ec14392/lesson/77119f90-6e7d-4033-ab21-1264e916bcec",
            "content": {
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Hereditary nonpolyposis colorectal cancer syndrome (HNPCC)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Hereditary nonpolyposis colorectal cancer syndrome"
                  },
                  {
                    "text": "Muir-Torre syndromeSubset of HNPCC patients who also have skin tumorsSebaceous neoplasmsKeratoacanthomas",
                    "sub_points": [
                      "Subset of HNPCC patients who also have skin tumorsSebaceous neoplasmsKeratoacanthomas",
                      "Sebaceous neoplasms",
                      "Keratoacanthomas"
                    ]
                  }
                ],
                "Definitions": [
                  {
                    "text": "Germline defect in 1 or more DNA mismatch repair enzymes, which leads to neoplasiaAutosomal dominant inheritanceMutations inMLH1,MSH2,MSH6,orPMS2account for vast majority of casesSmall subset of cases is caused by mutations inEPCAM,which is gene adjacent toMSH2EPCAMmutations lead to epigenetic silencing ofMSH2",
                    "sub_points": [
                      "Autosomal dominant inheritanceMutations inMLH1,MSH2,MSH6,orPMS2account for vast majority of casesSmall subset of cases is caused by mutations inEPCAM,which is gene adjacent toMSH2EPCAMmutations lead to epigenetic silencing ofMSH2",
                      "Mutations inMLH1,MSH2,MSH6,orPMS2account for vast majority of casesSmall subset of cases is caused by mutations inEPCAM,which is gene adjacent toMSH2EPCAMmutations lead to epigenetic silencing ofMSH2",
                      "Small subset of cases is caused by mutations inEPCAM,which is gene adjacent toMSH2",
                      "EPCAMmutations lead to epigenetic silencing ofMSH2"
                    ]
                  },
                  {
                    "text": "1st described by pathologist Aldrich Warthin in 1895"
                  },
                  {
                    "text": "Constitutional mismatch repair deficiencyPatients have germline mutations in both copies of mismatch repair gene (oftenPMS2)Childhood onset of hematologic, brain, and GI tract malignanciesCafé au lait macules",
                    "sub_points": [
                      "Patients have germline mutations in both copies of mismatch repair gene (oftenPMS2)Childhood onset of hematologic, brain, and GI tract malignanciesCafé au lait macules",
                      "Childhood onset of hematologic, brain, and GI tract malignancies",
                      "Café au lait macules"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "IncidenceMost common form of heritable colon cancer2-4% of all colon cancers in USA",
                    "sub_points": [
                      "Most common form of heritable colon cancer",
                      "2-4% of all colon cancers in USA"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Amsterdam criteriaAt least 3 relatives with colorectal cancer (CRC)1 should be first-degree relative of other 2At least 2 consecutive generations involvedAt least 1 CRC before age 50Familial adenomatous polyposis (FAP) excludedTumor histology verifiedMany patients with HNPCC do not fulfill these criteriaPathologic features of tumor can help predict HNPCC in these patients> 90% of tumors are microsatellite unstable (MSI-H)",
                    "sub_points": [
                      "At least 3 relatives with colorectal cancer (CRC)1 should be first-degree relative of other 2",
                      "1 should be first-degree relative of other 2",
                      "At least 2 consecutive generations involved",
                      "At least 1 CRC before age 50",
                      "Familial adenomatous polyposis (FAP) excluded",
                      "Tumor histology verified",
                      "Many patients with HNPCC do not fulfill these criteriaPathologic features of tumor can help predict HNPCC in these patients> 90% of tumors are microsatellite unstable (MSI-H)",
                      "Pathologic features of tumor can help predict HNPCC in these patients> 90% of tumors are microsatellite unstable (MSI-H)",
                      "> 90% of tumors are microsatellite unstable (MSI-H)"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Microsatellite instability (MSI-H) testingPCR assay done on paraffin-embedded formalin-fixed tissueRequires both normal and tumor tissueMost MSI-H tumors will be sporadic due to methylation of mismatch repair genesPresence ofBRAFV600E mutation excludes Lynch syndrome in MSI-H tumorsThis can now be detected using immunohistochemistry for Braf V600EMay also test for methylation ofMLH1, as presence of methylation usually excludes Lynch syndromeNot all CRCs in HNPCC are MSI-H (90-95% are)",
                    "sub_points": [
                      "PCR assay done on paraffin-embedded formalin-fixed tissueRequires both normal and tumor tissue",
                      "Requires both normal and tumor tissue",
                      "Most MSI-H tumors will be sporadic due to methylation of mismatch repair genesPresence ofBRAFV600E mutation excludes Lynch syndrome in MSI-H tumorsThis can now be detected using immunohistochemistry for Braf V600EMay also test for methylation ofMLH1, as presence of methylation usually excludes Lynch syndrome",
                      "Presence ofBRAFV600E mutation excludes Lynch syndrome in MSI-H tumorsThis can now be detected using immunohistochemistry for Braf V600E",
                      "This can now be detected using immunohistochemistry for Braf V600E",
                      "May also test for methylation ofMLH1, as presence of methylation usually excludes Lynch syndrome",
                      "Not all CRCs in HNPCC are MSI-H (90-95% are)"
                    ]
                  },
                  {
                    "text": "Immunoperoxidase stains for mismatch repair proteinsAntibodies for 4 major mismatch repair gene proteins are commercially availableLack of staining in tumor cells indicative of deficient proteinAlways need to compare tumor to adjacent inflammatory cells to make sure the stain worked (internal positive control)In rare cases of constitutional mismatch repair deficiency, there will be no staining of nonneoplastic cells since both copies are knocked outMost of these will be due to sporadic methylation ofMLH1",
                    "sub_points": [
                      "Antibodies for 4 major mismatch repair gene proteins are commercially available",
                      "Lack of staining in tumor cells indicative of deficient proteinAlways need to compare tumor to adjacent inflammatory cells to make sure the stain worked (internal positive control)In rare cases of constitutional mismatch repair deficiency, there will be no staining of nonneoplastic cells since both copies are knocked outMost of these will be due to sporadic methylation ofMLH1",
                      "Always need to compare tumor to adjacent inflammatory cells to make sure the stain worked (internal positive control)In rare cases of constitutional mismatch repair deficiency, there will be no staining of nonneoplastic cells since both copies are knocked out",
                      "In rare cases of constitutional mismatch repair deficiency, there will be no staining of nonneoplastic cells since both copies are knocked out",
                      "Most of these will be due to sporadic methylation ofMLH1"
                    ]
                  },
                  {
                    "text": "Direct sequencing of mismatch repair genes for mutationsOnce missing protein is determined using immunostains, gene should be sequenced to identify specific mutation for family screeningIn some cases, no germline mutation will be found despite presence of MSI-H tumor with absent mismatch repair protein expressionIn these cases it appears that biallelic somatic inactivation is causeThis has been termed Lynch-like syndrome",
                    "sub_points": [
                      "Once missing protein is determined using immunostains, gene should be sequenced to identify specific mutation for family screening",
                      "In some cases, no germline mutation will be found despite presence of MSI-H tumor with absent mismatch repair protein expressionIn these cases it appears that biallelic somatic inactivation is causeThis has been termed Lynch-like syndrome",
                      "In these cases it appears that biallelic somatic inactivation is cause",
                      "This has been termed Lynch-like syndrome"
                    ]
                  },
                  {
                    "text": "No single test or combination of tests is both cost effective and sensitive/specificMost laboratories use algorithm starting with either MSI testing by PCR or immunostains",
                    "sub_points": [
                      "Most laboratories use algorithm starting with either MSI testing by PCR or immunostains"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Lifetime risk of CRC: ~ 80%Higher risk in men than womenIncreased risk of endometrial, ovarian, pancreaticobiliary, small bowel, renal pelvis, adrenal, and brain tumorsSubset of prostate cancer also appears to be related to Lynch syndrome",
                    "sub_points": [
                      "Higher risk in men than women",
                      "Increased risk of endometrial, ovarian, pancreaticobiliary, small bowel, renal pelvis, adrenal, and brain tumorsSubset of prostate cancer also appears to be related to Lynch syndrome",
                      "Subset of prostate cancer also appears to be related to Lynch syndrome"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Options, risks, complicationsPatients need annual colonoscopic surveillance or total colectomyVery few patients without cancer opt for prophylactic colectomy",
                    "sub_points": [
                      "Patients need annual colonoscopic surveillance or total colectomyVery few patients without cancer opt for prophylactic colectomy",
                      "Very few patients without cancer opt for prophylactic colectomy"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Tumors tend to be faster growing compared to sporadic CRCNewer evidence suggests that adenomas transition to invasive carcinomas faster than in sporadic cases of CRCDwell time for usual adenoma-carcinoma sequence is thought to be 10-15 years, whereas it may only be 2-3 years in Lynch syndrome",
                    "sub_points": [
                      "Newer evidence suggests that adenomas transition to invasive carcinomas faster than in sporadic cases of CRCDwell time for usual adenoma-carcinoma sequence is thought to be 10-15 years, whereas it may only be 2-3 years in Lynch syndrome",
                      "Dwell time for usual adenoma-carcinoma sequence is thought to be 10-15 years, whereas it may only be 2-3 years in Lynch syndrome"
                    ]
                  },
                  {
                    "text": "Better survival in Lynch CRCs compared to sporadic CRCsMay be in part due to prominent host response often found in these tumors",
                    "sub_points": [
                      "May be in part due to prominent host response often found in these tumors"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Hereditary nonpolyposis colorectal cancer syndrome CRCs arise from adenomasAdenomas in HNPCC have increased tumor-infiltrating lymphocytes and decreased apoptosis compared to sporadic adenomas",
                    "sub_points": [
                      "Adenomas in HNPCC have increased tumor-infiltrating lymphocytes and decreased apoptosis compared to sporadic adenomas"
                    ]
                  },
                  {
                    "text": "Most CRCs are MSI-HRight sidedIncreased tumor infiltrating lymphocytes (> 2/HPF) and Crohn-like reactionPoorly differentiated, well differentiated, or mucinous",
                    "sub_points": [
                      "Right sided",
                      "Increased tumor infiltrating lymphocytes (> 2/HPF) and Crohn-like reaction",
                      "Poorly differentiated, well differentiated, or mucinous"
                    ]
                  },
                  {
                    "text": "CRCs arising in sessile serrated adenomas may be MSI-H, but they are not due to Lynch syndrome"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Familial Adenomatous Polyposis": [
                  {
                    "text": "100s to 1,000s of adenomas"
                  },
                  {
                    "text": "Cancers that arise are generally microsatellite stable"
                  },
                  {
                    "text": "Look forAPCgene mutation"
                  }
                ],
                "MYH Polyposis": [
                  {
                    "text": "Autosomal recessive inheritance"
                  },
                  {
                    "text": "Looks like attenuated FAPFewer adenomas and older onset",
                    "sub_points": [
                      "Fewer adenomas and older onset"
                    ]
                  },
                  {
                    "text": "Genetic testing required to make diagnosisG:C to T:A transversions in DNA",
                    "sub_points": [
                      "G:C to T:A transversions in DNA"
                    ]
                  }
                ],
                "Hereditary Mixed Polyposis Syndrome": [
                  {
                    "text": "Adenomas, serrated polyps, juvenile polyps, and colorectal cancer"
                  }
                ],
                "Polymerase Proofreading Associated Polyposis (POLEandPOLD1)": [
                  {
                    "text": "Adenomas, colorectal carcinomas, and endometrial carcinomas"
                  },
                  {
                    "text": "Autosomal dominant"
                  },
                  {
                    "text": "Genetic testing required to make diagnosisG:C to T:A and T:A to G:C transversions in DNA",
                    "sub_points": [
                      "G:C to T:A and T:A to G:C transversions in DNA"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Think of hereditary nonpolyposis colorectal cancer syndrome when patients are < 50 years &/or tumor morphology suggests MSI-HHowever, ~ 1/3 of HNPCC patients will present at older age",
                    "sub_points": [
                      "However, ~ 1/3 of HNPCC patients will present at older age"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Familial Adenomatous Polyposis": {
            "name": "Familial Adenomatous Polyposis",
            "url": "https://app.pathprimer.com/document/58329893-420f-4204-8a1c-e842743e5d60/lesson/77119f90-6e7d-4033-ab21-1264e916bcec",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Familial adenomatous polyposis (FAP): Autosomal dominant inherited syndrome; > 100 colorectal adenomas → inevitably progress to adenocarcinoma at young age"
                  },
                  {
                    "text": "Attenuated FAP: < 100 adenomas, right-sided, ↑ age"
                  },
                  {
                    "text": "Variants: Gardner syndrome (FAP and extraintestinal lesions), Turcot syndrome (FAP and medulloblastoma)"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Germline mutation inAPCtumor suppressor gene (Chr 5q)Almost complete (90-100%) penetrance by 40 years",
                    "sub_points": [
                      "Almost complete (90-100%) penetrance by 40 years"
                    ]
                  },
                  {
                    "text": "1/3 of FAP: No family history, de novo mutations"
                  },
                  {
                    "text": "SpecificAPCmutations correlate with FAP phenotypes"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Incidence: ~ 0.01%, < 1% of colorectal carcinoma (CRC)1st adenoma at age 10; mean age of CRC: 40 years",
                    "sub_points": [
                      "1st adenoma at age 10; mean age of CRC: 40 years"
                    ]
                  },
                  {
                    "text": "AFAP (10% of FAP): adenoma/CRC 15 years later than FAP"
                  },
                  {
                    "text": "FAP adenomas/CRC: Similar distribution to sporadic"
                  },
                  {
                    "text": "Hundreds of small (< 1 cm) polyps carpet entire colonRectal sparing has been described (especially in AFAP)",
                    "sub_points": [
                      "Rectal sparing has been described (especially in AFAP)"
                    ]
                  },
                  {
                    "text": "Screening: Annual sigmoidoscopy starting at age 10-12Upper GI endoscopy, prophylactic colectomy at age 20",
                    "sub_points": [
                      "Upper GI endoscopy, prophylactic colectomy at age 20"
                    ]
                  },
                  {
                    "text": "Drugs: NSAIDs (sulindac) and selective COX-2 inhibitors"
                  },
                  {
                    "text": "Duodenal/periampullary adenomas (90% of FAP patients)"
                  },
                  {
                    "text": "Gastric fundic gland polyps and adenomas (85% of FAP)"
                  },
                  {
                    "text": "> 70% of FAP patients have extraintestinal manifestationsDesmoids: Benign (no metastases), but locally aggressiveMultiple osteomas, epidermoid cysts, retinal lesions",
                    "sub_points": [
                      "Desmoids: Benign (no metastases), but locally aggressive",
                      "Multiple osteomas, epidermoid cysts, retinal lesions"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "FAP: Similar histology to sporadic adenomas/CRCEarliest recognizable lesion: Unicryptal adenoma",
                    "sub_points": [
                      "Earliest recognizable lesion: Unicryptal adenoma"
                    ]
                  },
                  {
                    "text": "Desmoids: Elongated myofibroblasts in fascicles/whorls"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "MYH-associated polyposis (MAP): Autosomal recessiveResults inAPCmutations → FAP-like phenotype",
                    "sub_points": [
                      "Results inAPCmutations → FAP-like phenotype"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Familial adenomatous polyposis (FAP)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Adenomatous polyposis coli (APC)"
                  },
                  {
                    "text": "Familial polyposis coli, multiple adenomatosis"
                  },
                  {
                    "text": "Hereditary flat adenoma syndrome = attenuated familial adenomatous polyposis (AFAP)"
                  },
                  {
                    "text": "Attenuated adenomatous polyposis coli (AAPC) = AFAP"
                  },
                  {
                    "text": "Mesenteric fibromatosis = intraabdominal desmoids"
                  }
                ],
                "Definitions": [
                  {
                    "text": "FAP: Autosomal dominant inherited syndromeNumerous (> 100 in classic FAP) colorectal adenomasInevitably progress to adenocarcinoma at young age",
                    "sub_points": [
                      "Numerous (> 100 in classic FAP) colorectal adenomas",
                      "Inevitably progress to adenocarcinoma at young age"
                    ]
                  },
                  {
                    "text": "Gardner syndrome (Bussey-Gardner polyposis): FAP with (prominent) extraintestinal manifestations (EIM)"
                  },
                  {
                    "text": "AFAP: < 100 adenomas, right-sided, later age at diagnosis"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Predisposition": [
                  {
                    "text": "Inherited (germline) mutation inAPCgeneAlmost complete (90-100%) penetrance by 40 years",
                    "sub_points": [
                      "Almost complete (90-100%) penetrance by 40 years"
                    ]
                  },
                  {
                    "text": "APCtumor suppressor gene (chromosome 5q21-22)Downregulates β-catenin (Wnt signaling pathway)Blocks transcription (otherwise uncontrolled growth)Controls cell cycle, cell adhesion, enterocyte migration, actin/microtubule networks, chromosome segregationKnudson’s 2-hit hypothesis: Somatic mutation or loss of heterozygosity at 2ndAPCallele → FAP-related tumors",
                    "sub_points": [
                      "Downregulates β-catenin (Wnt signaling pathway)Blocks transcription (otherwise uncontrolled growth)",
                      "Blocks transcription (otherwise uncontrolled growth)",
                      "Controls cell cycle, cell adhesion, enterocyte migration, actin/microtubule networks, chromosome segregation",
                      "Knudson’s 2-hit hypothesis: Somatic mutation or loss of heterozygosity at 2ndAPCallele → FAP-related tumors"
                    ]
                  },
                  {
                    "text": "SpecificAPCmutations correlate with FAP phenotypesMost FAP cases: Truncating mutations on 5qProfuse polyposis (> 1,000 polyps): Mutation hot spotsEspecially in exon 15: Mutation cluster region (MCR)Codon 1061 (11%) and 1309 (13-17%) mutationsAFAP: Mutations at more 5' and 3' ends ofAPCgeneNo detectableAPCmutation in some patients10-30% of classical FAP, up to 90% of AFAPMutations at 3' end of theAPCgeneAssociated with aggressive and atypical desmoids",
                    "sub_points": [
                      "Most FAP cases: Truncating mutations on 5q",
                      "Profuse polyposis (> 1,000 polyps): Mutation hot spotsEspecially in exon 15: Mutation cluster region (MCR)Codon 1061 (11%) and 1309 (13-17%) mutations",
                      "Especially in exon 15: Mutation cluster region (MCR)",
                      "Codon 1061 (11%) and 1309 (13-17%) mutations",
                      "AFAP: Mutations at more 5' and 3' ends ofAPCgene",
                      "No detectableAPCmutation in some patients10-30% of classical FAP, up to 90% of AFAP",
                      "10-30% of classical FAP, up to 90% of AFAP",
                      "Mutations at 3' end of theAPCgeneAssociated with aggressive and atypical desmoids",
                      "Associated with aggressive and atypical desmoids"
                    ]
                  },
                  {
                    "text": "20-40% of FAP: New solitary cases (no family history)10-25% spontaneous, de novoAPCmutationsArise during embryogenesis, no risk for siblings11-20% parents with somatic or gonadal mosaicismMay present with less severe phenotype",
                    "sub_points": [
                      "10-25% spontaneous, de novoAPCmutationsArise during embryogenesis, no risk for siblings",
                      "Arise during embryogenesis, no risk for siblings",
                      "11-20% parents with somatic or gonadal mosaicismMay present with less severe phenotype",
                      "May present with less severe phenotype"
                    ]
                  },
                  {
                    "text": "Single nucleotide mutation (APCI1307K) in exon 15Autosomal dominant, but low penetranceAffects 6% of Ashkenazi Jewish populationRendersAPCgene susceptible to further mutationsNo polyposis or extracolonic FAP manifestations10-20% lifetime cancer risk; age similar to sporadic",
                    "sub_points": [
                      "Autosomal dominant, but low penetranceAffects 6% of Ashkenazi Jewish population",
                      "Affects 6% of Ashkenazi Jewish population",
                      "RendersAPCgene susceptible to further mutations",
                      "No polyposis or extracolonic FAP manifestations",
                      "10-20% lifetime cancer risk; age similar to sporadic"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "0.005-0.02% (1 in 5,000 to 20,000 births)Most frequent genetic polyposis syndrome",
                    "sub_points": [
                      "Most frequent genetic polyposis syndrome"
                    ]
                  },
                  {
                    "text": "FAP accounts for < 1% of colorectal carcinoma (CRC)"
                  },
                  {
                    "text": "AFAP comprises ~ 10% of all FAP cases"
                  }
                ],
                "Age": [
                  {
                    "text": "Mean age of 1st adenoma: 10-15 years oldFound on screening flexible sigmoidoscopy",
                    "sub_points": [
                      "Found on screening flexible sigmoidoscopy"
                    ]
                  },
                  {
                    "text": "Mean age of FAP diagnosis: 35-43 years oldIn otherwise unscreened populations",
                    "sub_points": [
                      "In otherwise unscreened populations"
                    ]
                  },
                  {
                    "text": "Mean age of CRC diagnosis: 40 years oldBut can occur as early as teen yearsLater in AFAP (CRC diagnosis at mean 50 years old)",
                    "sub_points": [
                      "But can occur as early as teen years",
                      "Later in AFAP (CRC diagnosis at mean 50 years old)"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "No sex predilection in FAP reported"
                  },
                  {
                    "text": "Desmoids are more common in women (F:M = 3:1)Sex hormones (estrogens) may affect growth",
                    "sub_points": [
                      "Sex hormones (estrogens) may affect growth"
                    ]
                  }
                ],
                "Site": [
                  {
                    "text": "FAP adenomas: Similar distribution to sporadic adenomasMostly in sigmoid colon and rectum",
                    "sub_points": [
                      "Mostly in sigmoid colon and rectum"
                    ]
                  },
                  {
                    "text": "CRC distribution follows adenomas (70-80% left-sided)"
                  },
                  {
                    "text": "> 70% of FAP patients develop extracolonic manifestations"
                  },
                  {
                    "text": "Desmoid: In small bowel mesentery (most common site), retroperitoneum, abdomen/abdominal wall, extremities"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Diarrhea, colicky abdominal pain"
                  },
                  {
                    "text": "Rectal bleeding, mucous discharge, intussusception"
                  },
                  {
                    "text": "Rarely severe electrolyte depletion (in diffuse polyposis)"
                  },
                  {
                    "text": "Acute pancreatitis (adenoma obstructing duct/ampulla)"
                  }
                ],
                "Endoscopic Findings": [
                  {
                    "text": "Hundreds of small (< 1 cm) polyps carpet entire colonPedunculated or sessile; some larger (> 1 cm)Rectal sparing has been described (especially in AFAP)5% can be nonpolypoid, flat adenomas",
                    "sub_points": [
                      "Pedunculated or sessile; some larger (> 1 cm)",
                      "Rectal sparing has been described (especially in AFAP)",
                      "5% can be nonpolypoid, flat adenomas"
                    ]
                  },
                  {
                    "text": "In severe cases: Thousands of polyps, back to back"
                  },
                  {
                    "text": "AFAP: Fewer, smaller, flatter, more often right-sided polyps"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Earliest recognizable lesion: Unicryptal adenomaSingle dysplastic colonic crypt, usually incidentalBecomes oligocryptal, eventually visible adenomaThrough excessive, asymmetric crypt fission",
                    "sub_points": [
                      "Single dysplastic colonic crypt, usually incidental",
                      "Becomes oligocryptal, eventually visible adenomaThrough excessive, asymmetric crypt fission",
                      "Through excessive, asymmetric crypt fission"
                    ]
                  },
                  {
                    "text": "Adenomas increase in number and size with agePolyp count and patient age predict CRC riskOverall, only small % of adenomas progress to CRC",
                    "sub_points": [
                      "Polyp count and patient age predict CRC risk",
                      "Overall, only small % of adenomas progress to CRC"
                    ]
                  },
                  {
                    "text": "Neighboring normal colonic mucosa epithelium↑ cell proliferation/mitotic activity (controversial)",
                    "sub_points": [
                      "↑ cell proliferation/mitotic activity (controversial)"
                    ]
                  },
                  {
                    "text": "Multiple CRC: Synchronous or metachronous"
                  },
                  {
                    "text": "AFAP: Fewer adenomas/CRC, 15 years later than FAPUpper GI lesions almost always present, but EIM rare",
                    "sub_points": [
                      "Upper GI lesions almost always present, but EIM rare"
                    ]
                  }
                ],
                "Treatment": [],
                "Options, risks, complications": [
                  {
                    "text": "Annual flexible sigmoidoscopy starting at 10-12 years oldPatients withAPCmutation or clinical FAP diagnosis",
                    "sub_points": [
                      "Patients withAPCmutation or clinical FAP diagnosis"
                    ]
                  },
                  {
                    "text": "Endoscopic evaluation of upper GI tract at age 20Remove adenomas > 1 cm or with high-grade dysplasia (HGD) rather than eradicate all neoplasiaProgression rate to carcinoma in small bowel is low",
                    "sub_points": [
                      "Remove adenomas > 1 cm or with high-grade dysplasia (HGD) rather than eradicate all neoplasiaProgression rate to carcinoma in small bowel is low",
                      "Progression rate to carcinoma in small bowel is low"
                    ]
                  },
                  {
                    "text": "AFAP: Close endoscopic surveillance, upper/lower GIComplete colonoscopy (common right-sided lesions)",
                    "sub_points": [
                      "Complete colonoscopy (common right-sided lesions)"
                    ]
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Prophylactic colectomy by age 20-25In mutation-positive patients with adenomas",
                    "sub_points": [
                      "In mutation-positive patients with adenomas"
                    ]
                  },
                  {
                    "text": "Operation: Colectomy and ileorectal anastomosis, orProctocolectomy with ileal pouch–anal anastomosisContraindications: Mesenteric desmoids, advanced low rectal cancer, poor anal sphincter functionScreening of rectal stump/ileal pouch after surgery",
                    "sub_points": [
                      "Proctocolectomy with ileal pouch–anal anastomosisContraindications: Mesenteric desmoids, advanced low rectal cancer, poor anal sphincter function",
                      "Contraindications: Mesenteric desmoids, advanced low rectal cancer, poor anal sphincter function",
                      "Screening of rectal stump/ileal pouch after surgery"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "NSAIDs (sulindac) and selective COX-2 inhibitorsReduce rectal adenomas after subtotal colectomyDo not completely prevent CRCTreatment cessation leads to polyp regrowthSide effects: Cardiovascular/thrombotic eventsUsed in desmoid tumors together with antiestrogens",
                    "sub_points": [
                      "Reduce rectal adenomas after subtotal colectomyDo not completely prevent CRC",
                      "Do not completely prevent CRC",
                      "Treatment cessation leads to polyp regrowth",
                      "Side effects: Cardiovascular/thrombotic events",
                      "Used in desmoid tumors together with antiestrogens"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Patients invariably progress to CRC (100% by 60 years)Cancer risk already 1-6% at 20-25 years old50-75% of FAP patients have CRC by 30 years of ageIf untreated/unscreened, patients die by 5th decade",
                    "sub_points": [
                      "Cancer risk already 1-6% at 20-25 years old",
                      "50-75% of FAP patients have CRC by 30 years of age",
                      "If untreated/unscreened, patients die by 5th decade"
                    ]
                  }
                ],
                "Extracolonic GI Lesions": [
                  {
                    "text": "Small intestine/duodenumDuodenal/ampullary/periampullary adenomasPossible cocarcinogenic effect of bileOccur 10-15 years later than colorectal adenomas30 years earlier than general population90% of FAP patients on routine screening (50-100%)Cumulative risk of small intestinal carcinoma: 1-10%Cause of death after prophylactic colectomy (20%)Small intestinal (nonduodenal) adenomas: < 10% of FAPSmall intestinal carcinoma in < 1 % of FAP patientsDuodenal polyp classification: 5 Spigelman stagesBased on size, number, dysplasia degree, architecture",
                    "sub_points": [
                      "Duodenal/ampullary/periampullary adenomasPossible cocarcinogenic effect of bile",
                      "Possible cocarcinogenic effect of bile",
                      "Occur 10-15 years later than colorectal adenomas30 years earlier than general population",
                      "30 years earlier than general population",
                      "90% of FAP patients on routine screening (50-100%)",
                      "Cumulative risk of small intestinal carcinoma: 1-10%Cause of death after prophylactic colectomy (20%)",
                      "Cause of death after prophylactic colectomy (20%)",
                      "Small intestinal (nonduodenal) adenomas: < 10% of FAPSmall intestinal carcinoma in < 1 % of FAP patients",
                      "Small intestinal carcinoma in < 1 % of FAP patients",
                      "Duodenal polyp classification: 5 Spigelman stagesBased on size, number, dysplasia degree, architecture",
                      "Based on size, number, dysplasia degree, architecture"
                    ]
                  },
                  {
                    "text": "Stomach: Up to 85% of FAP patients develop gastric polypsMostly fundic gland polyps (40-60% of FAP patients)More numerous, occur at younger age than sporadicGastric antral adenomas also described (6% of FAP)↓ numbers and ↓ frequency than fundic gland polypsMay be present diffusely throughout stomachRarely may be precursors to malignancyGastric carcinoma is rare, but cases have been reportedPossibly due to duodenogastric bile refluxMostly in Japan (additional environmental role)",
                    "sub_points": [
                      "Mostly fundic gland polyps (40-60% of FAP patients)More numerous, occur at younger age than sporadic",
                      "More numerous, occur at younger age than sporadic",
                      "Gastric antral adenomas also described (6% of FAP)↓ numbers and ↓ frequency than fundic gland polypsMay be present diffusely throughout stomachRarely may be precursors to malignancy",
                      "↓ numbers and ↓ frequency than fundic gland polyps",
                      "May be present diffusely throughout stomach",
                      "Rarely may be precursors to malignancy",
                      "Gastric carcinoma is rare, but cases have been reportedPossibly due to duodenogastric bile refluxMostly in Japan (additional environmental role)",
                      "Possibly due to duodenogastric bile reflux",
                      "Mostly in Japan (additional environmental role)"
                    ]
                  }
                ],
                "Extraintestinal Manifestations": [
                  {
                    "text": "Desmoid tumors of soft tissueBenign (no metastases), but locally aggressiveRecurrence or progression common after excisionIntraabdominal desmoids are most frequent in FAP10-30% of FAP, more in females & after early colectomyIncidence ↑ during child-bearing years, during/after pregnancy, after oral contraceptive useOften seen post trauma or post surgeryAdverse factors: ↑ complications, tumor recurrenceComplications: Obstruction (small bowel or ureters)Thrombosis/occlusion of mesenteric vesselsCompression of peripheral nerves, perforation2nd cause of death in FAP (in ~ 20%), after CRC",
                    "sub_points": [
                      "Benign (no metastases), but locally aggressiveRecurrence or progression common after excision",
                      "Recurrence or progression common after excision",
                      "Intraabdominal desmoids are most frequent in FAP",
                      "10-30% of FAP, more in females & after early colectomyIncidence ↑ during child-bearing years, during/after pregnancy, after oral contraceptive useOften seen post trauma or post surgery",
                      "Incidence ↑ during child-bearing years, during/after pregnancy, after oral contraceptive use",
                      "Often seen post trauma or post surgery",
                      "Adverse factors: ↑ complications, tumor recurrence",
                      "Complications: Obstruction (small bowel or ureters)Thrombosis/occlusion of mesenteric vesselsCompression of peripheral nerves, perforation2nd cause of death in FAP (in ~ 20%), after CRC",
                      "Thrombosis/occlusion of mesenteric vessels",
                      "Compression of peripheral nerves, perforation",
                      "2nd cause of death in FAP (in ~ 20%), after CRC"
                    ]
                  },
                  {
                    "text": "Liver, biliary tract, and pancreas↑ rate of hepatoblastoma (~ 0.5% of FAP, male infants)Bile duct/gallbladder dysplasia, adenocarcinomaPancreas: Adenocarcinoma, intraductal papillary mucinous neoplasm, intraepithelial neoplasia",
                    "sub_points": [
                      "↑ rate of hepatoblastoma (~ 0.5% of FAP, male infants)",
                      "Bile duct/gallbladder dysplasia, adenocarcinoma",
                      "Pancreas: Adenocarcinoma, intraductal papillary mucinous neoplasm, intraepithelial neoplasia"
                    ]
                  },
                  {
                    "text": "Bones and teeth (in 70-80% of FAP patients)Multiple osteomas of skull, long bones, mandibleBenign, asymptomatic, osteosclerotic, radiopaqueImpacted, supernumerary/absent teeth, abnormal roots",
                    "sub_points": [
                      "Multiple osteomas of skull, long bones, mandibleBenign, asymptomatic, osteosclerotic, radiopaque",
                      "Benign, asymptomatic, osteosclerotic, radiopaque",
                      "Impacted, supernumerary/absent teeth, abnormal roots"
                    ]
                  },
                  {
                    "text": "Eye (75-90% of FAP patients)Congenital hypertrophy of retinal pigment epitheliumEarliest diagnostic stigma of FAP (young infants)Especially bilateral pigmented lesions with haloLarge or multiple lesions: 100% specific for FAP",
                    "sub_points": [
                      "Congenital hypertrophy of retinal pigment epitheliumEarliest diagnostic stigma of FAP (young infants)Especially bilateral pigmented lesions with haloLarge or multiple lesions: 100% specific for FAP",
                      "Earliest diagnostic stigma of FAP (young infants)Especially bilateral pigmented lesions with halo",
                      "Especially bilateral pigmented lesions with halo",
                      "Large or multiple lesions: 100% specific for FAP"
                    ]
                  },
                  {
                    "text": "Skin, adnexa, and soft tissueMultiple epidermal inclusion (\"epidermoid\") cystsFace, scalp, extremities (vs. non-FAP patients: Back)Lipomas, fibromas, sebaceous cystsSebaceous cysts and FAP: Oldfield syndrome",
                    "sub_points": [
                      "Multiple epidermal inclusion (\"epidermoid\") cystsFace, scalp, extremities (vs. non-FAP patients: Back)",
                      "Face, scalp, extremities (vs. non-FAP patients: Back)",
                      "Lipomas, fibromas, sebaceous cystsSebaceous cysts and FAP: Oldfield syndrome",
                      "Sebaceous cysts and FAP: Oldfield syndrome"
                    ]
                  },
                  {
                    "text": "Endocrine systemNeoplasia: Pituitary, pancreatic islets, adrenal cortexPapillary thyroid carcinoma (1-12%, mostly women)",
                    "sub_points": [
                      "Neoplasia: Pituitary, pancreatic islets, adrenal cortex",
                      "Papillary thyroid carcinoma (1-12%, mostly women)"
                    ]
                  },
                  {
                    "text": "Nasopharyngeal angiofibromaHighly vascular, locally invasive, seen in adolescent boys",
                    "sub_points": [
                      "Highly vascular, locally invasive, seen in adolescent boys"
                    ]
                  }
                ],
                "Variants of FAP": [
                  {
                    "text": "Turcot (Crail) syndrome (glioma-polyposis syndrome)Coexistence: Hereditary colon cancer and brain tumorFAP patients: Medulloblastomas (APCmutation)Lynch: Gliomas (DNA mismatch repair mutation)",
                    "sub_points": [
                      "Coexistence: Hereditary colon cancer and brain tumorFAP patients: Medulloblastomas (APCmutation)Lynch: Gliomas (DNA mismatch repair mutation)",
                      "FAP patients: Medulloblastomas (APCmutation)",
                      "Lynch: Gliomas (DNA mismatch repair mutation)"
                    ]
                  },
                  {
                    "text": "Hereditary desmoid disease: Multiple, unusual desmoidsAutosomal dominantAPCmutation, rare colonic lesions",
                    "sub_points": [
                      "Autosomal dominantAPCmutation, rare colonic lesions"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Hundreds/thousands of colonic polyps, mostly < 1 cm"
                  },
                  {
                    "text": "Duodenal/ampullary/periampullary adenomasMultiple, sessile, and mostly on mucosal folds",
                    "sub_points": [
                      "Multiple, sessile, and mostly on mucosal folds"
                    ]
                  },
                  {
                    "text": "Desmoid tumors: Slow-growing, fibrous massesFlat or lobulated, nonencapsulated, may be multipleIntralesional hemorrhage, cystic degeneration",
                    "sub_points": [
                      "Flat or lobulated, nonencapsulated, may be multiple",
                      "Intralesional hemorrhage, cystic degeneration"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "FAP-associated adenomas/CRCSimilar histology to sporadic adenomas/CRCTubular adenomas, rarely tubulovillous or villous",
                    "sub_points": [
                      "Similar histology to sporadic adenomas/CRC",
                      "Tubular adenomas, rarely tubulovillous or villous"
                    ]
                  },
                  {
                    "text": "Desmoid tumorsElongated, highly differentiated myofibroblastsGrowth in fascicles or whorls, abundant collagen matrixVariable collagen, numerous small blood vessels",
                    "sub_points": [
                      "Elongated, highly differentiated myofibroblasts",
                      "Growth in fascicles or whorls, abundant collagen matrix",
                      "Variable collagen, numerous small blood vessels"
                    ]
                  },
                  {
                    "text": "Duodenal/ampullary/periampullary AdenomasSimilar histology to colonic tubular adenomasHyperchromatic, crowded, elongated nucleiMostly low-grade dysplasia (retain polarity)Dysplasia also seen in grossly normal duodenal mucosa",
                    "sub_points": [
                      "Similar histology to colonic tubular adenomasHyperchromatic, crowded, elongated nucleiMostly low-grade dysplasia (retain polarity)",
                      "Hyperchromatic, crowded, elongated nuclei",
                      "Mostly low-grade dysplasia (retain polarity)",
                      "Dysplasia also seen in grossly normal duodenal mucosa"
                    ]
                  },
                  {
                    "text": "Stomach: Fundic gland polyps (FGPs)Cystic dilatation, irregular budding of fundic glandsMore often have dysplasia (up to 25%) than sporadic",
                    "sub_points": [
                      "Cystic dilatation, irregular budding of fundic glands",
                      "More often have dysplasia (up to 25%) than sporadic"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Genetic Testing": [
                  {
                    "text": "APCmutations detected in 60-90% of FAP familiesProtein truncation testing, DNA sequencingConfirm diagnosis by flexible sigmoidoscopy",
                    "sub_points": [
                      "Protein truncation testing, DNA sequencing",
                      "Confirm diagnosis by flexible sigmoidoscopy"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "MYH-Associated Polyposis (MAP)": [
                  {
                    "text": "Autosomal recessive inheritanceBiallelic germline mutations needed for phenotypeChildren of patients are obligate carriersScreen partners before offspring of their own",
                    "sub_points": [
                      "Biallelic germline mutations needed for phenotype",
                      "Children of patients are obligate carriersScreen partners before offspring of their own",
                      "Screen partners before offspring of their own"
                    ]
                  },
                  {
                    "text": "MYH(MUTYH) gene located on chromosome 1pGene product involved in base excision repairRemediates oxidative DNA damageDefect results inAPCandrasgene mutations",
                    "sub_points": [
                      "Gene product involved in base excision repairRemediates oxidative DNA damage",
                      "Remediates oxidative DNA damage",
                      "Defect results inAPCandrasgene mutations"
                    ]
                  },
                  {
                    "text": "Multiple adenomas (typically < 100), may have EIM of FAP"
                  },
                  {
                    "text": "↑ CRC (especially right-sided), even in absence of polyps"
                  }
                ],
                "Juvenile Intestinal Polyposis": [
                  {
                    "text": "Rare autosomal dominant syndrome"
                  },
                  {
                    "text": "100s of small pedunculated polyps"
                  },
                  {
                    "text": "Branched dilated crypts, inflamed edematous stroma"
                  }
                ],
                "Hyperplastic Polyposis": [
                  {
                    "text": "Generally < 100 colorectal polypsHyperplastic, serrated, adenomas, and mixed polypsMay mimic FAP or AFAP endoscopically",
                    "sub_points": [
                      "Hyperplastic, serrated, adenomas, and mixed polyps",
                      "May mimic FAP or AFAP endoscopically"
                    ]
                  },
                  {
                    "text": "Familial aggregation, no definite genetic associationMay have underlying defect in DNA methylationProbably at increased risk for CRC",
                    "sub_points": [
                      "May have underlying defect in DNA methylation",
                      "Probably at increased risk for CRC"
                    ]
                  }
                ],
                "Hereditary Mixed Polyposis": [
                  {
                    "text": "Atypical juvenile polyps, serrated polyps, classic adenomas"
                  },
                  {
                    "text": "Only colon affected; 2 separate loci implicated"
                  },
                  {
                    "text": "Increased risk for development of CRC"
                  }
                ],
                "Cronkhite-Canada Syndrome": [
                  {
                    "text": "Rare syndrome, not considered geneticControversial malignant potential",
                    "sub_points": [
                      "Controversial malignant potential"
                    ]
                  },
                  {
                    "text": "Diffuse polyposis throughout GI tract (not esophagus)Hamartomatous, juvenile polyps",
                    "sub_points": [
                      "Hamartomatous, juvenile polyps"
                    ]
                  },
                  {
                    "text": "Alopecia, onychodystrophy, skin hyperpigmentation"
                  }
                ],
                "Diffuse Lipomatous Polyposis": [
                  {
                    "text": "Rare; diffusely involves small and large intestine"
                  },
                  {
                    "text": "Histologically, multiple benign mature lipomas"
                  }
                ],
                "Nodular Lymphoid Hyperplasia": [
                  {
                    "text": "Often associated with immunodeficiency"
                  },
                  {
                    "text": "Numerous nodules in small and large intestine"
                  },
                  {
                    "text": "Large lymphoid clusters, prominent germinal centersIn lamina propria and superficial submucosa",
                    "sub_points": [
                      "In lamina propria and superficial submucosa"
                    ]
                  }
                ],
                "Lymphomatous Polyposis": [
                  {
                    "text": "Rare form of 1° GI lymphoma (mostly mantle cell)"
                  },
                  {
                    "text": "Widespread lymphomatous polyps, poor prognosis"
                  }
                ],
                "Inflammatory Polyposis": [
                  {
                    "text": "Mostly in association with inflammatory bowel disease"
                  },
                  {
                    "text": "Regenerating mucosal islands and granulation tissue"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Diagnostic criteria for FAP: Any of the following≥ 100 colorectal adenomas (classical FAP)< 100 colon adenomas in AFAP (usually 1-50)GermlineAPCmutationFamily history of FAP + at least 1 of the followingEpidermoid cyst, osteoma, or desmoid",
                    "sub_points": [
                      "≥ 100 colorectal adenomas (classical FAP)< 100 colon adenomas in AFAP (usually 1-50)",
                      "< 100 colon adenomas in AFAP (usually 1-50)",
                      "GermlineAPCmutation",
                      "Family history of FAP + at least 1 of the followingEpidermoid cyst, osteoma, or desmoid",
                      "Epidermoid cyst, osteoma, or desmoid"
                    ]
                  },
                  {
                    "text": "Suspect and test for FAP when patients present withCRC at an age < 45 years old or multiple CRCAdenomatous polyps at age < 40 years old> 10 polyps in their lifetime with positive family historyFamily with multiple generations with CRCAnd familial clustering of extracolonic cancers",
                    "sub_points": [
                      "CRC at an age < 45 years old or multiple CRC",
                      "Adenomatous polyps at age < 40 years old",
                      "> 10 polyps in their lifetime with positive family history",
                      "Family with multiple generations with CRCAnd familial clustering of extracolonic cancers",
                      "And familial clustering of extracolonic cancers"
                    ]
                  },
                  {
                    "text": "Features of FAP/AFAP but no germlineAPCmutationTest forMYHmutations: 10-20% will be positive for MAP",
                    "sub_points": [
                      "Test forMYHmutations: 10-20% will be positive for MAP"
                    ]
                  },
                  {
                    "text": "Genetic counseling in relatives of newly diagnosed patientsIf asymptomatic and clearly negative DNA testNo further screening or testing necessaryIf specific family mutation present is unknownNegative result is inconclusive, continue screeningAnnual endoscopic surveillance begins at age 10-12Inadvisable to test children < 10 years oldEmotional stress and family conflictsResult does not change treatment strategy",
                    "sub_points": [
                      "If asymptomatic and clearly negative DNA testNo further screening or testing necessary",
                      "No further screening or testing necessary",
                      "If specific family mutation present is unknownNegative result is inconclusive, continue screeningAnnual endoscopic surveillance begins at age 10-12",
                      "Negative result is inconclusive, continue screeningAnnual endoscopic surveillance begins at age 10-12",
                      "Annual endoscopic surveillance begins at age 10-12",
                      "Inadvisable to test children < 10 years oldEmotional stress and family conflictsResult does not change treatment strategy",
                      "Emotional stress and family conflicts",
                      "Result does not change treatment strategy"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Duodenal adenomas in FAPMore Paneth/endocrine cells per crypt than sporadic",
                    "sub_points": [
                      "More Paneth/endocrine cells per crypt than sporadic"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Infectious Diseases": {
        "name": "Infectious Diseases",
        "url": "https://app.pathprimer.com/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
        "topics": {
          "Cytomegalovirus": {
            "name": "Cytomegalovirus",
            "url": "https://app.pathprimer.com/document/0df5b276-7e9f-404c-b598-7ce240c23290/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Asymptomatic latency in immunocompetent"
                  },
                  {
                    "text": "Viral shedding in infected hosts"
                  },
                  {
                    "text": "Loss of cell-mediated immunity (immunosuppression)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Seropositivity rates depend on population and ageTransplant patients (20-60%) experience symptomatic infections",
                    "sub_points": [
                      "Transplant patients (20-60%) experience symptomatic infections"
                    ]
                  },
                  {
                    "text": "ImmunocompetentIn utero: TORCH organism",
                    "sub_points": [
                      "In utero: TORCH organism"
                    ]
                  },
                  {
                    "text": "Solid organ transplantsDonor positive/recipient negative = highest risk",
                    "sub_points": [
                      "Donor positive/recipient negative = highest risk"
                    ]
                  },
                  {
                    "text": "Bone marrow transplantsDonor negative/recipient positive = highest risk",
                    "sub_points": [
                      "Donor negative/recipient positive = highest risk"
                    ]
                  },
                  {
                    "text": "Quantitative PCR on bloodDoes not correlate with organ-specific disease",
                    "sub_points": [
                      "Does not correlate with organ-specific disease"
                    ]
                  },
                  {
                    "text": "CMV organ-specific disease in immunosuppressedUnmonitored, acute-onset disease, worse prognosis",
                    "sub_points": [
                      "Unmonitored, acute-onset disease, worse prognosis"
                    ]
                  },
                  {
                    "text": "HIV-infected patientsUntreated, acute-onset disease, worst prognosis",
                    "sub_points": [
                      "Untreated, acute-onset disease, worst prognosis"
                    ]
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "3-4x size of macrophages"
                  },
                  {
                    "text": "Large \"owl's-eye\" nucleusRed-purple inclusion within large cleared nucleus",
                    "sub_points": [
                      "Red-purple inclusion within large cleared nucleus"
                    ]
                  },
                  {
                    "text": "Abundant cytoplasm ± distinctive red-purple granules"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Herpesvirus family"
                  },
                  {
                    "text": "Adenovirus"
                  },
                  {
                    "text": "Diffuse alveolar damage"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Cytomegalovirus (CMV)"
                  },
                  {
                    "text": "Human herpesvirus-5 (HHV-5)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "\"Cytomegalovirus\" derived from \"cyto-\" (cell) and \"megalo-\" (large)"
                  },
                  {
                    "text": "\"Herpesvirus\" derived from \"herpein\" (to creep)"
                  },
                  {
                    "text": "Herpesviridae: Ubiquitous enveloped icosahedral double-stranded DNA virus present in most vertebrates"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Infectious Agents": [
                  {
                    "text": "Ubiquitous virus able to infect many cell types"
                  },
                  {
                    "text": "Commonly found in saliva, urine, semen > > > other body fluids"
                  },
                  {
                    "text": "Initial infectionRoute of entry is salivary glandsLytic infection that is self limited",
                    "sub_points": [
                      "Route of entry is salivary glands",
                      "Lytic infection that is self limited"
                    ]
                  },
                  {
                    "text": "Chronic infectionAsymptomatic latency in immunocompetentViral shedding in infected hostsLoss of cell-mediated immunity (immunosuppression)Viral reactivation and lytic cycle infection",
                    "sub_points": [
                      "Asymptomatic latency in immunocompetent",
                      "Viral shedding in infected hosts",
                      "Loss of cell-mediated immunity (immunosuppression)Viral reactivation and lytic cycle infection",
                      "Viral reactivation and lytic cycle infection"
                    ]
                  },
                  {
                    "text": "No direct evidence of oncogenesis but may work through oncomodulation to increase malignancy of tumors"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "Ubiquitous virus affecting all age groups"
                  },
                  {
                    "text": "Seropositivity rates depend on population and age~ 40% of population on average worldwide~ 60% of adults in United States~ 90% of male homosexuals36% in children rises to 91% of adults > 80 years",
                    "sub_points": [
                      "~ 40% of population on average worldwide",
                      "~ 60% of adults in United States",
                      "~ 90% of male homosexuals",
                      "36% in children rises to 91% of adults > 80 years"
                    ]
                  },
                  {
                    "text": "Immunocompetent individuals have asymptomatic initial infection or (rarely) mononucleosis-like illness"
                  },
                  {
                    "text": "Transplant patients (20-60%) experience symptomatic infections"
                  }
                ],
                "Site": [
                  {
                    "text": "Symptomatic infection in immunocompetent (rare)PneumoniaHepatitisColitisEncephalitisRare sites of clinical infectionEsophagusSalivary glandsKidneysAdrenalsPancreas",
                    "sub_points": [
                      "Pneumonia",
                      "Hepatitis",
                      "Colitis",
                      "Encephalitis",
                      "Rare sites of clinical infectionEsophagusSalivary glandsKidneysAdrenalsPancreas",
                      "Esophagus",
                      "Salivary glands",
                      "Kidneys",
                      "Adrenals",
                      "Pancreas"
                    ]
                  },
                  {
                    "text": "Mononucleosis-like initial presentationLymphadenopathySplenomegalyHepatitisMimics Epstein-Barr virus infection (mononucleosis)",
                    "sub_points": [
                      "Lymphadenopathy",
                      "Splenomegaly",
                      "Hepatitis",
                      "Mimics Epstein-Barr virus infection (mononucleosis)"
                    ]
                  },
                  {
                    "text": "Symptomatic infection in the immunosuppressedCan involve any organCan involve many cell types",
                    "sub_points": [
                      "Can involve any organ",
                      "Can involve many cell types"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "A range of clinical infections (mild to life threatening)"
                  },
                  {
                    "text": "Primary infection (9-60 days incubation) or reactivation of latency"
                  },
                  {
                    "text": "ImmunocompetentIn utero: TORCH organismChildren and young adults: Mononucleosis-like illness",
                    "sub_points": [
                      "In utero: TORCH organism",
                      "Children and young adults: Mononucleosis-like illness"
                    ]
                  },
                  {
                    "text": "ImmunosuppressedHIV infectionLow CD4 countCoinfection with other opportunistic pathogenSolid organ transplantsDonor positive/recipient negative = highest riskBone marrow transplantsDonor negative/recipient positive = highest riskOrgan-specific symptoms",
                    "sub_points": [
                      "HIV infectionLow CD4 countCoinfection with other opportunistic pathogen",
                      "Low CD4 count",
                      "Coinfection with other opportunistic pathogen",
                      "Solid organ transplantsDonor positive/recipient negative = highest risk",
                      "Donor positive/recipient negative = highest risk",
                      "Bone marrow transplantsDonor negative/recipient positive = highest risk",
                      "Donor negative/recipient positive = highest risk",
                      "Organ-specific symptoms"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Serology (IgG &/or IgM)"
                  },
                  {
                    "text": "Direct or indirect immunofluorescence for CMV antigens (urine, saliva, blood, fluids)"
                  },
                  {
                    "text": "Culture from direct tissue sample > blood"
                  },
                  {
                    "text": "Qualitative PCR on blood"
                  },
                  {
                    "text": "Quantitative PCR on bloodUsed to follow immunosuppressionCorrelates with level of immunosuppression directlyDoes not correlate with organ-specific diseaseExample A: Patient with low CMV viral load may present with severe CMV pneumoniaExample B: Patient with high CMV viral load has no organ-specific symptoms or actual pathology",
                    "sub_points": [
                      "Used to follow immunosuppression",
                      "Correlates with level of immunosuppression directly",
                      "Does not correlate with organ-specific disease",
                      "Example A: Patient with low CMV viral load may present with severe CMV pneumonia",
                      "Example B: Patient with high CMV viral load has no organ-specific symptoms or actual pathology"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Self-limited in immunocompetent"
                  },
                  {
                    "text": "Moderate to severe in immunosuppressedModerate to severe organ-specific diseaseSevere disseminated disease",
                    "sub_points": [
                      "Moderate to severe organ-specific disease",
                      "Severe disseminated disease"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Prevention in immunosuppressed (prophylaxis)Valganciclovir (favored)Ganciclovir",
                    "sub_points": [
                      "Valganciclovir (favored)",
                      "Ganciclovir"
                    ]
                  },
                  {
                    "text": "Treatment in immunosuppressed (all sites)Ganciclovir (first-line)Foscarnet, cidofovir, maribavir (second-line)CMV immune globulinWith ganciclovir for lung transplant patients",
                    "sub_points": [
                      "Ganciclovir (first-line)",
                      "Foscarnet, cidofovir, maribavir (second-line)",
                      "CMV immune globulinWith ganciclovir for lung transplant patients",
                      "With ganciclovir for lung transplant patients"
                    ]
                  },
                  {
                    "text": "Treatment of CMV retinitisValganciclovir",
                    "sub_points": [
                      "Valganciclovir"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Dependent on host and disease context"
                  },
                  {
                    "text": "TORCH: Pregnancy loss to severe long-term complications"
                  },
                  {
                    "text": "CMV organ-specific disease in immunosuppressedWith preemptive &/or prophylaxis = better prognosisUnmonitored, acute onset disease = worse prognosis",
                    "sub_points": [
                      "With preemptive &/or prophylaxis = better prognosis",
                      "Unmonitored, acute onset disease = worse prognosis"
                    ]
                  },
                  {
                    "text": "HIV-infected patientsOn highly active anti-retroviral therapy (HAART) disease less common, best prognosisUntreated, acute-onset disease, worst prognosis",
                    "sub_points": [
                      "On highly active anti-retroviral therapy (HAART) disease less common, best prognosis",
                      "Untreated, acute-onset disease, worst prognosis"
                    ]
                  }
                ]
              },
              "Microbiology": {
                "Virus Features": [
                  {
                    "text": "Enveloped, lytic, double-stranded DNA virus"
                  },
                  {
                    "text": "150-200 nm in size with icosahedral capsid"
                  },
                  {
                    "text": "Human CMV (single type)"
                  },
                  {
                    "text": "235,645 bp genome (largest of the herpesviruses)"
                  }
                ],
                "Culture": [
                  {
                    "text": "Grows in cell cultureHuman fetal fibroblasts (HFF) cell lines",
                    "sub_points": [
                      "Human fetal fibroblasts (HFF) cell lines"
                    ]
                  },
                  {
                    "text": "1-2 weeks for growth"
                  },
                  {
                    "text": "Confirmed by cytopathic effect with positive direct antigen visualization"
                  },
                  {
                    "text": "Shell-vial cultureRapid, pre-\"viral cytopathic effect\" detection by antibody",
                    "sub_points": [
                      "Rapid, pre-\"viral cytopathic effect\" detection by antibody"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Very large cells3-4x size of macrophages",
                    "sub_points": [
                      "3-4x size of macrophages"
                    ]
                  },
                  {
                    "text": "Large \"owl's-eye\" nucleusRed-purple inclusion within large cleared nucleus",
                    "sub_points": [
                      "Red-purple inclusion within large cleared nucleus"
                    ]
                  },
                  {
                    "text": "Abundant cytoplasm ± distinctive red-purple granules"
                  },
                  {
                    "text": "Selected specific tissue patterns of injury (in addition to viral cytopathic effect)Ischemia &/or necrosis (with vascular endothelial infection)Ulceration (gastrointestinal tract)",
                    "sub_points": [
                      "Ischemia &/or necrosis (with vascular endothelial infection)",
                      "Ulceration (gastrointestinal tract)"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Markedly enlarged mononuclear cells"
                  },
                  {
                    "text": "Basophilic intranuclear inclusions"
                  },
                  {
                    "text": "Small granular cytoplasmic inclusions"
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "For CMV antigen(s)"
                  },
                  {
                    "text": "Should always be considered in concert with herpesvirus without prior diagnosisExample A: Patient with known positive CMV viral load = single IHC for confirmation of suspicious cellsExample B: Patient with new-onset organ specific symptoms and suspicious (but not diagnostic) viral cytopathic effects on biopsy = panel of CMV and other herpesviruses",
                    "sub_points": [
                      "Example A: Patient with known positive CMV viral load = single IHC for confirmation of suspicious cells",
                      "Example B: Patient with new-onset organ specific symptoms and suspicious (but not diagnostic) viral cytopathic effects on biopsy = panel of CMV and other herpesviruses"
                    ]
                  }
                ],
                "Immunofluorescence": [
                  {
                    "text": "Direct or indirect immunofluorescence for CMV antigens (tissue biopsies, cytology samples)Immunohistochemistry is preferred over immunofluorescence for routine confirmation",
                    "sub_points": [
                      "Immunohistochemistry is preferred over immunofluorescence for routine confirmation"
                    ]
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "Specific DNA probes for cytomegalovirus target(s)Available in reference/research laboratories",
                    "sub_points": [
                      "Available in reference/research laboratories"
                    ]
                  },
                  {
                    "text": "Directly performed on tissue samples (rarely needed)"
                  }
                ],
                "PCR": [
                  {
                    "text": "Molecular detection of CMV DNA or RNAMost commonly used on blood to monitor immunosuppression",
                    "sub_points": [
                      "Most commonly used on blood to monitor immunosuppression"
                    ]
                  },
                  {
                    "text": "Qualitative and quantitative"
                  },
                  {
                    "text": "Directly on tissue sample, fluid, or blood (rarely needed)Available via reference/research laboratories",
                    "sub_points": [
                      "Available via reference/research laboratories"
                    ]
                  }
                ],
                "Electron Microscopy": [],
                "Transmission": [
                  {
                    "text": "Icosahedral viral capsid with (infective particle) or without (incomplete particle) surrounding cell membrane"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Herpesvirus Family (All Sites)": [
                  {
                    "text": "Herpes simplex 1 & 2MultinucleationClassic Cowdry type A nuclei",
                    "sub_points": [
                      "Multinucleation",
                      "Classic Cowdry type A nuclei"
                    ]
                  },
                  {
                    "text": "Varicella-Zoster virusClassic Cowdry type A nuclei",
                    "sub_points": [
                      "Classic Cowdry type A nuclei"
                    ]
                  },
                  {
                    "text": "When viral cytopathic effect is suspected,  panel of HSV, VZV, CMV, and adenovirus immunohistochemistry is advised"
                  }
                ],
                "Adenovirus": [
                  {
                    "text": "Suspicious viral cytopathic effect"
                  }
                ],
                "Other Viral Infections (All Sites)": [
                  {
                    "text": "RNA viruses resulting in necrosis ± inflammation"
                  },
                  {
                    "text": "Correlated with CMV immune status, viral load, and immunohistochemistry"
                  },
                  {
                    "text": "Reference testing for confirmation of other viral infections is recommended"
                  }
                ],
                "Bacterial Infections (All Sites)": [
                  {
                    "text": "Destructive, necrotic lesions"
                  },
                  {
                    "text": "Demonstration of bacteria on Gram or silver staining"
                  },
                  {
                    "text": "Positive cultures of bacteria from sample"
                  }
                ],
                "Diffuse Alveolar Damage (Lung)": [
                  {
                    "text": "Patients with acute respiratory distress syndrome (ARDS)"
                  },
                  {
                    "text": "Any condition leading to DAD can mimic CMV infection (and vice versa)"
                  },
                  {
                    "text": "CMV can lead directly to DAD"
                  },
                  {
                    "text": "Reactive, degenerative cells may be suspicious for viral cytopathic effect"
                  },
                  {
                    "text": "CMV can reactivate in damaged lung tissue incidentally and not be the root cause of DAD"
                  },
                  {
                    "text": "Clinical history, culture, and immunohistochemistry can exclude DAD of other causes"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Suspected viral cytopathic effect should be thoroughly evaluated due to broad differential in immunosuppressed populations"
                  },
                  {
                    "text": "Tissue necrosis = fulminant disease = worst prognosis"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "In immunosuppressed, apply low threshold for suspicious viral cytopathic effect (HIV)"
                  },
                  {
                    "text": "Immunohistochemistry, &/or culture confirm diagnosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Herpes Viruses": {
            "name": "Herpes Viruses",
            "url": "https://app.pathprimer.com/document/62db8bc3-3182-4c42-89d3-13befb0b4d3e/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
            "content": {
              "Key Facts": {
                "Clinical Issues": [
                  {
                    "text": "Primary HSV infection (most common)Oral skin/mucosa (HSV-1)Genital skin (HSV-2)Temporal lobes, uni- or bilateral (HSV-1)Liver (fulminant hepatitis)",
                    "sub_points": [
                      "Oral skin/mucosa (HSV-1)",
                      "Genital skin (HSV-2)",
                      "Temporal lobes, uni- or bilateral (HSV-1)",
                      "Liver (fulminant hepatitis)"
                    ]
                  },
                  {
                    "text": "ImmunocompromisedMild to severe (life threatening)",
                    "sub_points": [
                      "Mild to severe (life threatening)"
                    ]
                  },
                  {
                    "text": "HSV IgM positive (primary infection)"
                  },
                  {
                    "text": "HSV PCRQualitative (primary diagnosis on CSF)",
                    "sub_points": [
                      "Qualitative (primary diagnosis on CSF)"
                    ]
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Epithelial vesicles with viral cytopathic effectPustules with neutrophils",
                    "sub_points": [
                      "Pustules with neutrophils"
                    ]
                  },
                  {
                    "text": "Necrosis with little inflammation (fulminant disease)"
                  },
                  {
                    "text": "Multinucleation, classic Cowdry A appearance"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Herpesvirus family"
                  },
                  {
                    "text": "Adenovirus"
                  },
                  {
                    "text": "Other viral infections (all sites)"
                  },
                  {
                    "text": "Bacterial infections (all sites)"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "New onset vesicular rash in an immunosuppressed or pregnant female"
                  },
                  {
                    "text": "Exaggerated or nonhealing oral ulcer with superinfection"
                  },
                  {
                    "text": "Histologic diagnoses based on viral cytopathic change should be confirmed by immunohistochemistry"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Herpes simplex virus 1 (HSV-1)"
                  },
                  {
                    "text": "Herpes simplex virus 2 (HSV-2)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Genital herpes"
                  },
                  {
                    "text": "Cold sore or fever blister"
                  },
                  {
                    "text": "Herpetic whitlow"
                  },
                  {
                    "text": "Herpes gladiatorum"
                  },
                  {
                    "text": "Ocular herpes"
                  },
                  {
                    "text": "Neonatal herpes"
                  },
                  {
                    "text": "Herpes encephalitis"
                  },
                  {
                    "text": "Mollaret meningitis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Greek: \"Herpein\" (to creep)"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Infectious Agents": [
                  {
                    "text": "Herpesviridae: Ubiquitous enveloped icosahedral double-stranded DNA viruses present in most vertebrates"
                  },
                  {
                    "text": "Herpes simplex virus 1 and 2Common human virus transmitted by contact",
                    "sub_points": [
                      "Common human virus transmitted by contact"
                    ]
                  },
                  {
                    "text": "HSV-1 and HSV-2 can cause oral/genital lesionsHSV-1 = oralHSV-2 = genital",
                    "sub_points": [
                      "HSV-1 = oral",
                      "HSV-2 = genital"
                    ]
                  },
                  {
                    "text": "Infects mucoepithelial cellsHeparan sulfate bound by viral gB (glycoprotein)Fusion and entry into cellLytic infection",
                    "sub_points": [
                      "Heparan sulfate bound by viral gB (glycoprotein)",
                      "Fusion and entry into cell",
                      "Lytic infection"
                    ]
                  },
                  {
                    "text": "Initial infectionErythematous-based vesicles filled with viral particlesProgress toPustulesCrusted lesionsUlcerations",
                    "sub_points": [
                      "Erythematous-based vesicles filled with viral particles",
                      "Progress toPustulesCrusted lesionsUlcerations",
                      "Pustules",
                      "Crusted lesions",
                      "Ulcerations"
                    ]
                  },
                  {
                    "text": "Fulminant primary infectionHSV encephalitisHSV hepatitis",
                    "sub_points": [
                      "HSV encephalitis",
                      "HSV hepatitis"
                    ]
                  },
                  {
                    "text": "Chronic infectionLatencyPermanent infectionNo vaccine or cureResides in neuronsReactivationImmunocompetent: Resurgence in primary sitesImmunosuppressed: Dissemination to any body site",
                    "sub_points": [
                      "LatencyPermanent infectionNo vaccine or cureResides in neurons",
                      "Permanent infection",
                      "No vaccine or cure",
                      "Resides in neurons",
                      "ReactivationImmunocompetent: Resurgence in primary sitesImmunosuppressed: Dissemination to any body site",
                      "Immunocompetent: Resurgence in primary sites",
                      "Immunosuppressed: Dissemination to any body site"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "Common human virus affecting any age group"
                  },
                  {
                    "text": "Direct human contact for transmissionOral/genital most commonIncidence increases with age/number of oral contacts and sex partnersGeographic variability of incidenceLowest: Japan, Western Europe (30,000 to 300,000/year)Middle: North America, Eastern Europe (600,000 to 800,000/year)Highest: Sub-Saharan Africa, Eastern Asia (3 to 3.5 million/year)",
                    "sub_points": [
                      "Oral/genital most common",
                      "Incidence increases with age/number of oral contacts and sex partners",
                      "Geographic variability of incidenceLowest: Japan, Western Europe (30,000 to 300,000/year)Middle: North America, Eastern Europe (600,000 to 800,000/year)Highest: Sub-Saharan Africa, Eastern Asia (3 to 3.5 million/year)",
                      "Lowest: Japan, Western Europe (30,000 to 300,000/year)",
                      "Middle: North America, Eastern Europe (600,000 to 800,000/year)",
                      "Highest: Sub-Saharan Africa, Eastern Asia (3 to 3.5 million/year)"
                    ]
                  }
                ],
                "Site": [
                  {
                    "text": "Primary HSV infection (most common)Oral skin/mucosa (HSV-1)Nongenital skin (HSV-1 or -2)Genital skin (HSV-2)Temporal lobes, uni- or bilateral (HSV-1)EyeLiver (fulminant hepatitis)",
                    "sub_points": [
                      "Oral skin/mucosa (HSV-1)",
                      "Nongenital skin (HSV-1 or -2)",
                      "Genital skin (HSV-2)",
                      "Temporal lobes, uni- or bilateral (HSV-1)",
                      "Eye",
                      "Liver (fulminant hepatitis)"
                    ]
                  },
                  {
                    "text": "ReactivationImmunocompetentOral skin/mucosa (HSV-1)Genital skin (HSV-2)ImmunocompromisedAny body site or organMild to severe (life threatening)",
                    "sub_points": [
                      "ImmunocompetentOral skin/mucosa (HSV-1)Genital skin (HSV-2)",
                      "Oral skin/mucosa (HSV-1)",
                      "Genital skin (HSV-2)",
                      "ImmunocompromisedAny body site or organMild to severe (life threatening)",
                      "Any body site or organ",
                      "Mild to severe (life threatening)"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Primary HSV infectionPainful new lesions of mouth/genitaliaSevere headache with temporal lobe signsNew onset rash with historical contactNewborn ocular lesions (infected mother)New onset right upper quadrant pain ± jaundice",
                    "sub_points": [
                      "Painful new lesions of mouth/genitalia",
                      "Severe headache with temporal lobe signs",
                      "New onset rash with historical contact",
                      "Newborn ocular lesions (infected mother)",
                      "New onset right upper quadrant pain ± jaundice"
                    ]
                  },
                  {
                    "text": "ReactivationResurgence of painful lesions on mouth/genitaliaNew onset of disseminated rash (immunosuppressed)Organ site-specific symptoms (any site)Example A: Painful swallowing = esophageal HSVExample B: Painful large oral ulcer = HSV with secondary colonization",
                    "sub_points": [
                      "Resurgence of painful lesions on mouth/genitalia",
                      "New onset of disseminated rash (immunosuppressed)",
                      "Organ site-specific symptoms (any site)Example A: Painful swallowing = esophageal HSVExample B: Painful large oral ulcer = HSV with secondary colonization",
                      "Example A: Painful swallowing = esophageal HSV",
                      "Example B: Painful large oral ulcer = HSV with secondary colonization"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "HSV IgM positive (primary infection)"
                  },
                  {
                    "text": "HSV IgG positive (ongoing, latent, reactivation)"
                  },
                  {
                    "text": "HSV PCRQualitative (primary diagnosis on CSF)Quantitative (following immunosuppression)",
                    "sub_points": [
                      "Qualitative (primary diagnosis on CSF)",
                      "Quantitative (following immunosuppression)"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Primary infectionSelf-limited (resolution) to life-threatening (CNS/liver involvement)",
                    "sub_points": [
                      "Self-limited (resolution) to life-threatening (CNS/liver involvement)"
                    ]
                  },
                  {
                    "text": "Lifelong latency"
                  },
                  {
                    "text": "Latency/reactivation cycles (with outbreaks)Plethora of potential triggersTraumatic injurySurgeryExposure to extreme elementsMenstruationCoinfectionHIV infectionViral protein VP16 (trans-acting protein) induces immediate gene transcription in host transcription factors",
                    "sub_points": [
                      "Plethora of potential triggersTraumatic injurySurgeryExposure to extreme elementsMenstruationCoinfectionHIV infection",
                      "Traumatic injury",
                      "Surgery",
                      "Exposure to extreme elements",
                      "Menstruation",
                      "Coinfection",
                      "HIV infection",
                      "Viral protein VP16 (trans-acting protein) induces immediate gene transcription in host transcription factors"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Primary treatment &/or suppressionAcyclovirValacyclovir",
                    "sub_points": [
                      "Acyclovir",
                      "Valacyclovir"
                    ]
                  },
                  {
                    "text": "Alternatives in cases of resistanceFamciclovirPenciclovir",
                    "sub_points": [
                      "Famciclovir",
                      "Penciclovir"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Lifelong infection with common reactivation within 1st year of infection"
                  },
                  {
                    "text": "Fulminant disease (encephalitis &/or hepatitis) is rapidly fatal without treatment"
                  },
                  {
                    "text": "Immunosuppression leads to more severe disease with reactivation"
                  }
                ]
              },
              "Microbiology": {
                "Virus Features": [
                  {
                    "text": "Double-stranded DNA virusHSV-1 has a genome of 152 kilobases encoding > 80 proteinsHSV-2 has a genome of 155 kilobases encoding > 70 proteins",
                    "sub_points": [
                      "HSV-1 has a genome of 152 kilobases encoding > 80 proteins",
                      "HSV-2 has a genome of 155 kilobases encoding > 70 proteins"
                    ]
                  },
                  {
                    "text": "Icosopentahedral capsid composed of 162 capsomers"
                  },
                  {
                    "text": "4 envelope proteins (gD, gH, gL, and gB) are essential for entry to host cells"
                  }
                ],
                "Culture": [
                  {
                    "text": "High-quality swab or needle aspiration placed in viral transport media required"
                  },
                  {
                    "text": "Virus is propagated on 1 of a variety of susceptible mammalian cell linesGrows in ~ 1 weekWill grow on all mammalian cells, including those used for Adenovirus, VZV, and CMV cultureOften overgrows these viruses (they take > 1 week)Difficult to exclude coinfection if suspected (although rare)",
                    "sub_points": [
                      "Grows in ~ 1 week",
                      "Will grow on all mammalian cells, including those used for Adenovirus, VZV, and CMV cultureOften overgrows these viruses (they take > 1 week)Difficult to exclude coinfection if suspected (although rare)",
                      "Often overgrows these viruses (they take > 1 week)",
                      "Difficult to exclude coinfection if suspected (although rare)"
                    ]
                  },
                  {
                    "text": "Virus is subtyped after culture by HSV-1- or HSV-2-specific antibodies"
                  },
                  {
                    "text": "Molecular techniques have largely replaced culture methods"
                  }
                ]
              },
              "Macroscopic Features": {
                "Skin": [
                  {
                    "text": "Vesicles/pustules with erythematous base"
                  }
                ],
                "Oral Mucosa/Esophagus": [
                  {
                    "text": "Linear to irregular ulcers with purulent crust"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Epithelial vesicles with viral cytopathic effectPustules with neutrophils",
                    "sub_points": [
                      "Pustules with neutrophils"
                    ]
                  },
                  {
                    "text": "Necrosis with little inflammation (fulminant disease)"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Multinucleation is common"
                  },
                  {
                    "text": "Large cells with classic Cowdry A appearanceProminent nucleus with viral inclusion",
                    "sub_points": [
                      "Prominent nucleus with viral inclusion"
                    ]
                  },
                  {
                    "text": "Tzanck test/smearSterilely unroofed vesicle is smeared onto a clean slideAir dried, fixed with methanol, stained with available cytology stainGiemsa, Wright stain, Diff-Quick, Field stain, methylene blueIdentifies multinucleated cells with viral cytopathic effect",
                    "sub_points": [
                      "Sterilely unroofed vesicle is smeared onto a clean slide",
                      "Air dried, fixed with methanol, stained with available cytology stainGiemsa, Wright stain, Diff-Quick, Field stain, methylene blue",
                      "Giemsa, Wright stain, Diff-Quick, Field stain, methylene blue",
                      "Identifies multinucleated cells with viral cytopathic effect"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "HSV antigen targetsGlycoproteins (polyclonal preparations)Thymidine kinase (monoclonal preparation)",
                    "sub_points": [
                      "Glycoproteins (polyclonal preparations)",
                      "Thymidine kinase (monoclonal preparation)"
                    ]
                  },
                  {
                    "text": "HSV-1 and HSV-2 performed as cocktailNo distinction required for treatmentOverlap of both virus types for all conditions",
                    "sub_points": [
                      "No distinction required for treatment",
                      "Overlap of both virus types for all conditions"
                    ]
                  }
                ],
                "PCR": [
                  {
                    "text": "Gold standard for diagnosis of central nervous system HSV infection"
                  },
                  {
                    "text": "Rapid PCR (qualitative) on cerebrospinal fluid (< 24 hours turnaround time)"
                  },
                  {
                    "text": "Therapy instituted with suspected diagnosisContinued if PCR positiveDiscontinued if PCR negative",
                    "sub_points": [
                      "Continued if PCR positive",
                      "Discontinued if PCR negative"
                    ]
                  },
                  {
                    "text": "For tissue biopsies (histology/cytology), viral cytopathic effect, culture, &/or immunohistochemistry are usually sufficient"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Herpesvirus Family": [
                  {
                    "text": "Cytomegalovirus\"Owl's-eye\" nucleusNuclear clearing and a large pink-purple intranuclear inclusion",
                    "sub_points": [
                      "\"Owl's-eye\" nucleusNuclear clearing and a large pink-purple intranuclear inclusion",
                      "Nuclear clearing and a large pink-purple intranuclear inclusion"
                    ]
                  },
                  {
                    "text": "Varicella-zoster virusClassic Cowdry type A nucleiMay appear identicalImmunohistochemistry or PCR required to distinguish",
                    "sub_points": [
                      "Classic Cowdry type A nuclei",
                      "May appear identical",
                      "Immunohistochemistry or PCR required to distinguish"
                    ]
                  },
                  {
                    "text": "When viral cytopathic effect is suspected, a panel of HSV, VZV, and CMV immunostains are recommended"
                  },
                  {
                    "text": "HSV is more likely to show multinucleation than are other herpesviruses"
                  }
                ],
                "Adenovirus": [
                  {
                    "text": "Suspicious viral cytopathic effect"
                  },
                  {
                    "text": "Typically more glassy or smudged in appearance"
                  }
                ],
                "Other Viral Infections (All Sites)": [
                  {
                    "text": "RNA viruses resulting in necrosis ± inflammation"
                  },
                  {
                    "text": "Reference testing for confirmation of other viral infections is recommended"
                  }
                ],
                "Bacterial Infections (All Sites)": [
                  {
                    "text": "Destructive necrotic lesions"
                  },
                  {
                    "text": "Demonstration of bacteria on Gram or silver stains"
                  },
                  {
                    "text": "Positive cultures of bacteria from sample"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "New onset vesicular rash in an immunosuppressed or pregnant female"
                  },
                  {
                    "text": "Exaggerated or nonhealing oral ulcer with superinfection"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Histologic diagnoses based on viral cytopathic change should be confirmed by immunohistochemistry"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Viral Hepatitis": {
            "name": "Viral Hepatitis",
            "url": "https://app.pathprimer.com/document/ef4b910b-da5e-450f-b5e4-f460361ba2ac/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Hepatotropic viruses: Hepatitis A, B, C, D, and E"
                  },
                  {
                    "text": "Herpes virus group: HSV, CMV, EBV, VZV, HHV-6"
                  },
                  {
                    "text": "Viral hemorrhagic fevers: Yellow fever, dengue fever, Ebola, hantavirus, etc."
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Important elements of chart review: Travel, food consumption, and sexual history, history of injection drug use, blood transfusions, tattoos/piercings, blood/body fluid exposures, immunosuppression"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Acute hepatitis: Hepatomegaly, cholestasis, necrosis, regenerative nodules, hemorrhage"
                  },
                  {
                    "text": "Chronic hepatitis: Hepatomegaly or atrophy, cirrhosis, masses"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Acute hepatitis (HAV, HBV ± HDV, HCV, HEV): Lobular inflammation, acidophil bodies, variable necrosis, swollen hepatocytes, lobular disarray, cholestasis, variable portal inflammation"
                  },
                  {
                    "text": "Chronic hepatitis (HBV ± HDV, HCV, rarely HEV): Portal inflammation, variable interface and lobular activity, fibrosis, cirrhosis, ± siderosis, dysplastic nodules, hepatocellular carcinoma"
                  }
                ],
                "Reporting Considerations": [
                  {
                    "text": "Final report should include: Type of viral hepatitis, extent of hepatic disease, associated extrahepatic findings, whether the virus was the cause of death or a contributing factor"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Hepatotropic Viruses": [
                  {
                    "text": "Hepatitis A (HAV), B (HBV), C (HCV), D (HDV), and E (HEV)"
                  }
                ],
                "Systemic Viruses": [
                  {
                    "text": "Herpes virus groupRisk factors: Immunocompromised states, especially HIV, pregnancy, and neonatal period, rare in immunocompetent hostsHerpes simplex virus (HSV):  Disseminated infection often fatalCytomegalovirus (CMV): May cause infectious mononucleosis-like syndrome in immunocompetentEpstein-Barr virus (EBV): Infectious mononucleosis with liver involvement, lymphoproliferative disorders, and hemophagocytic syndrome (usually fatal)Varicella zoster virus (VZV)Human herpesvirus 6 (HHV-6): May cause hemophagocytic syndrome",
                    "sub_points": [
                      "Risk factors: Immunocompromised states, especially HIV, pregnancy, and neonatal period, rare in immunocompetent hosts",
                      "Herpes simplex virus (HSV):  Disseminated infection often fatal",
                      "Cytomegalovirus (CMV): May cause infectious mononucleosis-like syndrome in immunocompetent",
                      "Epstein-Barr virus (EBV): Infectious mononucleosis with liver involvement, lymphoproliferative disorders, and hemophagocytic syndrome (usually fatal)",
                      "Varicella zoster virus (VZV)",
                      "Human herpesvirus 6 (HHV-6): May cause hemophagocytic syndrome"
                    ]
                  },
                  {
                    "text": "Viral hemorrhagic fevers (VHF)4 families of RNA viruses: Filovirus (e.g., Marburg and Ebola), flavivirus (e.g., yellow fever, dengue), arenavirus (e.g., Argentine, Bolivian, Lassa, etc.), and bunyavirus (e.g., Rift Valley fever, hantavirus)Life cycles involve humans, primates, rodents, bats, mosquitos, and ticks; also nosocomial spreadSeverity and mortality vary, not all infected patients develop diseaseHemorrhage due to abnormal vascular regulation/damage → capillary leakage → effusions, edema, hemorrhage → disseminated intravascular coagulation (DIC), hepatic/organ necrosis, shock",
                    "sub_points": [
                      "4 families of RNA viruses: Filovirus (e.g., Marburg and Ebola), flavivirus (e.g., yellow fever, dengue), arenavirus (e.g., Argentine, Bolivian, Lassa, etc.), and bunyavirus (e.g., Rift Valley fever, hantavirus)",
                      "Life cycles involve humans, primates, rodents, bats, mosquitos, and ticks; also nosocomial spread",
                      "Severity and mortality vary, not all infected patients develop disease",
                      "Hemorrhage due to abnormal vascular regulation/damage → capillary leakage → effusions, edema, hemorrhage → disseminated intravascular coagulation (DIC), hepatic/organ necrosis, shock"
                    ]
                  },
                  {
                    "text": "Other viruses that rarely affect liverAdenovirus, enterovirus, parvovirus",
                    "sub_points": [
                      "Adenovirus, enterovirus, parvovirus"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Hepatotropic virusesHAV: ~ 2,800 acute infections in USA (2011)HBV: ~ 18,000 acute infections in USA (2011), ~ 1 million chronic infectionsHCV: ~ 16,500 acute infections in USA (2011), ~ 3 million chronic infectionsHDV: Rare in US, ~ 5% of HBV carriersHEV: Clinical hepatitis rare in USA; seroprevalence may be higher",
                    "sub_points": [
                      "HAV: ~ 2,800 acute infections in USA (2011)",
                      "HBV: ~ 18,000 acute infections in USA (2011), ~ 1 million chronic infections",
                      "HCV: ~ 16,500 acute infections in USA (2011), ~ 3 million chronic infections",
                      "HDV: Rare in US, ~ 5% of HBV carriers",
                      "HEV: Clinical hepatitis rare in USA; seroprevalence may be higher"
                    ]
                  },
                  {
                    "text": "Viral hemorrhagic feverRare in USA, endemic viruses include dengue and Sin Nombre viruses",
                    "sub_points": [
                      "Rare in USA, endemic viruses include dengue and Sin Nombre viruses"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Fever, jaundice, abdominal pain, nausea, vomiting, anorexia, fatigue, arthritis, pruritis, hematuria"
                  },
                  {
                    "text": "Maculopapular, urticarial, purpural, or vesicular/pustular rash, neurologic symptoms"
                  },
                  {
                    "text": "Cough, dyspnea, hemoptysis (pneumonitis), chest pain and palpitations (myocarditis)"
                  },
                  {
                    "text": "Headache, neck stiffness, photophobia, seizures (meningoencephalitis)"
                  },
                  {
                    "text": "Petechial rash, epistaxis, melena, hematemesis, conjunctival bleeding, shock (VHF)"
                  },
                  {
                    "text": "Important elements of chart reviewTravel, food consumption, sexual history, history of injection drug use, blood transfusions, tattoos/piercings, other blood/body fluid exposures, immunosuppression, sick contacts",
                    "sub_points": [
                      "Travel, food consumption, sexual history, history of injection drug use, blood transfusions, tattoos/piercings, other blood/body fluid exposures, immunosuppression, sick contacts"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "↑ transaminases, bilirubin, ammonia, and α-fetoprotein, + viral hepatitis antibodies/RNA/DNA, + other viral serologies/RNA/DNAPostmortem blood testing for HBV and HCV antibodies and PCR has been shown to workConsider postmortem viral testing in cases of unknown liver injury",
                    "sub_points": [
                      "Postmortem blood testing for HBV and HCV antibodies and PCR has been shown to work",
                      "Consider postmortem viral testing in cases of unknown liver injury"
                    ]
                  },
                  {
                    "text": "↑ blood urea nitrogen and creatinine, proteinuria, hematuria, hypocomplementemia, + serum cryoglobulins"
                  },
                  {
                    "text": "Thrombocytopenia, anemia, lymphocytosis, prolonged prothrombin and partial thromboplastin times"
                  },
                  {
                    "text": "↑ C-reactive protein and erythrocyte sedimentation rate, pancytopenia, hemophagocytosis on blood smear"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "~ 25% chronic HBV and HCV infection will → cirrhosis/chronic liver failure → ↑ risk of hepatocellular carcinoma (HCC)Coinfection with HIV accelerates liver damage by HBV and HCV",
                    "sub_points": [
                      "Coinfection with HIV accelerates liver damage by HBV and HCV"
                    ]
                  },
                  {
                    "text": "Mortality of acute viral hepatitis varies, higher in immunocompromised"
                  }
                ]
              },
              "Macroscopic Features": {
                "External Examination/Autopsy Safety": [
                  {
                    "text": "Jaundice, scleral icterus, abdominal distension, pitting edema, anasarca, caput medusae, spider angiomas (liver failure/portal hypertension)"
                  },
                  {
                    "text": "Maculopapular, purpural, urticarial, pustular, vesicular rashes (viral exanthems)"
                  },
                  {
                    "text": "Pallor (shock), petechiae, gangrene, and mucocutaneous hemorrhage (DIC)"
                  },
                  {
                    "text": "Universal precautions mandatory in setting of necrotic or cirrhotic liver, always consider HIV coinfection"
                  }
                ],
                "Internal Examination": [
                  {
                    "text": "Ascites"
                  }
                ],
                "Organ Examination": [
                  {
                    "text": "LiverAcute/fulminant hepatitis: Hepatomegaly, edematous capsule, green discoloration (cholestasis), necrosis ± atrophy with wrinkled capsule and regenerative nodules if extensive, hemorrhagic fociChronic hepatitis: Hepatomegaly or atrophy, cirrhosis (usually macronodular), masses (HCC usually softer than surrounding nodules and vary in color ± necrosis)",
                    "sub_points": [
                      "Acute/fulminant hepatitis: Hepatomegaly, edematous capsule, green discoloration (cholestasis), necrosis ± atrophy with wrinkled capsule and regenerative nodules if extensive, hemorrhagic foci",
                      "Chronic hepatitis: Hepatomegaly or atrophy, cirrhosis (usually macronodular), masses (HCC usually softer than surrounding nodules and vary in color ± necrosis)"
                    ]
                  },
                  {
                    "text": "Other organsNecrosis/hemorrhage (DIC)Gastrointestinal tract: Ulcers, inflammation, gastric/esophageal varicesLungs: Consolidation, edemaKidneys: Cortical pallor and medullary congestion (shock), atrophic with granular subcapsular surface (chronic glomerulonephritis)Spleen: Splenomegaly",
                    "sub_points": [
                      "Necrosis/hemorrhage (DIC)",
                      "Gastrointestinal tract: Ulcers, inflammation, gastric/esophageal varices",
                      "Lungs: Consolidation, edema",
                      "Kidneys: Cortical pallor and medullary congestion (shock), atrophic with granular subcapsular surface (chronic glomerulonephritis)",
                      "Spleen: Splenomegaly"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "LiverAcute hepatitis (HAV, HBV ± HDV, HCV, HEV): Lobular inflammation, acidophil bodies, necrosis (spotty, confluent, bridging, submassive), swollen hepatocytes, lobular disarray ± parenchymal collapse, cholestasis, variable portal inflammationSpecific findings in HAV: Periportal/interface inflammatory activity and necrosis, + plasma cells, perivenular cholestasis without inflammation/necrosisChronic hepatitis (HBV ± HDV, HCV, rarely HEV): Chronic hepatitis (portal inflammation) with variable interface and lobular inflammatory activity, variable fibrosis, cirrhosis, ± siderosis, HCCHBV: Ground-glass hepatocytes (cytoplasmic inclusions containing HBV surface antigen), \"sanded\" nuclei (pale pink inclusions containing HBV core antigen)HDV: Same as HBV but usually more severe activity and necrosisHCV: Lymphoid aggregates ± germinal centers in portal tracts, acidophil bodies, ± steatosis, ± mild bile duct injuryRarely fibrosing cholestatic hepatitis in immunocompromised with HBV or HCV (periportal/perisinusoidal fibrosis, cholestasis, little/no inflammation)Nonhepatotropic viral hepatitisHSV: Geographic coagulative necrosis ± inflammation, purple glassy intranuclear inclusions with chromatin margination ± clear halo and multinucleationCMV: Intranuclear inclusions with clear halo, intracytoplasmic basophilic granules, ± microabscesses, infectious mononucleosis-like syndrome (lymphocytes in sinusoids, no inclusions), neonatal giant cell hepatitisEBV: Diffuse sinusoidal lymphocytic infiltratesVZV: Variable necrosis, little inflammation, intranuclear inclusionsHHV-6: Nonspecific lobular inflammationViral hemorrhagic feversMost appear similar with perivenular or mid-zonal necrosis without inflammation or cholestasis, ± steatosis, ballooned hepatocytes",
                    "sub_points": [
                      "Acute hepatitis (HAV, HBV ± HDV, HCV, HEV): Lobular inflammation, acidophil bodies, necrosis (spotty, confluent, bridging, submassive), swollen hepatocytes, lobular disarray ± parenchymal collapse, cholestasis, variable portal inflammationSpecific findings in HAV: Periportal/interface inflammatory activity and necrosis, + plasma cells, perivenular cholestasis without inflammation/necrosis",
                      "Specific findings in HAV: Periportal/interface inflammatory activity and necrosis, + plasma cells, perivenular cholestasis without inflammation/necrosis",
                      "Chronic hepatitis (HBV ± HDV, HCV, rarely HEV): Chronic hepatitis (portal inflammation) with variable interface and lobular inflammatory activity, variable fibrosis, cirrhosis, ± siderosis, HCCHBV: Ground-glass hepatocytes (cytoplasmic inclusions containing HBV surface antigen), \"sanded\" nuclei (pale pink inclusions containing HBV core antigen)HDV: Same as HBV but usually more severe activity and necrosisHCV: Lymphoid aggregates ± germinal centers in portal tracts, acidophil bodies, ± steatosis, ± mild bile duct injuryRarely fibrosing cholestatic hepatitis in immunocompromised with HBV or HCV (periportal/perisinusoidal fibrosis, cholestasis, little/no inflammation)",
                      "HBV: Ground-glass hepatocytes (cytoplasmic inclusions containing HBV surface antigen), \"sanded\" nuclei (pale pink inclusions containing HBV core antigen)",
                      "HDV: Same as HBV but usually more severe activity and necrosis",
                      "HCV: Lymphoid aggregates ± germinal centers in portal tracts, acidophil bodies, ± steatosis, ± mild bile duct injury",
                      "Rarely fibrosing cholestatic hepatitis in immunocompromised with HBV or HCV (periportal/perisinusoidal fibrosis, cholestasis, little/no inflammation)",
                      "Nonhepatotropic viral hepatitisHSV: Geographic coagulative necrosis ± inflammation, purple glassy intranuclear inclusions with chromatin margination ± clear halo and multinucleationCMV: Intranuclear inclusions with clear halo, intracytoplasmic basophilic granules, ± microabscesses, infectious mononucleosis-like syndrome (lymphocytes in sinusoids, no inclusions), neonatal giant cell hepatitisEBV: Diffuse sinusoidal lymphocytic infiltratesVZV: Variable necrosis, little inflammation, intranuclear inclusionsHHV-6: Nonspecific lobular inflammation",
                      "HSV: Geographic coagulative necrosis ± inflammation, purple glassy intranuclear inclusions with chromatin margination ± clear halo and multinucleation",
                      "CMV: Intranuclear inclusions with clear halo, intracytoplasmic basophilic granules, ± microabscesses, infectious mononucleosis-like syndrome (lymphocytes in sinusoids, no inclusions), neonatal giant cell hepatitis",
                      "EBV: Diffuse sinusoidal lymphocytic infiltrates",
                      "VZV: Variable necrosis, little inflammation, intranuclear inclusions",
                      "HHV-6: Nonspecific lobular inflammation",
                      "Viral hemorrhagic feversMost appear similar with perivenular or mid-zonal necrosis without inflammation or cholestasis, ± steatosis, ballooned hepatocytes",
                      "Most appear similar with perivenular or mid-zonal necrosis without inflammation or cholestasis, ± steatosis, ballooned hepatocytes"
                    ]
                  },
                  {
                    "text": "Other organsEsophageal/gastrointestinal ulcers ± viral inclusionsPneumonitis, myocarditis ± viral inclusionsGlomerulonephritis, acute tubular injury/necrosisDIC: Widespread microthrombi ± hemorrhage and ischemic necrosis, schistocytes in peripheral blood",
                    "sub_points": [
                      "Esophageal/gastrointestinal ulcers ± viral inclusions",
                      "Pneumonitis, myocarditis ± viral inclusions",
                      "Glomerulonephritis, acute tubular injury/necrosis",
                      "DIC: Widespread microthrombi ± hemorrhage and ischemic necrosis, schistocytes in peripheral blood"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "HBV surface and core antigens, HDV antigen, HSV, CMV, VZV, HHV-6, adenovirus, parvovirus, enterovirus"
                  },
                  {
                    "text": "Some VHFs: Dengue ([+] in Kupffer cells), Lassa, Ebola"
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "EBER for EBV"
                  }
                ],
                "Special Stains": [
                  {
                    "text": "Trichrome to evaluate fibrosis/staging"
                  },
                  {
                    "text": "Iron stain for siderosis"
                  },
                  {
                    "text": "Reticulin stain to evaluate sinusoidal architecture and presence of parenchymal collapse"
                  }
                ]
              },
              "Reporting Criteria": {
                "Final Report Should Include": [
                  {
                    "text": "Type of viral hepatitis, extent of hepatic disease, associated extrahepatic findings, whether virus was the cause of death or a contributing factor"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Epstein-Barr Virus": {
            "name": "Epstein-Barr Virus",
            "url": "https://app.pathprimer.com/document/468afefd-2b12-4503-8a6d-93634ad88e90/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Infects B-lineage lymphocytes"
                  },
                  {
                    "text": "Infectious mononucleosis: Flu-like systemic disease"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "50% of children at 5 years of age are seropositive"
                  },
                  {
                    "text": "95% of adults are seropositive"
                  },
                  {
                    "text": "Infectious mononucleosis &/or reactivationLymphadenopathyHepatosplenomegaly ± jaundiceRash (less common)",
                    "sub_points": [
                      "Lymphadenopathy",
                      "Hepatosplenomegaly ± jaundice",
                      "Rash (less common)"
                    ]
                  },
                  {
                    "text": "Lymphocyte + monocyte count > 50%"
                  },
                  {
                    "text": "EBV VCA IgM positive"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Reactive lymph nodes with prominent germinal centers"
                  },
                  {
                    "text": "Large, reactive lymphocytes with abundant cytoplasm"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Epstein-Barr virus (EBV)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Infectious mononucleosis"
                  },
                  {
                    "text": "Human herpesvirus-4 (HHV-4)"
                  },
                  {
                    "text": "Glandular fever, mono, Pfeiffer disease, kissing disease"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Epstein-Barr virus derived from M. A. Epstein & Y. Barr (University of Bristol and of London, 1966)"
                  },
                  {
                    "text": "Burkitt Lymphoma derived from D. P. Burkitt (Surgeon in Uganda, 1963)"
                  },
                  {
                    "text": "Hodgkin Lymphoma derived from T. Hodgkin (1832)"
                  },
                  {
                    "text": "\"Herpesvirus\" derived from \"herpein\" (to creep)"
                  },
                  {
                    "text": "Herpesviridae: Ubiquitous enveloped icosahedral double-stranded DNA viruses present in most vertebrates"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Infectious Agents": [
                  {
                    "text": "Ubiquitous virusInfects B-lineage lymphocytesCD21 (complement receptor 2) bound by viral gp350 and MHC class II bound by gp42Fusion and entry into cellInfects epithelial cellsβ-1 integrins bound by viral BMRF-2 and α-V-β-6/-8 integrins bound by viral gH/gLFusion and entry into cellInitial infection (asymptomatic in most patients)Infectious mononucleosis: Flu-like systemic diseaseChronic infectionLatency: AsymptomaticReactivation: Flu-like systemic diseaseTransformation: Malignancies",
                    "sub_points": [
                      "Infects B-lineage lymphocytesCD21 (complement receptor 2) bound by viral gp350 and MHC class II bound by gp42Fusion and entry into cell",
                      "CD21 (complement receptor 2) bound by viral gp350 and MHC class II bound by gp42",
                      "Fusion and entry into cell",
                      "Infects epithelial cellsβ-1 integrins bound by viral BMRF-2 and α-V-β-6/-8 integrins bound by viral gH/gLFusion and entry into cell",
                      "β-1 integrins bound by viral BMRF-2 and α-V-β-6/-8 integrins bound by viral gH/gL",
                      "Fusion and entry into cell",
                      "Initial infection (asymptomatic in most patients)Infectious mononucleosis: Flu-like systemic disease",
                      "Infectious mononucleosis: Flu-like systemic disease",
                      "Chronic infectionLatency: AsymptomaticReactivation: Flu-like systemic diseaseTransformation: Malignancies",
                      "Latency: Asymptomatic",
                      "Reactivation: Flu-like systemic disease",
                      "Transformation: Malignancies"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "Ubiquitous virus affecting young children to adults"
                  },
                  {
                    "text": "Oral secretion/genital secretion viral transfer"
                  },
                  {
                    "text": "50% of children at 5 years of age are seropositive"
                  },
                  {
                    "text": "95% of adults are seropositive"
                  }
                ],
                "Site": [
                  {
                    "text": "Infectious mononucleosis &/or reactivationLymph nodes, liver, skin",
                    "sub_points": [
                      "Lymph nodes, liver, skin"
                    ]
                  },
                  {
                    "text": "Transformation = malignanciesB-lineage malignancies of any body sitesNasopharyngeal carcinoma",
                    "sub_points": [
                      "B-lineage malignancies of any body sites",
                      "Nasopharyngeal carcinoma"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Infectious mononucleosisFatigueLymphadenopathyAcute pharyngitisHepatosplenomegaly ± jaundice (adults)Frank hepatitis (rare)Rash (less common)MaculopapularPalatal petechiaeErythema nodosum/multiforme (very rare)Periorbital edema (rare)",
                    "sub_points": [
                      "Fatigue",
                      "Lymphadenopathy",
                      "Acute pharyngitis",
                      "Hepatosplenomegaly ± jaundice (adults)Frank hepatitis (rare)",
                      "Frank hepatitis (rare)",
                      "Rash (less common)MaculopapularPalatal petechiaeErythema nodosum/multiforme (very rare)",
                      "Maculopapular",
                      "Palatal petechiae",
                      "Erythema nodosum/multiforme (very rare)",
                      "Periorbital edema (rare)"
                    ]
                  },
                  {
                    "text": "Incubation period: 4-6 weeks"
                  },
                  {
                    "text": "Viral prodrome: 1-2 weeks"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Lymphocyte + monocyte count > 50%"
                  },
                  {
                    "text": "Heterophil agglutination antibody test positive"
                  },
                  {
                    "text": "EBV viral capsid antigen IgM positive"
                  },
                  {
                    "text": "Transaminitis (with liver involvement)"
                  }
                ],
                "Natural History": [
                  {
                    "text": "With supportive care, self limited with lifelong latent infection"
                  },
                  {
                    "text": "Rare complications of primary infection (< 5%)MeningoencephalitisGuillain-Barré syndromeMyocarditisFulminant hepatitisSplenic ruptureHemolytic anemia and other cytopeniasHemophagocytic lymphohistiocytosis",
                    "sub_points": [
                      "Meningoencephalitis",
                      "Guillain-Barré syndrome",
                      "Myocarditis",
                      "Fulminant hepatitis",
                      "Splenic rupture",
                      "Hemolytic anemia and other cytopenias",
                      "Hemophagocytic lymphohistiocytosis"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Supportive (complication management is specific to symptom &/or manifestation)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "95% of primary infections resolve without complications"
                  },
                  {
                    "text": "Lifelong viral infection with latency"
                  },
                  {
                    "text": "Risk of EBV-related malignancies"
                  }
                ]
              },
              "Microbiology": {
                "Virus Features": [
                  {
                    "text": "Enveloped, lytic/latent, double-stranded DNA virus"
                  },
                  {
                    "text": "120-180 nm"
                  },
                  {
                    "text": "192,000 bp genome (85 genes)"
                  }
                ]
              },
              "Macroscopic Features": {
                "Lymphadenopathy": [
                  {
                    "text": "Large reactive lymph nodes may be biopsied in nonclassical cases"
                  },
                  {
                    "text": "Primary EBV in children may histologically mimic lymphoma"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Reactive lymph nodes with prominent germinal centers"
                  },
                  {
                    "text": "Hepatitis with increased lymphoid cells, nonaggregate, in sinusoids"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Large, reactive lymphocytes with abundant cytoplasmCommonly seen in peripheral blood during acute infection",
                    "sub_points": [
                      "Commonly seen in peripheral blood during acute infection"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "In Situ Hybridization": [
                  {
                    "text": "Direct probe for EBV nuclear antigen (EBNA)"
                  }
                ],
                "Serologic Testing": [
                  {
                    "text": "IgM for VCA is present in acute, recurrent, or reactivated diseasePositive IgM for VCA in presence of any other pattern of antibodies suggests active disease",
                    "sub_points": [
                      "Positive IgM for VCA in presence of any other pattern of antibodies suggests active disease"
                    ]
                  },
                  {
                    "text": "IgG for VCA peaks 2-4 months after acute infection (persists for life of patient)"
                  },
                  {
                    "text": "IgG for EBNA or early antigen (EA) peaks 2-8 months after acute infection"
                  },
                  {
                    "text": "Immunosuppressed patients may respond abnormally and present incomplete patterns"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Cytomegalovirus Primary Infection": [
                  {
                    "text": "May present with mono-like syndrome identical to EBV"
                  }
                ],
                "Primary HIV Infection": [
                  {
                    "text": "May present with mono-like syndrome identical to EBV"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Helicobacteriosis": {
            "name": "Helicobacteriosis",
            "url": "https://app.pathprimer.com/document/f8fd1c86-69cf-4c3c-8116-081de6ffedf0/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Worldwide, fecal-oral or oral-oral transmission"
                  },
                  {
                    "text": "Helicobacter pyloriAccounts for 99% of helicobacteriosisRisk of ulcer with exposure: 20%; risk of cancer: < 5%",
                    "sub_points": [
                      "Accounts for 99% of helicobacteriosis",
                      "Risk of ulcer with exposure: 20%; risk of cancer: < 5%"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Breath urease/urea testDetects active production of urease enzyme, highly sensitive and specific",
                    "sub_points": [
                      "Detects active production of urease enzyme, highly sensitive and specific"
                    ]
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "H. pylorion biopsySmall, faint collections of long, curved rods at epithelia cell border (within upper quarter of cell) or collections in lumen",
                    "sub_points": [
                      "Small, faint collections of long, curved rods at epithelia cell border (within upper quarter of cell) or collections in lumen"
                    ]
                  },
                  {
                    "text": "Chronic gastritis: Lymphoid aggregates in mucosa"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Infectious ulcer, gastric ulcer, duodenal ulcer"
                  },
                  {
                    "text": "Helicobacter pyloriinfection"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Greek: \"Heliks\" (twisted or spiral) + \"bakterion\" (small staff)"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Environmental Exposure": [
                  {
                    "text": "Worldwide distribution transmitted by fecal-oral or oral-oral transmission"
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "Helicobacter pylori(formerlyCampylobacter pylori) infectionAccounts for 99% of helicobacteriosisRisk of ulcer with exposure: 20%Risk of cancer: < 5%",
                    "sub_points": [
                      "Accounts for 99% of helicobacteriosis",
                      "Risk of ulcer with exposure: 20%",
                      "Risk of cancer: < 5%"
                    ]
                  },
                  {
                    "text": "Helicobacter heilmannii1% of allHelicobacterinfections",
                    "sub_points": [
                      "1% of allHelicobacterinfections"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "Upper gastrointestinal tract colonization/infection in 50% of world population"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic (80%)"
                  },
                  {
                    "text": "Nausea, vomiting, abdominal pain"
                  },
                  {
                    "text": "\"Heartburn,\" halitosis, morning hunger"
                  },
                  {
                    "text": "Diarrhea"
                  },
                  {
                    "text": "Gastric ulcer: Worsens with food due to increased acid productionGastric adenocarcinoma: Complication of chronic untreated infection with ulceration (early satiety, hematochezia)Gastric lymphoma: Complication of chronic inflammation due to infection",
                    "sub_points": [
                      "Gastric adenocarcinoma: Complication of chronic untreated infection with ulceration (early satiety, hematochezia)",
                      "Gastric lymphoma: Complication of chronic inflammation due to infection"
                    ]
                  },
                  {
                    "text": "Duodenal ulcer: Improves with food due to closing of pylorusUsually associated with predominantly antral gastritis",
                    "sub_points": [
                      "Usually associated with predominantly antral gastritis"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Serum antibody testExposure to bacteria, least sensitive for presence of bacteriaSensitivity and specificity > 90% (new infection)",
                    "sub_points": [
                      "Exposure to bacteria, least sensitive for presence of bacteria",
                      "Sensitivity and specificity > 90% (new infection)"
                    ]
                  },
                  {
                    "text": "Stool antigen testPresence of bacteria, does not indicate degree of disease, can determine eradicationSensitivity and specificity are 98% and 94% (initial stage of disease)",
                    "sub_points": [
                      "Presence of bacteria, does not indicate degree of disease, can determine eradication",
                      "Sensitivity and specificity are 98% and 94% (initial stage of disease)"
                    ]
                  },
                  {
                    "text": "Breath urease/urea testDetects active production of urease enzyme (which bacteria uses to neutralize stomach acid)Highly sensitive and specific",
                    "sub_points": [
                      "Detects active production of urease enzyme (which bacteria uses to neutralize stomach acid)",
                      "Highly sensitive and specific"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Triple regiment of antibiotics and antacid medications are used to heal ulcer and eradicate organisme.g., omeprazole (or lansoprazole), amoxicillin, clarithromycin; bismuth subsalicylate, metronidazole, and tetracycline",
                    "sub_points": [
                      "e.g., omeprazole (or lansoprazole), amoxicillin, clarithromycin; bismuth subsalicylate, metronidazole, and tetracycline"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "In patients where infection is eradicated, risk of cancer is reduced"
                  },
                  {
                    "text": "Reinfection may occur"
                  }
                ]
              },
              "Microbiology": {
                "Characteristics": [
                  {
                    "text": "Gram-negative, microaerophilic curved bacterium with flagella"
                  },
                  {
                    "text": "Produces urease for protection from stomach acid"
                  },
                  {
                    "text": "Positive for hydrogenase, oxidase, and catalase"
                  },
                  {
                    "text": "Contains adhesins, porins, iron transporters, and flagellum-associated proteins"
                  },
                  {
                    "text": "Pathogenicity island (cag)"
                  }
                ],
                "Culture": [
                  {
                    "text": "Indicated if patient fails basic triple regimen therapy for eradication of organism (drug resistance)"
                  },
                  {
                    "text": "Homogenized stomach biopsies are plated onto trypticase soy sheep blood agar and incubated at 5-7% oxygen/5% carbon dioxide at 35 °C (growth within 2-4 days)"
                  },
                  {
                    "text": "Antibiotic susceptibility testing is performed using a battery of antibiotics to determine resistance and select additional treatment"
                  }
                ]
              },
              "Macroscopic Features": {
                "Endoscopy": [
                  {
                    "text": "Ulceration of mucosa (active infection)"
                  },
                  {
                    "text": "Puckered ulcers with fixed borders (carcinoma)"
                  },
                  {
                    "text": "Large, fixed masses (lymphoma)"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "H. pylorion biopsySmall, faint collections of long, curved rods at epithelia cell border (within upper quarter of cell) or collections in lumen",
                    "sub_points": [
                      "Small, faint collections of long, curved rods at epithelia cell border (within upper quarter of cell) or collections in lumen"
                    ]
                  },
                  {
                    "text": "Chronic gastritisIncreased plasma cells in lamina propriaLymphoid aggregates in mucosa",
                    "sub_points": [
                      "Increased plasma cells in lamina propria",
                      "Lymphoid aggregates in mucosa"
                    ]
                  },
                  {
                    "text": "Atrophic gastritisLoss of mucosal epithelial cells, glandular metaplasia, fibrosis",
                    "sub_points": [
                      "Loss of mucosal epithelial cells, glandular metaplasia, fibrosis"
                    ]
                  },
                  {
                    "text": "Mucinous intestinal type gland metaplasia ± dysplasia"
                  },
                  {
                    "text": "Gastric adenocarcinoma"
                  },
                  {
                    "text": "Mucosa-associated lymphatic tissue (MALT) lymphoma"
                  }
                ]
              },
              "Ancillary Tests": {
                "Histochemistry": [
                  {
                    "text": "Organisms seen on Gram stain (negative), Giemsa stain (faint), Warthin-Starry silver stain (black), Alcian yellow (blue-green), Wright-Giemsa (blue), and Toluidine blue (dark blue)"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Anti-H. pyloriantibodies are more sensitive and specific than histochemistry and should be used for confirmationBoth curved rod forms and coccoid forms (after therapy) are detected by IHC",
                    "sub_points": [
                      "Both curved rod forms and coccoid forms (after therapy) are detected by IHC"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Autoimmune Gastritis": [
                  {
                    "text": "Limited to body and fundus, atrophy of oxyntic glands with mucinous metaplasia, hyperplasia of enterochromaffin-like cells"
                  },
                  {
                    "text": "Absence ofHelicobacteron special stains/IHC; history of autoimmune disease(s)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Mycobacterium tuberculosis": {
            "name": "Mycobacterium tuberculosis",
            "url": "https://app.pathprimer.com/document/44e1144b-9efd-4e0a-b288-135ca4e1ea4a/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Members of MTB complex are rod-shaped, acid-fast, aerobic, slow-growing intracellular pathogens that subvert phagosomal cells in order to persist and evade immune system"
                  },
                  {
                    "text": "Humans are the only natural reservoir for mycobacterial speciesM. tuberculosis,M. africanum, andM. canetti"
                  },
                  {
                    "text": "Most common in developing world"
                  },
                  {
                    "text": "Drug resistance is a serious problem and some infections are virtually untreatable"
                  },
                  {
                    "text": "Transmission is mainly by inhalation of contaminated droplets, thoughM. bovisinfection can be transmitted from cattle via undercooked meat or unpasteurized milk"
                  },
                  {
                    "text": "May establish itself in a subclinical, latent state, or immediately progress to active disease (~ 10%)"
                  },
                  {
                    "text": "Latent disease may reactivate in old age, in periods of stress or nutrient deprivation, or upon immunosuppression or HIV infection"
                  },
                  {
                    "text": "Pulmonary tuberculosis is most common manifestationUsually presents with nonspecific constitutional symptoms and productive cough",
                    "sub_points": [
                      "Usually presents with nonspecific constitutional symptoms and productive cough"
                    ]
                  },
                  {
                    "text": "Extrapulmonary tuberculosis can affect virtually any organ system and result from contiguous or lymphohematogenous spread"
                  },
                  {
                    "text": "Histopathologic hallmark is a necrotizing granuloma with giant cells and epithelioid histiocytes"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Mycobacterium tuberculosis(MTB)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Tubercle bacillus, Koch bacillus"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Greek: \"Myco\" (fungi, for similarity of mycobacteria to fungal growth on liquid media surfaces)"
                  },
                  {
                    "text": "Latin: \"Tuber\" (lump or swelling)"
                  }
                ],
                "Manifestations": [
                  {
                    "text": "Phthisis, consumption"
                  },
                  {
                    "text": "Tuberculosis"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Environmental Exposure": [
                  {
                    "text": "Humans are the only natural reservoir for mycobacterial speciesM. tuberculosis,Mycobacterium africanum, andMycobacterium canetti"
                  },
                  {
                    "text": "Most common in developing world"
                  },
                  {
                    "text": "Cattle are also reservoirs of mycobacterial speciesMycobacterium bovisandMycobacterium caprae"
                  },
                  {
                    "text": "Seals are reservoir forMycobacterium pinnipedii"
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "Mycobacterium tuberculosiscomplex comprises several species with > 99.9% identityMembers pertinent for human disease includeM. tuberculosis,M. africanum,M. canetti,M. bovis,M. caprae, andM.pinnipedii",
                    "sub_points": [
                      "Members pertinent for human disease includeM. tuberculosis,M. africanum,M. canetti,M. bovis,M. caprae, andM.pinnipedii"
                    ]
                  },
                  {
                    "text": "Transmission is mainly by inhalation of contaminated droplets, thoughM. bovisinfection can be transmitted from cattle via undercooked meat or unpasteurized milk"
                  },
                  {
                    "text": "MTB are intracellular pathogens that subvert phagosomal cell in order to persist and evade immune system"
                  },
                  {
                    "text": "Immunomodulatory components include cell wall, which contains a unique complement of glycolipid moietiesIncludes lipomannan, lipoarabinomannan and mycolic acids, responsible for acid-fastness of organism",
                    "sub_points": [
                      "Includes lipomannan, lipoarabinomannan and mycolic acids, responsible for acid-fastness of organism"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Presentation": [
                  {
                    "text": "Upon infection, MTB may establish itself in a subclinical, latent state or immediately progress to active disease (~ 10%)"
                  },
                  {
                    "text": "Latent disease may reactivate in old age, in periods of stress or nutrient deprivation, or upon immunosuppression or HIV infection"
                  },
                  {
                    "text": "Risk factors for active disease include extremes of age, immunosuppression, and coinfection with HIV"
                  },
                  {
                    "text": "Pulmonary tuberculosisTypically, very early disease is asymptomaticProgresses to nonspecific constitutional symptomsUsually includes productive coughHemoptysis usually indicates endobronchial erosion in advanced diseaseOften diagnosed upon chest imaging that shows infiltrates in lung apices or cavitation (CT or MR) in advanced disease",
                    "sub_points": [
                      "Typically, very early disease is asymptomaticProgresses to nonspecific constitutional symptomsUsually includes productive coughHemoptysis usually indicates endobronchial erosion in advanced disease",
                      "Progresses to nonspecific constitutional symptoms",
                      "Usually includes productive cough",
                      "Hemoptysis usually indicates endobronchial erosion in advanced disease",
                      "Often diagnosed upon chest imaging that shows infiltrates in lung apices or cavitation (CT or MR) in advanced disease"
                    ]
                  },
                  {
                    "text": "Extrapulmonary tuberculosis can result from contiguous or lymphohematogenous spreadMiliary tuberculosis: Progressive, widely disseminated disease (foci resemble \"millet seeds\")Central nervous system (CNS) tuberculosisCommon complication of childhood diseaseSymptoms range widely, include headache, vomiting, mental status changes, meningismus, focal neurologic signs, and comaCSF usually shows lymphocytic predominance, high protein, and low glucoseAcid-fast bacilli (AFB) may be present on Gram stainPleurisy: Most common in young childrenPericarditis: Most common in HIV(+) patientsSkeletal tuberculosis (Pott disease)Occurs in 1/3 of casesTypically begins on anterior aspect of vertebral bodySpreads to disks and other vertebraTends to affect lower thoracic or lumbar spine (also hips and knees)Commonly progresses to paraspinal abscess (can be extensive)Lymphadenitis (scrofula)Most common form of extrapulmonary tuberculosisHIV negative: Usually unilateral and cervical; no systemic symptomsHIV positive and AIDS: Often multifocal and marked systemic symptomsCommonly complicated by suppuration, sinus formation, and enlargement of surrounding nodes (which may represent immune activation rather than spread)RenalAsymptomatic lesions common in pulmonary TBUsually sterile pyuriaAdvanced disease includes papillar necrosis, uretal stricture, hydronephrosis, cavitation, and autonephrectomyGenitourinaryMales: Often a tender scrotal mass with draining sinus; may have calcified foci in prostateFemales: Hematogenous spread commonly involves endometrium and ovaries; may mimic carcinoma in cervix or peritoneal carcinomatosisOther extrapulmonary manifestationsGastrointestinal: Can affect any part of GI tract (also hepatic and pancreatic inflammation and masses)Peritoneal: Plastic and serous typesCutaneous: Lupus vulgaris (most common form), scrofuloderma",
                    "sub_points": [
                      "Miliary tuberculosis: Progressive, widely disseminated disease (foci resemble \"millet seeds\")",
                      "Central nervous system (CNS) tuberculosisCommon complication of childhood diseaseSymptoms range widely, include headache, vomiting, mental status changes, meningismus, focal neurologic signs, and comaCSF usually shows lymphocytic predominance, high protein, and low glucoseAcid-fast bacilli (AFB) may be present on Gram stain",
                      "Common complication of childhood disease",
                      "Symptoms range widely, include headache, vomiting, mental status changes, meningismus, focal neurologic signs, and coma",
                      "CSF usually shows lymphocytic predominance, high protein, and low glucose",
                      "Acid-fast bacilli (AFB) may be present on Gram stain",
                      "Pleurisy: Most common in young children",
                      "Pericarditis: Most common in HIV(+) patients",
                      "Skeletal tuberculosis (Pott disease)Occurs in 1/3 of casesTypically begins on anterior aspect of vertebral bodySpreads to disks and other vertebraTends to affect lower thoracic or lumbar spine (also hips and knees)Commonly progresses to paraspinal abscess (can be extensive)",
                      "Occurs in 1/3 of cases",
                      "Typically begins on anterior aspect of vertebral body",
                      "Spreads to disks and other vertebra",
                      "Tends to affect lower thoracic or lumbar spine (also hips and knees)",
                      "Commonly progresses to paraspinal abscess (can be extensive)",
                      "Lymphadenitis (scrofula)Most common form of extrapulmonary tuberculosisHIV negative: Usually unilateral and cervical; no systemic symptomsHIV positive and AIDS: Often multifocal and marked systemic symptomsCommonly complicated by suppuration, sinus formation, and enlargement of surrounding nodes (which may represent immune activation rather than spread)",
                      "Most common form of extrapulmonary tuberculosis",
                      "HIV negative: Usually unilateral and cervical; no systemic symptoms",
                      "HIV positive and AIDS: Often multifocal and marked systemic symptoms",
                      "Commonly complicated by suppuration, sinus formation, and enlargement of surrounding nodes (which may represent immune activation rather than spread)",
                      "RenalAsymptomatic lesions common in pulmonary TBUsually sterile pyuriaAdvanced disease includes papillar necrosis, uretal stricture, hydronephrosis, cavitation, and autonephrectomy",
                      "Asymptomatic lesions common in pulmonary TB",
                      "Usually sterile pyuria",
                      "Advanced disease includes papillar necrosis, uretal stricture, hydronephrosis, cavitation, and autonephrectomy",
                      "GenitourinaryMales: Often a tender scrotal mass with draining sinus; may have calcified foci in prostateFemales: Hematogenous spread commonly involves endometrium and ovaries; may mimic carcinoma in cervix or peritoneal carcinomatosis",
                      "Males: Often a tender scrotal mass with draining sinus; may have calcified foci in prostate",
                      "Females: Hematogenous spread commonly involves endometrium and ovaries; may mimic carcinoma in cervix or peritoneal carcinomatosis",
                      "Other extrapulmonary manifestationsGastrointestinal: Can affect any part of GI tract (also hepatic and pancreatic inflammation and masses)Peritoneal: Plastic and serous typesCutaneous: Lupus vulgaris (most common form), scrofuloderma",
                      "Gastrointestinal: Can affect any part of GI tract (also hepatic and pancreatic inflammation and masses)",
                      "Peritoneal: Plastic and serous types",
                      "Cutaneous: Lupus vulgaris (most common form), scrofuloderma"
                    ]
                  },
                  {
                    "text": "Other MTB complex organismsM. africanumCauses a tuberculosis-like (clinically and histologically equivalent) disease predominantly in West AfricaPatients affected with symptoms are usually immunocompromisedLacks \"region of difference 9,\" which may be related to differences in pathogenesisM. canettiCauses a tuberculosis-like (clinically and histologically equivalent) disease predominantly in Horn of AfricaPatients affected with symptoms may be immunocompetent or immunocompromisedSpecies has a novel phenolic glycolipid and lipo-oligosaccharideM. bovisCauses a tuberculosis-like (clinically and histologically equivalent) disease after animal exposureControl is primarily through culling of affected animalsInherently resistant to pyrazinamideM. capraeCauses a tuberculosis-like (clinically and histologically equivalent) disease after animal exposure in Eastern EuropeControl is primarily through culling of affected animalsDistinguished by molecular genotyping techniquesM. pinnipediiCauses a tuberculosis-like (clinically and histologically equivalent) disease after exposure to seals, guinea pigs, rabbits, or tapirsDistinguished by molecular genotyping techniques",
                    "sub_points": [
                      "M. africanumCauses a tuberculosis-like (clinically and histologically equivalent) disease predominantly in West AfricaPatients affected with symptoms are usually immunocompromisedLacks \"region of difference 9,\" which may be related to differences in pathogenesis",
                      "Causes a tuberculosis-like (clinically and histologically equivalent) disease predominantly in West Africa",
                      "Patients affected with symptoms are usually immunocompromised",
                      "Lacks \"region of difference 9,\" which may be related to differences in pathogenesis",
                      "M. canettiCauses a tuberculosis-like (clinically and histologically equivalent) disease predominantly in Horn of AfricaPatients affected with symptoms may be immunocompetent or immunocompromisedSpecies has a novel phenolic glycolipid and lipo-oligosaccharide",
                      "Causes a tuberculosis-like (clinically and histologically equivalent) disease predominantly in Horn of Africa",
                      "Patients affected with symptoms may be immunocompetent or immunocompromised",
                      "Species has a novel phenolic glycolipid and lipo-oligosaccharide",
                      "M. bovisCauses a tuberculosis-like (clinically and histologically equivalent) disease after animal exposureControl is primarily through culling of affected animalsInherently resistant to pyrazinamide",
                      "Causes a tuberculosis-like (clinically and histologically equivalent) disease after animal exposure",
                      "Control is primarily through culling of affected animals",
                      "Inherently resistant to pyrazinamide",
                      "M. capraeCauses a tuberculosis-like (clinically and histologically equivalent) disease after animal exposure in Eastern EuropeControl is primarily through culling of affected animalsDistinguished by molecular genotyping techniques",
                      "Causes a tuberculosis-like (clinically and histologically equivalent) disease after animal exposure in Eastern Europe",
                      "Control is primarily through culling of affected animals",
                      "Distinguished by molecular genotyping techniques",
                      "M. pinnipediiCauses a tuberculosis-like (clinically and histologically equivalent) disease after exposure to seals, guinea pigs, rabbits, or tapirsDistinguished by molecular genotyping techniques",
                      "Causes a tuberculosis-like (clinically and histologically equivalent) disease after exposure to seals, guinea pigs, rabbits, or tapirs",
                      "Distinguished by molecular genotyping techniques"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Tuberculin skin testingUsed screen to detect exposure by reaction to an intradermal dose of purified protein derivative (PPD)",
                    "sub_points": [
                      "Used screen to detect exposure by reaction to an intradermal dose of purified protein derivative (PPD)"
                    ]
                  },
                  {
                    "text": "Interferon release assaysELISA-based assay to determine the release of interferon gamma in response to multiple, purified MTB productsDoes not cross-react with BCG, though may with other mycobacterial species",
                    "sub_points": [
                      "ELISA-based assay to determine the release of interferon gamma in response to multiple, purified MTB products",
                      "Does not cross-react with BCG, though may with other mycobacterial species"
                    ]
                  },
                  {
                    "text": "SputumAcid-fast staining, culture, and direct detection or organisms by PCRIn a suspected patient, 3 sputa are required to rule out/rule in infection",
                    "sub_points": [
                      "Acid-fast staining, culture, and direct detection or organisms by PCR",
                      "In a suspected patient, 3 sputa are required to rule out/rule in infection"
                    ]
                  },
                  {
                    "text": "Lumbar punctureMay demonstrate organisms (by culture or AFB stain) in meningitisHigh protein, low glucose, lymphocytic predominance",
                    "sub_points": [
                      "May demonstrate organisms (by culture or AFB stain) in meningitis",
                      "High protein, low glucose, lymphocytic predominance"
                    ]
                  },
                  {
                    "text": "Fine-needle aspirationMay show organisms in lymphadenitisOften smear positive in HIV(+)May need biopsy and culture to detect in HIV(-)",
                    "sub_points": [
                      "May show organisms in lymphadenitis",
                      "Often smear positive in HIV(+)",
                      "May need biopsy and culture to detect in HIV(-)"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Mycobacterial lymphadenitis may have to be surgically excised"
                  },
                  {
                    "text": "Large lesions of any organ may be resected to prevent catastrophic erosions (e.g., aorta)"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Several possible months-long, multi-drug regimens available for active diseaseUsually some combination of isoniazid, rifampin, pyrazinamide, and ethambutolDrug resistance is a serious problem in MTB therapy and some or all commonly used agents may be ineffective",
                    "sub_points": [
                      "Usually some combination of isoniazid, rifampin, pyrazinamide, and ethambutol",
                      "Drug resistance is a serious problem in MTB therapy and some or all commonly used agents may be ineffective"
                    ]
                  },
                  {
                    "text": "Standard treatment for latent MTB infection consists of 9 months of daily isoniazid"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent in immunocompetent individuals with drug-susceptible infections"
                  },
                  {
                    "text": "Outcomes can be quite poor in ill/immunocompromised patients, particularly if infected with resistant strains"
                  }
                ]
              },
              "Image Findings": {
                "Radiographic Findings": [
                  {
                    "text": "Classically, MTB will show upper lobe involvement with apical scarring"
                  },
                  {
                    "text": "Miliary TB, pleural effusions, lobar pneumonias, and hilar masses are also possible"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Pulmonary sites may show cavitation"
                  },
                  {
                    "text": "Nonpulmonary sites may show small (miliary) disseminated nodules up to large solid or cavitary lesions with variable calcification"
                  }
                ]
              },
              "Microbiology": {
                "Morphologic and Biochemical Characteristics": [
                  {
                    "text": "Acid-fast, aerobic rods"
                  }
                ],
                "Culture": [
                  {
                    "text": "Slow growingDoubling time may be > 20 hoursTime to detection is 2-8 weeks",
                    "sub_points": [
                      "Doubling time may be > 20 hours",
                      "Time to detection is 2-8 weeks"
                    ]
                  },
                  {
                    "text": "Agar is usually composed of salt base and amino acids with glycerol, Tween 80, and malachite greenMalachite green will inhibit rapidly growing contaminants",
                    "sub_points": [
                      "Malachite green will inhibit rapidly growing contaminants"
                    ]
                  },
                  {
                    "text": "Colonies can be beige to yellowish, and have a \"piled up\" or \"crinkled\" appearance"
                  },
                  {
                    "text": "Commonly cultured in liquid media as part of automated BACTEC mycobacterial growth indicator tube (MGIT) systemTime to detection is 1-3 weeks",
                    "sub_points": [
                      "Time to detection is 1-3 weeks"
                    ]
                  }
                ],
                "Molecular Microbiologic Identification": [
                  {
                    "text": "Commonly by nucleic acid amplification test (NAAT)Gen-Probe (ribosomal RNA)AMPLICOR (DNA)GeneXpert MTB/RIF (real-time PCR, also assays rifampin resistance)",
                    "sub_points": [
                      "Gen-Probe (ribosomal RNA)",
                      "AMPLICOR (DNA)",
                      "GeneXpert MTB/RIF (real-time PCR, also assays rifampin resistance)"
                    ]
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "LungsCavities, caseating (necrotic) zones, and old calcified fociCommonly involves hilar and mediastinal lymph nodesLung lesions and hilar foci may both heal and calcify (Ghon foci)",
                    "sub_points": [
                      "Cavities, caseating (necrotic) zones, and old calcified foci",
                      "Commonly involves hilar and mediastinal lymph nodes",
                      "Lung lesions and hilar foci may both heal and calcify (Ghon foci)"
                    ]
                  },
                  {
                    "text": "Extrapulmonary featuresWidespread caseating granulomasPeripheral involved lymph nodes tend to be in supraclavicular fossa or posterior cervical triangleIntestinal ulcers may be transversal, granular, and punched out against smooth, hyperemic mucosa (tubercles may proliferate along edges)Peritoneal tuberculosis can develop from miliary tubercles in omental fat or propagate from infected abdominal lymph nodes or intestinal ulcersSkeletal involvement commonly in lower thoracic and lumbar vertebrae (Pott disease)Also knees and hips",
                    "sub_points": [
                      "Widespread caseating granulomas",
                      "Peripheral involved lymph nodes tend to be in supraclavicular fossa or posterior cervical triangle",
                      "Intestinal ulcers may be transversal, granular, and punched out against smooth, hyperemic mucosa (tubercles may proliferate along edges)",
                      "Peritoneal tuberculosis can develop from miliary tubercles in omental fat or propagate from infected abdominal lymph nodes or intestinal ulcers",
                      "Skeletal involvement commonly in lower thoracic and lumbar vertebrae (Pott disease)Also knees and hips",
                      "Also knees and hips"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "PulmonaryMost common site of both primary and reactivation tuberculosisCan involve airways, parenchyma, and pleuraPrimary tuberculosisMost commonly self-limitedLung lesions and hilar foci heal and calcify (Ghon foci)Can be progressiveHallmark lesion is caseating granulomaContain Langerhans giant cells with nuclei in a horseshoe arrangement, as well as activated epithelioid macrophagesAs granulomas progress, center becomes necrotic (caseous necrosis, coagulative necrosis speckled with basophilic particles of hydroxyapatite)With erosion into airways, exudative material is available to be expressed and transmitted to othersWith erosion into blood vessels, may spread widely",
                    "sub_points": [
                      "Most common site of both primary and reactivation tuberculosis",
                      "Can involve airways, parenchyma, and pleura",
                      "Primary tuberculosisMost commonly self-limitedLung lesions and hilar foci heal and calcify (Ghon foci)Can be progressiveHallmark lesion is caseating granulomaContain Langerhans giant cells with nuclei in a horseshoe arrangement, as well as activated epithelioid macrophagesAs granulomas progress, center becomes necrotic (caseous necrosis, coagulative necrosis speckled with basophilic particles of hydroxyapatite)With erosion into airways, exudative material is available to be expressed and transmitted to othersWith erosion into blood vessels, may spread widely",
                      "Most commonly self-limited",
                      "Lung lesions and hilar foci heal and calcify (Ghon foci)",
                      "Can be progressive",
                      "Hallmark lesion is caseating granuloma",
                      "Contain Langerhans giant cells with nuclei in a horseshoe arrangement, as well as activated epithelioid macrophages",
                      "As granulomas progress, center becomes necrotic (caseous necrosis, coagulative necrosis speckled with basophilic particles of hydroxyapatite)",
                      "With erosion into airways, exudative material is available to be expressed and transmitted to others",
                      "With erosion into blood vessels, may spread widely"
                    ]
                  },
                  {
                    "text": "ExtrapulmonaryPericardialConstrictive, constrictive-effusive, or effusive pericarditisAbdominalCan spread via propagation to abdominal lymph nodesIntestinal tuberculosis may demonstrate clubbing of villi, inflammatory infiltrates, and necrosis of lamina propria and submucosaTuberculous hepatitis can manifest as caseating granulomas as well as diffuse inflammatory and fibrous lesions (usually in context of miliary TB)Can involve virtually any other organLymphadenitisMay occur in isolation from pulmonary or miliary tuberculosisUsually demonstrates well-formed granulomas with scarce AFBCNSCaseating granulomas of brain parenchymaLeptomeningitisAFB are normally scarce except in AIDS patients; can have dramatic, exudative CNS lesions with dense colonies of AFBDermatologicLupus vulgaris: Rare, focal, chronic, granulomatous dermatitisScrofuloderma: Ulcerative lesions arising from contiguous spread of underlying affected lymph nodesErythema induratum: Granulomatous panniculitis with necrosis and vasculitis on posterior aspect of legsSkeletalGranulomatous lesions with degeneration of bone and disksCommonly spreads into contiguous soft tissue with abscess formation",
                    "sub_points": [
                      "PericardialConstrictive, constrictive-effusive, or effusive pericarditis",
                      "Constrictive, constrictive-effusive, or effusive pericarditis",
                      "AbdominalCan spread via propagation to abdominal lymph nodesIntestinal tuberculosis may demonstrate clubbing of villi, inflammatory infiltrates, and necrosis of lamina propria and submucosaTuberculous hepatitis can manifest as caseating granulomas as well as diffuse inflammatory and fibrous lesions (usually in context of miliary TB)Can involve virtually any other organ",
                      "Can spread via propagation to abdominal lymph nodes",
                      "Intestinal tuberculosis may demonstrate clubbing of villi, inflammatory infiltrates, and necrosis of lamina propria and submucosa",
                      "Tuberculous hepatitis can manifest as caseating granulomas as well as diffuse inflammatory and fibrous lesions (usually in context of miliary TB)",
                      "Can involve virtually any other organ",
                      "LymphadenitisMay occur in isolation from pulmonary or miliary tuberculosisUsually demonstrates well-formed granulomas with scarce AFB",
                      "May occur in isolation from pulmonary or miliary tuberculosis",
                      "Usually demonstrates well-formed granulomas with scarce AFB",
                      "CNSCaseating granulomas of brain parenchymaLeptomeningitisAFB are normally scarce except in AIDS patients; can have dramatic, exudative CNS lesions with dense colonies of AFB",
                      "Caseating granulomas of brain parenchyma",
                      "Leptomeningitis",
                      "AFB are normally scarce except in AIDS patients; can have dramatic, exudative CNS lesions with dense colonies of AFB",
                      "DermatologicLupus vulgaris: Rare, focal, chronic, granulomatous dermatitisScrofuloderma: Ulcerative lesions arising from contiguous spread of underlying affected lymph nodesErythema induratum: Granulomatous panniculitis with necrosis and vasculitis on posterior aspect of legs",
                      "Lupus vulgaris: Rare, focal, chronic, granulomatous dermatitis",
                      "Scrofuloderma: Ulcerative lesions arising from contiguous spread of underlying affected lymph nodes",
                      "Erythema induratum: Granulomatous panniculitis with necrosis and vasculitis on posterior aspect of legs",
                      "SkeletalGranulomatous lesions with degeneration of bone and disksCommonly spreads into contiguous soft tissue with abscess formation",
                      "Granulomatous lesions with degeneration of bone and disks",
                      "Commonly spreads into contiguous soft tissue with abscess formation"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Necrotizing Granulomatous Disease": [
                  {
                    "text": "Fungal infectionsNegative AFB stain, positive stain for fungi on silver or periodic acid-Schiff stain",
                    "sub_points": [
                      "Negative AFB stain, positive stain for fungi on silver or periodic acid-Schiff stain"
                    ]
                  },
                  {
                    "text": "Atypical mycobacteriaPositive AFB stain, must be differentiated using PCR &/or culture methods",
                    "sub_points": [
                      "Positive AFB stain, must be differentiated using PCR &/or culture methods"
                    ]
                  },
                  {
                    "text": "SarcoidosisGenerally small, tightly circumscribed granulomas, not necrotizingMay contain asteroid bodies or small calcifications",
                    "sub_points": [
                      "Generally small, tightly circumscribed granulomas, not necrotizing",
                      "May contain asteroid bodies or small calcifications"
                    ]
                  },
                  {
                    "text": "Granulomatosis with polyangiitisTends to feature more mixed inflammation, e.g., neutrophils, eosinophilsHas collagenolytic debris and evidence of hemorrhage and small vessel vasculitis",
                    "sub_points": [
                      "Tends to feature more mixed inflammation, e.g., neutrophils, eosinophils",
                      "Has collagenolytic debris and evidence of hemorrhage and small vessel vasculitis"
                    ]
                  },
                  {
                    "text": "Crohn diseaseGranulomas tend to be small and nonnecrotizing, confined to gastrointestinal tractOther features of chronic colitis should be present",
                    "sub_points": [
                      "Granulomas tend to be small and nonnecrotizing, confined to gastrointestinal tract",
                      "Other features of chronic colitis should be present"
                    ]
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "History of foreign birth, known exposures (prisons, homeless, affected family member), or positive sputum AFB should prompt AFB staining of tissue samples and PCR/culture"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Mycobacteria on a standard AFB stain cannot be reliably distinguished on morphology alone"
                  },
                  {
                    "text": "Confirmation with culture &/or PCR is required for definitive diagnosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Clostridium difficile": {
            "name": "Clostridium difficile",
            "url": "https://app.pathprimer.com/document/d09700a7-f12c-4136-a5c0-b20c73afda7d/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Infection byClostridium difficile, most common nosocomial GI infection"
                  },
                  {
                    "text": "Causes colitis, most often pseudomembranous colitis"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Usually associated with recent antibiotic use, most commonly oral antibiotics"
                  },
                  {
                    "text": "Chronic inflammatory bowel disease"
                  },
                  {
                    "text": "Indwelling gastric tube, antacids, hospitalization"
                  },
                  {
                    "text": "Elderly, debilitated patients are at increased risk"
                  },
                  {
                    "text": "Pathogenic strains produce toxin A, which has more enterotoxic activity (mucosal permeability and fluid secretion), and toxin B, of little toxicity"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Typical symptomsDiarrhea, initially watery but variably bloodyFeverLeukocytosisAbdominal pain",
                    "sub_points": [
                      "Diarrhea, initially watery but variably bloody",
                      "Fever",
                      "Leukocytosis",
                      "Abdominal pain"
                    ]
                  },
                  {
                    "text": "Recurrence common despite successful therapy"
                  },
                  {
                    "text": "Patients with fulminant disease may have signs of acute abdomen but lack diarrhea"
                  },
                  {
                    "text": "Incidence of severe or life-threatening infection is increasing"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Yellow-white exudates or pseudomembranes"
                  },
                  {
                    "text": "Distribution: Entire colon or segmental/patchy"
                  },
                  {
                    "text": "Friable erythematous mucosa"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Ballooned or dilated glands"
                  },
                  {
                    "text": "Intercrypt necrosis"
                  },
                  {
                    "text": "Degenerating surface or glandular epithelial cells"
                  },
                  {
                    "text": "Pseudomembranous exudate"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Infection byClostridium difficile, potent toxigenic bacteriaProduces 2 toxins: Toxin A and toxin BCauses colitis, most often pseudomembranous colitis",
                    "sub_points": [
                      "Produces 2 toxins: Toxin A and toxin B",
                      "Causes colitis, most often pseudomembranous colitis"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Recent Prior Antibiotic Exposure": [
                  {
                    "text": "Usually orally administered antibiotics"
                  },
                  {
                    "text": "Bacteria cannot infect in presence of normal gut flora"
                  },
                  {
                    "text": "Most common nosocomial GI pathogen"
                  }
                ],
                "Other Risk Factors": [
                  {
                    "text": "Inflammatory bowel disease"
                  },
                  {
                    "text": "Severe comorbid illness"
                  },
                  {
                    "text": "Admission to ICU"
                  },
                  {
                    "text": "Solid organ recipient"
                  },
                  {
                    "text": "Indwelling nasogastric tubes"
                  },
                  {
                    "text": "GI procedures"
                  },
                  {
                    "text": "Antacids"
                  },
                  {
                    "text": "Long hospitalization"
                  },
                  {
                    "text": "Age greater than 65 years"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Leading cause of antibiotic-associated diarrhea"
                  },
                  {
                    "text": "Infection rates are increasing"
                  },
                  {
                    "text": "Hospital-acquired infection withC. difficileexceeds the rate of hospital-acquired infections with methicillin-resistantStaphylococcus aureus"
                  },
                  {
                    "text": "Incidence tripled between 1996 and 2005"
                  },
                  {
                    "text": "10% to 21% of hospital inpatients receiving antibiotics are carriers"
                  },
                  {
                    "text": "Emergence of hypervirulent NAP1/ribotype 027 strain is associated with rise in severity"
                  },
                  {
                    "text": "Mortality reported in 6.9% of cases"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Some patients are asymptomatic despite having toxigenic strains in stools"
                  },
                  {
                    "text": "DiarrheaDevelops within 3 months of receiving antibiotics or within 72 hours of hospitalizationRanging from mild to severeInitially wateryVariably bloody",
                    "sub_points": [
                      "Develops within 3 months of receiving antibiotics or within 72 hours of hospitalization",
                      "Ranging from mild to severe",
                      "Initially watery",
                      "Variably bloody"
                    ]
                  },
                  {
                    "text": "Fever"
                  },
                  {
                    "text": "Leukocytosis"
                  },
                  {
                    "text": "Bacteremia is rare"
                  },
                  {
                    "text": "Abdominal pain"
                  },
                  {
                    "text": "Cramping"
                  },
                  {
                    "text": "Symptoms can occur weeks after stopping antibiotics"
                  },
                  {
                    "text": "ComplicationsColonic ileusToxic megacolonPerforationReactive polyarthritis",
                    "sub_points": [
                      "Colonic ileus",
                      "Toxic megacolon",
                      "Perforation",
                      "Reactive polyarthritis"
                    ]
                  },
                  {
                    "text": "Variant presentationsMay be superimposed on IBDPatients with fulminant disease may have signs of acute abdomen but lack diarrhea",
                    "sub_points": [
                      "May be superimposed on IBD",
                      "Patients with fulminant disease may have signs of acute abdomen but lack diarrhea"
                    ]
                  },
                  {
                    "text": "Septic arthritis is rare"
                  },
                  {
                    "text": "Splenic abscess is uncommon"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Cytotoxin assayHighly specific and sensitive",
                    "sub_points": [
                      "Highly specific and sensitive"
                    ]
                  },
                  {
                    "text": "Enzyme immunoassayHigh specificity, moderate sensitivity",
                    "sub_points": [
                      "High specificity, moderate sensitivity"
                    ]
                  },
                  {
                    "text": "Latex agglutination assayLacks specificity and sensitivity",
                    "sub_points": [
                      "Lacks specificity and sensitivity"
                    ]
                  },
                  {
                    "text": "CultureSensitive but not specific",
                    "sub_points": [
                      "Sensitive but not specific"
                    ]
                  },
                  {
                    "text": "Polymerase chain reactionHighly sensitive and specific",
                    "sub_points": [
                      "Highly sensitive and specific"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Antibiotics, supportive careMetronidazole is agent of choice for mild to moderate infection (and 1st recurrence)Vancomycin is recommended as initial therapy for severe infection",
                    "sub_points": [
                      "Metronidazole is agent of choice for mild to moderate infection (and 1st recurrence)",
                      "Vancomycin is recommended as initial therapy for severe infection"
                    ]
                  },
                  {
                    "text": "Fulminant cases may require surgery"
                  },
                  {
                    "text": "Fecal microbiota transplantation holds promise for treatment of recurrent infection"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Recurrence commonUp to 50% of cases recur despite successful therapy",
                    "sub_points": [
                      "Up to 50% of cases recur despite successful therapy"
                    ]
                  },
                  {
                    "text": "Incidence of severe or life-threatening infection is increasingEpidemic strain ofC. difficile, BI/NAP1Hypervirulent, with increased toxin productionTherapy resistant",
                    "sub_points": [
                      "Epidemic strain ofC. difficile, BI/NAP1",
                      "Hypervirulent, with increased toxin production",
                      "Therapy resistant"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Yellow-white exudates or pseudomembranesBleed when scraped off",
                    "sub_points": [
                      "Bleed when scraped off"
                    ]
                  },
                  {
                    "text": "Friable erythematous mucosa can be observed without pseudomembranes"
                  },
                  {
                    "text": "DistributionEntire colon often involvedMay be patchy or segmentalInvolving any segment of colonPseudomembranes most common in the distal left colonSmall bowel, appendix can be affectedIleal pouch may be affected in ulcerative colitis patients with ileal pouch-anal anastomosis",
                    "sub_points": [
                      "Entire colon often involved",
                      "May be patchy or segmentalInvolving any segment of colonPseudomembranes most common in the distal left colon",
                      "Involving any segment of colon",
                      "Pseudomembranes most common in the distal left colon",
                      "Small bowel, appendix can be affected",
                      "Ileal pouch may be affected in ulcerative colitis patients with ileal pouch-anal anastomosis"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Ballooned or dilated glandsFilled with neutrophils, mucinSuperficial epithelial cells often lostDegenerated goblet cells may slough into lumen, resembling signet-ring cell carcinoma",
                    "sub_points": [
                      "Filled with neutrophils, mucin",
                      "Superficial epithelial cells often lost",
                      "Degenerated goblet cells may slough into lumen, resembling signet-ring cell carcinoma"
                    ]
                  },
                  {
                    "text": "Intercrypt necrosisSevere disease may feature full-thickness mucosal necrosis",
                    "sub_points": [
                      "Severe disease may feature full-thickness mucosal necrosis"
                    ]
                  },
                  {
                    "text": "Pseudomembranous exudateVolcano or mushroom shapeComposed of fibrin, mucin, neutrophils with laminated or layered appearance",
                    "sub_points": [
                      "Volcano or mushroom shape",
                      "Composed of fibrin, mucin, neutrophils with laminated or layered appearance"
                    ]
                  },
                  {
                    "text": "Early or nonspecific findingsFocal cryptitisStromal hyalinizationCrypt abscessesLack pseudomembranes, other characteristic features",
                    "sub_points": [
                      "Focal cryptitis",
                      "Stromal hyalinization",
                      "Crypt abscesses",
                      "Lack pseudomembranes, other characteristic features"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Other Infections": [
                  {
                    "text": "Particularly those that cause pseudomembranes"
                  },
                  {
                    "text": "Cultures,C. difficiletoxin assay help resolveShigellaSalmonellaEnterohemorrhagicE. coliKlebsiella oxytoca",
                    "sub_points": [
                      "Shigella",
                      "Salmonella",
                      "EnterohemorrhagicE. coli",
                      "Klebsiella oxytoca"
                    ]
                  }
                ],
                "Ischemic Colitis": [
                  {
                    "text": "Crypt withering, pseudomembranes, and mucosal necrosis seen in both"
                  },
                  {
                    "text": "Lamina propria hyalinization favors ischemia"
                  },
                  {
                    "text": "Presence of pseudomembranes favorsC. difficile"
                  },
                  {
                    "text": "Mass-forming mucosal changes can be seen in ischemia, particularly in the right colon"
                  },
                  {
                    "text": "C. difficiletoxin assay, clinical presentation, macroscopic features help resolve"
                  }
                ],
                "Signet-Ring Cell Carcinoma": [
                  {
                    "text": "If degenerating goblet cells are present"
                  },
                  {
                    "text": "Degenerated goblet cells usually form clusters, are not invasive, and present only in superficial mucus"
                  },
                  {
                    "text": "Other features of pseudomembranous colitis, macroscopic features help distinguish"
                  }
                ],
                "Collagenous Colitis With Pseudomembrane": [
                  {
                    "text": "Exact pathogenesis is unknown"
                  },
                  {
                    "text": "Frequently associated with macroscopic inflammation &/or ulceration"
                  },
                  {
                    "text": "Characteristic thickened collagenous table"
                  },
                  {
                    "text": "NegativeC. difficiletoxin assay"
                  },
                  {
                    "text": "Patients respond to anti-inflammatory agents"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Temporal association with antibiotic use or other risk factors such as hospital stay, GI procedure, or inflammatory bowel disease"
                  },
                  {
                    "text": "Presence of pseudomembranes"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Characteristic featuresBallooning cryptsDegenerated goblet cells with signet ring cell featuresIntercrypt necrosisPseudomembrane",
                    "sub_points": [
                      "Ballooning crypts",
                      "Degenerated goblet cells with signet ring cell features",
                      "Intercrypt necrosis",
                      "Pseudomembrane"
                    ]
                  },
                  {
                    "text": "Correlate with macroscopic findings"
                  },
                  {
                    "text": "C. difficiletoxin assay"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Syphilis": {
            "name": "Syphilis",
            "url": "https://app.pathprimer.com/document/5ed97d8c-24ec-4834-a441-1e15b0adbef5/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Syphilis is a sexually transmitted infection caused by bacteriaTreponema pallidum"
                  },
                  {
                    "text": "Pathologic treponematoses: Venereal syphilis (T. pallidum), yaws (T. pertenue), bejel (T. endemicum), pinta (T. carateum)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Primary: Single small, red, painless papule with ulceration (chancre)"
                  },
                  {
                    "text": "Secondary: Widespread skin rash; mainly affect soles and palms but can spread to whole body"
                  },
                  {
                    "text": "Tertiary: Solitary lesion (gummas)"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Primary: Acanthotic epidermis, ulceration, endothelial swelling, and dense lymphoplasmacytic response"
                  },
                  {
                    "text": "Secondary: Cellular infiltrate consists of lymphocytes, plasma cells, macrophages, some neutrophils, epithelioid cells, and occasional giant cells"
                  },
                  {
                    "text": "Tertiary: Necrotizing granulomatous inflammation"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Psoriasis, drug reaction, and lichenoid hypersensitivity reaction"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Venereal syphilis (Treponema pallidum pallidum), yaws (Treponema pallidum pertenue), bejel (Treponema pallidum endemicum), pinta (Treponema pallidum carateum)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Greek: \"Trepein\" (to turn) + \"nema\" (thread)"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Infectious Agents": [
                  {
                    "text": "Syphilis is a sexually transmitted infection caused by bacteriaT.p.pallidum"
                  },
                  {
                    "text": "T. p. pallidumspecies belongs to Spirochaetaceae family"
                  }
                ],
                "Risk Factors": [
                  {
                    "text": "Any sexually active person can get syphilis through unprotected anal, vaginal, or oral sex"
                  },
                  {
                    "text": "Estimated incidence of 12 million new cases each year (WHO)"
                  },
                  {
                    "text": "North America and Western Europe: Men who have sex with men (MSM), coinfection with HIV"
                  }
                ]
              },
              "Clinical Issues": {
                "Presentation": [
                  {
                    "text": "Primary stageSingle small, red, painless papule with ulceration (chancre)Lasts 3-6 weeks and heals without treatmentWithout treatment, progresses to secondary stage",
                    "sub_points": [
                      "Single small, red, painless papule with ulceration (chancre)",
                      "Lasts 3-6 weeks and heals without treatment",
                      "Without treatment, progresses to secondary stage"
                    ]
                  },
                  {
                    "text": "Secondary stage3 weeks to 3 months after primary stageWidespread skin rash mainly affect soles and palms but can spread to whole bodyDifferential diagnosis includes Rocky Mountain spotted fever, graft-vs.-host disease, erythema migrans, and meningococcemiaRaised patches (condyloma latum)Fever, muscle and joint pains, headache, and swollen lymph glandsCan affect any organ (e.g., CNS, liver, kidneys, skeletal muscles)",
                    "sub_points": [
                      "3 weeks to 3 months after primary stage",
                      "Widespread skin rash mainly affect soles and palms but can spread to whole bodyDifferential diagnosis includes Rocky Mountain spotted fever, graft-vs.-host disease, erythema migrans, and meningococcemia",
                      "Differential diagnosis includes Rocky Mountain spotted fever, graft-vs.-host disease, erythema migrans, and meningococcemia",
                      "Raised patches (condyloma latum)",
                      "Fever, muscle and joint pains, headache, and swollen lymph glands",
                      "Can affect any organ (e.g., CNS, liver, kidneys, skeletal muscles)"
                    ]
                  },
                  {
                    "text": "Latent stageBegins when all clinical symptoms disappearWith no treatment, may remain latent for yearsMost people with untreated syphilis do not develop tertiary stage syphilis",
                    "sub_points": [
                      "Begins when all clinical symptoms disappear",
                      "With no treatment, may remain latent for years",
                      "Most people with untreated syphilis do not develop tertiary stage syphilis"
                    ]
                  },
                  {
                    "text": "Tertiary stageMay develop 3-10 years laterSolitary lesion (gummas)Brain involvement (neurosyphilis), spinal cord diseaseCan affect heart, eyes, or any other organsSymptoms of late stage can include difficulty coordinating muscle movements, paralysis, numbness, gradual blindness, and dementia",
                    "sub_points": [
                      "May develop 3-10 years later",
                      "Solitary lesion (gummas)",
                      "Brain involvement (neurosyphilis), spinal cord disease",
                      "Can affect heart, eyes, or any other organs",
                      "Symptoms of late stage can include difficulty coordinating muscle movements, paralysis, numbness, gradual blindness, and dementia"
                    ]
                  },
                  {
                    "text": "Congenital syphilisOne of the TORCH infectionsCause of spontaneous abortion and stillbirthLive-born neonates may present with secondary syphilis and progress to latent stages",
                    "sub_points": [
                      "One of the TORCH infections",
                      "Cause of spontaneous abortion and stillbirth",
                      "Live-born neonates may present with secondary syphilis and progress to latent stages"
                    ]
                  },
                  {
                    "text": "Other treponematoses often affect skin and present skin lesions through contact with infected personAlmost 75% of people affected are children < 15 yearsOvercrowding, poor personal hygiene and sanitation facilitate spread of disease in warm communities",
                    "sub_points": [
                      "Almost 75% of people affected are children < 15 years",
                      "Overcrowding, poor personal hygiene and sanitation facilitate spread of disease in warm communities"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "High-dose penicillin"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Syphilis is easily cured in early stages"
                  },
                  {
                    "text": "Congenital syphilis is most serious outcome of syphilis in women"
                  }
                ]
              },
              "Microbiology": {
                "Culture": [
                  {
                    "text": "Syphilis cannot be cultured"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "PrimaryAcanthotic epidermis, ulceration, endothelial swelling, and dense lymphoplasmacytic response",
                    "sub_points": [
                      "Acanthotic epidermis, ulceration, endothelial swelling, and dense lymphoplasmacytic response"
                    ]
                  },
                  {
                    "text": "SecondaryCellular infiltrate consists of lymphocytes, plasma cells, macrophages, some neutrophils, epithelioid cells, and occasional giant cellsPsoriasiform hyperplasiaGranulomatous inflammation is an atypical feature of secondary stage (papular or nodular clinical presentation)",
                    "sub_points": [
                      "Cellular infiltrate consists of lymphocytes, plasma cells, macrophages, some neutrophils, epithelioid cells, and occasional giant cells",
                      "Psoriasiform hyperplasia",
                      "Granulomatous inflammation is an atypical feature of secondary stage (papular or nodular clinical presentation)"
                    ]
                  },
                  {
                    "text": "TertiaryNecrotizing granulomatous inflammation",
                    "sub_points": [
                      "Necrotizing granulomatous inflammation"
                    ]
                  },
                  {
                    "text": "CongenitalPlacental histological features include the triad of enlarged hypercellular villi, proliferative fetal vascular changes, and acute or chronic villitis",
                    "sub_points": [
                      "Placental histological features include the triad of enlarged hypercellular villi, proliferative fetal vascular changes, and acute or chronic villitis"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Histochemistry": [
                  {
                    "text": "Darkfield microscopy (mainly used in early stages)"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Spirochete antibodies:T. p. pallidumreacts"
                  }
                ],
                "PCR": [
                  {
                    "text": "Amplification of bacterial DNA from infected tissue"
                  },
                  {
                    "text": "In late stages, sensitivity of PCR is lower than immunohistochemistry techniques"
                  }
                ],
                "Serologic Testing": [
                  {
                    "text": "ScreeningVenereal disease research laboratory (VDRL) testRapid plasma reagin (RPR) testEnzyme immunoassay (EIA) test",
                    "sub_points": [
                      "Venereal disease research laboratory (VDRL) test",
                      "Rapid plasma reagin (RPR) test",
                      "Enzyme immunoassay (EIA) test"
                    ]
                  },
                  {
                    "text": "DiagnosisFluorescent treponemal antibody absorption (FTA-ABS) testT. pallidumparticle agglutination assay (TPA)Microhemagglutination assay (MA-PT)",
                    "sub_points": [
                      "Fluorescent treponemal antibody absorption (FTA-ABS) test",
                      "T. pallidumparticle agglutination assay (TPA)",
                      "Microhemagglutination assay (MA-PT)"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Primary Syphilis": [
                  {
                    "text": "Candidiasis, chancroid, granuloma inguinale, herpes simplex, herpes zoster, lymphogranuloma venereum"
                  },
                  {
                    "text": "Microscopic features consistent with syphilis and lacking fungal, viral, or other bacterial morphology"
                  }
                ],
                "Secondary Syphilis": [
                  {
                    "text": "PsoriasisPsoriasiform hyperplasia with neutrophils in stratum corneumLack of positive serology, or positive tissue staining or PCR for syphilis",
                    "sub_points": [
                      "Psoriasiform hyperplasia with neutrophils in stratum corneum",
                      "Lack of positive serology, or positive tissue staining or PCR for syphilis"
                    ]
                  },
                  {
                    "text": "Drug reactionEosinophils and plasma cell infiltrateNegative serology, tissue staining, or PCR for syphilis",
                    "sub_points": [
                      "Eosinophils and plasma cell infiltrate",
                      "Negative serology, tissue staining, or PCR for syphilis"
                    ]
                  },
                  {
                    "text": "Lichenoid hypersensitivity reactionEosinophils and plasma cell infiltrate",
                    "sub_points": [
                      "Eosinophils and plasma cell infiltrate"
                    ]
                  }
                ],
                "Tertiary Syphilis": [
                  {
                    "text": "Neurological degenerative diseases (clinically)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Candidiasis": {
            "name": "Candidiasis",
            "url": "https://app.pathprimer.com/document/8a10918d-811b-47dc-81cd-6f9da66b8bee/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Normal flora associated with skin, gastrointestinal and genitourinary tracts of humans"
                  },
                  {
                    "text": "Yeast form is associated with dissemination, and hyphal form with adhesion and tissue invasion"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Diseases range from superficial, invasive to disseminated infections, depending on host immune status"
                  },
                  {
                    "text": "> 20 different species ofCandidareported as etiologic agents of invasive candidiasis in humans"
                  },
                  {
                    "text": "Candida albicansis the most common agent for invasive infections, followed byC. glabrataandC. parapsilosis"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Small yeast cells (2-6 μm in diameter) intermingled with pseudohyphae and branching septate hyphae"
                  },
                  {
                    "text": "Suppurative inflammation and necrosis is often seen, but inflammation can be minimal"
                  },
                  {
                    "text": "Giant cells and granulomas are sparse"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Candidaspp.are gram positive"
                  },
                  {
                    "text": "Periodic acid-Schiff and fungal silver stains highlight fungal forms for histologic examination"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Aspergillosis"
                  },
                  {
                    "text": "Trichosporon infections"
                  },
                  {
                    "text": "Histoplasmosis"
                  },
                  {
                    "text": "Cryptococcosis"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Candidosis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Latin: \"Candidatus\" (a candidate for public office, who dressed in white)"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Infectious Agents": [
                  {
                    "text": "Candidaspp. are the most common cause of fungal infections"
                  },
                  {
                    "text": "> 20 different species reported as etiologic agents of invasive candidiasis in humans"
                  },
                  {
                    "text": "Candida albicansis the most common infectious agent, accounting for 1/3-2/3 of invasive cases, followed byCandida glabrataandCandida parapsilosis"
                  },
                  {
                    "text": "Normal flora associated with skin, gastrointestinal and genitourinary tracts of humans"
                  },
                  {
                    "text": "Superficial infectionsMinimal to suppurative inflammationOccur when there are microbial imbalances caused by fluctuations in reproductive hormones, antibiotic use, and immunosuppression",
                    "sub_points": [
                      "Minimal to suppurative inflammation",
                      "Occur when there are microbial imbalances caused by fluctuations in reproductive hormones, antibiotic use, and immunosuppression"
                    ]
                  },
                  {
                    "text": "Invasive infectionsVarious inflammatory responses depending on host immune statusPrimarily suppurative inflammation with rare granulomas, invasion of blood vessels, necrotizing vasculitisCan involve any organ",
                    "sub_points": [
                      "Various inflammatory responses depending on host immune status",
                      "Primarily suppurative inflammation with rare granulomas, invasion of blood vessels, necrotizing vasculitis",
                      "Can involve any organ"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "Candidaare ubiquitous organisms that cause disease worldwide in a range of human hosts"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Superficial skin infections: Commonly seen in immunosuppressed patients"
                  },
                  {
                    "text": "Oropharyngeal candidiasis (thrush): White plaques on buccal mucosa; commonly seen in patients with immunodeficiency"
                  },
                  {
                    "text": "Esophagitis: Most common in HIV-infected patients and patients with hematologic malignancies"
                  },
                  {
                    "text": "Vulvovaginitis: Most common form of mucosal candidiasis"
                  },
                  {
                    "text": "Mastitis: Lactating women with injured nipples are at increased risk"
                  },
                  {
                    "text": "Urinary tract infectionRenal infection: Often secondary to hematogenous seeding in setting of disseminated candidiasisCandiduria may represent merely colonization and not infection; microscopic, culture, and clinical correlation need to be made to determine its relevance and need for antifungal therapy",
                    "sub_points": [
                      "Renal infection: Often secondary to hematogenous seeding in setting of disseminated candidiasis",
                      "Candiduria may represent merely colonization and not infection; microscopic, culture, and clinical correlation need to be made to determine its relevance and need for antifungal therapy"
                    ]
                  },
                  {
                    "text": "Osteoarticular infectionsHematogenous seeding in cases of candidemiaInoculation during trauma, intraarticular injection, surgical procedures, or injection drug use",
                    "sub_points": [
                      "Hematogenous seeding in cases of candidemia",
                      "Inoculation during trauma, intraarticular injection, surgical procedures, or injection drug use"
                    ]
                  },
                  {
                    "text": "MeningitisManifestation of disseminated candidiasis, or in premature neonates as a complication of contaminated ventricular drainage devices",
                    "sub_points": [
                      "Manifestation of disseminated candidiasis, or in premature neonates as a complication of contaminated ventricular drainage devices"
                    ]
                  },
                  {
                    "text": "Endocarditis: Most common cause of fungal endocarditisSeen in intravenous drug users or patients with prosthetic heart valves, indwelling central venous catheters, or fungemia",
                    "sub_points": [
                      "Seen in intravenous drug users or patients with prosthetic heart valves, indwelling central venous catheters, or fungemia"
                    ]
                  },
                  {
                    "text": "Peritonitis and intraabdominal infectionsOften exists in polymicrobial infections that occur following gastrointestinal tract perforation, or acute necrotizing pancreatitis",
                    "sub_points": [
                      "Often exists in polymicrobial infections that occur following gastrointestinal tract perforation, or acute necrotizing pancreatitis"
                    ]
                  },
                  {
                    "text": "Pneumonia: Rare"
                  },
                  {
                    "text": "Empyema: Most commonly seen in patients with malignancies"
                  },
                  {
                    "text": "Pericarditis: Rare; often a complication of thoracic surgery, contiguous spread from an adjacent focus, or hematogenous spread"
                  },
                  {
                    "text": "EndophthalmitisDevelops following trauma or eye surgeryHematogenous seeding in cases of candidemia",
                    "sub_points": [
                      "Develops following trauma or eye surgery",
                      "Hematogenous seeding in cases of candidemia"
                    ]
                  },
                  {
                    "text": "Chronic disseminated candidiasisPersistent microabscesses in liver, spleen, and occasionally kidneysRisk factors: Acute leukemia, neutropenia, intravascular catheters",
                    "sub_points": [
                      "Persistent microabscesses in liver, spleen, and occasionally kidneys",
                      "Risk factors: Acute leukemia, neutropenia, intravascular catheters"
                    ]
                  },
                  {
                    "text": "Chronic mucocutaneous candidiasis: Heterogeneous group of syndromes with autoimmune manifestations associated with chronic noninvasiveCandidainfections of skin, nails, and mucous membranes"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Culture and Gram stain of biopsy tissue"
                  },
                  {
                    "text": "Culture of blood or other body fluids"
                  },
                  {
                    "text": "Non-culture methodsBiopsy for histopathologic examinationKOH preparation on skin scrapings to evaluate for hyphae and pseudohyphaeβ-D-glucan in serumMarker of fungemia or disseminated diseaseUseful in patients with deep-seated invasive candidiasis for which blood cultures may be insensitiveSensitivity: 57-90%; specificity: 44-92%",
                    "sub_points": [
                      "Biopsy for histopathologic examination",
                      "KOH preparation on skin scrapings to evaluate for hyphae and pseudohyphae",
                      "β-D-glucan in serumMarker of fungemia or disseminated diseaseUseful in patients with deep-seated invasive candidiasis for which blood cultures may be insensitiveSensitivity: 57-90%; specificity: 44-92%",
                      "Marker of fungemia or disseminated disease",
                      "Useful in patients with deep-seated invasive candidiasis for which blood cultures may be insensitive",
                      "Sensitivity: 57-90%; specificity: 44-92%"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Different species have slightly different intrinsic susceptibilities to antifungal agents"
                  },
                  {
                    "text": "Mucocutaneous infectionsTherapy is dominated by azole antifungal agents",
                    "sub_points": [
                      "Therapy is dominated by azole antifungal agents"
                    ]
                  },
                  {
                    "text": "Invasive infectionsAmphotericin B–based preparations, azole and echinocandin antifungal agents",
                    "sub_points": [
                      "Amphotericin B–based preparations, azole and echinocandin antifungal agents"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Successful treatment depends on site of lesion and immune status of host"
                  }
                ]
              },
              "Microbiology": {
                "Fungal Features": [
                  {
                    "text": "In tissue and cytologic preparationsRound to oval yeast cells (2-6 μm in diameter); size varies according to speciesPseudohyphae and branching septate hyphaeC. glabrataonly forms small (2-4 μm in diameter) oval yeast cells; no pseudohyphae are formed",
                    "sub_points": [
                      "Round to oval yeast cells (2-6 μm in diameter); size varies according to species",
                      "Pseudohyphae and branching septate hyphae",
                      "C. glabrataonly forms small (2-4 μm in diameter) oval yeast cells; no pseudohyphae are formed"
                    ]
                  }
                ],
                "Culture": [
                  {
                    "text": "Species identified according to macroscopic colony morphology on agar and microscopic morphology on specific medium"
                  },
                  {
                    "text": "Microscopic morphology on cornmeal-Tween 80 agarPseudohyphae and some true hyphae with clusters of round blastoconidia (blastospores) at septaTerminal chlamydospores are formed",
                    "sub_points": [
                      "Pseudohyphae and some true hyphae with clusters of round blastoconidia (blastospores) at septa",
                      "Terminal chlamydospores are formed"
                    ]
                  },
                  {
                    "text": "Most are rapid growers that mature in 3-5 days"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Small yeast cells (2-6 μm in diameter) intermingled with pseudohyphae and branching septate hyphae"
                  },
                  {
                    "text": "Neutrophilic inflammation with some lymphocytes and macrophages, fibrin, and coagulative necrosis"
                  },
                  {
                    "text": "Giant cells and granulomas can be present but are sparse"
                  },
                  {
                    "text": "Mycotic aneurysms or thrombophlebitis can occur in cases of vascular invasions"
                  },
                  {
                    "text": "Superficial mucosal infections can be associated with enlarged hyperchromatic nuclei with perinuclear halos in gynecologic specimens or pap smearsChanges can be confused with low-grade squamous intraepithelial lesions",
                    "sub_points": [
                      "Changes can be confused with low-grade squamous intraepithelial lesions"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Histochemistry": [
                  {
                    "text": "Gram stain:Candidaspp.stain purple/blue (gram positive)"
                  },
                  {
                    "text": "Fungal silver stains (Gomori methenamine silver (GMS): Fungal cell wall appears black or dark brown"
                  },
                  {
                    "text": "Periodic acid-Schiff (PAS): Fungal cell wall appears pink to red-purple"
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "Peptide nucleic acid fluorescent in situ hybridization can identify the most frequentCandidaspp. directly from positive blood culture bottles without need for subcultures"
                  },
                  {
                    "text": "Probes used to detect fungi are unique, organism-specific rRNA targets"
                  }
                ],
                "PCR": [
                  {
                    "text": "Direct PCR using blood samplesBetter sensitivity and specificity for diagnosis of invasive candidiasis than blood cultures",
                    "sub_points": [
                      "Better sensitivity and specificity for diagnosis of invasive candidiasis than blood cultures"
                    ]
                  },
                  {
                    "text": "Its effects on clinical outcomes are still being investigated"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Aspergillosis": [
                  {
                    "text": "Nonpigmented (hyaline), uniform, septate hyphae with dichotomous branching at 45° angles"
                  },
                  {
                    "text": "Aspergillushyphae may be mistaken for nonbudding yeast cells when the hyphae are cut transversely on sectionsCandidaspp. form pseudohyphae with distinct constrictions in addition to true hyphae",
                    "sub_points": [
                      "Candidaspp. form pseudohyphae with distinct constrictions in addition to true hyphae"
                    ]
                  },
                  {
                    "text": "Fungal hyphae ofAspergillusspp. may be scant or fragmented on histologic or cytologic preparations, making it challenging to assess for septation and type of branching"
                  }
                ],
                "TrichosporonInfections": [
                  {
                    "text": "Pleomorphic yeast-like cells (3-8 µm in diameter) intermingled with pseudohyphae, septate true hyphae without predominant dichotomous branching"
                  },
                  {
                    "text": "Distinguished by the presence of arthroconidia (formed by fragmentation of true hyphae), which can be sparse or absent on tissue sections"
                  }
                ],
                "Histoplasmosis": [
                  {
                    "text": "Small yeast forms (2-4 µm in diameter) with narrow-based budding"
                  },
                  {
                    "text": "Often intracellular in macrophages but extracellularHistoplasmaspp.can be easily confused with yeast forms ofCandidaspp., particularlyC. glabrata,which lacks pseudohyphae production"
                  },
                  {
                    "text": "Candidaspp.lack  pseudocapsule and stain better with H&E and Gram stain"
                  },
                  {
                    "text": "Candidaspp.generally tend to generate suppurative tissue reaction, while it is more common amongHistoplasmaspp.to elicit a granulomatous reaction"
                  }
                ],
                "Cryptococcosis": [
                  {
                    "text": "Narrow-based budding pleomorphic yeast forms (4-10 µm in diameter)"
                  },
                  {
                    "text": "Fontana-Masson stain is positive in melanin-producingCryptococcusand mucicarmine stain highlights capsule ofCryptococcusspp."
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Generally elicits an acute suppurative inflammation"
                  },
                  {
                    "text": "Coagulative necrosis often seen in neutropenic patients"
                  },
                  {
                    "text": "Granulomas rarely occur; mostly seen in chronic systemic candidiasis"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Small round to oval budding yeast cells, pseudohyphae, and branching septate true hyphae"
                  },
                  {
                    "text": "Candidaspp.are gram positive"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cryptococcosis": {
            "name": "Cryptococcosis",
            "url": "https://app.pathprimer.com/document/990213b3-682b-404d-9a51-17a942649df4/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Cryptococcus neoformansandCryptococcus gattiiare the main pathogenic species causing human infections"
                  },
                  {
                    "text": "C. neoformansaccounts for majority of cases in immunocompromised individuals"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most cases are seen in immunocompromised patients"
                  },
                  {
                    "text": "Most common risk factors: HIV infection, prolonged use of glucocorticoids or immunosuppressants, history of stem cell and organ transplants, malignancies"
                  },
                  {
                    "text": "Lung is the primary site of infection caused by inhaled yeasts or basidiospores of fungus"
                  },
                  {
                    "text": "Central nervous system and skin are the most common secondary sites of infection"
                  },
                  {
                    "text": "Untreated disseminatedCryptococcusinfection has a mortality rate of up to 100%"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Encapsulated, spherical to oval yeast cells (5-10 μm in diameter) with narrow-based budding and polysaccharide capsule"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Yeast cells are positive for GMS, PAS, Fontana-Masson stains"
                  },
                  {
                    "text": "Mucicarmine and Alcian blue stain polysaccharide capsule"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Candidiasis"
                  },
                  {
                    "text": "Histoplasmosis"
                  },
                  {
                    "text": "Blastomycosis"
                  }
                ]
              },
              "Terminology": {
                "Definitions": [
                  {
                    "text": "Greek: \"Crypto\" (hidden) + \"kokkus\"  (berry, grain)"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Infectious Agents": [
                  {
                    "text": "Cryptococcus neoformansandCryptococcus gattii(formerlyCryptococcus neoformans var. gattii) produce basidiomycetous encapsulated yeasts and are the main pathogenic species causing human infections"
                  },
                  {
                    "text": "C. neoformans: Corresponds to serotypes A and DFound in association with rotting vegetation, soil samples in roosting sites of pigeons, or areas frequented by pigeons and chickensRole of pigeon guano in pathogenesis is unclear; direct transmission from pigeons to humans has not been reported",
                    "sub_points": [
                      "Found in association with rotting vegetation, soil samples in roosting sites of pigeons, or areas frequented by pigeons and chickens",
                      "Role of pigeon guano in pathogenesis is unclear; direct transmission from pigeons to humans has not been reported"
                    ]
                  },
                  {
                    "text": "Cryptococcus gattii: Corresponds to serotypes B and C"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "Most cases are seen in immunocompromised patients"
                  },
                  {
                    "text": "Risk factorsMost common: HIV infectionOther risk factorsProlonged use of glucocorticoids or immunosuppressantsStem cell and organ transplant recipientsMalignanciesUnderlying chronic lung disease, e.g., sarcoidosis",
                    "sub_points": [
                      "Most common: HIV infection",
                      "Other risk factorsProlonged use of glucocorticoids or immunosuppressantsStem cell and organ transplant recipientsMalignanciesUnderlying chronic lung disease, e.g., sarcoidosis",
                      "Prolonged use of glucocorticoids or immunosuppressants",
                      "Stem cell and organ transplant recipients",
                      "Malignancies",
                      "Underlying chronic lung disease, e.g., sarcoidosis"
                    ]
                  },
                  {
                    "text": "Infections caused byC.neoformansAccounts for majority of infections found in immunocompromised individualsWorldwide distribution",
                    "sub_points": [
                      "Accounts for majority of infections found in immunocompromised individuals",
                      "Worldwide distribution"
                    ]
                  },
                  {
                    "text": "Infections caused byC.gattiiCauses infection more often in immunocompetent individuals than in immunocompromised patients; however, testing for underlying HIV infection and other causes of immunodeficiency is recommended in patients with no apparent immunocompromiseGeographic distributionTropical and subtropical regions, including Australia, Papua New Guinea, parts of Africa, Mexico, and southern CaliforniaIn 1999, outbreak of cryptococcosis due toC. gattiiwas detected in British Columbia, with subsequent spread to Pacific Northwest of  United StatesSporadic cases also occur in various regions around world",
                    "sub_points": [
                      "Causes infection more often in immunocompetent individuals than in immunocompromised patients; however, testing for underlying HIV infection and other causes of immunodeficiency is recommended in patients with no apparent immunocompromise",
                      "Geographic distributionTropical and subtropical regions, including Australia, Papua New Guinea, parts of Africa, Mexico, and southern CaliforniaIn 1999, outbreak of cryptococcosis due toC. gattiiwas detected in British Columbia, with subsequent spread to Pacific Northwest of  United StatesSporadic cases also occur in various regions around world",
                      "Tropical and subtropical regions, including Australia, Papua New Guinea, parts of Africa, Mexico, and southern California",
                      "In 1999, outbreak of cryptococcosis due toC. gattiiwas detected in British Columbia, with subsequent spread to Pacific Northwest of  United States",
                      "Sporadic cases also occur in various regions around world"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Most common presentations: Pulmonary, central nervous system, or skin disease"
                  },
                  {
                    "text": "Lung is the primary site of infection caused by inhaled yeasts or basidiospores of fungus"
                  },
                  {
                    "text": "Cryptococci can disseminate via bloodstream to other tissuesCentral nervous system and skin are most common secondary sites of infectionInvolvement of other body sites have been reported, e.g., osteomyelitis, hepatitis, pyelonephritis, prostatitis, and peritonitis",
                    "sub_points": [
                      "Central nervous system and skin are most common secondary sites of infection",
                      "Involvement of other body sites have been reported, e.g., osteomyelitis, hepatitis, pyelonephritis, prostatitis, and peritonitis"
                    ]
                  },
                  {
                    "text": "Pulmonary involvementClinical course is determined by host immune status, inoculum size of fungus, and innate virulence of organismImmunocompromised patientsPulmonary involvement can be due to primary infection in naive host, reactivation of latent infection, or reinfection with new strainMore likely to have extrapulmonary disease than immunocompetent patientsCNS involvement should be ruled out in immunocompromised patients presenting with pulmonary cryptococcosis",
                    "sub_points": [
                      "Clinical course is determined by host immune status, inoculum size of fungus, and innate virulence of organism",
                      "Immunocompromised patientsPulmonary involvement can be due to primary infection in naive host, reactivation of latent infection, or reinfection with new strainMore likely to have extrapulmonary disease than immunocompetent patientsCNS involvement should be ruled out in immunocompromised patients presenting with pulmonary cryptococcosis",
                      "Pulmonary involvement can be due to primary infection in naive host, reactivation of latent infection, or reinfection with new strain",
                      "More likely to have extrapulmonary disease than immunocompetent patients",
                      "CNS involvement should be ruled out in immunocompromised patients presenting with pulmonary cryptococcosis"
                    ]
                  },
                  {
                    "text": "CNS involvementMore commonly seen in immunocompromised patientsBrain parenchyma is often involved in addition to meningeal infectionSymptoms are nonspecific and clinical course can vary from indolent, subacute to acute presentations depending on the species causing infection and the host immune statusHIV patients with CNS infection are likely to have extraneural diseaseLumbar puncture criteriaNeurologic symptomsHigh serum cryptococcal antigen titerUnderlying condition that predisposes to CNS dissemination, e.g., immunosuppression",
                    "sub_points": [
                      "More commonly seen in immunocompromised patients",
                      "Brain parenchyma is often involved in addition to meningeal infection",
                      "Symptoms are nonspecific and clinical course can vary from indolent, subacute to acute presentations depending on the species causing infection and the host immune status",
                      "HIV patients with CNS infection are likely to have extraneural disease",
                      "Lumbar puncture criteriaNeurologic symptomsHigh serum cryptococcal antigen titerUnderlying condition that predisposes to CNS dissemination, e.g., immunosuppression",
                      "Neurologic symptoms",
                      "High serum cryptococcal antigen titer",
                      "Underlying condition that predisposes to CNS dissemination, e.g., immunosuppression"
                    ]
                  },
                  {
                    "text": "Cutaneous involvementDue to secondary or primary infectionsManifestations are variableSecondary infection due to cryptococcal disseminationCutaneous signs of infection may be the 1st indication of cryptococcosis and precede diagnosis of disseminated diseaseFactors suggesting secondary infection: Presence of systemic symptoms, multicentric skin lesions, deep dermal or subcutaneous lesions, lesions on covered partsPrimary infection due to direct inoculation of organismsLess common than secondary infectionFactors suggesting primary infection: solitary lesion, regional lymph node involvement, lesions on uncovered parts, history of primary inoculationCases of primary infection due to rarer species such asCryptococcus laurentiiandCryptococcus albidushave been reported",
                    "sub_points": [
                      "Due to secondary or primary infections",
                      "Manifestations are variable",
                      "Secondary infection due to cryptococcal disseminationCutaneous signs of infection may be the 1st indication of cryptococcosis and precede diagnosis of disseminated diseaseFactors suggesting secondary infection: Presence of systemic symptoms, multicentric skin lesions, deep dermal or subcutaneous lesions, lesions on covered parts",
                      "Cutaneous signs of infection may be the 1st indication of cryptococcosis and precede diagnosis of disseminated disease",
                      "Factors suggesting secondary infection: Presence of systemic symptoms, multicentric skin lesions, deep dermal or subcutaneous lesions, lesions on covered parts",
                      "Primary infection due to direct inoculation of organismsLess common than secondary infectionFactors suggesting primary infection: solitary lesion, regional lymph node involvement, lesions on uncovered parts, history of primary inoculationCases of primary infection due to rarer species such asCryptococcus laurentiiandCryptococcus albidushave been reported",
                      "Less common than secondary infection",
                      "Factors suggesting primary infection: solitary lesion, regional lymph node involvement, lesions on uncovered parts, history of primary inoculation",
                      "Cases of primary infection due to rarer species such asCryptococcus laurentiiandCryptococcus albidushave been reported"
                    ]
                  },
                  {
                    "text": "Disseminated diseaseMost commonly seen in immunocompromised patients",
                    "sub_points": [
                      "Most commonly seen in immunocompromised patients"
                    ]
                  },
                  {
                    "text": "Infection caused byC. gattiivs. infection caused byC. neoformansLarge mass lesions, (i.e., cryptococcomas) of lungs &/or brain are more likely to be caused byC. gattiithanC. neoformansInfections due toC. gattiiare more likely to be associated with neurologic complications",
                    "sub_points": [
                      "Large mass lesions, (i.e., cryptococcomas) of lungs &/or brain are more likely to be caused byC. gattiithanC. neoformans",
                      "Infections due toC. gattiiare more likely to be associated with neurologic complications"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Direct examination of clinical specimensEncapsulated yeast forms may be visualized in sputum, bronchoalveolar lavage, CSF, or tissue smearsCapsule highlighted by India ink in body fluid or tissue smears as a halo against black background",
                    "sub_points": [
                      "Encapsulated yeast forms may be visualized in sputum, bronchoalveolar lavage, CSF, or tissue smears",
                      "Capsule highlighted by India ink in body fluid or tissue smears as a halo against black background"
                    ]
                  },
                  {
                    "text": "Cryptococcal antigen (CRAG) testingLatex agglutination or enzyme-linked immunosorbent assay (ELISA) to detect cryptococcal polysaccharide antigenCSF: Sensitivity: 93-100%; specificity: 93-98%Serum (immunocompromised patients)Negative serum cryptococcal antigen result does not exclude diagnosis of cryptococcosisPositive serum cryptococcal antigen result should prompt investigation for disseminated infectionPositive in essentially all patients with HIV infection and pulmonary cryptococcosis, and up to 84% of patients with other underlying immunocompromising conditionsAntigen titer generally correlates with burden of organismsLimitationsFalse-positive results have been reported with serologic assays in cases of fungal infection due toTrichosporon asahii, and bacterial infections due toStomatococcusspp.orCapnocytophagaspp.False-negative results can occur due to low fungal burden or prozone effectMost serologic tests detect antigens present in capsule; therefore, tests may not be helpful in cases caused by capsule-deficient cryptococcalorganismsAssays do not allow distinction of differentCryptococcusspp.No role for monitoring serum cryptococcal antigen titers to determine duration of therapy in either immunosuppressed or immunocompetent hostsCRAG lateral flow immunochromatographic assaySemiquantitativeCan be used as a rapid point-of-care test with CSF, serum and plasma samplesCompared with culture: 99.5% sensitivity and 98% specificity",
                    "sub_points": [
                      "Latex agglutination or enzyme-linked immunosorbent assay (ELISA) to detect cryptococcal polysaccharide antigen",
                      "CSF: Sensitivity: 93-100%; specificity: 93-98%",
                      "Serum (immunocompromised patients)Negative serum cryptococcal antigen result does not exclude diagnosis of cryptococcosisPositive serum cryptococcal antigen result should prompt investigation for disseminated infectionPositive in essentially all patients with HIV infection and pulmonary cryptococcosis, and up to 84% of patients with other underlying immunocompromising conditions",
                      "Negative serum cryptococcal antigen result does not exclude diagnosis of cryptococcosis",
                      "Positive serum cryptococcal antigen result should prompt investigation for disseminated infection",
                      "Positive in essentially all patients with HIV infection and pulmonary cryptococcosis, and up to 84% of patients with other underlying immunocompromising conditions",
                      "Antigen titer generally correlates with burden of organisms",
                      "LimitationsFalse-positive results have been reported with serologic assays in cases of fungal infection due toTrichosporon asahii, and bacterial infections due toStomatococcusspp.orCapnocytophagaspp.False-negative results can occur due to low fungal burden or prozone effectMost serologic tests detect antigens present in capsule; therefore, tests may not be helpful in cases caused by capsule-deficient cryptococcalorganismsAssays do not allow distinction of differentCryptococcusspp.No role for monitoring serum cryptococcal antigen titers to determine duration of therapy in either immunosuppressed or immunocompetent hosts",
                      "False-positive results have been reported with serologic assays in cases of fungal infection due toTrichosporon asahii, and bacterial infections due toStomatococcusspp.orCapnocytophagaspp.",
                      "False-negative results can occur due to low fungal burden or prozone effect",
                      "Most serologic tests detect antigens present in capsule; therefore, tests may not be helpful in cases caused by capsule-deficient cryptococcalorganisms",
                      "Assays do not allow distinction of differentCryptococcusspp.",
                      "No role for monitoring serum cryptococcal antigen titers to determine duration of therapy in either immunosuppressed or immunocompetent hosts",
                      "CRAG lateral flow immunochromatographic assaySemiquantitativeCan be used as a rapid point-of-care test with CSF, serum and plasma samplesCompared with culture: 99.5% sensitivity and 98% specificity",
                      "Semiquantitative",
                      "Can be used as a rapid point-of-care test with CSF, serum and plasma samples",
                      "Compared with culture: 99.5% sensitivity and 98% specificity"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "CNS diseaseIn general: Induction therapy with amphotericin B plus flucytosine followed by consolidation and maintenance therapy with fluconazoleDosages and duration of treatments vary based on patient's immune status and clinical conditions",
                    "sub_points": [
                      "In general: Induction therapy with amphotericin B plus flucytosine followed by consolidation and maintenance therapy with fluconazole",
                      "Dosages and duration of treatments vary based on patient's immune status and clinical conditions"
                    ]
                  },
                  {
                    "text": "Nonmeningeal pulmonary diseaseGenerally treated with fluconazoleSevere pulmonary disease presenting with acute respiratory distress syndrome (ARDS) or extrapulmonary manifestations should be treated like CNS diseasePatients who have negative cultures and undetectable cryptococcal antigen titers may not require antifungal therapy",
                    "sub_points": [
                      "Generally treated with fluconazole",
                      "Severe pulmonary disease presenting with acute respiratory distress syndrome (ARDS) or extrapulmonary manifestations should be treated like CNS disease",
                      "Patients who have negative cultures and undetectable cryptococcal antigen titers may not require antifungal therapy"
                    ]
                  },
                  {
                    "text": "Nonmeningeal nonpulmonary diseaseSingle site: Generally treated with fluconazoleMultiple sites or high serum fungal titer: Treated like CNS disease",
                    "sub_points": [
                      "Single site: Generally treated with fluconazole",
                      "Multiple sites or high serum fungal titer: Treated like CNS disease"
                    ]
                  },
                  {
                    "text": "Surgery may be considered for large, accessible lesions with mass effect or for lesions not responding to antifungal therapies"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Untreated disseminated cryptococcal infection has a mortality rate of up to 100%"
                  },
                  {
                    "text": "ARDS is often associated with disseminated infection and high mortality"
                  },
                  {
                    "text": "High rate of extrapulmonary disease is seen among immunocompromised patients with cryptococcal pneumonia"
                  },
                  {
                    "text": "Cerebral cryptococcomas are associated with delayed or poor response to therapy and substantial neurologic sequelae"
                  }
                ]
              },
              "Image Findings": {
                "Radiographic Findings": [
                  {
                    "text": "ChestFeatures are variable and not specificMost common findings: Solitary or few well-defined nodules; cavitations within nodules/masses are more commonly seen in immunocompromised patientsOther findings: Lobar infiltrates, hilar and mediastinal adenopathy, and pleural effusions",
                    "sub_points": [
                      "Features are variable and not specific",
                      "Most common findings: Solitary or few well-defined nodules; cavitations within nodules/masses are more commonly seen in immunocompromised patients",
                      "Other findings: Lobar infiltrates, hilar and mediastinal adenopathy, and pleural effusions"
                    ]
                  },
                  {
                    "text": "BrainNo abnormality or cerebral atrophyMass lesions &/or hydrocephalus have been reported but are rareBrain mass lesions seen in HIV or immunocompromised patients should prompt consideration of alternative diagnoses, such as toxoplasmosis, lymphoma, tuberculosis",
                    "sub_points": [
                      "No abnormality or cerebral atrophy",
                      "Mass lesions &/or hydrocephalus have been reported but are rare",
                      "Brain mass lesions seen in HIV or immunocompromised patients should prompt consideration of alternative diagnoses, such as toxoplasmosis, lymphoma, tuberculosis"
                    ]
                  },
                  {
                    "text": "Cryptococcomas may mimic neoplasia or pyogenic abscesses"
                  }
                ]
              },
              "Microbiology": {
                "Culture": [
                  {
                    "text": "Sabouraud dextrose agar, bird seed agar, or creatinine dextrose bromothymol blue thymine (CDBT) agar (distinguishes cryptococcal species)Provides a definitive diagnosis and differentiates betweenC. neoformansandC. gattii",
                    "sub_points": [
                      "Provides a definitive diagnosis and differentiates betweenC. neoformansandC. gattii"
                    ]
                  },
                  {
                    "text": "C. neoformansandC. gattiiusually take 3-5 days to grow in culture"
                  },
                  {
                    "text": "Cultures are specific, but sensitivity can vary depending on sample and fungal load"
                  },
                  {
                    "text": "Blood, respiratory samples, CSF, and other body fluids can be collected for cultures"
                  }
                ]
              },
              "Macroscopic Features": {
                "Brain Lesions": [
                  {
                    "text": "In patients with severe immunosuppression and disseminated disease, classic \"soap bubble\" lesions with clear gelatinous capsule can be present dissecting through brain tissue without inflammation"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Encapsulated, spherical to oval yeast cells (5-10 μm in diameter) with narrow-based budding and polysaccharide capsule"
                  },
                  {
                    "text": "Yeast cells vary in size"
                  },
                  {
                    "text": "Organisms can be capsule deficient"
                  },
                  {
                    "text": "Immunocompetent patientsMixed suppurative and granulomatous reaction or just granulomatous reactionGranulomas and cryptococcomas can be seen in chronic pulmonary infection; organisms may be found inside macrophages and giant cellsGranulomatous inflammatory reaction may vary from abundant fibrosis to abundant necrosisPseudotumoral spindle cell reactions to cryptococcal organisms have been reported in rare cases",
                    "sub_points": [
                      "Mixed suppurative and granulomatous reaction or just granulomatous reaction",
                      "Granulomas and cryptococcomas can be seen in chronic pulmonary infection; organisms may be found inside macrophages and giant cells",
                      "Granulomatous inflammatory reaction may vary from abundant fibrosis to abundant necrosis",
                      "Pseudotumoral spindle cell reactions to cryptococcal organisms have been reported in rare cases"
                    ]
                  },
                  {
                    "text": "Immunocompromised patientsInflammatory reaction may be minimal or absentProliferation of organisms forms cyst-like gelatinous lesions packed with cryptococci that look like \"soap bubbles\" (most commonly seen in brain)",
                    "sub_points": [
                      "Inflammatory reaction may be minimal or absent",
                      "Proliferation of organisms forms cyst-like gelatinous lesions packed with cryptococci that look like \"soap bubbles\" (most commonly seen in brain)"
                    ]
                  },
                  {
                    "text": "Cases with autolysing human cells surrounded by capsule-like vacuolated spaces mimickingCryptococcusspp. in inflammatory infiltrate have been reported in patients with malignancies and immune dysregulationsSpecial stains and cultures are needed to rule out fungal infections in such cases",
                    "sub_points": [
                      "Special stains and cultures are needed to rule out fungal infections in such cases"
                    ]
                  },
                  {
                    "text": "DifferentCryptococcusspp. cannot be distinguished by histologic features"
                  }
                ]
              },
              "Ancillary Tests": {
                "Histochemistry": [
                  {
                    "text": "Yeast cells are positive by Gomori methenamine silver (GMS) and periodic acid-Schiff (PAS) stains and negative by Gram stain"
                  },
                  {
                    "text": "Fontana-Masson stain highlights melanin contained by yeast cells"
                  },
                  {
                    "text": "Mucicarmine and Alcian blue stain polysaccharide capsule, when present, of yeast cells"
                  }
                ],
                "Molecular Diagnostics": [
                  {
                    "text": "Molecular tests, such as DNA hybridization and PCR-based assays, are useful in cases when clinical isolates do not grow in culture or when distinction amongCryptococcusspp. is needed"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Candidiasis": [
                  {
                    "text": "Yeast forms ofCandidaspp. can be confused with capsule-deficient forms ofCryptococcusspp."
                  },
                  {
                    "text": "Positivity for Fontana-Masson stain differentiatesCryptococcusspp. fromCandidaspp."
                  },
                  {
                    "text": "Candidaspp.can be distinguished by positive Gram stain and presence of pseudohyphae"
                  },
                  {
                    "text": "Candidaspp.commonly elicits a pyogenic tissue reaction whileCryptococcusspp.generates a granulomatous or mixed suppurative granulomatous inflammation"
                  }
                ],
                "Histoplasmosis": [
                  {
                    "text": "Histoplasmaspp. can be mistaken with capsule-deficient forms ofCryptococcusspp."
                  },
                  {
                    "text": "Yeast cells ofCryptococcusspp.show a larger variety of sizes, whileHistoplasmayeast cells are more uniform in size"
                  },
                  {
                    "text": "Positive Fontana-Masson stain distinguishesCryptococcusspp.fromHistoplasmaspp.,as the latter are negative for melanin stains"
                  },
                  {
                    "text": "Encapsulated forms ofCryptococcusspp. can be differentiated fromHistoplasmaspp.by their capsular material, which stains with mucicarmine"
                  }
                ],
                "Blastomycosis": [
                  {
                    "text": "Mucicarmine stain can be positive for cell walls ofBlastomycesspp. and capsules of encapsulatedCryptococcusspp."
                  },
                  {
                    "text": "Blastomycesspp. are larger in size (8-15 µm in diameter) and usually exhibit broad-based budding whileCryptococcusspp. are generally smaller (5-10 µm in diameter) with narrow-based budding"
                  },
                  {
                    "text": "Cryptococcusspp. are positive for Fontana-Masson stain whileBlastomycesspp. are negative for melanin stains"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Most cases are seen in immunocompromised patients"
                  },
                  {
                    "text": "Clinical and radiographic presentations are nonspecific"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Encapsulated, spherical to oval yeast cells (5-10 μm in diameter) with narrow-based budding and polysaccharide capsule which stains with mucicarmine"
                  },
                  {
                    "text": "Yeast cells usually exhibit variability of sizes within microscopic field"
                  },
                  {
                    "text": "Capsule-deficient yeast forms can be present"
                  },
                  {
                    "text": "Yeast cells are positive for Fontana-Masson stain"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Entamebiasis": {
            "name": "Entamebiasis",
            "url": "https://app.pathprimer.com/document/f73c5921-c197-4a24-95df-efcd850e4e0a/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Entamoebacontains many species butE. histolytica(\"lyser of tissue\") is the only one associated with disease"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "E. histolyticais transmitted via ingestion of cystic form"
                  },
                  {
                    "text": "Dysentery (bloody diarrhea)"
                  },
                  {
                    "text": "Invasive extraintestinal disease"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "GastrointestinalMucosal thickening, multiple discrete ulcers separated by regions of normal-appearing colonic mucosaDiffusely inflamed and edematous mucosa, necrosis, or wall perforationFlask-shaped ulcer of amebic colitis",
                    "sub_points": [
                      "Mucosal thickening, multiple discrete ulcers separated by regions of normal-appearing colonic mucosa",
                      "Diffusely inflamed and edematous mucosa, necrosis, or wall perforation",
                      "Flask-shaped ulcer of amebic colitis"
                    ]
                  },
                  {
                    "text": "Disseminated diseaseAcellular abscess containing necrotic debris, trophozoites, and variable rimLiver abscess aspirate is usually thick, yellow-brown liquid classically referred to as \"anchovy paste\"Minimal inflammation may be present due to direct cell lysis by parasite",
                    "sub_points": [
                      "Acellular abscess containing necrotic debris, trophozoites, and variable rim",
                      "Liver abscess aspirate is usually thick, yellow-brown liquid classically referred to as \"anchovy paste\"",
                      "Minimal inflammation may be present due to direct cell lysis by parasite"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Gastrointestinal bloody diarrheaEscherichia coliShigellaspecies infectionsCampylobacterinfections",
                    "sub_points": [
                      "Escherichia coli",
                      "Shigellaspecies infections",
                      "Campylobacterinfections"
                    ]
                  },
                  {
                    "text": "Pyogenic bacterial hepatic abscesses"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Amebic dysentery"
                  },
                  {
                    "text": "Amebiasis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Latin: \"Ent\" (intestine, internal) + Greek: \"Amoiba\" (change, alteration)"
                  },
                  {
                    "text": "Latin: \"Histo\" (tissue) + \"lytica\" (lyses)"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Environmental Exposure": [
                  {
                    "text": "Poor sanitation and exposure to water contaminated with human fecesHumans are the only known reservoir forEntamoeba histolytica",
                    "sub_points": [
                      "Humans are the only known reservoir forEntamoeba histolytica"
                    ]
                  },
                  {
                    "text": "Fecal-oral and sexual transmission occursMen who have sex with men (MSM) have higher incidence than general population",
                    "sub_points": [
                      "Men who have sex with men (MSM) have higher incidence than general population"
                    ]
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "Entamoebacontains many species includingE. histolytica,Entamoeba dispar,Entamoeba moshkovskii,Entamoeba polecki,Entamoeba coli, andEntamoeba hartmanniEntamoeba histolytica(\"lyser of tissue\") is the only one associated with disease",
                    "sub_points": [
                      "Entamoeba histolytica(\"lyser of tissue\") is the only one associated with disease"
                    ]
                  },
                  {
                    "text": "Entamoebaare anaerobic, eukaryotic, parasitic protozoan"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "~ 50 million cases of invasiveE. histolyticadisease occur each year worldwide"
                  },
                  {
                    "text": "Commonly affects people in tropical areas with poor sanitary conditions"
                  },
                  {
                    "text": "Prevalence of amebiasis in United States is ~ 4%"
                  },
                  {
                    "text": "E. histolyticais transmitted via ingestion of cystic formExcystation then occurs in terminal ileum or colon, resulting in trophozoites",
                    "sub_points": [
                      "Excystation then occurs in terminal ileum or colon, resulting in trophozoites"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Dysentery (bloody diarrhea)"
                  },
                  {
                    "text": "Fulminant colitis"
                  },
                  {
                    "text": "Toxic megacolon"
                  },
                  {
                    "text": "Invasive extraintestinal diseaseLiver abscess, pleuropulmonary disease, pericarditis, brain abscess, peritonitis, and genitourinary disease",
                    "sub_points": [
                      "Liver abscess, pleuropulmonary disease, pericarditis, brain abscess, peritonitis, and genitourinary disease"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Asymptomatic amebiasis: Iodoquinol, paromomycin, or diloxanide furoate"
                  },
                  {
                    "text": "Amebic colitis: Nitroimidazole derivative, paromomycin"
                  },
                  {
                    "text": "Amebic liver abscess: Drainage or metronidazole"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Mortality is related to extent of dissemination and lack of treatment"
                  },
                  {
                    "text": "Toxic megacolon can present with bacteria sepsis with high mortality"
                  }
                ]
              },
              "Image Findings": {
                "Ultrasonographic Findings": [
                  {
                    "text": "To evaluate amebic liver abscess, which is solitary homogeneous, hypoechoic, round lesion"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Gastrointestinal diseaseMucosal thickening, multiple discrete ulcers separated by regions of normal-appearing colonic mucosaDiffuse inflammation and edematous mucosa, necrosis, or wall perforationFlask-shaped ulcer of amebic colitis",
                    "sub_points": [
                      "Mucosal thickening, multiple discrete ulcers separated by regions of normal-appearing colonic mucosa",
                      "Diffuse inflammation and edematous mucosa, necrosis, or wall perforation",
                      "Flask-shaped ulcer of amebic colitis"
                    ]
                  },
                  {
                    "text": "Disseminated diseaseAcellular abscess containing necrotic debris, trophozoites, and variable rimMinimal inflammation may be present due to direct cell lysis by parasite",
                    "sub_points": [
                      "Acellular abscess containing necrotic debris, trophozoites, and variable rim",
                      "Minimal inflammation may be present due to direct cell lysis by parasite"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Liver abscess aspirate is usually thick, yellow-brown liquid classically referred to as \"anchovy paste\""
                  },
                  {
                    "text": "Amebae may be rarely seen and no inflammatory cells are present in aspirate"
                  }
                ]
              },
              "Ancillary Tests": {
                "PCR": [
                  {
                    "text": "Performed on stool or tissue samples"
                  },
                  {
                    "text": "Wide variety of PCR-based methods targeting different genes, including 18S rDNA"
                  }
                ],
                "Serologic Testing": [
                  {
                    "text": "ELISA testing uses monoclonal antibodies against galactose/N-acetylgalactosamine (GAL/GalNAc), which is specific lectin ofEntamoeba histolyticawith up to 100% sensitivity and specificity"
                  },
                  {
                    "text": "Other ELISA kits use monoclonal antibodies against serine-rich antigen"
                  }
                ],
                "Stool Examination": [
                  {
                    "text": "Microscopic examination of fresh stool smears for trophozoites that contain ingested red blood cells"
                  },
                  {
                    "text": "3 stool samples over no more than 10 days can improve detection rate to 85-95%"
                  },
                  {
                    "text": "Stool examination cannot distinguishE. histolyticafrom nonpathogenicEntamoebadisparandEntamoebamoshkovskii"
                  }
                ],
                "Culture": [
                  {
                    "text": "Complex system not used for routine diagnosis with success rate of 50-70%"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Enteroinvasive or EnterohemorrhagicEscherichia coliInfections": [
                  {
                    "text": "Absence of parasites, positive stool cultures"
                  },
                  {
                    "text": "Negative ELISA and PCR forE. histolytica"
                  }
                ],
                "ShigellaSpecies Infections": [
                  {
                    "text": "Fecal leukocytes, which are absent or rare inE.histolytica"
                  },
                  {
                    "text": "Fresh blood  in stool"
                  }
                ],
                "Pyogenic Hepatic Abscesses": [
                  {
                    "text": "Microorganisms most commonly isolated from blood and abscess cultures includeE. coli,Bacteroidesspecies,Streptococcusspecies, and others"
                  },
                  {
                    "text": "Can be cryptogenic in 1/2 of cases (no cause)"
                  }
                ],
                "CampylobacterInfections": [
                  {
                    "text": "Positive Gram stain of stool samples for characteristic curved rods organisms"
                  },
                  {
                    "text": "ELISA or PCR are specific for detectingCampylobacter jejuni"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Giardiasis": {
            "name": "Giardiasis",
            "url": "https://app.pathprimer.com/document/5c31dc55-62bf-43ab-8d2c-73f044751842/lesson/6b8ab63e-cd9e-47cf-8ff4-d5c388b0f993",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Transmission by ingestion of cysts, which can occur from contaminated food and water"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Acute infection presents as diarrhea with steatorrhea, flatulence, abdominal pain, nausea, vomiting"
                  },
                  {
                    "text": "Chronic infection can lead to chronic steatorrhea and malabsorption with significant weight loss"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Organisms are purple to pink bodies with a tapered end on mucosa"
                  },
                  {
                    "text": "Cysts visible on fresh smear (saline suspension of feces)"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Consider giardiasis in setting of diarrhea with steatorrhea of > 1 week duration"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Beaver fever"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Infection by the protozoanGiardia lambliaNamed after French biologist Alfred M. Giard and after Czech physician Vilém Lambl",
                    "sub_points": [
                      "Named after French biologist Alfred M. Giard and after Czech physician Vilém Lambl"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Infectious Agents": [
                  {
                    "text": "G. lamblia: Protozoa found in water and stool of humans and animals"
                  },
                  {
                    "text": "Transmission by ingestion of cystsFecal-oral transmission: Contaminated food and water",
                    "sub_points": [
                      "Fecal-oral transmission: Contaminated food and water"
                    ]
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "Affects 2% of adults and 6-8% of children in developed countries"
                  },
                  {
                    "text": "Most common intestinal parasitic disease in USA20,000 cases reported per year, but true incidence likely much higher",
                    "sub_points": [
                      "20,000 cases reported per year, but true incidence likely much higher"
                    ]
                  },
                  {
                    "text": "1/3 of those in developing countries have been infected"
                  },
                  {
                    "text": "Rates of infection appear to increase during summer months in USA"
                  },
                  {
                    "text": "Some strains may infect both humans and animals, but transmission from animal to human is extremely rare"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Incubation period of 1-3 weeks between ingestion of cysts and onset of symptoms"
                  },
                  {
                    "text": "Those infected may remain asymptomatic but can shed the organism"
                  },
                  {
                    "text": "Acute infection presents as diarrhea with steatorrhea, flatulence, abdominal pain, nausea, vomitingSymptoms can last up to 4 weeks",
                    "sub_points": [
                      "Symptoms can last up to 4 weeks"
                    ]
                  },
                  {
                    "text": "Chronic infection can lead to chronic steatorrhea and malabsorption with significant weight loss"
                  },
                  {
                    "text": "Infected patients can shed 1-10 billion cysts daily in their feces, which can continue for several months"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Metronidazole"
                  },
                  {
                    "text": "Supportive treatment to maintain hydration"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Full recovery in vast majority of cases"
                  },
                  {
                    "text": "Poorer outcomes associated with severe infection in infants or immunocompromised"
                  }
                ],
                "Risk Factors": [
                  {
                    "text": "Travel to high-prevalence areas"
                  },
                  {
                    "text": "Child care settings"
                  },
                  {
                    "text": "Drinking fresh river or lake water"
                  },
                  {
                    "text": "Men who have sex with men"
                  }
                ]
              },
              "Microbiology": {
                "Parasite Features": [
                  {
                    "text": "2 main forms: Cysts and trophozoitesCysts are infectious and can survive in environment for prolonged periods of timeFollowing ingestion, trophozoites excyst in small intestine and attach to mucosal surface via ventral sucking diskTrophozoites re-encyst in large intestine and are shed as cysts, hence relatively low ratio of trophozoites to cysts in feces",
                    "sub_points": [
                      "Cysts are infectious and can survive in environment for prolonged periods of time",
                      "Following ingestion, trophozoites excyst in small intestine and attach to mucosal surface via ventral sucking disk",
                      "Trophozoites re-encyst in large intestine and are shed as cysts, hence relatively low ratio of trophozoites to cysts in feces"
                    ]
                  },
                  {
                    "text": "Trophozoites attach to duodenal and jejunal mucosal surface but do not invade mucosa"
                  },
                  {
                    "text": "Diarrhea is thought to result from a combination of malabsorption and hypersecretion in small intestine"
                  },
                  {
                    "text": "Cysts are oval (11-14 μm), contain 4 nuclei, 4 axonemes, and 4 median bodies"
                  },
                  {
                    "text": "Trophozoites are pear-shaped (10-20 μm), contain 2 nuclei, a sucking disk, 4 pairs of flagella, 2 axonemes, and 2 median bodies"
                  },
                  {
                    "text": "Can be subdivided into 7 distinct genetic assemblages (A-G) based on molecular characteristics"
                  },
                  {
                    "text": "Multiply by longitudinal binary fission"
                  },
                  {
                    "text": "As few as 10 cysts are sufficient to cause infection"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Organisms are seen on surface of mucosa as purple to pink bodies with a tapered end"
                  },
                  {
                    "text": "Changes in mucosa may be subtle to severe (depending on chronicity)Rarely see villous atrophyIncreased crypt depth with shortening of microvilliBiopsies are commonly done in cases of diarrhea to rule out other possible causes of symptoms",
                    "sub_points": [
                      "Rarely see villous atrophy",
                      "Increased crypt depth with shortening of microvilli",
                      "Biopsies are commonly done in cases of diarrhea to rule out other possible causes of symptoms"
                    ]
                  },
                  {
                    "text": "Trichrome stain will highlight organisms"
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunofluorescence": [
                  {
                    "text": "Direct fluorescent antibody testing of feces"
                  }
                ],
                "Stool Examination": [
                  {
                    "text": "Light microscopic exam for morphological detectionCysts &/or trophozoites are visible on fresh smear (saline suspension of feces)Formalin preparation for permanent staining",
                    "sub_points": [
                      "Cysts &/or trophozoites are visible on fresh smear (saline suspension of feces)",
                      "Formalin preparation for permanent staining"
                    ]
                  },
                  {
                    "text": "Enzyme-linked immunosorbent assay for antigen detection"
                  },
                  {
                    "text": "Immunochromatographic assay for antigen detection (rapid test)"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Infectious": [
                  {
                    "text": "Amebiasis, viral gastroenteritis, cryptosporidiosis, strongyloidiasisDifferentiate based on morphological ova and parasite examination of stool and antibody testing",
                    "sub_points": [
                      "Differentiate based on morphological ova and parasite examination of stool and antibody testing"
                    ]
                  }
                ],
                "Noninfectious": [
                  {
                    "text": "Irritable bowel syndrome lacks mucosal abnormalities on biopsy"
                  },
                  {
                    "text": "Celiac disease (severe villous atrophy, hyperplastic crypts, lymphocytic infiltrate, and plasma cells in lamina propria)"
                  },
                  {
                    "text": "Lactose intolerance (hydrogen breath test)"
                  },
                  {
                    "text": "Cystic fibrosis (chloride sweat test and genetic testing)"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Consider giardiasis in setting of diarrhea with steatorrhea of > 1 week duration"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      }
    }
  }
}